{"paragraphs":[{"title":"Import Clinical Trials (Rawdata)","text":"%pyspark\n\nrawdata = sc.textFile(\"/clinicaltrials.txt\")\n\nheader  = rawdata.take(1)\n\nprint \"\\r\\n\" + \"#\"*150\nprint \"\\r\\nTotal Number of Clinical Trials: \" + str(rawdata.count())\nprint \"Number of variables in dataset:  \" + str(len(header[0].split(\"|\")))\nprint header\nprint \"\\r\\n\" + \"#\"*150\n","dateUpdated":"2016-12-06T17:42:13+0000","config":{"colWidth":12,"editorMode":"ace/mode/scala","editorHide":false,"title":true,"graph":{"mode":"table","height":300,"optionOpen":false,"keys":[],"values":[],"groups":[],"scatter":{}},"enabled":true},"settings":{"params":{},"forms":{}},"jobName":"paragraph_1481045468648_-399130711","id":"20161204-131042_1856155362","result":{"code":"SUCCESS","type":"TEXT","msg":"\r\n######################################################################################################################################################\n\r\nTotal Number of Clinical Trials: 4681\nNumber of variables in dataset:  12\n[u'rank|status|study|conditions|interventions|study_type|phase|funder_type|outcome_measures|number_enrolled|nct_number|start_date']\n\r\n######################################################################################################################################################\n"},"dateCreated":"2016-12-06T17:31:08+0000","dateStarted":"2016-12-06T17:42:15+0000","dateFinished":"2016-12-06T17:42:24+0000","status":"FINISHED","progressUpdateIntervalMs":500,"$$hashKey":"object:2222"},{"title":"Format and Structure Dataframe","text":"%pyspark\n\ndf = rawdata.filter(lambda x: x not in header)      \\\n        .map(lambda x: x.split('|'))                \\\n        .toDF(header[0].split(\"|\"))\n\ndf.registerTempTable(\"table_df\")\ndf.cache()\n","dateUpdated":"2016-12-06T18:04:12+0000","config":{"colWidth":12,"editorMode":"ace/mode/scala","title":true,"graph":{"mode":"table","height":300,"optionOpen":false,"keys":[],"values":[],"groups":[],"scatter":{}},"enabled":true,"tableHide":true},"settings":{"params":{},"forms":{}},"jobName":"paragraph_1481045468649_-399515460","id":"20161204-132423_1796173164","result":{"code":"SUCCESS","type":"TEXT","msg":"DataFrame[rank: string, status: string, study: string, conditions: string, interventions: string, study_type: string, phase: string, funder_type: string, outcome_measures: string, number_enrolled: string, nct_number: string, start_date: string]\n"},"dateCreated":"2016-12-06T17:31:08+0000","status":"READY","errorMessage":"","progressUpdateIntervalMs":500,"$$hashKey":"object:2223"},{"title":"Explore Raw Clinical Data","text":"%sql\n\nselect * from table_df where study_type=\"${study_type=Interventional,Interventional|Observational|Expanded Access}\" and phase=\"${phase=Phase 0,Phase 0|Phase 1|Phase 2|Phase 3|Phase 4}\" limit 50","dateUpdated":"2016-12-06T17:31:08+0000","config":{"colWidth":12,"editorMode":"ace/mode/sql","editorHide":true,"title":true,"graph":{"mode":"table","height":300,"optionOpen":true,"keys":[{"name":"rank","index":0,"aggr":"sum"}],"values":[{"name":"status","index":1,"aggr":"sum"}],"groups":[],"scatter":{"xAxis":{"name":"rank","index":0,"aggr":"sum"},"yAxis":{"name":"status","index":1,"aggr":"sum"}}},"enabled":true},"settings":{"params":{"phase":"Phase 4","":"","study":"Diabetes","study in \"\"":"","study_type":"Interventional","study in":""},"forms":{"phase":{"name":"phase","defaultValue":"Phase 0","options":[{"value":"Phase 0","$$hashKey":"object:2813"},{"value":"Phase 1","$$hashKey":"object:2814"},{"value":"Phase 2","$$hashKey":"object:2815"},{"value":"Phase 3","$$hashKey":"object:2816"},{"value":"Phase 4","$$hashKey":"object:2817"}],"hidden":false},"study_type":{"name":"study_type","defaultValue":"Interventional","options":[{"value":"Interventional","$$hashKey":"object:2821"},{"value":"Observational","$$hashKey":"object:2822"},{"value":"Expanded Access","$$hashKey":"object:2823"}],"hidden":false}}},"jobName":"paragraph_1481045468650_-398361213","id":"20161204-132726_987647264","result":{"code":"SUCCESS","type":"TABLE","msg":"rank\tstatus\tstudy\tconditions\tinterventions\tstudy_type\tphase\tfunder_type\toutcome_measures\tnumber_enrolled\tnct_number\tstart_date\n21\tNot yet recruiting\tComparison of PIEB vs CEI for Labor Analgesia\t\tOther:ProgrammedIntermittentEpiduralBolus;  Other:ContinuousEpiduralInfusion;  Drug:Ropivacaine;  Drug:Fentanyl\tInterventional\tPhase 4\tOther\tVolume of local anesthetic received through Patient Controlled Epidural Analgesia (PCEA) per hour-computerized information;  Total required local anesthetic required per hour- computerized information;  Time to first patient controlled epidural analgesia (PCEA) bolus- computerized information;  Laborpainscores-patientquestionnaire;  Degree of motor blockade measured as lowest recorded modified Bromage score;  Modeofdelivery;  Patient controlled epidural analgesia (PCEA) attempts-computerized information;  Patient controlled epidural analgesia (PCEA) ratio of successful attempts to unsuccessful attempts - computerized information;  Frequencyofhypotension-physiologicalparameter;  Durationoffirstandsecondstagesoflabor;  Level of patient satisfaction- patient questionnaire\t120\tNCT02949271\tNovember 2016\n23\tNot yet recruiting\tOptimal Volume Rate and Interval of Bolus Nerve Catheters for Shoulder Surgery\t\tDrug:Ropivacaine\tInterventional\tPhase 4\tOther\tOptimal Volume of Ropivacaine 0.2% bolus via interscalene catheter;  Optimal Rate of Ropivacaine 0.2% administration bolus via interscalene cathter\t99\tNCT02946268\tNovember 2016\n33\tRecruiting\tAssessment of Infection Control Practice Efficiency and Health Economics of Sheathed Versus Standard Cystoscopy\t\tDevice:EndoSheathCST-5000Scope;  Device:OlympusViseraEliteOTV-S190Scope\tInterventional\tPhase 4\tOther / Industry\tTheChangeinBacteriuria\t60\tNCT02922868\tMarch 2016\n46\tRecruiting\tComparison of 1000 Hertz (Hz) Burst and Standard Spinal Cord Stimulation in Chronic Pain Relief\t\tDevice:Spinalcordstimulator\tInterventional\tPhase 4\tOther\tNPRS;  OswestryDisabilityIndex;  PatientsGlobalImpressionofChange;  PreferabilitySurvey\t22\tNCT02902796\tSeptember 2016\n59\tRecruiting\tSpironolactone After Liver Transplant\t\tDrug:Spironolactone\tInterventional\tPhase 4\tOther\tGFR\t36\tNCT02883400\tDecember 2014\n67\tRecruiting\tAccelerated Invisalign Therapy in Conjunction With Acceledent Aura\t\tDevice:AcceleDentAura;  Device:AcceleratedInvisaligntherapy\tInterventional\tPhase 4\tOther / Industry\tRate of orthodontic tooth movement [Little&apos;s Irregularity Index mm/day percent];  Activity of Bone Turnover Markers (BTMs) during Orthodontic Tooth Movement [Quantitative Polymerase Chain Reaction (qPCR) Cycle threshold values (Ct)];  Patient Discomfort [Visual Analog Scale in conjunction with Faces Pain Scale 1-10]\t30\tNCT02868554\tAugust 2016\n87\tRecruiting\tA Volumetric Analysis of Soft and Hard Tissue Healing for Ridge Preservation and Socket Seal After Tooth Extraction\t\tBiological:Xenograftbonesubstitute;  Biological:Collagendressing;  Biological:3D-collagenmatrix\tInterventional\tPhase 4\tOther / Industry\tThicknessofthebuccalplate;  Heightofthealveolarridge;  Softtissuevolume;  Bonevolume;  Woundhealingassessment\t24\tNCT02844569\tJuly 2016\n142\tRecruiting\tAnalgesic Benefit of PECS Blocks for Biceps Tenodesis Shoulder Surgery\t\tProcedure: Interscalene plus PECS &quot;Pectoralis&quot; 1 and 2 Blocks;  Procedure:InterscaleneplusShamBlock\tInterventional\tPhase 4\tOther\tPost-operativeAxillaryPain;  NumericalRatingScalePainScoresatrest;  NauseaorVomiting;  TotalOpioidUsage;  TimetoReturnofAxillaryPain\t40\tNCT02741713\tApril 2016\n149\tCompleted\tEfficacy and Tolerability of New Topical Formulations in Subjects With Atopic Dermatitis\t\tDrug:InvestigationalOTCCream;  Other:CosmeticEczemaCream;  Drug:0.05%DesonideCream;  Other:PlaceboCream\tInterventional\tPhase 4\tIndustry\tSCORAD(SeverityScoringofAtopicDermatitis)\t53\tNCT02732314\tMarch 2016\n151\tNot yet recruiting\tRejuvesol&#174; Washed RBC in Sickle Cell Patients Requiring Frequent Transfusions\t\tDrug:Rejuvesol;  Procedure:Bloodtransfusion\tInterventional\tPhase 4\tOther\tPercenthemoglobin(HbA)decrement;  Actual HbA decrement (g/dl) with indexing to calculated circulating blood volume;  Actual HbA decrement (g/dl) without indexing to calculated circulating blood volume;  ChangeinRBCmicroparticles(MP)counts;  ChangeinRBC/RBC-MP-mediatedthrombingeneration;  Changeinp50pre-andpost-transfusion\t4\tNCT02731157\tMay 2016\n160\tRecruiting\tComparison of Two Gingival Displacement Procedures\t\tDevice:AquasilUltraCordlessDentsply;  Device:UltrapakUltradentcord\tInterventional\tPhase 4\tOther\tPercentage of errors in impressions made for indirect restorations;  Timerequiredtomaketheimpression;  Patientdiscomfort\t60\tNCT02716727\tOctober 2016\n171\tRecruiting\tTACE and MWA Combination Therapy in Early-stage Hepatocellular Carcinoma\t\tProcedure:TransarterialChemoembolization;  Procedure:MicrowaveAblation\tInterventional\tPhase 4\tOther\tIntrahepaticdisease-freesurvival;  Overallsurvival;  Postoperativemorbidity;  Postoperativemortality\t100\tNCT02704130\tMarch 2016\n183\tRecruiting\tPredicting Understanding and Speeding Recovery After TKA\t\tDrug:Gabapentin;  Drug:Placebo\tInterventional\tPhase 4\tOther / NIH\tChanges in daily worst-pain score after discharge from hospital\t300\tNCT02685735\tFebruary 2016\n197\tRecruiting\tInternet Surveys and Their Impact on Adherence to Brimonidine Topical Gel and QOL in Patients With Rosacea\t\tOther:internetsurvey;  Drug:brimonidinetopicalgel0.33%\tInterventional\tPhase 4\tOther\tChange from baseline Disease severity measure: Clinician Erythema Assessment (CEA) to month 6.;  Change from baseline Disease severity measure: Patient Severity Assessment (PSA) to month 6.;  Change from baseline Disease severity measures: Investigator Visual Analogue Scale (VAS) to month 6.;  Change from baseline Disease severity measure: Lesion Count (Performed by investigator) to month 6.;  Change from baseline Subjective Symptom Improvement: Quality of Life Survey to month 6.;  Subject survey to identify factors that affect adherence to rosacea treatment\t20\tNCT02659670\tJanuary 2016\n219\tRecruiting\tBilateral Comparison of Treatment of Facial Actinic Keratoses Using Microneedling and Photodynamic Therapy With Aminolevulinic Acid and Blue Light Versus Photodynamic Therapy With Aminolevulinic Acid and Blue Light Using Two Incubation Times\t\tDrug:AminolevulinicAcid(ALA);  Device:EnvironCosmeticRoller;  Device:BLU-UIIlluminator\tInterventional\tPhase 4\tOther\tEfficacy-Percentage of treatment areas with &gt;75% reduction in lesion count as compared to baseline;  Efficacy-Percentage of treatment areas with 100% cure rate as compared to baseline\t10\tNCT02622594\tOctober 2015\n232\tRecruiting\tCelestone Versus Ketorolac Injection for the Treatment of DeQuervains Tenosyovitis\t\tDrug:Celestone;  Drug:Ketorolac\tInterventional\tPhase 4\tOther\tVisualanalogscaleofpainwithfinklesteintest;  Visual analog scale of pain with tenderness over tendon;  Visual analog scale of pain on radial side of wrist;  The Disabilities of the Arm Shoulder and Hand Score (DASH);  Veterans-Rand12(VR-12);  PinchStrength;  GripStrength\t64\tNCT02604537\tNovember 2015\n241\tActive not recruiting\tFoot and Ankle Clinic Application for Liposomal Related Anesthetic\t\tDrug:Exparel\tInterventional\tPhase 4\tOther / Industry\tAmountofNarcoticUse;  VisualAnalogScaleofpain(0-10);  Anti-emeticuse;  Patient Satisfaction Questionnaire regarding post surgical pain relief;  Complications\t36\tNCT02586077\tFebruary 2014\n261\tCompleted                  Has Results\tLazanda Fentanyl Nasal Spray Pre Radiofrequency Nerve Ablations(RFA) of Lumbar Facet Joints\t\tDrug:Lazanda\tInterventional\tPhase 4\tOther / Industry\tSafety and Tolerability as Measured by the Number of Adverse Events;  Pain Score Differences Using the DVPRS (Defense and Veterans Pain Rating Scale) Tool.;  Patient Satisfaction Using a Likert Satisfaction Survey;  AdverseEvents;  SedationLevelAssessedbyPOSSTool\t23\tNCT02571634\tMay 2015\n311\tRecruiting\tRejuvenated Washed Packed Red Blood Cells in Pediatric Cardiac Surgery\t\tDrug:Rejuvesol;  Procedure:Cardiacsurgery\tInterventional\tPhase 4\tOther\tChange in tissue oxygenation/perfusion during cardiac surgery measured by whole blood lactate concentration;  Change in ischemic organ injury during cardiac surgery measured by urinary neutrophil gelatinase associated lipocalin (NGAL);  Change in hemolysis during cardiac surgery as measured by plasma free hemoglobin levels\t15\tNCT02485366\tJune 2015\n324\tNot yet recruiting\tTolvaptan For Worsening Outpatient Heart Failure: Role of Copeptin In Identifying Responders\t\tDrug:tolvaptan;  Other:Placebo\tInterventional\tPhase 4\tOther\tChangeinbodyweightat48hours;  Changes in congestion (patient reported and investigator assessed);  Changeinbodyweightatday8;  Clinicalcompositeofmorbidity\t40\tNCT02476409\tJuly 2015\n338\tRecruiting\tSystemic Steroids for Peripheral Nerve Blocks\t\tDrug:Dexamethasone;  Drug:Bupivacaine;  Drug:Epinephrine;  Procedure:LumbarPlexusNerveBlock;  Drug:Saline\tInterventional\tPhase 4\tOther\tDurationofSensoryBlockade;  Timetofirstanalgesicrequest;  TotalOpioidConsumption;  VerbalNumericPainScoreComparisons\t115\tNCT02464176\tJune 2015\n341\tRecruiting\tPerineural Steroids for Peripheral Nerve Blocks\t\tDrug:Dexamethasone;  Drug:Bupivacaine;  Drug:Epinephrine;  Procedure:SaphenousPeripheralNerveBlock\tInterventional\tPhase 4\tOther\tDurationofSensoryNerveBlock;  VerbalPainScores;  RateofPostOperativeNauseaandVomiting;  NeurologicComplications;  PostOperativeOpioidUseandConsumption;  Timetofirstopioidanalgesicrequest\t115\tNCT02462148\tJuly 2015\n358\tWithdrawn\tPreoperative Antibiotic Dosing for Total Knee Arthroplasty\t\tDevice:NewIntraosseous;  Drug:Cefazolin\tInterventional\tPhase 4\tOther\trateofacutesurgicalsiteinfection;  correlation of clinical comorbidities to acute infection rates;  numberofcomplications;  tourniquettime;  bloodloss\t0\tNCT02433704\tMay 2015\n360\tCompleted\tEovist vs. Dotarem Healthy Volunteer MRI\t\tDrug:gadoxetatedisodium;  Drug:gadoteratedimeglumine;  Drug:Saline\tInterventional\tPhase 4\tOther\tSubject breath hold capacity as measured by number of seconds a subject can hold his/her breath;  Subject-reported dyspnea a measured by questionnaire;  ChangesinO2saturation;  Changesinpulserate;  Presence of motion artifacts at arterial phase imaging;  Severity of motion artifacts at arterial phase imaging measured on a 1-5 scale\t48\tNCT02431598\tJune 2015\n367\tRecruiting\tEfficacy of Ranolazine in Patients With Chronic Total Occlusions of Coronary Arteries\t\tDrug:Ranolazine;  Drug:Placebo\tInterventional\tPhase 4\tOther / Industry\tCardiacMRI(CMR)strain;  Dobutaminewallmotionscoringindex(WMSI);  QualityofLife/burdenofangina;  TreadmillECGexercisedistance;  Time to ECG changes (ST depression) on exercise ECG\t30\tNCT02423265\tJune 2015\n393\tRecruiting\tCilostazol After Lower Extremity Arterial Revascularization Trial\t\tDrug:Cilostazol\tInterventional\tPhase 4\tOther\tDifference in quality of life in relation to use of cilostazol after lower extremity revascularization;  Patency of the graft/stent and re intervention rate after initial procedure\t30\tNCT02374957\tFebruary 2015\n406\tRecruiting\tPerampanel in Seizure Patients With Primary Glial Brain Tumors\t\tDrug:Perampanel\tInterventional\tPhase 4\tOther\tPercentage of patients with &#8805;50% seizure reduction during the maintenance period compared with seizure frequency before initiation of perampanel;  Percentage of patients who experience a adverse event possibly probably or definitely attributable to perampanel treatment\t71\tNCT02363933\tFebruary 2015\n416\tRecruiting\tLiposomal Bupivacaine in Simultaneous Bilateral Total Knee Arthroplasty\t\tDrug:Liposomalbupivacaine\tInterventional\tPhase 4\tOther\tAdverseEvents;  Plasmabupivacainelevels\t15\tNCT02349542\tJanuary 2015\n457\tRecruiting\tIntravesicular Onabotulinumtoxin A in Interstitial Cystitis\t\tDrug:OnabotulinumtoxinA;  Procedure: injections upper aspect of trigone of urinary bladder;  Procedure: injections on posterior bladder wall excluding the trigone\tInterventional\tPhase 4\tOther / Industry\tThe primary outcome will be assessing change in a measurement of subjective patient pain using the Pelvic Pain and Urinary Urgency Frequency (PUF) questionnaire and the O&apos;Leary-Sant Symptom and Problem Indexes.;  Secondary outcomes will be assessing change in patient performance in uroflowmetry.\t40\tNCT02297100\tDecember 2014\n460\tCompleted\tThoracoabdominal Arortic CTA Study\t\tDrug:Isovue\tInterventional\tPhase 4\tOther\tRadiationdose;  Noise;  Signaltonoiseratio;  Hounsfieldunitattenuationvalues;  Contrasttonoiseratio\t150\tNCT02291718\tJanuary 2014\n461\tCompleted                  Has Results\tReducing Pain of Lidocaine Injection\t\tDrug:1%Lidocaine;  Drug:1%Lidocaineplussodiumbicarbonate\tInterventional\tPhase 4\tOther\tPain\t88\tNCT02288364\tDecember 2014\n469\tCompleted\tDexamethasone and Pain Following Total Knee Arthroplasty\t\tDrug:Dexamethasone;  Other:Placebo\tInterventional\tPhase 4\tOther\tChangeinVisualanaloguepainscore;  ChangeinOpioidconsumption;  ChangeinChronicPain;  ChangeinFunctionalstatus;  ChangeinInterleukin6and10levels;  ChangeinMacrophageproliferation\t45\tNCT02271698\tDecember 2014\n476\tCompleted                  Has Results\tHigh Frequency Stimulation Trials in Patients With Precision Spinal Cord Stimulator System\t\tOther:Highfrequencystimulation;  Other:Lowfrequencystimulation\tInterventional\tPhase 4\tOther\tNumericPainRatingScale(NPRS);  OswestryDisabilityIndexQuestionnaire(ODI).;  Patient&apos;sGlobalImpressionofChange(PGIC)\t22\tNCT02265848\tOctober 2014\n484\tRecruiting\tPerimenopausal Effects of Estradiol on Reward Responsiveness\t\tDrug:Estradiol;  Drug:Progesterone\tInterventional\tPhase 4\tOther / NIH\tChange in frontostriatal reactivity to reward during the MID fMRI task;  Change in neural connectivity measured during resting-state fMRI;  Change in response latency to reward versus non-reward during the MID fMRI task;  Change in Inventory of Depression and Anxiety Symptoms (IDAS) scores;  Change in the Positive and Negative Affect Schedule (PANAS);  Change in Mood and Anxiety Symptom Questionnaire--Anhedonic Depression subscale (MASQ-AD)\t50\tNCT02255175\tOctober 2015\n510\tRecruiting\tSurgery Prevention by Transforaminal Injection of Epidural Steroids for Cervical Radicular Pain\t\tDrug:Lidocaine;  Drug:LidocainewithDexamethasone\tInterventional\tPhase 4\tOther\tavoidanceofnecksurgery;  Disability;  Pain;  PatientSatisfaction\t60\tNCT02226159\tAugust 2014\n521\tCompleted\tThe Effect of Prophylactic Antipyretics on Immune Responses and Fever After 2014-2015 and 2015-2016 Inactivated Influenza Vaccine\t\tDrug:AcetaminophenArm;  Drug:PlaceboArm;  Drug:IbuprofenArm\tInterventional\tPhase 4\tOther / U.S. Fed\tSeroconversion;  Seroprotection;  GeometricmeanHAItiter\t104\tNCT02212990\tSeptember 2014\n536\tRecruiting\tMultimodal Analgesia vs. Routine Care Pain Management for Lumbar Spine Fusion Surgery: A Prospective Randomized Study\t\tOther:MultimodalAnalgesiaTreatment;  Other:StandardofCarePainManagementProtocol\tInterventional\tPhase 4\tOther\tPatient reported pain level using a verbal numeric pain scale (NPS);  Patientsatisfaction;  Narcoticconsumption;  Lengthofstay;  Dischargedestination;  OswestryDisabilityIndex(ODI);  TheVeteransRand12(VR-12)\t124\tNCT02202369\tFebruary 2015\n564\tRecruiting\tComparison of Combigan BID Versus Simbrinza TID\t\tDrug:CombiganBID;  Drug:SimbrinzaTID\tInterventional\tPhase 4\tOther / Industry\tIntraOcularPressure;  Tolerability\t40\tNCT02167035\tAugust 2014\n573\tSuspended\tEffect of a Multimodal Pain Regimen on Pain Control Patient Satisfaction and Narcotic Use in Orthopaedic Trauma Patients\t\tDrug:Gabapentin;  Drug:Acetaminophen;  Drug:Celecoxib;  Drug:Dexamethasone;  Drug:Oxycodone\tInterventional\tPhase 4\tOther\tPain;  NarcoticUse;  PatientSatisfaction;  Patientfunction;  FractureUnion;  Adverseevents\t160\tNCT02160301\tNovember 2017\n576\tRecruiting\tPain Expectations in Subjects With Osteoarthritis\t\tDrug:Modafinil;  Drug:Gabapentin;  Drug:Placebo\tInterventional\tPhase 4\tOther\tRestingpupildiameter\t30\tNCT02155257\tJuly 2014\n604\tRecruiting\tLNG-IUS at 2 Weeks Postpartum\t\tDrug: Levonorgestrel Intrauterine System (LNG-IUS)\tInterventional\tPhase 4\tOther\tTo report the acceptability of receiving an LNG-IUS two-weeks postpartum.;  To estimate the expulsion rate (complete or partial) at six months of LNG-IUS placed at two-weeks postpartum.;  To assess the pain experience of LNG-IUS insertion.\t50\tNCT02121067\tSeptember 2014\n606\tWithdrawn\tA Randomized Comparison of AmnioClear&#8482; Human Allograft Amniotic Membrane vs. Moist Wound Dressing in the Treatment of Diabetic Wounds\t\tBiological: AmnioClear&#8482; Human Allograft Amniotic Membrane\tInterventional\tPhase 4\tIndustry\tReductioninWoundSize\t0\tNCT02120755\t\n643\tCompleted\tEfficacy of Belatacept in Reducing DSA\t\tDrug:Belatacept\tInterventional\tPhase 4\tOther\tReductionofDonorSpecificAntibodies(DSA);  AssessingSafety\t3\tNCT02078193\tNovember 2013\n663\tRecruiting\tIntravenous Exenatide in Patients With Acute Brain Injury\t\tDrug:Exenatide\tInterventional\tPhase 4\tOther / Industry\tFeasibility defined as the proportion of patients 1) experiencing severe hypoglycemia (&lt;40 mg/dL); 2) achieving glucose measurements within goal (110-180 mg/dL); and 3) experiencing nausea requiring discontinuation of exenatide therapy;  Mean glucose concentration during exenatide infusion;  Number of glucose measurements within goal (110-180 mg/dL)/total number of glucose measurements;  Mean time to reach glucose measurements within goal (110-180 mg/dL);  Glycemic variability defined as the standard deviation of glucose;  Meaninsulinuse(units/kgbodyweight);  Proportion of subjects requiring rescue insulin infusion protocol;  Number of hypoglycemic episodes (&lt;80 mg/dL)/total number of glucose measurements;  Number of subjects with &gt;1 episode of hypoglycemia (&lt;80 mg/dL)/total number of subjects;  Proportion of patients experiencing metabolic crisis defined as cerebral microdialysate glucose concentration &lt;0.7 mmol/L in combination with lactate pyruvate ratio &gt;40;  Mean daily intracranial and cerebral perfusion pressures;  Number of hypotensive episodes (SBP&lt;100 mmHg)/total number of blood pressure measurements;  Proportion of patients experiencing serious adverse events;  Pharmacokinetics of exenatide infusion defined as the correlation of exenatide concentrations with creatinine clearance\t24\tNCT02058940\tAugust 2015\n670\tCompleted                  Has Results\tA Five Day Clinical Study to Examine the Effects of a Benzoyl Peroxide Treatment on Facial Acne Lesions\t\tDrug:3%BenzoylPeroxide;  Drug:3%BenzoylPeroxidePlacebo;  Drug:NeutrogenaRapidClear&#174;\tInterventional\tPhase 4\tIndustry\tTo Assess the Percentage Change in Acne Lesion Swelling (Height) of the Target Lesion for 3% Benzoyl Peroxide (BPO) Gel Test Product Relative to the Vehicle Gel After 4 Once-daily Applications.;  To Assess the Percentage Change in Acne Lesion Swelling (Height) for the 3% Benzoyl Peroxide Gel Test Product and Positive Control Relative to the Vehicle Gel.;  To Assess the Change in Acne Lesion Redness (Erythema) for the 3% BPO Gel Test Product and Positive Control Relative to the Vehicle Gel.;  To Assess the Percentage Change in Acne Lesion Diameter (Size) for the 3% BPO Gel Test Product and Positive Control Relative to the Vehicle Gel.;  To Assess the Change in Facial Skin Clarity for the 3% BPO Gel Test Product and Positive Control Relative to the Vehicle Gel;  To Assess the Change in Perceptions of the Overall Appearance of Their Skin for the 3% BPO Gel Test Product and Positive Control Relative to the Vehicle Gel\t90\tNCT02052752\tFebruary 2014\n693\tRecruiting\tTXA vs. Amicar in Total Knee and Hip Arthroplasty\t\tDrug:Amicar;  Drug:TXA\tInterventional\tPhase 4\tOther\tBloodLoss;  NumberofTransfusions;  Preoperative and lowest postoperative hematocrit and hemoglobin;  Lengthofhospitalizationstay;  CostofHospitalization\t400\tNCT02030821\tJanuary 2015\n700\tRecruiting\tPhenylephrine Versus Ephedrine in Pre-eclampsia\t\tDrug:Phenylephrine;  Drug:Ephedrine\tInterventional\tPhase 4\tOther\tCerebraltissueoxygensaturation;  Cardiacoutput\t40\tNCT02025426\tSeptember 2012\n702\tCompleted\tEfficacy Study of Riociguat and Its Effects on Exercise Performance and Pulmonary Artery Pressure at High Altitude\t\tDrug:Riociguat\tInterventional\tPhase 4\tOther\tChangefromBaselineinPulmonaryArteryPressure;  ChangefromBaselineinRadialArterialPressure;  Change from Baseline in Arterial Oxygen Saturation (PaO2);  ChangefromBaselineinVentilationRate;  ChangefromBaselineinWorkRateatExhaustion;  ChangefromBaselineinCardiacOutput\t28\tNCT02024386\tJanuary 2014\n720\tRecruiting\tBone Marrow Aspirate Concentrate (BMAC) Supplementation for Osteochondral Lesions\t\tProcedure: ankle arthroscopy with debridement and microfracture of the OLT;  Other:BoneMarrowAspirateinjection\tInterventional\tPhase 4\tOther\tChangeinPainAssessment;  ChangeinFunctionalAssessment;  MRIAssessment\t30\tNCT02011295\tDecember 2013\n731\tCompleted\tThe Role of Estrogen in Luteinizing Hormone Surge and Ovulation\t\tDrug:Letrozole\tInterventional\tPhase 4\tOther\tIncreaseinProgesteronelevel;  ChangeinLHlevel;  FollicularDevelopment\t10\tNCT01999569\tApril 2007\n","comment":"","msgTable":[[{"key":"status","value":"21"},{"key":"status","value":"Not yet recruiting"},{"key":"status","value":"Comparison of PIEB vs CEI for Labor Analgesia"},{"key":"status","value":""},{"key":"status","value":"Other:ProgrammedIntermittentEpiduralBolus;  Other:ContinuousEpiduralInfusion;  Drug:Ropivacaine;  Drug:Fentanyl"},{"key":"status","value":"Interventional"},{"key":"status","value":"Phase 4"},{"key":"status","value":"Other"},{"key":"status","value":"Volume of local anesthetic received through Patient Controlled Epidural Analgesia (PCEA) per hour-computerized information;  Total required local anesthetic required per hour- computerized information;  Time to first patient controlled epidural analgesia (PCEA) bolus- computerized information;  Laborpainscores-patientquestionnaire;  Degree of motor blockade measured as lowest recorded modified Bromage score;  Modeofdelivery;  Patient controlled epidural analgesia (PCEA) attempts-computerized information;  Patient controlled epidural analgesia (PCEA) ratio of successful attempts to unsuccessful attempts - computerized information;  Frequencyofhypotension-physiologicalparameter;  Durationoffirstandsecondstagesoflabor;  Level of patient satisfaction- patient questionnaire"},{"key":"status","value":"120"},{"key":"status","value":"NCT02949271"},{"key":"status","value":"November 2016"}],[{"key":"study","value":"23"},{"key":"study","value":"Not yet recruiting"},{"key":"study","value":"Optimal Volume Rate and Interval of Bolus Nerve Catheters for Shoulder Surgery"},{"key":"study","value":""},{"key":"study","value":"Drug:Ropivacaine"},{"key":"study","value":"Interventional"},{"key":"study","value":"Phase 4"},{"key":"study","value":"Other"},{"key":"study","value":"Optimal Volume of Ropivacaine 0.2% bolus via interscalene catheter;  Optimal Rate of Ropivacaine 0.2% administration bolus via interscalene cathter"},{"key":"study","value":"99"},{"key":"study","value":"NCT02946268"},{"key":"study","value":"November 2016"}],[{"key":"conditions","value":"33"},{"key":"conditions","value":"Recruiting"},{"key":"conditions","value":"Assessment of Infection Control Practice Efficiency and Health Economics of Sheathed Versus Standard Cystoscopy"},{"key":"conditions","value":""},{"key":"conditions","value":"Device:EndoSheathCST-5000Scope;  Device:OlympusViseraEliteOTV-S190Scope"},{"key":"conditions","value":"Interventional"},{"key":"conditions","value":"Phase 4"},{"key":"conditions","value":"Other / Industry"},{"key":"conditions","value":"TheChangeinBacteriuria"},{"key":"conditions","value":"60"},{"key":"conditions","value":"NCT02922868"},{"key":"conditions","value":"March 2016"}],[{"key":"interventions","value":"46"},{"key":"interventions","value":"Recruiting"},{"key":"interventions","value":"Comparison of 1000 Hertz (Hz) Burst and Standard Spinal Cord Stimulation in Chronic Pain Relief"},{"key":"interventions","value":""},{"key":"interventions","value":"Device:Spinalcordstimulator"},{"key":"interventions","value":"Interventional"},{"key":"interventions","value":"Phase 4"},{"key":"interventions","value":"Other"},{"key":"interventions","value":"NPRS;  OswestryDisabilityIndex;  PatientsGlobalImpressionofChange;  PreferabilitySurvey"},{"key":"interventions","value":"22"},{"key":"interventions","value":"NCT02902796"},{"key":"interventions","value":"September 2016"}],[{"key":"study_type","value":"59"},{"key":"study_type","value":"Recruiting"},{"key":"study_type","value":"Spironolactone After Liver Transplant"},{"key":"study_type","value":""},{"key":"study_type","value":"Drug:Spironolactone"},{"key":"study_type","value":"Interventional"},{"key":"study_type","value":"Phase 4"},{"key":"study_type","value":"Other"},{"key":"study_type","value":"GFR"},{"key":"study_type","value":"36"},{"key":"study_type","value":"NCT02883400"},{"key":"study_type","value":"December 2014"}],[{"key":"phase","value":"67"},{"key":"phase","value":"Recruiting"},{"key":"phase","value":"Accelerated Invisalign Therapy in Conjunction With Acceledent Aura"},{"key":"phase","value":""},{"key":"phase","value":"Device:AcceleDentAura;  Device:AcceleratedInvisaligntherapy"},{"key":"phase","value":"Interventional"},{"key":"phase","value":"Phase 4"},{"key":"phase","value":"Other / Industry"},{"key":"phase","value":"Rate of orthodontic tooth movement [Little&apos;s Irregularity Index mm/day percent];  Activity of Bone Turnover Markers (BTMs) during Orthodontic Tooth Movement [Quantitative Polymerase Chain Reaction (qPCR) Cycle threshold values (Ct)];  Patient Discomfort [Visual Analog Scale in conjunction with Faces Pain Scale 1-10]"},{"key":"phase","value":"30"},{"key":"phase","value":"NCT02868554"},{"key":"phase","value":"August 2016"}],[{"key":"funder_type","value":"87"},{"key":"funder_type","value":"Recruiting"},{"key":"funder_type","value":"A Volumetric Analysis of Soft and Hard Tissue Healing for Ridge Preservation and Socket Seal After Tooth Extraction"},{"key":"funder_type","value":""},{"key":"funder_type","value":"Biological:Xenograftbonesubstitute;  Biological:Collagendressing;  Biological:3D-collagenmatrix"},{"key":"funder_type","value":"Interventional"},{"key":"funder_type","value":"Phase 4"},{"key":"funder_type","value":"Other / Industry"},{"key":"funder_type","value":"Thicknessofthebuccalplate;  Heightofthealveolarridge;  Softtissuevolume;  Bonevolume;  Woundhealingassessment"},{"key":"funder_type","value":"24"},{"key":"funder_type","value":"NCT02844569"},{"key":"funder_type","value":"July 2016"}],[{"key":"outcome_measures","value":"142"},{"key":"outcome_measures","value":"Recruiting"},{"key":"outcome_measures","value":"Analgesic Benefit of PECS Blocks for Biceps Tenodesis Shoulder Surgery"},{"key":"outcome_measures","value":""},{"key":"outcome_measures","value":"Procedure: Interscalene plus PECS &quot;Pectoralis&quot; 1 and 2 Blocks;  Procedure:InterscaleneplusShamBlock"},{"key":"outcome_measures","value":"Interventional"},{"key":"outcome_measures","value":"Phase 4"},{"key":"outcome_measures","value":"Other"},{"key":"outcome_measures","value":"Post-operativeAxillaryPain;  NumericalRatingScalePainScoresatrest;  NauseaorVomiting;  TotalOpioidUsage;  TimetoReturnofAxillaryPain"},{"key":"outcome_measures","value":"40"},{"key":"outcome_measures","value":"NCT02741713"},{"key":"outcome_measures","value":"April 2016"}],[{"key":"number_enrolled","value":"149"},{"key":"number_enrolled","value":"Completed"},{"key":"number_enrolled","value":"Efficacy and Tolerability of New Topical Formulations in Subjects With Atopic Dermatitis"},{"key":"number_enrolled","value":""},{"key":"number_enrolled","value":"Drug:InvestigationalOTCCream;  Other:CosmeticEczemaCream;  Drug:0.05%DesonideCream;  Other:PlaceboCream"},{"key":"number_enrolled","value":"Interventional"},{"key":"number_enrolled","value":"Phase 4"},{"key":"number_enrolled","value":"Industry"},{"key":"number_enrolled","value":"SCORAD(SeverityScoringofAtopicDermatitis)"},{"key":"number_enrolled","value":"53"},{"key":"number_enrolled","value":"NCT02732314"},{"key":"number_enrolled","value":"March 2016"}],[{"key":"nct_number","value":"151"},{"key":"nct_number","value":"Not yet recruiting"},{"key":"nct_number","value":"Rejuvesol&#174; Washed RBC in Sickle Cell Patients Requiring Frequent Transfusions"},{"key":"nct_number","value":""},{"key":"nct_number","value":"Drug:Rejuvesol;  Procedure:Bloodtransfusion"},{"key":"nct_number","value":"Interventional"},{"key":"nct_number","value":"Phase 4"},{"key":"nct_number","value":"Other"},{"key":"nct_number","value":"Percenthemoglobin(HbA)decrement;  Actual HbA decrement (g/dl) with indexing to calculated circulating blood volume;  Actual HbA decrement (g/dl) without indexing to calculated circulating blood volume;  ChangeinRBCmicroparticles(MP)counts;  ChangeinRBC/RBC-MP-mediatedthrombingeneration;  Changeinp50pre-andpost-transfusion"},{"key":"nct_number","value":"4"},{"key":"nct_number","value":"NCT02731157"},{"key":"nct_number","value":"May 2016"}],[{"key":"start_date","value":"160"},{"key":"start_date","value":"Recruiting"},{"key":"start_date","value":"Comparison of Two Gingival Displacement Procedures"},{"key":"start_date","value":""},{"key":"start_date","value":"Device:AquasilUltraCordlessDentsply;  Device:UltrapakUltradentcord"},{"key":"start_date","value":"Interventional"},{"key":"start_date","value":"Phase 4"},{"key":"start_date","value":"Other"},{"key":"start_date","value":"Percentage of errors in impressions made for indirect restorations;  Timerequiredtomaketheimpression;  Patientdiscomfort"},{"key":"start_date","value":"60"},{"key":"start_date","value":"NCT02716727"},{"key":"start_date","value":"October 2016"}],[{"value":"171"},{"value":"Recruiting"},{"value":"TACE and MWA Combination Therapy in Early-stage Hepatocellular Carcinoma"},{"value":""},{"value":"Procedure:TransarterialChemoembolization;  Procedure:MicrowaveAblation"},{"value":"Interventional"},{"value":"Phase 4"},{"value":"Other"},{"value":"Intrahepaticdisease-freesurvival;  Overallsurvival;  Postoperativemorbidity;  Postoperativemortality"},{"value":"100"},{"value":"NCT02704130"},{"value":"March 2016"}],[{"value":"183"},{"value":"Recruiting"},{"value":"Predicting Understanding and Speeding Recovery After TKA"},{"value":""},{"value":"Drug:Gabapentin;  Drug:Placebo"},{"value":"Interventional"},{"value":"Phase 4"},{"value":"Other / NIH"},{"value":"Changes in daily worst-pain score after discharge from hospital"},{"value":"300"},{"value":"NCT02685735"},{"value":"February 2016"}],[{"value":"197"},{"value":"Recruiting"},{"value":"Internet Surveys and Their Impact on Adherence to Brimonidine Topical Gel and QOL in Patients With Rosacea"},{"value":""},{"value":"Other:internetsurvey;  Drug:brimonidinetopicalgel0.33%"},{"value":"Interventional"},{"value":"Phase 4"},{"value":"Other"},{"value":"Change from baseline Disease severity measure: Clinician Erythema Assessment (CEA) to month 6.;  Change from baseline Disease severity measure: Patient Severity Assessment (PSA) to month 6.;  Change from baseline Disease severity measures: Investigator Visual Analogue Scale (VAS) to month 6.;  Change from baseline Disease severity measure: Lesion Count (Performed by investigator) to month 6.;  Change from baseline Subjective Symptom Improvement: Quality of Life Survey to month 6.;  Subject survey to identify factors that affect adherence to rosacea treatment"},{"value":"20"},{"value":"NCT02659670"},{"value":"January 2016"}],[{"value":"219"},{"value":"Recruiting"},{"value":"Bilateral Comparison of Treatment of Facial Actinic Keratoses Using Microneedling and Photodynamic Therapy With Aminolevulinic Acid and Blue Light Versus Photodynamic Therapy With Aminolevulinic Acid and Blue Light Using Two Incubation Times"},{"value":""},{"value":"Drug:AminolevulinicAcid(ALA);  Device:EnvironCosmeticRoller;  Device:BLU-UIIlluminator"},{"value":"Interventional"},{"value":"Phase 4"},{"value":"Other"},{"value":"Efficacy-Percentage of treatment areas with &gt;75% reduction in lesion count as compared to baseline;  Efficacy-Percentage of treatment areas with 100% cure rate as compared to baseline"},{"value":"10"},{"value":"NCT02622594"},{"value":"October 2015"}],[{"value":"232"},{"value":"Recruiting"},{"value":"Celestone Versus Ketorolac Injection for the Treatment of DeQuervains Tenosyovitis"},{"value":""},{"value":"Drug:Celestone;  Drug:Ketorolac"},{"value":"Interventional"},{"value":"Phase 4"},{"value":"Other"},{"value":"Visualanalogscaleofpainwithfinklesteintest;  Visual analog scale of pain with tenderness over tendon;  Visual analog scale of pain on radial side of wrist;  The Disabilities of the Arm Shoulder and Hand Score (DASH);  Veterans-Rand12(VR-12);  PinchStrength;  GripStrength"},{"value":"64"},{"value":"NCT02604537"},{"value":"November 2015"}],[{"value":"241"},{"value":"Active not recruiting"},{"value":"Foot and Ankle Clinic Application for Liposomal Related Anesthetic"},{"value":""},{"value":"Drug:Exparel"},{"value":"Interventional"},{"value":"Phase 4"},{"value":"Other / Industry"},{"value":"AmountofNarcoticUse;  VisualAnalogScaleofpain(0-10);  Anti-emeticuse;  Patient Satisfaction Questionnaire regarding post surgical pain relief;  Complications"},{"value":"36"},{"value":"NCT02586077"},{"value":"February 2014"}],[{"value":"261"},{"value":"Completed                  Has Results"},{"value":"Lazanda Fentanyl Nasal Spray Pre Radiofrequency Nerve Ablations(RFA) of Lumbar Facet Joints"},{"value":""},{"value":"Drug:Lazanda"},{"value":"Interventional"},{"value":"Phase 4"},{"value":"Other / Industry"},{"value":"Safety and Tolerability as Measured by the Number of Adverse Events;  Pain Score Differences Using the DVPRS (Defense and Veterans Pain Rating Scale) Tool.;  Patient Satisfaction Using a Likert Satisfaction Survey;  AdverseEvents;  SedationLevelAssessedbyPOSSTool"},{"value":"23"},{"value":"NCT02571634"},{"value":"May 2015"}],[{"value":"311"},{"value":"Recruiting"},{"value":"Rejuvenated Washed Packed Red Blood Cells in Pediatric Cardiac Surgery"},{"value":""},{"value":"Drug:Rejuvesol;  Procedure:Cardiacsurgery"},{"value":"Interventional"},{"value":"Phase 4"},{"value":"Other"},{"value":"Change in tissue oxygenation/perfusion during cardiac surgery measured by whole blood lactate concentration;  Change in ischemic organ injury during cardiac surgery measured by urinary neutrophil gelatinase associated lipocalin (NGAL);  Change in hemolysis during cardiac surgery as measured by plasma free hemoglobin levels"},{"value":"15"},{"value":"NCT02485366"},{"value":"June 2015"}],[{"value":"324"},{"value":"Not yet recruiting"},{"value":"Tolvaptan For Worsening Outpatient Heart Failure: Role of Copeptin In Identifying Responders"},{"value":""},{"value":"Drug:tolvaptan;  Other:Placebo"},{"value":"Interventional"},{"value":"Phase 4"},{"value":"Other"},{"value":"Changeinbodyweightat48hours;  Changes in congestion (patient reported and investigator assessed);  Changeinbodyweightatday8;  Clinicalcompositeofmorbidity"},{"value":"40"},{"value":"NCT02476409"},{"value":"July 2015"}],[{"value":"338"},{"value":"Recruiting"},{"value":"Systemic Steroids for Peripheral Nerve Blocks"},{"value":""},{"value":"Drug:Dexamethasone;  Drug:Bupivacaine;  Drug:Epinephrine;  Procedure:LumbarPlexusNerveBlock;  Drug:Saline"},{"value":"Interventional"},{"value":"Phase 4"},{"value":"Other"},{"value":"DurationofSensoryBlockade;  Timetofirstanalgesicrequest;  TotalOpioidConsumption;  VerbalNumericPainScoreComparisons"},{"value":"115"},{"value":"NCT02464176"},{"value":"June 2015"}],[{"value":"341"},{"value":"Recruiting"},{"value":"Perineural Steroids for Peripheral Nerve Blocks"},{"value":""},{"value":"Drug:Dexamethasone;  Drug:Bupivacaine;  Drug:Epinephrine;  Procedure:SaphenousPeripheralNerveBlock"},{"value":"Interventional"},{"value":"Phase 4"},{"value":"Other"},{"value":"DurationofSensoryNerveBlock;  VerbalPainScores;  RateofPostOperativeNauseaandVomiting;  NeurologicComplications;  PostOperativeOpioidUseandConsumption;  Timetofirstopioidanalgesicrequest"},{"value":"115"},{"value":"NCT02462148"},{"value":"July 2015"}],[{"value":"358"},{"value":"Withdrawn"},{"value":"Preoperative Antibiotic Dosing for Total Knee Arthroplasty"},{"value":""},{"value":"Device:NewIntraosseous;  Drug:Cefazolin"},{"value":"Interventional"},{"value":"Phase 4"},{"value":"Other"},{"value":"rateofacutesurgicalsiteinfection;  correlation of clinical comorbidities to acute infection rates;  numberofcomplications;  tourniquettime;  bloodloss"},{"value":"0"},{"value":"NCT02433704"},{"value":"May 2015"}],[{"value":"360"},{"value":"Completed"},{"value":"Eovist vs. Dotarem Healthy Volunteer MRI"},{"value":""},{"value":"Drug:gadoxetatedisodium;  Drug:gadoteratedimeglumine;  Drug:Saline"},{"value":"Interventional"},{"value":"Phase 4"},{"value":"Other"},{"value":"Subject breath hold capacity as measured by number of seconds a subject can hold his/her breath;  Subject-reported dyspnea a measured by questionnaire;  ChangesinO2saturation;  Changesinpulserate;  Presence of motion artifacts at arterial phase imaging;  Severity of motion artifacts at arterial phase imaging measured on a 1-5 scale"},{"value":"48"},{"value":"NCT02431598"},{"value":"June 2015"}],[{"value":"367"},{"value":"Recruiting"},{"value":"Efficacy of Ranolazine in Patients With Chronic Total Occlusions of Coronary Arteries"},{"value":""},{"value":"Drug:Ranolazine;  Drug:Placebo"},{"value":"Interventional"},{"value":"Phase 4"},{"value":"Other / Industry"},{"value":"CardiacMRI(CMR)strain;  Dobutaminewallmotionscoringindex(WMSI);  QualityofLife/burdenofangina;  TreadmillECGexercisedistance;  Time to ECG changes (ST depression) on exercise ECG"},{"value":"30"},{"value":"NCT02423265"},{"value":"June 2015"}],[{"value":"393"},{"value":"Recruiting"},{"value":"Cilostazol After Lower Extremity Arterial Revascularization Trial"},{"value":""},{"value":"Drug:Cilostazol"},{"value":"Interventional"},{"value":"Phase 4"},{"value":"Other"},{"value":"Difference in quality of life in relation to use of cilostazol after lower extremity revascularization;  Patency of the graft/stent and re intervention rate after initial procedure"},{"value":"30"},{"value":"NCT02374957"},{"value":"February 2015"}],[{"value":"406"},{"value":"Recruiting"},{"value":"Perampanel in Seizure Patients With Primary Glial Brain Tumors"},{"value":""},{"value":"Drug:Perampanel"},{"value":"Interventional"},{"value":"Phase 4"},{"value":"Other"},{"value":"Percentage of patients with &#8805;50% seizure reduction during the maintenance period compared with seizure frequency before initiation of perampanel;  Percentage of patients who experience a adverse event possibly probably or definitely attributable to perampanel treatment"},{"value":"71"},{"value":"NCT02363933"},{"value":"February 2015"}],[{"value":"416"},{"value":"Recruiting"},{"value":"Liposomal Bupivacaine in Simultaneous Bilateral Total Knee Arthroplasty"},{"value":""},{"value":"Drug:Liposomalbupivacaine"},{"value":"Interventional"},{"value":"Phase 4"},{"value":"Other"},{"value":"AdverseEvents;  Plasmabupivacainelevels"},{"value":"15"},{"value":"NCT02349542"},{"value":"January 2015"}],[{"value":"457"},{"value":"Recruiting"},{"value":"Intravesicular Onabotulinumtoxin A in Interstitial Cystitis"},{"value":""},{"value":"Drug:OnabotulinumtoxinA;  Procedure: injections upper aspect of trigone of urinary bladder;  Procedure: injections on posterior bladder wall excluding the trigone"},{"value":"Interventional"},{"value":"Phase 4"},{"value":"Other / Industry"},{"value":"The primary outcome will be assessing change in a measurement of subjective patient pain using the Pelvic Pain and Urinary Urgency Frequency (PUF) questionnaire and the O&apos;Leary-Sant Symptom and Problem Indexes.;  Secondary outcomes will be assessing change in patient performance in uroflowmetry."},{"value":"40"},{"value":"NCT02297100"},{"value":"December 2014"}],[{"value":"460"},{"value":"Completed"},{"value":"Thoracoabdominal Arortic CTA Study"},{"value":""},{"value":"Drug:Isovue"},{"value":"Interventional"},{"value":"Phase 4"},{"value":"Other"},{"value":"Radiationdose;  Noise;  Signaltonoiseratio;  Hounsfieldunitattenuationvalues;  Contrasttonoiseratio"},{"value":"150"},{"value":"NCT02291718"},{"value":"January 2014"}],[{"value":"461"},{"value":"Completed                  Has Results"},{"value":"Reducing Pain of Lidocaine Injection"},{"value":""},{"value":"Drug:1%Lidocaine;  Drug:1%Lidocaineplussodiumbicarbonate"},{"value":"Interventional"},{"value":"Phase 4"},{"value":"Other"},{"value":"Pain"},{"value":"88"},{"value":"NCT02288364"},{"value":"December 2014"}],[{"value":"469"},{"value":"Completed"},{"value":"Dexamethasone and Pain Following Total Knee Arthroplasty"},{"value":""},{"value":"Drug:Dexamethasone;  Other:Placebo"},{"value":"Interventional"},{"value":"Phase 4"},{"value":"Other"},{"value":"ChangeinVisualanaloguepainscore;  ChangeinOpioidconsumption;  ChangeinChronicPain;  ChangeinFunctionalstatus;  ChangeinInterleukin6and10levels;  ChangeinMacrophageproliferation"},{"value":"45"},{"value":"NCT02271698"},{"value":"December 2014"}],[{"value":"476"},{"value":"Completed                  Has Results"},{"value":"High Frequency Stimulation Trials in Patients With Precision Spinal Cord Stimulator System"},{"value":""},{"value":"Other:Highfrequencystimulation;  Other:Lowfrequencystimulation"},{"value":"Interventional"},{"value":"Phase 4"},{"value":"Other"},{"value":"NumericPainRatingScale(NPRS);  OswestryDisabilityIndexQuestionnaire(ODI).;  Patient&apos;sGlobalImpressionofChange(PGIC)"},{"value":"22"},{"value":"NCT02265848"},{"value":"October 2014"}],[{"value":"484"},{"value":"Recruiting"},{"value":"Perimenopausal Effects of Estradiol on Reward Responsiveness"},{"value":""},{"value":"Drug:Estradiol;  Drug:Progesterone"},{"value":"Interventional"},{"value":"Phase 4"},{"value":"Other / NIH"},{"value":"Change in frontostriatal reactivity to reward during the MID fMRI task;  Change in neural connectivity measured during resting-state fMRI;  Change in response latency to reward versus non-reward during the MID fMRI task;  Change in Inventory of Depression and Anxiety Symptoms (IDAS) scores;  Change in the Positive and Negative Affect Schedule (PANAS);  Change in Mood and Anxiety Symptom Questionnaire--Anhedonic Depression subscale (MASQ-AD)"},{"value":"50"},{"value":"NCT02255175"},{"value":"October 2015"}],[{"value":"510"},{"value":"Recruiting"},{"value":"Surgery Prevention by Transforaminal Injection of Epidural Steroids for Cervical Radicular Pain"},{"value":""},{"value":"Drug:Lidocaine;  Drug:LidocainewithDexamethasone"},{"value":"Interventional"},{"value":"Phase 4"},{"value":"Other"},{"value":"avoidanceofnecksurgery;  Disability;  Pain;  PatientSatisfaction"},{"value":"60"},{"value":"NCT02226159"},{"value":"August 2014"}],[{"value":"521"},{"value":"Completed"},{"value":"The Effect of Prophylactic Antipyretics on Immune Responses and Fever After 2014-2015 and 2015-2016 Inactivated Influenza Vaccine"},{"value":""},{"value":"Drug:AcetaminophenArm;  Drug:PlaceboArm;  Drug:IbuprofenArm"},{"value":"Interventional"},{"value":"Phase 4"},{"value":"Other / U.S. Fed"},{"value":"Seroconversion;  Seroprotection;  GeometricmeanHAItiter"},{"value":"104"},{"value":"NCT02212990"},{"value":"September 2014"}],[{"value":"536"},{"value":"Recruiting"},{"value":"Multimodal Analgesia vs. Routine Care Pain Management for Lumbar Spine Fusion Surgery: A Prospective Randomized Study"},{"value":""},{"value":"Other:MultimodalAnalgesiaTreatment;  Other:StandardofCarePainManagementProtocol"},{"value":"Interventional"},{"value":"Phase 4"},{"value":"Other"},{"value":"Patient reported pain level using a verbal numeric pain scale (NPS);  Patientsatisfaction;  Narcoticconsumption;  Lengthofstay;  Dischargedestination;  OswestryDisabilityIndex(ODI);  TheVeteransRand12(VR-12)"},{"value":"124"},{"value":"NCT02202369"},{"value":"February 2015"}],[{"value":"564"},{"value":"Recruiting"},{"value":"Comparison of Combigan BID Versus Simbrinza TID"},{"value":""},{"value":"Drug:CombiganBID;  Drug:SimbrinzaTID"},{"value":"Interventional"},{"value":"Phase 4"},{"value":"Other / Industry"},{"value":"IntraOcularPressure;  Tolerability"},{"value":"40"},{"value":"NCT02167035"},{"value":"August 2014"}],[{"value":"573"},{"value":"Suspended"},{"value":"Effect of a Multimodal Pain Regimen on Pain Control Patient Satisfaction and Narcotic Use in Orthopaedic Trauma Patients"},{"value":""},{"value":"Drug:Gabapentin;  Drug:Acetaminophen;  Drug:Celecoxib;  Drug:Dexamethasone;  Drug:Oxycodone"},{"value":"Interventional"},{"value":"Phase 4"},{"value":"Other"},{"value":"Pain;  NarcoticUse;  PatientSatisfaction;  Patientfunction;  FractureUnion;  Adverseevents"},{"value":"160"},{"value":"NCT02160301"},{"value":"November 2017"}],[{"value":"576"},{"value":"Recruiting"},{"value":"Pain Expectations in Subjects With Osteoarthritis"},{"value":""},{"value":"Drug:Modafinil;  Drug:Gabapentin;  Drug:Placebo"},{"value":"Interventional"},{"value":"Phase 4"},{"value":"Other"},{"value":"Restingpupildiameter"},{"value":"30"},{"value":"NCT02155257"},{"value":"July 2014"}],[{"value":"604"},{"value":"Recruiting"},{"value":"LNG-IUS at 2 Weeks Postpartum"},{"value":""},{"value":"Drug: Levonorgestrel Intrauterine System (LNG-IUS)"},{"value":"Interventional"},{"value":"Phase 4"},{"value":"Other"},{"value":"To report the acceptability of receiving an LNG-IUS two-weeks postpartum.;  To estimate the expulsion rate (complete or partial) at six months of LNG-IUS placed at two-weeks postpartum.;  To assess the pain experience of LNG-IUS insertion."},{"value":"50"},{"value":"NCT02121067"},{"value":"September 2014"}],[{"value":"606"},{"value":"Withdrawn"},{"value":"A Randomized Comparison of AmnioClear&#8482; Human Allograft Amniotic Membrane vs. Moist Wound Dressing in the Treatment of Diabetic Wounds"},{"value":""},{"value":"Biological: AmnioClear&#8482; Human Allograft Amniotic Membrane"},{"value":"Interventional"},{"value":"Phase 4"},{"value":"Industry"},{"value":"ReductioninWoundSize"},{"value":"0"},{"value":"NCT02120755"},{"value":""}],[{"value":"643"},{"value":"Completed"},{"value":"Efficacy of Belatacept in Reducing DSA"},{"value":""},{"value":"Drug:Belatacept"},{"value":"Interventional"},{"value":"Phase 4"},{"value":"Other"},{"value":"ReductionofDonorSpecificAntibodies(DSA);  AssessingSafety"},{"value":"3"},{"value":"NCT02078193"},{"value":"November 2013"}],[{"value":"663"},{"value":"Recruiting"},{"value":"Intravenous Exenatide in Patients With Acute Brain Injury"},{"value":""},{"value":"Drug:Exenatide"},{"value":"Interventional"},{"value":"Phase 4"},{"value":"Other / Industry"},{"value":"Feasibility defined as the proportion of patients 1) experiencing severe hypoglycemia (&lt;40 mg/dL); 2) achieving glucose measurements within goal (110-180 mg/dL); and 3) experiencing nausea requiring discontinuation of exenatide therapy;  Mean glucose concentration during exenatide infusion;  Number of glucose measurements within goal (110-180 mg/dL)/total number of glucose measurements;  Mean time to reach glucose measurements within goal (110-180 mg/dL);  Glycemic variability defined as the standard deviation of glucose;  Meaninsulinuse(units/kgbodyweight);  Proportion of subjects requiring rescue insulin infusion protocol;  Number of hypoglycemic episodes (&lt;80 mg/dL)/total number of glucose measurements;  Number of subjects with &gt;1 episode of hypoglycemia (&lt;80 mg/dL)/total number of subjects;  Proportion of patients experiencing metabolic crisis defined as cerebral microdialysate glucose concentration &lt;0.7 mmol/L in combination with lactate pyruvate ratio &gt;40;  Mean daily intracranial and cerebral perfusion pressures;  Number of hypotensive episodes (SBP&lt;100 mmHg)/total number of blood pressure measurements;  Proportion of patients experiencing serious adverse events;  Pharmacokinetics of exenatide infusion defined as the correlation of exenatide concentrations with creatinine clearance"},{"value":"24"},{"value":"NCT02058940"},{"value":"August 2015"}],[{"value":"670"},{"value":"Completed                  Has Results"},{"value":"A Five Day Clinical Study to Examine the Effects of a Benzoyl Peroxide Treatment on Facial Acne Lesions"},{"value":""},{"value":"Drug:3%BenzoylPeroxide;  Drug:3%BenzoylPeroxidePlacebo;  Drug:NeutrogenaRapidClear&#174;"},{"value":"Interventional"},{"value":"Phase 4"},{"value":"Industry"},{"value":"To Assess the Percentage Change in Acne Lesion Swelling (Height) of the Target Lesion for 3% Benzoyl Peroxide (BPO) Gel Test Product Relative to the Vehicle Gel After 4 Once-daily Applications.;  To Assess the Percentage Change in Acne Lesion Swelling (Height) for the 3% Benzoyl Peroxide Gel Test Product and Positive Control Relative to the Vehicle Gel.;  To Assess the Change in Acne Lesion Redness (Erythema) for the 3% BPO Gel Test Product and Positive Control Relative to the Vehicle Gel.;  To Assess the Percentage Change in Acne Lesion Diameter (Size) for the 3% BPO Gel Test Product and Positive Control Relative to the Vehicle Gel.;  To Assess the Change in Facial Skin Clarity for the 3% BPO Gel Test Product and Positive Control Relative to the Vehicle Gel;  To Assess the Change in Perceptions of the Overall Appearance of Their Skin for the 3% BPO Gel Test Product and Positive Control Relative to the Vehicle Gel"},{"value":"90"},{"value":"NCT02052752"},{"value":"February 2014"}],[{"value":"693"},{"value":"Recruiting"},{"value":"TXA vs. Amicar in Total Knee and Hip Arthroplasty"},{"value":""},{"value":"Drug:Amicar;  Drug:TXA"},{"value":"Interventional"},{"value":"Phase 4"},{"value":"Other"},{"value":"BloodLoss;  NumberofTransfusions;  Preoperative and lowest postoperative hematocrit and hemoglobin;  Lengthofhospitalizationstay;  CostofHospitalization"},{"value":"400"},{"value":"NCT02030821"},{"value":"January 2015"}],[{"value":"700"},{"value":"Recruiting"},{"value":"Phenylephrine Versus Ephedrine in Pre-eclampsia"},{"value":""},{"value":"Drug:Phenylephrine;  Drug:Ephedrine"},{"value":"Interventional"},{"value":"Phase 4"},{"value":"Other"},{"value":"Cerebraltissueoxygensaturation;  Cardiacoutput"},{"value":"40"},{"value":"NCT02025426"},{"value":"September 2012"}],[{"value":"702"},{"value":"Completed"},{"value":"Efficacy Study of Riociguat and Its Effects on Exercise Performance and Pulmonary Artery Pressure at High Altitude"},{"value":""},{"value":"Drug:Riociguat"},{"value":"Interventional"},{"value":"Phase 4"},{"value":"Other"},{"value":"ChangefromBaselineinPulmonaryArteryPressure;  ChangefromBaselineinRadialArterialPressure;  Change from Baseline in Arterial Oxygen Saturation (PaO2);  ChangefromBaselineinVentilationRate;  ChangefromBaselineinWorkRateatExhaustion;  ChangefromBaselineinCardiacOutput"},{"value":"28"},{"value":"NCT02024386"},{"value":"January 2014"}],[{"value":"720"},{"value":"Recruiting"},{"value":"Bone Marrow Aspirate Concentrate (BMAC) Supplementation for Osteochondral Lesions"},{"value":""},{"value":"Procedure: ankle arthroscopy with debridement and microfracture of the OLT;  Other:BoneMarrowAspirateinjection"},{"value":"Interventional"},{"value":"Phase 4"},{"value":"Other"},{"value":"ChangeinPainAssessment;  ChangeinFunctionalAssessment;  MRIAssessment"},{"value":"30"},{"value":"NCT02011295"},{"value":"December 2013"}],[{"value":"731"},{"value":"Completed"},{"value":"The Role of Estrogen in Luteinizing Hormone Surge and Ovulation"},{"value":""},{"value":"Drug:Letrozole"},{"value":"Interventional"},{"value":"Phase 4"},{"value":"Other"},{"value":"IncreaseinProgesteronelevel;  ChangeinLHlevel;  FollicularDevelopment"},{"value":"10"},{"value":"NCT01999569"},{"value":"April 2007"}]],"columnNames":[{"name":"rank","index":0,"aggr":"sum"},{"name":"status","index":1,"aggr":"sum"},{"name":"study","index":2,"aggr":"sum"},{"name":"conditions","index":3,"aggr":"sum"},{"name":"interventions","index":4,"aggr":"sum"},{"name":"study_type","index":5,"aggr":"sum"},{"name":"phase","index":6,"aggr":"sum"},{"name":"funder_type","index":7,"aggr":"sum"},{"name":"outcome_measures","index":8,"aggr":"sum"},{"name":"number_enrolled","index":9,"aggr":"sum"},{"name":"nct_number","index":10,"aggr":"sum"},{"name":"start_date","index":11,"aggr":"sum"}],"rows":[["21","Not yet recruiting","Comparison of PIEB vs CEI for Labor Analgesia","","Other:ProgrammedIntermittentEpiduralBolus;  Other:ContinuousEpiduralInfusion;  Drug:Ropivacaine;  Drug:Fentanyl","Interventional","Phase 4","Other","Volume of local anesthetic received through Patient Controlled Epidural Analgesia (PCEA) per hour-computerized information;  Total required local anesthetic required per hour- computerized information;  Time to first patient controlled epidural analgesia (PCEA) bolus- computerized information;  Laborpainscores-patientquestionnaire;  Degree of motor blockade measured as lowest recorded modified Bromage score;  Modeofdelivery;  Patient controlled epidural analgesia (PCEA) attempts-computerized information;  Patient controlled epidural analgesia (PCEA) ratio of successful attempts to unsuccessful attempts - computerized information;  Frequencyofhypotension-physiologicalparameter;  Durationoffirstandsecondstagesoflabor;  Level of patient satisfaction- patient questionnaire","120","NCT02949271","November 2016"],["23","Not yet recruiting","Optimal Volume Rate and Interval of Bolus Nerve Catheters for Shoulder Surgery","","Drug:Ropivacaine","Interventional","Phase 4","Other","Optimal Volume of Ropivacaine 0.2% bolus via interscalene catheter;  Optimal Rate of Ropivacaine 0.2% administration bolus via interscalene cathter","99","NCT02946268","November 2016"],["33","Recruiting","Assessment of Infection Control Practice Efficiency and Health Economics of Sheathed Versus Standard Cystoscopy","","Device:EndoSheathCST-5000Scope;  Device:OlympusViseraEliteOTV-S190Scope","Interventional","Phase 4","Other / Industry","TheChangeinBacteriuria","60","NCT02922868","March 2016"],["46","Recruiting","Comparison of 1000 Hertz (Hz) Burst and Standard Spinal Cord Stimulation in Chronic Pain Relief","","Device:Spinalcordstimulator","Interventional","Phase 4","Other","NPRS;  OswestryDisabilityIndex;  PatientsGlobalImpressionofChange;  PreferabilitySurvey","22","NCT02902796","September 2016"],["59","Recruiting","Spironolactone After Liver Transplant","","Drug:Spironolactone","Interventional","Phase 4","Other","GFR","36","NCT02883400","December 2014"],["67","Recruiting","Accelerated Invisalign Therapy in Conjunction With Acceledent Aura","","Device:AcceleDentAura;  Device:AcceleratedInvisaligntherapy","Interventional","Phase 4","Other / Industry","Rate of orthodontic tooth movement [Little&apos;s Irregularity Index mm/day percent];  Activity of Bone Turnover Markers (BTMs) during Orthodontic Tooth Movement [Quantitative Polymerase Chain Reaction (qPCR) Cycle threshold values (Ct)];  Patient Discomfort [Visual Analog Scale in conjunction with Faces Pain Scale 1-10]","30","NCT02868554","August 2016"],["87","Recruiting","A Volumetric Analysis of Soft and Hard Tissue Healing for Ridge Preservation and Socket Seal After Tooth Extraction","","Biological:Xenograftbonesubstitute;  Biological:Collagendressing;  Biological:3D-collagenmatrix","Interventional","Phase 4","Other / Industry","Thicknessofthebuccalplate;  Heightofthealveolarridge;  Softtissuevolume;  Bonevolume;  Woundhealingassessment","24","NCT02844569","July 2016"],["142","Recruiting","Analgesic Benefit of PECS Blocks for Biceps Tenodesis Shoulder Surgery","","Procedure: Interscalene plus PECS &quot;Pectoralis&quot; 1 and 2 Blocks;  Procedure:InterscaleneplusShamBlock","Interventional","Phase 4","Other","Post-operativeAxillaryPain;  NumericalRatingScalePainScoresatrest;  NauseaorVomiting;  TotalOpioidUsage;  TimetoReturnofAxillaryPain","40","NCT02741713","April 2016"],["149","Completed","Efficacy and Tolerability of New Topical Formulations in Subjects With Atopic Dermatitis","","Drug:InvestigationalOTCCream;  Other:CosmeticEczemaCream;  Drug:0.05%DesonideCream;  Other:PlaceboCream","Interventional","Phase 4","Industry","SCORAD(SeverityScoringofAtopicDermatitis)","53","NCT02732314","March 2016"],["151","Not yet recruiting","Rejuvesol&#174; Washed RBC in Sickle Cell Patients Requiring Frequent Transfusions","","Drug:Rejuvesol;  Procedure:Bloodtransfusion","Interventional","Phase 4","Other","Percenthemoglobin(HbA)decrement;  Actual HbA decrement (g/dl) with indexing to calculated circulating blood volume;  Actual HbA decrement (g/dl) without indexing to calculated circulating blood volume;  ChangeinRBCmicroparticles(MP)counts;  ChangeinRBC/RBC-MP-mediatedthrombingeneration;  Changeinp50pre-andpost-transfusion","4","NCT02731157","May 2016"],["160","Recruiting","Comparison of Two Gingival Displacement Procedures","","Device:AquasilUltraCordlessDentsply;  Device:UltrapakUltradentcord","Interventional","Phase 4","Other","Percentage of errors in impressions made for indirect restorations;  Timerequiredtomaketheimpression;  Patientdiscomfort","60","NCT02716727","October 2016"],["171","Recruiting","TACE and MWA Combination Therapy in Early-stage Hepatocellular Carcinoma","","Procedure:TransarterialChemoembolization;  Procedure:MicrowaveAblation","Interventional","Phase 4","Other","Intrahepaticdisease-freesurvival;  Overallsurvival;  Postoperativemorbidity;  Postoperativemortality","100","NCT02704130","March 2016"],["183","Recruiting","Predicting Understanding and Speeding Recovery After TKA","","Drug:Gabapentin;  Drug:Placebo","Interventional","Phase 4","Other / NIH","Changes in daily worst-pain score after discharge from hospital","300","NCT02685735","February 2016"],["197","Recruiting","Internet Surveys and Their Impact on Adherence to Brimonidine Topical Gel and QOL in Patients With Rosacea","","Other:internetsurvey;  Drug:brimonidinetopicalgel0.33%","Interventional","Phase 4","Other","Change from baseline Disease severity measure: Clinician Erythema Assessment (CEA) to month 6.;  Change from baseline Disease severity measure: Patient Severity Assessment (PSA) to month 6.;  Change from baseline Disease severity measures: Investigator Visual Analogue Scale (VAS) to month 6.;  Change from baseline Disease severity measure: Lesion Count (Performed by investigator) to month 6.;  Change from baseline Subjective Symptom Improvement: Quality of Life Survey to month 6.;  Subject survey to identify factors that affect adherence to rosacea treatment","20","NCT02659670","January 2016"],["219","Recruiting","Bilateral Comparison of Treatment of Facial Actinic Keratoses Using Microneedling and Photodynamic Therapy With Aminolevulinic Acid and Blue Light Versus Photodynamic Therapy With Aminolevulinic Acid and Blue Light Using Two Incubation Times","","Drug:AminolevulinicAcid(ALA);  Device:EnvironCosmeticRoller;  Device:BLU-UIIlluminator","Interventional","Phase 4","Other","Efficacy-Percentage of treatment areas with &gt;75% reduction in lesion count as compared to baseline;  Efficacy-Percentage of treatment areas with 100% cure rate as compared to baseline","10","NCT02622594","October 2015"],["232","Recruiting","Celestone Versus Ketorolac Injection for the Treatment of DeQuervains Tenosyovitis","","Drug:Celestone;  Drug:Ketorolac","Interventional","Phase 4","Other","Visualanalogscaleofpainwithfinklesteintest;  Visual analog scale of pain with tenderness over tendon;  Visual analog scale of pain on radial side of wrist;  The Disabilities of the Arm Shoulder and Hand Score (DASH);  Veterans-Rand12(VR-12);  PinchStrength;  GripStrength","64","NCT02604537","November 2015"],["241","Active not recruiting","Foot and Ankle Clinic Application for Liposomal Related Anesthetic","","Drug:Exparel","Interventional","Phase 4","Other / Industry","AmountofNarcoticUse;  VisualAnalogScaleofpain(0-10);  Anti-emeticuse;  Patient Satisfaction Questionnaire regarding post surgical pain relief;  Complications","36","NCT02586077","February 2014"],["261","Completed                  Has Results","Lazanda Fentanyl Nasal Spray Pre Radiofrequency Nerve Ablations(RFA) of Lumbar Facet Joints","","Drug:Lazanda","Interventional","Phase 4","Other / Industry","Safety and Tolerability as Measured by the Number of Adverse Events;  Pain Score Differences Using the DVPRS (Defense and Veterans Pain Rating Scale) Tool.;  Patient Satisfaction Using a Likert Satisfaction Survey;  AdverseEvents;  SedationLevelAssessedbyPOSSTool","23","NCT02571634","May 2015"],["311","Recruiting","Rejuvenated Washed Packed Red Blood Cells in Pediatric Cardiac Surgery","","Drug:Rejuvesol;  Procedure:Cardiacsurgery","Interventional","Phase 4","Other","Change in tissue oxygenation/perfusion during cardiac surgery measured by whole blood lactate concentration;  Change in ischemic organ injury during cardiac surgery measured by urinary neutrophil gelatinase associated lipocalin (NGAL);  Change in hemolysis during cardiac surgery as measured by plasma free hemoglobin levels","15","NCT02485366","June 2015"],["324","Not yet recruiting","Tolvaptan For Worsening Outpatient Heart Failure: Role of Copeptin In Identifying Responders","","Drug:tolvaptan;  Other:Placebo","Interventional","Phase 4","Other","Changeinbodyweightat48hours;  Changes in congestion (patient reported and investigator assessed);  Changeinbodyweightatday8;  Clinicalcompositeofmorbidity","40","NCT02476409","July 2015"],["338","Recruiting","Systemic Steroids for Peripheral Nerve Blocks","","Drug:Dexamethasone;  Drug:Bupivacaine;  Drug:Epinephrine;  Procedure:LumbarPlexusNerveBlock;  Drug:Saline","Interventional","Phase 4","Other","DurationofSensoryBlockade;  Timetofirstanalgesicrequest;  TotalOpioidConsumption;  VerbalNumericPainScoreComparisons","115","NCT02464176","June 2015"],["341","Recruiting","Perineural Steroids for Peripheral Nerve Blocks","","Drug:Dexamethasone;  Drug:Bupivacaine;  Drug:Epinephrine;  Procedure:SaphenousPeripheralNerveBlock","Interventional","Phase 4","Other","DurationofSensoryNerveBlock;  VerbalPainScores;  RateofPostOperativeNauseaandVomiting;  NeurologicComplications;  PostOperativeOpioidUseandConsumption;  Timetofirstopioidanalgesicrequest","115","NCT02462148","July 2015"],["358","Withdrawn","Preoperative Antibiotic Dosing for Total Knee Arthroplasty","","Device:NewIntraosseous;  Drug:Cefazolin","Interventional","Phase 4","Other","rateofacutesurgicalsiteinfection;  correlation of clinical comorbidities to acute infection rates;  numberofcomplications;  tourniquettime;  bloodloss","0","NCT02433704","May 2015"],["360","Completed","Eovist vs. Dotarem Healthy Volunteer MRI","","Drug:gadoxetatedisodium;  Drug:gadoteratedimeglumine;  Drug:Saline","Interventional","Phase 4","Other","Subject breath hold capacity as measured by number of seconds a subject can hold his/her breath;  Subject-reported dyspnea a measured by questionnaire;  ChangesinO2saturation;  Changesinpulserate;  Presence of motion artifacts at arterial phase imaging;  Severity of motion artifacts at arterial phase imaging measured on a 1-5 scale","48","NCT02431598","June 2015"],["367","Recruiting","Efficacy of Ranolazine in Patients With Chronic Total Occlusions of Coronary Arteries","","Drug:Ranolazine;  Drug:Placebo","Interventional","Phase 4","Other / Industry","CardiacMRI(CMR)strain;  Dobutaminewallmotionscoringindex(WMSI);  QualityofLife/burdenofangina;  TreadmillECGexercisedistance;  Time to ECG changes (ST depression) on exercise ECG","30","NCT02423265","June 2015"],["393","Recruiting","Cilostazol After Lower Extremity Arterial Revascularization Trial","","Drug:Cilostazol","Interventional","Phase 4","Other","Difference in quality of life in relation to use of cilostazol after lower extremity revascularization;  Patency of the graft/stent and re intervention rate after initial procedure","30","NCT02374957","February 2015"],["406","Recruiting","Perampanel in Seizure Patients With Primary Glial Brain Tumors","","Drug:Perampanel","Interventional","Phase 4","Other","Percentage of patients with &#8805;50% seizure reduction during the maintenance period compared with seizure frequency before initiation of perampanel;  Percentage of patients who experience a adverse event possibly probably or definitely attributable to perampanel treatment","71","NCT02363933","February 2015"],["416","Recruiting","Liposomal Bupivacaine in Simultaneous Bilateral Total Knee Arthroplasty","","Drug:Liposomalbupivacaine","Interventional","Phase 4","Other","AdverseEvents;  Plasmabupivacainelevels","15","NCT02349542","January 2015"],["457","Recruiting","Intravesicular Onabotulinumtoxin A in Interstitial Cystitis","","Drug:OnabotulinumtoxinA;  Procedure: injections upper aspect of trigone of urinary bladder;  Procedure: injections on posterior bladder wall excluding the trigone","Interventional","Phase 4","Other / Industry","The primary outcome will be assessing change in a measurement of subjective patient pain using the Pelvic Pain and Urinary Urgency Frequency (PUF) questionnaire and the O&apos;Leary-Sant Symptom and Problem Indexes.;  Secondary outcomes will be assessing change in patient performance in uroflowmetry.","40","NCT02297100","December 2014"],["460","Completed","Thoracoabdominal Arortic CTA Study","","Drug:Isovue","Interventional","Phase 4","Other","Radiationdose;  Noise;  Signaltonoiseratio;  Hounsfieldunitattenuationvalues;  Contrasttonoiseratio","150","NCT02291718","January 2014"],["461","Completed                  Has Results","Reducing Pain of Lidocaine Injection","","Drug:1%Lidocaine;  Drug:1%Lidocaineplussodiumbicarbonate","Interventional","Phase 4","Other","Pain","88","NCT02288364","December 2014"],["469","Completed","Dexamethasone and Pain Following Total Knee Arthroplasty","","Drug:Dexamethasone;  Other:Placebo","Interventional","Phase 4","Other","ChangeinVisualanaloguepainscore;  ChangeinOpioidconsumption;  ChangeinChronicPain;  ChangeinFunctionalstatus;  ChangeinInterleukin6and10levels;  ChangeinMacrophageproliferation","45","NCT02271698","December 2014"],["476","Completed                  Has Results","High Frequency Stimulation Trials in Patients With Precision Spinal Cord Stimulator System","","Other:Highfrequencystimulation;  Other:Lowfrequencystimulation","Interventional","Phase 4","Other","NumericPainRatingScale(NPRS);  OswestryDisabilityIndexQuestionnaire(ODI).;  Patient&apos;sGlobalImpressionofChange(PGIC)","22","NCT02265848","October 2014"],["484","Recruiting","Perimenopausal Effects of Estradiol on Reward Responsiveness","","Drug:Estradiol;  Drug:Progesterone","Interventional","Phase 4","Other / NIH","Change in frontostriatal reactivity to reward during the MID fMRI task;  Change in neural connectivity measured during resting-state fMRI;  Change in response latency to reward versus non-reward during the MID fMRI task;  Change in Inventory of Depression and Anxiety Symptoms (IDAS) scores;  Change in the Positive and Negative Affect Schedule (PANAS);  Change in Mood and Anxiety Symptom Questionnaire--Anhedonic Depression subscale (MASQ-AD)","50","NCT02255175","October 2015"],["510","Recruiting","Surgery Prevention by Transforaminal Injection of Epidural Steroids for Cervical Radicular Pain","","Drug:Lidocaine;  Drug:LidocainewithDexamethasone","Interventional","Phase 4","Other","avoidanceofnecksurgery;  Disability;  Pain;  PatientSatisfaction","60","NCT02226159","August 2014"],["521","Completed","The Effect of Prophylactic Antipyretics on Immune Responses and Fever After 2014-2015 and 2015-2016 Inactivated Influenza Vaccine","","Drug:AcetaminophenArm;  Drug:PlaceboArm;  Drug:IbuprofenArm","Interventional","Phase 4","Other / U.S. Fed","Seroconversion;  Seroprotection;  GeometricmeanHAItiter","104","NCT02212990","September 2014"],["536","Recruiting","Multimodal Analgesia vs. Routine Care Pain Management for Lumbar Spine Fusion Surgery: A Prospective Randomized Study","","Other:MultimodalAnalgesiaTreatment;  Other:StandardofCarePainManagementProtocol","Interventional","Phase 4","Other","Patient reported pain level using a verbal numeric pain scale (NPS);  Patientsatisfaction;  Narcoticconsumption;  Lengthofstay;  Dischargedestination;  OswestryDisabilityIndex(ODI);  TheVeteransRand12(VR-12)","124","NCT02202369","February 2015"],["564","Recruiting","Comparison of Combigan BID Versus Simbrinza TID","","Drug:CombiganBID;  Drug:SimbrinzaTID","Interventional","Phase 4","Other / Industry","IntraOcularPressure;  Tolerability","40","NCT02167035","August 2014"],["573","Suspended","Effect of a Multimodal Pain Regimen on Pain Control Patient Satisfaction and Narcotic Use in Orthopaedic Trauma Patients","","Drug:Gabapentin;  Drug:Acetaminophen;  Drug:Celecoxib;  Drug:Dexamethasone;  Drug:Oxycodone","Interventional","Phase 4","Other","Pain;  NarcoticUse;  PatientSatisfaction;  Patientfunction;  FractureUnion;  Adverseevents","160","NCT02160301","November 2017"],["576","Recruiting","Pain Expectations in Subjects With Osteoarthritis","","Drug:Modafinil;  Drug:Gabapentin;  Drug:Placebo","Interventional","Phase 4","Other","Restingpupildiameter","30","NCT02155257","July 2014"],["604","Recruiting","LNG-IUS at 2 Weeks Postpartum","","Drug: Levonorgestrel Intrauterine System (LNG-IUS)","Interventional","Phase 4","Other","To report the acceptability of receiving an LNG-IUS two-weeks postpartum.;  To estimate the expulsion rate (complete or partial) at six months of LNG-IUS placed at two-weeks postpartum.;  To assess the pain experience of LNG-IUS insertion.","50","NCT02121067","September 2014"],["606","Withdrawn","A Randomized Comparison of AmnioClear&#8482; Human Allograft Amniotic Membrane vs. Moist Wound Dressing in the Treatment of Diabetic Wounds","","Biological: AmnioClear&#8482; Human Allograft Amniotic Membrane","Interventional","Phase 4","Industry","ReductioninWoundSize","0","NCT02120755",""],["643","Completed","Efficacy of Belatacept in Reducing DSA","","Drug:Belatacept","Interventional","Phase 4","Other","ReductionofDonorSpecificAntibodies(DSA);  AssessingSafety","3","NCT02078193","November 2013"],["663","Recruiting","Intravenous Exenatide in Patients With Acute Brain Injury","","Drug:Exenatide","Interventional","Phase 4","Other / Industry","Feasibility defined as the proportion of patients 1) experiencing severe hypoglycemia (&lt;40 mg/dL); 2) achieving glucose measurements within goal (110-180 mg/dL); and 3) experiencing nausea requiring discontinuation of exenatide therapy;  Mean glucose concentration during exenatide infusion;  Number of glucose measurements within goal (110-180 mg/dL)/total number of glucose measurements;  Mean time to reach glucose measurements within goal (110-180 mg/dL);  Glycemic variability defined as the standard deviation of glucose;  Meaninsulinuse(units/kgbodyweight);  Proportion of subjects requiring rescue insulin infusion protocol;  Number of hypoglycemic episodes (&lt;80 mg/dL)/total number of glucose measurements;  Number of subjects with &gt;1 episode of hypoglycemia (&lt;80 mg/dL)/total number of subjects;  Proportion of patients experiencing metabolic crisis defined as cerebral microdialysate glucose concentration &lt;0.7 mmol/L in combination with lactate pyruvate ratio &gt;40;  Mean daily intracranial and cerebral perfusion pressures;  Number of hypotensive episodes (SBP&lt;100 mmHg)/total number of blood pressure measurements;  Proportion of patients experiencing serious adverse events;  Pharmacokinetics of exenatide infusion defined as the correlation of exenatide concentrations with creatinine clearance","24","NCT02058940","August 2015"],["670","Completed                  Has Results","A Five Day Clinical Study to Examine the Effects of a Benzoyl Peroxide Treatment on Facial Acne Lesions","","Drug:3%BenzoylPeroxide;  Drug:3%BenzoylPeroxidePlacebo;  Drug:NeutrogenaRapidClear&#174;","Interventional","Phase 4","Industry","To Assess the Percentage Change in Acne Lesion Swelling (Height) of the Target Lesion for 3% Benzoyl Peroxide (BPO) Gel Test Product Relative to the Vehicle Gel After 4 Once-daily Applications.;  To Assess the Percentage Change in Acne Lesion Swelling (Height) for the 3% Benzoyl Peroxide Gel Test Product and Positive Control Relative to the Vehicle Gel.;  To Assess the Change in Acne Lesion Redness (Erythema) for the 3% BPO Gel Test Product and Positive Control Relative to the Vehicle Gel.;  To Assess the Percentage Change in Acne Lesion Diameter (Size) for the 3% BPO Gel Test Product and Positive Control Relative to the Vehicle Gel.;  To Assess the Change in Facial Skin Clarity for the 3% BPO Gel Test Product and Positive Control Relative to the Vehicle Gel;  To Assess the Change in Perceptions of the Overall Appearance of Their Skin for the 3% BPO Gel Test Product and Positive Control Relative to the Vehicle Gel","90","NCT02052752","February 2014"],["693","Recruiting","TXA vs. Amicar in Total Knee and Hip Arthroplasty","","Drug:Amicar;  Drug:TXA","Interventional","Phase 4","Other","BloodLoss;  NumberofTransfusions;  Preoperative and lowest postoperative hematocrit and hemoglobin;  Lengthofhospitalizationstay;  CostofHospitalization","400","NCT02030821","January 2015"],["700","Recruiting","Phenylephrine Versus Ephedrine in Pre-eclampsia","","Drug:Phenylephrine;  Drug:Ephedrine","Interventional","Phase 4","Other","Cerebraltissueoxygensaturation;  Cardiacoutput","40","NCT02025426","September 2012"],["702","Completed","Efficacy Study of Riociguat and Its Effects on Exercise Performance and Pulmonary Artery Pressure at High Altitude","","Drug:Riociguat","Interventional","Phase 4","Other","ChangefromBaselineinPulmonaryArteryPressure;  ChangefromBaselineinRadialArterialPressure;  Change from Baseline in Arterial Oxygen Saturation (PaO2);  ChangefromBaselineinVentilationRate;  ChangefromBaselineinWorkRateatExhaustion;  ChangefromBaselineinCardiacOutput","28","NCT02024386","January 2014"],["720","Recruiting","Bone Marrow Aspirate Concentrate (BMAC) Supplementation for Osteochondral Lesions","","Procedure: ankle arthroscopy with debridement and microfracture of the OLT;  Other:BoneMarrowAspirateinjection","Interventional","Phase 4","Other","ChangeinPainAssessment;  ChangeinFunctionalAssessment;  MRIAssessment","30","NCT02011295","December 2013"],["731","Completed","The Role of Estrogen in Luteinizing Hormone Surge and Ovulation","","Drug:Letrozole","Interventional","Phase 4","Other","IncreaseinProgesteronelevel;  ChangeinLHlevel;  FollicularDevelopment","10","NCT01999569","April 2007"]]},"dateCreated":"2016-12-06T17:31:08+0000","status":"READY","errorMessage":"","progressUpdateIntervalMs":500,"$$hashKey":"object:2224"},{"text":"%sql\n\nselect number_enrolled,status from table_df","dateUpdated":"2016-12-06T17:31:08+0000","config":{"colWidth":6,"editorMode":"ace/mode/sql","editorHide":true,"graph":{"mode":"pieChart","height":434,"optionOpen":false,"keys":[{"name":"status","index":1,"aggr":"sum"}],"values":[{"name":"status","index":1,"aggr":"sum"}],"groups":[],"scatter":{"xAxis":{"name":"number_enrolled","index":0,"aggr":"sum"},"yAxis":{"name":"status","index":1,"aggr":"sum"}}},"enabled":true},"settings":{"params":{},"forms":{}},"jobName":"paragraph_1481045468652_-400669707","id":"20161204-182947_461973247","result":{"code":"SUCCESS","type":"TABLE","msg":"number_enrolled\tstatus\n100\tRecruiting\n150\tRecruiting\n450\tRecruiting\n60\tRecruiting\n35\tNot yet recruiting\n40\tNot yet recruiting\n230\tNot yet recruiting\n500\tNot yet recruiting\n100\tRecruiting\n20\tNot yet recruiting\n80\tNot yet recruiting\n350\tRecruiting\n102\tRecruiting\n120\tRecruiting\n8\tNot yet recruiting\n60\tRecruiting\n60\tRecruiting\n60\tRecruiting\n20\tRecruiting\n75\tNot yet recruiting\n120\tNot yet recruiting\n20\tRecruiting\n99\tNot yet recruiting\n24\tNot yet recruiting\n30\tRecruiting\n40\tRecruiting\n5000\tRecruiting\n60\tNot yet recruiting\n400\tRecruiting\n100\tNot yet recruiting\n100\tRecruiting\n180\tRecruiting\n60\tRecruiting\n100\tNot yet recruiting\n60\tRecruiting\n60\tRecruiting\n60\tNot yet recruiting\n350\tNot yet recruiting\n20\tNot yet recruiting\n32\tNot yet recruiting\n54\tNot yet recruiting\n24\tRecruiting\n300\tNot yet recruiting\n50\tEnrolling by invitation\n100\tRecruiting\n22\tRecruiting\n12\tNot yet recruiting\n60\tRecruiting\n20\tRecruiting\n100\tRecruiting\n120\tNot yet recruiting\n25\tRecruiting\n60\tRecruiting\n50\tNot yet recruiting\n102\tCompleted\n167\tCompleted\n40\tNot yet recruiting\n880\tRecruiting\n36\tRecruiting\n44\tRecruiting\n60\tNot yet recruiting\n7\tRecruiting\n210\tNot yet recruiting\n100\tRecruiting\n32\tRecruiting\n200\tRecruiting\n30\tRecruiting\n164\tRecruiting\n68\tCompleted\n45\tNot yet recruiting\n139\tActive not recruiting\n200\tActive not recruiting\n200\tRecruiting\n50\tNot yet recruiting\n16\tNot yet recruiting\n100\tEnrolling by invitation\n75\tRecruiting\n1000\tRecruiting\n40\tRecruiting\n10\tRecruiting\n20\tNot yet recruiting\n30\tNot yet recruiting\n20\tRecruiting\n40\tRecruiting\n165\tRecruiting\n3000\tRecruiting\n24\tRecruiting\n12\tRecruiting\n60\tEnrolling by invitation\n18\tCompleted\n850\tNot yet recruiting\n40\tRecruiting\n70\tNot yet recruiting\n50\tNot yet recruiting\n250\tNot yet recruiting\n46\tRecruiting\n300\tRecruiting\n200\tEnrolling by invitation\n20\tNot yet recruiting\n400\tRecruiting\n100\tRecruiting\n25\tRecruiting\n250\tNot yet recruiting\n40\tRecruiting\n276\tNot yet recruiting\n25\tRecruiting\n30\tNot yet recruiting\n34\tRecruiting\n40\tRecruiting\n300\tRecruiting\n330\tNot yet recruiting\n28\tNot yet recruiting\n274\tNot yet recruiting\n30\tRecruiting\n\tRecruiting\n350\tRecruiting\n1000\tNot yet recruiting\n24\tActive not recruiting\n40\tRecruiting\n45\tRecruiting\n20\tRecruiting\n2400\tRecruiting\n50\tRecruiting\n30\tRecruiting\n87\tRecruiting\n360\tRecruiting\n40\tRecruiting\n85\tRecruiting\n36\tRecruiting\n24\tRecruiting\n0\tWithdrawn\n60\tRecruiting\n70\tNot yet recruiting\n1520\tRecruiting\n20\tNot yet recruiting\n74\tNot yet recruiting\n98\tRecruiting\n50\tRecruiting\n24\tNot yet recruiting\n100\tNot yet recruiting\n25\tRecruiting\n40\tRecruiting\n200\tRecruiting\n120\tRecruiting\n18\tActive not recruiting\n30\tNot yet recruiting\n432\tRecruiting\n10\tCompleted\n53\tCompleted\n19\tActive not recruiting\n4\tNot yet recruiting\n124\tRecruiting\n54\tTerminated\n15\tRecruiting\n96\tNot yet recruiting\n40\tRecruiting\n5\tRecruiting\n16\tEnrolling by invitation\n120\tRecruiting\n60\tRecruiting\n125\tRecruiting\n40\tNot yet recruiting\n40\tNot yet recruiting\n220\tRecruiting\n250\tRecruiting\n50\tActive not recruiting\n8\tRecruiting\n23\tActive not recruiting\n60\tNot yet recruiting\n12\tRecruiting\n100\tRecruiting\n1000\tRecruiting\n32\tNot yet recruiting\n77\tActive not recruiting\n158\tRecruiting\n1200\tRecruiting\n98\tRecruiting\n80\tRecruiting\n96\tRecruiting\n39\tRecruiting\n31\tRecruiting\n12\tRecruiting\n300\tRecruiting\n65\tActive not recruiting\n105\tRecruiting\n75\tRecruiting\n200\tRecruiting\n70\tRecruiting\n30\tRecruiting\n60\tRecruiting\n120\tRecruiting\n100\tCompleted\n48\tCompleted\n500\tRecruiting\n2310\tRecruiting\n18\tRecruiting\n20\tRecruiting\n210\tRecruiting\n66\tRecruiting\n345\tRecruiting\n100\tRecruiting\n510\tRecruiting\n110\tEnrolling by invitation\n60\tRecruiting\n41\tCompleted\n24\tCompleted\n60\tActive not recruiting\n22\tRecruiting\n30\tRecruiting\n24\tActive not recruiting\n150\tRecruiting\n84\tRecruiting\n60\tRecruiting\n90\tRecruiting\n50\tRecruiting\n30\tRecruiting\n80\tRecruiting\n30\tRecruiting\n10\tRecruiting\n24\tRecruiting\n50\tRecruiting\n50\tRecruiting\n100\tRecruiting\n46\tRecruiting\n160\tRecruiting\n18\tRecruiting\n10\tCompleted\n29\tRecruiting\n22\tRecruiting\n40\tRecruiting\n75\tRecruiting\n64\tRecruiting\n300\tRecruiting\n30\tRecruiting\n2000\tCompleted\n15\tActive not recruiting\n84\tRecruiting\n36\tRecruiting\n375\tNot yet recruiting\n240\tRecruiting\n36\tActive not recruiting\n24\tRecruiting\n75\tRecruiting\n30\tRecruiting\n250\tRecruiting\n27\tRecruiting\n20\tRecruiting\n75\tRecruiting\n60\tNot yet recruiting\n90\tRecruiting\n20\tRecruiting\n222\tActive not recruiting\n30\tRecruiting\n40\tCompleted\n20\tRecruiting\n120\tRecruiting\n100\tRecruiting\n65\tRecruiting\n100\tRecruiting\n50\tRecruiting\n23\tCompleted                  Has Results\n100\tRecruiting\n110\tRecruiting\n48\tRecruiting\n100\tRecruiting\n300\tRecruiting\n30\tRecruiting\n60\tRecruiting\n1656\tActive not recruiting\n248\tRecruiting\n250\tRecruiting\n500000\tActive not recruiting\n120\tRecruiting\n25\tRecruiting\n25\tEnrolling by invitation\n78\tRecruiting\n61\tRecruiting\n240\tRecruiting\n300\tRecruiting\n70\tCompleted\n66\tRecruiting\n80\tRecruiting\n52\tRecruiting\n99\tCompleted\n66\tRecruiting\n26\tRecruiting\n5\tRecruiting\n40\tCompleted\n160\tRecruiting\n400\tRecruiting\n16\tSuspended\n80\tRecruiting\n28\tCompleted\n150\tRecruiting\n260\tEnrolling by invitation\n39\tCompleted\n100\tRecruiting\n40\tCompleted\n13\tActive not recruiting\n50\tRecruiting\n30\tRecruiting\n400\tRecruiting\n550\tRecruiting\n600\tNot yet recruiting\n350\tRecruiting\n360\tActive not recruiting\n130\tRecruiting\n186\tCompleted\n33\tCompleted\n300\tNot yet recruiting\n15\tRecruiting\n50\tRecruiting\n12\tRecruiting\n750\tRecruiting\n15\tCompleted\n15\tEnrolling by invitation\n50\tCompleted\n100\tRecruiting\n40\tRecruiting\n3000\tActive not recruiting\n35\tRecruiting\n10000\tEnrolling by invitation\n6\tCompleted\n40\tNot yet recruiting\n100\tRecruiting\n500\tNot yet recruiting\n0\tWithdrawn\n20\tRecruiting\n0\tWithdrawn\n45\tRecruiting\n20\tActive not recruiting\n200\tNot yet recruiting\n14\tActive not recruiting\n5975\tRecruiting\n200\tRecruiting\n400\tActive not recruiting\n28\tCompleted\n115\tRecruiting\n60\tCompleted\n30\tRecruiting\n115\tRecruiting\n104\tActive not recruiting\n50\tRecruiting\n0\tWithdrawn\n131\tRecruiting\n100\tRecruiting\n100\tRecruiting\n210\tRecruiting\n20\tRecruiting\n315\tRecruiting\n20\tActive not recruiting\n30\tRecruiting\n60\tRecruiting\n84\tActive not recruiting\n60\tRecruiting\n70\tRecruiting\n100\tRecruiting\n0\tWithdrawn\n2\tTerminated\n48\tCompleted\n40\tRecruiting\n472\tRecruiting\n16\tRecruiting\n500\tEnrolling by invitation\n30\tRecruiting\n0\tWithdrawn\n30\tRecruiting\n36\tSuspended\n80\tCompleted\n40\tRecruiting\n11\tCompleted\n131\tCompleted\n41\tCompleted\n50\tRecruiting\n220\tCompleted\n30\tRecruiting\n60\tNot yet recruiting\n30\tRecruiting\n93\tRecruiting\n113\tCompleted\n6\tCompleted\n20\tNot yet recruiting\n500\tActive not recruiting\n60\tActive not recruiting\n80\tCompleted\n150\tRecruiting\n100\tRecruiting\n416\tRecruiting\n30\tCompleted\n260\tRecruiting\n100\tCompleted\n50\tSuspended\n30\tRecruiting\n90\tActive not recruiting\n30\tRecruiting\n20\tCompleted\n570\tRecruiting\n200\tRecruiting\n75\tActive not recruiting\n50\tRecruiting\n32\tCompleted\n116\tRecruiting\n12\tCompleted\n18\tTerminated                  Has Results\n40\tRecruiting\n71\tRecruiting\n440\tRecruiting\n60\tRecruiting\n1017\tCompleted\n24\tCompleted\n25\tActive not recruiting\n34\tCompleted\n90\tRecruiting\n67\tRecruiting\n1\tTerminated\n15\tRecruiting\n68\tRecruiting\n24\tRecruiting\n46\tRecruiting\n150\tRecruiting\n0\tWithdrawn\n90\tRecruiting\n51\tActive not recruiting\n39\tRecruiting\n66\tActive not recruiting\n120\tCompleted\n20\tSuspended\n2160\tActive not recruiting\n302\tActive not recruiting\n100\tRecruiting\n15\tRecruiting\n50\tRecruiting\n200\tRecruiting\n60\tActive not recruiting\n75\tRecruiting\n30\tRecruiting\n25\tTerminated\n50\tNot yet recruiting\n10\tCompleted\n25\tRecruiting\n9\tActive not recruiting\n240\tCompleted\n150\tRecruiting\n33\tActive not recruiting\n350\tActive not recruiting\n20\tCompleted\n50\tRecruiting\n10\tRecruiting\n100\tCompleted\n82\tRecruiting\n100\tRecruiting\n30\tActive not recruiting\n45\tRecruiting\n60\tRecruiting\n21\tActive not recruiting\n161\tCompleted\n40\tRecruiting\n40\tRecruiting\n20\tRecruiting\n150\tCompleted\n88\tCompleted                  Has Results\n275711\tActive not recruiting\n60\tRecruiting\n100\tActive not recruiting\n2000\tRecruiting\n60\tRecruiting\n300\tRecruiting\n203\tCompleted\n45\tCompleted\n100\tRecruiting\n12\tCompleted\n53\tCompleted\n60\tRecruiting\n6484\tEnrolling by invitation\n180\tRecruiting\n22\tCompleted                  Has Results\n10\tCompleted\n200\tRecruiting\n2669\tCompleted\n32\tCompleted\n80\tRecruiting\n0\tWithdrawn\n50\tRecruiting\n50\tRecruiting\n12\tRecruiting\n40\tCompleted\n50\tRecruiting\n10\tCompleted\n24\tRecruiting\n650\tNot yet recruiting\n18\tCompleted\n165\tRecruiting\n37\tCompleted\n7\tTerminated\n120\tActive not recruiting\n100\tRecruiting\n200\tRecruiting\n15\tActive not recruiting\n61\tCompleted\n150\tRecruiting\n1\tTerminated\n200\tRecruiting\n25\tActive not recruiting\n20\tRecruiting\n60\tEnrolling by invitation\n40\tRecruiting\n198\tRecruiting\n30\tRecruiting\n26\tCompleted\n60\tRecruiting\n100\tRecruiting\n24\tRecruiting\n28\tActive not recruiting\n20\tCompleted\n180\tRecruiting\n450\tNot yet recruiting\n33\tCompleted\n500\tUnknown&nbsp;&#8224;\n40\tRecruiting\n72\tRecruiting\n104\tCompleted\n109\tCompleted                  Has Results\n400\tActive not recruiting\n240\tActive not recruiting\n100\tRecruiting\n135\tCompleted\n12\tRecruiting\n10\tCompleted\n40\tActive not recruiting\n73\tCompleted\n82\tCompleted\n60\tCompleted\n250\tCompleted\n20\tRecruiting\n50\tRecruiting\n124\tRecruiting\n79\tCompleted\n60\tActive not recruiting\n9\tCompleted\n90\tRecruiting\n100\tActive not recruiting\n24\tRecruiting\n10\tTerminated                  Has Results\n150\tRecruiting\n40\tRecruiting\n102\tRecruiting\n300\tRecruiting\n100\tActive not recruiting\n175\tCompleted\n39\tCompleted\n60\tEnrolling by invitation\n30\tEnrolling by invitation\n60\tRecruiting\n500\tEnrolling by invitation\n230\tRecruiting\n25\tCompleted\n40\tRecruiting\n60\tRecruiting\n1\tTerminated\n0\tWithdrawn\n14\tRecruiting\n48\tRecruiting\n15\tActive not recruiting\n40\tRecruiting\n17\tActive not recruiting\n50\tRecruiting\n6\tTerminated\n120\tRecruiting\n11\tActive not recruiting\n24\tSuspended\n10\tCompleted\n26\tCompleted\n160\tSuspended\n13\tTerminated                  Has Results\n68\tCompleted\n30\tRecruiting\n27\tCompleted\n30\tRecruiting\n59\tCompleted\n1000\tNot yet recruiting\n2000\tEnrolling by invitation\n13\tTerminated\n15\tTerminated\n60\tNot yet recruiting\n30\tRecruiting\n0\tWithdrawn\n6\tCompleted\n56\tCompleted\n17\tCompleted\n54\tActive not recruiting\n50\tRecruiting\n90\tRecruiting\n220\tRecruiting\n20\tCompleted\n0\tWithdrawn\n6\tCompleted\n10\tRecruiting\n30\tUnknown&nbsp;&#8224;\n14\tCompleted\n50\tNot yet recruiting\n0\tWithdrawn\n6\tCompleted\n30\tCompleted\n50\tRecruiting\n28\tCompleted\n0\tWithdrawn\n30\tActive not recruiting\n30\tRecruiting\n23\tCompleted\n24\tActive not recruiting\n2\tCompleted\n44\tActive not recruiting\n0\tWithdrawn\n156\tUnknown&nbsp;&#8224;\n37\tCompleted\n421\tCompleted                  Has Results\n30\tRecruiting\n64\tCompleted\n60\tUnknown&nbsp;&#8224;\n374\tEnrolling by invitation\n30\tCompleted\n15\tActive not recruiting\n215\tRecruiting\n40\tCompleted\n75\tEnrolling by invitation\n40\tRecruiting\n65\tRecruiting\n132\tSuspended\n23\tCompleted\n6\tCompleted\n51\tCompleted\n46\tCompleted\n9\tCompleted                  Has Results\n30\tCompleted\n60\tCompleted\n\tNo longer available\n30\tEnrolling by invitation\n100\tRecruiting\n24\tCompleted\n85\tRecruiting\n20\tRecruiting\n28\tCompleted\n3\tCompleted\n0\tWithdrawn\n81\tCompleted\n700\tRecruiting\n28\tCompleted\n100\tRecruiting\n1\tTerminated                  Has Results\n34\tEnrolling by invitation\n11\tCompleted\n48\tCompleted\n20\tRecruiting\n0\tWithdrawn\n75\tRecruiting\n0\tWithdrawn\n16400\tUnknown&nbsp;&#8224;\n30\tCompleted\n42\tCompleted\n0\tWithdrawn\n17\tTerminated\n18\tCompleted\n24\tRecruiting\n50\tRecruiting\n30\tRecruiting\n71\tCompleted\n14717\tActive not recruiting\n20\tRecruiting\n25\tRecruiting\n90\tCompleted                  Has Results\n0\tWithdrawn\n34\tCompleted                  Has Results\n9\tCompleted\n8\tTerminated\n45\tCompleted\n57\tCompleted\n1500\tActive not recruiting\n20\tNot yet recruiting\n30\tRecruiting\n1\tTerminated\n32\tCompleted\n4\tTerminated\n6\tCompleted\n1500\tCompleted\n16\tCompleted\n19\tCompleted\n50\tRecruiting\n6\tCompleted\n20\tRecruiting\n30\tCompleted\n80\tActive not recruiting\n450\tActive not recruiting\n400\tRecruiting\n35\tCompleted\n37\tTerminated\n150\tUnknown&nbsp;&#8224;\n17\tTerminated\n20\tActive not recruiting\n250\tUnknown&nbsp;&#8224;\n40\tRecruiting\n80\tActive not recruiting\n28\tCompleted\n60\tRecruiting\n6\tTerminated\n\tNo longer available\n6\tTerminated\n60\tActive not recruiting\n122\tRecruiting\n100\tRecruiting\n6\tCompleted\n25\tCompleted\n60\tCompleted\n100\tRecruiting\n200\tRecruiting\n70\tCompleted                  Has Results\n350\tCompleted\n50\tSuspended\n30\tRecruiting\n153\tRecruiting\n30\tRecruiting\n1\tTerminated\n45\tActive not recruiting\n0\tWithdrawn\n30\tRecruiting\n50\tRecruiting\n0\tWithdrawn\n60\tCompleted\n40\tCompleted\n15\tActive not recruiting\n10\tCompleted\n10\tCompleted\n20\tRecruiting\n210\tCompleted                  Has Results\n36\tRecruiting\n575\tCompleted\n300\tActive not recruiting\n24\tActive not recruiting\n140\tRecruiting\n522\tRecruiting\n140\tRecruiting\n10\tEnrolling by invitation\n364\tCompleted\n15\tCompleted\n8\tTerminated\n101\tCompleted\n9\tTerminated\n250\tRecruiting\n50\tCompleted\n800\tEnrolling by invitation\n17\tTerminated                  Has Results\n1000\tEnrolling by invitation\n20\tRecruiting\n72\tCompleted\n16\tCompleted\n120\tRecruiting\n0\tWithdrawn\n308\tEnrolling by invitation\n0\tWithdrawn\n20\tActive not recruiting\n21\tCompleted\n57\tRecruiting\n120\tUnknown&nbsp;&#8224;\n10\tCompleted\n30\tCompleted\n138\tCompleted                  Has Results\n40\tCompleted\n20\tCompleted\n645\tActive not recruiting\n38\tCompleted\n134\tCompleted\n20\tCompleted                  Has Results\n20\tCompleted\n60\tActive not recruiting\n5000\tUnknown&nbsp;&#8224;\n20\tCompleted\n26\tCompleted\n13\tCompleted\n110\tCompleted\n140\tRecruiting\n1\tCompleted\n300\tUnknown&nbsp;&#8224;\n17\tTerminated\n382\tActive not recruiting\n10\tNot yet recruiting\n0\tWithdrawn\n30\tCompleted\n1000\tUnknown&nbsp;&#8224;\n250\tUnknown&nbsp;&#8224;\n60\tActive not recruiting\n38\tActive not recruiting\n100\tUnknown&nbsp;&#8224;\n38\tCompleted\n41\tCompleted\n2\tTerminated                  Has Results\n459\tCompleted                  Has Results\n28\tRecruiting\n17\tActive not recruiting\n0\tWithdrawn\n202\tActive not recruiting\n20\tRecruiting\n17\tCompleted\n41\tCompleted                  Has Results\n100\tActive not recruiting\n468\tRecruiting\n60\tActive not recruiting\n48\tCompleted\n20\tActive not recruiting\n50\tCompleted\n100\tRecruiting\n110\tCompleted\n20\tCompleted\n239\tCompleted\n50\tEnrolling by invitation\n60\tRecruiting\n13\tCompleted                  Has Results\n6\tCompleted\n120\tCompleted\n59\tCompleted                  Has Results\n18\tCompleted\n19\tTerminated\n13000\tRecruiting\n50\tRecruiting\n100\tActive not recruiting\n34\tCompleted\n36\tCompleted                  Has Results\n28\tCompleted\n320\tEnrolling by invitation\n6\tCompleted\n30\tActive not recruiting\n126\tRecruiting\n99\tCompleted\n10\tRecruiting\n48\tCompleted\n31\tCompleted\n20\tRecruiting\n50\tRecruiting\n78\tCompleted\n30\tRecruiting\n11\tCompleted\n38\tCompleted\n90\tRecruiting\n5\tCompleted\n20\tCompleted\n46\tCompleted                  Has Results\n2003\tCompleted\n25\tCompleted\n36\tCompleted\n21\tCompleted\n1000\tRecruiting\n12\tRecruiting\n41\tCompleted\n26\tCompleted\n35\tCompleted\n60\tActive not recruiting\n102\tCompleted                  Has Results\n16\tActive not recruiting\n200\tRecruiting\n15\tCompleted\n115\tCompleted\n\tAvailable\n15\tCompleted\n17\tCompleted\n30\tRecruiting\n102\tRecruiting\n60\tRecruiting\n500\tCompleted\n100\tRecruiting\n400\tActive not recruiting\n2623\tActive not recruiting\n90\tCompleted\n8\tCompleted\n4344\tCompleted\n14\tCompleted\n30\tCompleted\n81\tCompleted\n25\tCompleted\n95\tRecruiting\n90\tCompleted\n16\tCompleted\n10\tActive not recruiting\n20\tUnknown&nbsp;&#8224;\n107\tCompleted\n80\tRecruiting\n1650\tActive not recruiting\n50\tUnknown&nbsp;&#8224;\n67\tCompleted\n10\tActive not recruiting\n76\tCompleted\n21\tActive not recruiting\n76\tCompleted\n13\tTerminated\n100\tRecruiting\n225\tActive not recruiting\n50\tCompleted\n48\tCompleted\n10\tTerminated                  Has Results\n26\tCompleted\n24\tCompleted                  Has Results\n285\tActive not recruiting\n26\tCompleted                  Has Results\n230\tCompleted\n351\tActive not recruiting\n0\tWithdrawn\n83\tCompleted\n37\tCompleted\n60\tActive not recruiting\n511\tRecruiting\n40\tEnrolling by invitation\n70\tCompleted\n73\tCompleted\n67\tCompleted                  Has Results\n210\tActive not recruiting\n40\tCompleted\n40\tCompleted\n30\tActive not recruiting\n72\tUnknown&nbsp;&#8224;\n29\tTerminated\n150\tRecruiting\n57\tCompleted\n150\tCompleted\n626\tCompleted                  Has Results\n135\tCompleted                  Has Results\n12\tUnknown&nbsp;&#8224;\n20\tCompleted\n0\tWithdrawn\n100\tRecruiting\n20\tCompleted\n18\tCompleted\n28\tCompleted\n48\tCompleted\n57\tCompleted                  Has Results\n100\tActive not recruiting\n243\tActive not recruiting\n63\tCompleted\n25\tCompleted                  Has Results\n569\tCompleted\n12\tActive not recruiting\n100\tRecruiting\n192\tCompleted\n77\tTerminated\n260\tActive not recruiting\n200\tCompleted\n44\tCompleted\n237\tCompleted\n90\tActive not recruiting\n36\tCompleted\n359\tCompleted\n1276\tActive not recruiting\n40\tCompleted\n8\tCompleted\n15\tActive not recruiting\n240\tCompleted\n5\tTerminated\n5\tTerminated                  Has Results\n96\tRecruiting\n18\tCompleted\n7\tTerminated\n10\tRecruiting\n30\tActive not recruiting\n24\tActive not recruiting\n12\tUnknown&nbsp;&#8224;\n130\tCompleted\n690\tRecruiting\n24\tCompleted                  Has Results\n40\tCompleted                  Has Results\n29\tActive not recruiting\n25\tCompleted\n194\tActive not recruiting\n20\tCompleted\n1000\tActive not recruiting\n170\tActive not recruiting\n66\tCompleted\n68\tCompleted                  Has Results\n132\tCompleted\n40\tCompleted\n18\tCompleted                  Has Results\n24\tTerminated\n100\tRecruiting\n58\tCompleted\n16\tCompleted\n18\tEnrolling by invitation\n38\tCompleted\n5\tCompleted                  Has Results\n34\tCompleted\n50\tCompleted                  Has Results\n140\tCompleted\n240\tActive not recruiting\n150\tRecruiting\n34\tCompleted\n100\tRecruiting\n26\tCompleted\n61\tActive not recruiting\n33\tActive not recruiting\n1\tTerminated\n60\tCompleted\n22\tCompleted\n13\tRecruiting\n\tAvailable\n60\tRecruiting\n60\tCompleted\n\n<font color=red>Results are limited by 1000.</font>","comment":"<font color=red>Results are limited by 1000.</font>","msgTable":[[{"key":"status","value":"100"},{"key":"status","value":"Recruiting"}],[{"value":"150"},{"value":"Recruiting"}],[{"value":"450"},{"value":"Recruiting"}],[{"value":"60"},{"value":"Recruiting"}],[{"value":"35"},{"value":"Not yet recruiting"}],[{"value":"40"},{"value":"Not yet recruiting"}],[{"value":"230"},{"value":"Not yet recruiting"}],[{"value":"500"},{"value":"Not yet recruiting"}],[{"value":"100"},{"value":"Recruiting"}],[{"value":"20"},{"value":"Not yet recruiting"}],[{"value":"80"},{"value":"Not yet recruiting"}],[{"value":"350"},{"value":"Recruiting"}],[{"value":"102"},{"value":"Recruiting"}],[{"value":"120"},{"value":"Recruiting"}],[{"value":"8"},{"value":"Not yet recruiting"}],[{"value":"60"},{"value":"Recruiting"}],[{"value":"60"},{"value":"Recruiting"}],[{"value":"60"},{"value":"Recruiting"}],[{"value":"20"},{"value":"Recruiting"}],[{"value":"75"},{"value":"Not yet recruiting"}],[{"value":"120"},{"value":"Not yet recruiting"}],[{"value":"20"},{"value":"Recruiting"}],[{"value":"99"},{"value":"Not yet recruiting"}],[{"value":"24"},{"value":"Not yet recruiting"}],[{"value":"30"},{"value":"Recruiting"}],[{"value":"40"},{"value":"Recruiting"}],[{"value":"5000"},{"value":"Recruiting"}],[{"value":"60"},{"value":"Not yet recruiting"}],[{"value":"400"},{"value":"Recruiting"}],[{"value":"100"},{"value":"Not yet recruiting"}],[{"value":"100"},{"value":"Recruiting"}],[{"value":"180"},{"value":"Recruiting"}],[{"value":"60"},{"value":"Recruiting"}],[{"value":"100"},{"value":"Not yet recruiting"}],[{"value":"60"},{"value":"Recruiting"}],[{"value":"60"},{"value":"Recruiting"}],[{"value":"60"},{"value":"Not yet recruiting"}],[{"value":"350"},{"value":"Not yet recruiting"}],[{"value":"20"},{"value":"Not yet recruiting"}],[{"value":"32"},{"value":"Not yet recruiting"}],[{"value":"54"},{"value":"Not yet recruiting"}],[{"value":"24"},{"value":"Recruiting"}],[{"value":"300"},{"value":"Not yet recruiting"}],[{"value":"50"},{"value":"Enrolling by invitation"}],[{"value":"100"},{"value":"Recruiting"}],[{"value":"22"},{"value":"Recruiting"}],[{"value":"12"},{"value":"Not yet recruiting"}],[{"value":"60"},{"value":"Recruiting"}],[{"value":"20"},{"value":"Recruiting"}],[{"value":"100"},{"value":"Recruiting"}],[{"value":"120"},{"value":"Not yet recruiting"}],[{"value":"25"},{"value":"Recruiting"}],[{"value":"60"},{"value":"Recruiting"}],[{"value":"50"},{"value":"Not yet recruiting"}],[{"value":"102"},{"value":"Completed"}],[{"value":"167"},{"value":"Completed"}],[{"value":"40"},{"value":"Not yet recruiting"}],[{"value":"880"},{"value":"Recruiting"}],[{"value":"36"},{"value":"Recruiting"}],[{"value":"44"},{"value":"Recruiting"}],[{"value":"60"},{"value":"Not yet recruiting"}],[{"value":"7"},{"value":"Recruiting"}],[{"value":"210"},{"value":"Not yet recruiting"}],[{"value":"100"},{"value":"Recruiting"}],[{"value":"32"},{"value":"Recruiting"}],[{"value":"200"},{"value":"Recruiting"}],[{"value":"30"},{"value":"Recruiting"}],[{"value":"164"},{"value":"Recruiting"}],[{"value":"68"},{"value":"Completed"}],[{"value":"45"},{"value":"Not yet recruiting"}],[{"value":"139"},{"value":"Active not recruiting"}],[{"value":"200"},{"value":"Active not recruiting"}],[{"value":"200"},{"value":"Recruiting"}],[{"value":"50"},{"value":"Not yet recruiting"}],[{"value":"16"},{"value":"Not yet recruiting"}],[{"value":"100"},{"value":"Enrolling by invitation"}],[{"value":"75"},{"value":"Recruiting"}],[{"value":"1000"},{"value":"Recruiting"}],[{"value":"40"},{"value":"Recruiting"}],[{"value":"10"},{"value":"Recruiting"}],[{"value":"20"},{"value":"Not yet recruiting"}],[{"value":"30"},{"value":"Not yet recruiting"}],[{"value":"20"},{"value":"Recruiting"}],[{"value":"40"},{"value":"Recruiting"}],[{"value":"165"},{"value":"Recruiting"}],[{"value":"3000"},{"value":"Recruiting"}],[{"value":"24"},{"value":"Recruiting"}],[{"value":"12"},{"value":"Recruiting"}],[{"value":"60"},{"value":"Enrolling by invitation"}],[{"value":"18"},{"value":"Completed"}],[{"value":"850"},{"value":"Not yet recruiting"}],[{"value":"40"},{"value":"Recruiting"}],[{"value":"70"},{"value":"Not yet recruiting"}],[{"value":"50"},{"value":"Not yet recruiting"}],[{"value":"250"},{"value":"Not yet recruiting"}],[{"value":"46"},{"value":"Recruiting"}],[{"value":"300"},{"value":"Recruiting"}],[{"value":"200"},{"value":"Enrolling by invitation"}],[{"value":"20"},{"value":"Not yet recruiting"}],[{"value":"400"},{"value":"Recruiting"}],[{"value":"100"},{"value":"Recruiting"}],[{"value":"25"},{"value":"Recruiting"}],[{"value":"250"},{"value":"Not yet recruiting"}],[{"value":"40"},{"value":"Recruiting"}],[{"value":"276"},{"value":"Not yet recruiting"}],[{"value":"25"},{"value":"Recruiting"}],[{"value":"30"},{"value":"Not yet recruiting"}],[{"value":"34"},{"value":"Recruiting"}],[{"value":"40"},{"value":"Recruiting"}],[{"value":"300"},{"value":"Recruiting"}],[{"value":"330"},{"value":"Not yet recruiting"}],[{"value":"28"},{"value":"Not yet recruiting"}],[{"value":"274"},{"value":"Not yet recruiting"}],[{"value":"30"},{"value":"Recruiting"}],[{"value":""},{"value":"Recruiting"}],[{"value":"350"},{"value":"Recruiting"}],[{"value":"1000"},{"value":"Not yet recruiting"}],[{"value":"24"},{"value":"Active not recruiting"}],[{"value":"40"},{"value":"Recruiting"}],[{"value":"45"},{"value":"Recruiting"}],[{"value":"20"},{"value":"Recruiting"}],[{"value":"2400"},{"value":"Recruiting"}],[{"value":"50"},{"value":"Recruiting"}],[{"value":"30"},{"value":"Recruiting"}],[{"value":"87"},{"value":"Recruiting"}],[{"value":"360"},{"value":"Recruiting"}],[{"value":"40"},{"value":"Recruiting"}],[{"value":"85"},{"value":"Recruiting"}],[{"value":"36"},{"value":"Recruiting"}],[{"value":"24"},{"value":"Recruiting"}],[{"value":"0"},{"value":"Withdrawn"}],[{"value":"60"},{"value":"Recruiting"}],[{"value":"70"},{"value":"Not yet recruiting"}],[{"value":"1520"},{"value":"Recruiting"}],[{"value":"20"},{"value":"Not yet recruiting"}],[{"value":"74"},{"value":"Not yet recruiting"}],[{"value":"98"},{"value":"Recruiting"}],[{"value":"50"},{"value":"Recruiting"}],[{"value":"24"},{"value":"Not yet recruiting"}],[{"value":"100"},{"value":"Not yet recruiting"}],[{"value":"25"},{"value":"Recruiting"}],[{"value":"40"},{"value":"Recruiting"}],[{"value":"200"},{"value":"Recruiting"}],[{"value":"120"},{"value":"Recruiting"}],[{"value":"18"},{"value":"Active not recruiting"}],[{"value":"30"},{"value":"Not yet recruiting"}],[{"value":"432"},{"value":"Recruiting"}],[{"value":"10"},{"value":"Completed"}],[{"value":"53"},{"value":"Completed"}],[{"value":"19"},{"value":"Active not recruiting"}],[{"value":"4"},{"value":"Not yet recruiting"}],[{"value":"124"},{"value":"Recruiting"}],[{"value":"54"},{"value":"Terminated"}],[{"value":"15"},{"value":"Recruiting"}],[{"value":"96"},{"value":"Not yet recruiting"}],[{"value":"40"},{"value":"Recruiting"}],[{"value":"5"},{"value":"Recruiting"}],[{"value":"16"},{"value":"Enrolling by invitation"}],[{"value":"120"},{"value":"Recruiting"}],[{"value":"60"},{"value":"Recruiting"}],[{"value":"125"},{"value":"Recruiting"}],[{"value":"40"},{"value":"Not yet recruiting"}],[{"value":"40"},{"value":"Not yet recruiting"}],[{"value":"220"},{"value":"Recruiting"}],[{"value":"250"},{"value":"Recruiting"}],[{"value":"50"},{"value":"Active not recruiting"}],[{"value":"8"},{"value":"Recruiting"}],[{"value":"23"},{"value":"Active not recruiting"}],[{"value":"60"},{"value":"Not yet recruiting"}],[{"value":"12"},{"value":"Recruiting"}],[{"value":"100"},{"value":"Recruiting"}],[{"value":"1000"},{"value":"Recruiting"}],[{"value":"32"},{"value":"Not yet recruiting"}],[{"value":"77"},{"value":"Active not recruiting"}],[{"value":"158"},{"value":"Recruiting"}],[{"value":"1200"},{"value":"Recruiting"}],[{"value":"98"},{"value":"Recruiting"}],[{"value":"80"},{"value":"Recruiting"}],[{"value":"96"},{"value":"Recruiting"}],[{"value":"39"},{"value":"Recruiting"}],[{"value":"31"},{"value":"Recruiting"}],[{"value":"12"},{"value":"Recruiting"}],[{"value":"300"},{"value":"Recruiting"}],[{"value":"65"},{"value":"Active not recruiting"}],[{"value":"105"},{"value":"Recruiting"}],[{"value":"75"},{"value":"Recruiting"}],[{"value":"200"},{"value":"Recruiting"}],[{"value":"70"},{"value":"Recruiting"}],[{"value":"30"},{"value":"Recruiting"}],[{"value":"60"},{"value":"Recruiting"}],[{"value":"120"},{"value":"Recruiting"}],[{"value":"100"},{"value":"Completed"}],[{"value":"48"},{"value":"Completed"}],[{"value":"500"},{"value":"Recruiting"}],[{"value":"2310"},{"value":"Recruiting"}],[{"value":"18"},{"value":"Recruiting"}],[{"value":"20"},{"value":"Recruiting"}],[{"value":"210"},{"value":"Recruiting"}],[{"value":"66"},{"value":"Recruiting"}],[{"value":"345"},{"value":"Recruiting"}],[{"value":"100"},{"value":"Recruiting"}],[{"value":"510"},{"value":"Recruiting"}],[{"value":"110"},{"value":"Enrolling by invitation"}],[{"value":"60"},{"value":"Recruiting"}],[{"value":"41"},{"value":"Completed"}],[{"value":"24"},{"value":"Completed"}],[{"value":"60"},{"value":"Active not recruiting"}],[{"value":"22"},{"value":"Recruiting"}],[{"value":"30"},{"value":"Recruiting"}],[{"value":"24"},{"value":"Active not recruiting"}],[{"value":"150"},{"value":"Recruiting"}],[{"value":"84"},{"value":"Recruiting"}],[{"value":"60"},{"value":"Recruiting"}],[{"value":"90"},{"value":"Recruiting"}],[{"value":"50"},{"value":"Recruiting"}],[{"value":"30"},{"value":"Recruiting"}],[{"value":"80"},{"value":"Recruiting"}],[{"value":"30"},{"value":"Recruiting"}],[{"value":"10"},{"value":"Recruiting"}],[{"value":"24"},{"value":"Recruiting"}],[{"value":"50"},{"value":"Recruiting"}],[{"value":"50"},{"value":"Recruiting"}],[{"value":"100"},{"value":"Recruiting"}],[{"value":"46"},{"value":"Recruiting"}],[{"value":"160"},{"value":"Recruiting"}],[{"value":"18"},{"value":"Recruiting"}],[{"value":"10"},{"value":"Completed"}],[{"value":"29"},{"value":"Recruiting"}],[{"value":"22"},{"value":"Recruiting"}],[{"value":"40"},{"value":"Recruiting"}],[{"value":"75"},{"value":"Recruiting"}],[{"value":"64"},{"value":"Recruiting"}],[{"value":"300"},{"value":"Recruiting"}],[{"value":"30"},{"value":"Recruiting"}],[{"value":"2000"},{"value":"Completed"}],[{"value":"15"},{"value":"Active not recruiting"}],[{"value":"84"},{"value":"Recruiting"}],[{"value":"36"},{"value":"Recruiting"}],[{"value":"375"},{"value":"Not yet recruiting"}],[{"value":"240"},{"value":"Recruiting"}],[{"value":"36"},{"value":"Active not recruiting"}],[{"value":"24"},{"value":"Recruiting"}],[{"value":"75"},{"value":"Recruiting"}],[{"value":"30"},{"value":"Recruiting"}],[{"value":"250"},{"value":"Recruiting"}],[{"value":"27"},{"value":"Recruiting"}],[{"value":"20"},{"value":"Recruiting"}],[{"value":"75"},{"value":"Recruiting"}],[{"value":"60"},{"value":"Not yet recruiting"}],[{"value":"90"},{"value":"Recruiting"}],[{"value":"20"},{"value":"Recruiting"}],[{"value":"222"},{"value":"Active not recruiting"}],[{"value":"30"},{"value":"Recruiting"}],[{"value":"40"},{"value":"Completed"}],[{"value":"20"},{"value":"Recruiting"}],[{"value":"120"},{"value":"Recruiting"}],[{"value":"100"},{"value":"Recruiting"}],[{"value":"65"},{"value":"Recruiting"}],[{"value":"100"},{"value":"Recruiting"}],[{"value":"50"},{"value":"Recruiting"}],[{"value":"23"},{"value":"Completed                  Has Results"}],[{"value":"100"},{"value":"Recruiting"}],[{"value":"110"},{"value":"Recruiting"}],[{"value":"48"},{"value":"Recruiting"}],[{"value":"100"},{"value":"Recruiting"}],[{"value":"300"},{"value":"Recruiting"}],[{"value":"30"},{"value":"Recruiting"}],[{"value":"60"},{"value":"Recruiting"}],[{"value":"1656"},{"value":"Active not recruiting"}],[{"value":"248"},{"value":"Recruiting"}],[{"value":"250"},{"value":"Recruiting"}],[{"value":"500000"},{"value":"Active not recruiting"}],[{"value":"120"},{"value":"Recruiting"}],[{"value":"25"},{"value":"Recruiting"}],[{"value":"25"},{"value":"Enrolling by invitation"}],[{"value":"78"},{"value":"Recruiting"}],[{"value":"61"},{"value":"Recruiting"}],[{"value":"240"},{"value":"Recruiting"}],[{"value":"300"},{"value":"Recruiting"}],[{"value":"70"},{"value":"Completed"}],[{"value":"66"},{"value":"Recruiting"}],[{"value":"80"},{"value":"Recruiting"}],[{"value":"52"},{"value":"Recruiting"}],[{"value":"99"},{"value":"Completed"}],[{"value":"66"},{"value":"Recruiting"}],[{"value":"26"},{"value":"Recruiting"}],[{"value":"5"},{"value":"Recruiting"}],[{"value":"40"},{"value":"Completed"}],[{"value":"160"},{"value":"Recruiting"}],[{"value":"400"},{"value":"Recruiting"}],[{"value":"16"},{"value":"Suspended"}],[{"value":"80"},{"value":"Recruiting"}],[{"value":"28"},{"value":"Completed"}],[{"value":"150"},{"value":"Recruiting"}],[{"value":"260"},{"value":"Enrolling by invitation"}],[{"value":"39"},{"value":"Completed"}],[{"value":"100"},{"value":"Recruiting"}],[{"value":"40"},{"value":"Completed"}],[{"value":"13"},{"value":"Active not recruiting"}],[{"value":"50"},{"value":"Recruiting"}],[{"value":"30"},{"value":"Recruiting"}],[{"value":"400"},{"value":"Recruiting"}],[{"value":"550"},{"value":"Recruiting"}],[{"value":"600"},{"value":"Not yet recruiting"}],[{"value":"350"},{"value":"Recruiting"}],[{"value":"360"},{"value":"Active not recruiting"}],[{"value":"130"},{"value":"Recruiting"}],[{"value":"186"},{"value":"Completed"}],[{"value":"33"},{"value":"Completed"}],[{"value":"300"},{"value":"Not yet recruiting"}],[{"value":"15"},{"value":"Recruiting"}],[{"value":"50"},{"value":"Recruiting"}],[{"value":"12"},{"value":"Recruiting"}],[{"value":"750"},{"value":"Recruiting"}],[{"value":"15"},{"value":"Completed"}],[{"value":"15"},{"value":"Enrolling by invitation"}],[{"value":"50"},{"value":"Completed"}],[{"value":"100"},{"value":"Recruiting"}],[{"value":"40"},{"value":"Recruiting"}],[{"value":"3000"},{"value":"Active not recruiting"}],[{"value":"35"},{"value":"Recruiting"}],[{"value":"10000"},{"value":"Enrolling by invitation"}],[{"value":"6"},{"value":"Completed"}],[{"value":"40"},{"value":"Not yet recruiting"}],[{"value":"100"},{"value":"Recruiting"}],[{"value":"500"},{"value":"Not yet recruiting"}],[{"value":"0"},{"value":"Withdrawn"}],[{"value":"20"},{"value":"Recruiting"}],[{"value":"0"},{"value":"Withdrawn"}],[{"value":"45"},{"value":"Recruiting"}],[{"value":"20"},{"value":"Active not recruiting"}],[{"value":"200"},{"value":"Not yet recruiting"}],[{"value":"14"},{"value":"Active not recruiting"}],[{"value":"5975"},{"value":"Recruiting"}],[{"value":"200"},{"value":"Recruiting"}],[{"value":"400"},{"value":"Active not recruiting"}],[{"value":"28"},{"value":"Completed"}],[{"value":"115"},{"value":"Recruiting"}],[{"value":"60"},{"value":"Completed"}],[{"value":"30"},{"value":"Recruiting"}],[{"value":"115"},{"value":"Recruiting"}],[{"value":"104"},{"value":"Active not recruiting"}],[{"value":"50"},{"value":"Recruiting"}],[{"value":"0"},{"value":"Withdrawn"}],[{"value":"131"},{"value":"Recruiting"}],[{"value":"100"},{"value":"Recruiting"}],[{"value":"100"},{"value":"Recruiting"}],[{"value":"210"},{"value":"Recruiting"}],[{"value":"20"},{"value":"Recruiting"}],[{"value":"315"},{"value":"Recruiting"}],[{"value":"20"},{"value":"Active not recruiting"}],[{"value":"30"},{"value":"Recruiting"}],[{"value":"60"},{"value":"Recruiting"}],[{"value":"84"},{"value":"Active not recruiting"}],[{"value":"60"},{"value":"Recruiting"}],[{"value":"70"},{"value":"Recruiting"}],[{"value":"100"},{"value":"Recruiting"}],[{"value":"0"},{"value":"Withdrawn"}],[{"value":"2"},{"value":"Terminated"}],[{"value":"48"},{"value":"Completed"}],[{"value":"40"},{"value":"Recruiting"}],[{"value":"472"},{"value":"Recruiting"}],[{"value":"16"},{"value":"Recruiting"}],[{"value":"500"},{"value":"Enrolling by invitation"}],[{"value":"30"},{"value":"Recruiting"}],[{"value":"0"},{"value":"Withdrawn"}],[{"value":"30"},{"value":"Recruiting"}],[{"value":"36"},{"value":"Suspended"}],[{"value":"80"},{"value":"Completed"}],[{"value":"40"},{"value":"Recruiting"}],[{"value":"11"},{"value":"Completed"}],[{"value":"131"},{"value":"Completed"}],[{"value":"41"},{"value":"Completed"}],[{"value":"50"},{"value":"Recruiting"}],[{"value":"220"},{"value":"Completed"}],[{"value":"30"},{"value":"Recruiting"}],[{"value":"60"},{"value":"Not yet recruiting"}],[{"value":"30"},{"value":"Recruiting"}],[{"value":"93"},{"value":"Recruiting"}],[{"value":"113"},{"value":"Completed"}],[{"value":"6"},{"value":"Completed"}],[{"value":"20"},{"value":"Not yet recruiting"}],[{"value":"500"},{"value":"Active not recruiting"}],[{"value":"60"},{"value":"Active not recruiting"}],[{"value":"80"},{"value":"Completed"}],[{"value":"150"},{"value":"Recruiting"}],[{"value":"100"},{"value":"Recruiting"}],[{"value":"416"},{"value":"Recruiting"}],[{"value":"30"},{"value":"Completed"}],[{"value":"260"},{"value":"Recruiting"}],[{"value":"100"},{"value":"Completed"}],[{"value":"50"},{"value":"Suspended"}],[{"value":"30"},{"value":"Recruiting"}],[{"value":"90"},{"value":"Active not recruiting"}],[{"value":"30"},{"value":"Recruiting"}],[{"value":"20"},{"value":"Completed"}],[{"value":"570"},{"value":"Recruiting"}],[{"value":"200"},{"value":"Recruiting"}],[{"value":"75"},{"value":"Active not recruiting"}],[{"value":"50"},{"value":"Recruiting"}],[{"value":"32"},{"value":"Completed"}],[{"value":"116"},{"value":"Recruiting"}],[{"value":"12"},{"value":"Completed"}],[{"value":"18"},{"value":"Terminated                  Has Results"}],[{"value":"40"},{"value":"Recruiting"}],[{"value":"71"},{"value":"Recruiting"}],[{"value":"440"},{"value":"Recruiting"}],[{"value":"60"},{"value":"Recruiting"}],[{"value":"1017"},{"value":"Completed"}],[{"value":"24"},{"value":"Completed"}],[{"value":"25"},{"value":"Active not recruiting"}],[{"value":"34"},{"value":"Completed"}],[{"value":"90"},{"value":"Recruiting"}],[{"value":"67"},{"value":"Recruiting"}],[{"value":"1"},{"value":"Terminated"}],[{"value":"15"},{"value":"Recruiting"}],[{"value":"68"},{"value":"Recruiting"}],[{"value":"24"},{"value":"Recruiting"}],[{"value":"46"},{"value":"Recruiting"}],[{"value":"150"},{"value":"Recruiting"}],[{"value":"0"},{"value":"Withdrawn"}],[{"value":"90"},{"value":"Recruiting"}],[{"value":"51"},{"value":"Active not recruiting"}],[{"value":"39"},{"value":"Recruiting"}],[{"value":"66"},{"value":"Active not recruiting"}],[{"value":"120"},{"value":"Completed"}],[{"value":"20"},{"value":"Suspended"}],[{"value":"2160"},{"value":"Active not recruiting"}],[{"value":"302"},{"value":"Active not recruiting"}],[{"value":"100"},{"value":"Recruiting"}],[{"value":"15"},{"value":"Recruiting"}],[{"value":"50"},{"value":"Recruiting"}],[{"value":"200"},{"value":"Recruiting"}],[{"value":"60"},{"value":"Active not recruiting"}],[{"value":"75"},{"value":"Recruiting"}],[{"value":"30"},{"value":"Recruiting"}],[{"value":"25"},{"value":"Terminated"}],[{"value":"50"},{"value":"Not yet recruiting"}],[{"value":"10"},{"value":"Completed"}],[{"value":"25"},{"value":"Recruiting"}],[{"value":"9"},{"value":"Active not recruiting"}],[{"value":"240"},{"value":"Completed"}],[{"value":"150"},{"value":"Recruiting"}],[{"value":"33"},{"value":"Active not recruiting"}],[{"value":"350"},{"value":"Active not recruiting"}],[{"value":"20"},{"value":"Completed"}],[{"value":"50"},{"value":"Recruiting"}],[{"value":"10"},{"value":"Recruiting"}],[{"value":"100"},{"value":"Completed"}],[{"value":"82"},{"value":"Recruiting"}],[{"value":"100"},{"value":"Recruiting"}],[{"value":"30"},{"value":"Active not recruiting"}],[{"value":"45"},{"value":"Recruiting"}],[{"value":"60"},{"value":"Recruiting"}],[{"value":"21"},{"value":"Active not recruiting"}],[{"value":"161"},{"value":"Completed"}],[{"value":"40"},{"value":"Recruiting"}],[{"value":"40"},{"value":"Recruiting"}],[{"value":"20"},{"value":"Recruiting"}],[{"value":"150"},{"value":"Completed"}],[{"value":"88"},{"value":"Completed                  Has Results"}],[{"value":"275711"},{"value":"Active not recruiting"}],[{"value":"60"},{"value":"Recruiting"}],[{"value":"100"},{"value":"Active not recruiting"}],[{"value":"2000"},{"value":"Recruiting"}],[{"value":"60"},{"value":"Recruiting"}],[{"value":"300"},{"value":"Recruiting"}],[{"value":"203"},{"value":"Completed"}],[{"value":"45"},{"value":"Completed"}],[{"value":"100"},{"value":"Recruiting"}],[{"value":"12"},{"value":"Completed"}],[{"value":"53"},{"value":"Completed"}],[{"value":"60"},{"value":"Recruiting"}],[{"value":"6484"},{"value":"Enrolling by invitation"}],[{"value":"180"},{"value":"Recruiting"}],[{"value":"22"},{"value":"Completed                  Has Results"}],[{"value":"10"},{"value":"Completed"}],[{"value":"200"},{"value":"Recruiting"}],[{"value":"2669"},{"value":"Completed"}],[{"value":"32"},{"value":"Completed"}],[{"value":"80"},{"value":"Recruiting"}],[{"value":"0"},{"value":"Withdrawn"}],[{"value":"50"},{"value":"Recruiting"}],[{"value":"50"},{"value":"Recruiting"}],[{"value":"12"},{"value":"Recruiting"}],[{"value":"40"},{"value":"Completed"}],[{"value":"50"},{"value":"Recruiting"}],[{"value":"10"},{"value":"Completed"}],[{"value":"24"},{"value":"Recruiting"}],[{"value":"650"},{"value":"Not yet recruiting"}],[{"value":"18"},{"value":"Completed"}],[{"value":"165"},{"value":"Recruiting"}],[{"value":"37"},{"value":"Completed"}],[{"value":"7"},{"value":"Terminated"}],[{"value":"120"},{"value":"Active not recruiting"}],[{"value":"100"},{"value":"Recruiting"}],[{"value":"200"},{"value":"Recruiting"}],[{"value":"15"},{"value":"Active not recruiting"}],[{"value":"61"},{"value":"Completed"}],[{"value":"150"},{"value":"Recruiting"}],[{"value":"1"},{"value":"Terminated"}],[{"value":"200"},{"value":"Recruiting"}],[{"value":"25"},{"value":"Active not recruiting"}],[{"value":"20"},{"value":"Recruiting"}],[{"value":"60"},{"value":"Enrolling by invitation"}],[{"value":"40"},{"value":"Recruiting"}],[{"value":"198"},{"value":"Recruiting"}],[{"value":"30"},{"value":"Recruiting"}],[{"value":"26"},{"value":"Completed"}],[{"value":"60"},{"value":"Recruiting"}],[{"value":"100"},{"value":"Recruiting"}],[{"value":"24"},{"value":"Recruiting"}],[{"value":"28"},{"value":"Active not recruiting"}],[{"value":"20"},{"value":"Completed"}],[{"value":"180"},{"value":"Recruiting"}],[{"value":"450"},{"value":"Not yet recruiting"}],[{"value":"33"},{"value":"Completed"}],[{"value":"500"},{"value":"Unknown&nbsp;&#8224;"}],[{"value":"40"},{"value":"Recruiting"}],[{"value":"72"},{"value":"Recruiting"}],[{"value":"104"},{"value":"Completed"}],[{"value":"109"},{"value":"Completed                  Has Results"}],[{"value":"400"},{"value":"Active not recruiting"}],[{"value":"240"},{"value":"Active not recruiting"}],[{"value":"100"},{"value":"Recruiting"}],[{"value":"135"},{"value":"Completed"}],[{"value":"12"},{"value":"Recruiting"}],[{"value":"10"},{"value":"Completed"}],[{"value":"40"},{"value":"Active not recruiting"}],[{"value":"73"},{"value":"Completed"}],[{"value":"82"},{"value":"Completed"}],[{"value":"60"},{"value":"Completed"}],[{"value":"250"},{"value":"Completed"}],[{"value":"20"},{"value":"Recruiting"}],[{"value":"50"},{"value":"Recruiting"}],[{"value":"124"},{"value":"Recruiting"}],[{"value":"79"},{"value":"Completed"}],[{"value":"60"},{"value":"Active not recruiting"}],[{"value":"9"},{"value":"Completed"}],[{"value":"90"},{"value":"Recruiting"}],[{"value":"100"},{"value":"Active not recruiting"}],[{"value":"24"},{"value":"Recruiting"}],[{"value":"10"},{"value":"Terminated                  Has Results"}],[{"value":"150"},{"value":"Recruiting"}],[{"value":"40"},{"value":"Recruiting"}],[{"value":"102"},{"value":"Recruiting"}],[{"value":"300"},{"value":"Recruiting"}],[{"value":"100"},{"value":"Active not recruiting"}],[{"value":"175"},{"value":"Completed"}],[{"value":"39"},{"value":"Completed"}],[{"value":"60"},{"value":"Enrolling by invitation"}],[{"value":"30"},{"value":"Enrolling by invitation"}],[{"value":"60"},{"value":"Recruiting"}],[{"value":"500"},{"value":"Enrolling by invitation"}],[{"value":"230"},{"value":"Recruiting"}],[{"value":"25"},{"value":"Completed"}],[{"value":"40"},{"value":"Recruiting"}],[{"value":"60"},{"value":"Recruiting"}],[{"value":"1"},{"value":"Terminated"}],[{"value":"0"},{"value":"Withdrawn"}],[{"value":"14"},{"value":"Recruiting"}],[{"value":"48"},{"value":"Recruiting"}],[{"value":"15"},{"value":"Active not recruiting"}],[{"value":"40"},{"value":"Recruiting"}],[{"value":"17"},{"value":"Active not recruiting"}],[{"value":"50"},{"value":"Recruiting"}],[{"value":"6"},{"value":"Terminated"}],[{"value":"120"},{"value":"Recruiting"}],[{"value":"11"},{"value":"Active not recruiting"}],[{"value":"24"},{"value":"Suspended"}],[{"value":"10"},{"value":"Completed"}],[{"value":"26"},{"value":"Completed"}],[{"value":"160"},{"value":"Suspended"}],[{"value":"13"},{"value":"Terminated                  Has Results"}],[{"value":"68"},{"value":"Completed"}],[{"value":"30"},{"value":"Recruiting"}],[{"value":"27"},{"value":"Completed"}],[{"value":"30"},{"value":"Recruiting"}],[{"value":"59"},{"value":"Completed"}],[{"value":"1000"},{"value":"Not yet recruiting"}],[{"value":"2000"},{"value":"Enrolling by invitation"}],[{"value":"13"},{"value":"Terminated"}],[{"value":"15"},{"value":"Terminated"}],[{"value":"60"},{"value":"Not yet recruiting"}],[{"value":"30"},{"value":"Recruiting"}],[{"value":"0"},{"value":"Withdrawn"}],[{"value":"6"},{"value":"Completed"}],[{"value":"56"},{"value":"Completed"}],[{"value":"17"},{"value":"Completed"}],[{"value":"54"},{"value":"Active not recruiting"}],[{"value":"50"},{"value":"Recruiting"}],[{"value":"90"},{"value":"Recruiting"}],[{"value":"220"},{"value":"Recruiting"}],[{"value":"20"},{"value":"Completed"}],[{"value":"0"},{"value":"Withdrawn"}],[{"value":"6"},{"value":"Completed"}],[{"value":"10"},{"value":"Recruiting"}],[{"value":"30"},{"value":"Unknown&nbsp;&#8224;"}],[{"value":"14"},{"value":"Completed"}],[{"value":"50"},{"value":"Not yet recruiting"}],[{"value":"0"},{"value":"Withdrawn"}],[{"value":"6"},{"value":"Completed"}],[{"value":"30"},{"value":"Completed"}],[{"value":"50"},{"value":"Recruiting"}],[{"value":"28"},{"value":"Completed"}],[{"value":"0"},{"value":"Withdrawn"}],[{"value":"30"},{"value":"Active not recruiting"}],[{"value":"30"},{"value":"Recruiting"}],[{"value":"23"},{"value":"Completed"}],[{"value":"24"},{"value":"Active not recruiting"}],[{"value":"2"},{"value":"Completed"}],[{"value":"44"},{"value":"Active not recruiting"}],[{"value":"0"},{"value":"Withdrawn"}],[{"value":"156"},{"value":"Unknown&nbsp;&#8224;"}],[{"value":"37"},{"value":"Completed"}],[{"value":"421"},{"value":"Completed                  Has Results"}],[{"value":"30"},{"value":"Recruiting"}],[{"value":"64"},{"value":"Completed"}],[{"value":"60"},{"value":"Unknown&nbsp;&#8224;"}],[{"value":"374"},{"value":"Enrolling by invitation"}],[{"value":"30"},{"value":"Completed"}],[{"value":"15"},{"value":"Active not recruiting"}],[{"value":"215"},{"value":"Recruiting"}],[{"value":"40"},{"value":"Completed"}],[{"value":"75"},{"value":"Enrolling by invitation"}],[{"value":"40"},{"value":"Recruiting"}],[{"value":"65"},{"value":"Recruiting"}],[{"value":"132"},{"value":"Suspended"}],[{"value":"23"},{"value":"Completed"}],[{"value":"6"},{"value":"Completed"}],[{"value":"51"},{"value":"Completed"}],[{"value":"46"},{"value":"Completed"}],[{"value":"9"},{"value":"Completed                  Has Results"}],[{"value":"30"},{"value":"Completed"}],[{"value":"60"},{"value":"Completed"}],[{"value":""},{"value":"No longer available"}],[{"value":"30"},{"value":"Enrolling by invitation"}],[{"value":"100"},{"value":"Recruiting"}],[{"value":"24"},{"value":"Completed"}],[{"value":"85"},{"value":"Recruiting"}],[{"value":"20"},{"value":"Recruiting"}],[{"value":"28"},{"value":"Completed"}],[{"value":"3"},{"value":"Completed"}],[{"value":"0"},{"value":"Withdrawn"}],[{"value":"81"},{"value":"Completed"}],[{"value":"700"},{"value":"Recruiting"}],[{"value":"28"},{"value":"Completed"}],[{"value":"100"},{"value":"Recruiting"}],[{"value":"1"},{"value":"Terminated                  Has Results"}],[{"value":"34"},{"value":"Enrolling by invitation"}],[{"value":"11"},{"value":"Completed"}],[{"value":"48"},{"value":"Completed"}],[{"value":"20"},{"value":"Recruiting"}],[{"value":"0"},{"value":"Withdrawn"}],[{"value":"75"},{"value":"Recruiting"}],[{"value":"0"},{"value":"Withdrawn"}],[{"value":"16400"},{"value":"Unknown&nbsp;&#8224;"}],[{"value":"30"},{"value":"Completed"}],[{"value":"42"},{"value":"Completed"}],[{"value":"0"},{"value":"Withdrawn"}],[{"value":"17"},{"value":"Terminated"}],[{"value":"18"},{"value":"Completed"}],[{"value":"24"},{"value":"Recruiting"}],[{"value":"50"},{"value":"Recruiting"}],[{"value":"30"},{"value":"Recruiting"}],[{"value":"71"},{"value":"Completed"}],[{"value":"14717"},{"value":"Active not recruiting"}],[{"value":"20"},{"value":"Recruiting"}],[{"value":"25"},{"value":"Recruiting"}],[{"value":"90"},{"value":"Completed                  Has Results"}],[{"value":"0"},{"value":"Withdrawn"}],[{"value":"34"},{"value":"Completed                  Has Results"}],[{"value":"9"},{"value":"Completed"}],[{"value":"8"},{"value":"Terminated"}],[{"value":"45"},{"value":"Completed"}],[{"value":"57"},{"value":"Completed"}],[{"value":"1500"},{"value":"Active not recruiting"}],[{"value":"20"},{"value":"Not yet recruiting"}],[{"value":"30"},{"value":"Recruiting"}],[{"value":"1"},{"value":"Terminated"}],[{"value":"32"},{"value":"Completed"}],[{"value":"4"},{"value":"Terminated"}],[{"value":"6"},{"value":"Completed"}],[{"value":"1500"},{"value":"Completed"}],[{"value":"16"},{"value":"Completed"}],[{"value":"19"},{"value":"Completed"}],[{"value":"50"},{"value":"Recruiting"}],[{"value":"6"},{"value":"Completed"}],[{"value":"20"},{"value":"Recruiting"}],[{"value":"30"},{"value":"Completed"}],[{"value":"80"},{"value":"Active not recruiting"}],[{"value":"450"},{"value":"Active not recruiting"}],[{"value":"400"},{"value":"Recruiting"}],[{"value":"35"},{"value":"Completed"}],[{"value":"37"},{"value":"Terminated"}],[{"value":"150"},{"value":"Unknown&nbsp;&#8224;"}],[{"value":"17"},{"value":"Terminated"}],[{"value":"20"},{"value":"Active not recruiting"}],[{"value":"250"},{"value":"Unknown&nbsp;&#8224;"}],[{"value":"40"},{"value":"Recruiting"}],[{"value":"80"},{"value":"Active not recruiting"}],[{"value":"28"},{"value":"Completed"}],[{"value":"60"},{"value":"Recruiting"}],[{"value":"6"},{"value":"Terminated"}],[{"value":""},{"value":"No longer available"}],[{"value":"6"},{"value":"Terminated"}],[{"value":"60"},{"value":"Active not recruiting"}],[{"value":"122"},{"value":"Recruiting"}],[{"value":"100"},{"value":"Recruiting"}],[{"value":"6"},{"value":"Completed"}],[{"value":"25"},{"value":"Completed"}],[{"value":"60"},{"value":"Completed"}],[{"value":"100"},{"value":"Recruiting"}],[{"value":"200"},{"value":"Recruiting"}],[{"value":"70"},{"value":"Completed                  Has Results"}],[{"value":"350"},{"value":"Completed"}],[{"value":"50"},{"value":"Suspended"}],[{"value":"30"},{"value":"Recruiting"}],[{"value":"153"},{"value":"Recruiting"}],[{"value":"30"},{"value":"Recruiting"}],[{"value":"1"},{"value":"Terminated"}],[{"value":"45"},{"value":"Active not recruiting"}],[{"value":"0"},{"value":"Withdrawn"}],[{"value":"30"},{"value":"Recruiting"}],[{"value":"50"},{"value":"Recruiting"}],[{"value":"0"},{"value":"Withdrawn"}],[{"value":"60"},{"value":"Completed"}],[{"value":"40"},{"value":"Completed"}],[{"value":"15"},{"value":"Active not recruiting"}],[{"value":"10"},{"value":"Completed"}],[{"value":"10"},{"value":"Completed"}],[{"value":"20"},{"value":"Recruiting"}],[{"value":"210"},{"value":"Completed                  Has Results"}],[{"value":"36"},{"value":"Recruiting"}],[{"value":"575"},{"value":"Completed"}],[{"value":"300"},{"value":"Active not recruiting"}],[{"value":"24"},{"value":"Active not recruiting"}],[{"value":"140"},{"value":"Recruiting"}],[{"value":"522"},{"value":"Recruiting"}],[{"value":"140"},{"value":"Recruiting"}],[{"value":"10"},{"value":"Enrolling by invitation"}],[{"value":"364"},{"value":"Completed"}],[{"value":"15"},{"value":"Completed"}],[{"value":"8"},{"value":"Terminated"}],[{"value":"101"},{"value":"Completed"}],[{"value":"9"},{"value":"Terminated"}],[{"value":"250"},{"value":"Recruiting"}],[{"value":"50"},{"value":"Completed"}],[{"value":"800"},{"value":"Enrolling by invitation"}],[{"value":"17"},{"value":"Terminated                  Has Results"}],[{"value":"1000"},{"value":"Enrolling by invitation"}],[{"value":"20"},{"value":"Recruiting"}],[{"value":"72"},{"value":"Completed"}],[{"value":"16"},{"value":"Completed"}],[{"value":"120"},{"value":"Recruiting"}],[{"value":"0"},{"value":"Withdrawn"}],[{"value":"308"},{"value":"Enrolling by invitation"}],[{"value":"0"},{"value":"Withdrawn"}],[{"value":"20"},{"value":"Active not recruiting"}],[{"value":"21"},{"value":"Completed"}],[{"value":"57"},{"value":"Recruiting"}],[{"value":"120"},{"value":"Unknown&nbsp;&#8224;"}],[{"value":"10"},{"value":"Completed"}],[{"value":"30"},{"value":"Completed"}],[{"value":"138"},{"value":"Completed                  Has Results"}],[{"value":"40"},{"value":"Completed"}],[{"value":"20"},{"value":"Completed"}],[{"value":"645"},{"value":"Active not recruiting"}],[{"value":"38"},{"value":"Completed"}],[{"value":"134"},{"value":"Completed"}],[{"value":"20"},{"value":"Completed                  Has Results"}],[{"value":"20"},{"value":"Completed"}],[{"value":"60"},{"value":"Active not recruiting"}],[{"value":"5000"},{"value":"Unknown&nbsp;&#8224;"}],[{"value":"20"},{"value":"Completed"}],[{"value":"26"},{"value":"Completed"}],[{"value":"13"},{"value":"Completed"}],[{"value":"110"},{"value":"Completed"}],[{"value":"140"},{"value":"Recruiting"}],[{"value":"1"},{"value":"Completed"}],[{"value":"300"},{"value":"Unknown&nbsp;&#8224;"}],[{"value":"17"},{"value":"Terminated"}],[{"value":"382"},{"value":"Active not recruiting"}],[{"value":"10"},{"value":"Not yet recruiting"}],[{"value":"0"},{"value":"Withdrawn"}],[{"value":"30"},{"value":"Completed"}],[{"value":"1000"},{"value":"Unknown&nbsp;&#8224;"}],[{"value":"250"},{"value":"Unknown&nbsp;&#8224;"}],[{"value":"60"},{"value":"Active not recruiting"}],[{"value":"38"},{"value":"Active not recruiting"}],[{"value":"100"},{"value":"Unknown&nbsp;&#8224;"}],[{"value":"38"},{"value":"Completed"}],[{"value":"41"},{"value":"Completed"}],[{"value":"2"},{"value":"Terminated                  Has Results"}],[{"value":"459"},{"value":"Completed                  Has Results"}],[{"value":"28"},{"value":"Recruiting"}],[{"value":"17"},{"value":"Active not recruiting"}],[{"value":"0"},{"value":"Withdrawn"}],[{"value":"202"},{"value":"Active not recruiting"}],[{"value":"20"},{"value":"Recruiting"}],[{"value":"17"},{"value":"Completed"}],[{"value":"41"},{"value":"Completed                  Has Results"}],[{"value":"100"},{"value":"Active not recruiting"}],[{"value":"468"},{"value":"Recruiting"}],[{"value":"60"},{"value":"Active not recruiting"}],[{"value":"48"},{"value":"Completed"}],[{"value":"20"},{"value":"Active not recruiting"}],[{"value":"50"},{"value":"Completed"}],[{"value":"100"},{"value":"Recruiting"}],[{"value":"110"},{"value":"Completed"}],[{"value":"20"},{"value":"Completed"}],[{"value":"239"},{"value":"Completed"}],[{"value":"50"},{"value":"Enrolling by invitation"}],[{"value":"60"},{"value":"Recruiting"}],[{"value":"13"},{"value":"Completed                  Has Results"}],[{"value":"6"},{"value":"Completed"}],[{"value":"120"},{"value":"Completed"}],[{"value":"59"},{"value":"Completed                  Has Results"}],[{"value":"18"},{"value":"Completed"}],[{"value":"19"},{"value":"Terminated"}],[{"value":"13000"},{"value":"Recruiting"}],[{"value":"50"},{"value":"Recruiting"}],[{"value":"100"},{"value":"Active not recruiting"}],[{"value":"34"},{"value":"Completed"}],[{"value":"36"},{"value":"Completed                  Has Results"}],[{"value":"28"},{"value":"Completed"}],[{"value":"320"},{"value":"Enrolling by invitation"}],[{"value":"6"},{"value":"Completed"}],[{"value":"30"},{"value":"Active not recruiting"}],[{"value":"126"},{"value":"Recruiting"}],[{"value":"99"},{"value":"Completed"}],[{"value":"10"},{"value":"Recruiting"}],[{"value":"48"},{"value":"Completed"}],[{"value":"31"},{"value":"Completed"}],[{"value":"20"},{"value":"Recruiting"}],[{"value":"50"},{"value":"Recruiting"}],[{"value":"78"},{"value":"Completed"}],[{"value":"30"},{"value":"Recruiting"}],[{"value":"11"},{"value":"Completed"}],[{"value":"38"},{"value":"Completed"}],[{"value":"90"},{"value":"Recruiting"}],[{"value":"5"},{"value":"Completed"}],[{"value":"20"},{"value":"Completed"}],[{"value":"46"},{"value":"Completed                  Has Results"}],[{"value":"2003"},{"value":"Completed"}],[{"value":"25"},{"value":"Completed"}],[{"value":"36"},{"value":"Completed"}],[{"value":"21"},{"value":"Completed"}],[{"value":"1000"},{"value":"Recruiting"}],[{"value":"12"},{"value":"Recruiting"}],[{"value":"41"},{"value":"Completed"}],[{"value":"26"},{"value":"Completed"}],[{"value":"35"},{"value":"Completed"}],[{"value":"60"},{"value":"Active not recruiting"}],[{"value":"102"},{"value":"Completed                  Has Results"}],[{"value":"16"},{"value":"Active not recruiting"}],[{"value":"200"},{"value":"Recruiting"}],[{"value":"15"},{"value":"Completed"}],[{"value":"115"},{"value":"Completed"}],[{"value":""},{"value":"Available"}],[{"value":"15"},{"value":"Completed"}],[{"value":"17"},{"value":"Completed"}],[{"value":"30"},{"value":"Recruiting"}],[{"value":"102"},{"value":"Recruiting"}],[{"value":"60"},{"value":"Recruiting"}],[{"value":"500"},{"value":"Completed"}],[{"value":"100"},{"value":"Recruiting"}],[{"value":"400"},{"value":"Active not recruiting"}],[{"value":"2623"},{"value":"Active not recruiting"}],[{"value":"90"},{"value":"Completed"}],[{"value":"8"},{"value":"Completed"}],[{"value":"4344"},{"value":"Completed"}],[{"value":"14"},{"value":"Completed"}],[{"value":"30"},{"value":"Completed"}],[{"value":"81"},{"value":"Completed"}],[{"value":"25"},{"value":"Completed"}],[{"value":"95"},{"value":"Recruiting"}],[{"value":"90"},{"value":"Completed"}],[{"value":"16"},{"value":"Completed"}],[{"value":"10"},{"value":"Active not recruiting"}],[{"value":"20"},{"value":"Unknown&nbsp;&#8224;"}],[{"value":"107"},{"value":"Completed"}],[{"value":"80"},{"value":"Recruiting"}],[{"value":"1650"},{"value":"Active not recruiting"}],[{"value":"50"},{"value":"Unknown&nbsp;&#8224;"}],[{"value":"67"},{"value":"Completed"}],[{"value":"10"},{"value":"Active not recruiting"}],[{"value":"76"},{"value":"Completed"}],[{"value":"21"},{"value":"Active not recruiting"}],[{"value":"76"},{"value":"Completed"}],[{"value":"13"},{"value":"Terminated"}],[{"value":"100"},{"value":"Recruiting"}],[{"value":"225"},{"value":"Active not recruiting"}],[{"value":"50"},{"value":"Completed"}],[{"value":"48"},{"value":"Completed"}],[{"value":"10"},{"value":"Terminated                  Has Results"}],[{"value":"26"},{"value":"Completed"}],[{"value":"24"},{"value":"Completed                  Has Results"}],[{"value":"285"},{"value":"Active not recruiting"}],[{"value":"26"},{"value":"Completed                  Has Results"}],[{"value":"230"},{"value":"Completed"}],[{"value":"351"},{"value":"Active not recruiting"}],[{"value":"0"},{"value":"Withdrawn"}],[{"value":"83"},{"value":"Completed"}],[{"value":"37"},{"value":"Completed"}],[{"value":"60"},{"value":"Active not recruiting"}],[{"value":"511"},{"value":"Recruiting"}],[{"value":"40"},{"value":"Enrolling by invitation"}],[{"value":"70"},{"value":"Completed"}],[{"value":"73"},{"value":"Completed"}],[{"value":"67"},{"value":"Completed                  Has Results"}],[{"value":"210"},{"value":"Active not recruiting"}],[{"value":"40"},{"value":"Completed"}],[{"value":"40"},{"value":"Completed"}],[{"value":"30"},{"value":"Active not recruiting"}],[{"value":"72"},{"value":"Unknown&nbsp;&#8224;"}],[{"value":"29"},{"value":"Terminated"}],[{"value":"150"},{"value":"Recruiting"}],[{"value":"57"},{"value":"Completed"}],[{"value":"150"},{"value":"Completed"}],[{"value":"626"},{"value":"Completed                  Has Results"}],[{"value":"135"},{"value":"Completed                  Has Results"}],[{"value":"12"},{"value":"Unknown&nbsp;&#8224;"}],[{"value":"20"},{"value":"Completed"}],[{"value":"0"},{"value":"Withdrawn"}],[{"value":"100"},{"value":"Recruiting"}],[{"value":"20"},{"value":"Completed"}],[{"value":"18"},{"value":"Completed"}],[{"value":"28"},{"value":"Completed"}],[{"value":"48"},{"value":"Completed"}],[{"value":"57"},{"value":"Completed                  Has Results"}],[{"value":"100"},{"value":"Active not recruiting"}],[{"value":"243"},{"value":"Active not recruiting"}],[{"value":"63"},{"value":"Completed"}],[{"value":"25"},{"value":"Completed                  Has Results"}],[{"value":"569"},{"value":"Completed"}],[{"value":"12"},{"value":"Active not recruiting"}],[{"value":"100"},{"value":"Recruiting"}],[{"value":"192"},{"value":"Completed"}],[{"value":"77"},{"value":"Terminated"}],[{"value":"260"},{"value":"Active not recruiting"}],[{"value":"200"},{"value":"Completed"}],[{"value":"44"},{"value":"Completed"}],[{"value":"237"},{"value":"Completed"}],[{"value":"90"},{"value":"Active not recruiting"}],[{"value":"36"},{"value":"Completed"}],[{"value":"359"},{"value":"Completed"}],[{"value":"1276"},{"value":"Active not recruiting"}],[{"value":"40"},{"value":"Completed"}],[{"value":"8"},{"value":"Completed"}],[{"value":"15"},{"value":"Active not recruiting"}],[{"value":"240"},{"value":"Completed"}],[{"value":"5"},{"value":"Terminated"}],[{"value":"5"},{"value":"Terminated                  Has Results"}],[{"value":"96"},{"value":"Recruiting"}],[{"value":"18"},{"value":"Completed"}],[{"value":"7"},{"value":"Terminated"}],[{"value":"10"},{"value":"Recruiting"}],[{"value":"30"},{"value":"Active not recruiting"}],[{"value":"24"},{"value":"Active not recruiting"}],[{"value":"12"},{"value":"Unknown&nbsp;&#8224;"}],[{"value":"130"},{"value":"Completed"}],[{"value":"690"},{"value":"Recruiting"}],[{"value":"24"},{"value":"Completed                  Has Results"}],[{"value":"40"},{"value":"Completed                  Has Results"}],[{"value":"29"},{"value":"Active not recruiting"}],[{"value":"25"},{"value":"Completed"}],[{"value":"194"},{"value":"Active not recruiting"}],[{"value":"20"},{"value":"Completed"}],[{"value":"1000"},{"value":"Active not recruiting"}],[{"value":"170"},{"value":"Active not recruiting"}],[{"value":"66"},{"value":"Completed"}],[{"value":"68"},{"value":"Completed                  Has Results"}],[{"value":"132"},{"value":"Completed"}],[{"value":"40"},{"value":"Completed"}],[{"value":"18"},{"value":"Completed                  Has Results"}],[{"value":"24"},{"value":"Terminated"}],[{"value":"100"},{"value":"Recruiting"}],[{"value":"58"},{"value":"Completed"}],[{"value":"16"},{"value":"Completed"}],[{"value":"18"},{"value":"Enrolling by invitation"}],[{"value":"38"},{"value":"Completed"}],[{"value":"5"},{"value":"Completed                  Has Results"}],[{"value":"34"},{"value":"Completed"}],[{"value":"50"},{"value":"Completed                  Has Results"}],[{"value":"140"},{"value":"Completed"}],[{"value":"240"},{"value":"Active not recruiting"}],[{"value":"150"},{"value":"Recruiting"}],[{"value":"34"},{"value":"Completed"}],[{"value":"100"},{"value":"Recruiting"}],[{"value":"26"},{"value":"Completed"}],[{"value":"61"},{"value":"Active not recruiting"}],[{"value":"33"},{"value":"Active not recruiting"}],[{"value":"1"},{"value":"Terminated"}],[{"value":"60"},{"value":"Completed"}],[{"value":"22"},{"value":"Completed"}],[{"value":"13"},{"value":"Recruiting"}],[{"value":""},{"value":"Available"}],[{"value":"60"},{"value":"Recruiting"}],[{"value":"60"},{"value":"Completed"}]],"columnNames":[{"name":"number_enrolled","index":0,"aggr":"sum"},{"name":"status","index":1,"aggr":"sum"}],"rows":[["100","Recruiting"],["150","Recruiting"],["450","Recruiting"],["60","Recruiting"],["35","Not yet recruiting"],["40","Not yet recruiting"],["230","Not yet recruiting"],["500","Not yet recruiting"],["100","Recruiting"],["20","Not yet recruiting"],["80","Not yet recruiting"],["350","Recruiting"],["102","Recruiting"],["120","Recruiting"],["8","Not yet recruiting"],["60","Recruiting"],["60","Recruiting"],["60","Recruiting"],["20","Recruiting"],["75","Not yet recruiting"],["120","Not yet recruiting"],["20","Recruiting"],["99","Not yet recruiting"],["24","Not yet recruiting"],["30","Recruiting"],["40","Recruiting"],["5000","Recruiting"],["60","Not yet recruiting"],["400","Recruiting"],["100","Not yet recruiting"],["100","Recruiting"],["180","Recruiting"],["60","Recruiting"],["100","Not yet recruiting"],["60","Recruiting"],["60","Recruiting"],["60","Not yet recruiting"],["350","Not yet recruiting"],["20","Not yet recruiting"],["32","Not yet recruiting"],["54","Not yet recruiting"],["24","Recruiting"],["300","Not yet recruiting"],["50","Enrolling by invitation"],["100","Recruiting"],["22","Recruiting"],["12","Not yet recruiting"],["60","Recruiting"],["20","Recruiting"],["100","Recruiting"],["120","Not yet recruiting"],["25","Recruiting"],["60","Recruiting"],["50","Not yet recruiting"],["102","Completed"],["167","Completed"],["40","Not yet recruiting"],["880","Recruiting"],["36","Recruiting"],["44","Recruiting"],["60","Not yet recruiting"],["7","Recruiting"],["210","Not yet recruiting"],["100","Recruiting"],["32","Recruiting"],["200","Recruiting"],["30","Recruiting"],["164","Recruiting"],["68","Completed"],["45","Not yet recruiting"],["139","Active not recruiting"],["200","Active not recruiting"],["200","Recruiting"],["50","Not yet recruiting"],["16","Not yet recruiting"],["100","Enrolling by invitation"],["75","Recruiting"],["1000","Recruiting"],["40","Recruiting"],["10","Recruiting"],["20","Not yet recruiting"],["30","Not yet recruiting"],["20","Recruiting"],["40","Recruiting"],["165","Recruiting"],["3000","Recruiting"],["24","Recruiting"],["12","Recruiting"],["60","Enrolling by invitation"],["18","Completed"],["850","Not yet recruiting"],["40","Recruiting"],["70","Not yet recruiting"],["50","Not yet recruiting"],["250","Not yet recruiting"],["46","Recruiting"],["300","Recruiting"],["200","Enrolling by invitation"],["20","Not yet recruiting"],["400","Recruiting"],["100","Recruiting"],["25","Recruiting"],["250","Not yet recruiting"],["40","Recruiting"],["276","Not yet recruiting"],["25","Recruiting"],["30","Not yet recruiting"],["34","Recruiting"],["40","Recruiting"],["300","Recruiting"],["330","Not yet recruiting"],["28","Not yet recruiting"],["274","Not yet recruiting"],["30","Recruiting"],["","Recruiting"],["350","Recruiting"],["1000","Not yet recruiting"],["24","Active not recruiting"],["40","Recruiting"],["45","Recruiting"],["20","Recruiting"],["2400","Recruiting"],["50","Recruiting"],["30","Recruiting"],["87","Recruiting"],["360","Recruiting"],["40","Recruiting"],["85","Recruiting"],["36","Recruiting"],["24","Recruiting"],["0","Withdrawn"],["60","Recruiting"],["70","Not yet recruiting"],["1520","Recruiting"],["20","Not yet recruiting"],["74","Not yet recruiting"],["98","Recruiting"],["50","Recruiting"],["24","Not yet recruiting"],["100","Not yet recruiting"],["25","Recruiting"],["40","Recruiting"],["200","Recruiting"],["120","Recruiting"],["18","Active not recruiting"],["30","Not yet recruiting"],["432","Recruiting"],["10","Completed"],["53","Completed"],["19","Active not recruiting"],["4","Not yet recruiting"],["124","Recruiting"],["54","Terminated"],["15","Recruiting"],["96","Not yet recruiting"],["40","Recruiting"],["5","Recruiting"],["16","Enrolling by invitation"],["120","Recruiting"],["60","Recruiting"],["125","Recruiting"],["40","Not yet recruiting"],["40","Not yet recruiting"],["220","Recruiting"],["250","Recruiting"],["50","Active not recruiting"],["8","Recruiting"],["23","Active not recruiting"],["60","Not yet recruiting"],["12","Recruiting"],["100","Recruiting"],["1000","Recruiting"],["32","Not yet recruiting"],["77","Active not recruiting"],["158","Recruiting"],["1200","Recruiting"],["98","Recruiting"],["80","Recruiting"],["96","Recruiting"],["39","Recruiting"],["31","Recruiting"],["12","Recruiting"],["300","Recruiting"],["65","Active not recruiting"],["105","Recruiting"],["75","Recruiting"],["200","Recruiting"],["70","Recruiting"],["30","Recruiting"],["60","Recruiting"],["120","Recruiting"],["100","Completed"],["48","Completed"],["500","Recruiting"],["2310","Recruiting"],["18","Recruiting"],["20","Recruiting"],["210","Recruiting"],["66","Recruiting"],["345","Recruiting"],["100","Recruiting"],["510","Recruiting"],["110","Enrolling by invitation"],["60","Recruiting"],["41","Completed"],["24","Completed"],["60","Active not recruiting"],["22","Recruiting"],["30","Recruiting"],["24","Active not recruiting"],["150","Recruiting"],["84","Recruiting"],["60","Recruiting"],["90","Recruiting"],["50","Recruiting"],["30","Recruiting"],["80","Recruiting"],["30","Recruiting"],["10","Recruiting"],["24","Recruiting"],["50","Recruiting"],["50","Recruiting"],["100","Recruiting"],["46","Recruiting"],["160","Recruiting"],["18","Recruiting"],["10","Completed"],["29","Recruiting"],["22","Recruiting"],["40","Recruiting"],["75","Recruiting"],["64","Recruiting"],["300","Recruiting"],["30","Recruiting"],["2000","Completed"],["15","Active not recruiting"],["84","Recruiting"],["36","Recruiting"],["375","Not yet recruiting"],["240","Recruiting"],["36","Active not recruiting"],["24","Recruiting"],["75","Recruiting"],["30","Recruiting"],["250","Recruiting"],["27","Recruiting"],["20","Recruiting"],["75","Recruiting"],["60","Not yet recruiting"],["90","Recruiting"],["20","Recruiting"],["222","Active not recruiting"],["30","Recruiting"],["40","Completed"],["20","Recruiting"],["120","Recruiting"],["100","Recruiting"],["65","Recruiting"],["100","Recruiting"],["50","Recruiting"],["23","Completed                  Has Results"],["100","Recruiting"],["110","Recruiting"],["48","Recruiting"],["100","Recruiting"],["300","Recruiting"],["30","Recruiting"],["60","Recruiting"],["1656","Active not recruiting"],["248","Recruiting"],["250","Recruiting"],["500000","Active not recruiting"],["120","Recruiting"],["25","Recruiting"],["25","Enrolling by invitation"],["78","Recruiting"],["61","Recruiting"],["240","Recruiting"],["300","Recruiting"],["70","Completed"],["66","Recruiting"],["80","Recruiting"],["52","Recruiting"],["99","Completed"],["66","Recruiting"],["26","Recruiting"],["5","Recruiting"],["40","Completed"],["160","Recruiting"],["400","Recruiting"],["16","Suspended"],["80","Recruiting"],["28","Completed"],["150","Recruiting"],["260","Enrolling by invitation"],["39","Completed"],["100","Recruiting"],["40","Completed"],["13","Active not recruiting"],["50","Recruiting"],["30","Recruiting"],["400","Recruiting"],["550","Recruiting"],["600","Not yet recruiting"],["350","Recruiting"],["360","Active not recruiting"],["130","Recruiting"],["186","Completed"],["33","Completed"],["300","Not yet recruiting"],["15","Recruiting"],["50","Recruiting"],["12","Recruiting"],["750","Recruiting"],["15","Completed"],["15","Enrolling by invitation"],["50","Completed"],["100","Recruiting"],["40","Recruiting"],["3000","Active not recruiting"],["35","Recruiting"],["10000","Enrolling by invitation"],["6","Completed"],["40","Not yet recruiting"],["100","Recruiting"],["500","Not yet recruiting"],["0","Withdrawn"],["20","Recruiting"],["0","Withdrawn"],["45","Recruiting"],["20","Active not recruiting"],["200","Not yet recruiting"],["14","Active not recruiting"],["5975","Recruiting"],["200","Recruiting"],["400","Active not recruiting"],["28","Completed"],["115","Recruiting"],["60","Completed"],["30","Recruiting"],["115","Recruiting"],["104","Active not recruiting"],["50","Recruiting"],["0","Withdrawn"],["131","Recruiting"],["100","Recruiting"],["100","Recruiting"],["210","Recruiting"],["20","Recruiting"],["315","Recruiting"],["20","Active not recruiting"],["30","Recruiting"],["60","Recruiting"],["84","Active not recruiting"],["60","Recruiting"],["70","Recruiting"],["100","Recruiting"],["0","Withdrawn"],["2","Terminated"],["48","Completed"],["40","Recruiting"],["472","Recruiting"],["16","Recruiting"],["500","Enrolling by invitation"],["30","Recruiting"],["0","Withdrawn"],["30","Recruiting"],["36","Suspended"],["80","Completed"],["40","Recruiting"],["11","Completed"],["131","Completed"],["41","Completed"],["50","Recruiting"],["220","Completed"],["30","Recruiting"],["60","Not yet recruiting"],["30","Recruiting"],["93","Recruiting"],["113","Completed"],["6","Completed"],["20","Not yet recruiting"],["500","Active not recruiting"],["60","Active not recruiting"],["80","Completed"],["150","Recruiting"],["100","Recruiting"],["416","Recruiting"],["30","Completed"],["260","Recruiting"],["100","Completed"],["50","Suspended"],["30","Recruiting"],["90","Active not recruiting"],["30","Recruiting"],["20","Completed"],["570","Recruiting"],["200","Recruiting"],["75","Active not recruiting"],["50","Recruiting"],["32","Completed"],["116","Recruiting"],["12","Completed"],["18","Terminated                  Has Results"],["40","Recruiting"],["71","Recruiting"],["440","Recruiting"],["60","Recruiting"],["1017","Completed"],["24","Completed"],["25","Active not recruiting"],["34","Completed"],["90","Recruiting"],["67","Recruiting"],["1","Terminated"],["15","Recruiting"],["68","Recruiting"],["24","Recruiting"],["46","Recruiting"],["150","Recruiting"],["0","Withdrawn"],["90","Recruiting"],["51","Active not recruiting"],["39","Recruiting"],["66","Active not recruiting"],["120","Completed"],["20","Suspended"],["2160","Active not recruiting"],["302","Active not recruiting"],["100","Recruiting"],["15","Recruiting"],["50","Recruiting"],["200","Recruiting"],["60","Active not recruiting"],["75","Recruiting"],["30","Recruiting"],["25","Terminated"],["50","Not yet recruiting"],["10","Completed"],["25","Recruiting"],["9","Active not recruiting"],["240","Completed"],["150","Recruiting"],["33","Active not recruiting"],["350","Active not recruiting"],["20","Completed"],["50","Recruiting"],["10","Recruiting"],["100","Completed"],["82","Recruiting"],["100","Recruiting"],["30","Active not recruiting"],["45","Recruiting"],["60","Recruiting"],["21","Active not recruiting"],["161","Completed"],["40","Recruiting"],["40","Recruiting"],["20","Recruiting"],["150","Completed"],["88","Completed                  Has Results"],["275711","Active not recruiting"],["60","Recruiting"],["100","Active not recruiting"],["2000","Recruiting"],["60","Recruiting"],["300","Recruiting"],["203","Completed"],["45","Completed"],["100","Recruiting"],["12","Completed"],["53","Completed"],["60","Recruiting"],["6484","Enrolling by invitation"],["180","Recruiting"],["22","Completed                  Has Results"],["10","Completed"],["200","Recruiting"],["2669","Completed"],["32","Completed"],["80","Recruiting"],["0","Withdrawn"],["50","Recruiting"],["50","Recruiting"],["12","Recruiting"],["40","Completed"],["50","Recruiting"],["10","Completed"],["24","Recruiting"],["650","Not yet recruiting"],["18","Completed"],["165","Recruiting"],["37","Completed"],["7","Terminated"],["120","Active not recruiting"],["100","Recruiting"],["200","Recruiting"],["15","Active not recruiting"],["61","Completed"],["150","Recruiting"],["1","Terminated"],["200","Recruiting"],["25","Active not recruiting"],["20","Recruiting"],["60","Enrolling by invitation"],["40","Recruiting"],["198","Recruiting"],["30","Recruiting"],["26","Completed"],["60","Recruiting"],["100","Recruiting"],["24","Recruiting"],["28","Active not recruiting"],["20","Completed"],["180","Recruiting"],["450","Not yet recruiting"],["33","Completed"],["500","Unknown&nbsp;&#8224;"],["40","Recruiting"],["72","Recruiting"],["104","Completed"],["109","Completed                  Has Results"],["400","Active not recruiting"],["240","Active not recruiting"],["100","Recruiting"],["135","Completed"],["12","Recruiting"],["10","Completed"],["40","Active not recruiting"],["73","Completed"],["82","Completed"],["60","Completed"],["250","Completed"],["20","Recruiting"],["50","Recruiting"],["124","Recruiting"],["79","Completed"],["60","Active not recruiting"],["9","Completed"],["90","Recruiting"],["100","Active not recruiting"],["24","Recruiting"],["10","Terminated                  Has Results"],["150","Recruiting"],["40","Recruiting"],["102","Recruiting"],["300","Recruiting"],["100","Active not recruiting"],["175","Completed"],["39","Completed"],["60","Enrolling by invitation"],["30","Enrolling by invitation"],["60","Recruiting"],["500","Enrolling by invitation"],["230","Recruiting"],["25","Completed"],["40","Recruiting"],["60","Recruiting"],["1","Terminated"],["0","Withdrawn"],["14","Recruiting"],["48","Recruiting"],["15","Active not recruiting"],["40","Recruiting"],["17","Active not recruiting"],["50","Recruiting"],["6","Terminated"],["120","Recruiting"],["11","Active not recruiting"],["24","Suspended"],["10","Completed"],["26","Completed"],["160","Suspended"],["13","Terminated                  Has Results"],["68","Completed"],["30","Recruiting"],["27","Completed"],["30","Recruiting"],["59","Completed"],["1000","Not yet recruiting"],["2000","Enrolling by invitation"],["13","Terminated"],["15","Terminated"],["60","Not yet recruiting"],["30","Recruiting"],["0","Withdrawn"],["6","Completed"],["56","Completed"],["17","Completed"],["54","Active not recruiting"],["50","Recruiting"],["90","Recruiting"],["220","Recruiting"],["20","Completed"],["0","Withdrawn"],["6","Completed"],["10","Recruiting"],["30","Unknown&nbsp;&#8224;"],["14","Completed"],["50","Not yet recruiting"],["0","Withdrawn"],["6","Completed"],["30","Completed"],["50","Recruiting"],["28","Completed"],["0","Withdrawn"],["30","Active not recruiting"],["30","Recruiting"],["23","Completed"],["24","Active not recruiting"],["2","Completed"],["44","Active not recruiting"],["0","Withdrawn"],["156","Unknown&nbsp;&#8224;"],["37","Completed"],["421","Completed                  Has Results"],["30","Recruiting"],["64","Completed"],["60","Unknown&nbsp;&#8224;"],["374","Enrolling by invitation"],["30","Completed"],["15","Active not recruiting"],["215","Recruiting"],["40","Completed"],["75","Enrolling by invitation"],["40","Recruiting"],["65","Recruiting"],["132","Suspended"],["23","Completed"],["6","Completed"],["51","Completed"],["46","Completed"],["9","Completed                  Has Results"],["30","Completed"],["60","Completed"],["","No longer available"],["30","Enrolling by invitation"],["100","Recruiting"],["24","Completed"],["85","Recruiting"],["20","Recruiting"],["28","Completed"],["3","Completed"],["0","Withdrawn"],["81","Completed"],["700","Recruiting"],["28","Completed"],["100","Recruiting"],["1","Terminated                  Has Results"],["34","Enrolling by invitation"],["11","Completed"],["48","Completed"],["20","Recruiting"],["0","Withdrawn"],["75","Recruiting"],["0","Withdrawn"],["16400","Unknown&nbsp;&#8224;"],["30","Completed"],["42","Completed"],["0","Withdrawn"],["17","Terminated"],["18","Completed"],["24","Recruiting"],["50","Recruiting"],["30","Recruiting"],["71","Completed"],["14717","Active not recruiting"],["20","Recruiting"],["25","Recruiting"],["90","Completed                  Has Results"],["0","Withdrawn"],["34","Completed                  Has Results"],["9","Completed"],["8","Terminated"],["45","Completed"],["57","Completed"],["1500","Active not recruiting"],["20","Not yet recruiting"],["30","Recruiting"],["1","Terminated"],["32","Completed"],["4","Terminated"],["6","Completed"],["1500","Completed"],["16","Completed"],["19","Completed"],["50","Recruiting"],["6","Completed"],["20","Recruiting"],["30","Completed"],["80","Active not recruiting"],["450","Active not recruiting"],["400","Recruiting"],["35","Completed"],["37","Terminated"],["150","Unknown&nbsp;&#8224;"],["17","Terminated"],["20","Active not recruiting"],["250","Unknown&nbsp;&#8224;"],["40","Recruiting"],["80","Active not recruiting"],["28","Completed"],["60","Recruiting"],["6","Terminated"],["","No longer available"],["6","Terminated"],["60","Active not recruiting"],["122","Recruiting"],["100","Recruiting"],["6","Completed"],["25","Completed"],["60","Completed"],["100","Recruiting"],["200","Recruiting"],["70","Completed                  Has Results"],["350","Completed"],["50","Suspended"],["30","Recruiting"],["153","Recruiting"],["30","Recruiting"],["1","Terminated"],["45","Active not recruiting"],["0","Withdrawn"],["30","Recruiting"],["50","Recruiting"],["0","Withdrawn"],["60","Completed"],["40","Completed"],["15","Active not recruiting"],["10","Completed"],["10","Completed"],["20","Recruiting"],["210","Completed                  Has Results"],["36","Recruiting"],["575","Completed"],["300","Active not recruiting"],["24","Active not recruiting"],["140","Recruiting"],["522","Recruiting"],["140","Recruiting"],["10","Enrolling by invitation"],["364","Completed"],["15","Completed"],["8","Terminated"],["101","Completed"],["9","Terminated"],["250","Recruiting"],["50","Completed"],["800","Enrolling by invitation"],["17","Terminated                  Has Results"],["1000","Enrolling by invitation"],["20","Recruiting"],["72","Completed"],["16","Completed"],["120","Recruiting"],["0","Withdrawn"],["308","Enrolling by invitation"],["0","Withdrawn"],["20","Active not recruiting"],["21","Completed"],["57","Recruiting"],["120","Unknown&nbsp;&#8224;"],["10","Completed"],["30","Completed"],["138","Completed                  Has Results"],["40","Completed"],["20","Completed"],["645","Active not recruiting"],["38","Completed"],["134","Completed"],["20","Completed                  Has Results"],["20","Completed"],["60","Active not recruiting"],["5000","Unknown&nbsp;&#8224;"],["20","Completed"],["26","Completed"],["13","Completed"],["110","Completed"],["140","Recruiting"],["1","Completed"],["300","Unknown&nbsp;&#8224;"],["17","Terminated"],["382","Active not recruiting"],["10","Not yet recruiting"],["0","Withdrawn"],["30","Completed"],["1000","Unknown&nbsp;&#8224;"],["250","Unknown&nbsp;&#8224;"],["60","Active not recruiting"],["38","Active not recruiting"],["100","Unknown&nbsp;&#8224;"],["38","Completed"],["41","Completed"],["2","Terminated                  Has Results"],["459","Completed                  Has Results"],["28","Recruiting"],["17","Active not recruiting"],["0","Withdrawn"],["202","Active not recruiting"],["20","Recruiting"],["17","Completed"],["41","Completed                  Has Results"],["100","Active not recruiting"],["468","Recruiting"],["60","Active not recruiting"],["48","Completed"],["20","Active not recruiting"],["50","Completed"],["100","Recruiting"],["110","Completed"],["20","Completed"],["239","Completed"],["50","Enrolling by invitation"],["60","Recruiting"],["13","Completed                  Has Results"],["6","Completed"],["120","Completed"],["59","Completed                  Has Results"],["18","Completed"],["19","Terminated"],["13000","Recruiting"],["50","Recruiting"],["100","Active not recruiting"],["34","Completed"],["36","Completed                  Has Results"],["28","Completed"],["320","Enrolling by invitation"],["6","Completed"],["30","Active not recruiting"],["126","Recruiting"],["99","Completed"],["10","Recruiting"],["48","Completed"],["31","Completed"],["20","Recruiting"],["50","Recruiting"],["78","Completed"],["30","Recruiting"],["11","Completed"],["38","Completed"],["90","Recruiting"],["5","Completed"],["20","Completed"],["46","Completed                  Has Results"],["2003","Completed"],["25","Completed"],["36","Completed"],["21","Completed"],["1000","Recruiting"],["12","Recruiting"],["41","Completed"],["26","Completed"],["35","Completed"],["60","Active not recruiting"],["102","Completed                  Has Results"],["16","Active not recruiting"],["200","Recruiting"],["15","Completed"],["115","Completed"],["","Available"],["15","Completed"],["17","Completed"],["30","Recruiting"],["102","Recruiting"],["60","Recruiting"],["500","Completed"],["100","Recruiting"],["400","Active not recruiting"],["2623","Active not recruiting"],["90","Completed"],["8","Completed"],["4344","Completed"],["14","Completed"],["30","Completed"],["81","Completed"],["25","Completed"],["95","Recruiting"],["90","Completed"],["16","Completed"],["10","Active not recruiting"],["20","Unknown&nbsp;&#8224;"],["107","Completed"],["80","Recruiting"],["1650","Active not recruiting"],["50","Unknown&nbsp;&#8224;"],["67","Completed"],["10","Active not recruiting"],["76","Completed"],["21","Active not recruiting"],["76","Completed"],["13","Terminated"],["100","Recruiting"],["225","Active not recruiting"],["50","Completed"],["48","Completed"],["10","Terminated                  Has Results"],["26","Completed"],["24","Completed                  Has Results"],["285","Active not recruiting"],["26","Completed                  Has Results"],["230","Completed"],["351","Active not recruiting"],["0","Withdrawn"],["83","Completed"],["37","Completed"],["60","Active not recruiting"],["511","Recruiting"],["40","Enrolling by invitation"],["70","Completed"],["73","Completed"],["67","Completed                  Has Results"],["210","Active not recruiting"],["40","Completed"],["40","Completed"],["30","Active not recruiting"],["72","Unknown&nbsp;&#8224;"],["29","Terminated"],["150","Recruiting"],["57","Completed"],["150","Completed"],["626","Completed                  Has Results"],["135","Completed                  Has Results"],["12","Unknown&nbsp;&#8224;"],["20","Completed"],["0","Withdrawn"],["100","Recruiting"],["20","Completed"],["18","Completed"],["28","Completed"],["48","Completed"],["57","Completed                  Has Results"],["100","Active not recruiting"],["243","Active not recruiting"],["63","Completed"],["25","Completed                  Has Results"],["569","Completed"],["12","Active not recruiting"],["100","Recruiting"],["192","Completed"],["77","Terminated"],["260","Active not recruiting"],["200","Completed"],["44","Completed"],["237","Completed"],["90","Active not recruiting"],["36","Completed"],["359","Completed"],["1276","Active not recruiting"],["40","Completed"],["8","Completed"],["15","Active not recruiting"],["240","Completed"],["5","Terminated"],["5","Terminated                  Has Results"],["96","Recruiting"],["18","Completed"],["7","Terminated"],["10","Recruiting"],["30","Active not recruiting"],["24","Active not recruiting"],["12","Unknown&nbsp;&#8224;"],["130","Completed"],["690","Recruiting"],["24","Completed                  Has Results"],["40","Completed                  Has Results"],["29","Active not recruiting"],["25","Completed"],["194","Active not recruiting"],["20","Completed"],["1000","Active not recruiting"],["170","Active not recruiting"],["66","Completed"],["68","Completed                  Has Results"],["132","Completed"],["40","Completed"],["18","Completed                  Has Results"],["24","Terminated"],["100","Recruiting"],["58","Completed"],["16","Completed"],["18","Enrolling by invitation"],["38","Completed"],["5","Completed                  Has Results"],["34","Completed"],["50","Completed                  Has Results"],["140","Completed"],["240","Active not recruiting"],["150","Recruiting"],["34","Completed"],["100","Recruiting"],["26","Completed"],["61","Active not recruiting"],["33","Active not recruiting"],["1","Terminated"],["60","Completed"],["22","Completed"],["13","Recruiting"],["","Available"],["60","Recruiting"],["60","Completed"]]},"dateCreated":"2016-12-06T17:31:08+0000","status":"READY","errorMessage":"","progressUpdateIntervalMs":500,"$$hashKey":"object:2225"},{"text":"%sql\n\nselect number_enrolled,phase from table_df where phase != \"\"","dateUpdated":"2016-12-06T17:31:08+0000","config":{"colWidth":6,"editorMode":"ace/mode/sql","editorHide":true,"graph":{"mode":"multiBarChart","height":428,"optionOpen":false,"keys":[{"name":"phase","index":1,"aggr":"sum"}],"values":[{"name":"phase","index":1,"aggr":"count"}],"groups":[],"scatter":{"xAxis":{"name":"number_enrolled","index":0,"aggr":"sum"},"yAxis":{"name":"phase","index":1,"aggr":"sum"}}},"enabled":true},"settings":{"params":{},"forms":{}},"jobName":"paragraph_1481045468657_-390281486","id":"20161204-182955_1078852669","result":{"code":"SUCCESS","type":"TABLE","msg":"number_enrolled\tphase\n150\tPhase 2\n450\tPhase 2\n60\tPhase 2\n100\tPhase 0\n75\tPhase 2\n120\tPhase 4\n20\tPhase 1 / Phase 2\n99\tPhase 4\n24\tPhase 1 / Phase 2\n40\tPhase 2\n400\tPhase 3\n100\tPhase 1 / Phase 2\n100\tPhase 2\n60\tPhase 4\n350\tPhase 3\n32\tPhase 2\n54\tPhase 2\n300\tPhase 2\n22\tPhase 4\n12\tPhase 1 / Phase 2\n20\tPhase 1\n36\tPhase 4\n60\tPhase 2\n7\tPhase 1\n100\tPhase 1 / Phase 2\n32\tPhase 1\n30\tPhase 4\n68\tPhase 2\n45\tPhase 1\n200\tPhase 2\n50\tPhase 0\n40\tPhase 3\n10\tPhase 2\n40\tPhase 1\n165\tPhase 2\n24\tPhase 4\n12\tPhase 2\n60\tPhase 1\n18\tPhase 2\n70\tPhase 2\n50\tPhase 2\n276\tPhase 3\n25\tPhase 2\n274\tPhase 3\n\tPhase 3\n24\tPhase 1\n36\tPhase 2\n24\tPhase 0\n0\tPhase 1\n74\tPhase 1 / Phase 2\n40\tPhase 4\n18\tPhase 2\n30\tPhase 1\n53\tPhase 4\n4\tPhase 4\n15\tPhase 0\n96\tPhase 2\n60\tPhase 4\n125\tPhase 2\n40\tPhase 2\n50\tPhase 2\n8\tPhase 1\n12\tPhase 1\n100\tPhase 4\n158\tPhase 2\n39\tPhase 2\n31\tPhase 1 / Phase 2\n300\tPhase 4\n65\tPhase 3\n105\tPhase 2\n75\tPhase 2\n70\tPhase 1\n30\tPhase 1 / Phase 2\n48\tPhase 1\n18\tPhase 1\n20\tPhase 4\n66\tPhase 1 / Phase 2\n90\tPhase 1 / Phase 2\n10\tPhase 4\n46\tPhase 2\n160\tPhase 2\n18\tPhase 1\n29\tPhase 2\n40\tPhase 2\n64\tPhase 4\n30\tPhase 1 / Phase 2\n15\tPhase 1\n36\tPhase 1\n240\tPhase 3\n36\tPhase 4\n24\tPhase 1\n30\tPhase 1\n27\tPhase 2\n20\tPhase 2\n90\tPhase 2\n23\tPhase 4\n30\tPhase 3\n25\tPhase 1\n25\tPhase 1 / Phase 2\n78\tPhase 2\n61\tPhase 2\n66\tPhase 1\n80\tPhase 2\n13\tPhase 2 / Phase 3\n600\tPhase 2\n130\tPhase 1 / Phase 2\n33\tPhase 1\n300\tPhase 2\n15\tPhase 4\n50\tPhase 2\n12\tPhase 1\n100\tPhase 2\n40\tPhase 2\n35\tPhase 1\n6\tPhase 2\n40\tPhase 4\n20\tPhase 1\n0\tPhase 1 / Phase 2\n115\tPhase 4\n30\tPhase 1\n115\tPhase 4\n100\tPhase 2\n0\tPhase 4\n48\tPhase 4\n16\tPhase 1\n30\tPhase 2\n0\tPhase 2\n30\tPhase 4\n36\tPhase 1\n30\tPhase 4\n30\tPhase 2\n116\tPhase 2\n40\tPhase 2\n71\tPhase 4\n24\tPhase 1\n25\tPhase 2\n67\tPhase 0\n15\tPhase 4\n24\tPhase 2\n46\tPhase 2\n0\tPhase 1\n51\tPhase 1\n39\tPhase 2\n50\tPhase 2\n50\tPhase 4\n50\tPhase 2\n30\tPhase 0\n45\tPhase 1\n40\tPhase 4\n20\tPhase 1\n150\tPhase 4\n88\tPhase 4\n60\tPhase 2\n60\tPhase 2\n300\tPhase 4\n45\tPhase 4\n60\tPhase 1\n22\tPhase 4\n32\tPhase 1\n50\tPhase 4\n12\tPhase 1\n50\tPhase 2\n120\tPhase 2\n61\tPhase 2\n1\tPhase 1\n20\tPhase 1\n40\tPhase 1\n26\tPhase 1\n60\tPhase 4\n24\tPhase 1\n20\tPhase 4\n500\tPhase 3\n40\tPhase 2\n72\tPhase 1 / Phase 2\n104\tPhase 4\n12\tPhase 1\n60\tPhase 2\n124\tPhase 4\n24\tPhase 1\n39\tPhase 0\n60\tPhase 3\n25\tPhase 1\n40\tPhase 0\n1\tPhase 1\n14\tPhase 1\n40\tPhase 4\n17\tPhase 1\n24\tPhase 2\n160\tPhase 4\n13\tPhase 2\n30\tPhase 4\n27\tPhase 2 / Phase 3\n60\tPhase 3\n10\tPhase 2\n50\tPhase 2\n6\tPhase 1\n50\tPhase 4\n0\tPhase 4\n24\tPhase 1\n44\tPhase 1\n0\tPhase 2\n421\tPhase 3\n30\tPhase 1\n64\tPhase 2\n15\tPhase 1 / Phase 2\n40\tPhase 2\n40\tPhase 2\n132\tPhase 2\n24\tPhase 1\n20\tPhase 2\n3\tPhase 4\n1\tPhase 2\n34\tPhase 2\n20\tPhase 3\n0\tPhase 1\n24\tPhase 4\n50\tPhase 2\n30\tPhase 4\n20\tPhase 2\n90\tPhase 4\n9\tPhase 1 / Phase 2\n30\tPhase 1\n1\tPhase 0\n6\tPhase 1 / Phase 2\n6\tPhase 1\n20\tPhase 1\n400\tPhase 4\n17\tPhase 1\n40\tPhase 4\n28\tPhase 4\n6\tPhase 1\n60\tPhase 2\n100\tPhase 2\n70\tPhase 3\n50\tPhase 2\n30\tPhase 4\n30\tPhase 1\n10\tPhase 4\n36\tPhase 2\n24\tPhase 1\n140\tPhase 4\n364\tPhase 3\n9\tPhase 1\n250\tPhase 2\n17\tPhase 3\n120\tPhase 2\n0\tPhase 2\n40\tPhase 4\n20\tPhase 4\n20\tPhase 1\n60\tPhase 4\n20\tPhase 4\n13\tPhase 2\n140\tPhase 2\n17\tPhase 1\n10\tPhase 1 / Phase 2\n0\tPhase 2\n38\tPhase 4\n41\tPhase 4\n2\tPhase 1 / Phase 2\n28\tPhase 1\n17\tPhase 1 / Phase 2\n20\tPhase 1\n100\tPhase 1\n239\tPhase 1\n13\tPhase 4\n6\tPhase 0\n59\tPhase 4\n28\tPhase 0\n30\tPhase 0\n99\tPhase 2\n10\tPhase 0\n20\tPhase 2\n50\tPhase 2 / Phase 3\n90\tPhase 2 / Phase 3\n5\tPhase 1\n36\tPhase 0\n21\tPhase 2\n12\tPhase 1\n41\tPhase 1\n26\tPhase 1\n35\tPhase 1\n102\tPhase 1 / Phase 2\n16\tPhase 1 / Phase 2\n60\tPhase 2\n8\tPhase 1\n16\tPhase 1\n10\tPhase 1\n20\tPhase 2\n10\tPhase 1\n21\tPhase 1\n10\tPhase 2\n24\tPhase 4\n26\tPhase 3\n83\tPhase 1\n37\tPhase 4\n60\tPhase 4\n30\tPhase 2\n150\tPhase 1\n626\tPhase 3\n12\tPhase 1\n0\tPhase 2\n20\tPhase 2\n48\tPhase 4\n25\tPhase 4\n90\tPhase 2 / Phase 3\n5\tPhase 0\n5\tPhase 4\n7\tPhase 1\n130\tPhase 2 / Phase 3\n20\tPhase 1\n18\tPhase 2\n24\tPhase 2\n18\tPhase 1\n5\tPhase 4\n50\tPhase 0\n61\tPhase 1\n60\tPhase 4\n22\tPhase 1\n13\tPhase 1 / Phase 2\n56\tPhase 1 / Phase 2\n15\tPhase 1\n68\tPhase 2\n48\tPhase 2\n19\tPhase 2\n2\tPhase 1 / Phase 2\n15\tPhase 1\n12\tPhase 1\n17\tPhase 2\n1\tPhase 1 / Phase 2\n20\tPhase 2\n21\tPhase 2\n7\tPhase 0\n14\tPhase 4\n150\tPhase 1\n22\tPhase 0\n42\tPhase 1\n44\tPhase 1\n350\tPhase 3\n250\tPhase 3\n100\tPhase 1 / Phase 2\n126\tPhase 4\n42\tPhase 4\n38\tPhase 2\n12\tPhase 1\n45\tPhase 2\n37\tPhase 1\n32\tPhase 2\n96\tPhase 4\n50\tPhase 1\n282\tPhase 3\n39\tPhase 2\n36\tPhase 4\n250\tPhase 1 / Phase 2\n105\tPhase 1\n11\tPhase 1\n204\tPhase 4\n48\tPhase 1\n15\tPhase 1\n34\tPhase 1\n12\tPhase 1 / Phase 2\n180\tPhase 4\n40\tPhase 2\n0\tPhase 1\n48\tPhase 1\n50\tPhase 1\n9\tPhase 4\n10\tPhase 0\n200\tPhase 4\n3\tPhase 1\n26\tPhase 1\n60\tPhase 1\n17\tPhase 1\n50\tPhase 1\n1167\tPhase 3\n64\tPhase 1\n45\tPhase 2\n61\tPhase 4\n0\tPhase 2\n20\tPhase 2\n30\tPhase 4\n60\tPhase 3\n72\tPhase 1\n112\tPhase 4\n117\tPhase 1\n130\tPhase 2\n18\tPhase 1\n22\tPhase 1\n40\tPhase 0\n20\tPhase 2\n123\tPhase 2\n8\tPhase 4\n20\tPhase 1\n20\tPhase 1\n5\tPhase 2\n48\tPhase 1\n0\tPhase 2\n65\tPhase 1\n33\tPhase 1 / Phase 2\n1\tPhase 1\n375\tPhase 2\n50\tPhase 1\n70\tPhase 1\n38\tPhase 0\n2\tPhase 2\n62\tPhase 2\n14\tPhase 1\n6\tPhase 1\n61\tPhase 1\n136\tPhase 2\n163\tPhase 4\n92\tPhase 4\n3\tPhase 4\n20\tPhase 1\n2\tPhase 1\n339\tPhase 3\n140\tPhase 3\n34\tPhase 2\n30\tPhase 1 / Phase 2\n42\tPhase 2\n10\tPhase 1\n60\tPhase 4\n68\tPhase 1\n60\tPhase 0\n202\tPhase 4\n52\tPhase 4\n30\tPhase 4\n49\tPhase 1 / Phase 2\n21\tPhase 1\n1184\tPhase 4\n30\tPhase 1 / Phase 2\n17\tPhase 1\n22\tPhase 1\n18\tPhase 1\n97\tPhase 0\n21\tPhase 4\n12\tPhase 2 / Phase 3\n82\tPhase 2\n40\tPhase 1\n24\tPhase 1\n12\tPhase 1\n49\tPhase 1\n12\tPhase 4\n0\tPhase 4\n15\tPhase 1\n37\tPhase 1 / Phase 2\n350\tPhase 2 / Phase 3\n25\tPhase 2\n80\tPhase 3\n40\tPhase 3\n110\tPhase 2\n60\tPhase 4\n23\tPhase 4\n916\tPhase 4\n80\tPhase 2\n6\tPhase 1\n14\tPhase 2\n160\tPhase 1\n0\tPhase 2\n0\tPhase 2\n5\tPhase 1 / Phase 2\n20\tPhase 1\n45\tPhase 2\n29\tPhase 1\n36\tPhase 4\n141\tPhase 2\n19\tPhase 1\n6\tPhase 2\n17\tPhase 2\n74\tPhase 1 / Phase 2\n50\tPhase 1 / Phase 2\n10\tPhase 1\n22\tPhase 1\n2\tPhase 1\n0\tPhase 2\n20\tPhase 3\n2\tPhase 1\n41\tPhase 2\n5\tPhase 2\n314\tPhase 3\n18\tPhase 4\n11\tPhase 1\n122\tPhase 1\n21\tPhase 1\n89\tPhase 3\n21\tPhase 1\n62\tPhase 1\n67\tPhase 1 / Phase 2\n18\tPhase 1\n40\tPhase 4\n63\tPhase 2\n80\tPhase 1 / Phase 2\n96\tPhase 1\n246\tPhase 1\n15000\tPhase 1\n18\tPhase 1\n26\tPhase 1\n26\tPhase 1\n24\tPhase 1\n26\tPhase 1\n9\tPhase 1\n11\tPhase 2\n0\tPhase 2\n38\tPhase 2\n36\tPhase 2\n20\tPhase 2\n140\tPhase 2\n5\tPhase 1\n50\tPhase 2\n24\tPhase 1\n365\tPhase 2\n24\tPhase 1\n31\tPhase 2\n3\tPhase 2\n54\tPhase 2\n21\tPhase 2\n100\tPhase 1\n60\tPhase 0\n147\tPhase 1\n14\tPhase 1\n0\tPhase 0\n0\tPhase 4\n20\tPhase 2\n156\tPhase 3\n22\tPhase 1\n70\tPhase 1\n20\tPhase 4\n26\tPhase 4\n24\tPhase 4\n32\tPhase 4\n3\tPhase 2\n26\tPhase 1\n77\tPhase 4\n54\tPhase 2\n25\tPhase 1\n45\tPhase 1\n26\tPhase 4\n9\tPhase 1\n1\tPhase 1\n38\tPhase 1 / Phase 2\n60\tPhase 1 / Phase 2\n16\tPhase 2\n14\tPhase 4\n18\tPhase 4\n38\tPhase 4\n9\tPhase 1\n40\tPhase 1\n0\tPhase 2\n80\tPhase 2\n12\tPhase 4\n48\tPhase 2\n40\tPhase 4\n380\tPhase 3\n40\tPhase 2\n0\tPhase 2\n49\tPhase 2\n52\tPhase 4\n5\tPhase 1\n41\tPhase 2\n50\tPhase 2\n3\tPhase 2\n53\tPhase 2\n530\tPhase 3\n519\tPhase 3\n9\tPhase 1 / Phase 2\n104\tPhase 2\n12\tPhase 1 / Phase 2\n36\tPhase 4\n52\tPhase 4\n0\tPhase 4\n578\tPhase 3\n161\tPhase 3\n32\tPhase 1\n20\tPhase 1\n60\tPhase 2\n49\tPhase 4\n48\tPhase 1 / Phase 2\n301\tPhase 3\n16\tPhase 2\n60\tPhase 1 / Phase 2\n11\tPhase 1 / Phase 2\n15\tPhase 1\n67\tPhase 4\n12\tPhase 1\n25\tPhase 1\n116\tPhase 2\n60\tPhase 2\n63\tPhase 4\n61\tPhase 4\n160\tPhase 4\n12\tPhase 1\n21\tPhase 2\n21\tPhase 2\n57\tPhase 2\n1\tPhase 1 / Phase 2\n606\tPhase 3\n50\tPhase 1\n228\tPhase 4\n13\tPhase 1\n30\tPhase 3\n60\tPhase 3\n80\tPhase 2 / Phase 3\n100\tPhase 2\n16\tPhase 1\n16\tPhase 2\n35\tPhase 2\n333\tPhase 2\n40\tPhase 1\n30\tPhase 1\n26\tPhase 1\n26\tPhase 1\n12\tPhase 2\n20\tPhase 4\n112\tPhase 3\n13\tPhase 1\n34\tPhase 4\n4\tPhase 1\n25\tPhase 1\n11\tPhase 1\n32\tPhase 1\n26\tPhase 1\n25\tPhase 1\n133\tPhase 3\n31\tPhase 2\n13\tPhase 1 / Phase 2\n100\tPhase 4\n257\tPhase 1\n20\tPhase 3\n15\tPhase 1\n20\tPhase 1\n10\tPhase 0\n31\tPhase 1 / Phase 2\n60\tPhase 2\n1\tPhase 2\n6\tPhase 2\n18\tPhase 1\n13\tPhase 1\n125\tPhase 2\n5\tPhase 1\n5\tPhase 1\n68\tPhase 2\n1884\tPhase 3\n24\tPhase 1\n14\tPhase 1\n40\tPhase 0\n100\tPhase 4\n94\tPhase 1\n12\tPhase 1\n364\tPhase 3\n40\tPhase 4\n49\tPhase 4\n150\tPhase 4\n2\tPhase 1\n7\tPhase 1\n22\tPhase 1\n3\tPhase 4\n50\tPhase 4\n14\tPhase 1\n11\tPhase 4\n20\tPhase 2\n300\tPhase 1 / Phase 2\n18\tPhase 2\n12\tPhase 1\n15\tPhase 0\n115\tPhase 4\n0\tPhase 1\n479\tPhase 3\n15\tPhase 1\n45\tPhase 2\n88\tPhase 2\n100\tPhase 1\n46\tPhase 2\n88\tPhase 2\n25\tPhase 2\n400\tPhase 3\n12\tPhase 4\n20\tPhase 4\n80\tPhase 4\n20\tPhase 4\n30\tPhase 4\n30\tPhase 4\n30\tPhase 2\n23\tPhase 1\n4\tPhase 2\n37\tPhase 1\n18\tPhase 2\n5\tPhase 2\n0\tPhase 2\n0\tPhase 2\n41\tPhase 4\n13\tPhase 1\n86\tPhase 0\n3\tPhase 1 / Phase 2\n137\tPhase 4\n12\tPhase 1\n32\tPhase 2\n1\tPhase 1 / Phase 2\n8\tPhase 1\n57\tPhase 2\n855\tPhase 1\n40\tPhase 1\n610\tPhase 3\n16\tPhase 1\n614\tPhase 3\n223\tPhase 2\n20\tPhase 4\n40\tPhase 4\n15\tPhase 4\n30\tPhase 4\n20\tPhase 1\n59\tPhase 1\n17\tPhase 1\n7\tPhase 4\n70\tPhase 1\n16\tPhase 1\n51\tPhase 4\n24\tPhase 1\n63\tPhase 2\n30\tPhase 0\n56\tPhase 2\n20\tPhase 2\n2\tPhase 2\n301\tPhase 3\n18\tPhase 1\n56\tPhase 1\n4\tPhase 1\n35\tPhase 2\n321697\tPhase 4\n18\tPhase 1\n16\tPhase 1\n87\tPhase 0\n54\tPhase 2\n7\tPhase 2\n67\tPhase 4\n30\tPhase 2\n9\tPhase 2\n1\tPhase 2\n17\tPhase 0\n120\tPhase 3\n41\tPhase 2\n64\tPhase 2\n6\tPhase 2\n49\tPhase 1\n78\tPhase 1\n67\tPhase 2\n27\tPhase 1\n23\tPhase 2\n42\tPhase 1\n42\tPhase 1 / Phase 2\n37\tPhase 1\n96\tPhase 1\n94\tPhase 2\n59\tPhase 2\n41\tPhase 2\n25\tPhase 1\n2\tPhase 1\n56\tPhase 2\n74\tPhase 1\n60\tPhase 4\n62\tPhase 1\n15\tPhase 3\n47\tPhase 1\n33\tPhase 2\n12\tPhase 1\n55\tPhase 0\n40\tPhase 1\n21\tPhase 4\n60\tPhase 1\n40\tPhase 1\n24\tPhase 0\n66\tPhase 1\n0\tPhase 2\n264\tPhase 2\n50\tPhase 2\n32\tPhase 2\n6\tPhase 1\n125\tPhase 2\n851\tPhase 3\n20\tPhase 3\n302\tPhase 2 / Phase 3\n52\tPhase 1\n25\tPhase 1\n13\tPhase 1\n13\tPhase 4\n21\tPhase 1\n47\tPhase 1\n56\tPhase 1\n45\tPhase 1\n176\tPhase 2\n15\tPhase 1\n28\tPhase 1 / Phase 2\n7\tPhase 4\n48\tPhase 2\n29\tPhase 1 / Phase 2\n21\tPhase 1\n39\tPhase 2\n28\tPhase 2\n26\tPhase 2\n127\tPhase 4\n31\tPhase 1\n40\tPhase 4\n11\tPhase 4\n25\tPhase 1\n2\tPhase 2\n33\tPhase 4\n12\tPhase 4\n256\tPhase 2 / Phase 3\n711\tPhase 3\n10\tPhase 2\n21\tPhase 4\n30\tPhase 2\n188\tPhase 4\n24\tPhase 1 / Phase 2\n8\tPhase 1 / Phase 2\n67\tPhase 4\n28\tPhase 1 / Phase 2\n24\tPhase 4\n239\tPhase 3\n434\tPhase 3\n468\tPhase 3\n4\tPhase 2\n14\tPhase 2\n19\tPhase 2\n7\tPhase 2\n55\tPhase 3\n40\tPhase 2\n0\tPhase 4\n32\tPhase 2\n13\tPhase 2\n26\tPhase 2\n82\tPhase 4\n14\tPhase 2\n4\tPhase 1\n33\tPhase 2\n15\tPhase 2\n1467\tPhase 3\n18\tPhase 1\n110\tPhase 4\n341\tPhase 3\n8\tPhase 1\n71\tPhase 1\n295\tPhase 3\n44\tPhase 4\n54\tPhase 1\n16\tPhase 1\n30\tPhase 2\n290\tPhase 2\n66\tPhase 2\n14\tPhase 2\n30\tPhase 2\n13\tPhase 1\n60\tPhase 1 / Phase 2\n70\tPhase 2\n276\tPhase 4\n24\tPhase 1\n8\tPhase 1\n61\tPhase 4\n3604\tPhase 3\n24\tPhase 1\n15\tPhase 4\n90\tPhase 4\n16\tPhase 2 / Phase 3\n140\tPhase 2\n24\tPhase 1\n278\tPhase 2 / Phase 3\n23\tPhase 1 / Phase 2\n36\tPhase 2\n1600\tPhase 4\n50\tPhase 2\n51\tPhase 1\n116\tPhase 2\n5\tPhase 2\n569\tPhase 4\n37\tPhase 1\n16\tPhase 1\n454\tPhase 2\n27\tPhase 2\n20\tPhase 1\n61\tPhase 2\n4\tPhase 4\n475\tPhase 2 / Phase 3\n58\tPhase 4\n52\tPhase 2\n21\tPhase 2\n2\tPhase 2\n65\tPhase 1\n20\tPhase 2\n40\tPhase 4\n93\tPhase 4\n29\tPhase 1\n62\tPhase 2\n516\tPhase 4\n65\tPhase 1\n100\tPhase 2\n0\tPhase 4\n10\tPhase 1 / Phase 2\n18\tPhase 2\n457\tPhase 3\n275\tPhase 4\n318\tPhase 3\n20\tPhase 2\n111\tPhase 2 / Phase 3\n41\tPhase 1\n113\tPhase 4\n88\tPhase 4\n33\tPhase 1\n15\tPhase 4\n150\tPhase 3\n89\tPhase 2\n14\tPhase 1\n34\tPhase 1 / Phase 2\n262\tPhase 4\n48\tPhase 1 / Phase 2\n45\tPhase 1\n29\tPhase 2\n4\tPhase 1\n18\tPhase 1\n27\tPhase 2\n113\tPhase 3\n37\tPhase 1\n101\tPhase 3\n60\tPhase 2\n12\tPhase 2 / Phase 3\n53\tPhase 1\n152\tPhase 3\n231\tPhase 2\n20\tPhase 4\n40\tPhase 1\n40\tPhase 4\n40\tPhase 3\n40\tPhase 1\n8\tPhase 1 / Phase 2\n15\tPhase 2\n13\tPhase 1\n64\tPhase 2 / Phase 3\n24\tPhase 2\n75\tPhase 2\n30\tPhase 1\n65\tPhase 1\n261\tPhase 2\n24\tPhase 2\n150\tPhase 2 / Phase 3\n68\tPhase 2\n26\tPhase 2\n23\tPhase 1\n97\tPhase 3\n279\tPhase 3\n\tPhase 3\n31\tPhase 2\n25\tPhase 1\n96\tPhase 4\n400\tPhase 3\n\tPhase 3\n107\tPhase 1 / Phase 2\n496\tPhase 2 / Phase 3\n15\tPhase 2\n200\tPhase 3\n136\tPhase 3\n10\tPhase 1\n\tPhase 2\n\tPhase 3\n64\tPhase 4\n15\tPhase 2 / Phase 3\n26\tPhase 2 / Phase 3\n14\tPhase 2\n354\tPhase 1 / Phase 2\n240\tPhase 2\n574\tPhase 2\n77\tPhase 2\n70\tPhase 2\n89\tPhase 2\n160\tPhase 2 / Phase 3\n30\tPhase 4\n16\tPhase 1\n28\tPhase 0\n40\tPhase 2 / Phase 3\n811\tPhase 3\n174\tPhase 2\n654\tPhase 3\n80\tPhase 3\n12\tPhase 2 / Phase 3\n2364\tPhase 3\n56\tPhase 2 / Phase 3\n600\tPhase 4\n30\tPhase 2\n\tPhase 1\n30\tPhase 1\n5\tPhase 2\n30\tPhase 1\n40\tPhase 2\n20\tPhase 2\n1800\tPhase 3\n18\tPhase 4\n15\tPhase 1 / Phase 2\n76\tPhase 2\n154\tPhase 1 / Phase 2\n33\tPhase 2\n55\tPhase 2\n45\tPhase 1\n101\tPhase 3\n\n<font color=red>Results are limited by 1000.</font>","comment":"<font color=red>Results are limited by 1000.</font>","msgTable":[[{"key":"phase","value":"150"},{"key":"phase","value":"Phase 2"}],[{"value":"450"},{"value":"Phase 2"}],[{"value":"60"},{"value":"Phase 2"}],[{"value":"100"},{"value":"Phase 0"}],[{"value":"75"},{"value":"Phase 2"}],[{"value":"120"},{"value":"Phase 4"}],[{"value":"20"},{"value":"Phase 1 / Phase 2"}],[{"value":"99"},{"value":"Phase 4"}],[{"value":"24"},{"value":"Phase 1 / Phase 2"}],[{"value":"40"},{"value":"Phase 2"}],[{"value":"400"},{"value":"Phase 3"}],[{"value":"100"},{"value":"Phase 1 / Phase 2"}],[{"value":"100"},{"value":"Phase 2"}],[{"value":"60"},{"value":"Phase 4"}],[{"value":"350"},{"value":"Phase 3"}],[{"value":"32"},{"value":"Phase 2"}],[{"value":"54"},{"value":"Phase 2"}],[{"value":"300"},{"value":"Phase 2"}],[{"value":"22"},{"value":"Phase 4"}],[{"value":"12"},{"value":"Phase 1 / Phase 2"}],[{"value":"20"},{"value":"Phase 1"}],[{"value":"36"},{"value":"Phase 4"}],[{"value":"60"},{"value":"Phase 2"}],[{"value":"7"},{"value":"Phase 1"}],[{"value":"100"},{"value":"Phase 1 / Phase 2"}],[{"value":"32"},{"value":"Phase 1"}],[{"value":"30"},{"value":"Phase 4"}],[{"value":"68"},{"value":"Phase 2"}],[{"value":"45"},{"value":"Phase 1"}],[{"value":"200"},{"value":"Phase 2"}],[{"value":"50"},{"value":"Phase 0"}],[{"value":"40"},{"value":"Phase 3"}],[{"value":"10"},{"value":"Phase 2"}],[{"value":"40"},{"value":"Phase 1"}],[{"value":"165"},{"value":"Phase 2"}],[{"value":"24"},{"value":"Phase 4"}],[{"value":"12"},{"value":"Phase 2"}],[{"value":"60"},{"value":"Phase 1"}],[{"value":"18"},{"value":"Phase 2"}],[{"value":"70"},{"value":"Phase 2"}],[{"value":"50"},{"value":"Phase 2"}],[{"value":"276"},{"value":"Phase 3"}],[{"value":"25"},{"value":"Phase 2"}],[{"value":"274"},{"value":"Phase 3"}],[{"value":""},{"value":"Phase 3"}],[{"value":"24"},{"value":"Phase 1"}],[{"value":"36"},{"value":"Phase 2"}],[{"value":"24"},{"value":"Phase 0"}],[{"value":"0"},{"value":"Phase 1"}],[{"value":"74"},{"value":"Phase 1 / Phase 2"}],[{"value":"40"},{"value":"Phase 4"}],[{"value":"18"},{"value":"Phase 2"}],[{"value":"30"},{"value":"Phase 1"}],[{"value":"53"},{"value":"Phase 4"}],[{"value":"4"},{"value":"Phase 4"}],[{"value":"15"},{"value":"Phase 0"}],[{"value":"96"},{"value":"Phase 2"}],[{"value":"60"},{"value":"Phase 4"}],[{"value":"125"},{"value":"Phase 2"}],[{"value":"40"},{"value":"Phase 2"}],[{"value":"50"},{"value":"Phase 2"}],[{"value":"8"},{"value":"Phase 1"}],[{"value":"12"},{"value":"Phase 1"}],[{"value":"100"},{"value":"Phase 4"}],[{"value":"158"},{"value":"Phase 2"}],[{"value":"39"},{"value":"Phase 2"}],[{"value":"31"},{"value":"Phase 1 / Phase 2"}],[{"value":"300"},{"value":"Phase 4"}],[{"value":"65"},{"value":"Phase 3"}],[{"value":"105"},{"value":"Phase 2"}],[{"value":"75"},{"value":"Phase 2"}],[{"value":"70"},{"value":"Phase 1"}],[{"value":"30"},{"value":"Phase 1 / Phase 2"}],[{"value":"48"},{"value":"Phase 1"}],[{"value":"18"},{"value":"Phase 1"}],[{"value":"20"},{"value":"Phase 4"}],[{"value":"66"},{"value":"Phase 1 / Phase 2"}],[{"value":"90"},{"value":"Phase 1 / Phase 2"}],[{"value":"10"},{"value":"Phase 4"}],[{"value":"46"},{"value":"Phase 2"}],[{"value":"160"},{"value":"Phase 2"}],[{"value":"18"},{"value":"Phase 1"}],[{"value":"29"},{"value":"Phase 2"}],[{"value":"40"},{"value":"Phase 2"}],[{"value":"64"},{"value":"Phase 4"}],[{"value":"30"},{"value":"Phase 1 / Phase 2"}],[{"value":"15"},{"value":"Phase 1"}],[{"value":"36"},{"value":"Phase 1"}],[{"value":"240"},{"value":"Phase 3"}],[{"value":"36"},{"value":"Phase 4"}],[{"value":"24"},{"value":"Phase 1"}],[{"value":"30"},{"value":"Phase 1"}],[{"value":"27"},{"value":"Phase 2"}],[{"value":"20"},{"value":"Phase 2"}],[{"value":"90"},{"value":"Phase 2"}],[{"value":"23"},{"value":"Phase 4"}],[{"value":"30"},{"value":"Phase 3"}],[{"value":"25"},{"value":"Phase 1"}],[{"value":"25"},{"value":"Phase 1 / Phase 2"}],[{"value":"78"},{"value":"Phase 2"}],[{"value":"61"},{"value":"Phase 2"}],[{"value":"66"},{"value":"Phase 1"}],[{"value":"80"},{"value":"Phase 2"}],[{"value":"13"},{"value":"Phase 2 / Phase 3"}],[{"value":"600"},{"value":"Phase 2"}],[{"value":"130"},{"value":"Phase 1 / Phase 2"}],[{"value":"33"},{"value":"Phase 1"}],[{"value":"300"},{"value":"Phase 2"}],[{"value":"15"},{"value":"Phase 4"}],[{"value":"50"},{"value":"Phase 2"}],[{"value":"12"},{"value":"Phase 1"}],[{"value":"100"},{"value":"Phase 2"}],[{"value":"40"},{"value":"Phase 2"}],[{"value":"35"},{"value":"Phase 1"}],[{"value":"6"},{"value":"Phase 2"}],[{"value":"40"},{"value":"Phase 4"}],[{"value":"20"},{"value":"Phase 1"}],[{"value":"0"},{"value":"Phase 1 / Phase 2"}],[{"value":"115"},{"value":"Phase 4"}],[{"value":"30"},{"value":"Phase 1"}],[{"value":"115"},{"value":"Phase 4"}],[{"value":"100"},{"value":"Phase 2"}],[{"value":"0"},{"value":"Phase 4"}],[{"value":"48"},{"value":"Phase 4"}],[{"value":"16"},{"value":"Phase 1"}],[{"value":"30"},{"value":"Phase 2"}],[{"value":"0"},{"value":"Phase 2"}],[{"value":"30"},{"value":"Phase 4"}],[{"value":"36"},{"value":"Phase 1"}],[{"value":"30"},{"value":"Phase 4"}],[{"value":"30"},{"value":"Phase 2"}],[{"value":"116"},{"value":"Phase 2"}],[{"value":"40"},{"value":"Phase 2"}],[{"value":"71"},{"value":"Phase 4"}],[{"value":"24"},{"value":"Phase 1"}],[{"value":"25"},{"value":"Phase 2"}],[{"value":"67"},{"value":"Phase 0"}],[{"value":"15"},{"value":"Phase 4"}],[{"value":"24"},{"value":"Phase 2"}],[{"value":"46"},{"value":"Phase 2"}],[{"value":"0"},{"value":"Phase 1"}],[{"value":"51"},{"value":"Phase 1"}],[{"value":"39"},{"value":"Phase 2"}],[{"value":"50"},{"value":"Phase 2"}],[{"value":"50"},{"value":"Phase 4"}],[{"value":"50"},{"value":"Phase 2"}],[{"value":"30"},{"value":"Phase 0"}],[{"value":"45"},{"value":"Phase 1"}],[{"value":"40"},{"value":"Phase 4"}],[{"value":"20"},{"value":"Phase 1"}],[{"value":"150"},{"value":"Phase 4"}],[{"value":"88"},{"value":"Phase 4"}],[{"value":"60"},{"value":"Phase 2"}],[{"value":"60"},{"value":"Phase 2"}],[{"value":"300"},{"value":"Phase 4"}],[{"value":"45"},{"value":"Phase 4"}],[{"value":"60"},{"value":"Phase 1"}],[{"value":"22"},{"value":"Phase 4"}],[{"value":"32"},{"value":"Phase 1"}],[{"value":"50"},{"value":"Phase 4"}],[{"value":"12"},{"value":"Phase 1"}],[{"value":"50"},{"value":"Phase 2"}],[{"value":"120"},{"value":"Phase 2"}],[{"value":"61"},{"value":"Phase 2"}],[{"value":"1"},{"value":"Phase 1"}],[{"value":"20"},{"value":"Phase 1"}],[{"value":"40"},{"value":"Phase 1"}],[{"value":"26"},{"value":"Phase 1"}],[{"value":"60"},{"value":"Phase 4"}],[{"value":"24"},{"value":"Phase 1"}],[{"value":"20"},{"value":"Phase 4"}],[{"value":"500"},{"value":"Phase 3"}],[{"value":"40"},{"value":"Phase 2"}],[{"value":"72"},{"value":"Phase 1 / Phase 2"}],[{"value":"104"},{"value":"Phase 4"}],[{"value":"12"},{"value":"Phase 1"}],[{"value":"60"},{"value":"Phase 2"}],[{"value":"124"},{"value":"Phase 4"}],[{"value":"24"},{"value":"Phase 1"}],[{"value":"39"},{"value":"Phase 0"}],[{"value":"60"},{"value":"Phase 3"}],[{"value":"25"},{"value":"Phase 1"}],[{"value":"40"},{"value":"Phase 0"}],[{"value":"1"},{"value":"Phase 1"}],[{"value":"14"},{"value":"Phase 1"}],[{"value":"40"},{"value":"Phase 4"}],[{"value":"17"},{"value":"Phase 1"}],[{"value":"24"},{"value":"Phase 2"}],[{"value":"160"},{"value":"Phase 4"}],[{"value":"13"},{"value":"Phase 2"}],[{"value":"30"},{"value":"Phase 4"}],[{"value":"27"},{"value":"Phase 2 / Phase 3"}],[{"value":"60"},{"value":"Phase 3"}],[{"value":"10"},{"value":"Phase 2"}],[{"value":"50"},{"value":"Phase 2"}],[{"value":"6"},{"value":"Phase 1"}],[{"value":"50"},{"value":"Phase 4"}],[{"value":"0"},{"value":"Phase 4"}],[{"value":"24"},{"value":"Phase 1"}],[{"value":"44"},{"value":"Phase 1"}],[{"value":"0"},{"value":"Phase 2"}],[{"value":"421"},{"value":"Phase 3"}],[{"value":"30"},{"value":"Phase 1"}],[{"value":"64"},{"value":"Phase 2"}],[{"value":"15"},{"value":"Phase 1 / Phase 2"}],[{"value":"40"},{"value":"Phase 2"}],[{"value":"40"},{"value":"Phase 2"}],[{"value":"132"},{"value":"Phase 2"}],[{"value":"24"},{"value":"Phase 1"}],[{"value":"20"},{"value":"Phase 2"}],[{"value":"3"},{"value":"Phase 4"}],[{"value":"1"},{"value":"Phase 2"}],[{"value":"34"},{"value":"Phase 2"}],[{"value":"20"},{"value":"Phase 3"}],[{"value":"0"},{"value":"Phase 1"}],[{"value":"24"},{"value":"Phase 4"}],[{"value":"50"},{"value":"Phase 2"}],[{"value":"30"},{"value":"Phase 4"}],[{"value":"20"},{"value":"Phase 2"}],[{"value":"90"},{"value":"Phase 4"}],[{"value":"9"},{"value":"Phase 1 / Phase 2"}],[{"value":"30"},{"value":"Phase 1"}],[{"value":"1"},{"value":"Phase 0"}],[{"value":"6"},{"value":"Phase 1 / Phase 2"}],[{"value":"6"},{"value":"Phase 1"}],[{"value":"20"},{"value":"Phase 1"}],[{"value":"400"},{"value":"Phase 4"}],[{"value":"17"},{"value":"Phase 1"}],[{"value":"40"},{"value":"Phase 4"}],[{"value":"28"},{"value":"Phase 4"}],[{"value":"6"},{"value":"Phase 1"}],[{"value":"60"},{"value":"Phase 2"}],[{"value":"100"},{"value":"Phase 2"}],[{"value":"70"},{"value":"Phase 3"}],[{"value":"50"},{"value":"Phase 2"}],[{"value":"30"},{"value":"Phase 4"}],[{"value":"30"},{"value":"Phase 1"}],[{"value":"10"},{"value":"Phase 4"}],[{"value":"36"},{"value":"Phase 2"}],[{"value":"24"},{"value":"Phase 1"}],[{"value":"140"},{"value":"Phase 4"}],[{"value":"364"},{"value":"Phase 3"}],[{"value":"9"},{"value":"Phase 1"}],[{"value":"250"},{"value":"Phase 2"}],[{"value":"17"},{"value":"Phase 3"}],[{"value":"120"},{"value":"Phase 2"}],[{"value":"0"},{"value":"Phase 2"}],[{"value":"40"},{"value":"Phase 4"}],[{"value":"20"},{"value":"Phase 4"}],[{"value":"20"},{"value":"Phase 1"}],[{"value":"60"},{"value":"Phase 4"}],[{"value":"20"},{"value":"Phase 4"}],[{"value":"13"},{"value":"Phase 2"}],[{"value":"140"},{"value":"Phase 2"}],[{"value":"17"},{"value":"Phase 1"}],[{"value":"10"},{"value":"Phase 1 / Phase 2"}],[{"value":"0"},{"value":"Phase 2"}],[{"value":"38"},{"value":"Phase 4"}],[{"value":"41"},{"value":"Phase 4"}],[{"value":"2"},{"value":"Phase 1 / Phase 2"}],[{"value":"28"},{"value":"Phase 1"}],[{"value":"17"},{"value":"Phase 1 / Phase 2"}],[{"value":"20"},{"value":"Phase 1"}],[{"value":"100"},{"value":"Phase 1"}],[{"value":"239"},{"value":"Phase 1"}],[{"value":"13"},{"value":"Phase 4"}],[{"value":"6"},{"value":"Phase 0"}],[{"value":"59"},{"value":"Phase 4"}],[{"value":"28"},{"value":"Phase 0"}],[{"value":"30"},{"value":"Phase 0"}],[{"value":"99"},{"value":"Phase 2"}],[{"value":"10"},{"value":"Phase 0"}],[{"value":"20"},{"value":"Phase 2"}],[{"value":"50"},{"value":"Phase 2 / Phase 3"}],[{"value":"90"},{"value":"Phase 2 / Phase 3"}],[{"value":"5"},{"value":"Phase 1"}],[{"value":"36"},{"value":"Phase 0"}],[{"value":"21"},{"value":"Phase 2"}],[{"value":"12"},{"value":"Phase 1"}],[{"value":"41"},{"value":"Phase 1"}],[{"value":"26"},{"value":"Phase 1"}],[{"value":"35"},{"value":"Phase 1"}],[{"value":"102"},{"value":"Phase 1 / Phase 2"}],[{"value":"16"},{"value":"Phase 1 / Phase 2"}],[{"value":"60"},{"value":"Phase 2"}],[{"value":"8"},{"value":"Phase 1"}],[{"value":"16"},{"value":"Phase 1"}],[{"value":"10"},{"value":"Phase 1"}],[{"value":"20"},{"value":"Phase 2"}],[{"value":"10"},{"value":"Phase 1"}],[{"value":"21"},{"value":"Phase 1"}],[{"value":"10"},{"value":"Phase 2"}],[{"value":"24"},{"value":"Phase 4"}],[{"value":"26"},{"value":"Phase 3"}],[{"value":"83"},{"value":"Phase 1"}],[{"value":"37"},{"value":"Phase 4"}],[{"value":"60"},{"value":"Phase 4"}],[{"value":"30"},{"value":"Phase 2"}],[{"value":"150"},{"value":"Phase 1"}],[{"value":"626"},{"value":"Phase 3"}],[{"value":"12"},{"value":"Phase 1"}],[{"value":"0"},{"value":"Phase 2"}],[{"value":"20"},{"value":"Phase 2"}],[{"value":"48"},{"value":"Phase 4"}],[{"value":"25"},{"value":"Phase 4"}],[{"value":"90"},{"value":"Phase 2 / Phase 3"}],[{"value":"5"},{"value":"Phase 0"}],[{"value":"5"},{"value":"Phase 4"}],[{"value":"7"},{"value":"Phase 1"}],[{"value":"130"},{"value":"Phase 2 / Phase 3"}],[{"value":"20"},{"value":"Phase 1"}],[{"value":"18"},{"value":"Phase 2"}],[{"value":"24"},{"value":"Phase 2"}],[{"value":"18"},{"value":"Phase 1"}],[{"value":"5"},{"value":"Phase 4"}],[{"value":"50"},{"value":"Phase 0"}],[{"value":"61"},{"value":"Phase 1"}],[{"value":"60"},{"value":"Phase 4"}],[{"value":"22"},{"value":"Phase 1"}],[{"value":"13"},{"value":"Phase 1 / Phase 2"}],[{"value":"56"},{"value":"Phase 1 / Phase 2"}],[{"value":"15"},{"value":"Phase 1"}],[{"value":"68"},{"value":"Phase 2"}],[{"value":"48"},{"value":"Phase 2"}],[{"value":"19"},{"value":"Phase 2"}],[{"value":"2"},{"value":"Phase 1 / Phase 2"}],[{"value":"15"},{"value":"Phase 1"}],[{"value":"12"},{"value":"Phase 1"}],[{"value":"17"},{"value":"Phase 2"}],[{"value":"1"},{"value":"Phase 1 / Phase 2"}],[{"value":"20"},{"value":"Phase 2"}],[{"value":"21"},{"value":"Phase 2"}],[{"value":"7"},{"value":"Phase 0"}],[{"value":"14"},{"value":"Phase 4"}],[{"value":"150"},{"value":"Phase 1"}],[{"value":"22"},{"value":"Phase 0"}],[{"value":"42"},{"value":"Phase 1"}],[{"value":"44"},{"value":"Phase 1"}],[{"value":"350"},{"value":"Phase 3"}],[{"value":"250"},{"value":"Phase 3"}],[{"value":"100"},{"value":"Phase 1 / Phase 2"}],[{"value":"126"},{"value":"Phase 4"}],[{"value":"42"},{"value":"Phase 4"}],[{"value":"38"},{"value":"Phase 2"}],[{"value":"12"},{"value":"Phase 1"}],[{"value":"45"},{"value":"Phase 2"}],[{"value":"37"},{"value":"Phase 1"}],[{"value":"32"},{"value":"Phase 2"}],[{"value":"96"},{"value":"Phase 4"}],[{"value":"50"},{"value":"Phase 1"}],[{"value":"282"},{"value":"Phase 3"}],[{"value":"39"},{"value":"Phase 2"}],[{"value":"36"},{"value":"Phase 4"}],[{"value":"250"},{"value":"Phase 1 / Phase 2"}],[{"value":"105"},{"value":"Phase 1"}],[{"value":"11"},{"value":"Phase 1"}],[{"value":"204"},{"value":"Phase 4"}],[{"value":"48"},{"value":"Phase 1"}],[{"value":"15"},{"value":"Phase 1"}],[{"value":"34"},{"value":"Phase 1"}],[{"value":"12"},{"value":"Phase 1 / Phase 2"}],[{"value":"180"},{"value":"Phase 4"}],[{"value":"40"},{"value":"Phase 2"}],[{"value":"0"},{"value":"Phase 1"}],[{"value":"48"},{"value":"Phase 1"}],[{"value":"50"},{"value":"Phase 1"}],[{"value":"9"},{"value":"Phase 4"}],[{"value":"10"},{"value":"Phase 0"}],[{"value":"200"},{"value":"Phase 4"}],[{"value":"3"},{"value":"Phase 1"}],[{"value":"26"},{"value":"Phase 1"}],[{"value":"60"},{"value":"Phase 1"}],[{"value":"17"},{"value":"Phase 1"}],[{"value":"50"},{"value":"Phase 1"}],[{"value":"1167"},{"value":"Phase 3"}],[{"value":"64"},{"value":"Phase 1"}],[{"value":"45"},{"value":"Phase 2"}],[{"value":"61"},{"value":"Phase 4"}],[{"value":"0"},{"value":"Phase 2"}],[{"value":"20"},{"value":"Phase 2"}],[{"value":"30"},{"value":"Phase 4"}],[{"value":"60"},{"value":"Phase 3"}],[{"value":"72"},{"value":"Phase 1"}],[{"value":"112"},{"value":"Phase 4"}],[{"value":"117"},{"value":"Phase 1"}],[{"value":"130"},{"value":"Phase 2"}],[{"value":"18"},{"value":"Phase 1"}],[{"value":"22"},{"value":"Phase 1"}],[{"value":"40"},{"value":"Phase 0"}],[{"value":"20"},{"value":"Phase 2"}],[{"value":"123"},{"value":"Phase 2"}],[{"value":"8"},{"value":"Phase 4"}],[{"value":"20"},{"value":"Phase 1"}],[{"value":"20"},{"value":"Phase 1"}],[{"value":"5"},{"value":"Phase 2"}],[{"value":"48"},{"value":"Phase 1"}],[{"value":"0"},{"value":"Phase 2"}],[{"value":"65"},{"value":"Phase 1"}],[{"value":"33"},{"value":"Phase 1 / Phase 2"}],[{"value":"1"},{"value":"Phase 1"}],[{"value":"375"},{"value":"Phase 2"}],[{"value":"50"},{"value":"Phase 1"}],[{"value":"70"},{"value":"Phase 1"}],[{"value":"38"},{"value":"Phase 0"}],[{"value":"2"},{"value":"Phase 2"}],[{"value":"62"},{"value":"Phase 2"}],[{"value":"14"},{"value":"Phase 1"}],[{"value":"6"},{"value":"Phase 1"}],[{"value":"61"},{"value":"Phase 1"}],[{"value":"136"},{"value":"Phase 2"}],[{"value":"163"},{"value":"Phase 4"}],[{"value":"92"},{"value":"Phase 4"}],[{"value":"3"},{"value":"Phase 4"}],[{"value":"20"},{"value":"Phase 1"}],[{"value":"2"},{"value":"Phase 1"}],[{"value":"339"},{"value":"Phase 3"}],[{"value":"140"},{"value":"Phase 3"}],[{"value":"34"},{"value":"Phase 2"}],[{"value":"30"},{"value":"Phase 1 / Phase 2"}],[{"value":"42"},{"value":"Phase 2"}],[{"value":"10"},{"value":"Phase 1"}],[{"value":"60"},{"value":"Phase 4"}],[{"value":"68"},{"value":"Phase 1"}],[{"value":"60"},{"value":"Phase 0"}],[{"value":"202"},{"value":"Phase 4"}],[{"value":"52"},{"value":"Phase 4"}],[{"value":"30"},{"value":"Phase 4"}],[{"value":"49"},{"value":"Phase 1 / Phase 2"}],[{"value":"21"},{"value":"Phase 1"}],[{"value":"1184"},{"value":"Phase 4"}],[{"value":"30"},{"value":"Phase 1 / Phase 2"}],[{"value":"17"},{"value":"Phase 1"}],[{"value":"22"},{"value":"Phase 1"}],[{"value":"18"},{"value":"Phase 1"}],[{"value":"97"},{"value":"Phase 0"}],[{"value":"21"},{"value":"Phase 4"}],[{"value":"12"},{"value":"Phase 2 / Phase 3"}],[{"value":"82"},{"value":"Phase 2"}],[{"value":"40"},{"value":"Phase 1"}],[{"value":"24"},{"value":"Phase 1"}],[{"value":"12"},{"value":"Phase 1"}],[{"value":"49"},{"value":"Phase 1"}],[{"value":"12"},{"value":"Phase 4"}],[{"value":"0"},{"value":"Phase 4"}],[{"value":"15"},{"value":"Phase 1"}],[{"value":"37"},{"value":"Phase 1 / Phase 2"}],[{"value":"350"},{"value":"Phase 2 / Phase 3"}],[{"value":"25"},{"value":"Phase 2"}],[{"value":"80"},{"value":"Phase 3"}],[{"value":"40"},{"value":"Phase 3"}],[{"value":"110"},{"value":"Phase 2"}],[{"value":"60"},{"value":"Phase 4"}],[{"value":"23"},{"value":"Phase 4"}],[{"value":"916"},{"value":"Phase 4"}],[{"value":"80"},{"value":"Phase 2"}],[{"value":"6"},{"value":"Phase 1"}],[{"value":"14"},{"value":"Phase 2"}],[{"value":"160"},{"value":"Phase 1"}],[{"value":"0"},{"value":"Phase 2"}],[{"value":"0"},{"value":"Phase 2"}],[{"value":"5"},{"value":"Phase 1 / Phase 2"}],[{"value":"20"},{"value":"Phase 1"}],[{"value":"45"},{"value":"Phase 2"}],[{"value":"29"},{"value":"Phase 1"}],[{"value":"36"},{"value":"Phase 4"}],[{"value":"141"},{"value":"Phase 2"}],[{"value":"19"},{"value":"Phase 1"}],[{"value":"6"},{"value":"Phase 2"}],[{"value":"17"},{"value":"Phase 2"}],[{"value":"74"},{"value":"Phase 1 / Phase 2"}],[{"value":"50"},{"value":"Phase 1 / Phase 2"}],[{"value":"10"},{"value":"Phase 1"}],[{"value":"22"},{"value":"Phase 1"}],[{"value":"2"},{"value":"Phase 1"}],[{"value":"0"},{"value":"Phase 2"}],[{"value":"20"},{"value":"Phase 3"}],[{"value":"2"},{"value":"Phase 1"}],[{"value":"41"},{"value":"Phase 2"}],[{"value":"5"},{"value":"Phase 2"}],[{"value":"314"},{"value":"Phase 3"}],[{"value":"18"},{"value":"Phase 4"}],[{"value":"11"},{"value":"Phase 1"}],[{"value":"122"},{"value":"Phase 1"}],[{"value":"21"},{"value":"Phase 1"}],[{"value":"89"},{"value":"Phase 3"}],[{"value":"21"},{"value":"Phase 1"}],[{"value":"62"},{"value":"Phase 1"}],[{"value":"67"},{"value":"Phase 1 / Phase 2"}],[{"value":"18"},{"value":"Phase 1"}],[{"value":"40"},{"value":"Phase 4"}],[{"value":"63"},{"value":"Phase 2"}],[{"value":"80"},{"value":"Phase 1 / Phase 2"}],[{"value":"96"},{"value":"Phase 1"}],[{"value":"246"},{"value":"Phase 1"}],[{"value":"15000"},{"value":"Phase 1"}],[{"value":"18"},{"value":"Phase 1"}],[{"value":"26"},{"value":"Phase 1"}],[{"value":"26"},{"value":"Phase 1"}],[{"value":"24"},{"value":"Phase 1"}],[{"value":"26"},{"value":"Phase 1"}],[{"value":"9"},{"value":"Phase 1"}],[{"value":"11"},{"value":"Phase 2"}],[{"value":"0"},{"value":"Phase 2"}],[{"value":"38"},{"value":"Phase 2"}],[{"value":"36"},{"value":"Phase 2"}],[{"value":"20"},{"value":"Phase 2"}],[{"value":"140"},{"value":"Phase 2"}],[{"value":"5"},{"value":"Phase 1"}],[{"value":"50"},{"value":"Phase 2"}],[{"value":"24"},{"value":"Phase 1"}],[{"value":"365"},{"value":"Phase 2"}],[{"value":"24"},{"value":"Phase 1"}],[{"value":"31"},{"value":"Phase 2"}],[{"value":"3"},{"value":"Phase 2"}],[{"value":"54"},{"value":"Phase 2"}],[{"value":"21"},{"value":"Phase 2"}],[{"value":"100"},{"value":"Phase 1"}],[{"value":"60"},{"value":"Phase 0"}],[{"value":"147"},{"value":"Phase 1"}],[{"value":"14"},{"value":"Phase 1"}],[{"value":"0"},{"value":"Phase 0"}],[{"value":"0"},{"value":"Phase 4"}],[{"value":"20"},{"value":"Phase 2"}],[{"value":"156"},{"value":"Phase 3"}],[{"value":"22"},{"value":"Phase 1"}],[{"value":"70"},{"value":"Phase 1"}],[{"value":"20"},{"value":"Phase 4"}],[{"value":"26"},{"value":"Phase 4"}],[{"value":"24"},{"value":"Phase 4"}],[{"value":"32"},{"value":"Phase 4"}],[{"value":"3"},{"value":"Phase 2"}],[{"value":"26"},{"value":"Phase 1"}],[{"value":"77"},{"value":"Phase 4"}],[{"value":"54"},{"value":"Phase 2"}],[{"value":"25"},{"value":"Phase 1"}],[{"value":"45"},{"value":"Phase 1"}],[{"value":"26"},{"value":"Phase 4"}],[{"value":"9"},{"value":"Phase 1"}],[{"value":"1"},{"value":"Phase 1"}],[{"value":"38"},{"value":"Phase 1 / Phase 2"}],[{"value":"60"},{"value":"Phase 1 / Phase 2"}],[{"value":"16"},{"value":"Phase 2"}],[{"value":"14"},{"value":"Phase 4"}],[{"value":"18"},{"value":"Phase 4"}],[{"value":"38"},{"value":"Phase 4"}],[{"value":"9"},{"value":"Phase 1"}],[{"value":"40"},{"value":"Phase 1"}],[{"value":"0"},{"value":"Phase 2"}],[{"value":"80"},{"value":"Phase 2"}],[{"value":"12"},{"value":"Phase 4"}],[{"value":"48"},{"value":"Phase 2"}],[{"value":"40"},{"value":"Phase 4"}],[{"value":"380"},{"value":"Phase 3"}],[{"value":"40"},{"value":"Phase 2"}],[{"value":"0"},{"value":"Phase 2"}],[{"value":"49"},{"value":"Phase 2"}],[{"value":"52"},{"value":"Phase 4"}],[{"value":"5"},{"value":"Phase 1"}],[{"value":"41"},{"value":"Phase 2"}],[{"value":"50"},{"value":"Phase 2"}],[{"value":"3"},{"value":"Phase 2"}],[{"value":"53"},{"value":"Phase 2"}],[{"value":"530"},{"value":"Phase 3"}],[{"value":"519"},{"value":"Phase 3"}],[{"value":"9"},{"value":"Phase 1 / Phase 2"}],[{"value":"104"},{"value":"Phase 2"}],[{"value":"12"},{"value":"Phase 1 / Phase 2"}],[{"value":"36"},{"value":"Phase 4"}],[{"value":"52"},{"value":"Phase 4"}],[{"value":"0"},{"value":"Phase 4"}],[{"value":"578"},{"value":"Phase 3"}],[{"value":"161"},{"value":"Phase 3"}],[{"value":"32"},{"value":"Phase 1"}],[{"value":"20"},{"value":"Phase 1"}],[{"value":"60"},{"value":"Phase 2"}],[{"value":"49"},{"value":"Phase 4"}],[{"value":"48"},{"value":"Phase 1 / Phase 2"}],[{"value":"301"},{"value":"Phase 3"}],[{"value":"16"},{"value":"Phase 2"}],[{"value":"60"},{"value":"Phase 1 / Phase 2"}],[{"value":"11"},{"value":"Phase 1 / Phase 2"}],[{"value":"15"},{"value":"Phase 1"}],[{"value":"67"},{"value":"Phase 4"}],[{"value":"12"},{"value":"Phase 1"}],[{"value":"25"},{"value":"Phase 1"}],[{"value":"116"},{"value":"Phase 2"}],[{"value":"60"},{"value":"Phase 2"}],[{"value":"63"},{"value":"Phase 4"}],[{"value":"61"},{"value":"Phase 4"}],[{"value":"160"},{"value":"Phase 4"}],[{"value":"12"},{"value":"Phase 1"}],[{"value":"21"},{"value":"Phase 2"}],[{"value":"21"},{"value":"Phase 2"}],[{"value":"57"},{"value":"Phase 2"}],[{"value":"1"},{"value":"Phase 1 / Phase 2"}],[{"value":"606"},{"value":"Phase 3"}],[{"value":"50"},{"value":"Phase 1"}],[{"value":"228"},{"value":"Phase 4"}],[{"value":"13"},{"value":"Phase 1"}],[{"value":"30"},{"value":"Phase 3"}],[{"value":"60"},{"value":"Phase 3"}],[{"value":"80"},{"value":"Phase 2 / Phase 3"}],[{"value":"100"},{"value":"Phase 2"}],[{"value":"16"},{"value":"Phase 1"}],[{"value":"16"},{"value":"Phase 2"}],[{"value":"35"},{"value":"Phase 2"}],[{"value":"333"},{"value":"Phase 2"}],[{"value":"40"},{"value":"Phase 1"}],[{"value":"30"},{"value":"Phase 1"}],[{"value":"26"},{"value":"Phase 1"}],[{"value":"26"},{"value":"Phase 1"}],[{"value":"12"},{"value":"Phase 2"}],[{"value":"20"},{"value":"Phase 4"}],[{"value":"112"},{"value":"Phase 3"}],[{"value":"13"},{"value":"Phase 1"}],[{"value":"34"},{"value":"Phase 4"}],[{"value":"4"},{"value":"Phase 1"}],[{"value":"25"},{"value":"Phase 1"}],[{"value":"11"},{"value":"Phase 1"}],[{"value":"32"},{"value":"Phase 1"}],[{"value":"26"},{"value":"Phase 1"}],[{"value":"25"},{"value":"Phase 1"}],[{"value":"133"},{"value":"Phase 3"}],[{"value":"31"},{"value":"Phase 2"}],[{"value":"13"},{"value":"Phase 1 / Phase 2"}],[{"value":"100"},{"value":"Phase 4"}],[{"value":"257"},{"value":"Phase 1"}],[{"value":"20"},{"value":"Phase 3"}],[{"value":"15"},{"value":"Phase 1"}],[{"value":"20"},{"value":"Phase 1"}],[{"value":"10"},{"value":"Phase 0"}],[{"value":"31"},{"value":"Phase 1 / Phase 2"}],[{"value":"60"},{"value":"Phase 2"}],[{"value":"1"},{"value":"Phase 2"}],[{"value":"6"},{"value":"Phase 2"}],[{"value":"18"},{"value":"Phase 1"}],[{"value":"13"},{"value":"Phase 1"}],[{"value":"125"},{"value":"Phase 2"}],[{"value":"5"},{"value":"Phase 1"}],[{"value":"5"},{"value":"Phase 1"}],[{"value":"68"},{"value":"Phase 2"}],[{"value":"1884"},{"value":"Phase 3"}],[{"value":"24"},{"value":"Phase 1"}],[{"value":"14"},{"value":"Phase 1"}],[{"value":"40"},{"value":"Phase 0"}],[{"value":"100"},{"value":"Phase 4"}],[{"value":"94"},{"value":"Phase 1"}],[{"value":"12"},{"value":"Phase 1"}],[{"value":"364"},{"value":"Phase 3"}],[{"value":"40"},{"value":"Phase 4"}],[{"value":"49"},{"value":"Phase 4"}],[{"value":"150"},{"value":"Phase 4"}],[{"value":"2"},{"value":"Phase 1"}],[{"value":"7"},{"value":"Phase 1"}],[{"value":"22"},{"value":"Phase 1"}],[{"value":"3"},{"value":"Phase 4"}],[{"value":"50"},{"value":"Phase 4"}],[{"value":"14"},{"value":"Phase 1"}],[{"value":"11"},{"value":"Phase 4"}],[{"value":"20"},{"value":"Phase 2"}],[{"value":"300"},{"value":"Phase 1 / Phase 2"}],[{"value":"18"},{"value":"Phase 2"}],[{"value":"12"},{"value":"Phase 1"}],[{"value":"15"},{"value":"Phase 0"}],[{"value":"115"},{"value":"Phase 4"}],[{"value":"0"},{"value":"Phase 1"}],[{"value":"479"},{"value":"Phase 3"}],[{"value":"15"},{"value":"Phase 1"}],[{"value":"45"},{"value":"Phase 2"}],[{"value":"88"},{"value":"Phase 2"}],[{"value":"100"},{"value":"Phase 1"}],[{"value":"46"},{"value":"Phase 2"}],[{"value":"88"},{"value":"Phase 2"}],[{"value":"25"},{"value":"Phase 2"}],[{"value":"400"},{"value":"Phase 3"}],[{"value":"12"},{"value":"Phase 4"}],[{"value":"20"},{"value":"Phase 4"}],[{"value":"80"},{"value":"Phase 4"}],[{"value":"20"},{"value":"Phase 4"}],[{"value":"30"},{"value":"Phase 4"}],[{"value":"30"},{"value":"Phase 4"}],[{"value":"30"},{"value":"Phase 2"}],[{"value":"23"},{"value":"Phase 1"}],[{"value":"4"},{"value":"Phase 2"}],[{"value":"37"},{"value":"Phase 1"}],[{"value":"18"},{"value":"Phase 2"}],[{"value":"5"},{"value":"Phase 2"}],[{"value":"0"},{"value":"Phase 2"}],[{"value":"0"},{"value":"Phase 2"}],[{"value":"41"},{"value":"Phase 4"}],[{"value":"13"},{"value":"Phase 1"}],[{"value":"86"},{"value":"Phase 0"}],[{"value":"3"},{"value":"Phase 1 / Phase 2"}],[{"value":"137"},{"value":"Phase 4"}],[{"value":"12"},{"value":"Phase 1"}],[{"value":"32"},{"value":"Phase 2"}],[{"value":"1"},{"value":"Phase 1 / Phase 2"}],[{"value":"8"},{"value":"Phase 1"}],[{"value":"57"},{"value":"Phase 2"}],[{"value":"855"},{"value":"Phase 1"}],[{"value":"40"},{"value":"Phase 1"}],[{"value":"610"},{"value":"Phase 3"}],[{"value":"16"},{"value":"Phase 1"}],[{"value":"614"},{"value":"Phase 3"}],[{"value":"223"},{"value":"Phase 2"}],[{"value":"20"},{"value":"Phase 4"}],[{"value":"40"},{"value":"Phase 4"}],[{"value":"15"},{"value":"Phase 4"}],[{"value":"30"},{"value":"Phase 4"}],[{"value":"20"},{"value":"Phase 1"}],[{"value":"59"},{"value":"Phase 1"}],[{"value":"17"},{"value":"Phase 1"}],[{"value":"7"},{"value":"Phase 4"}],[{"value":"70"},{"value":"Phase 1"}],[{"value":"16"},{"value":"Phase 1"}],[{"value":"51"},{"value":"Phase 4"}],[{"value":"24"},{"value":"Phase 1"}],[{"value":"63"},{"value":"Phase 2"}],[{"value":"30"},{"value":"Phase 0"}],[{"value":"56"},{"value":"Phase 2"}],[{"value":"20"},{"value":"Phase 2"}],[{"value":"2"},{"value":"Phase 2"}],[{"value":"301"},{"value":"Phase 3"}],[{"value":"18"},{"value":"Phase 1"}],[{"value":"56"},{"value":"Phase 1"}],[{"value":"4"},{"value":"Phase 1"}],[{"value":"35"},{"value":"Phase 2"}],[{"value":"321697"},{"value":"Phase 4"}],[{"value":"18"},{"value":"Phase 1"}],[{"value":"16"},{"value":"Phase 1"}],[{"value":"87"},{"value":"Phase 0"}],[{"value":"54"},{"value":"Phase 2"}],[{"value":"7"},{"value":"Phase 2"}],[{"value":"67"},{"value":"Phase 4"}],[{"value":"30"},{"value":"Phase 2"}],[{"value":"9"},{"value":"Phase 2"}],[{"value":"1"},{"value":"Phase 2"}],[{"value":"17"},{"value":"Phase 0"}],[{"value":"120"},{"value":"Phase 3"}],[{"value":"41"},{"value":"Phase 2"}],[{"value":"64"},{"value":"Phase 2"}],[{"value":"6"},{"value":"Phase 2"}],[{"value":"49"},{"value":"Phase 1"}],[{"value":"78"},{"value":"Phase 1"}],[{"value":"67"},{"value":"Phase 2"}],[{"value":"27"},{"value":"Phase 1"}],[{"value":"23"},{"value":"Phase 2"}],[{"value":"42"},{"value":"Phase 1"}],[{"value":"42"},{"value":"Phase 1 / Phase 2"}],[{"value":"37"},{"value":"Phase 1"}],[{"value":"96"},{"value":"Phase 1"}],[{"value":"94"},{"value":"Phase 2"}],[{"value":"59"},{"value":"Phase 2"}],[{"value":"41"},{"value":"Phase 2"}],[{"value":"25"},{"value":"Phase 1"}],[{"value":"2"},{"value":"Phase 1"}],[{"value":"56"},{"value":"Phase 2"}],[{"value":"74"},{"value":"Phase 1"}],[{"value":"60"},{"value":"Phase 4"}],[{"value":"62"},{"value":"Phase 1"}],[{"value":"15"},{"value":"Phase 3"}],[{"value":"47"},{"value":"Phase 1"}],[{"value":"33"},{"value":"Phase 2"}],[{"value":"12"},{"value":"Phase 1"}],[{"value":"55"},{"value":"Phase 0"}],[{"value":"40"},{"value":"Phase 1"}],[{"value":"21"},{"value":"Phase 4"}],[{"value":"60"},{"value":"Phase 1"}],[{"value":"40"},{"value":"Phase 1"}],[{"value":"24"},{"value":"Phase 0"}],[{"value":"66"},{"value":"Phase 1"}],[{"value":"0"},{"value":"Phase 2"}],[{"value":"264"},{"value":"Phase 2"}],[{"value":"50"},{"value":"Phase 2"}],[{"value":"32"},{"value":"Phase 2"}],[{"value":"6"},{"value":"Phase 1"}],[{"value":"125"},{"value":"Phase 2"}],[{"value":"851"},{"value":"Phase 3"}],[{"value":"20"},{"value":"Phase 3"}],[{"value":"302"},{"value":"Phase 2 / Phase 3"}],[{"value":"52"},{"value":"Phase 1"}],[{"value":"25"},{"value":"Phase 1"}],[{"value":"13"},{"value":"Phase 1"}],[{"value":"13"},{"value":"Phase 4"}],[{"value":"21"},{"value":"Phase 1"}],[{"value":"47"},{"value":"Phase 1"}],[{"value":"56"},{"value":"Phase 1"}],[{"value":"45"},{"value":"Phase 1"}],[{"value":"176"},{"value":"Phase 2"}],[{"value":"15"},{"value":"Phase 1"}],[{"value":"28"},{"value":"Phase 1 / Phase 2"}],[{"value":"7"},{"value":"Phase 4"}],[{"value":"48"},{"value":"Phase 2"}],[{"value":"29"},{"value":"Phase 1 / Phase 2"}],[{"value":"21"},{"value":"Phase 1"}],[{"value":"39"},{"value":"Phase 2"}],[{"value":"28"},{"value":"Phase 2"}],[{"value":"26"},{"value":"Phase 2"}],[{"value":"127"},{"value":"Phase 4"}],[{"value":"31"},{"value":"Phase 1"}],[{"value":"40"},{"value":"Phase 4"}],[{"value":"11"},{"value":"Phase 4"}],[{"value":"25"},{"value":"Phase 1"}],[{"value":"2"},{"value":"Phase 2"}],[{"value":"33"},{"value":"Phase 4"}],[{"value":"12"},{"value":"Phase 4"}],[{"value":"256"},{"value":"Phase 2 / Phase 3"}],[{"value":"711"},{"value":"Phase 3"}],[{"value":"10"},{"value":"Phase 2"}],[{"value":"21"},{"value":"Phase 4"}],[{"value":"30"},{"value":"Phase 2"}],[{"value":"188"},{"value":"Phase 4"}],[{"value":"24"},{"value":"Phase 1 / Phase 2"}],[{"value":"8"},{"value":"Phase 1 / Phase 2"}],[{"value":"67"},{"value":"Phase 4"}],[{"value":"28"},{"value":"Phase 1 / Phase 2"}],[{"value":"24"},{"value":"Phase 4"}],[{"value":"239"},{"value":"Phase 3"}],[{"value":"434"},{"value":"Phase 3"}],[{"value":"468"},{"value":"Phase 3"}],[{"value":"4"},{"value":"Phase 2"}],[{"value":"14"},{"value":"Phase 2"}],[{"value":"19"},{"value":"Phase 2"}],[{"value":"7"},{"value":"Phase 2"}],[{"value":"55"},{"value":"Phase 3"}],[{"value":"40"},{"value":"Phase 2"}],[{"value":"0"},{"value":"Phase 4"}],[{"value":"32"},{"value":"Phase 2"}],[{"value":"13"},{"value":"Phase 2"}],[{"value":"26"},{"value":"Phase 2"}],[{"value":"82"},{"value":"Phase 4"}],[{"value":"14"},{"value":"Phase 2"}],[{"value":"4"},{"value":"Phase 1"}],[{"value":"33"},{"value":"Phase 2"}],[{"value":"15"},{"value":"Phase 2"}],[{"value":"1467"},{"value":"Phase 3"}],[{"value":"18"},{"value":"Phase 1"}],[{"value":"110"},{"value":"Phase 4"}],[{"value":"341"},{"value":"Phase 3"}],[{"value":"8"},{"value":"Phase 1"}],[{"value":"71"},{"value":"Phase 1"}],[{"value":"295"},{"value":"Phase 3"}],[{"value":"44"},{"value":"Phase 4"}],[{"value":"54"},{"value":"Phase 1"}],[{"value":"16"},{"value":"Phase 1"}],[{"value":"30"},{"value":"Phase 2"}],[{"value":"290"},{"value":"Phase 2"}],[{"value":"66"},{"value":"Phase 2"}],[{"value":"14"},{"value":"Phase 2"}],[{"value":"30"},{"value":"Phase 2"}],[{"value":"13"},{"value":"Phase 1"}],[{"value":"60"},{"value":"Phase 1 / Phase 2"}],[{"value":"70"},{"value":"Phase 2"}],[{"value":"276"},{"value":"Phase 4"}],[{"value":"24"},{"value":"Phase 1"}],[{"value":"8"},{"value":"Phase 1"}],[{"value":"61"},{"value":"Phase 4"}],[{"value":"3604"},{"value":"Phase 3"}],[{"value":"24"},{"value":"Phase 1"}],[{"value":"15"},{"value":"Phase 4"}],[{"value":"90"},{"value":"Phase 4"}],[{"value":"16"},{"value":"Phase 2 / Phase 3"}],[{"value":"140"},{"value":"Phase 2"}],[{"value":"24"},{"value":"Phase 1"}],[{"value":"278"},{"value":"Phase 2 / Phase 3"}],[{"value":"23"},{"value":"Phase 1 / Phase 2"}],[{"value":"36"},{"value":"Phase 2"}],[{"value":"1600"},{"value":"Phase 4"}],[{"value":"50"},{"value":"Phase 2"}],[{"value":"51"},{"value":"Phase 1"}],[{"value":"116"},{"value":"Phase 2"}],[{"value":"5"},{"value":"Phase 2"}],[{"value":"569"},{"value":"Phase 4"}],[{"value":"37"},{"value":"Phase 1"}],[{"value":"16"},{"value":"Phase 1"}],[{"value":"454"},{"value":"Phase 2"}],[{"value":"27"},{"value":"Phase 2"}],[{"value":"20"},{"value":"Phase 1"}],[{"value":"61"},{"value":"Phase 2"}],[{"value":"4"},{"value":"Phase 4"}],[{"value":"475"},{"value":"Phase 2 / Phase 3"}],[{"value":"58"},{"value":"Phase 4"}],[{"value":"52"},{"value":"Phase 2"}],[{"value":"21"},{"value":"Phase 2"}],[{"value":"2"},{"value":"Phase 2"}],[{"value":"65"},{"value":"Phase 1"}],[{"value":"20"},{"value":"Phase 2"}],[{"value":"40"},{"value":"Phase 4"}],[{"value":"93"},{"value":"Phase 4"}],[{"value":"29"},{"value":"Phase 1"}],[{"value":"62"},{"value":"Phase 2"}],[{"value":"516"},{"value":"Phase 4"}],[{"value":"65"},{"value":"Phase 1"}],[{"value":"100"},{"value":"Phase 2"}],[{"value":"0"},{"value":"Phase 4"}],[{"value":"10"},{"value":"Phase 1 / Phase 2"}],[{"value":"18"},{"value":"Phase 2"}],[{"value":"457"},{"value":"Phase 3"}],[{"value":"275"},{"value":"Phase 4"}],[{"value":"318"},{"value":"Phase 3"}],[{"value":"20"},{"value":"Phase 2"}],[{"value":"111"},{"value":"Phase 2 / Phase 3"}],[{"value":"41"},{"value":"Phase 1"}],[{"value":"113"},{"value":"Phase 4"}],[{"value":"88"},{"value":"Phase 4"}],[{"value":"33"},{"value":"Phase 1"}],[{"value":"15"},{"value":"Phase 4"}],[{"value":"150"},{"value":"Phase 3"}],[{"value":"89"},{"value":"Phase 2"}],[{"value":"14"},{"value":"Phase 1"}],[{"value":"34"},{"value":"Phase 1 / Phase 2"}],[{"value":"262"},{"value":"Phase 4"}],[{"value":"48"},{"value":"Phase 1 / Phase 2"}],[{"value":"45"},{"value":"Phase 1"}],[{"value":"29"},{"value":"Phase 2"}],[{"value":"4"},{"value":"Phase 1"}],[{"value":"18"},{"value":"Phase 1"}],[{"value":"27"},{"value":"Phase 2"}],[{"value":"113"},{"value":"Phase 3"}],[{"value":"37"},{"value":"Phase 1"}],[{"value":"101"},{"value":"Phase 3"}],[{"value":"60"},{"value":"Phase 2"}],[{"value":"12"},{"value":"Phase 2 / Phase 3"}],[{"value":"53"},{"value":"Phase 1"}],[{"value":"152"},{"value":"Phase 3"}],[{"value":"231"},{"value":"Phase 2"}],[{"value":"20"},{"value":"Phase 4"}],[{"value":"40"},{"value":"Phase 1"}],[{"value":"40"},{"value":"Phase 4"}],[{"value":"40"},{"value":"Phase 3"}],[{"value":"40"},{"value":"Phase 1"}],[{"value":"8"},{"value":"Phase 1 / Phase 2"}],[{"value":"15"},{"value":"Phase 2"}],[{"value":"13"},{"value":"Phase 1"}],[{"value":"64"},{"value":"Phase 2 / Phase 3"}],[{"value":"24"},{"value":"Phase 2"}],[{"value":"75"},{"value":"Phase 2"}],[{"value":"30"},{"value":"Phase 1"}],[{"value":"65"},{"value":"Phase 1"}],[{"value":"261"},{"value":"Phase 2"}],[{"value":"24"},{"value":"Phase 2"}],[{"value":"150"},{"value":"Phase 2 / Phase 3"}],[{"value":"68"},{"value":"Phase 2"}],[{"value":"26"},{"value":"Phase 2"}],[{"value":"23"},{"value":"Phase 1"}],[{"value":"97"},{"value":"Phase 3"}],[{"value":"279"},{"value":"Phase 3"}],[{"value":""},{"value":"Phase 3"}],[{"value":"31"},{"value":"Phase 2"}],[{"value":"25"},{"value":"Phase 1"}],[{"value":"96"},{"value":"Phase 4"}],[{"value":"400"},{"value":"Phase 3"}],[{"value":""},{"value":"Phase 3"}],[{"value":"107"},{"value":"Phase 1 / Phase 2"}],[{"value":"496"},{"value":"Phase 2 / Phase 3"}],[{"value":"15"},{"value":"Phase 2"}],[{"value":"200"},{"value":"Phase 3"}],[{"value":"136"},{"value":"Phase 3"}],[{"value":"10"},{"value":"Phase 1"}],[{"value":""},{"value":"Phase 2"}],[{"value":""},{"value":"Phase 3"}],[{"value":"64"},{"value":"Phase 4"}],[{"value":"15"},{"value":"Phase 2 / Phase 3"}],[{"value":"26"},{"value":"Phase 2 / Phase 3"}],[{"value":"14"},{"value":"Phase 2"}],[{"value":"354"},{"value":"Phase 1 / Phase 2"}],[{"value":"240"},{"value":"Phase 2"}],[{"value":"574"},{"value":"Phase 2"}],[{"value":"77"},{"value":"Phase 2"}],[{"value":"70"},{"value":"Phase 2"}],[{"value":"89"},{"value":"Phase 2"}],[{"value":"160"},{"value":"Phase 2 / Phase 3"}],[{"value":"30"},{"value":"Phase 4"}],[{"value":"16"},{"value":"Phase 1"}],[{"value":"28"},{"value":"Phase 0"}],[{"value":"40"},{"value":"Phase 2 / Phase 3"}],[{"value":"811"},{"value":"Phase 3"}],[{"value":"174"},{"value":"Phase 2"}],[{"value":"654"},{"value":"Phase 3"}],[{"value":"80"},{"value":"Phase 3"}],[{"value":"12"},{"value":"Phase 2 / Phase 3"}],[{"value":"2364"},{"value":"Phase 3"}],[{"value":"56"},{"value":"Phase 2 / Phase 3"}],[{"value":"600"},{"value":"Phase 4"}],[{"value":"30"},{"value":"Phase 2"}],[{"value":""},{"value":"Phase 1"}],[{"value":"30"},{"value":"Phase 1"}],[{"value":"5"},{"value":"Phase 2"}],[{"value":"30"},{"value":"Phase 1"}],[{"value":"40"},{"value":"Phase 2"}],[{"value":"20"},{"value":"Phase 2"}],[{"value":"1800"},{"value":"Phase 3"}],[{"value":"18"},{"value":"Phase 4"}],[{"value":"15"},{"value":"Phase 1 / Phase 2"}],[{"value":"76"},{"value":"Phase 2"}],[{"value":"154"},{"value":"Phase 1 / Phase 2"}],[{"value":"33"},{"value":"Phase 2"}],[{"value":"55"},{"value":"Phase 2"}],[{"value":"45"},{"value":"Phase 1"}],[{"value":"101"},{"value":"Phase 3"}]],"columnNames":[{"name":"number_enrolled","index":0,"aggr":"sum"},{"name":"phase","index":1,"aggr":"sum"}],"rows":[["150","Phase 2"],["450","Phase 2"],["60","Phase 2"],["100","Phase 0"],["75","Phase 2"],["120","Phase 4"],["20","Phase 1 / Phase 2"],["99","Phase 4"],["24","Phase 1 / Phase 2"],["40","Phase 2"],["400","Phase 3"],["100","Phase 1 / Phase 2"],["100","Phase 2"],["60","Phase 4"],["350","Phase 3"],["32","Phase 2"],["54","Phase 2"],["300","Phase 2"],["22","Phase 4"],["12","Phase 1 / Phase 2"],["20","Phase 1"],["36","Phase 4"],["60","Phase 2"],["7","Phase 1"],["100","Phase 1 / Phase 2"],["32","Phase 1"],["30","Phase 4"],["68","Phase 2"],["45","Phase 1"],["200","Phase 2"],["50","Phase 0"],["40","Phase 3"],["10","Phase 2"],["40","Phase 1"],["165","Phase 2"],["24","Phase 4"],["12","Phase 2"],["60","Phase 1"],["18","Phase 2"],["70","Phase 2"],["50","Phase 2"],["276","Phase 3"],["25","Phase 2"],["274","Phase 3"],["","Phase 3"],["24","Phase 1"],["36","Phase 2"],["24","Phase 0"],["0","Phase 1"],["74","Phase 1 / Phase 2"],["40","Phase 4"],["18","Phase 2"],["30","Phase 1"],["53","Phase 4"],["4","Phase 4"],["15","Phase 0"],["96","Phase 2"],["60","Phase 4"],["125","Phase 2"],["40","Phase 2"],["50","Phase 2"],["8","Phase 1"],["12","Phase 1"],["100","Phase 4"],["158","Phase 2"],["39","Phase 2"],["31","Phase 1 / Phase 2"],["300","Phase 4"],["65","Phase 3"],["105","Phase 2"],["75","Phase 2"],["70","Phase 1"],["30","Phase 1 / Phase 2"],["48","Phase 1"],["18","Phase 1"],["20","Phase 4"],["66","Phase 1 / Phase 2"],["90","Phase 1 / Phase 2"],["10","Phase 4"],["46","Phase 2"],["160","Phase 2"],["18","Phase 1"],["29","Phase 2"],["40","Phase 2"],["64","Phase 4"],["30","Phase 1 / Phase 2"],["15","Phase 1"],["36","Phase 1"],["240","Phase 3"],["36","Phase 4"],["24","Phase 1"],["30","Phase 1"],["27","Phase 2"],["20","Phase 2"],["90","Phase 2"],["23","Phase 4"],["30","Phase 3"],["25","Phase 1"],["25","Phase 1 / Phase 2"],["78","Phase 2"],["61","Phase 2"],["66","Phase 1"],["80","Phase 2"],["13","Phase 2 / Phase 3"],["600","Phase 2"],["130","Phase 1 / Phase 2"],["33","Phase 1"],["300","Phase 2"],["15","Phase 4"],["50","Phase 2"],["12","Phase 1"],["100","Phase 2"],["40","Phase 2"],["35","Phase 1"],["6","Phase 2"],["40","Phase 4"],["20","Phase 1"],["0","Phase 1 / Phase 2"],["115","Phase 4"],["30","Phase 1"],["115","Phase 4"],["100","Phase 2"],["0","Phase 4"],["48","Phase 4"],["16","Phase 1"],["30","Phase 2"],["0","Phase 2"],["30","Phase 4"],["36","Phase 1"],["30","Phase 4"],["30","Phase 2"],["116","Phase 2"],["40","Phase 2"],["71","Phase 4"],["24","Phase 1"],["25","Phase 2"],["67","Phase 0"],["15","Phase 4"],["24","Phase 2"],["46","Phase 2"],["0","Phase 1"],["51","Phase 1"],["39","Phase 2"],["50","Phase 2"],["50","Phase 4"],["50","Phase 2"],["30","Phase 0"],["45","Phase 1"],["40","Phase 4"],["20","Phase 1"],["150","Phase 4"],["88","Phase 4"],["60","Phase 2"],["60","Phase 2"],["300","Phase 4"],["45","Phase 4"],["60","Phase 1"],["22","Phase 4"],["32","Phase 1"],["50","Phase 4"],["12","Phase 1"],["50","Phase 2"],["120","Phase 2"],["61","Phase 2"],["1","Phase 1"],["20","Phase 1"],["40","Phase 1"],["26","Phase 1"],["60","Phase 4"],["24","Phase 1"],["20","Phase 4"],["500","Phase 3"],["40","Phase 2"],["72","Phase 1 / Phase 2"],["104","Phase 4"],["12","Phase 1"],["60","Phase 2"],["124","Phase 4"],["24","Phase 1"],["39","Phase 0"],["60","Phase 3"],["25","Phase 1"],["40","Phase 0"],["1","Phase 1"],["14","Phase 1"],["40","Phase 4"],["17","Phase 1"],["24","Phase 2"],["160","Phase 4"],["13","Phase 2"],["30","Phase 4"],["27","Phase 2 / Phase 3"],["60","Phase 3"],["10","Phase 2"],["50","Phase 2"],["6","Phase 1"],["50","Phase 4"],["0","Phase 4"],["24","Phase 1"],["44","Phase 1"],["0","Phase 2"],["421","Phase 3"],["30","Phase 1"],["64","Phase 2"],["15","Phase 1 / Phase 2"],["40","Phase 2"],["40","Phase 2"],["132","Phase 2"],["24","Phase 1"],["20","Phase 2"],["3","Phase 4"],["1","Phase 2"],["34","Phase 2"],["20","Phase 3"],["0","Phase 1"],["24","Phase 4"],["50","Phase 2"],["30","Phase 4"],["20","Phase 2"],["90","Phase 4"],["9","Phase 1 / Phase 2"],["30","Phase 1"],["1","Phase 0"],["6","Phase 1 / Phase 2"],["6","Phase 1"],["20","Phase 1"],["400","Phase 4"],["17","Phase 1"],["40","Phase 4"],["28","Phase 4"],["6","Phase 1"],["60","Phase 2"],["100","Phase 2"],["70","Phase 3"],["50","Phase 2"],["30","Phase 4"],["30","Phase 1"],["10","Phase 4"],["36","Phase 2"],["24","Phase 1"],["140","Phase 4"],["364","Phase 3"],["9","Phase 1"],["250","Phase 2"],["17","Phase 3"],["120","Phase 2"],["0","Phase 2"],["40","Phase 4"],["20","Phase 4"],["20","Phase 1"],["60","Phase 4"],["20","Phase 4"],["13","Phase 2"],["140","Phase 2"],["17","Phase 1"],["10","Phase 1 / Phase 2"],["0","Phase 2"],["38","Phase 4"],["41","Phase 4"],["2","Phase 1 / Phase 2"],["28","Phase 1"],["17","Phase 1 / Phase 2"],["20","Phase 1"],["100","Phase 1"],["239","Phase 1"],["13","Phase 4"],["6","Phase 0"],["59","Phase 4"],["28","Phase 0"],["30","Phase 0"],["99","Phase 2"],["10","Phase 0"],["20","Phase 2"],["50","Phase 2 / Phase 3"],["90","Phase 2 / Phase 3"],["5","Phase 1"],["36","Phase 0"],["21","Phase 2"],["12","Phase 1"],["41","Phase 1"],["26","Phase 1"],["35","Phase 1"],["102","Phase 1 / Phase 2"],["16","Phase 1 / Phase 2"],["60","Phase 2"],["8","Phase 1"],["16","Phase 1"],["10","Phase 1"],["20","Phase 2"],["10","Phase 1"],["21","Phase 1"],["10","Phase 2"],["24","Phase 4"],["26","Phase 3"],["83","Phase 1"],["37","Phase 4"],["60","Phase 4"],["30","Phase 2"],["150","Phase 1"],["626","Phase 3"],["12","Phase 1"],["0","Phase 2"],["20","Phase 2"],["48","Phase 4"],["25","Phase 4"],["90","Phase 2 / Phase 3"],["5","Phase 0"],["5","Phase 4"],["7","Phase 1"],["130","Phase 2 / Phase 3"],["20","Phase 1"],["18","Phase 2"],["24","Phase 2"],["18","Phase 1"],["5","Phase 4"],["50","Phase 0"],["61","Phase 1"],["60","Phase 4"],["22","Phase 1"],["13","Phase 1 / Phase 2"],["56","Phase 1 / Phase 2"],["15","Phase 1"],["68","Phase 2"],["48","Phase 2"],["19","Phase 2"],["2","Phase 1 / Phase 2"],["15","Phase 1"],["12","Phase 1"],["17","Phase 2"],["1","Phase 1 / Phase 2"],["20","Phase 2"],["21","Phase 2"],["7","Phase 0"],["14","Phase 4"],["150","Phase 1"],["22","Phase 0"],["42","Phase 1"],["44","Phase 1"],["350","Phase 3"],["250","Phase 3"],["100","Phase 1 / Phase 2"],["126","Phase 4"],["42","Phase 4"],["38","Phase 2"],["12","Phase 1"],["45","Phase 2"],["37","Phase 1"],["32","Phase 2"],["96","Phase 4"],["50","Phase 1"],["282","Phase 3"],["39","Phase 2"],["36","Phase 4"],["250","Phase 1 / Phase 2"],["105","Phase 1"],["11","Phase 1"],["204","Phase 4"],["48","Phase 1"],["15","Phase 1"],["34","Phase 1"],["12","Phase 1 / Phase 2"],["180","Phase 4"],["40","Phase 2"],["0","Phase 1"],["48","Phase 1"],["50","Phase 1"],["9","Phase 4"],["10","Phase 0"],["200","Phase 4"],["3","Phase 1"],["26","Phase 1"],["60","Phase 1"],["17","Phase 1"],["50","Phase 1"],["1167","Phase 3"],["64","Phase 1"],["45","Phase 2"],["61","Phase 4"],["0","Phase 2"],["20","Phase 2"],["30","Phase 4"],["60","Phase 3"],["72","Phase 1"],["112","Phase 4"],["117","Phase 1"],["130","Phase 2"],["18","Phase 1"],["22","Phase 1"],["40","Phase 0"],["20","Phase 2"],["123","Phase 2"],["8","Phase 4"],["20","Phase 1"],["20","Phase 1"],["5","Phase 2"],["48","Phase 1"],["0","Phase 2"],["65","Phase 1"],["33","Phase 1 / Phase 2"],["1","Phase 1"],["375","Phase 2"],["50","Phase 1"],["70","Phase 1"],["38","Phase 0"],["2","Phase 2"],["62","Phase 2"],["14","Phase 1"],["6","Phase 1"],["61","Phase 1"],["136","Phase 2"],["163","Phase 4"],["92","Phase 4"],["3","Phase 4"],["20","Phase 1"],["2","Phase 1"],["339","Phase 3"],["140","Phase 3"],["34","Phase 2"],["30","Phase 1 / Phase 2"],["42","Phase 2"],["10","Phase 1"],["60","Phase 4"],["68","Phase 1"],["60","Phase 0"],["202","Phase 4"],["52","Phase 4"],["30","Phase 4"],["49","Phase 1 / Phase 2"],["21","Phase 1"],["1184","Phase 4"],["30","Phase 1 / Phase 2"],["17","Phase 1"],["22","Phase 1"],["18","Phase 1"],["97","Phase 0"],["21","Phase 4"],["12","Phase 2 / Phase 3"],["82","Phase 2"],["40","Phase 1"],["24","Phase 1"],["12","Phase 1"],["49","Phase 1"],["12","Phase 4"],["0","Phase 4"],["15","Phase 1"],["37","Phase 1 / Phase 2"],["350","Phase 2 / Phase 3"],["25","Phase 2"],["80","Phase 3"],["40","Phase 3"],["110","Phase 2"],["60","Phase 4"],["23","Phase 4"],["916","Phase 4"],["80","Phase 2"],["6","Phase 1"],["14","Phase 2"],["160","Phase 1"],["0","Phase 2"],["0","Phase 2"],["5","Phase 1 / Phase 2"],["20","Phase 1"],["45","Phase 2"],["29","Phase 1"],["36","Phase 4"],["141","Phase 2"],["19","Phase 1"],["6","Phase 2"],["17","Phase 2"],["74","Phase 1 / Phase 2"],["50","Phase 1 / Phase 2"],["10","Phase 1"],["22","Phase 1"],["2","Phase 1"],["0","Phase 2"],["20","Phase 3"],["2","Phase 1"],["41","Phase 2"],["5","Phase 2"],["314","Phase 3"],["18","Phase 4"],["11","Phase 1"],["122","Phase 1"],["21","Phase 1"],["89","Phase 3"],["21","Phase 1"],["62","Phase 1"],["67","Phase 1 / Phase 2"],["18","Phase 1"],["40","Phase 4"],["63","Phase 2"],["80","Phase 1 / Phase 2"],["96","Phase 1"],["246","Phase 1"],["15000","Phase 1"],["18","Phase 1"],["26","Phase 1"],["26","Phase 1"],["24","Phase 1"],["26","Phase 1"],["9","Phase 1"],["11","Phase 2"],["0","Phase 2"],["38","Phase 2"],["36","Phase 2"],["20","Phase 2"],["140","Phase 2"],["5","Phase 1"],["50","Phase 2"],["24","Phase 1"],["365","Phase 2"],["24","Phase 1"],["31","Phase 2"],["3","Phase 2"],["54","Phase 2"],["21","Phase 2"],["100","Phase 1"],["60","Phase 0"],["147","Phase 1"],["14","Phase 1"],["0","Phase 0"],["0","Phase 4"],["20","Phase 2"],["156","Phase 3"],["22","Phase 1"],["70","Phase 1"],["20","Phase 4"],["26","Phase 4"],["24","Phase 4"],["32","Phase 4"],["3","Phase 2"],["26","Phase 1"],["77","Phase 4"],["54","Phase 2"],["25","Phase 1"],["45","Phase 1"],["26","Phase 4"],["9","Phase 1"],["1","Phase 1"],["38","Phase 1 / Phase 2"],["60","Phase 1 / Phase 2"],["16","Phase 2"],["14","Phase 4"],["18","Phase 4"],["38","Phase 4"],["9","Phase 1"],["40","Phase 1"],["0","Phase 2"],["80","Phase 2"],["12","Phase 4"],["48","Phase 2"],["40","Phase 4"],["380","Phase 3"],["40","Phase 2"],["0","Phase 2"],["49","Phase 2"],["52","Phase 4"],["5","Phase 1"],["41","Phase 2"],["50","Phase 2"],["3","Phase 2"],["53","Phase 2"],["530","Phase 3"],["519","Phase 3"],["9","Phase 1 / Phase 2"],["104","Phase 2"],["12","Phase 1 / Phase 2"],["36","Phase 4"],["52","Phase 4"],["0","Phase 4"],["578","Phase 3"],["161","Phase 3"],["32","Phase 1"],["20","Phase 1"],["60","Phase 2"],["49","Phase 4"],["48","Phase 1 / Phase 2"],["301","Phase 3"],["16","Phase 2"],["60","Phase 1 / Phase 2"],["11","Phase 1 / Phase 2"],["15","Phase 1"],["67","Phase 4"],["12","Phase 1"],["25","Phase 1"],["116","Phase 2"],["60","Phase 2"],["63","Phase 4"],["61","Phase 4"],["160","Phase 4"],["12","Phase 1"],["21","Phase 2"],["21","Phase 2"],["57","Phase 2"],["1","Phase 1 / Phase 2"],["606","Phase 3"],["50","Phase 1"],["228","Phase 4"],["13","Phase 1"],["30","Phase 3"],["60","Phase 3"],["80","Phase 2 / Phase 3"],["100","Phase 2"],["16","Phase 1"],["16","Phase 2"],["35","Phase 2"],["333","Phase 2"],["40","Phase 1"],["30","Phase 1"],["26","Phase 1"],["26","Phase 1"],["12","Phase 2"],["20","Phase 4"],["112","Phase 3"],["13","Phase 1"],["34","Phase 4"],["4","Phase 1"],["25","Phase 1"],["11","Phase 1"],["32","Phase 1"],["26","Phase 1"],["25","Phase 1"],["133","Phase 3"],["31","Phase 2"],["13","Phase 1 / Phase 2"],["100","Phase 4"],["257","Phase 1"],["20","Phase 3"],["15","Phase 1"],["20","Phase 1"],["10","Phase 0"],["31","Phase 1 / Phase 2"],["60","Phase 2"],["1","Phase 2"],["6","Phase 2"],["18","Phase 1"],["13","Phase 1"],["125","Phase 2"],["5","Phase 1"],["5","Phase 1"],["68","Phase 2"],["1884","Phase 3"],["24","Phase 1"],["14","Phase 1"],["40","Phase 0"],["100","Phase 4"],["94","Phase 1"],["12","Phase 1"],["364","Phase 3"],["40","Phase 4"],["49","Phase 4"],["150","Phase 4"],["2","Phase 1"],["7","Phase 1"],["22","Phase 1"],["3","Phase 4"],["50","Phase 4"],["14","Phase 1"],["11","Phase 4"],["20","Phase 2"],["300","Phase 1 / Phase 2"],["18","Phase 2"],["12","Phase 1"],["15","Phase 0"],["115","Phase 4"],["0","Phase 1"],["479","Phase 3"],["15","Phase 1"],["45","Phase 2"],["88","Phase 2"],["100","Phase 1"],["46","Phase 2"],["88","Phase 2"],["25","Phase 2"],["400","Phase 3"],["12","Phase 4"],["20","Phase 4"],["80","Phase 4"],["20","Phase 4"],["30","Phase 4"],["30","Phase 4"],["30","Phase 2"],["23","Phase 1"],["4","Phase 2"],["37","Phase 1"],["18","Phase 2"],["5","Phase 2"],["0","Phase 2"],["0","Phase 2"],["41","Phase 4"],["13","Phase 1"],["86","Phase 0"],["3","Phase 1 / Phase 2"],["137","Phase 4"],["12","Phase 1"],["32","Phase 2"],["1","Phase 1 / Phase 2"],["8","Phase 1"],["57","Phase 2"],["855","Phase 1"],["40","Phase 1"],["610","Phase 3"],["16","Phase 1"],["614","Phase 3"],["223","Phase 2"],["20","Phase 4"],["40","Phase 4"],["15","Phase 4"],["30","Phase 4"],["20","Phase 1"],["59","Phase 1"],["17","Phase 1"],["7","Phase 4"],["70","Phase 1"],["16","Phase 1"],["51","Phase 4"],["24","Phase 1"],["63","Phase 2"],["30","Phase 0"],["56","Phase 2"],["20","Phase 2"],["2","Phase 2"],["301","Phase 3"],["18","Phase 1"],["56","Phase 1"],["4","Phase 1"],["35","Phase 2"],["321697","Phase 4"],["18","Phase 1"],["16","Phase 1"],["87","Phase 0"],["54","Phase 2"],["7","Phase 2"],["67","Phase 4"],["30","Phase 2"],["9","Phase 2"],["1","Phase 2"],["17","Phase 0"],["120","Phase 3"],["41","Phase 2"],["64","Phase 2"],["6","Phase 2"],["49","Phase 1"],["78","Phase 1"],["67","Phase 2"],["27","Phase 1"],["23","Phase 2"],["42","Phase 1"],["42","Phase 1 / Phase 2"],["37","Phase 1"],["96","Phase 1"],["94","Phase 2"],["59","Phase 2"],["41","Phase 2"],["25","Phase 1"],["2","Phase 1"],["56","Phase 2"],["74","Phase 1"],["60","Phase 4"],["62","Phase 1"],["15","Phase 3"],["47","Phase 1"],["33","Phase 2"],["12","Phase 1"],["55","Phase 0"],["40","Phase 1"],["21","Phase 4"],["60","Phase 1"],["40","Phase 1"],["24","Phase 0"],["66","Phase 1"],["0","Phase 2"],["264","Phase 2"],["50","Phase 2"],["32","Phase 2"],["6","Phase 1"],["125","Phase 2"],["851","Phase 3"],["20","Phase 3"],["302","Phase 2 / Phase 3"],["52","Phase 1"],["25","Phase 1"],["13","Phase 1"],["13","Phase 4"],["21","Phase 1"],["47","Phase 1"],["56","Phase 1"],["45","Phase 1"],["176","Phase 2"],["15","Phase 1"],["28","Phase 1 / Phase 2"],["7","Phase 4"],["48","Phase 2"],["29","Phase 1 / Phase 2"],["21","Phase 1"],["39","Phase 2"],["28","Phase 2"],["26","Phase 2"],["127","Phase 4"],["31","Phase 1"],["40","Phase 4"],["11","Phase 4"],["25","Phase 1"],["2","Phase 2"],["33","Phase 4"],["12","Phase 4"],["256","Phase 2 / Phase 3"],["711","Phase 3"],["10","Phase 2"],["21","Phase 4"],["30","Phase 2"],["188","Phase 4"],["24","Phase 1 / Phase 2"],["8","Phase 1 / Phase 2"],["67","Phase 4"],["28","Phase 1 / Phase 2"],["24","Phase 4"],["239","Phase 3"],["434","Phase 3"],["468","Phase 3"],["4","Phase 2"],["14","Phase 2"],["19","Phase 2"],["7","Phase 2"],["55","Phase 3"],["40","Phase 2"],["0","Phase 4"],["32","Phase 2"],["13","Phase 2"],["26","Phase 2"],["82","Phase 4"],["14","Phase 2"],["4","Phase 1"],["33","Phase 2"],["15","Phase 2"],["1467","Phase 3"],["18","Phase 1"],["110","Phase 4"],["341","Phase 3"],["8","Phase 1"],["71","Phase 1"],["295","Phase 3"],["44","Phase 4"],["54","Phase 1"],["16","Phase 1"],["30","Phase 2"],["290","Phase 2"],["66","Phase 2"],["14","Phase 2"],["30","Phase 2"],["13","Phase 1"],["60","Phase 1 / Phase 2"],["70","Phase 2"],["276","Phase 4"],["24","Phase 1"],["8","Phase 1"],["61","Phase 4"],["3604","Phase 3"],["24","Phase 1"],["15","Phase 4"],["90","Phase 4"],["16","Phase 2 / Phase 3"],["140","Phase 2"],["24","Phase 1"],["278","Phase 2 / Phase 3"],["23","Phase 1 / Phase 2"],["36","Phase 2"],["1600","Phase 4"],["50","Phase 2"],["51","Phase 1"],["116","Phase 2"],["5","Phase 2"],["569","Phase 4"],["37","Phase 1"],["16","Phase 1"],["454","Phase 2"],["27","Phase 2"],["20","Phase 1"],["61","Phase 2"],["4","Phase 4"],["475","Phase 2 / Phase 3"],["58","Phase 4"],["52","Phase 2"],["21","Phase 2"],["2","Phase 2"],["65","Phase 1"],["20","Phase 2"],["40","Phase 4"],["93","Phase 4"],["29","Phase 1"],["62","Phase 2"],["516","Phase 4"],["65","Phase 1"],["100","Phase 2"],["0","Phase 4"],["10","Phase 1 / Phase 2"],["18","Phase 2"],["457","Phase 3"],["275","Phase 4"],["318","Phase 3"],["20","Phase 2"],["111","Phase 2 / Phase 3"],["41","Phase 1"],["113","Phase 4"],["88","Phase 4"],["33","Phase 1"],["15","Phase 4"],["150","Phase 3"],["89","Phase 2"],["14","Phase 1"],["34","Phase 1 / Phase 2"],["262","Phase 4"],["48","Phase 1 / Phase 2"],["45","Phase 1"],["29","Phase 2"],["4","Phase 1"],["18","Phase 1"],["27","Phase 2"],["113","Phase 3"],["37","Phase 1"],["101","Phase 3"],["60","Phase 2"],["12","Phase 2 / Phase 3"],["53","Phase 1"],["152","Phase 3"],["231","Phase 2"],["20","Phase 4"],["40","Phase 1"],["40","Phase 4"],["40","Phase 3"],["40","Phase 1"],["8","Phase 1 / Phase 2"],["15","Phase 2"],["13","Phase 1"],["64","Phase 2 / Phase 3"],["24","Phase 2"],["75","Phase 2"],["30","Phase 1"],["65","Phase 1"],["261","Phase 2"],["24","Phase 2"],["150","Phase 2 / Phase 3"],["68","Phase 2"],["26","Phase 2"],["23","Phase 1"],["97","Phase 3"],["279","Phase 3"],["","Phase 3"],["31","Phase 2"],["25","Phase 1"],["96","Phase 4"],["400","Phase 3"],["","Phase 3"],["107","Phase 1 / Phase 2"],["496","Phase 2 / Phase 3"],["15","Phase 2"],["200","Phase 3"],["136","Phase 3"],["10","Phase 1"],["","Phase 2"],["","Phase 3"],["64","Phase 4"],["15","Phase 2 / Phase 3"],["26","Phase 2 / Phase 3"],["14","Phase 2"],["354","Phase 1 / Phase 2"],["240","Phase 2"],["574","Phase 2"],["77","Phase 2"],["70","Phase 2"],["89","Phase 2"],["160","Phase 2 / Phase 3"],["30","Phase 4"],["16","Phase 1"],["28","Phase 0"],["40","Phase 2 / Phase 3"],["811","Phase 3"],["174","Phase 2"],["654","Phase 3"],["80","Phase 3"],["12","Phase 2 / Phase 3"],["2364","Phase 3"],["56","Phase 2 / Phase 3"],["600","Phase 4"],["30","Phase 2"],["","Phase 1"],["30","Phase 1"],["5","Phase 2"],["30","Phase 1"],["40","Phase 2"],["20","Phase 2"],["1800","Phase 3"],["18","Phase 4"],["15","Phase 1 / Phase 2"],["76","Phase 2"],["154","Phase 1 / Phase 2"],["33","Phase 2"],["55","Phase 2"],["45","Phase 1"],["101","Phase 3"]]},"dateCreated":"2016-12-06T17:31:08+0000","status":"READY","errorMessage":"","progressUpdateIntervalMs":500,"$$hashKey":"object:2226"},{"text":"%sql\n\nselect start_date, rank from table_df where length(start_date) > 4","dateUpdated":"2016-12-06T17:31:08+0000","config":{"colWidth":12,"editorMode":"ace/mode/sql","editorHide":true,"graph":{"mode":"lineWithFocusChart","height":300,"optionOpen":false,"keys":[{"name":"start_date","index":0,"aggr":"sum"}],"values":[{"name":"rank","index":1,"aggr":"count"}],"groups":[],"scatter":{"xAxis":{"name":"start_date","index":0,"aggr":"sum"},"yAxis":{"name":"rank","index":1,"aggr":"sum"}},"lineWithFocus":true},"enabled":true},"settings":{"params":{},"forms":{}},"jobName":"paragraph_1481045468665_-393359478","id":"20161204-184546_464683047","result":{"code":"SUCCESS","type":"TABLE","msg":"start_date\trank\nNovember 2015\t1\nNovember 2016\t2\nNovember 2016\t3\nNovember 2016\t4\nNovember 2016\t5\nNovember 2016\t6\nJanuary 2017\t7\nMay 2017\t8\nMay 2016\t9\nNovember 2016\t10\nFebruary 2017\t11\nSeptember 2016\t12\nNovember 2016\t13\nNovember 2016\t14\nNovember 2016\t15\nNovember 2016\t16\nSeptember 2016\t17\nOctober 2016\t18\nDecember 2015\t19\nDecember 2016\t20\nNovember 2016\t21\nOctober 2016\t22\nNovember 2016\t23\nJanuary 2017\t24\nAugust 2016\t25\nNovember 2016\t26\nOctober 2016\t27\nOctober 2016\t28\nSeptember 2016\t29\nNovember 2016\t30\nOctober 2016\t31\nNovember 2016\t32\nMarch 2016\t33\nNovember 2016\t34\nAugust 2016\t35\nSeptember 2016\t36\nDecember 2016\t37\nOctober 2016\t38\nNovember 2016\t39\nSeptember 2016\t40\nNovember 2016\t41\nMay 2016\t42\nSeptember 2016\t43\nOctober 2016\t44\nFebruary 2015\t45\nSeptember 2016\t46\nNovember 2016\t47\nAugust 2016\t48\nJuly 2016\t49\nAugust 2016\t50\nOctober 2016\t51\nAugust 2016\t52\nOctober 2016\t53\nSeptember 2016\t54\nMay 2014\t55\nAugust 2016\t56\nOctober 2016\t57\nAugust 2016\t58\nDecember 2014\t59\nDecember 2016\t60\nMarch 2017\t61\nAugust 2016\t62\nDecember 2016\t63\nAugust 2016\t64\nMay 2016\t65\nOctober 2016\t66\nAugust 2016\t67\nAugust 2016\t68\nJuly 2015\t69\nDecember 2016\t70\nSeptember 2014\t71\nJuly 2015\t72\nNovember 2016\t73\nJuly 2016\t74\nAugust 2016\t75\nJuly 2016\t76\nJuly 2016\t77\nApril 2016\t78\nApril 2016\t79\nFebruary 2016\t80\nAugust 2016\t81\nAugust 2016\t82\nAugust 2016\t83\nOctober 2016\t84\nAugust 2016\t85\nJuly 2016\t86\nJuly 2016\t87\nSeptember 2016\t88\nSeptember 2016\t89\nJune 2012\t90\nAugust 2016\t91\nAugust 2016\t92\nSeptember 2016\t93\nAugust 2016\t94\nJuly 2016\t95\nJanuary 2016\t96\nJuly 2016\t97\nJune 2016\t98\nAugust 2016\t99\nJune 2016\t100\nJune 2016\t101\nJune 2016\t102\nJuly 2016\t103\nJuly 2016\t104\nSeptember 2016\t105\nMay 2016\t106\nJune 2016\t107\nApril 2016\t108\nApril 2016\t109\nSeptember 2016\t110\nJune 2016\t111\nJune 2016\t112\nSeptember 2016\t113\nAugust 2016\t114\nNovember 2016\t116\nApril 2017\t117\nAugust 2016\t118\nNovember 2016\t119\nFebruary 2016\t120\nMay 2016\t121\nMay 2016\t122\nJune 2016\t123\nApril 2016\t124\nMay 2016\t125\nNovember 2016\t126\nApril 2016\t127\nApril 2016\t128\nOctober 2016\t129\nNovember 2015\t130\nJanuary 2016\t131\nJanuary 2016\t132\nMay 2016\t133\nFebruary 2016\t134\nJune 2016\t135\nSeptember 2016\t136\nJanuary 2016\t137\nMay 2016\t138\nMay 2016\t139\nApril 2016\t140\nOctober 2016\t141\nApril 2016\t142\nMarch 2016\t143\nApril 2016\t144\nMarch 2016\t145\nMay 2016\t146\nSeptember 2014\t147\nMarch 2016\t148\nMarch 2016\t149\nApril 2016\t150\nMay 2016\t151\nJuly 2015\t152\nFebruary 2016\t153\nJune 2016\t154\nMay 2016\t155\nAugust 2016\t156\nAugust 2016\t157\nMarch 2016\t158\nMarch 2016\t159\nOctober 2016\t160\nSeptember 2014\t161\nMarch 2016\t162\nMay 2016\t163\nMay 2016\t164\nAugust 2011\t165\nApril 2016\t166\nApril 2016\t167\nMarch 2016\t168\nJune 2017\t169\nMarch 2016\t170\nMarch 2016\t171\nOctober 2016\t172\nMarch 2016\t173\nSeptember 2007\t174\nMay 2016\t175\nMay 2016\t176\nMarch 2016\t177\nFebruary 2016\t178\nApril 2016\t179\nMay 2016\t180\nApril 2016\t181\nMarch 2016\t182\nFebruary 2016\t183\nOctober 2012\t184\nAugust 2016\t185\nFebruary 2016\t186\nDecember 2015\t187\nSeptember 2016\t188\nOctober 2015\t189\nOctober 2015\t190\nMarch 2016\t191\nMay 2014\t192\nDecember 2015\t193\nJanuary 2016\t194\nFebruary 2016\t195\nMarch 2016\t196\nJanuary 2016\t197\nJanuary 2016\t198\nMay 2016\t199\nJuly 2016\t200\nOctober 2015\t201\nApril 2016\t202\nJanuary 2016\t203\nJanuary 2016\t204\nJune 2015\t205\nDecember 2015\t206\nDecember 2015\t207\nApril 2016\t208\nJanuary 2016\t209\nNovember 2015\t210\nMay 2015\t211\nAugust 2015\t212\nApril 2016\t213\nOctober 2015\t214\nMarch 2016\t215\nFebruary 2016\t216\nJuly 2015\t217\nFebruary 2016\t218\nOctober 2015\t219\nDecember 2015\t220\nOctober 2015\t221\nMay 2016\t222\nFebruary 2016\t223\nFebruary 2016\t224\nJanuary 2016\t225\nJanuary 2016\t226\nNovember 2015\t227\nFebruary 2016\t228\nAugust 2015\t229\nJuly 2014\t230\nNovember 2015\t231\nNovember 2015\t232\nOctober 2015\t233\nNovember 2015\t234\nJanuary 2002\t235\nNovember 2015\t236\nFebruary 2016\t237\nMay 2016\t238\nMarch 2017\t239\nFebruary 2016\t240\nFebruary 2014\t241\nFebruary 2016\t242\nOctober 2015\t243\nMarch 2016\t244\nJune 2015\t245\nMarch 2016\t246\nMay 2016\t247\nJuly 2016\t248\nOctober 2015\t249\nApril 2016\t250\nOctober 2015\t251\nSeptember 2015\t252\nMarch 2016\t253\nJune 2013\t254\nSeptember 2015\t255\nJuly 2014\t256\nOctober 2015\t257\nJune 2016\t258\nOctober 2015\t259\nDecember 2015\t260\nMay 2015\t261\nNovember 2013\t262\nOctober 2015\t263\nJuly 2015\t264\nOctober 2015\t265\nOctober 2015\t266\nMarch 2016\t267\nSeptember 2015\t268\nJanuary 2011\t269\nApril 2016\t270\nJuly 2015\t271\nSeptember 2015\t272\nJanuary 2016\t273\nApril 2016\t274\nFebruary 2016\t275\nSeptember 2015\t276\nOctober 2015\t277\nJune 2015\t278\nSeptember 2015\t279\nJuly 2015\t280\nMay 2015\t281\nApril 2016\t282\nSeptember 2015\t283\nMay 2015\t284\nJanuary 2016\t285\nSeptember 2015\t286\nMarch 2016\t287\nJuly 2015\t288\nMay 2016\t289\nJuly 2015\t290\nJanuary 2017\t291\nDecember 2015\t292\nOctober 2015\t293\nDecember 2015\t294\nNovember 2015\t295\nJanuary 2016\t296\nJuly 2015\t297\nDecember 2015\t298\nJuly 2015\t299\nOctober 2015\t300\nApril 2015\t301\nAugust 2015\t302\nJuly 2015\t303\nJuly 2016\t304\nMay 2016\t305\nJuly 2015\t306\nSeptember 2015\t307\nJuly 2015\t308\nJuly 2015\t309\nJanuary 2016\t310\nJune 2015\t311\nSeptember 2015\t312\nOctober 2015\t313\nFebruary 2015\t314\nJune 2015\t315\nMay 2015\t316\nJune 2015\t317\nOctober 2015\t318\nOctober 2015\t319\nJuly 2016\t320\nFebruary 2016\t321\nSeptember 2015\t322\nJuly 2015\t323\nJuly 2015\t324\nJuly 2015\t325\nMay 2015\t326\nJanuary 2016\t327\nApril 2015\t328\nDecember 2015\t329\nJuly 2015\t330\nDecember 2015\t331\nMay 2015\t332\nDecember 2013\t333\nJune 2015\t334\nOctober 2015\t335\nMay 2015\t336\nJanuary 2004\t337\nJune 2015\t338\nMarch 2013\t339\nMay 2015\t340\nJuly 2015\t341\nFebruary 2016\t342\nJuly 2015\t343\nJanuary 2016\t344\nJanuary 2016\t345\nOctober 2014\t346\nJune 2016\t347\nMay 2014\t348\nMay 2015\t349\nJanuary 2016\t350\nMay 2015\t351\nApril 2015\t352\nSeptember 2015\t353\nMay 2015\t354\nSeptember 2015\t355\nOctober 2015\t356\nJanuary 2016\t357\nMay 2015\t358\nAugust 2015\t359\nJune 2015\t360\nMay 2015\t361\nJuly 2015\t362\nApril 2015\t363\nMay 2015\t364\nMay 2015\t365\nOctober 2015\t366\nJune 2015\t367\nSeptember 2015\t368\nJune 2012\t369\nMarch 2015\t370\nSeptember 2014\t371\nMarch 2015\t372\nOctober 2014\t373\nAugust 2015\t374\nMarch 2015\t375\nDecember 2015\t376\nMarch 2015\t377\nMay 2015\t378\nDecember 2014\t379\nAugust 2015\t380\nMarch 2015\t381\nJune 2016\t382\nMay 2013\t383\nApril 2015\t384\nJanuary 2015\t385\nFebruary 2015\t386\nJanuary 2015\t387\nMarch 2015\t388\nMarch 2015\t389\nFebruary 2015\t390\nJanuary 2015\t391\nFebruary 2015\t392\nFebruary 2015\t393\nMarch 2015\t394\nFebruary 2015\t395\nNovember 2014\t396\nSeptember 2015\t397\nFebruary 2015\t398\nDecember 2014\t399\nJanuary 2015\t400\nJune 2015\t401\nSeptember 2015\t402\nJuly 2014\t403\nSeptember 2014\t404\nFebruary 2015\t405\nFebruary 2015\t406\nJanuary 2015\t407\nMay 2015\t408\nApril 2014\t409\nMarch 2015\t410\nFebruary 2015\t411\nMarch 2015\t412\nMay 2015\t413\nMay 2015\t414\nFebruary 2015\t415\nJanuary 2015\t416\nJune 2015\t417\nMay 2015\t418\nJanuary 2015\t419\nJune 2015\t420\nMay 2016\t421\nApril 2015\t422\nMarch 2015\t423\nMay 2015\t424\nJune 2014\t425\nJuly 2008\t426\nMarch 2015\t427\nMarch 2015\t428\nAugust 2013\t429\nOctober 2014\t430\nJune 2014\t431\nDecember 2014\t432\nDecember 2014\t433\nMay 2015\t434\nFebruary 2015\t435\nJanuary 2015\t436\nJanuary 2011\t437\nSeptember 2015\t438\nJune 2016\t439\nJanuary 2015\t440\nNovember 2014\t441\nDecember 2014\t442\nAugust 2015\t443\nMarch 2013\t444\nNovember 2014\t445\nNovember 2014\t446\nMarch 2015\t447\nNovember 2014\t448\nDecember 2014\t449\nJune 2014\t450\nDecember 2014\t451\nDecember 2014\t452\nFebruary 2015\t453\nMay 2015\t454\nDecember 2014\t455\nAugust 2012\t456\nDecember 2014\t457\nDecember 2015\t458\nJune 2015\t459\nJanuary 2014\t460\nDecember 2014\t461\nMay 2013\t462\nAugust 2014\t463\nOctober 2014\t464\nMarch 2014\t465\nOctober 2014\t466\nDecember 2013\t467\nNovember 2014\t468\nDecember 2014\t469\nOctober 2014\t470\nOctober 2014\t471\nOctober 2014\t472\nOctober 2014\t473\nMay 2014\t474\nOctober 2014\t475\nOctober 2014\t476\nSeptember 2014\t477\nJanuary 2015\t478\nSeptember 2014\t479\nOctober 2014\t480\nJune 2008\t481\nSeptember 2014\t482\nSeptember 2014\t483\nOctober 2015\t484\nSeptember 2014\t485\nApril 2015\t486\nJuly 2015\t487\nSeptember 2014\t488\nJanuary 2015\t489\nJanuary 2017\t490\nJanuary 2014\t491\nOctober 2014\t492\nOctober 2014\t493\nNovember 2014\t494\nSeptember 2014\t495\nAugust 2015\t496\nSeptember 2014\t497\nNovember 2014\t498\nJanuary 2015\t499\nOctober 2014\t500\nNovember 2014\t501\nNovember 2014\t502\nNovember 2014\t503\nApril 2015\t504\nFebruary 2015\t505\nDecember 2014\t506\nNovember 2014\t507\nAugust 2014\t508\nAugust 2014\t509\nAugust 2014\t510\nSeptember 2014\t511\nSeptember 2014\t512\nNovember 2014\t513\nOctober 2014\t514\nOctober 2014\t515\nOctober 2014\t516\nAugust 2014\t517\nJuly 2014\t518\nFebruary 2015\t519\nFebruary 2015\t520\nSeptember 2014\t521\nSeptember 2014\t522\nFebruary 2013\t523\nOctober 2010\t524\nAugust 2014\t525\nSeptember 2014\t526\nJanuary 2015\t527\nApril 2014\t528\nJuly 2014\t529\nNovember 2014\t530\nOctober 2014\t531\nJanuary 2012\t532\nJuly 2014\t533\nOctober 2014\t534\nOctober 2014\t535\nFebruary 2015\t536\nApril 2014\t537\nSeptember 2012\t538\nOctober 2009\t539\nAugust 2014\t540\nJuly 2014\t541\nDecember 2015\t542\nAugust 2014\t543\nJune 2014\t544\nJune 2014\t545\nApril 2013\t546\nJune 2014\t547\nOctober 2013\t548\nApril 2009\t549\nJuly 2014\t550\nSeptember 2013\t551\nNovember 2014\t552\nJanuary 2015\t553\nJuly 2009\t554\nOctober 2014\t555\nJune 2014\t556\nDecember 2014\t557\nJune 2014\t558\nDecember 2014\t559\nDecember 2014\t560\nSeptember 2014\t561\nMarch 2014\t562\nJuly 2014\t563\nAugust 2014\t564\nDecember 2014\t565\nJune 2014\t566\nJune 2014\t567\nDecember 2013\t568\nSeptember 2014\t569\nSeptember 2014\t570\nApril 2013\t571\nMay 2010\t572\nNovember 2017\t573\nMay 2006\t574\nMay 2014\t575\nJuly 2014\t576\nMay 2011\t577\nFebruary 2015\t578\nNovember 2011\t579\nMay 2016\t580\nNovember 2013\t581\nNovember 2011\t582\nOctober 2013\t583\nJune 2017\t584\nDecember 2014\t585\nJanuary 2016\t586\nMay 2014\t587\nMay 2011\t588\nMay 2014\t589\nJanuary 2014\t590\nMay 2014\t591\nOctober 2014\t592\nNovember 2014\t593\nJune 2014\t594\nApril 2014\t595\nJune 2014\t596\nApril 2016\t597\nApril 2014\t598\nJune 2014\t599\nNovember 2015\t600\nFebruary 2012\t601\nApril 2014\t602\nApril 2014\t603\nSeptember 2014\t604\nMay 2014\t605\nMay 2014\t607\nApril 2014\t608\nMarch 2014\t609\nAugust 2014\t610\nMarch 2014\t611\nMay 2014\t612\nDecember 2016\t613\nNovember 2011\t614\nDecember 2013\t615\nMarch 2014\t616\nJuly 2014\t617\nApril 2014\t618\nApril 2014\t619\nOctober 2014\t620\nNovember 2013\t621\nJuly 2014\t622\nNovember 2012\t623\nJune 2014\t624\nAugust 2015\t625\nApril 2014\t626\nMarch 2014\t627\nSeptember 2014\t628\nJune 2014\t629\nMarch 2014\t630\nMay 2014\t631\nMarch 2014\t632\nMay 2014\t633\nApril 2014\t634\nJune 2013\t635\nJanuary 2015\t637\nMarch 2014\t638\nMarch 2014\t639\nMarch 2014\t640\nJuly 2015\t641\nFebruary 2014\t642\nNovember 2013\t643\nJune 2014\t644\nFebruary 2014\t645\nMay 2014\t646\nAugust 2014\t647\nFebruary 2014\t648\nFebruary 2014\t649\nFebruary 2014\t650\nFebruary 2014\t651\nApril 2014\t652\nFebruary 2014\t653\nApril 2014\t654\nJanuary 2015\t655\nJanuary 2015\t656\nJanuary 2006\t657\nMarch 2014\t658\nFebruary 2014\t659\nJanuary 2014\t661\nMarch 2014\t662\nAugust 2015\t663\nNovember 2014\t664\nFebruary 2014\t665\nJanuary 2014\t666\nNovember 2013\t667\nJune 2013\t668\nDecember 2013\t669\nFebruary 2014\t670\nJanuary 2014\t671\nJuly 2012\t672\nMay 2014\t673\nJanuary 2013\t674\nJanuary 2014\t675\nJanuary 2014\t676\nAugust 2013\t677\nApril 2015\t678\nJuly 2014\t679\nDecember 2013\t680\nMarch 2011\t681\nFebruary 2014\t682\nMarch 2014\t683\nJanuary 2014\t684\nFebruary 2014\t685\nFebruary 2013\t686\nMarch 2014\t687\nFebruary 2014\t688\nMarch 2014\t689\nDecember 2013\t690\nMarch 2014\t691\nJanuary 2014\t692\nJanuary 2015\t693\nJanuary 2014\t694\nApril 2012\t695\nJanuary 2012\t696\nDecember 2013\t697\nMarch 2014\t698\nDecember 2013\t699\nSeptember 2012\t700\nNovember 2011\t701\nJanuary 2014\t702\nDecember 2013\t703\nMay 2014\t704\nJune 2012\t706\nSeptember 2013\t707\nOctober 2014\t708\nJune 2014\t709\nDecember 2013\t710\nNovember 2011\t711\nAugust 2006\t712\nMarch 2014\t713\nDecember 2013\t714\nDecember 2012\t715\nNovember 2013\t716\nJanuary 2016\t717\nNovember 2012\t718\nJuly 2014\t719\nDecember 2013\t720\nFebruary 2014\t721\nFebruary 2014\t722\nNovember 2011\t723\nJanuary 2014\t724\nDecember 2013\t725\nJanuary 2014\t726\nDecember 2013\t727\nNovember 2013\t728\nSeptember 2013\t729\nApril 2013\t730\nApril 2007\t731\nNovember 2013\t732\nNovember 2013\t733\nJune 2014\t734\nMay 2013\t735\nApril 2014\t736\nNovember 2013\t737\nAugust 2013\t738\nMarch 2014\t739\nNovember 2013\t740\nSeptember 2013\t741\nAugust 2013\t742\nDecember 2013\t743\nMarch 2014\t744\nSeptember 2014\t745\nMay 2014\t746\nFebruary 2014\t747\nSeptember 2011\t748\nJuly 2011\t749\nOctober 2013\t750\nJune 2007\t751\nDecember 2015\t752\nOctober 2013\t753\nSeptember 2011\t754\nNovember 2013\t755\nNovember 2013\t756\nDecember 2014\t757\nNovember 2013\t758\nJune 2013\t759\nOctober 2013\t760\nDecember 2010\t761\nOctober 2013\t762\nNovember 2014\t763\nNovember 2013\t764\nOctober 2013\t765\nDecember 2005\t766\nJanuary 2014\t767\nAugust 2012\t768\nOctober 2013\t769\nAugust 2013\t770\nOctober 2013\t771\nMay 2014\t772\nFebruary 2014\t773\nOctober 2013\t774\nNovember 2008\t775\nSeptember 2013\t776\nFebruary 2014\t777\nApril 2013\t778\nOctober 2013\t779\nJuly 2013\t780\nDecember 2009\t781\nOctober 2013\t782\nJanuary 2013\t783\nNovember 2013\t784\nSeptember 2013\t786\nJune 2007\t787\nSeptember 2005\t788\nDecember 2011\t789\nDecember 2013\t790\nJuly 2008\t791\nDecember 2013\t792\nOctober 2013\t793\nFebruary 2014\t794\nMarch 2014\t795\nSeptember 2014\t796\nSeptember 2013\t797\nSeptember 2013\t798\nJanuary 2010\t799\nNovember 2013\t800\nSeptember 2013\t801\nSeptember 2014\t802\nAugust 2013\t803\nOctober 2013\t804\nSeptember 2013\t805\nAugust 2013\t806\nOctober 2013\t807\nSeptember 2013\t808\nOctober 2013\t809\nJanuary 2013\t810\nJuly 2013\t811\nSeptember 2013\t812\nJuly 2013\t813\nSeptember 2014\t814\nApril 2011\t815\nSeptember 2013\t816\nJune 2010\t817\nJune 2013\t818\nJanuary 2008\t819\nAugust 2013\t820\nJune 2013\t821\nSeptember 2013\t822\nOctober 2013\t823\nAugust 2013\t824\nJuly 2013\t825\nMay 2011\t826\nJanuary 2012\t827\nOctober 2012\t828\nMarch 2013\t829\nOctober 2013\t830\nApril 2001\t831\nSeptember 2012\t832\nAugust 2013\t833\nJuly 2013\t834\nAugust 2013\t835\nDecember 2013\t836\nAugust 2013\t837\nJune 2015\t838\nSeptember 2013\t839\nAugust 2013\t840\nSeptember 2013\t841\nAugust 2013\t842\nAugust 2013\t843\nJuly 2013\t844\nAugust 2013\t845\nJuly 2013\t846\nApril 2004\t847\nApril 2003\t848\nMay 2001\t849\nNovember 2013\t850\nAugust 2002\t851\nMay 2001\t852\nJuly 2001\t853\nJune 2013\t854\nNovember 2011\t855\nJune 2013\t856\nJanuary 2015\t857\nNovember 2012\t858\nJanuary 2008\t859\nAugust 2010\t861\nMay 2014\t862\nAugust 2013\t863\nJuly 2013\t864\nNovember 2013\t865\nJune 2013\t866\nJune 2013\t867\nJanuary 2013\t868\nJuly 2013\t869\nMay 2012\t870\nJune 2012\t871\nNovember 2009\t873\nApril 2013\t874\nMay 2014\t875\nMarch 2013\t876\nApril 2013\t877\nJuly 2013\t878\nApril 2013\t879\nMay 2012\t880\nJuly 2010\t881\nJuly 2013\t882\nApril 2013\t883\nJanuary 2014\t884\nMay 2013\t885\nDecember 2012\t886\nJuly 2013\t887\nMay 2013\t888\nApril 2013\t889\nApril 2013\t890\nAugust 2012\t891\nJanuary 2015\t892\nApril 2013\t893\nSeptember 2013\t894\nFebruary 2014\t895\nMarch 2013\t896\nApril 2013\t897\nApril 2013\t898\nMay 2014\t899\nJuly 2011\t900\nFebruary 2013\t901\nJune 2013\t902\nJanuary 2014\t903\nJuly 2013\t904\nFebruary 2013\t905\nApril 2013\t906\nJune 2014\t907\nMay 2013\t908\nOctober 2010\t909\nMay 2013\t910\nFebruary 2013\t911\nMarch 2013\t912\nMarch 2013\t913\nMarch 2013\t914\nMarch 2013\t915\nMarch 2013\t916\nJune 2014\t917\nJanuary 2013\t918\nJanuary 2013\t919\nApril 2013\t920\nDecember 2012\t921\nJune 2013\t922\nFebruary 2013\t923\nJuly 2011\t924\nMarch 2013\t925\nJuly 2013\t926\nApril 2013\t927\nMarch 2013\t928\nOctober 2012\t929\nDecember 2012\t930\nMarch 2013\t931\nFebruary 2013\t932\nAugust 2012\t933\nSeptember 2012\t934\nJune 2013\t935\nMarch 2013\t936\nJuly 2012\t937\nFebruary 2012\t938\nMarch 2013\t939\nSeptember 2013\t940\nApril 2013\t941\nJanuary 2012\t942\nMarch 2013\t943\nSeptember 2012\t944\nJanuary 2012\t945\nMarch 2012\t946\nMarch 2013\t947\nSeptember 2014\t948\nOctober 2012\t949\nAugust 2013\t950\nJanuary 2013\t951\nSeptember 2012\t952\nAugust 2013\t953\nJanuary 2008\t954\nNovember 2012\t955\nOctober 2012\t956\nOctober 2012\t957\nOctober 2012\t958\nOctober 2012\t959\nFebruary 2013\t960\nAugust 2012\t961\nMarch 2013\t962\nFebruary 2013\t963\nJanuary 2013\t964\nFebruary 2013\t965\nOctober 2012\t966\nJanuary 2013\t967\nSeptember 2012\t968\nJune 2012\t969\nFebruary 2013\t970\nFebruary 2013\t971\nSeptember 2012\t972\nOctober 2012\t973\nJune 2012\t974\nFebruary 2013\t975\nFebruary 2013\t976\nOctober 2013\t977\nNovember 2011\t978\nJanuary 2013\t979\nFebruary 2013\t980\nJune 2012\t981\nOctober 2010\t982\nOctober 2010\t983\nMarch 2012\t984\nDecember 2013\t985\nOctober 2012\t986\nFebruary 2014\t987\nApril 2012\t988\nApril 2012\t989\nJanuary 2013\t990\nAugust 2013\t991\nJanuary 2013\t992\nJanuary 2013\t993\nJuly 2014\t994\nJanuary 2013\t995\nNovember 2012\t996\nMay 2013\t997\nJanuary 2013\t999\nDecember 2012\t1000\nAugust 2013\t1001\nSeptember 2009\t1002\nMarch 2013\t1003\nSeptember 2011\t1004\nDecember 2012\t1005\nOctober 2012\t1006\nFebruary 2013\t1007\nJanuary 2013\t1008\nNovember 2012\t1009\n\n<font color=red>Results are limited by 1000.</font>","comment":"<font color=red>Results are limited by 1000.</font>","msgTable":[[{"key":"rank","value":"November 2015"},{"key":"rank","value":"1"}],[{"value":"November 2016"},{"value":"2"}],[{"value":"November 2016"},{"value":"3"}],[{"value":"November 2016"},{"value":"4"}],[{"value":"November 2016"},{"value":"5"}],[{"value":"November 2016"},{"value":"6"}],[{"value":"January 2017"},{"value":"7"}],[{"value":"May 2017"},{"value":"8"}],[{"value":"May 2016"},{"value":"9"}],[{"value":"November 2016"},{"value":"10"}],[{"value":"February 2017"},{"value":"11"}],[{"value":"September 2016"},{"value":"12"}],[{"value":"November 2016"},{"value":"13"}],[{"value":"November 2016"},{"value":"14"}],[{"value":"November 2016"},{"value":"15"}],[{"value":"November 2016"},{"value":"16"}],[{"value":"September 2016"},{"value":"17"}],[{"value":"October 2016"},{"value":"18"}],[{"value":"December 2015"},{"value":"19"}],[{"value":"December 2016"},{"value":"20"}],[{"value":"November 2016"},{"value":"21"}],[{"value":"October 2016"},{"value":"22"}],[{"value":"November 2016"},{"value":"23"}],[{"value":"January 2017"},{"value":"24"}],[{"value":"August 2016"},{"value":"25"}],[{"value":"November 2016"},{"value":"26"}],[{"value":"October 2016"},{"value":"27"}],[{"value":"October 2016"},{"value":"28"}],[{"value":"September 2016"},{"value":"29"}],[{"value":"November 2016"},{"value":"30"}],[{"value":"October 2016"},{"value":"31"}],[{"value":"November 2016"},{"value":"32"}],[{"value":"March 2016"},{"value":"33"}],[{"value":"November 2016"},{"value":"34"}],[{"value":"August 2016"},{"value":"35"}],[{"value":"September 2016"},{"value":"36"}],[{"value":"December 2016"},{"value":"37"}],[{"value":"October 2016"},{"value":"38"}],[{"value":"November 2016"},{"value":"39"}],[{"value":"September 2016"},{"value":"40"}],[{"value":"November 2016"},{"value":"41"}],[{"value":"May 2016"},{"value":"42"}],[{"value":"September 2016"},{"value":"43"}],[{"value":"October 2016"},{"value":"44"}],[{"value":"February 2015"},{"value":"45"}],[{"value":"September 2016"},{"value":"46"}],[{"value":"November 2016"},{"value":"47"}],[{"value":"August 2016"},{"value":"48"}],[{"value":"July 2016"},{"value":"49"}],[{"value":"August 2016"},{"value":"50"}],[{"value":"October 2016"},{"value":"51"}],[{"value":"August 2016"},{"value":"52"}],[{"value":"October 2016"},{"value":"53"}],[{"value":"September 2016"},{"value":"54"}],[{"value":"May 2014"},{"value":"55"}],[{"value":"August 2016"},{"value":"56"}],[{"value":"October 2016"},{"value":"57"}],[{"value":"August 2016"},{"value":"58"}],[{"value":"December 2014"},{"value":"59"}],[{"value":"December 2016"},{"value":"60"}],[{"value":"March 2017"},{"value":"61"}],[{"value":"August 2016"},{"value":"62"}],[{"value":"December 2016"},{"value":"63"}],[{"value":"August 2016"},{"value":"64"}],[{"value":"May 2016"},{"value":"65"}],[{"value":"October 2016"},{"value":"66"}],[{"value":"August 2016"},{"value":"67"}],[{"value":"August 2016"},{"value":"68"}],[{"value":"July 2015"},{"value":"69"}],[{"value":"December 2016"},{"value":"70"}],[{"value":"September 2014"},{"value":"71"}],[{"value":"July 2015"},{"value":"72"}],[{"value":"November 2016"},{"value":"73"}],[{"value":"July 2016"},{"value":"74"}],[{"value":"August 2016"},{"value":"75"}],[{"value":"July 2016"},{"value":"76"}],[{"value":"July 2016"},{"value":"77"}],[{"value":"April 2016"},{"value":"78"}],[{"value":"April 2016"},{"value":"79"}],[{"value":"February 2016"},{"value":"80"}],[{"value":"August 2016"},{"value":"81"}],[{"value":"August 2016"},{"value":"82"}],[{"value":"August 2016"},{"value":"83"}],[{"value":"October 2016"},{"value":"84"}],[{"value":"August 2016"},{"value":"85"}],[{"value":"July 2016"},{"value":"86"}],[{"value":"July 2016"},{"value":"87"}],[{"value":"September 2016"},{"value":"88"}],[{"value":"September 2016"},{"value":"89"}],[{"value":"June 2012"},{"value":"90"}],[{"value":"August 2016"},{"value":"91"}],[{"value":"August 2016"},{"value":"92"}],[{"value":"September 2016"},{"value":"93"}],[{"value":"August 2016"},{"value":"94"}],[{"value":"July 2016"},{"value":"95"}],[{"value":"January 2016"},{"value":"96"}],[{"value":"July 2016"},{"value":"97"}],[{"value":"June 2016"},{"value":"98"}],[{"value":"August 2016"},{"value":"99"}],[{"value":"June 2016"},{"value":"100"}],[{"value":"June 2016"},{"value":"101"}],[{"value":"June 2016"},{"value":"102"}],[{"value":"July 2016"},{"value":"103"}],[{"value":"July 2016"},{"value":"104"}],[{"value":"September 2016"},{"value":"105"}],[{"value":"May 2016"},{"value":"106"}],[{"value":"June 2016"},{"value":"107"}],[{"value":"April 2016"},{"value":"108"}],[{"value":"April 2016"},{"value":"109"}],[{"value":"September 2016"},{"value":"110"}],[{"value":"June 2016"},{"value":"111"}],[{"value":"June 2016"},{"value":"112"}],[{"value":"September 2016"},{"value":"113"}],[{"value":"August 2016"},{"value":"114"}],[{"value":"November 2016"},{"value":"116"}],[{"value":"April 2017"},{"value":"117"}],[{"value":"August 2016"},{"value":"118"}],[{"value":"November 2016"},{"value":"119"}],[{"value":"February 2016"},{"value":"120"}],[{"value":"May 2016"},{"value":"121"}],[{"value":"May 2016"},{"value":"122"}],[{"value":"June 2016"},{"value":"123"}],[{"value":"April 2016"},{"value":"124"}],[{"value":"May 2016"},{"value":"125"}],[{"value":"November 2016"},{"value":"126"}],[{"value":"April 2016"},{"value":"127"}],[{"value":"April 2016"},{"value":"128"}],[{"value":"October 2016"},{"value":"129"}],[{"value":"November 2015"},{"value":"130"}],[{"value":"January 2016"},{"value":"131"}],[{"value":"January 2016"},{"value":"132"}],[{"value":"May 2016"},{"value":"133"}],[{"value":"February 2016"},{"value":"134"}],[{"value":"June 2016"},{"value":"135"}],[{"value":"September 2016"},{"value":"136"}],[{"value":"January 2016"},{"value":"137"}],[{"value":"May 2016"},{"value":"138"}],[{"value":"May 2016"},{"value":"139"}],[{"value":"April 2016"},{"value":"140"}],[{"value":"October 2016"},{"value":"141"}],[{"value":"April 2016"},{"value":"142"}],[{"value":"March 2016"},{"value":"143"}],[{"value":"April 2016"},{"value":"144"}],[{"value":"March 2016"},{"value":"145"}],[{"value":"May 2016"},{"value":"146"}],[{"value":"September 2014"},{"value":"147"}],[{"value":"March 2016"},{"value":"148"}],[{"value":"March 2016"},{"value":"149"}],[{"value":"April 2016"},{"value":"150"}],[{"value":"May 2016"},{"value":"151"}],[{"value":"July 2015"},{"value":"152"}],[{"value":"February 2016"},{"value":"153"}],[{"value":"June 2016"},{"value":"154"}],[{"value":"May 2016"},{"value":"155"}],[{"value":"August 2016"},{"value":"156"}],[{"value":"August 2016"},{"value":"157"}],[{"value":"March 2016"},{"value":"158"}],[{"value":"March 2016"},{"value":"159"}],[{"value":"October 2016"},{"value":"160"}],[{"value":"September 2014"},{"value":"161"}],[{"value":"March 2016"},{"value":"162"}],[{"value":"May 2016"},{"value":"163"}],[{"value":"May 2016"},{"value":"164"}],[{"value":"August 2011"},{"value":"165"}],[{"value":"April 2016"},{"value":"166"}],[{"value":"April 2016"},{"value":"167"}],[{"value":"March 2016"},{"value":"168"}],[{"value":"June 2017"},{"value":"169"}],[{"value":"March 2016"},{"value":"170"}],[{"value":"March 2016"},{"value":"171"}],[{"value":"October 2016"},{"value":"172"}],[{"value":"March 2016"},{"value":"173"}],[{"value":"September 2007"},{"value":"174"}],[{"value":"May 2016"},{"value":"175"}],[{"value":"May 2016"},{"value":"176"}],[{"value":"March 2016"},{"value":"177"}],[{"value":"February 2016"},{"value":"178"}],[{"value":"April 2016"},{"value":"179"}],[{"value":"May 2016"},{"value":"180"}],[{"value":"April 2016"},{"value":"181"}],[{"value":"March 2016"},{"value":"182"}],[{"value":"February 2016"},{"value":"183"}],[{"value":"October 2012"},{"value":"184"}],[{"value":"August 2016"},{"value":"185"}],[{"value":"February 2016"},{"value":"186"}],[{"value":"December 2015"},{"value":"187"}],[{"value":"September 2016"},{"value":"188"}],[{"value":"October 2015"},{"value":"189"}],[{"value":"October 2015"},{"value":"190"}],[{"value":"March 2016"},{"value":"191"}],[{"value":"May 2014"},{"value":"192"}],[{"value":"December 2015"},{"value":"193"}],[{"value":"January 2016"},{"value":"194"}],[{"value":"February 2016"},{"value":"195"}],[{"value":"March 2016"},{"value":"196"}],[{"value":"January 2016"},{"value":"197"}],[{"value":"January 2016"},{"value":"198"}],[{"value":"May 2016"},{"value":"199"}],[{"value":"July 2016"},{"value":"200"}],[{"value":"October 2015"},{"value":"201"}],[{"value":"April 2016"},{"value":"202"}],[{"value":"January 2016"},{"value":"203"}],[{"value":"January 2016"},{"value":"204"}],[{"value":"June 2015"},{"value":"205"}],[{"value":"December 2015"},{"value":"206"}],[{"value":"December 2015"},{"value":"207"}],[{"value":"April 2016"},{"value":"208"}],[{"value":"January 2016"},{"value":"209"}],[{"value":"November 2015"},{"value":"210"}],[{"value":"May 2015"},{"value":"211"}],[{"value":"August 2015"},{"value":"212"}],[{"value":"April 2016"},{"value":"213"}],[{"value":"October 2015"},{"value":"214"}],[{"value":"March 2016"},{"value":"215"}],[{"value":"February 2016"},{"value":"216"}],[{"value":"July 2015"},{"value":"217"}],[{"value":"February 2016"},{"value":"218"}],[{"value":"October 2015"},{"value":"219"}],[{"value":"December 2015"},{"value":"220"}],[{"value":"October 2015"},{"value":"221"}],[{"value":"May 2016"},{"value":"222"}],[{"value":"February 2016"},{"value":"223"}],[{"value":"February 2016"},{"value":"224"}],[{"value":"January 2016"},{"value":"225"}],[{"value":"January 2016"},{"value":"226"}],[{"value":"November 2015"},{"value":"227"}],[{"value":"February 2016"},{"value":"228"}],[{"value":"August 2015"},{"value":"229"}],[{"value":"July 2014"},{"value":"230"}],[{"value":"November 2015"},{"value":"231"}],[{"value":"November 2015"},{"value":"232"}],[{"value":"October 2015"},{"value":"233"}],[{"value":"November 2015"},{"value":"234"}],[{"value":"January 2002"},{"value":"235"}],[{"value":"November 2015"},{"value":"236"}],[{"value":"February 2016"},{"value":"237"}],[{"value":"May 2016"},{"value":"238"}],[{"value":"March 2017"},{"value":"239"}],[{"value":"February 2016"},{"value":"240"}],[{"value":"February 2014"},{"value":"241"}],[{"value":"February 2016"},{"value":"242"}],[{"value":"October 2015"},{"value":"243"}],[{"value":"March 2016"},{"value":"244"}],[{"value":"June 2015"},{"value":"245"}],[{"value":"March 2016"},{"value":"246"}],[{"value":"May 2016"},{"value":"247"}],[{"value":"July 2016"},{"value":"248"}],[{"value":"October 2015"},{"value":"249"}],[{"value":"April 2016"},{"value":"250"}],[{"value":"October 2015"},{"value":"251"}],[{"value":"September 2015"},{"value":"252"}],[{"value":"March 2016"},{"value":"253"}],[{"value":"June 2013"},{"value":"254"}],[{"value":"September 2015"},{"value":"255"}],[{"value":"July 2014"},{"value":"256"}],[{"value":"October 2015"},{"value":"257"}],[{"value":"June 2016"},{"value":"258"}],[{"value":"October 2015"},{"value":"259"}],[{"value":"December 2015"},{"value":"260"}],[{"value":"May 2015"},{"value":"261"}],[{"value":"November 2013"},{"value":"262"}],[{"value":"October 2015"},{"value":"263"}],[{"value":"July 2015"},{"value":"264"}],[{"value":"October 2015"},{"value":"265"}],[{"value":"October 2015"},{"value":"266"}],[{"value":"March 2016"},{"value":"267"}],[{"value":"September 2015"},{"value":"268"}],[{"value":"January 2011"},{"value":"269"}],[{"value":"April 2016"},{"value":"270"}],[{"value":"July 2015"},{"value":"271"}],[{"value":"September 2015"},{"value":"272"}],[{"value":"January 2016"},{"value":"273"}],[{"value":"April 2016"},{"value":"274"}],[{"value":"February 2016"},{"value":"275"}],[{"value":"September 2015"},{"value":"276"}],[{"value":"October 2015"},{"value":"277"}],[{"value":"June 2015"},{"value":"278"}],[{"value":"September 2015"},{"value":"279"}],[{"value":"July 2015"},{"value":"280"}],[{"value":"May 2015"},{"value":"281"}],[{"value":"April 2016"},{"value":"282"}],[{"value":"September 2015"},{"value":"283"}],[{"value":"May 2015"},{"value":"284"}],[{"value":"January 2016"},{"value":"285"}],[{"value":"September 2015"},{"value":"286"}],[{"value":"March 2016"},{"value":"287"}],[{"value":"July 2015"},{"value":"288"}],[{"value":"May 2016"},{"value":"289"}],[{"value":"July 2015"},{"value":"290"}],[{"value":"January 2017"},{"value":"291"}],[{"value":"December 2015"},{"value":"292"}],[{"value":"October 2015"},{"value":"293"}],[{"value":"December 2015"},{"value":"294"}],[{"value":"November 2015"},{"value":"295"}],[{"value":"January 2016"},{"value":"296"}],[{"value":"July 2015"},{"value":"297"}],[{"value":"December 2015"},{"value":"298"}],[{"value":"July 2015"},{"value":"299"}],[{"value":"October 2015"},{"value":"300"}],[{"value":"April 2015"},{"value":"301"}],[{"value":"August 2015"},{"value":"302"}],[{"value":"July 2015"},{"value":"303"}],[{"value":"July 2016"},{"value":"304"}],[{"value":"May 2016"},{"value":"305"}],[{"value":"July 2015"},{"value":"306"}],[{"value":"September 2015"},{"value":"307"}],[{"value":"July 2015"},{"value":"308"}],[{"value":"July 2015"},{"value":"309"}],[{"value":"January 2016"},{"value":"310"}],[{"value":"June 2015"},{"value":"311"}],[{"value":"September 2015"},{"value":"312"}],[{"value":"October 2015"},{"value":"313"}],[{"value":"February 2015"},{"value":"314"}],[{"value":"June 2015"},{"value":"315"}],[{"value":"May 2015"},{"value":"316"}],[{"value":"June 2015"},{"value":"317"}],[{"value":"October 2015"},{"value":"318"}],[{"value":"October 2015"},{"value":"319"}],[{"value":"July 2016"},{"value":"320"}],[{"value":"February 2016"},{"value":"321"}],[{"value":"September 2015"},{"value":"322"}],[{"value":"July 2015"},{"value":"323"}],[{"value":"July 2015"},{"value":"324"}],[{"value":"July 2015"},{"value":"325"}],[{"value":"May 2015"},{"value":"326"}],[{"value":"January 2016"},{"value":"327"}],[{"value":"April 2015"},{"value":"328"}],[{"value":"December 2015"},{"value":"329"}],[{"value":"July 2015"},{"value":"330"}],[{"value":"December 2015"},{"value":"331"}],[{"value":"May 2015"},{"value":"332"}],[{"value":"December 2013"},{"value":"333"}],[{"value":"June 2015"},{"value":"334"}],[{"value":"October 2015"},{"value":"335"}],[{"value":"May 2015"},{"value":"336"}],[{"value":"January 2004"},{"value":"337"}],[{"value":"June 2015"},{"value":"338"}],[{"value":"March 2013"},{"value":"339"}],[{"value":"May 2015"},{"value":"340"}],[{"value":"July 2015"},{"value":"341"}],[{"value":"February 2016"},{"value":"342"}],[{"value":"July 2015"},{"value":"343"}],[{"value":"January 2016"},{"value":"344"}],[{"value":"January 2016"},{"value":"345"}],[{"value":"October 2014"},{"value":"346"}],[{"value":"June 2016"},{"value":"347"}],[{"value":"May 2014"},{"value":"348"}],[{"value":"May 2015"},{"value":"349"}],[{"value":"January 2016"},{"value":"350"}],[{"value":"May 2015"},{"value":"351"}],[{"value":"April 2015"},{"value":"352"}],[{"value":"September 2015"},{"value":"353"}],[{"value":"May 2015"},{"value":"354"}],[{"value":"September 2015"},{"value":"355"}],[{"value":"October 2015"},{"value":"356"}],[{"value":"January 2016"},{"value":"357"}],[{"value":"May 2015"},{"value":"358"}],[{"value":"August 2015"},{"value":"359"}],[{"value":"June 2015"},{"value":"360"}],[{"value":"May 2015"},{"value":"361"}],[{"value":"July 2015"},{"value":"362"}],[{"value":"April 2015"},{"value":"363"}],[{"value":"May 2015"},{"value":"364"}],[{"value":"May 2015"},{"value":"365"}],[{"value":"October 2015"},{"value":"366"}],[{"value":"June 2015"},{"value":"367"}],[{"value":"September 2015"},{"value":"368"}],[{"value":"June 2012"},{"value":"369"}],[{"value":"March 2015"},{"value":"370"}],[{"value":"September 2014"},{"value":"371"}],[{"value":"March 2015"},{"value":"372"}],[{"value":"October 2014"},{"value":"373"}],[{"value":"August 2015"},{"value":"374"}],[{"value":"March 2015"},{"value":"375"}],[{"value":"December 2015"},{"value":"376"}],[{"value":"March 2015"},{"value":"377"}],[{"value":"May 2015"},{"value":"378"}],[{"value":"December 2014"},{"value":"379"}],[{"value":"August 2015"},{"value":"380"}],[{"value":"March 2015"},{"value":"381"}],[{"value":"June 2016"},{"value":"382"}],[{"value":"May 2013"},{"value":"383"}],[{"value":"April 2015"},{"value":"384"}],[{"value":"January 2015"},{"value":"385"}],[{"value":"February 2015"},{"value":"386"}],[{"value":"January 2015"},{"value":"387"}],[{"value":"March 2015"},{"value":"388"}],[{"value":"March 2015"},{"value":"389"}],[{"value":"February 2015"},{"value":"390"}],[{"value":"January 2015"},{"value":"391"}],[{"value":"February 2015"},{"value":"392"}],[{"value":"February 2015"},{"value":"393"}],[{"value":"March 2015"},{"value":"394"}],[{"value":"February 2015"},{"value":"395"}],[{"value":"November 2014"},{"value":"396"}],[{"value":"September 2015"},{"value":"397"}],[{"value":"February 2015"},{"value":"398"}],[{"value":"December 2014"},{"value":"399"}],[{"value":"January 2015"},{"value":"400"}],[{"value":"June 2015"},{"value":"401"}],[{"value":"September 2015"},{"value":"402"}],[{"value":"July 2014"},{"value":"403"}],[{"value":"September 2014"},{"value":"404"}],[{"value":"February 2015"},{"value":"405"}],[{"value":"February 2015"},{"value":"406"}],[{"value":"January 2015"},{"value":"407"}],[{"value":"May 2015"},{"value":"408"}],[{"value":"April 2014"},{"value":"409"}],[{"value":"March 2015"},{"value":"410"}],[{"value":"February 2015"},{"value":"411"}],[{"value":"March 2015"},{"value":"412"}],[{"value":"May 2015"},{"value":"413"}],[{"value":"May 2015"},{"value":"414"}],[{"value":"February 2015"},{"value":"415"}],[{"value":"January 2015"},{"value":"416"}],[{"value":"June 2015"},{"value":"417"}],[{"value":"May 2015"},{"value":"418"}],[{"value":"January 2015"},{"value":"419"}],[{"value":"June 2015"},{"value":"420"}],[{"value":"May 2016"},{"value":"421"}],[{"value":"April 2015"},{"value":"422"}],[{"value":"March 2015"},{"value":"423"}],[{"value":"May 2015"},{"value":"424"}],[{"value":"June 2014"},{"value":"425"}],[{"value":"July 2008"},{"value":"426"}],[{"value":"March 2015"},{"value":"427"}],[{"value":"March 2015"},{"value":"428"}],[{"value":"August 2013"},{"value":"429"}],[{"value":"October 2014"},{"value":"430"}],[{"value":"June 2014"},{"value":"431"}],[{"value":"December 2014"},{"value":"432"}],[{"value":"December 2014"},{"value":"433"}],[{"value":"May 2015"},{"value":"434"}],[{"value":"February 2015"},{"value":"435"}],[{"value":"January 2015"},{"value":"436"}],[{"value":"January 2011"},{"value":"437"}],[{"value":"September 2015"},{"value":"438"}],[{"value":"June 2016"},{"value":"439"}],[{"value":"January 2015"},{"value":"440"}],[{"value":"November 2014"},{"value":"441"}],[{"value":"December 2014"},{"value":"442"}],[{"value":"August 2015"},{"value":"443"}],[{"value":"March 2013"},{"value":"444"}],[{"value":"November 2014"},{"value":"445"}],[{"value":"November 2014"},{"value":"446"}],[{"value":"March 2015"},{"value":"447"}],[{"value":"November 2014"},{"value":"448"}],[{"value":"December 2014"},{"value":"449"}],[{"value":"June 2014"},{"value":"450"}],[{"value":"December 2014"},{"value":"451"}],[{"value":"December 2014"},{"value":"452"}],[{"value":"February 2015"},{"value":"453"}],[{"value":"May 2015"},{"value":"454"}],[{"value":"December 2014"},{"value":"455"}],[{"value":"August 2012"},{"value":"456"}],[{"value":"December 2014"},{"value":"457"}],[{"value":"December 2015"},{"value":"458"}],[{"value":"June 2015"},{"value":"459"}],[{"value":"January 2014"},{"value":"460"}],[{"value":"December 2014"},{"value":"461"}],[{"value":"May 2013"},{"value":"462"}],[{"value":"August 2014"},{"value":"463"}],[{"value":"October 2014"},{"value":"464"}],[{"value":"March 2014"},{"value":"465"}],[{"value":"October 2014"},{"value":"466"}],[{"value":"December 2013"},{"value":"467"}],[{"value":"November 2014"},{"value":"468"}],[{"value":"December 2014"},{"value":"469"}],[{"value":"October 2014"},{"value":"470"}],[{"value":"October 2014"},{"value":"471"}],[{"value":"October 2014"},{"value":"472"}],[{"value":"October 2014"},{"value":"473"}],[{"value":"May 2014"},{"value":"474"}],[{"value":"October 2014"},{"value":"475"}],[{"value":"October 2014"},{"value":"476"}],[{"value":"September 2014"},{"value":"477"}],[{"value":"January 2015"},{"value":"478"}],[{"value":"September 2014"},{"value":"479"}],[{"value":"October 2014"},{"value":"480"}],[{"value":"June 2008"},{"value":"481"}],[{"value":"September 2014"},{"value":"482"}],[{"value":"September 2014"},{"value":"483"}],[{"value":"October 2015"},{"value":"484"}],[{"value":"September 2014"},{"value":"485"}],[{"value":"April 2015"},{"value":"486"}],[{"value":"July 2015"},{"value":"487"}],[{"value":"September 2014"},{"value":"488"}],[{"value":"January 2015"},{"value":"489"}],[{"value":"January 2017"},{"value":"490"}],[{"value":"January 2014"},{"value":"491"}],[{"value":"October 2014"},{"value":"492"}],[{"value":"October 2014"},{"value":"493"}],[{"value":"November 2014"},{"value":"494"}],[{"value":"September 2014"},{"value":"495"}],[{"value":"August 2015"},{"value":"496"}],[{"value":"September 2014"},{"value":"497"}],[{"value":"November 2014"},{"value":"498"}],[{"value":"January 2015"},{"value":"499"}],[{"value":"October 2014"},{"value":"500"}],[{"value":"November 2014"},{"value":"501"}],[{"value":"November 2014"},{"value":"502"}],[{"value":"November 2014"},{"value":"503"}],[{"value":"April 2015"},{"value":"504"}],[{"value":"February 2015"},{"value":"505"}],[{"value":"December 2014"},{"value":"506"}],[{"value":"November 2014"},{"value":"507"}],[{"value":"August 2014"},{"value":"508"}],[{"value":"August 2014"},{"value":"509"}],[{"value":"August 2014"},{"value":"510"}],[{"value":"September 2014"},{"value":"511"}],[{"value":"September 2014"},{"value":"512"}],[{"value":"November 2014"},{"value":"513"}],[{"value":"October 2014"},{"value":"514"}],[{"value":"October 2014"},{"value":"515"}],[{"value":"October 2014"},{"value":"516"}],[{"value":"August 2014"},{"value":"517"}],[{"value":"July 2014"},{"value":"518"}],[{"value":"February 2015"},{"value":"519"}],[{"value":"February 2015"},{"value":"520"}],[{"value":"September 2014"},{"value":"521"}],[{"value":"September 2014"},{"value":"522"}],[{"value":"February 2013"},{"value":"523"}],[{"value":"October 2010"},{"value":"524"}],[{"value":"August 2014"},{"value":"525"}],[{"value":"September 2014"},{"value":"526"}],[{"value":"January 2015"},{"value":"527"}],[{"value":"April 2014"},{"value":"528"}],[{"value":"July 2014"},{"value":"529"}],[{"value":"November 2014"},{"value":"530"}],[{"value":"October 2014"},{"value":"531"}],[{"value":"January 2012"},{"value":"532"}],[{"value":"July 2014"},{"value":"533"}],[{"value":"October 2014"},{"value":"534"}],[{"value":"October 2014"},{"value":"535"}],[{"value":"February 2015"},{"value":"536"}],[{"value":"April 2014"},{"value":"537"}],[{"value":"September 2012"},{"value":"538"}],[{"value":"October 2009"},{"value":"539"}],[{"value":"August 2014"},{"value":"540"}],[{"value":"July 2014"},{"value":"541"}],[{"value":"December 2015"},{"value":"542"}],[{"value":"August 2014"},{"value":"543"}],[{"value":"June 2014"},{"value":"544"}],[{"value":"June 2014"},{"value":"545"}],[{"value":"April 2013"},{"value":"546"}],[{"value":"June 2014"},{"value":"547"}],[{"value":"October 2013"},{"value":"548"}],[{"value":"April 2009"},{"value":"549"}],[{"value":"July 2014"},{"value":"550"}],[{"value":"September 2013"},{"value":"551"}],[{"value":"November 2014"},{"value":"552"}],[{"value":"January 2015"},{"value":"553"}],[{"value":"July 2009"},{"value":"554"}],[{"value":"October 2014"},{"value":"555"}],[{"value":"June 2014"},{"value":"556"}],[{"value":"December 2014"},{"value":"557"}],[{"value":"June 2014"},{"value":"558"}],[{"value":"December 2014"},{"value":"559"}],[{"value":"December 2014"},{"value":"560"}],[{"value":"September 2014"},{"value":"561"}],[{"value":"March 2014"},{"value":"562"}],[{"value":"July 2014"},{"value":"563"}],[{"value":"August 2014"},{"value":"564"}],[{"value":"December 2014"},{"value":"565"}],[{"value":"June 2014"},{"value":"566"}],[{"value":"June 2014"},{"value":"567"}],[{"value":"December 2013"},{"value":"568"}],[{"value":"September 2014"},{"value":"569"}],[{"value":"September 2014"},{"value":"570"}],[{"value":"April 2013"},{"value":"571"}],[{"value":"May 2010"},{"value":"572"}],[{"value":"November 2017"},{"value":"573"}],[{"value":"May 2006"},{"value":"574"}],[{"value":"May 2014"},{"value":"575"}],[{"value":"July 2014"},{"value":"576"}],[{"value":"May 2011"},{"value":"577"}],[{"value":"February 2015"},{"value":"578"}],[{"value":"November 2011"},{"value":"579"}],[{"value":"May 2016"},{"value":"580"}],[{"value":"November 2013"},{"value":"581"}],[{"value":"November 2011"},{"value":"582"}],[{"value":"October 2013"},{"value":"583"}],[{"value":"June 2017"},{"value":"584"}],[{"value":"December 2014"},{"value":"585"}],[{"value":"January 2016"},{"value":"586"}],[{"value":"May 2014"},{"value":"587"}],[{"value":"May 2011"},{"value":"588"}],[{"value":"May 2014"},{"value":"589"}],[{"value":"January 2014"},{"value":"590"}],[{"value":"May 2014"},{"value":"591"}],[{"value":"October 2014"},{"value":"592"}],[{"value":"November 2014"},{"value":"593"}],[{"value":"June 2014"},{"value":"594"}],[{"value":"April 2014"},{"value":"595"}],[{"value":"June 2014"},{"value":"596"}],[{"value":"April 2016"},{"value":"597"}],[{"value":"April 2014"},{"value":"598"}],[{"value":"June 2014"},{"value":"599"}],[{"value":"November 2015"},{"value":"600"}],[{"value":"February 2012"},{"value":"601"}],[{"value":"April 2014"},{"value":"602"}],[{"value":"April 2014"},{"value":"603"}],[{"value":"September 2014"},{"value":"604"}],[{"value":"May 2014"},{"value":"605"}],[{"value":"May 2014"},{"value":"607"}],[{"value":"April 2014"},{"value":"608"}],[{"value":"March 2014"},{"value":"609"}],[{"value":"August 2014"},{"value":"610"}],[{"value":"March 2014"},{"value":"611"}],[{"value":"May 2014"},{"value":"612"}],[{"value":"December 2016"},{"value":"613"}],[{"value":"November 2011"},{"value":"614"}],[{"value":"December 2013"},{"value":"615"}],[{"value":"March 2014"},{"value":"616"}],[{"value":"July 2014"},{"value":"617"}],[{"value":"April 2014"},{"value":"618"}],[{"value":"April 2014"},{"value":"619"}],[{"value":"October 2014"},{"value":"620"}],[{"value":"November 2013"},{"value":"621"}],[{"value":"July 2014"},{"value":"622"}],[{"value":"November 2012"},{"value":"623"}],[{"value":"June 2014"},{"value":"624"}],[{"value":"August 2015"},{"value":"625"}],[{"value":"April 2014"},{"value":"626"}],[{"value":"March 2014"},{"value":"627"}],[{"value":"September 2014"},{"value":"628"}],[{"value":"June 2014"},{"value":"629"}],[{"value":"March 2014"},{"value":"630"}],[{"value":"May 2014"},{"value":"631"}],[{"value":"March 2014"},{"value":"632"}],[{"value":"May 2014"},{"value":"633"}],[{"value":"April 2014"},{"value":"634"}],[{"value":"June 2013"},{"value":"635"}],[{"value":"January 2015"},{"value":"637"}],[{"value":"March 2014"},{"value":"638"}],[{"value":"March 2014"},{"value":"639"}],[{"value":"March 2014"},{"value":"640"}],[{"value":"July 2015"},{"value":"641"}],[{"value":"February 2014"},{"value":"642"}],[{"value":"November 2013"},{"value":"643"}],[{"value":"June 2014"},{"value":"644"}],[{"value":"February 2014"},{"value":"645"}],[{"value":"May 2014"},{"value":"646"}],[{"value":"August 2014"},{"value":"647"}],[{"value":"February 2014"},{"value":"648"}],[{"value":"February 2014"},{"value":"649"}],[{"value":"February 2014"},{"value":"650"}],[{"value":"February 2014"},{"value":"651"}],[{"value":"April 2014"},{"value":"652"}],[{"value":"February 2014"},{"value":"653"}],[{"value":"April 2014"},{"value":"654"}],[{"value":"January 2015"},{"value":"655"}],[{"value":"January 2015"},{"value":"656"}],[{"value":"January 2006"},{"value":"657"}],[{"value":"March 2014"},{"value":"658"}],[{"value":"February 2014"},{"value":"659"}],[{"value":"January 2014"},{"value":"661"}],[{"value":"March 2014"},{"value":"662"}],[{"value":"August 2015"},{"value":"663"}],[{"value":"November 2014"},{"value":"664"}],[{"value":"February 2014"},{"value":"665"}],[{"value":"January 2014"},{"value":"666"}],[{"value":"November 2013"},{"value":"667"}],[{"value":"June 2013"},{"value":"668"}],[{"value":"December 2013"},{"value":"669"}],[{"value":"February 2014"},{"value":"670"}],[{"value":"January 2014"},{"value":"671"}],[{"value":"July 2012"},{"value":"672"}],[{"value":"May 2014"},{"value":"673"}],[{"value":"January 2013"},{"value":"674"}],[{"value":"January 2014"},{"value":"675"}],[{"value":"January 2014"},{"value":"676"}],[{"value":"August 2013"},{"value":"677"}],[{"value":"April 2015"},{"value":"678"}],[{"value":"July 2014"},{"value":"679"}],[{"value":"December 2013"},{"value":"680"}],[{"value":"March 2011"},{"value":"681"}],[{"value":"February 2014"},{"value":"682"}],[{"value":"March 2014"},{"value":"683"}],[{"value":"January 2014"},{"value":"684"}],[{"value":"February 2014"},{"value":"685"}],[{"value":"February 2013"},{"value":"686"}],[{"value":"March 2014"},{"value":"687"}],[{"value":"February 2014"},{"value":"688"}],[{"value":"March 2014"},{"value":"689"}],[{"value":"December 2013"},{"value":"690"}],[{"value":"March 2014"},{"value":"691"}],[{"value":"January 2014"},{"value":"692"}],[{"value":"January 2015"},{"value":"693"}],[{"value":"January 2014"},{"value":"694"}],[{"value":"April 2012"},{"value":"695"}],[{"value":"January 2012"},{"value":"696"}],[{"value":"December 2013"},{"value":"697"}],[{"value":"March 2014"},{"value":"698"}],[{"value":"December 2013"},{"value":"699"}],[{"value":"September 2012"},{"value":"700"}],[{"value":"November 2011"},{"value":"701"}],[{"value":"January 2014"},{"value":"702"}],[{"value":"December 2013"},{"value":"703"}],[{"value":"May 2014"},{"value":"704"}],[{"value":"June 2012"},{"value":"706"}],[{"value":"September 2013"},{"value":"707"}],[{"value":"October 2014"},{"value":"708"}],[{"value":"June 2014"},{"value":"709"}],[{"value":"December 2013"},{"value":"710"}],[{"value":"November 2011"},{"value":"711"}],[{"value":"August 2006"},{"value":"712"}],[{"value":"March 2014"},{"value":"713"}],[{"value":"December 2013"},{"value":"714"}],[{"value":"December 2012"},{"value":"715"}],[{"value":"November 2013"},{"value":"716"}],[{"value":"January 2016"},{"value":"717"}],[{"value":"November 2012"},{"value":"718"}],[{"value":"July 2014"},{"value":"719"}],[{"value":"December 2013"},{"value":"720"}],[{"value":"February 2014"},{"value":"721"}],[{"value":"February 2014"},{"value":"722"}],[{"value":"November 2011"},{"value":"723"}],[{"value":"January 2014"},{"value":"724"}],[{"value":"December 2013"},{"value":"725"}],[{"value":"January 2014"},{"value":"726"}],[{"value":"December 2013"},{"value":"727"}],[{"value":"November 2013"},{"value":"728"}],[{"value":"September 2013"},{"value":"729"}],[{"value":"April 2013"},{"value":"730"}],[{"value":"April 2007"},{"value":"731"}],[{"value":"November 2013"},{"value":"732"}],[{"value":"November 2013"},{"value":"733"}],[{"value":"June 2014"},{"value":"734"}],[{"value":"May 2013"},{"value":"735"}],[{"value":"April 2014"},{"value":"736"}],[{"value":"November 2013"},{"value":"737"}],[{"value":"August 2013"},{"value":"738"}],[{"value":"March 2014"},{"value":"739"}],[{"value":"November 2013"},{"value":"740"}],[{"value":"September 2013"},{"value":"741"}],[{"value":"August 2013"},{"value":"742"}],[{"value":"December 2013"},{"value":"743"}],[{"value":"March 2014"},{"value":"744"}],[{"value":"September 2014"},{"value":"745"}],[{"value":"May 2014"},{"value":"746"}],[{"value":"February 2014"},{"value":"747"}],[{"value":"September 2011"},{"value":"748"}],[{"value":"July 2011"},{"value":"749"}],[{"value":"October 2013"},{"value":"750"}],[{"value":"June 2007"},{"value":"751"}],[{"value":"December 2015"},{"value":"752"}],[{"value":"October 2013"},{"value":"753"}],[{"value":"September 2011"},{"value":"754"}],[{"value":"November 2013"},{"value":"755"}],[{"value":"November 2013"},{"value":"756"}],[{"value":"December 2014"},{"value":"757"}],[{"value":"November 2013"},{"value":"758"}],[{"value":"June 2013"},{"value":"759"}],[{"value":"October 2013"},{"value":"760"}],[{"value":"December 2010"},{"value":"761"}],[{"value":"October 2013"},{"value":"762"}],[{"value":"November 2014"},{"value":"763"}],[{"value":"November 2013"},{"value":"764"}],[{"value":"October 2013"},{"value":"765"}],[{"value":"December 2005"},{"value":"766"}],[{"value":"January 2014"},{"value":"767"}],[{"value":"August 2012"},{"value":"768"}],[{"value":"October 2013"},{"value":"769"}],[{"value":"August 2013"},{"value":"770"}],[{"value":"October 2013"},{"value":"771"}],[{"value":"May 2014"},{"value":"772"}],[{"value":"February 2014"},{"value":"773"}],[{"value":"October 2013"},{"value":"774"}],[{"value":"November 2008"},{"value":"775"}],[{"value":"September 2013"},{"value":"776"}],[{"value":"February 2014"},{"value":"777"}],[{"value":"April 2013"},{"value":"778"}],[{"value":"October 2013"},{"value":"779"}],[{"value":"July 2013"},{"value":"780"}],[{"value":"December 2009"},{"value":"781"}],[{"value":"October 2013"},{"value":"782"}],[{"value":"January 2013"},{"value":"783"}],[{"value":"November 2013"},{"value":"784"}],[{"value":"September 2013"},{"value":"786"}],[{"value":"June 2007"},{"value":"787"}],[{"value":"September 2005"},{"value":"788"}],[{"value":"December 2011"},{"value":"789"}],[{"value":"December 2013"},{"value":"790"}],[{"value":"July 2008"},{"value":"791"}],[{"value":"December 2013"},{"value":"792"}],[{"value":"October 2013"},{"value":"793"}],[{"value":"February 2014"},{"value":"794"}],[{"value":"March 2014"},{"value":"795"}],[{"value":"September 2014"},{"value":"796"}],[{"value":"September 2013"},{"value":"797"}],[{"value":"September 2013"},{"value":"798"}],[{"value":"January 2010"},{"value":"799"}],[{"value":"November 2013"},{"value":"800"}],[{"value":"September 2013"},{"value":"801"}],[{"value":"September 2014"},{"value":"802"}],[{"value":"August 2013"},{"value":"803"}],[{"value":"October 2013"},{"value":"804"}],[{"value":"September 2013"},{"value":"805"}],[{"value":"August 2013"},{"value":"806"}],[{"value":"October 2013"},{"value":"807"}],[{"value":"September 2013"},{"value":"808"}],[{"value":"October 2013"},{"value":"809"}],[{"value":"January 2013"},{"value":"810"}],[{"value":"July 2013"},{"value":"811"}],[{"value":"September 2013"},{"value":"812"}],[{"value":"July 2013"},{"value":"813"}],[{"value":"September 2014"},{"value":"814"}],[{"value":"April 2011"},{"value":"815"}],[{"value":"September 2013"},{"value":"816"}],[{"value":"June 2010"},{"value":"817"}],[{"value":"June 2013"},{"value":"818"}],[{"value":"January 2008"},{"value":"819"}],[{"value":"August 2013"},{"value":"820"}],[{"value":"June 2013"},{"value":"821"}],[{"value":"September 2013"},{"value":"822"}],[{"value":"October 2013"},{"value":"823"}],[{"value":"August 2013"},{"value":"824"}],[{"value":"July 2013"},{"value":"825"}],[{"value":"May 2011"},{"value":"826"}],[{"value":"January 2012"},{"value":"827"}],[{"value":"October 2012"},{"value":"828"}],[{"value":"March 2013"},{"value":"829"}],[{"value":"October 2013"},{"value":"830"}],[{"value":"April 2001"},{"value":"831"}],[{"value":"September 2012"},{"value":"832"}],[{"value":"August 2013"},{"value":"833"}],[{"value":"July 2013"},{"value":"834"}],[{"value":"August 2013"},{"value":"835"}],[{"value":"December 2013"},{"value":"836"}],[{"value":"August 2013"},{"value":"837"}],[{"value":"June 2015"},{"value":"838"}],[{"value":"September 2013"},{"value":"839"}],[{"value":"August 2013"},{"value":"840"}],[{"value":"September 2013"},{"value":"841"}],[{"value":"August 2013"},{"value":"842"}],[{"value":"August 2013"},{"value":"843"}],[{"value":"July 2013"},{"value":"844"}],[{"value":"August 2013"},{"value":"845"}],[{"value":"July 2013"},{"value":"846"}],[{"value":"April 2004"},{"value":"847"}],[{"value":"April 2003"},{"value":"848"}],[{"value":"May 2001"},{"value":"849"}],[{"value":"November 2013"},{"value":"850"}],[{"value":"August 2002"},{"value":"851"}],[{"value":"May 2001"},{"value":"852"}],[{"value":"July 2001"},{"value":"853"}],[{"value":"June 2013"},{"value":"854"}],[{"value":"November 2011"},{"value":"855"}],[{"value":"June 2013"},{"value":"856"}],[{"value":"January 2015"},{"value":"857"}],[{"value":"November 2012"},{"value":"858"}],[{"value":"January 2008"},{"value":"859"}],[{"value":"August 2010"},{"value":"861"}],[{"value":"May 2014"},{"value":"862"}],[{"value":"August 2013"},{"value":"863"}],[{"value":"July 2013"},{"value":"864"}],[{"value":"November 2013"},{"value":"865"}],[{"value":"June 2013"},{"value":"866"}],[{"value":"June 2013"},{"value":"867"}],[{"value":"January 2013"},{"value":"868"}],[{"value":"July 2013"},{"value":"869"}],[{"value":"May 2012"},{"value":"870"}],[{"value":"June 2012"},{"value":"871"}],[{"value":"November 2009"},{"value":"873"}],[{"value":"April 2013"},{"value":"874"}],[{"value":"May 2014"},{"value":"875"}],[{"value":"March 2013"},{"value":"876"}],[{"value":"April 2013"},{"value":"877"}],[{"value":"July 2013"},{"value":"878"}],[{"value":"April 2013"},{"value":"879"}],[{"value":"May 2012"},{"value":"880"}],[{"value":"July 2010"},{"value":"881"}],[{"value":"July 2013"},{"value":"882"}],[{"value":"April 2013"},{"value":"883"}],[{"value":"January 2014"},{"value":"884"}],[{"value":"May 2013"},{"value":"885"}],[{"value":"December 2012"},{"value":"886"}],[{"value":"July 2013"},{"value":"887"}],[{"value":"May 2013"},{"value":"888"}],[{"value":"April 2013"},{"value":"889"}],[{"value":"April 2013"},{"value":"890"}],[{"value":"August 2012"},{"value":"891"}],[{"value":"January 2015"},{"value":"892"}],[{"value":"April 2013"},{"value":"893"}],[{"value":"September 2013"},{"value":"894"}],[{"value":"February 2014"},{"value":"895"}],[{"value":"March 2013"},{"value":"896"}],[{"value":"April 2013"},{"value":"897"}],[{"value":"April 2013"},{"value":"898"}],[{"value":"May 2014"},{"value":"899"}],[{"value":"July 2011"},{"value":"900"}],[{"value":"February 2013"},{"value":"901"}],[{"value":"June 2013"},{"value":"902"}],[{"value":"January 2014"},{"value":"903"}],[{"value":"July 2013"},{"value":"904"}],[{"value":"February 2013"},{"value":"905"}],[{"value":"April 2013"},{"value":"906"}],[{"value":"June 2014"},{"value":"907"}],[{"value":"May 2013"},{"value":"908"}],[{"value":"October 2010"},{"value":"909"}],[{"value":"May 2013"},{"value":"910"}],[{"value":"February 2013"},{"value":"911"}],[{"value":"March 2013"},{"value":"912"}],[{"value":"March 2013"},{"value":"913"}],[{"value":"March 2013"},{"value":"914"}],[{"value":"March 2013"},{"value":"915"}],[{"value":"March 2013"},{"value":"916"}],[{"value":"June 2014"},{"value":"917"}],[{"value":"January 2013"},{"value":"918"}],[{"value":"January 2013"},{"value":"919"}],[{"value":"April 2013"},{"value":"920"}],[{"value":"December 2012"},{"value":"921"}],[{"value":"June 2013"},{"value":"922"}],[{"value":"February 2013"},{"value":"923"}],[{"value":"July 2011"},{"value":"924"}],[{"value":"March 2013"},{"value":"925"}],[{"value":"July 2013"},{"value":"926"}],[{"value":"April 2013"},{"value":"927"}],[{"value":"March 2013"},{"value":"928"}],[{"value":"October 2012"},{"value":"929"}],[{"value":"December 2012"},{"value":"930"}],[{"value":"March 2013"},{"value":"931"}],[{"value":"February 2013"},{"value":"932"}],[{"value":"August 2012"},{"value":"933"}],[{"value":"September 2012"},{"value":"934"}],[{"value":"June 2013"},{"value":"935"}],[{"value":"March 2013"},{"value":"936"}],[{"value":"July 2012"},{"value":"937"}],[{"value":"February 2012"},{"value":"938"}],[{"value":"March 2013"},{"value":"939"}],[{"value":"September 2013"},{"value":"940"}],[{"value":"April 2013"},{"value":"941"}],[{"value":"January 2012"},{"value":"942"}],[{"value":"March 2013"},{"value":"943"}],[{"value":"September 2012"},{"value":"944"}],[{"value":"January 2012"},{"value":"945"}],[{"value":"March 2012"},{"value":"946"}],[{"value":"March 2013"},{"value":"947"}],[{"value":"September 2014"},{"value":"948"}],[{"value":"October 2012"},{"value":"949"}],[{"value":"August 2013"},{"value":"950"}],[{"value":"January 2013"},{"value":"951"}],[{"value":"September 2012"},{"value":"952"}],[{"value":"August 2013"},{"value":"953"}],[{"value":"January 2008"},{"value":"954"}],[{"value":"November 2012"},{"value":"955"}],[{"value":"October 2012"},{"value":"956"}],[{"value":"October 2012"},{"value":"957"}],[{"value":"October 2012"},{"value":"958"}],[{"value":"October 2012"},{"value":"959"}],[{"value":"February 2013"},{"value":"960"}],[{"value":"August 2012"},{"value":"961"}],[{"value":"March 2013"},{"value":"962"}],[{"value":"February 2013"},{"value":"963"}],[{"value":"January 2013"},{"value":"964"}],[{"value":"February 2013"},{"value":"965"}],[{"value":"October 2012"},{"value":"966"}],[{"value":"January 2013"},{"value":"967"}],[{"value":"September 2012"},{"value":"968"}],[{"value":"June 2012"},{"value":"969"}],[{"value":"February 2013"},{"value":"970"}],[{"value":"February 2013"},{"value":"971"}],[{"value":"September 2012"},{"value":"972"}],[{"value":"October 2012"},{"value":"973"}],[{"value":"June 2012"},{"value":"974"}],[{"value":"February 2013"},{"value":"975"}],[{"value":"February 2013"},{"value":"976"}],[{"value":"October 2013"},{"value":"977"}],[{"value":"November 2011"},{"value":"978"}],[{"value":"January 2013"},{"value":"979"}],[{"value":"February 2013"},{"value":"980"}],[{"value":"June 2012"},{"value":"981"}],[{"value":"October 2010"},{"value":"982"}],[{"value":"October 2010"},{"value":"983"}],[{"value":"March 2012"},{"value":"984"}],[{"value":"December 2013"},{"value":"985"}],[{"value":"October 2012"},{"value":"986"}],[{"value":"February 2014"},{"value":"987"}],[{"value":"April 2012"},{"value":"988"}],[{"value":"April 2012"},{"value":"989"}],[{"value":"January 2013"},{"value":"990"}],[{"value":"August 2013"},{"value":"991"}],[{"value":"January 2013"},{"value":"992"}],[{"value":"January 2013"},{"value":"993"}],[{"value":"July 2014"},{"value":"994"}],[{"value":"January 2013"},{"value":"995"}],[{"value":"November 2012"},{"value":"996"}],[{"value":"May 2013"},{"value":"997"}],[{"value":"January 2013"},{"value":"999"}],[{"value":"December 2012"},{"value":"1000"}],[{"value":"August 2013"},{"value":"1001"}],[{"value":"September 2009"},{"value":"1002"}],[{"value":"March 2013"},{"value":"1003"}],[{"value":"September 2011"},{"value":"1004"}],[{"value":"December 2012"},{"value":"1005"}],[{"value":"October 2012"},{"value":"1006"}],[{"value":"February 2013"},{"value":"1007"}],[{"value":"January 2013"},{"value":"1008"}],[{"value":"November 2012"},{"value":"1009"}]],"columnNames":[{"name":"start_date","index":0,"aggr":"sum"},{"name":"rank","index":1,"aggr":"sum"}],"rows":[["November 2015","1"],["November 2016","2"],["November 2016","3"],["November 2016","4"],["November 2016","5"],["November 2016","6"],["January 2017","7"],["May 2017","8"],["May 2016","9"],["November 2016","10"],["February 2017","11"],["September 2016","12"],["November 2016","13"],["November 2016","14"],["November 2016","15"],["November 2016","16"],["September 2016","17"],["October 2016","18"],["December 2015","19"],["December 2016","20"],["November 2016","21"],["October 2016","22"],["November 2016","23"],["January 2017","24"],["August 2016","25"],["November 2016","26"],["October 2016","27"],["October 2016","28"],["September 2016","29"],["November 2016","30"],["October 2016","31"],["November 2016","32"],["March 2016","33"],["November 2016","34"],["August 2016","35"],["September 2016","36"],["December 2016","37"],["October 2016","38"],["November 2016","39"],["September 2016","40"],["November 2016","41"],["May 2016","42"],["September 2016","43"],["October 2016","44"],["February 2015","45"],["September 2016","46"],["November 2016","47"],["August 2016","48"],["July 2016","49"],["August 2016","50"],["October 2016","51"],["August 2016","52"],["October 2016","53"],["September 2016","54"],["May 2014","55"],["August 2016","56"],["October 2016","57"],["August 2016","58"],["December 2014","59"],["December 2016","60"],["March 2017","61"],["August 2016","62"],["December 2016","63"],["August 2016","64"],["May 2016","65"],["October 2016","66"],["August 2016","67"],["August 2016","68"],["July 2015","69"],["December 2016","70"],["September 2014","71"],["July 2015","72"],["November 2016","73"],["July 2016","74"],["August 2016","75"],["July 2016","76"],["July 2016","77"],["April 2016","78"],["April 2016","79"],["February 2016","80"],["August 2016","81"],["August 2016","82"],["August 2016","83"],["October 2016","84"],["August 2016","85"],["July 2016","86"],["July 2016","87"],["September 2016","88"],["September 2016","89"],["June 2012","90"],["August 2016","91"],["August 2016","92"],["September 2016","93"],["August 2016","94"],["July 2016","95"],["January 2016","96"],["July 2016","97"],["June 2016","98"],["August 2016","99"],["June 2016","100"],["June 2016","101"],["June 2016","102"],["July 2016","103"],["July 2016","104"],["September 2016","105"],["May 2016","106"],["June 2016","107"],["April 2016","108"],["April 2016","109"],["September 2016","110"],["June 2016","111"],["June 2016","112"],["September 2016","113"],["August 2016","114"],["November 2016","116"],["April 2017","117"],["August 2016","118"],["November 2016","119"],["February 2016","120"],["May 2016","121"],["May 2016","122"],["June 2016","123"],["April 2016","124"],["May 2016","125"],["November 2016","126"],["April 2016","127"],["April 2016","128"],["October 2016","129"],["November 2015","130"],["January 2016","131"],["January 2016","132"],["May 2016","133"],["February 2016","134"],["June 2016","135"],["September 2016","136"],["January 2016","137"],["May 2016","138"],["May 2016","139"],["April 2016","140"],["October 2016","141"],["April 2016","142"],["March 2016","143"],["April 2016","144"],["March 2016","145"],["May 2016","146"],["September 2014","147"],["March 2016","148"],["March 2016","149"],["April 2016","150"],["May 2016","151"],["July 2015","152"],["February 2016","153"],["June 2016","154"],["May 2016","155"],["August 2016","156"],["August 2016","157"],["March 2016","158"],["March 2016","159"],["October 2016","160"],["September 2014","161"],["March 2016","162"],["May 2016","163"],["May 2016","164"],["August 2011","165"],["April 2016","166"],["April 2016","167"],["March 2016","168"],["June 2017","169"],["March 2016","170"],["March 2016","171"],["October 2016","172"],["March 2016","173"],["September 2007","174"],["May 2016","175"],["May 2016","176"],["March 2016","177"],["February 2016","178"],["April 2016","179"],["May 2016","180"],["April 2016","181"],["March 2016","182"],["February 2016","183"],["October 2012","184"],["August 2016","185"],["February 2016","186"],["December 2015","187"],["September 2016","188"],["October 2015","189"],["October 2015","190"],["March 2016","191"],["May 2014","192"],["December 2015","193"],["January 2016","194"],["February 2016","195"],["March 2016","196"],["January 2016","197"],["January 2016","198"],["May 2016","199"],["July 2016","200"],["October 2015","201"],["April 2016","202"],["January 2016","203"],["January 2016","204"],["June 2015","205"],["December 2015","206"],["December 2015","207"],["April 2016","208"],["January 2016","209"],["November 2015","210"],["May 2015","211"],["August 2015","212"],["April 2016","213"],["October 2015","214"],["March 2016","215"],["February 2016","216"],["July 2015","217"],["February 2016","218"],["October 2015","219"],["December 2015","220"],["October 2015","221"],["May 2016","222"],["February 2016","223"],["February 2016","224"],["January 2016","225"],["January 2016","226"],["November 2015","227"],["February 2016","228"],["August 2015","229"],["July 2014","230"],["November 2015","231"],["November 2015","232"],["October 2015","233"],["November 2015","234"],["January 2002","235"],["November 2015","236"],["February 2016","237"],["May 2016","238"],["March 2017","239"],["February 2016","240"],["February 2014","241"],["February 2016","242"],["October 2015","243"],["March 2016","244"],["June 2015","245"],["March 2016","246"],["May 2016","247"],["July 2016","248"],["October 2015","249"],["April 2016","250"],["October 2015","251"],["September 2015","252"],["March 2016","253"],["June 2013","254"],["September 2015","255"],["July 2014","256"],["October 2015","257"],["June 2016","258"],["October 2015","259"],["December 2015","260"],["May 2015","261"],["November 2013","262"],["October 2015","263"],["July 2015","264"],["October 2015","265"],["October 2015","266"],["March 2016","267"],["September 2015","268"],["January 2011","269"],["April 2016","270"],["July 2015","271"],["September 2015","272"],["January 2016","273"],["April 2016","274"],["February 2016","275"],["September 2015","276"],["October 2015","277"],["June 2015","278"],["September 2015","279"],["July 2015","280"],["May 2015","281"],["April 2016","282"],["September 2015","283"],["May 2015","284"],["January 2016","285"],["September 2015","286"],["March 2016","287"],["July 2015","288"],["May 2016","289"],["July 2015","290"],["January 2017","291"],["December 2015","292"],["October 2015","293"],["December 2015","294"],["November 2015","295"],["January 2016","296"],["July 2015","297"],["December 2015","298"],["July 2015","299"],["October 2015","300"],["April 2015","301"],["August 2015","302"],["July 2015","303"],["July 2016","304"],["May 2016","305"],["July 2015","306"],["September 2015","307"],["July 2015","308"],["July 2015","309"],["January 2016","310"],["June 2015","311"],["September 2015","312"],["October 2015","313"],["February 2015","314"],["June 2015","315"],["May 2015","316"],["June 2015","317"],["October 2015","318"],["October 2015","319"],["July 2016","320"],["February 2016","321"],["September 2015","322"],["July 2015","323"],["July 2015","324"],["July 2015","325"],["May 2015","326"],["January 2016","327"],["April 2015","328"],["December 2015","329"],["July 2015","330"],["December 2015","331"],["May 2015","332"],["December 2013","333"],["June 2015","334"],["October 2015","335"],["May 2015","336"],["January 2004","337"],["June 2015","338"],["March 2013","339"],["May 2015","340"],["July 2015","341"],["February 2016","342"],["July 2015","343"],["January 2016","344"],["January 2016","345"],["October 2014","346"],["June 2016","347"],["May 2014","348"],["May 2015","349"],["January 2016","350"],["May 2015","351"],["April 2015","352"],["September 2015","353"],["May 2015","354"],["September 2015","355"],["October 2015","356"],["January 2016","357"],["May 2015","358"],["August 2015","359"],["June 2015","360"],["May 2015","361"],["July 2015","362"],["April 2015","363"],["May 2015","364"],["May 2015","365"],["October 2015","366"],["June 2015","367"],["September 2015","368"],["June 2012","369"],["March 2015","370"],["September 2014","371"],["March 2015","372"],["October 2014","373"],["August 2015","374"],["March 2015","375"],["December 2015","376"],["March 2015","377"],["May 2015","378"],["December 2014","379"],["August 2015","380"],["March 2015","381"],["June 2016","382"],["May 2013","383"],["April 2015","384"],["January 2015","385"],["February 2015","386"],["January 2015","387"],["March 2015","388"],["March 2015","389"],["February 2015","390"],["January 2015","391"],["February 2015","392"],["February 2015","393"],["March 2015","394"],["February 2015","395"],["November 2014","396"],["September 2015","397"],["February 2015","398"],["December 2014","399"],["January 2015","400"],["June 2015","401"],["September 2015","402"],["July 2014","403"],["September 2014","404"],["February 2015","405"],["February 2015","406"],["January 2015","407"],["May 2015","408"],["April 2014","409"],["March 2015","410"],["February 2015","411"],["March 2015","412"],["May 2015","413"],["May 2015","414"],["February 2015","415"],["January 2015","416"],["June 2015","417"],["May 2015","418"],["January 2015","419"],["June 2015","420"],["May 2016","421"],["April 2015","422"],["March 2015","423"],["May 2015","424"],["June 2014","425"],["July 2008","426"],["March 2015","427"],["March 2015","428"],["August 2013","429"],["October 2014","430"],["June 2014","431"],["December 2014","432"],["December 2014","433"],["May 2015","434"],["February 2015","435"],["January 2015","436"],["January 2011","437"],["September 2015","438"],["June 2016","439"],["January 2015","440"],["November 2014","441"],["December 2014","442"],["August 2015","443"],["March 2013","444"],["November 2014","445"],["November 2014","446"],["March 2015","447"],["November 2014","448"],["December 2014","449"],["June 2014","450"],["December 2014","451"],["December 2014","452"],["February 2015","453"],["May 2015","454"],["December 2014","455"],["August 2012","456"],["December 2014","457"],["December 2015","458"],["June 2015","459"],["January 2014","460"],["December 2014","461"],["May 2013","462"],["August 2014","463"],["October 2014","464"],["March 2014","465"],["October 2014","466"],["December 2013","467"],["November 2014","468"],["December 2014","469"],["October 2014","470"],["October 2014","471"],["October 2014","472"],["October 2014","473"],["May 2014","474"],["October 2014","475"],["October 2014","476"],["September 2014","477"],["January 2015","478"],["September 2014","479"],["October 2014","480"],["June 2008","481"],["September 2014","482"],["September 2014","483"],["October 2015","484"],["September 2014","485"],["April 2015","486"],["July 2015","487"],["September 2014","488"],["January 2015","489"],["January 2017","490"],["January 2014","491"],["October 2014","492"],["October 2014","493"],["November 2014","494"],["September 2014","495"],["August 2015","496"],["September 2014","497"],["November 2014","498"],["January 2015","499"],["October 2014","500"],["November 2014","501"],["November 2014","502"],["November 2014","503"],["April 2015","504"],["February 2015","505"],["December 2014","506"],["November 2014","507"],["August 2014","508"],["August 2014","509"],["August 2014","510"],["September 2014","511"],["September 2014","512"],["November 2014","513"],["October 2014","514"],["October 2014","515"],["October 2014","516"],["August 2014","517"],["July 2014","518"],["February 2015","519"],["February 2015","520"],["September 2014","521"],["September 2014","522"],["February 2013","523"],["October 2010","524"],["August 2014","525"],["September 2014","526"],["January 2015","527"],["April 2014","528"],["July 2014","529"],["November 2014","530"],["October 2014","531"],["January 2012","532"],["July 2014","533"],["October 2014","534"],["October 2014","535"],["February 2015","536"],["April 2014","537"],["September 2012","538"],["October 2009","539"],["August 2014","540"],["July 2014","541"],["December 2015","542"],["August 2014","543"],["June 2014","544"],["June 2014","545"],["April 2013","546"],["June 2014","547"],["October 2013","548"],["April 2009","549"],["July 2014","550"],["September 2013","551"],["November 2014","552"],["January 2015","553"],["July 2009","554"],["October 2014","555"],["June 2014","556"],["December 2014","557"],["June 2014","558"],["December 2014","559"],["December 2014","560"],["September 2014","561"],["March 2014","562"],["July 2014","563"],["August 2014","564"],["December 2014","565"],["June 2014","566"],["June 2014","567"],["December 2013","568"],["September 2014","569"],["September 2014","570"],["April 2013","571"],["May 2010","572"],["November 2017","573"],["May 2006","574"],["May 2014","575"],["July 2014","576"],["May 2011","577"],["February 2015","578"],["November 2011","579"],["May 2016","580"],["November 2013","581"],["November 2011","582"],["October 2013","583"],["June 2017","584"],["December 2014","585"],["January 2016","586"],["May 2014","587"],["May 2011","588"],["May 2014","589"],["January 2014","590"],["May 2014","591"],["October 2014","592"],["November 2014","593"],["June 2014","594"],["April 2014","595"],["June 2014","596"],["April 2016","597"],["April 2014","598"],["June 2014","599"],["November 2015","600"],["February 2012","601"],["April 2014","602"],["April 2014","603"],["September 2014","604"],["May 2014","605"],["May 2014","607"],["April 2014","608"],["March 2014","609"],["August 2014","610"],["March 2014","611"],["May 2014","612"],["December 2016","613"],["November 2011","614"],["December 2013","615"],["March 2014","616"],["July 2014","617"],["April 2014","618"],["April 2014","619"],["October 2014","620"],["November 2013","621"],["July 2014","622"],["November 2012","623"],["June 2014","624"],["August 2015","625"],["April 2014","626"],["March 2014","627"],["September 2014","628"],["June 2014","629"],["March 2014","630"],["May 2014","631"],["March 2014","632"],["May 2014","633"],["April 2014","634"],["June 2013","635"],["January 2015","637"],["March 2014","638"],["March 2014","639"],["March 2014","640"],["July 2015","641"],["February 2014","642"],["November 2013","643"],["June 2014","644"],["February 2014","645"],["May 2014","646"],["August 2014","647"],["February 2014","648"],["February 2014","649"],["February 2014","650"],["February 2014","651"],["April 2014","652"],["February 2014","653"],["April 2014","654"],["January 2015","655"],["January 2015","656"],["January 2006","657"],["March 2014","658"],["February 2014","659"],["January 2014","661"],["March 2014","662"],["August 2015","663"],["November 2014","664"],["February 2014","665"],["January 2014","666"],["November 2013","667"],["June 2013","668"],["December 2013","669"],["February 2014","670"],["January 2014","671"],["July 2012","672"],["May 2014","673"],["January 2013","674"],["January 2014","675"],["January 2014","676"],["August 2013","677"],["April 2015","678"],["July 2014","679"],["December 2013","680"],["March 2011","681"],["February 2014","682"],["March 2014","683"],["January 2014","684"],["February 2014","685"],["February 2013","686"],["March 2014","687"],["February 2014","688"],["March 2014","689"],["December 2013","690"],["March 2014","691"],["January 2014","692"],["January 2015","693"],["January 2014","694"],["April 2012","695"],["January 2012","696"],["December 2013","697"],["March 2014","698"],["December 2013","699"],["September 2012","700"],["November 2011","701"],["January 2014","702"],["December 2013","703"],["May 2014","704"],["June 2012","706"],["September 2013","707"],["October 2014","708"],["June 2014","709"],["December 2013","710"],["November 2011","711"],["August 2006","712"],["March 2014","713"],["December 2013","714"],["December 2012","715"],["November 2013","716"],["January 2016","717"],["November 2012","718"],["July 2014","719"],["December 2013","720"],["February 2014","721"],["February 2014","722"],["November 2011","723"],["January 2014","724"],["December 2013","725"],["January 2014","726"],["December 2013","727"],["November 2013","728"],["September 2013","729"],["April 2013","730"],["April 2007","731"],["November 2013","732"],["November 2013","733"],["June 2014","734"],["May 2013","735"],["April 2014","736"],["November 2013","737"],["August 2013","738"],["March 2014","739"],["November 2013","740"],["September 2013","741"],["August 2013","742"],["December 2013","743"],["March 2014","744"],["September 2014","745"],["May 2014","746"],["February 2014","747"],["September 2011","748"],["July 2011","749"],["October 2013","750"],["June 2007","751"],["December 2015","752"],["October 2013","753"],["September 2011","754"],["November 2013","755"],["November 2013","756"],["December 2014","757"],["November 2013","758"],["June 2013","759"],["October 2013","760"],["December 2010","761"],["October 2013","762"],["November 2014","763"],["November 2013","764"],["October 2013","765"],["December 2005","766"],["January 2014","767"],["August 2012","768"],["October 2013","769"],["August 2013","770"],["October 2013","771"],["May 2014","772"],["February 2014","773"],["October 2013","774"],["November 2008","775"],["September 2013","776"],["February 2014","777"],["April 2013","778"],["October 2013","779"],["July 2013","780"],["December 2009","781"],["October 2013","782"],["January 2013","783"],["November 2013","784"],["September 2013","786"],["June 2007","787"],["September 2005","788"],["December 2011","789"],["December 2013","790"],["July 2008","791"],["December 2013","792"],["October 2013","793"],["February 2014","794"],["March 2014","795"],["September 2014","796"],["September 2013","797"],["September 2013","798"],["January 2010","799"],["November 2013","800"],["September 2013","801"],["September 2014","802"],["August 2013","803"],["October 2013","804"],["September 2013","805"],["August 2013","806"],["October 2013","807"],["September 2013","808"],["October 2013","809"],["January 2013","810"],["July 2013","811"],["September 2013","812"],["July 2013","813"],["September 2014","814"],["April 2011","815"],["September 2013","816"],["June 2010","817"],["June 2013","818"],["January 2008","819"],["August 2013","820"],["June 2013","821"],["September 2013","822"],["October 2013","823"],["August 2013","824"],["July 2013","825"],["May 2011","826"],["January 2012","827"],["October 2012","828"],["March 2013","829"],["October 2013","830"],["April 2001","831"],["September 2012","832"],["August 2013","833"],["July 2013","834"],["August 2013","835"],["December 2013","836"],["August 2013","837"],["June 2015","838"],["September 2013","839"],["August 2013","840"],["September 2013","841"],["August 2013","842"],["August 2013","843"],["July 2013","844"],["August 2013","845"],["July 2013","846"],["April 2004","847"],["April 2003","848"],["May 2001","849"],["November 2013","850"],["August 2002","851"],["May 2001","852"],["July 2001","853"],["June 2013","854"],["November 2011","855"],["June 2013","856"],["January 2015","857"],["November 2012","858"],["January 2008","859"],["August 2010","861"],["May 2014","862"],["August 2013","863"],["July 2013","864"],["November 2013","865"],["June 2013","866"],["June 2013","867"],["January 2013","868"],["July 2013","869"],["May 2012","870"],["June 2012","871"],["November 2009","873"],["April 2013","874"],["May 2014","875"],["March 2013","876"],["April 2013","877"],["July 2013","878"],["April 2013","879"],["May 2012","880"],["July 2010","881"],["July 2013","882"],["April 2013","883"],["January 2014","884"],["May 2013","885"],["December 2012","886"],["July 2013","887"],["May 2013","888"],["April 2013","889"],["April 2013","890"],["August 2012","891"],["January 2015","892"],["April 2013","893"],["September 2013","894"],["February 2014","895"],["March 2013","896"],["April 2013","897"],["April 2013","898"],["May 2014","899"],["July 2011","900"],["February 2013","901"],["June 2013","902"],["January 2014","903"],["July 2013","904"],["February 2013","905"],["April 2013","906"],["June 2014","907"],["May 2013","908"],["October 2010","909"],["May 2013","910"],["February 2013","911"],["March 2013","912"],["March 2013","913"],["March 2013","914"],["March 2013","915"],["March 2013","916"],["June 2014","917"],["January 2013","918"],["January 2013","919"],["April 2013","920"],["December 2012","921"],["June 2013","922"],["February 2013","923"],["July 2011","924"],["March 2013","925"],["July 2013","926"],["April 2013","927"],["March 2013","928"],["October 2012","929"],["December 2012","930"],["March 2013","931"],["February 2013","932"],["August 2012","933"],["September 2012","934"],["June 2013","935"],["March 2013","936"],["July 2012","937"],["February 2012","938"],["March 2013","939"],["September 2013","940"],["April 2013","941"],["January 2012","942"],["March 2013","943"],["September 2012","944"],["January 2012","945"],["March 2012","946"],["March 2013","947"],["September 2014","948"],["October 2012","949"],["August 2013","950"],["January 2013","951"],["September 2012","952"],["August 2013","953"],["January 2008","954"],["November 2012","955"],["October 2012","956"],["October 2012","957"],["October 2012","958"],["October 2012","959"],["February 2013","960"],["August 2012","961"],["March 2013","962"],["February 2013","963"],["January 2013","964"],["February 2013","965"],["October 2012","966"],["January 2013","967"],["September 2012","968"],["June 2012","969"],["February 2013","970"],["February 2013","971"],["September 2012","972"],["October 2012","973"],["June 2012","974"],["February 2013","975"],["February 2013","976"],["October 2013","977"],["November 2011","978"],["January 2013","979"],["February 2013","980"],["June 2012","981"],["October 2010","982"],["October 2010","983"],["March 2012","984"],["December 2013","985"],["October 2012","986"],["February 2014","987"],["April 2012","988"],["April 2012","989"],["January 2013","990"],["August 2013","991"],["January 2013","992"],["January 2013","993"],["July 2014","994"],["January 2013","995"],["November 2012","996"],["May 2013","997"],["January 2013","999"],["December 2012","1000"],["August 2013","1001"],["September 2009","1002"],["March 2013","1003"],["September 2011","1004"],["December 2012","1005"],["October 2012","1006"],["February 2013","1007"],["January 2013","1008"],["November 2012","1009"]]},"dateCreated":"2016-12-06T17:31:08+0000","status":"READY","errorMessage":"","progressUpdateIntervalMs":500,"$$hashKey":"object:2227"},{"title":"Extract Tokens","text":"%pyspark\n\nimport re\nfrom pyspark.sql.functions import udf\nfrom pyspark.sql.types import *\n\ndef parse_text(text):\n    ##############################################################################################\n    #\n    #   Stopwords\n    #   This is a list of common/low-value words that you'd like excluded from the word counts\n    #   You can customize this list and there are many packages out there that has a pre-defined\n    #   list that you can start with (in addition to the short one I have listed below)\n    #\n    ##############################################################################################\n    stopwords_core = ['a', u'about', u'above', u'after', u'again', u'against', u'ain', u'all', u'am', u'an', u'and', u'any', u'are', u'aren', u'as', u'at', u'be', u'because',\n        u'been', u'before', u'being', u'below', u'between', u'both', u'but', u'by', u'can', 'come', u'could', u'd', u'did', u'didn', u'do', u'does', u'doesn', u'doing', u'don',\n        u'down', u'during', u'each', u'few', u'for', u'from', u'further', u'had', u'hadn', u'has', u'hasn', u'have', u'haven', u'having', u'he', u'her', u'here', u'hers', \n        u'herself', u'him', u'himself', u'his', u'how', u'i', u'if', u'in', u'into', u'is', u'isn', u'it', u'its', u'itself', u'just', u'll', u'm', u'ma', u'me', u'mightn',\n        u'more', u'most', u'mustn', u'my', u'myself', u'needn', u'no', u'nor', u'not', u'now', u'o', u'of', u'off', u'on', u'once', u'only', u'or', u'other', u'our', u'ours',\n        u'ourselves', u'out', u'over', u'own', u're', u's', u'same', u'shan', u'she', u'should', u'shouldn', u'so', u'some', u'such', u't', u'than', u'that', u'the', u'their',\n        u'theirs', u'them',u'themselves', u'then', u'there', u'these', u'they', u'this', u'those', u'through', u'to', u'too', u'under', u'until', u'up', u've', u'very', u'was',\n        u'wasnt', u'we', 'without', u'were',u'weren', u'what', u'when', u'where', u'which', u'while', u'who', u'whom', u'why', u'will', u'with', u'would', u'y', u'you', u'your',\n        u'yours', u'yourself',u'yourselves']\n    stopwords_custom = ['study','subjects','patients','patient','treating','phase']\n    stopwords = stopwords_core + stopwords_custom\n    stopwords = [word.lower() for word in stopwords]\n    tokens = re.sub('[^a-zA-Z\\- ]','',text.lower().replace(\"'s\",\"\")).split(\" \")\n    return [token for token in tokens if token not in stopwords]\n\ndata_tokens =  rawdata.filter(lambda x: x not in header)    \\\n                .map(lambda x: x.split('|'))                \\\n                .map(lambda x: parse_text(x[2]))            \\\n                .flatMap(lambda x: x)                       \\\n                .filter(lambda x: len(x) > 3)               \\\n                .map(lambda x: (x.lower(), 1))              \\\n                .reduceByKey(lambda x,y: x+y)               \\\n                .map(lambda x: (x[1],x[0]))                 \\\n                .sortByKey(ascending=False)\n\nfor token in data_tokens.take(100):\n    print token","dateUpdated":"2016-12-06T17:36:06+0000","config":{"colWidth":6,"editorMode":"ace/mode/scala","editorHide":true,"title":true,"graph":{"mode":"table","height":300,"optionOpen":false,"keys":[],"values":[],"groups":[],"scatter":{}},"enabled":true},"settings":{"params":{},"forms":{}},"jobName":"paragraph_1481045468671_-394128975","id":"20161204-195231_1446217384","result":{"code":"SUCCESS","type":"TEXT","msg":"(805, u'cancer')\n(464, u'safety')\n(421, u'therapy')\n(419, u'treatment')\n(350, u'efficacy')\n(270, u'stage')\n(236, u'disease')\n(235, u'cell')\n(235, u'trial')\n(229, u'chemotherapy')\n(219, u'breast')\n(194, u'combination')\n(189, u'surgery')\n(181, u'metastatic')\n(178, u'acute')\n(168, u'radiation')\n(162, u'lung')\n(156, u'advanced')\n(152, u'chronic')\n(151, u'pain')\n(137, u'versus')\n(135, u'evaluation')\n(135, u'evaluate')\n(135, u'effect')\n(128, u'women')\n(127, u'recurrent')\n(123, u'diabetes')\n(121, u'adults')\n(118, u'effects')\n(118, u'leukemia')\n(117, u'children')\n(112, u'prostate')\n(110, u'clinical')\n(104, u'risk')\n(101, u'intervention')\n(101, u'syndrome')\n(98, u'type')\n(96, u'diagnosed')\n(95, u'tumors')\n(93, u'newly')\n(93, u'blood')\n(92, u'pilot')\n(90, u'care')\n(85, u'using')\n(84, u'brain')\n(83, u'vaccine')\n(82, u'outcomes')\n(82, u'dose')\n(81, u'prevention')\n(81, u'randomized')\n(79, u'non-small')\n(79, u'health')\n(77, u'healthy')\n(76, u'bevacizumab')\n(76, u'tolerability')\n(75, u'lymphoma')\n(75, u'cardiovascular')\n(73, u'undergoing')\n(73, u'severe')\n(73, u'refractory')\n(72, u'primary')\n(71, u'plus')\n(71, u'response')\n(70, u'heart')\n(69, u'disorder')\n(68, u'receiving')\n(68, u'older')\n(67, u'oral')\n(67, u'comparison')\n(66, u'system')\n(65, u'function')\n(63, u'early')\n(63, u'exercise')\n(62, u'solid')\n(61, u'management')\n(60, u'paclitaxel')\n(60, u'moderate')\n(60, u'registry')\n(58, u'kidney')\n(58, u'program')\n(58, u'pharmacokinetics')\n(57, u'multiple')\n(57, u'assess')\n(57, u'hydrochloride')\n(56, u'evaluating')\n(56, u'knee')\n(55, u'carboplatin')\n(55, u'pulmonary')\n(55, u'tumor')\n(55, u'weight')\n(55, u'malignant')\n(53, u'relapsed')\n(53, u'high')\n(53, u'effectiveness')\n(52, u'training')\n(52, u'compared')\n(52, u'treat')\n(51, u'following')\n(51, u'glioma')\n(51, u'placebo')\n"},"dateCreated":"2016-12-06T17:31:08+0000","status":"READY","errorMessage":"","progressUpdateIntervalMs":500,"$$hashKey":"object:2228"},{"title":"Extract N-Grams (Common Phrases)","text":"%pyspark\n\ndef find_ngrams(list, n):\n   return zip(*[list[i:] for i in range(n)])\n\nngrams =  rawdata.filter(lambda x: x not in header)     \\\n              .map(lambda x: x.split('|')[2])           \\\n              .map(lambda x: x.split(' '))              \\\n              .flatMap(lambda x: find_ngrams(x, 5))     \\\n              .map(lambda x: (x,1))                     \\\n              .reduceByKey(lambda x,y: x+y)             \\\n              .map(lambda x: [x[1],x[0]])               \\\n              .sortByKey(ascending=False)\n\nfor i in ngrams.take(50):\n    print i","dateUpdated":"2016-12-06T17:31:08+0000","config":{"colWidth":6,"editorMode":"ace/mode/scala","editorHide":true,"title":true,"graph":{"mode":"table","height":300,"optionOpen":false,"keys":[],"values":[],"groups":[],"scatter":{}},"enabled":true},"settings":{"params":{},"forms":{}},"jobName":"paragraph_1481045468672_-703851840","id":"20161204-210357_1520442405","result":{"code":"SUCCESS","type":"TEXT","msg":"(81, (u'Therapy', u'in', u'Treating', u'Patients', u'With'))\n(65, (u'in', u'Treating', u'Patients', u'With', u'Stage'))\n(43, (u'in', u'Treating', u'Patients', u'With', u'Recurrent'))\n(38, (u'in', u'Treating', u'Patients', u'With', u'Metastatic'))\n(37, (u'Radiation', u'Therapy', u'in', u'Treating', u'Patients'))\n(34, (u'the', u'Safety', u'and', u'Efficacy', u'of'))\n(34, (u'the', u'Efficacy', u'and', u'Safety', u'of'))\n(32, (u'Treating', u'Patients', u'With', u'Newly', u'Diagnosed'))\n(32, (u'in', u'Treating', u'Patients', u'With', u'Newly'))\n(29, (u'in', u'Treating', u'Patients', u'With', u'Advanced'))\n(24, (u'Patients', u'With', u'Type', u'2', u'Diabetes'))\n(24, (u'Chemotherapy', u'in', u'Treating', u'Patients', u'With'))\n(22, (u'Safety', u'and', u'Efficacy', u'Study', u'of'))\n(22, (u'Stage', u'III', u'or', u'Stage', u'IV'))\n(21, (u'in', u'Treating', u'Patients', u'With', u'Relapsed'))\n(21, (u'Study', u'to', u'Evaluate', u'the', u'Safety'))\n(21, (u'in', u'Patients', u'With', u'Type', u'2'))\n(20, (u'Surgery', u'in', u'Treating', u'Patients', u'With'))\n(20, (u'Patients', u'With', u'Relapsed', u'or', u'Refractory'))\n(20, (u'Radiation', u'Therapy', u'With', u'or', u'Without'))\n(19, (u'Efficacy', u'and', u'Safety', u'Study', u'of'))\n(19, (u'A', u'Study', u'to', u'Evaluate', u'the'))\n(18, (u'and', u'Radiation', u'Therapy', u'in', u'Treating'))\n(18, (u'in', u'Treating', u'Young', u'Patients', u'With'))\n(17, (u'With', u'Type', u'2', u'Diabetes', u'Mellitus'))\n(17, (u'Bevacizumab', u'in', u'Treating', u'Patients', u'With'))\n(17, (u'Treating', u'Patients', u'With', u'Relapsed', u'or'))\n(17, (u'in', u'Treating', u'Patients', u'With', u'Locally'))\n(16, (u'With', u'or', u'Without', u'Bevacizumab', u'in'))\n(16, (u'Subjects', u'With', u'Type', u'2', u'Diabetes'))\n(16, (u'or', u'Without', u'Bevacizumab', u'in', u'Treating'))\n(16, (u'to', u'Evaluate', u'the', u'Safety', u'and'))\n(16, (u'Treating', u'Patients', u'With', u'Recurrent', u'or'))\n(15, (u'Efficacy', u'Safety', u'and', u'Tolerability', u'of'))\n(15, (u'Stage', u'II', u'or', u'Stage', u'III'))\n(15, (u'Treating', u'Patients', u'With', u'Locally', u'Advanced'))\n(15, (u'Combination', u'Chemotherapy', u'in', u'Treating', u'Patients'))\n(15, (u'Chronic', u'Obstructive', u'Pulmonary', u'Disease', u'(COPD)'))\n(14, (u'Study', u'of', u'the', u'Safety', u'and'))\n(14, (u'in', u'Subjects', u'With', u'Type', u'2'))\n(14, (u'Treating', u'Patients', u'With', u'Stage', u'III'))\n(14, (u'Patients', u'With', u'Advanced', u'Solid', u'Tumors'))\n(14, (u'Patients', u'With', u'Newly', u'Diagnosed', u'Acute'))\n(14, (u'Without', u'Bevacizumab', u'in', u'Treating', u'Patients'))\n(13, (u'Evaluate', u'the', u'Safety', u'and', u'Efficacy'))\n(13, (u'of', u'the', u'Safety', u'and', u'Efficacy'))\n(13, (u'Combination', u'Chemotherapy', u'With', u'or', u'Without'))\n(13, (u'Vaccine', u'Therapy', u'in', u'Treating', u'Patients'))\n(13, (u'in', u'Subjects', u'With', u'Moderate', u'to'))\n(13, (u'in', u'Patients', u'With', u'Newly', u'Diagnosed'))\n"},"dateCreated":"2016-12-06T17:31:08+0000","status":"READY","errorMessage":"","progressUpdateIntervalMs":500,"$$hashKey":"object:2229"},{"title":"Categorize the Study (based on Title)","text":"%pyspark\n\nimport re\nfrom pyspark.sql.functions import udf\nfrom pyspark.sql.types import *\n\ndef categorize_text(text):\n    text = text.lower()\n    if re.search(\"(cancer|chemotherapy|lymphoma|leukemia)\",text):\n        category = \"cancer\"\n    elif re.search(\"(diabete|insulin)\",text):\n        category = \"diabetes\"\n    elif re.search(\"(arthritis)\",text):\n        category = \"arthritis\"\n    elif re.search(\"(asthma)\",text):\n        category = \"asthma\"\n    elif re.search(\"(influenza|flu )\",text):\n        category = \"influenza\"\n    elif re.search(\"(epilepsy)\",text):\n        category = \"epilepsy\"\n    elif re.search(\"(alcohol)\",text):\n        category = \"alcohol\"\n    elif re.search(\"(heart disease|cardiovascular|heart attack|heartattack|stint |cholesterol)\",text):\n        category = \"heart disease\"\n    elif re.search(\"(hepatitis)\",text):\n        category = \"hepatitis\"\n    elif re.search(\"(kidney)\",text):\n        category = \"kidney disease\"\n    elif re.search(\"(tuberculosis)\",text):\n        category = \"tuberculosis\"\n    elif re.search(\"(respiratory)\",text):\n        category = \"respiratory disease\"\n    elif re.search(\"(tumor)\",text):\n        category = \"tumors\"\n    elif re.search(\"(hiv )\",text):\n        category = \"hiv\"\n    elif re.search(\"( burn )\",text):\n        category = \"burns\"\n    elif re.search(\"(dermatitis)\",text):\n        category = \"dermatitis\"\n    elif re.search(\"(fasciitis)\",text):\n        category = \"fasciitis\"\n    elif re.search(\"(elderly)\",text):\n        category = \"elderly\"\n    elif re.search(\"(surgery)\",text):\n        category = \"surgery\"\n    elif re.search(\"(probiotics)\",text):\n        category = \"probiotics\"\n    elif re.search(\"(biometric)\",text):\n        category = \"biometric\"\n    elif re.search(\"(smoker|smoking)\",text):\n        category = \"smoker study\"\n    elif re.search(\"(neuro|brain)\",text):\n        category = \"neurological\"\n    elif re.search(\"(nerve)\",text):\n        category = \"nerve study\"\n    elif re.search(\"(sleep)\",text):\n        category = \"sleep study\"\n    else:\n        category = \"Unclassified\"\n    \n    return category\n\nf = udf(categorize_text, StringType() )\n\ndf_tokens = df.withColumn('category', f(df.study)).registerTempTable(\"table_df_tokens\")\n","dateUpdated":"2016-12-06T17:31:08+0000","config":{"colWidth":12,"editorMode":"ace/mode/scala","editorHide":true,"title":true,"graph":{"mode":"table","height":300,"optionOpen":false,"keys":[],"values":[],"groups":[],"scatter":{}},"enabled":true},"settings":{"params":{},"forms":{}},"jobName":"paragraph_1481045468672_-703851840","id":"20161204-195044_1559095484","result":{"code":"SUCCESS","type":"TEXT","msg":""},"dateCreated":"2016-12-06T17:31:08+0000","status":"READY","errorMessage":"","progressUpdateIntervalMs":500,"$$hashKey":"object:2230"},{"title":"View / Explore Study Categories","text":"%sql\n\nselect rank,study,phase,category,number_enrolled from table_df_tokens where category != \"Unclassified\" and category != \"cancer\"","dateUpdated":"2016-12-06T17:31:08+0000","config":{"colWidth":12,"editorMode":"ace/mode/sql","editorHide":true,"title":true,"graph":{"mode":"multiBarChart","height":300,"optionOpen":false,"keys":[{"name":"category","index":3,"aggr":"sum"}],"values":[{"name":"rank","index":0,"aggr":"count"}],"groups":[],"scatter":{"xAxis":{"name":"rank","index":0,"aggr":"sum"},"yAxis":{"name":"study","index":1,"aggr":"sum"}}},"enabled":true},"settings":{"params":{},"forms":{}},"jobName":"paragraph_1481045468672_-703851840","id":"20161204-195628_1312482384","result":{"code":"SUCCESS","type":"TABLE","msg":"rank\tstudy\tphase\tcategory\tnumber_enrolled\n2\tStudy of the Efficacy Safety &amp; Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury\tPhase 2\tburns\t150\n3\tStudy of the Efficacy Safety and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis\tPhase 2\tdermatitis\t450\n4\tDaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis\tPhase 2\tfasciitis\t60\n10\tA Study Promoting Critical Illness Recovery in the Elderly-- Pilot\t\telderly\t20\n17\tProbiotics in Occupational Shift Workers\t\tprobiotics\t60\n18\tProtein Supplementation Post Bariatric Surgery\t\tsurgery\t60\n23\tOptimal Volume Rate and Interval of Bolus Nerve Catheters for Shoulder Surgery\tPhase 4\tsurgery\t99\n25\tMagnetic Resonance Imaging of Human Biometrics\t\tbiometric\t30\n30\tNeuroimaging Reward Behavioral Treatment and Smoking Cessation\tPhase 1 / Phase 2\tsmoker study\t100\n34\tFeasibility and Smokers&apos; Reactions to DNA Feedback\t\tsmoker study\t100\n37\tTMS Modulation of Insula-related Brain Networks.02\t\tneurological\t60\n42\tA Pilot Study of Nocturnal Hypoglycemia Prevention in Type 1 Diabetes Using the Vigilant Diabetes Management Companion\t\tdiabetes\t24\n43\tCombination Nicotine Patch / Lorcaserin for Smoking Cessation\tPhase 2\tsmoker study\t300\n45\tAn Observational Study of Post-cesarean Delivery Respiratory Patterns Using a Non-invasive Minute Ventilation Monitor (Exspiron &#8482; System)\t\trespiratory disease\t100\n48\tSleep Dysfunction and Neurocognitive Outcomes in Adolescent ADHD\t\tneurological\t60\n53\tEffects of Exercise Training Intensity on Fitness and Insulin Sensitivity in African Americans\t\tdiabetes\t60\n57\tSIMT Stereotactic Radiosurgery Outcomes Study\t\tsurgery\t40\n71\tCOMRADE: Collaborative Care Management for Distress and Depression in Rural Diabetes\t\tdiabetes\t139\n83\tEffects of E-cigarettes (ECIGs) on Pulmonary Inflammation and Behavior in HIV Infected Smokers\t\thiv\t20\n86\tStudy on Smoking Cessation and Cost Outcomes in the Duke Smoking Cessation Program\t\tsmoker study\t3000\n93\tMobile Technology and Online Tools to Improve Asthma Control in Adolescents\tPhase 2\tasthma\t70\n106\tMobile Technology and Online Tools to Improve Asthma Control in Adolescents - Usability\tPhase 2\tasthma\t25\n109\tIntranasal Insulin and Post-stroke Cognition: A Pilot Study\t\tdiabetes\t40\n112\tRespiratory Muscle Training in LOPD\t\trespiratory disease\t28\n125\tBedside Ultrasound to Measure Optic Nerve Sheath Diameter in Pediatric CSF Shunts\t\tnerve study\t87\n138\tQualitative Qualitative and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors\t\ttumors\t50\n142\tAnalgesic Benefit of PECS Blocks for Biceps Tenodesis Shoulder Surgery\tPhase 4\tsurgery\t40\n144\tThe Effect of Reducing Posttraumatic Stress Disorder Symptoms on Cardiovascular Risk\t\theart disease\t120\n145\tAntagonism of Opioid-Induced Respiratory Depression by CX1739 With Preservation of Opioid Analgesia\tPhase 2\trespiratory disease\t18\n149\tEfficacy and Tolerability of New Topical Formulations in Subjects With Atopic Dermatitis\tPhase 4\tdermatitis\t53\n178\tDietary Acid Load Kidney Function and Disability in Elderly\t\tkidney disease\t80\n182\tTMS Modulation of Insula-related Brain Networks\t\tneurological\t12\n184\tThe Use of Tranexamic Acid to Reduce Blood Loss in Acetabular Surgery\tPhase 3\tsurgery\t65\n186\tContrast-enhanced Ultrasound of the Kidney\tPhase 2\tkidney disease\t75\n190\tProspective Evaluation of Patient Reported Xerostomia After Whole Brain Radiation\t\tneurological\t60\n193\tSafety Study of CN-105 Neuroprotective Peptide for Intracerebral Hemorrhage\tPhase 1\tneurological\t48\n200\tSTepped Exercise Program for Knee OsteoArthritis\t\tarthritis\t345\n207\tEfficacy of Neuro+ Attention Training\t\tneurological\t60\n210\tThe Compartmental Biology of HIV in the Male Genital Tract\t\thiv\t24\n212\tExercise Intolerance in Elderly Patients With HFpEF(Heart Failure With Preserved Ejection Fraction)\t\telderly\t84\n213\tStage Ib Trial of mSMART for Smoking Cessation Medication Adherence\t\tsmoker study\t60\n214\tThe KNEEhabilitation Study: Improving Disability in Individuals With Knee Osteoarthritis\tPhase 1 / Phase 2\tarthritis\t90\n230\tAngiotensin Receptors and Age Related Mitochondrial Decline in HIV Patients\tPhase 2\thiv\t40\n231\tVibratory Stimuli A Novel Rehabilitation Method for Preventing Post - Traumatic Knee Osteoarthritis\t\tarthritis\t75\n244\tMuscadine Grape Skin Extract in Treating Patients With Malignancy That Is Metastatic or Cannot Be Removed by Surgery\tPhase 1\tsurgery\t30\n252\tReducing HIV Risk Among Adolescents: Evaluating Project HEART\t\thiv\t222\n254\tEvaluation of Cardiorespiratory Performance After Interval Exercise Training Prior to Hematopoietic Cell Transplantation\t\trespiratory disease\t40\n258\tNeuromodulation Enhanced Cognitive Restructuring: A Proof of Concept Study\t\tneurological\t65\n261\tLazanda Fentanyl Nasal Spray Pre Radiofrequency Nerve Ablations(RFA) of Lumbar Facet Joints\tPhase 4\tnerve study\t23\n265\tPlatelets as Regulators of Inflammation in Cardiac Surgery\t\tsurgery\t100\n270\tPain Coping Skills Training for African Americans With Osteoarthritis\t\tarthritis\t248\n273\tEffects of Smoking Environments on Craving and Smoking (CameraCue2.0)\t\tsmoker study\t120\n274\tIncretin Action in Physiology and Diabetes\tPhase 1\tdiabetes\t25\n279\tStrengthening Instrumental Extinction to Prevent Smoking Relapse (VLNCCue)\t\tsmoker study\t300\n285\tNivolumab With DC Vaccines for Recurrent Brain Tumors\tPhase 1\ttumors\t66\n286\tHigh Intensity Interval Training and Rheumatoid Arthritis\t\tarthritis\t26\n295\tMobile Contingency Management for Smoking Cessation in Returning US Veterans\t\tsmoker study\t260\n301\tVestibular Function After Cochlear Implantation Using Soft Surgery Techniques\t\tsurgery\t30\n305\tTelephone-based Smoking Cessation\t\tsmoker study\t350\n306\tUsing Question Prompt Lists During Pediatric Asthma Visits to Increase Adolescent Involvement\t\tasthma\t360\n307\tTemporary Autonomic Blockade to Prevent Atrial Fibrillation After Cardiac Surgery\tPhase 1 / Phase 2\tsurgery\t130\n308\tThe Use of Aging Biomarkers to Predict Adverse Outcomes After Cardiac Surgery\t\tsurgery\t186\n310\tElectronic Nicotine Delivery Systems as a Smoking Cessation Treatment\tPhase 2\tsmoker study\t300\n311\tRejuvenated Washed Packed Red Blood Cells in Pediatric Cardiac Surgery\tPhase 4\tsurgery\t15\n316\tFeasibility of an Interval Exercise and Nutrition Intervention to Reduce Cardiovascular Disease Risk Factors\t\theart disease\t15\n327\tPathways to Improving Functional Capacity in Older Patients With Chronic Kidney Disease and Cardiovascular Disease\t\theart disease\t0\n328\tPredictors of Opioid-Induced Respiratory Depression (OIRD)\tPhase 1\trespiratory disease\t20\n331\tPersonalized Health Planning in Shared Medical Appointments for Individuals With Type II Diabetes Pilot Study\t\tdiabetes\t20\n338\tSystemic Steroids for Peripheral Nerve Blocks\tPhase 4\tnerve study\t115\n340\tStudy of Nasal Insulin to Fight Forgetfulness - Short-Acting Insulin Aspart\tPhase 1\tdiabetes\t30\n341\tPerineural Steroids for Peripheral Nerve Blocks\tPhase 4\tnerve study\t115\n361\tVIDA Mobile Health Cardiovascular Prevention Program\t\theart disease\t40\n363\tAcid-Base Compensation in Chronic Kidney Disease\tPhase 1\tkidney disease\t16\n372\tIntegrated Population Program for Diabetic Kidney Disease\t\tkidney disease\t131\n373\tEffects of Smoking Environment on Craving and Smoking\t\tsmoker study\t41\n374\tPackHealth: Asthma Engagement Tool\t\tasthma\t50\n375\tClinical Study to Evaluate Patient Outcomes Following Pharmacogenetic Testing of Subjects Exhibiting Neuropsychiatric Disorders\t\tneurological\t220\n379\tDetermine the Prevalence and Severity of Asthma in HIV (Human Immunodeficiency Virus) Infected Patients\t\tasthma\t93\n386\tObstructive Sleep Apnea in Pregnancy\t\tsleep study\t150\n390\tDoes Physical Therapy Prevent Total Knee Arthroplasty in Patients With End Stage Osteoarthritis\t\tarthritis\t260\n394\tWebsite Application Based Education and Text Messaging in Improving Skin Wound Care in Patients Undergoing Mohs Surgery\t\tsurgery\t90\n397\tTransplant Social Worker Support for Live Kidney Donation in African Americans\t\tkidney disease\t570\n398\tNutrition Education for Cardiovascular Disease Prevention in Spinal Cord Injury\t\theart disease\t200\n406\tPerampanel in Seizure Patients With Primary Glial Brain Tumors\tPhase 4\ttumors\t71\n431\tFLT PET/MR for Evaluation of Pseudoprogression in Patients With Brain Lesions\t\tneurological\t15\n433\tNHALES (Natural History of Asthma With Longitudinal Environmental Sampling)\t\tasthma\t200\n443\tCauses of Comorbid Infertility Among Women With Rheumatoid Arthritis\t\tarthritis\t150\n445\tPhysical Therapy Versus Internet-Based Exercise Training for Patients With Knee Osteoarthritis\t\tarthritis\t350\n471\tEffects of Neuromodulation on Verbal Fluency in Post-stroke Aphasia\t\tneurological\t12\n473\tContingency Management Quitting Smoking and ADHD\tPhase 1\tsmoker study\t60\n477\tRelationship of Pulmonary Contusion to Pulmonary Inflammation and Incidence of Acute Respiratory Distress Syndrome\t\trespiratory disease\t10\n478\tNovel Biomarkers for Risk Prediction of Contrast-Induced Acute Kidney Injury Post Coronary Angiography\t\tkidney disease\t200\n479\tRespiratory Viral Infections in Pediatric Transplantation\t\trespiratory disease\t2669\n487\tOxytocin Treatment of Alcohol Dependence\tPhase 2\talcohol\t50\n492\tAbstinence Reinforcement Therapy (ART) for Homeless Veteran Smokers\t\tsmoker study\t165\n493\tArthritis Pilot for Preserving Muscle While Losing Weight\t\tarthritis\t37\n498\tFunction and Scoliosis Surgery\t\tsurgery\t15\n500\tStudy of an Emergency Department-based Intervention to Reduce Alcohol Misuse in Older Adults\t\talcohol\t150\n503\tEffects of Chemoradiation and Surgery on Cardiopulmonary Fitness and Tumor Neoplastic Phenotype in Gastrointestinal Malignancies\t\ttumors\t25\n504\tEffect of Non-Alcoholic Steatohepatitis (NASH) on the Pharmacokinetics of 99mTechnetium-Mebrofenin\tPhase 1\talcohol\t20\n510\tSurgery Prevention by Transforaminal Injection of Epidural Steroids for Cervical Radicular Pain\tPhase 4\tsurgery\t60\n513\tFabrication of a Definitive Cad/Cam Titanium Abutment Prior to Guided Surgery: a Pilot Study.\t\tsurgery\t28\n521\tThe Effect of Prophylactic Antipyretics on Immune Responses and Fever After 2014-2015 and 2015-2016 Inactivated Influenza Vaccine\tPhase 4\tinfluenza\t104\n524\tElectronic Medical Record Review in Monitoring the Effects of Adherence on Myelosuppression and Morbidity in Patients With Newly Diagnosed Brain Tumors Receiving Temozolomide and Radiation Therapy\t\ttumors\t240\n525\tA Validated Necrosis Assay to Determine the Need for Revision Surgery in Metal-on-metal Total Hip Arthroplasty\t\tsurgery\t100\n527\tPhase I Study of HIV 1 Antigen Expanded Specific T Cell Therapy\tPhase 1\thiv\t12\n530\tHydration Monitor Validation in Elderly\t\telderly\t73\n536\tMultimodal Analgesia vs. Routine Care Pain Management for Lumbar Spine Fusion Surgery: A Prospective Randomized Study\tPhase 4\tsurgery\t124\n543\tTEA vs. PVB vs. PCA in Liver Resection Surgery\t\tsurgery\t10\n547\tAromatherapy Using a Nasal Clip After Surgery\t\tsurgery\t300\n550\tEffects of Wood Smoke Particles on Influenza-induced Nasal Inflammation in Normal Volunteers\tPhase 0\tinfluenza\t39\n555\tHepatitis C Alcohol Reduction Treatment\t\talcohol\t230\n576\tPain Expectations in Subjects With Osteoarthritis\tPhase 4\tarthritis\t30\n577\tA Double-Blind Placebo-Controlled Cross-over Study of Armodafinil Treatment of Daytime Sleepiness Associated With Treated Nocturia\tPhase 2 / Phase 3\tsleep study\t27\n578\tInterleukin-2&#8212;Induced Cognitive/Affective/Sleep Symptoms\t\tsleep study\t30\n587\tA Pilot Study of a Non-Invasive Neuromodulation Device for Treatment of Parkinson&apos;s Disease\t\tneurological\t6\n589\tDetermining Relationships Among Maternity Stress &amp; Sleep\t\tsleep study\t17\n596\tExamining the Effects of Neuromodulation on Glucose Metabolism in Type 2 Diabetes\t\tdiabetes\t6\n598\tMultivitamin Adherence Following Bariatric Surgery\t\tsurgery\t30\n601\tExercise Heart Failure and Type 2 Diabetes\t\tdiabetes\t0\n609\tModulation of Insulin Sensitivity by Betaine Upregulation of FGF21\t\tdiabetes\t23\n611\tMobile Sensing of Smoking Behavior\t\tsmoker study\t2\n614\tA Family-Based Diabetes Intervention for Hispanic Adults in an Emerging Community\t\tdiabetes\t156\n624\tAnti-thrombin III (ATIII) vs Placebo in Children (&lt;7mo) Undergoing Open Congenital Cardiac Surgery\tPhase 2\tsurgery\t40\n626\tEfficacy of Intrathecal Oxytocin in Patients With Neuropathic Pain\tPhase 2\tneurological\t40\n628\tA Safety and Efficacy Study of NNZ-2566 in Patients With Mild Traumatic Brain Injury (mTBI)\tPhase 2\tneurological\t132\n637\tNonconvulsive Seizure Identification on Quantitative EEG by Neuro ICU Nurses\t\tneurological\t30\n639\tEffects of a Cocoa Shot on the Human Brain 2\tPhase 1\tneurological\t24\n640\tCharacterization of Circulating Tumor Cells Captured by c-MET (CTC-MET)\t\ttumors\t85\n646\tIntegrated Approaches for Identifying Molecular Targets in Alcoholic Hepatitis\t\talcohol\t700\n649\tStudy of Tolerability and Efficacy of BVS857 in Severe Burn Subjects\tPhase 2\tburns\t1\n652\tTesting Methods of Self-persuasion Involving Cigarette Smoking\t\tsmoker study\t48\n659\tEfficacy and Safety of the DASH Diet in Adults With Moderate Chronic Kidney Disease: Pilot Study\t\tkidney disease\t42\n660\tUse of Recombinant Hyaluronidase Human is Effective for the Use of Local Blocks for Eyelid&apos;s Surgery\t\tsurgery\t0\n663\tIntravenous Exenatide in Patients With Acute Brain Injury\tPhase 4\tneurological\t24\n669\tImproving Diabetes Outcomes for Persons With Severe Mental Illness\t\tdiabetes\t25\n678\tAirway Inflammatory Response During Illness in Children With Respiratory Failure\t\trespiratory disease\t20\n692\tThree Approaches to Glucose Monitoring in Non-insulin Treated Diabetes\t\tdiabetes\t450\n701\tIsolation of Circulating Tumor Cells Using a Novel EMT-Based Capture Method\t\ttumors\t80\n709\tEffects of Tobacco Products on Live Attenuated Influenza Virus (LAIV) Infections in Human Volunteers\t\tinfluenza\t100\n712\tEffects of Shock Absorbing Insoles on Knee Pain and Walking in Persons With Knee Osteoarthritis\tPhase 2\tarthritis\t60\n728\tEchinacea and Acute Respiratory Illness\t\trespiratory disease\t40\n736\tBrain Connectivity in Age-Related Macular Degeneration\t\tneurological\t300\n739\tBABY STEPS II: SMS Scheduled Gradual Reduction Text Messages to Help Pregnant Smokers Quit\t\tsmoker study\t522\n743\tUse of Technological Advances to Prevent Smoking Relapse Among Smokers With PTSD\t\tsmoker study\t15\n747\tPreventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)\tPhase 2\theart disease\t250\n751\tTotal Ankle Replacement for Ankle Arthritis\t\tarthritis\t1000\n755\tEfficacy and Safety of High Dose Baclofen for Alcohol Dependence\tPhase 2\talcohol\t120\n757\tJump Starting Shared Medical Appointments for Diabetes With Weight Management\t\tdiabetes\t308\n760\tNeurocognitive Visual Reaction Training\t\tneurological\t21\n763\tEffect of Tourniquet on Sensory Nerve Conduction Threshold (sNCT) and OxyNeuroGram (ONG) Index- A Volunteer Study\t\tneurological\t10\n774\tStudy of Awareness and Detection of Familial Hypercholesterolemia\t\theart disease\t5000\n779\tComplementary Neurosteroid Intervention in Gulf War Illnesses (GWVI)\tPhase 2\tneurological\t140\n781\tEstablishment of a Human Tissue Bank for Studying the Microbial Etiology of Neurodegenerative Diseases\t\tneurological\t300\n787\tEstablishment of a Tissue Bank (Blood CSF) for the Understanding of the Disease Progression and Early Diagnosis of Motor Neuron Disease (MND)\t\tneurological\t1000\n796\tBrain Imaging of Intranasal Oxytocin Treatment in Autism\tPhase 1\tneurological\t28\n811\tEvaluation of Efficacy and Accuracy of Aquamantys Device in General Surgery\t\tsurgery\t20\n813\tFluid Intake Application to Reduce Kidney Stone Risks\t\tkidney disease\t50\n816\tEffects of a Cocoa Shot on the Human Brain\tPhase 0\tneurological\t6\n818\tThe Effect of Anticholinergics on Cognitive Function in the Elderly\tPhase 4\telderly\t59\n820\tBlood Pressure Heart Rate Variability &amp; Sleep in Veterans With PTSD\t\tsleep study\t19\n832\tAuditory Brainstem Implantation in Young Children\tPhase 0\tneurological\t10\n836\tCPT and Smoking Cessation\tPhase 2 / Phase 3\tsmoker study\t50\n838\tVirtual Reality for Osteoarthritis Knee Pain Pilot\t\tarthritis\t30\n841\tNeurosteroids as Novel Therapeutic Agents for Chronic Pain in OEF/OIF Veterans\tPhase 2 / Phase 3\tneurological\t90\n846\tObservational Assessment of Baseline Asthma Control in African-American Children\t\tasthma\t25\n873\tSleep Apnea and Visual Perceptual Skill Learning\t\tsleep study\t14\n874\tAn Evaluation of Neurofeedback Efficacy in Adults With ADHD\t\tneurological\t30\n877\tSuperior Laryngeal Nerve Block For Awake Endotracheal Intubation Study\t\tnerve study\t95\n879\tSulforaphane Supplementation in Atopic Asthmatics\tPhase 1\tasthma\t16\n886\tEnvironments as Smoking Cues: Imaging Brain Substrates Developing New Treatments (CameraCue)\t\tsmoker study\t67\n890\tTranslational Research Evaluating Neurocognitive Memory Processes\t\tneurological\t76\n893\tLatinos Combating Diabetes\t\tdiabetes\t225\n899\tSimultaneous Risk Factor Control Using Telehealth to slOw Progression of Diabetic Kidney Disease (STOP-DKD)\t\tkidney disease\t285\n900\tMilnacipran and Neurocognition Pain and Fatigue in Fibromyalgia : A 13-week Randomized Placebo Controlled Cross Over Trial\tPhase 3\tneurological\t26\n908\tBone Metabolism After Bariatric Surgery\t\tsurgery\t40\n916\tParents and Children Together Preventing Diabetes (PACT PD)\t\tdiabetes\t72\n918\tNicotine Non-Smokers With and Without ADHD and Genetics Study\tPhase 1\tsmoker study\t150\n925\tTrial of Directed High-dose Nasal Steroids on Residual Smell Loss in Sinus Patients After Sinus Surgery\tPhase 2\tsurgery\t0\n931\tPostoperative Subtenons Anesthesia for Postoperative Pain in Pediatric Strabismus Surgery\t\tsurgery\t57\n941\tLifestyle Intervention for Treatment of Diabetes\t\tdiabetes\t260\n942\tEmpowering Rural African American Women and Communities to Improve Diabetes Outcomes\t\tdiabetes\t200\n945\tMindfulness: a Novel Approach for the Management of Diabetes-related Distress\tPhase 2 / Phase 3\tdiabetes\t90\n951\tPET/MRI in CNS and Extra-CNS Tumors of Patients With Neurofibromatosis-1 (NF1)\t\ttumors\t15\n954\tA Trial Examining the Efficacy of Escitalopram Oxalate Upon Depressive Symptoms and Fatigue in HIV Seropositive Women\tPhase 4\thiv\t5\n959\tPost-traumatic Arthritis Associated With Joint Injury\t\tarthritis\t30\n963\tCarolina Alcohol and Drug Resources\t\talcohol\t690\n967\tContingency Management for Smoking Cessation in Homeless Smokers\t\tsmoker study\t25\n972\tUnderstanding the Response to Fesoterodine Through Genetic Evaluation in the Elderly (URGE)\t\telderly\t66\n973\tiCare vs Tonopen vs Goldmann Applanation Post-vitrectomy Surgery\t\tsurgery\t68\n974\tRegulation of Branched-chain Amino Acid Metabolism in Pre-Diabetes\t\tdiabetes\t132\n975\tNeuromuscular Ultrasound in ALS\t\tneurological\t40\n980\tPilot Testing a Patient and Provider Intervention for Managing Osteoarthritis in Hispanic Adults.\t\tarthritis\t16\n985\tAdvanced Comprehensive Diabetes Care for Veterans With Poorly-Controlled Diabetes\tPhase 0\tdiabetes\t50\n994\tCryosurgery and Radiation Therapy in Treating Patients With Painful Bone Metastases\t\tsurgery\t1\n1000\tPhysiologic Mechanisms in Pediatric Traumatic Brain Injury (TBI)\t\tneurological\t60\n1001\tNeurophysiology of Postpartum Depression in an Experimental Model of Pregnancy and Parturition\t\tneurological\t30\n1014\tDelayed-Enhancement Cardiovascular Magnetic Resonance in Patients With Sarcoidosis\t\theart disease\t400\n1029\tStudy to Evaluate the Impact of FeNO Assessments on Asthma Management Decisions in Subject 7 to 60 Years of Age\t\tasthma\t50\n1038\tAbstinence Reinforcement Therapy (ART) for Rural Veteran Smokers\t\tsmoker study\t300\n1048\tExploring Massage Benefits for Arthritis of the Knee for VA Healthcare Users\t\tarthritis\t25\n1055\tEffect Of Acute Inflammatory Mediators On Functional Limitations In Patients With Acute Respiratory Failure\tPhase 1 / Phase 2\trespiratory disease\t100\n1058\tAlmased Multi-Center Diabetes Intervention Trial\t\tdiabetes\t240\n1059\tAssessing Short and Long Term Compliance With Caloric Intake in HIV Positive Women Taking Complera\t\thiv\t33\n1060\tThe Effects of Respiratory Muscle Strength Training (RMST) on Inspiratory and Expiratory Muscle Strength in Adults and Children With Pompe Disease\t\trespiratory disease\t11\n1065\tMRI to Assess the Effects of Dysautonomia and Chronic Nausea on Brain Transmitters\t\tneurological\t18\n1067\tMiraLAX Versus Placebo to Prevent Constipation Following Urogynecologic Surgery\t\tsurgery\t131\n1072\tMild Traumatic Brain Injury Registry\t\tneurological\t40\n1088\tAdvanced Image Guidance Utilized in Liver Surgery\t\tsurgery\t13\n1092\tGene Expression Variation and Implant Wound Healing Among Smokers and Diabetics\t\tsmoker study\t44\n1094\tSurgical Outcomes Database For Faculty of Hepatopancreatic Biliary Surgery\t\tsurgery\t300\n1099\tVisceral (Kidney and Abdominal Organ) Function After Fenestrated and Branched Endovascular Aneurysm Repair (FEVAR/BEVAR) of Thoracoabdominal Aortic Aneurysms\t\tkidney disease\t160\n1100\tStudy of Effectiveness of Liraglutide Added to High Dose Insulin in Type II Diabetics\tPhase 4\tdiabetes\t36\n1109\tThe Effects of Smoking Withdrawal On Resting State Functional Connectivity\t\tsmoker study\t0\n1112\tNeurostimulation Device for Treatment of Migraine Headache\t\tneurological\t7\n1116\tHIV Prevention Among Latino MSM: Evaluation of a Locally Developed Intervention\t\thiv\t304\n1119\tEffects of Tai Chi Chuan on Psychobiological Indicators of Anxiety and Sleep Quality in Young Adults\t\tsleep study\t75\n1122\tVentilatory Heterogeneity in Participants With Asthma (MK-0476-513)\tPhase 1\tasthma\t34\n1123\tEvaluation of DVD and Internet Decision Aids for Hip and Knee Osteoarthritis: Focus on Health Literacy\t\tarthritis\t155\n1129\tMultimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery\tPhase 2\tsurgery\t40\n1137\tCombinatorial Therapy for Peristent Type 2 Diabetes After Gastric Banding\tPhase 4\tdiabetes\t9\n1141\tMindful Movement and Breathing to Improve Outcomes of Gynecologic Surgery\tPhase 0\tsurgery\t10\n1142\tStudy of Anesthesia Techniques to Reduce Nausea and Vomiting After Jaw Corrective Surgery\t\tsurgery\t233\n1154\tENLIGHTEN: Exercise and NutritionaL Interventions for coGnitive and Cardiovascular HealTh ENhancement\t\theart disease\t160\n1158\tTo Compare the Safety Tolerability and Pharmacokinetics of QBX258 in Patients With Asthma\tPhase 1\tasthma\t50\n1170\tTherapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery\tPhase 2\tsurgery\t20\n1173\tCardiovascular Effects of Incremental Diesel Exhaust Inhalation in Middle-Aged Healthy GSTM1 Null Human Volunteers\t\theart disease\t6\n1182\tMapping Multidimensional Illness Trajectories of Patients With End-stage Kidney Disease\t\tkidney disease\t227\n1186\tA Phase I Study To Evaluate The Antitumor Activity And Safety Of AVX901\tPhase 1\ttumors\t22\n1195\tEffect of Blueberries on Cognition and Body Composition in Elderly With Mild Cognitive Decline\tPhase 2\telderly\t123\n1197\tEating Disorders in Type 1 Diabetes: Mechanisms of Comorbidity\t\tdiabetes\t83\n1200\tStudy to Evaluate the Effect of RGMA001 on Patients With Non Alcoholic Fatty Liver Disease (NAFLD)\t\talcohol\t40\n1206\tNeurostimulation in Temporomandibular Disorders (TMD) Patients\t\tneurological\t5\n1216\tStrength Training for ARthritis Trial\tPhase 2\tarthritis\t375\n1226\tTrivalent Influenza Vaccine in Preventing Flu in Patients With Central Nervous System Tumors\tPhase 0\tinfluenza\t38\n1229\tEfficacy of Fluocinonide Cream 0.1% (Vanos(R)) in Reducing Itch in Subjects With Atopic Dermatitis\t\tdermatitis\t10\n1233\tVasospasm in Pediatric Traumatic Brain Injury\t\tneurological\t6\n1234\tObesity in HIV After Antiretroviral Therapy\t\thiv\t200\n1241\tDevelopment of a Tumor Molecular Analyses Program and Its Use to Support Treatment Decisions\t\ttumors\t5000\n1242\tStudy to Assess the Effects of Daily Administration of Pioglitazone on Brain Hemodynamics in Healthy Elderly Participants\tPhase 1\telderly\t61\n1255\tPatient and Provider Interventions for Managing Osteoarthritis in Primary Care\t\tarthritis\t537\n1261\tMindfulness-based Personalized Health Planning for Reducing Risk of Heart Disease and Diabetes\tPhase 3\tdiabetes\t140\n1268\tNeural Markers and Rehabilitation of Executive Functioning in Veterans With Traumatic Brain Injury and Posttraumatic Stress Disorder\t\tneurological\t100\n1270\tEarly Brain Development in Twins\t\tneurological\t600\n1278\tNeuromuscular Ultrasound for Focal Neuropathies\t\tneurological\t120\n1280\tPain and Function After Orthopedic Surgery\t\tsurgery\t75\n1282\tPediatric Atopic Dermatitis (AD) Internet Survey\t\tdermatitis\t40\n1284\tStrategies for Enhancing Mucosal Immunity to Influenza Vaccine\tPhase 0\tinfluenza\t60\n1287\tPersonalized Diabetic Kidney Disease Risk Info to Initiate and Maintain Health Behavior Changes\t\tkidney disease\t19\n1297\tFamilies and Pediatric Cardiac Surgery Multidisciplinary Teams: How Well Do We Communicate\t\tsurgery\t23\n1304\tEffect of Growth Hormone on Early Brain Development in Girls With Turner Syndrome\t\tneurological\t25\n1307\tBrain Connectivity in Neurodevelopmental Disorders in Response to Treatment\t\tneurological\t25\n1316\tStress Reduction Training to Improve Sleep Quality Stress Physiology &amp; Cardiovascular Disease (CVD) Risk Markers\t\theart disease\t87\n1318\tNeuroactive Steroids and Traumatic Brain Injury (TBI) in OEF/OIF Veterans\tPhase 2\tneurological\t82\n1324\tEarly Intervention for Morbidly Obese Patients After Roux-en-Y Gastric Bypass (RYGB) Surgery\t\tsurgery\t8\n1328\tPatient Positioning in Lumbar Fusion Surgery and Its Impact on Spinal Sagittal Balance and Surgeon Satisfaction\t\tsurgery\t7\n1331\tCardiovascular Effects in Psoriasis Patients Treated With Adalimumab.\t\theart disease\t17\n1332\tThe Effect of Vorinostat on HIV RNA Expression in the Resting CD4+ T Cells of HIV+ Pts on Stable ART\tPhase 1 / Phase 2\thiv\t37\n1333\tMeasurement of Kidney Blood Flow and Oxygen Levels by MRI\t\tkidney disease\t10\n1341\tTissueLink Study During Multi-Level Spine Surgery\tPhase 4\tsurgery\t60\n1347\tSweet Preference and Alcohol Craving\tPhase 2\talcohol\t80\n1351\tClinical Assessment of Nonin 7600 Near Infrared Spectroscopy (NIRS) Tissue Oximetry During Cardiovascular Surgery\t\theart disease\t50\n1355\tFeasibility of a Minimally Invasive Image-Guided Surgery System for Hepatic Procedures\t\tsurgery\t30\n1364\tEffects of Sulforaphane (SFN) on Immune Response to Live Attenuated Influenza Virus in Smokers and Nonsmokers\t\tinfluenza\t51\n1372\tEffect of Calcium Polycarbophil on Type II Diabetes Mellitus Control: a Randomized Double-blind Study\t\tdiabetes\t48\n1376\tA Study of FolateScan in Patients With Knee Osteoarthritis\t\tarthritis\t25\n1377\tBenazepril Hydrochloride Lisinopril Ramipril or Losartan Potassium in Treating Hypertension in Patients With Solid Tumors\tPhase 2\ttumors\t6\n1378\tYoga Therapy in Treating Patients With Malignant Brain Tumors\t\ttumors\t9\n1379\tAtypical Antipsychotic Treatment Effect On Brain Function In Schizophrenia Measured By FMRI\t\tneurological\t34\n1380\tEfficacy and Tolerability Study of Device RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis in Adults\tPhase 2\tdermatitis\t17\n1381\tWe Can Prevent Diabetes: A Behavioral Intervention to Reduce Diabetes Risk in African Americans\tPhase 1 / Phase 2\tdiabetes\t74\n1390\tDischarge Planning for Elderly Patients in the Emergency Department: Use of a Brief Phone Call After Discharge to Improve Medication Utilization and Physician Follow-up\t\telderly\t157\n1396\tEhealth: Second Life Impacts Diabetes Education &amp; Self-Management\t\tdiabetes\t20\n1398\tUnderstanding of Genetic Risk Information for Type 2 Diabetes\t\tdiabetes\t300\n1400\tStatin Therapy To Limit Cognitive Dysfunction After Cardiac Surgery\t\tsurgery\t0\n1403\tIncidence of Respiratory Depression in Cesarean Section\t\trespiratory disease\t100\n1412\tReusable Versus Disposable Draping System in Breast Reconstruction Surgery\t\tsurgery\t107\n1422\tEvaluation of Continuous Saphenous Nerve Block to Supplement a Continuous Sciatic Nerve Block After Ankle Surgery\t\tsurgery\t74\n1430\tPioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors\tPhase 1\ttumors\t18\n1439\tCardiovascular Intervention Improvement Telemedicine Study\t\theart disease\t428\n1445\tPersonalized Cardiovascular Risk Information to Initiate and Maintain Health Behavior Changes\t\theart disease\t98\n1452\tPatient and Provider Interventions for Managing Osteoarthritis in Primary Care\t\tarthritis\t300\n1457\tNeuroimaging of Smokers With and Without Attention Deficit Hyperactivity Disorder (ADHD)\t\tsmoker study\t101\n1462\tA Panobinostat Presurgery\tPhase 2\tsurgery\t0\n1463\tEvaluating the Effect of Mucinex 1200mg on Mucociliary and Cough Clearance During an Acute Respiratory Infection\tPhase 2\trespiratory disease\t38\n1468\tFast Spectral Imaging Device for Tumor Margin Mapping\t\ttumors\t54\n1472\tA Pilot Trial in a Sleep Laboratory Setting to Observe Night Time Bladder Function of Subjects With Overactive Bladder (OAB)\t\tsleep study\t15\n1494\tGenetic Testing for Type 2 Diabetes\t\tdiabetes\t601\n1495\tTransoral Robotic Surgery (TORS) for Oral and Laryngopharyngeal Lesions Using Da Vinci Robotic Surgical System\tPhase 0\tsurgery\t60\n1496\tGroup Physical Therapy for Knee Osteoarthritis\t\tarthritis\t320\n1497\tNeurobiology of Nicotine and Non-nicotine Components of Tobacco Addiction\tPhase 1\tneurological\t147\n1498\tSupplemental Nicotine Administration for Smoking Cessation in Posttraumatic Stress Disorder (PTSD)\t\tsmoker study\t69\n1499\tSafety Study of Bevacizumab Everolimus and LBH589 (BEL) for Advanced Solid Tumors\tPhase 1\ttumors\t14\n1503\tManaging Chronic Kidney Disease in Eastern North Carolina\t\tkidney disease\t1257\n1511\tA Study Evaluating the Efficacy of Fluocinonide Cream 0.1% (Vanos) in Subjects With Atopic Dermatitis\tPhase 4\tdermatitis\t20\n1512\tInvestigating Fitness Interventions in the Elderly (INFINITE)\t\telderly\t180\n1514\tPilot Study of Lovaza (Omega 3 Fatty Acids) to Improve Cardiac Antioxidant/Anti-inflammatory Profile Before Cardiac Surgery\tPhase 4\tsurgery\t24\n1515\tReducing Donor Specific Antibody (DSA) Strength in Maintenance Kidney Transplant Recipients (DSA Study)\tPhase 4\tkidney disease\t32\n1518\tEn Pareja: A Latino Couples Intervention to Help Expectant Fathers Quit Smoking\t\tsmoker study\t705\n1521\tp16 Methylation for Smoking Cessation\t\tsmoker study\t35\n1527\tArmodafinil in Treating Fatigue Caused By Radiation Therapy in Patients With Primary Brain Tumors\tPhase 2\ttumors\t54\n1532\tPilot Trial in Sleep Laboratory Setting to Compare the Physiology of Night Time Bladder Function in Subjects With Overactive Bladder (OAB) Versus Subjects That Have Insomnia and Healthy Normal Subjects\tPhase 4\tsleep study\t26\n1538\tIntensive Computerized Brain Training (ICBT) in Youth With Early Onset Psychosis (EOP)\t\tneurological\t35\n1542\tDietary Patterns and Cardiovascular (CVD) Risk in Spinal Cord Injury (SCI) Factors In Individuals With Chronic Spinal Cord Injury\t\theart disease\t100\n1544\tSafety Metabolism and Antioxidant Activity of Silymarin and Green Tea Extract in Patients With Chronic Hepatitis C\tPhase 1 / Phase 2\thepatitis\t60\n1547\tOptimal Planning Target Volume With Stereotactic Radiosurgery\t\tsurgery\t49\n1549\tRadiosurgery and Avastin for Recurrent Malignant Gliomas\t\tsurgery\t15\n1550\tDexmedetomidine Sedation With Third Molar Surgery\tPhase 4\tsurgery\t18\n1551\tModerate to Persistent Asthma in the Obese Subject\tPhase 4\tasthma\t38\n1563\tInternet-Based Smoking Cessation for Operations Enduring Freedom and Iraqi Freedom (OEF/OIF) Veterans\t\tsmoker study\t413\n1582\tThe Arthritis Diet and Activity Promotion Trial\t\tarthritis\t318\n1585\tTailored Case Management for Diabetes and Hypertension\t\tdiabetes\t377\n1588\tStandardized Rehabilitation for Intensive Care Unit (ICU) Patients With Acute Respiratory Failure\t\trespiratory disease\t300\n1589\tLowering Salt Intake in Chronic Kidney Disease: A Pilot Randomized Crossover Trial\t\tkidney disease\t35\n1595\tExercise Dose-Response Effects in Prediabetes\t\tdiabetes\t288\n1600\tExercise Intolerance in Elderly Patients With Diastolic Heart Failure\t\telderly\t100\n1628\tFunctional Imaging of Tumor and Normal Tissue\t\ttumors\t21\n1638\tA Study of Inhalation of 20000 EU CCRE and Mucociliary Clearance (MCC) in Otherwise Healthy Individuals Who Are Current Cigarette Smokers\tPhase 1\tsmoker study\t12\n1641\tSafety and Efficacy Study to Compare Continuous Infusion of Interferon With Standard of Care for Chronic Hepatitis C\tPhase 2\thepatitis\t116\n1642\tPreventing Postpartum Return to Smoking\t\tsmoker study\t386\n1651\tA Controlled Laboratory Study of the Effects on Cue-Induced Craving in Dependent Smokers\tPhase 2\tsmoker study\t21\n1656\tCollection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors\t\ttumors\t2500\n1662\tPrevalence of Sleep Disturbances in Psoriasis\t\tsleep study\t80\n1663\tEvaluation of a Tailored Smoking Cessation Treatment Algorithm Based on Initial Treatment Response and Genotype\tPhase 3\tsmoker study\t606\n1664\tVaccine Therapy in Treating Patients Undergoing Surgery for Recurrent Glioblastoma Multiforme\tPhase 1\tsurgery\t50\n1666\tSafety/Biomarker Study of CNTO 95 and Avastin in Solid Tumors\tPhase 1\ttumors\t13\n1667\tTreatment Effects of Escitalopram (Lexapro&#174;) on Generalized Anxiety Disorder in Patients With HIV and AIDS\tPhase 3\thiv\t30\n1668\tMindfulness Emotional Well-being and Sleep Quality\t\tsleep study\t372\n1674\tSex Differences in Early Brain Development; Brain Development in Turner Syndrome\t\tneurological\t295\n1675\tEfficacy and Tolerability of Baclofen for Alcohol Dependence\tPhase 2 / Phase 3\talcohol\t80\n1682\tStudy of Massage Therapy Within a Brain Tumor Setting\t\ttumors\t10\n1683\tBTC Neuropsychological Database\t\tneurological\t0\n1699\tValidation of Brain Oxygenation Monitor on Pediatric Patients\t\tneurological\t72\n1702\tCompatibility of a Mild Moisturizing Hand Cleanser for Patients With Mild to Moderate Hand Dermatitis\t\tdermatitis\t46\n1703\tBronchoscopy Assisted Sampling of Cells and Fluid From the Lower Respiratory Tract of Human Subjects\t\trespiratory disease\t30\n1706\tEffect of a 10000 EU Dose of Endotoxin in Allergic and Mildly Asthmatic Adults\tPhase 1\tasthma\t11\n1707\tA Study of Inhalation of 20000 EU CCRE in Normal Volunteers Compared to Allergic Asthmatic Individuals\tPhase 1\tasthma\t32\n1709\tIn Vitro Basophil Responsiveness to Allergen Challenge After Gamma-tocopherol Supplementation in Allergic Asthmatics\tPhase 1\tasthma\t25\n1710\tImproving Neurologic Outcomes in People With Diabetes Who Are Undergoing Heart Surgery\tPhase 3\tdiabetes\t133\n1711\tEffectiveness of Metformin Compared to Insulin in Pregnant Women With Mild Preexisting or Early Gestational Diabetes\tPhase 2\tdiabetes\t31\n1715\tRole of RhuMab-E25 in Reducing Exhaled Nitric Oxide (NO) in Allergic Asthma\tPhase 3\tasthma\t20\n1718\tRapid Administration of Insulin in Sepsis\tPhase 1\tdiabetes\t20\n1719\tCholesterol Hypertension and Glucose Education Study\t\theart disease\t362\n1721\tValidation of Brain Oxygenation Monitor\t\tneurological\t18\n1725\tStereotactic Radiosurgery After Surgery in Treating Patients With Brain Metastases\tPhase 2\tsurgery\t1\n1726\tStereotactic Radiosurgery in Treating Patients With Brain Metastases\tPhase 2\tsurgery\t6\n1730\tAmantadine and Temporal Discrimination in Patients With Traumatic Brain Injury (TBI)\t\tneurological\t16\n1732\tPharmacokinetics of NRL972 in Patients With Nonalcoholic Steatohepatitis (NASH) and Non-Alcoholic Fatty Liver Disease (NAFLD)\tPhase 2\talcohol\t125\n1739\tImpact of GBS on CVD in Type 2 Diabetes Mellitus\t\tdiabetes\t84\n1745\tEffectiveness of Bridging Anticoagulation for Surgery (The BRIDGE Study)\tPhase 3\tsurgery\t1884\n1774\tRange of Neutrophil Response to 20000 EU of Clinical Center Reference Endotoxin in Otherwise Healthy Smokers\tPhase 1\tsmoker study\t2\n1783\tEvaluating the Effects of Hormone Replacement Therapy on Brain Function (The WHIMS-MRI Study)\t\tneurological\t1426\n1788\tMetformin for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD)\tPhase 4\talcohol\t11\n1789\tAttention Deficit Hyperactivity Disorder (ADHD) Smoking Cessation Study\t\tsmoker study\t32\n1791\tA Study to Determine if Carbon Dioxide Lavage During Total Knee Surgery Reduces Intraoperative Embolic Events\tPhase 2\tsurgery\t20\n1797\tAn Optical Assay System for Intra Operative Assessment of Tumor Margins in Patients\t\ttumors\t530\n1801\tTreating Co-Morbid Sleep Difficulties in Veterans With Posttraumatic Stress Disorder (PTSD): A Pilot Study\t\tsleep study\t22\n1802\tConcurrent Nicotine Patch / Denicotinized Cigarette Therapy for Smoking Cessation II\tPhase 3\tsmoker study\t479\n1814\tA Multicenter Randomized Placebo-Controlled Phase 2 Study to Evaluate the Clinical Efficacy Safety and Tolerability of ARX-F01 Sublingual Sufentanil in Patients Undergoing Major Abdominal Surgery\tPhase 2\tsurgery\t88\n1818\tLoteprednol Etabonate in an Ophthalmic Base vs Vehicle for the Treatment of Inflammation Following Cataract Surgery\tPhase 3\tsurgery\t400\n1819\tEffects of Capsaicin on the Structure Distribution and Function of Cutaneous Small Nerve Fibers in Psoriatic Skin\tPhase 4\tnerve study\t12\n1822\tComprehensive Investigation of Opiates Neuropeptides Barrier Function Scratching and Sleep Physiology\t\tneurological\t31\n1824\tAdherence to Topical Hydrocortisone 17-Butyrate 0.1% (Locoid&#174;) Using Different Vehicles in Adults With Atopic Dermatitis\tPhase 4\tdermatitis\t30\n1830\tNeuroimaging Attentional Impairment During Abstinence\t\tneurological\t80\n1833\tComprehensive Investigation of Heart Rate Variability as a Measure of the Autonomic Nervous System in Atopic Dermatitis\t\tdermatitis\t45\n1837\tEfficacy of Desonide (Desonatetm) Gel 0.05% in Younger and Older Subjects With Atopic Dermatitis\tPhase 4\tdermatitis\t41\n1845\tSupplemental Choline and Brain Development in Humans\t\tneurological\t150\n1855\tImmunotherapy of Melanoma With Tumor Antigen RNA and Small Inhibitory RNA Transfected Autologous Dendritic Cells\tPhase 1\ttumors\t12\n1857\tNeuroimaging Decision Making and Response Inhibition During Smoking Abstinence\t\tsmoker study\t62\n1862\tRole of TLR4 in Environmental Asthma\tPhase 1\tasthma\t855\n1864\tNitric Oxide LPS and the Pathogenesis of Asthma Phase 1\t\tasthma\t420\n1869\tEfficacy Study of PN400 (VIMOVO) Twice Daily and Celebrex Once Daily in Patients With Osteoarthritis\tPhase 3\tarthritis\t610\n1873\tEfficacy Study of PN400 (VIMOVO) Twice Daily and Celebrex Once Daily in Patients With Osteoarthritis\tPhase 3\tarthritis\t614\n1875\tThe Effect of Visual Stimuli on Itch Perception Intensity in Healthy and Atopic Dermatitis Patients\t\tdermatitis\t25\n1876\tPhase 2B Dose-Ranging Study of PAC113 Mouthrinse in HIV Seropositive Individuals With Oral Candidiasis\tPhase 2\thiv\t223\n1881\tMeasuring Adherence to Topical Therapy in Children With Atopic Dermatitis and the Impact of a Return Visit\tPhase 4\tdermatitis\t30\n1886\tGenetics of Asthma - Bronchoscopy Studies\tPhase 1\tasthma\t17\n1890\tNitric Oxide LPS and the Pathogenesis of Asthma Phase II\tPhase 1\tasthma\t70\n1891\tGroup Physical Therapy for Knee Osteoarthritis\t\tarthritis\t24\n1895\tThe Gene Expression Studies of the Role of Tumor Microenvironments in Tumor Progression\t\ttumors\t0\n1899\tInsulin Resistance in Nonalcoholic Fatty Liver Disease: A Case Control Study\t\tdiabetes\t80\n1911\tHealthy Living Partnership to Prevent Diabetes\tPhase 3\tdiabetes\t301\n1915\tSafety Study of 20000 EU of Clinical Center Reference Endotoxin in Allergic Adults With and Without Mild Asthma\tPhase 1\tasthma\t4\n1916\tFeasibility Study of Vessel Analysis for Noninvasive Diagnosis of Malignancy in Breast Tumors\t\ttumors\t6\n1918\tInnohep for Prophylaxis of Venous Thromboembolism in Brain Tumor Patients\t\ttumors\t40\n1920\tCoronary Heart Disease as Measured by Coronary Calcium Score Among Individuals With Chronic Traumatic Spinal Cord Injury\t\theart disease\t45\n1924\tNicotine Patch Pretreatment for Smoking Cessation in PTSD\tPhase 0\tsmoker study\t87\n1928\tCarbamazepine for the Treatment of Chronic Post-Traumatic Brain Injury Irritability and Aggression\t\tneurological\t74\n1939\tEffects of Diesel Exhaust Followed by Administration of Nasal Spray Flu Vaccine on Individuals With &amp; Without Allergies\t\tinfluenza\t54\n1942\tStudy of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-003)\tPhase 3\tsurgery\t120\n1947\tMK-0518 Intensification And HDAC Inhibition In Depletion Of Resting CD4+ T Cell HIV Infection\tPhase 2\thiv\t6\n1963\tEverolimus Fluorouracil Leucovorin Panitumumab and Oxaliplatin in Treating Patients With Solid Tumors That Did Not Respond to Treatment\tPhase 1\ttumors\t74\n1969\tGIOP Prevention Among People With Rheumatoid Arthritis\t\tarthritis\t273\n1972\tBrain Imaging of Psychotherapy for Depression\t\tneurological\t27\n1976\tU-500R Insulin In Type 2 Diabetes With Severe Insulin Resistance Via Omnipod\tPhase 4\tdiabetes\t21\n1990\tChronic Hepatitis Intervention Project for Drug Users\tPhase 3\thepatitis\t851\n1993\tAlcohol in the Treatment of Obesity\t\talcohol\t18\n2005\tA Phase I Study of ABT-510 in Combination With Bevacizumab in Advanced Solid Tumors\tPhase 1\ttumors\t45\n2011\tExenatide Pregnancy Registry - Type 2 Diabetes in Pregnancy\tPhase 4\tdiabetes\t7\n2018\tDuke Conte Center for the Neuroscience of Depression in Late Life\t\tneurological\t795\n2022\tPathogenesis and Genetics of Environmental Asthma Ozone Study\t\tasthma\t170\n2023\tSorafenib Combined With Cisplatin and Etoposide or Carboplatin and Pemetrexed in Treating Patients With Metastatic Solid Tumors\tPhase 1\ttumors\t31\n2024\tA Randomized Double-Blind Study Testing the Effects of Pregabalin on Diabetic Neuropathy\tPhase 4\tneurological\t40\n2026\tENCORE: Exercise and Nutritional Interventions for Cardiovascular Health\t\theart disease\t144\n2028\tIsolation and Culture of Circulating Tumor Cells From Peripheral Blood\t\ttumors\t500\n2029\tRetisert and Cataract Surgery in Patients With Severe Uveitis\t\tsurgery\t21\n2030\tNeurocognitive Outcomes of Depression in the Elderly\t\telderly\t795\n2031\tUtility of Exercise-induced N-terminal (NT) Pro-brain Natriuretic Peptide Levels in Predicting Prognosis in Asymptomatic Aortic Stenosis\t\tneurological\t110\n2049\tPrecedex Versus Propofol-Awakening for Reducing Brain Injury Expansion\tPhase 1 / Phase 2\tneurological\t8\n2056\tEvaluation of Walk With Ease in Arthritis\tPhase 3\tarthritis\t468\n2065\tNICardipine Neuroprotection in AortiC Surgery (NICNACS)\tPhase 2\tsurgery\t7\n2067\tKetamine In Thoracic Surgery (KITS) Trial\tPhase 2\tsurgery\t40\n2071\tChanges in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed Progressive or Recurrent Primary Malignant Brain Tumors\t\ttumors\t16\n2079\tEffect of Nepafenac on Post-operative Macular Swelling Following Uncomplicated Cataract Surgery\tPhase 4\tsurgery\t82\n2085\tUse of Bicarbonate to Reduce the Incidence of Acute Renal Failure After Cardiac Surgery\t\tsurgery\t123\n2092\tAngiotensin-(1-7) in Treating Patients With Metastatic or Unresectable Solid Tumors\tPhase 1\ttumors\t18\n2094\tImproving Care for Primary Care Patients With Diabetes and Poor Literacy and Numeracy Skills\tPhase 4\tdiabetes\t110\n2095\tSafety and Efficacy Study of Re-treatment With Rituximab (MabThera/Rituxan) in Patients With Active Rheumatoid Arthritis Who Respond Poorly to Anti-TNF&#945; Therapies\tPhase 3\tarthritis\t341\n2097\tEffect of Burn Size on Cytomegalovirus Reactivation and Correlates of T Cell Immune Function in Burned Patients\t\tburns\t60\n2101\tThe Treatment of Insomnia in Patients With HIV Disease\tPhase 4\thiv\t44\n2111\tCigarette Smoke and Susceptibility to Influenza Infection\t\tinfluenza\t138\n2112\tDevelopment and Evaluation of A Mailed Arthritis Self-Management Program\t\tarthritis\t900\n2114\tFamily-supported Smoking Cessation for Chronically Ill Veterans\t\tsmoker study\t471\n2129\tLifestyle Modification for Obesity-Related Type 2 Diabetes\tPhase 4\tdiabetes\t90\n2132\tOvercoming Psychiatric Barriers to the Treatment of Hepatitis C\t\thepatitis\t101\n2148\tSleep Specialty Consultation: Improving Management of Sleep Disorders\t\tsleep study\t156\n2150\tImproving Drug Use for Elderly Heart Failure Patients\t\telderly\t314\n2153\tSafety Study of a Vitamin E Supplement in Normal Volunteers and Those With Both Allergy and Asthma\tPhase 1\tasthma\t16\n2157\tIntensive Diet and Exercise for Improving Knee Osteoarthritis in Obese and Overweight Older Adults\tPhase 2\tarthritis\t454\n2161\tZinc Supplements in Lowering Cadmium Levels in Smokers\tPhase 2\tsmoker study\t61\n2163\tEffects of an Alternative Treatment for Military Sexual Trauma on PTSD Symptoms Neurosteroids and Brain Function\t\tneurological\t34\n2164\tFunctional Brain Imaging of Medication Treatment Response in Mild Alzheimer&apos;s Disease Patients\tPhase 4\tneurological\t4\n2193\tExposure to Neurotoxins as Risk Factors for Amyotrophic Lateral Sclerosis\t\tneurological\t0\n2198\tEffect of Dexmedetomidine Upon Sleep Postoperatively\tPhase 4\tsleep study\t0\n2202\tStudy of Alemtuzumab Versus Anti-thymocyte Globulin to Help Prevent Rejection in Kidney and Pancreas Transplantation\tPhase 4\tkidney disease\t275\n2204\tLevetiracetam for Cramps Spasticity and Neuroprotection in Motor Neuron Disease\tPhase 2\tneurological\t20\n2205\tStudy of an Intervention to Improve Use of Life-saving Medications for Heart Disease\t\theart disease\t143\n2207\tA Patient-Spouse Intervention for Self-Managing High Cholesterol\t\theart disease\t255\n2209\tVinflunine and Erlotinib or Pemetrexed in Treating Patients With Unresectable or Metastatic Solid Tumors\tPhase 1\ttumors\t41\n2211\tExamining the Link Between Trace Elements and Cardiovascular Disease Risk Factors in Young Adults\t\theart disease\t4362\n2213\tThe Impact of Patient Involvement in Decision-Making About Heart Disease Prevention\t\theart disease\t120\n2220\tStudy of Valproic Acid to Treat HIV Infected Adults\tPhase 1\thiv\t14\n2223\tExtracranial Stereotactic Radiosurgery in Treating Patients With Solid Tumors\tPhase 1 / Phase 2\ttumors\t48\n2224\tA Church Based Intervention to Improve Diabetes Care\t\tdiabetes\t201\n2229\tPaclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine in Treating Patients With Advanced Metastatic Solid Tumors\tPhase 1\ttumors\t18\n2233\tWeight Management and Coping Skills Training For Patients With Knee Osteoarthritis\t\tarthritis\t412\n2234\tVatalanib and Everolimus in Treating Patients With Advanced Solid Tumors\tPhase 1\ttumors\t37\n2235\tExercise to Treat Depression in Individuals With Coronary Heart Disease\tPhase 3\theart disease\t101\n2244\tSelf-Management of Osteoarthritis\t\tarthritis\t523\n2247\tMeasuring Cholesterol in the Fasting and Postmeal State in Patients With Type 2 Diabetes\t\tdiabetes\t30\n2248\tSleep Disorders and Gastroesophageal Reflux Disease (GERD)\tPhase 4\tsleep study\t20\n2249\tEffect of Ozone on Airway Inflammation in Allergic Asthmatics Treated With Omalizumab\t\tasthma\t1\n2250\tGenetic Susceptibility to Ozone in Mild Asthmatic Volunteers\t\tasthma\t52\n2263\tA Phase I Study of STA-5312 in Subjects With Advanced or Metastatic Solid Tumors\tPhase 1\ttumors\t30\n2264\tBevacizumab Everolimus and Erlotinib in Treating Patients With Advanced Solid Tumors\tPhase 1\ttumors\t65\n2266\tEffects of Resistance and Aerobic Exercise on Cardiovascular Health\tPhase 2\theart disease\t261\n2276\tPolicosanol for the Treatment of Hypercholesterolemia\t\theart disease\t40\n2277\tImatinib Mesylate and Capecitabine in Treating Patients With Advanced Solid Tumors\tPhase 1\ttumors\t25\n2278\tImproving Sleep and Psychological Functioning in People With Depression and Insomnia\tPhase 4\tsleep study\t96\n2284\tA Trial to Assess the Efficacy and Safety of SPM 927 in Subjects With Painful Distal Diabetic Neuropathy\tPhase 2 / Phase 3\tneurological\t496\n2299\tComparing ASHC and CDSMP Outcomes In Arthritis\t\tarthritis\t416\n2303\tInterventions to Improve Hypertension Control and Reduce Cardiovascular Disease Risk\tPhase 2\theart disease\t574\n2310\tThe Role of Vitamins E and C in Maintaining Lung Health in People With Asthma\tPhase 1\tasthma\t16\n2314\tComparing Paroxetine and Duloxetine on Cardiovascular Measures\tPhase 2 / Phase 3\theart disease\t40\n2317\tTrial to Assess the Efficacy and Safety of SPM 927 (200 400 and 600mg/Day) in Subjects With Painful Distal Diabetic Neuropathy\tPhase 3\tneurological\t654\n2321\tPIE II: Pharmacological Intervention in the Elderly II\tPhase 3\telderly\t80\n2331\tTumor RNA Transfected Dendritic Cell Vaccines\tPhase 1\ttumors\t\n2344\tSafety of KAI-9803 for Injection With Angioplasty Following Heart Attack\tPhase 1 / Phase 2\theart disease\t154\n2351\tPainful HIV Neuropathy and Alpha-Lipoic Acid\tPhase 1 / Phase 2\thiv\t60\n2355\tAssessing the Results of Lip Surgery in Patients With Cleft Lip and Palate\tPhase 2 / Phase 3\tsurgery\t127\n2358\tHIV Symptom Management Program for African American Mothers\tPhase 3\thiv\t\n2363\tImaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma\tPhase 1\tsurgery\t18\n2364\tStudy of Karenitecin (BNP1350) in Patients With Brain Tumors\tPhase 2\ttumors\t40\n2366\tReduced Manipulation of the Aorta and Neurobehavioral Outcome Trial\tPhase 3\tneurological\t300\n2373\tPhase 1 Study OF CDC-501 in Patients With Solid Tumors\tPhase 1\ttumors\t24\n2382\tScreening Adolescents for Type 2 Diabetes Mellitus in a Community Clinic\t\tdiabetes\t400\n2383\tEffects of Magnesium on Individuals Undergoing Coronary Artery Bypass Graft Surgery\tPhase 2\tsurgery\t389\n2384\tImatinib Mesylate in Treating Patients With Primary Gastrointestinal Stromal Tumor That Has Been Completely Removed By Surgery\tPhase 3\ttumors\t732\n2394\tImatinib Mesylate in Treating Patients With Gastrointestinal Stromal Tumor That Has Been Completely Removed During Surgery\tPhase 2\ttumors\t89\n2396\tAntibiotics to Reduce Chorioamnionitis-Related Perinatal HIV Transmission\tPhase 3\thiv\t3720\n2397\tTreatment to Quit Smoking\tPhase 2\tsmoker study\t\n2398\tThe Genetics of Environmental Asthma\t\tasthma\t176\n2399\tIntensive Pharmacokinetics of the Nelfinavir-Rifabutin Interaction in Patients With HIV-Related Tuberculosis Treated With a Rifabutin-Based Regimen\t\ttuberculosis\t\n2407\tTo Determine the Prevalence of HIV and Other Related Infections Such as Hepatitis C Along With Associated Risk Behaviors in Patients With Severe Mental Illness (SMI).\t\thepatitis\t\n2408\tFinding Diabetes Mellitus Among Veterans\t\tdiabetes\t1276\n2415\tAcute Glycemic Effects of a Very Low Fat Diet in Type 2 Diabetes\t\tdiabetes\t\n2416\tActive Immunotherapy Of Metastatic Renal Cell Carcinoma Using Autologous Dendritic Cells Transfected With Autologous Total Tumor RNA\tPhase 1\ttumors\t\n2417\tA Safety and Feasibility Study of Active Immunotherapy in Patients With Metastatic Prostate Carcinoma Using Autologous Dendritic Cells Pulsed With Antigen Encoded in Amplified Autologous Tumor RNA\tPhase 1\ttumors\t\n2418\tEffectiveness of AZT and Nevirapine in Preventing HIV Transmission From Ugandan Mothers to Their Newborns\tPhase 3\thiv\t1500\n2419\tGenetic Study in Patients Receiving Treatment for Hodgkin&apos;s Disease or Childhood Brain Tumor\t\ttumors\t19\n2427\tTemozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors\tPhase 2\ttumors\t\n2428\tTemozolomide in Treating Patients With Brain Metastases\tPhase 2\tneurological\t\n2429\tTemozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors\tPhase 1 / Phase 2\ttumors\t30\n2437\tEffectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received Treatment\tPhase 4\thiv\t300\n2442\tPhase II Study of Stereotypes and Mental Retardation: Neurobiological Basis\tPhase 2\tneurological\t40\n2445\tMelphalan With or Without Tumor Necrosis Factor in Treating Patients With Locally Advanced Melanoma of the Arm or Leg\tPhase 3\ttumors\t216\n2446\tRadiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors\tPhase 1\ttumors\t21\n2447\tRadiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain Tumors\tPhase 1 / Phase 2\ttumors\t10\n2451\tIntrathecal Busulfan in Treating Patients With Recurrent Refractory or Metastatic Leptomeningeal Tumors\tPhase 1\ttumors\t20\n2452\tRadiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors\tPhase 1 / Phase 2\ttumors\t\n2458\tCarmustine Plus O(6)-Benzylguanine in Treating Patients With Recurrent or Progressive Gliomas of the Brain\tPhase 1\tneurological\t56\n2468\tMonoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain Tumors\tPhase 1\ttumors\t6\n2471\tMonoclonal Antibody Therapy in Treating Patients With Brain Metastases\tPhase 1 / Phase 2\tneurological\t6\n2476\tA Study of Retrovir in the Prevention of HIV Infection in Health Care Workers Accidentally Exposed to the Virus\t\thiv\t\n2478\tA Study of Zidovudine and T Lymphocyte Transfer in the Treatment of HIV Type III in Patients With AIDS\t\thiv\t\n2483\tA Prospective Double-Blind Study of Retrovir in Early HIV Infection\t\thiv\t\n2484\tA Pilot Study To Evaluate the Effect of Retrovir (Zidovudine: AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Associated Dementia and Neuromuscular Diseases\t\tneurological\t\n2485\tAn Oral Dose-Ranging Finding Study in Patients With HIV Disease CDC Classification Groups IIB III and IV-C2\t\thiv\t\n2490\tA Study of Zidovudine in the Prevention of HIV Infection in Individuals Exposed to the Virus\t\thiv\t\n2491\tA Study of Nonoxynol-9 (N-9) and HIV Infection\tPhase 3\thiv\t4400\n2492\tA Treatment IND for Retrovir Brand Zidovudine (AZT) Therapy of Pediatric Patients With HIV Disease\t\thiv\t\n2494\tiOmit: Reducing Intentional Insulin Misuse in Type 1 Diabetes\t\tdiabetes\t60\n2501\tTo Determine the Measurement Properties of the ACT in an African American Adolescent Population With Persistent Asthma\t\tasthma\t80\n2502\tTo Determine the Validity of the ACT in an Adolescent Population With Persistent Asthma\t\tasthma\t80\n2506\tSafety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV Infection\t\thiv\t40\n2507\tBiomarkers of Aging as Predictors of Kidney Transplant Function\t\tkidney disease\t35\n2515\tRespiratory Event-Related Potentials in Patients With Spinal Cord Injury\t\trespiratory disease\t40\n2521\tPatient Self-management and Gene Guided Therapy for Chronic Hepatitis C\t\thepatitis\t20\n2531\tOptimizing Outcomes in Women With Gestational Diabetes Mellitus and Their Infants\t\tdiabetes\t200\n2535\tCholesterol Medication Packaging Study\t\theart disease\t240\n2536\tDonepezil Compared to Placebo in Patients With Chronic Neuropathic Pain\tPhase 4\tneurological\t33\n2538\tTreatment of Acute HIV Infection With Quad Fixed-dose Combination (FDC) Tablet\tPhase 3\thiv\t30\n2539\tInternet-Based Osteoarthritis Pain Coping Skills Intervention\tPhase 3\tarthritis\t113\n2542\tTailored Smoking Cessation Treatment for LIVE FOR LIFE&#174; Participants\tPhase 2 / Phase 3\tsmoker study\t19\n2544\tSafety Efficacy and Dosing of Stereotactic Radiosurgery for Hepato-cellular Carc/Colo-rectal Liver Metastases\tPhase 1\tsurgery\t30\n2546\tMechanistic Evaluations of Pre-Cessation Therapies for Smoking Cessation\tPhase 3\tsmoker study\t282\n2553\tTitle: Comparative Effectiveness of Asthma Interventions Within an AHRQ PBRN\t\tasthma\t1040\n2556\tOxytocin Treatment of Alcohol Withdrawal\tPhase 1\talcohol\t14\n2557\tTemsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma Bone Sarcoma or Soft Tissue Sarcoma\tPhase 1\tneurological\t7\n2560\tPacing Affects Cardiovascular Endpoints in Patients With Right Bundle-Branch Block (The PACE-RBBB Trial)\t\theart disease\t16\n2561\tCollaborative Study Of Neurofeedback Training Of 6-18 Year Olds With Autism\tPhase 1\tneurological\t30\n2562\tProject POWER Adapting Project SAFE: Reducing STD/HIV Risk in Women Prisoners\t\thiv\t598\n2563\tFMRI Brain Activation of Aripiprazole Treatment in Autism Spectrum Disorders\tPhase 4\tneurological\t13\n2569\tTreatment of Acute HIV With Emtricitabine Tenofovir and Efavirenz (CID 0805)\tPhase 4\thiv\t90\n2571\tThe Effects of One-Time Pregnenolone Dehydroepiandrosterone (DHEA) or Placebo Administration On Withdrawal Symptoms Mood Craving And Cigarette Evaluation Ratings In Male Smokers\tPhase 2\tsmoker study\t22\n2572\tStudy to Evaluate HIV Viremia and Persistence in Acutely HIV-Infected ARV Na&#239;ve Patients Treated With Darunavir/Ritonavir and Etravirine\tPhase 4\thiv\t15\n2573\tEffect of Type 2 Diabetes Genetic Risk Information on Health Behaviors and Outcomes\t\tdiabetes\t450\n2574\tCognitive Effects of Inhalational Versus Intravenous General Anesthesia in the Elderly\t\telderly\t200\n2577\tRaltegravir as Early Therapy in African-Americans Living With HIV Study\tPhase 4\thiv\t43\n2580\tFeasibility of Cocooning Immunization Strategy With Influenza Vaccine\t\tinfluenza\t544\n2582\tErythropoietin Resistance in Anemia of Chronic Kidney Disease\t\tkidney disease\t32\n2584\tEvaluating a Web-Based Educational Program for Adults at Risk for Coronary Heart Disease (The Heart to Heart Feasibility Study)\t\theart disease\t186\n2588\tClonidine-induced Spinal Acetylcholine Release: Normal Volunteers vs. Neuropathic Pain\tPhase 2\tneurological\t43\n2589\tClonidine Versus Adenosine to Treat Neuropathic Pain\tPhase 2\tneurological\t24\n2594\tFunctional Brain Imaging and Employment in First-Episode Psychotic Patients Treated With Risperdal\tPhase 4\tneurological\t30\n2599\tTesting Pharmacological Therapies for Pregnant Smokers\tPhase 4\tsmoker study\t181\n2602\tSensory Re-Training Following Facial Surgery for Correction of Facial Skeletal Disharmony\tPhase 3\tsurgery\t186\n2604\tCoping Skills Training for Early Rheumatoid Arthritis\t\tarthritis\t105\n2611\tEffects of Nicotine Reduction on Smoking Behavior in ADHD Smokers\t\tsmoker study\t350\n2623\tDouble-Blind 2-Site Randomized Clinical Trial of Neurofeedback for ADHD\t\tneurological\t140\n2625\tStudy To Compare Single Dose Of Three Modified Release Formulations Of PF-04937319 With Immediate Release Material-Sparing-Tablet (IR MST) Formulation Previously Studied In Adults With Type 2 Diabetes Mellitus.\tPhase 1\tdiabetes\t39\n2641\tEvaluation of Behavioral Intervention for HIV Positive Prisoners in NC and TX\t\thiv\t381\n2642\tStudy of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120)\tPhase 2\tdiabetes\t36\n2643\tIntraoperative OCT Guidance of Intraocular Surgery\t\tsurgery\t802\n2646\tSchool Support as Structural HIV Prevention for Adolescent Orphans in Kenya\tPhase 2\thiv\t835\n2652\tA Novel Optical Spectral Imaging System for Imaging Breast Tumor Margins\t\ttumors\t210\n2668\tCP-868596 And CP-868596 Plus AG-013736 In Combination With Docetaxel In Advanced Solid Tumors\tPhase 1\ttumors\t50\n2669\tLidocaine For Neuroprotection During Cardiac Surgery\t\tsurgery\t476\n2680\tPhysical Activity Following Surgery Induced Weight Loss\t\tsurgery\t128\n2686\tThree Way Interaction Between Gabapentin Duloxetine and Donepezil in Patients With Diabetic Neuropathy\t\tneurological\t22\n2696\tStudy of Campral (Acamprosate) for Alcohol Dependence in a Family Medicine Clinic\tPhase 4\talcohol\t100\n2699\tComparison Of Molecular Targets In Mild To Severe Asthmatics And Healthy Subjects\tPhase 1\tasthma\t58\n2700\tCan Group Visits Improve Outcomes of Veterans With Diabetes\tPhase 3\tdiabetes\t239\n2706\tMEND-CABG (MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery)\tPhase 2\tsurgery\t900\n2710\tGW786034 in Treating Patients With Advanced Solid Tumors\tPhase 1\ttumors\t\n2715\tVaccine Therapy in Treating Patients With Metastatic Melanoma Who Are Undergoing Surgery for Lymph Node and Tumor Removal\tPhase 1 / Phase 2\ttumors\t\n2719\tA Study of Zidovudine in HIV-Infected Patients With Kidney Problems\tPhase 1\tkidney disease\t0\n2721\tWeight Loss and Exercise for Communities With Arthritis in North Carolina\tPhase 3\tarthritis\t820\n2725\tEvaluation of Moclobemide a Reversible MAO-A Inhibitor as an Adjunct to Nicotine Replacement Therapy in Female Smokers\tPhase 2\tsmoker study\t76\n2733\tEvaluating Once Daily Etravirine in Treatment-Naive Adults With HIV Infection\tPhase 2\thiv\t80\n2739\tEffects of Anti-HIV Therapy on Red Blood Cells of HIV-infected Mothers and Their Infants\t\thiv\t0\n2769\tTreatment for Teens With Alcohol Abuse and Depression\t\talcohol\t170\n2773\tDiabetes Self-Management &amp; Support LIVE\t\tdiabetes\t300\n2775\tCardioneuroablation for Neurocardiogenic Syncope\t\tneurological\t3\n2778\tHigh-Dose Trivalent Influenza Vaccine in Inducing Immune Response Patients With Central Nervous System Tumors\tPhase 1\tinfluenza\t60\n2781\tMechanisms and Functional Outcomes of Exercise Progression Models in the Elderly\t\telderly\t108\n2785\tA Prospective Evaluation of the Effect of Curcumin on Dose Limiting Toxicity and Pharmacokinetics of Irinotecan in Patients With Solid Tumors.\tPhase 1\ttumors\t23\n2786\tDeployment Related Mild Traumatic Brain Injury (mTBI)\t\tneurological\t1500\n2791\tSevere Asthma Research Program - Wake Forest University\t\tasthma\t700\n2798\tSymptomatic Pulmonary Arterial Hypertension After Mitral Valve Surgery\t\tsurgery\t100\n2812\tStudy to Evaluate the Bronchoprotective Effects of a Single Dose of N6022 in Patients With Mild Asthma\tPhase 1 / Phase 2\tasthma\t14\n2823\tProspective Evaluation of the Incidence of NSF in Patients With Kidney Disease Undergoing MR\t\tkidney disease\t2\n2828\tLymphedema Following Hand/Wrist Surgery in Women Post Axillary Node Dissection\tPhase 4\tsurgery\t206\n2854\tGlucose/Insulin Responses:Subjects With Type 2 Diabetes Consuming Diabetes-Specific vs Standard Nutritional Formulas\tPhase 3\tdiabetes\t54\n2855\tInduction of Donor Specific Tolerance in Recipients of Living Kidney Allografts by Donor FCRx Infusion\tPhase 2\tkidney disease\t60\n2858\tArthritis Self-Management Education Program\t\tarthritis\t690\n2860\tDonepezil in Treating Young Patients With Primary Brain Tumors Previously Treated With Radiation Therapy to the Brain\t\ttumors\t14\n2868\tEffect of Brain Lesion Severity on Treatment Response in Late-Life Depression\t\tneurological\t131\n2886\tPain and Stress Management for People With Rheumatoid Arthritis\tPhase 2\tarthritis\t280\n2888\tImmunotoxin Therapy in Treating Patients With Advanced Solid Tumors\tPhase 1\ttumors\t\n2900\tA Study of Foscarnet in the Treatment of HIV Infection in Patients Who Have Taken Zidovudine for a Long Time\tPhase 1\thiv\t12\n2915\tEarly Mobility for the Critically Injured Burn Patient\t\tburns\t150\n2922\tSafety and Immune Response of Candidate H1N1 Influenza Vaccine GSK2340274A Following Seasonal Influenza Vaccination in Adults\tPhase 1\tinfluenza\t133\n2925\tAutomated Chest Physiotherapy to Improve Outcomes in Neuro\t\tneurological\t40\n2932\tProof-Of-Concept Investigation With a Neurosteroid Analog (Ganaxolone) as a Smoking Cessation Candidate\tPhase 2\tsmoker study\t36\n2933\tCombination Bupropion / Varenicline for Smoking Cessation in Male Smokers\tPhase 2\tsmoker study\t376\n2934\tMeclizine as a Potential Smoking Cessation Treatment\tPhase 2\tsmoker study\t146\n2935\tConcurrent Bupropion / Varenicline for Smoking Cessation\tPhase 3\tsmoker study\t702\n2943\tTrial of Collaborative Depression Care Management for HIV Patients\t\thiv\t304\n2952\tSafety Study of MGD009 in B7-H3-expressing Tumors\tPhase 1\ttumors\t114\n2956\tStudy to Determine the Pharmacokinetics and Tolerability of Fluticasone Propionate MDPI and Fluticasone Propionate/Salmeterol MDPI Compared to High Strength FLOVENT&#174; DISKUS&#174; and ADVAIR&#174; DISKUS&#174; in Patients With Persistent Asthma 12 Years of Age and Older\tPhase 1\tasthma\t43\n2957\tPhase 1/2a Dose-Escalation Study of CRLX301 in Patients With Advanced Solid Tumors\tPhase 1 / Phase 2\ttumors\t60\n2959\tFirst in Human Dose Escalation Study of TEW-7197 in Subjects With Advanced Stage Solid Tumors\tPhase 1\ttumors\t50\n2962\tClinical Performance Study of the Ultra Influenza A&amp;B Test Using Nasal Swabs for Identifying Subjects Who Are Infected With the Influenza Virus Strain Type A or Type B\t\tinfluenza\t677\n2965\tSurgery and Oxaliplatin or Mitomycin C in Treating Patients With Tumors of the Appendix\tPhase 2\ttumors\t116\n2970\tSafety and Efficacy of LCL161 in Patients With Solid Tumors\tPhase 1\ttumors\t71\n2981\tEfficacy of Seprapack Sinus Dressing Versus No Dressing in the Prevention of Intranasal Adhesions Following Sinus Surgery\t\tsurgery\t\n2984\tStudy to Evaluate the Safety and Pharmacokinetics of MEDI9090 in Subjects With Advanced Solid Tumors\tPhase 1\ttumors\t36\n2990\tA Double Blind Open Label Comparator Study to Compare Treatments in 4 to 11 Year Old Patients With Asthma\tPhase 1\tasthma\t20\n3003\tStudy of A Cell-Phone System to Improve Health of Youth With Diabetes\t\tdiabetes\t74\n3004\tPharmacokinetics and Clinical Response of Tolvaptan in Neurocritical Care Patients\t\tneurological\t1\n3008\tThe Pathogenesis of Hepatitis C Virus Vertical Transmission\t\thepatitis\t50\n3009\tEfficacy and Safety of Beta-adrenoceptor Inverse Agonist Nadolol in Mild Asthma\tPhase 2\tasthma\t60\n3014\tNAPS-MS: NAtalizumab Effects on Parameters of Sleep in Patients With Multiple Sclerosis Experiencing Fatigue or Sleepiness\tPhase 4\tsleep study\t37\n3028\tA Phase 1 Dose Escalation Study of AMG 780 in Adult Subjects With Advanced Solid Tumors\tPhase 1\ttumors\t44\n3032\tTrial of Tasigna (Nilotinib) 400 mg Twice Daily Alone or With Gleevec (Imatinib Mesylate) 400 mg Daily for Patients With Advanced Gastrointestinal Stromal Tumor (GIST)\tPhase 2\ttumors\t5\n3034\tCollection and Extraction of Respiratory Specimens\t\trespiratory disease\t600\n3037\tSanofi H1N1 Influenza Vaccine Administered at Two Dose Levels in Adult and Elderly Populations\tPhase 2\tinfluenza\t406\n3041\tSafety and Dosage Study of RAD001 (Everolimus) in Combination With Current Standard of Care to Treat Advanced Solid Tumors.\tPhase 1\ttumors\t32\n3045\tStudy of IMC-1121B in Patients With Advanced Solid Tumors Not Responding To Standard Therapy\tPhase 1\ttumors\t25\n3055\tStudy of Tumor Necrosis Factor Receptor Fusion Protein Etanercept (Enbrel) in Psoriasis of the Hands and/or Feet\tPhase 1 / Phase 2\ttumors\t20\n3083\tSafety of the Candidate Vaccine C4-V3 Alone or With Interleukin-12 (IL-12) in HIV-Infected Patients Receiving Effective Anti-HIV Drug Therapy\tPhase 1\thiv\t12\n3089\tA Multicenter 2 Part Study to Assess the Efficacy and Safety of H.P. Acthar&#174; Gel in Subjects With Rheumatoid Arthritis\tPhase 4\tarthritis\t232\n3091\tOpen-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder\tPhase 2\tsleep study\t80\n3113\tExploring Massage Benefits for Arthritis of the Knee\tPhase 2\tarthritis\t222\n3144\tA Phase 1 Double-Blind Randomized Single Dose Escalation Safety Study of Intra-articular OP-1 in Subjects With Osteoarthritis of the Knee\tPhase 1\tarthritis\t33\n3154\tFibroScan in Patients With Hepatitis B and C Presenting for Liver Biopsy\tPhase 3\thepatitis\t300\n3157\tSafety and Tolerability of Pegylated Interferon (PEG-IFN) Alfa-2a in HIV Infected People\tPhase 2\thiv\t12\n3160\tA Study of 141W94 in Combination With Other Anti-HIV Drugs\tPhase 1\thiv\t48\n3173\tSoutheastern Diabetes Initiative Clinical Intervention\t\tdiabetes\t648\n3181\tRisk of Developing Antibodies to Heparin-PF4 After Heart Surgery\t\tsurgery\t1015\n3183\tA Study of Autologous Neo-Kidney Augment&#8482; (NKA) in Type 2 Diabetics With Chronic Kidney Disease\tPhase 2\tkidney disease\t50\n3188\tHeart to Health: A Combined Lifestyle and Medication Intervention to Reduce Cardiovascular Disease (CVD) Risk\t\theart disease\t489\n3191\tEarly Weight Bearing on Supracondylar Distal Femur Fractures in Elderly Patients\t\telderly\t200\n3204\tStudy to Investigate the Safety Pharmacokinetics Pharmacodynamics and Clinical Activity of GSK2126458 and GSK1120212 Combination Therapy in Subjects With Advanced Solid Tumors.\tPhase 1\ttumors\t69\n3205\tA Study of Influenza Virus Vaccines in Children and Adults\tPhase 2\tinfluenza\t600\n3211\tEarly Life Factors and Respiratory Health in Mexico City Children\t\trespiratory disease\t6800\n3213\tInfluenza Vaccine Feasibility Study in Children With Persistent Asthma\tPhase 4\tasthma\t50\n3222\tPTC596 in Patients With Advanced Solid Tumors\tPhase 1\ttumors\t60\n3227\tSafety and Efficacy Study of Single Doses of TT-034 in Patients With Chronic Hepatitis C\tPhase 1 / Phase 2\thepatitis\t9\n3228\tA Study to Evaluate the Safety Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABT-122 in Subjects With Rheumatoid Arthritis\tPhase 1\tarthritis\t19\n3230\tRESULT (REflux Surgery in Lung Transplantation) Preliminary Study Protocol\t\tsurgery\t647\n3232\tStudy of SCY-635 Pegasys and Copegus in Hepatitis C\tPhase 2\thepatitis\t11\n3235\tBioavailability and Food Effect Study of TKI258 (CSF Capsule vs. FMI Tablet) in Adult Patients With Advanced Solid Tumors\tPhase 1\ttumors\t63\n3241\tStudy of ACE-041 in Patients With Advanced Solid Tumors or Relapsed/Refractory Multiple Myeloma\tPhase 1\ttumors\t37\n3254\tAffect Recognition: Enhancing Performance of Persons With Acquired Brain Injury (ABI)\tPhase 2 / Phase 3\tneurological\t71\n3261\tEffects of Treating Obstructive Sleep Apnea in Epilepsy\tPhase 2\tepilepsy\t68\n3264\tRisk Evaluation and Education for Alzheimer&apos;s Disease - the Study of Communicating Amyloid Neuroimaging (REVEAL-SCAN)\t\tneurological\t270\n3284\tEvaluating the Impact of Year Long Augmented Diabetes Self Management Support\t\tdiabetes\t449\n3288\tThe Tobacco Alcohol Prescription Medication and Other Substances Tool\t\talcohol\t2000\n3317\tBioavailability and Food Effect Study of TKI258 (CSF Capsules vs. FMI Capsules)in Adult Patients With Advanced Solid Tumors\tPhase 1\ttumors\t60\n3320\tSafety Trial of Single Versus Multiple Dose Thymoglobulin Induction in Kidney Transplantation\tPhase 2\tkidney disease\t99\n3329\tPharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) Tumors\tPhase 2\ttumors\t26\n3333\tA Study of R547 in Patients With Advanced Solid Tumors.\tPhase 1\ttumors\t58\n3342\tDose-Escalation Study Of SB-485232 Administered As Daily Subcutaneous Injections In Adults With Solid Tumors\tPhase 1\ttumors\t25\n3344\tDonepezil or EGb761 in Improving Neurocognitive Function in Patients Who Have Previously Undergone Radiation Therapy for Primary Brain Tumor or Brain Metastases\tPhase 2\ttumors\t\n3345\tOmega-3 Fatty Acids That Affect the Immune System in Kidney Transplant Patients\tPhase 0\tkidney disease\t75\n3347\tSingle Dose and 34-Day Tolerance Study of INGAP Peptide in Insulin Deficient Patients\tPhase 1 / Phase 2\tdiabetes\t62\n3349\tImproving Diabetes Care Via Telephone Assessment and Patient Education\t\tdiabetes\t480\n3352\tTrial of Nonpharmacologic Interventions in Elderly (TONE)\tPhase 3\telderly\t\n3359\tSafety Study of Inhaled Carbon Monoxide to Treat Acute Respiratory Distress Syndrome (ARDS)\tPhase 1\trespiratory disease\t48\n3363\tDovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors\tPhase 2\ttumors\t0\n3373\tCardiovascular Effects of Exposure to Ozone\t\theart disease\t90\n3374\tA Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors\tPhase 1\ttumors\t30\n3382\tDosimetry Study of I-131-CLR1404 in Patients With Relapsed or Refractory Advanced Solid Tumors\tPhase 1\ttumors\t9\n3383\tStudy to Compare the Safety and Anti-HIV Effect of GSK1265744 Versus Placebo in HIV-1 Infected Adults (ITZ112929)\tPhase 2\thiv\t9\n3385\tSafety Study of ABT-263 in Combination With Paclitaxel in Subjects With Solid Tumors\tPhase 1\ttumors\t19\n3396\tSafety and Tolerability Study of SNS-314 for Advanced Solid Tumors\tPhase 1\ttumors\t50\n3407\tA Comparison of Two Anti-HIV Drug Regimens for Youth Who Have Failed Prior Therapy\tPhase 2\thiv\t6\n3408\tSafety Assessment of Weekly Intravenous Infusions of SNS-595 for the Treatment of Solid Tumors\tPhase 1\ttumors\t\n3409\tInitial Safety Assessment of SNS-595 for the Treatment of Solid Tumors.\tPhase 1\ttumors\t\n3412\tNBI-3001 Followed by Surgery in Treating Patients With Recurrent Glioblastoma Multiforme\tPhase 2\tsurgery\t\n3422\tRadiation Therapy Plus Thalidomide and Temozolomide in Treating Patients With Newly Diagnosed Brain Metastases\tPhase 2\tneurological\t\n3444\tA Non-Invasive Neuromodulation Device for Treatment of Migraine Headache\t\tneurological\t81\n3448\tA Smoking Cessation Study to Understand the Biological and Functional Changes After One Year of Smoking Cessation\t\tsmoker study\t1020\n3455\tIL13-PE38QQR Infusion After Tumor Resection Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma\tPhase 1\ttumors\t24\n3468\t2010-2011 Trivalent Influenza Vaccine (TIV) in Pregnant Women\tPhase 2\tinfluenza\t183\n3473\tCombination Study of BMS-754807 and Erbitux&#174; in Subjects With Advanced or Metastatic Solid Tumors\tPhase 1 / Phase 2\ttumors\t54\n3478\tPhase II Trial of Silymarin for Patients With Chronic Hepatitis C Who Have Failed Conventional Antiviral Treatment\tPhase 2\thepatitis\t154\n3480\tEfficacy and Safety Study of Caldolor (Intravenous Ibuprofen) in Hospitalized Adult and Pediatric Burn Patients\tPhase 3\tburns\t61\n3486\tAutologous Neo-Kidney Augment (NKA) in Patients With Type 2 Diabetes and Chronic Kidney Disease (CKD)\tPhase 2\tdiabetes\t30\n3490\tA Study Evaluating Oxybutynin in Patients With Neurogenic Overactive Bladder Associated With a Neurological Condition\tPhase 4\tneurological\t24\n3502\tA Study of the Safety and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee\tPhase 2\tarthritis\t81\n3505\tStudy of Diclofenac Capsules to Treat Pain Following Surgery in Children Ages 6 to &lt;17 Years of Age\tPhase 2\tsurgery\t30\n3507\tSafety and PK Study of CC-90003 in Relapsed/Refractory Solid Tumors\tPhase 1\ttumors\t19\n3517\tGenetic Studies of Non-Alcoholic Fatty Liver Disease\t\talcohol\t1000\n3530\tComparison of the Efficacy and Safety of Two Topical Creams for Pediatric Atopic Dermatitis\tPhase 4\tdermatitis\t100\n3531\tA Clinical Demonstration of EEG Brain-computer Interface for ALS Patients\t\tneurological\t27\n3534\tFLU A+B Nasal Swab Clinical Study\t\tinfluenza\t800\n3543\tStudy of XTL6865 in Patients With Chronic Hepatitis C Virus Infection\tPhase 1\thepatitis\t36\n3544\tThe Effects of the Magnetic Molecular Energizer (MME) on Diabetic Peripheral Neuropathy\tPhase 3\tneurological\t100\n3558\tTradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis\tPhase 2\tdermatitis\t150\n3563\tSafety Tolerability and PK of AN2728 in Adolescents With Atopic Dermatitis\tPhase 1 / Phase 2\tdermatitis\t23\n3575\tStudy of Indomethacin Capsules to Treat Pain Following Surgery in Children Ages 6 to &lt;17 Years of Age\tPhase 2\tsurgery\t30\n3576\tA Phase 1/2 Study of MEDI4276 in Adults Subjects With Select HER2-expressing Advanced Solid Tumors.\tPhase 1 / Phase 2\ttumors\t216\n3581\tAutologous Cell Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery\tPhase 1 / Phase 2\tsurgery\t30\n3589\tTumor Collection From Routine Nephrectomy for Subjects With Advanced Stage RCC\t\ttumors\t11\n3590\tA Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated Biomarkers\tPhase 2\ttumors\t18\n3593\tA Study to Evaluate the Effectiveness and Safety of RXI 109 on the Outcome of Scar Revision Surgery in Healthy Adults\tPhase 2\tsurgery\t25\n3594\tA Phase 1 Open-label Safety Study of NKA in Patients With Type 2 Diabetes\tPhase 1\tdiabetes\t1\n3597\tA First-in-Human Double Blind Single Dose Study in Healthy Subjects and Subjects With Mild Atopic Asthma.\tPhase 1\tasthma\t70\n3612\tHyperbaric Oxygen Therapy (HBO2) for Persistent Post-concussive Symptoms After Mild Traumatic Brain Injury (mTBI)\tPhase 2\tneurological\t79\n3613\tCollection and Testing of Respiratory Samples\t\trespiratory disease\t272\n3614\t1-Methyl-D-Tryptophan and Docetaxel in Treating Patients With Metastatic Solid Tumors\tPhase 1\ttumors\t27\n3619\tA Phase 2a Study to Evaluate the Safety and Efficacy of AZX100 in Trocar Sites of Arthroscopic Shoulder Surgery Patients\tPhase 2\tsurgery\t150\n3626\tPhase 2 Study of the Safety of Diannexin in Kidney Transplant Recipients\tPhase 2\tkidney disease\t58\n3631\tInfluenza Vaccine in Premature Infants\tPhase 4\tinfluenza\t66\n3640\tRegistry for African Americans With Early Rheumatoid Arthritis\t\tarthritis\t357\n3643\tStudy of Adding Entecavir to Current Lamivudine Therapy in HIV and HBV Co-Infected Patients\tPhase 2 / Phase 3\thiv\t\n3648\tOpen Label Drug-Drug Interaction (DDI) Study of Dupilumab (REGN668/SAR231893) in Patients With Moderate to Severe Atopic Dermatitis (AD)\tPhase 1\tdermatitis\t14\n3666\tVaccine Immunotherapy for Recurrent Medulloblastoma and Primitive Neuroectodermal Tumor\tPhase 1 / Phase 2\ttumors\t50\n3669\tSafety Tolerability Pharmacokinetic and Pharmacodynamic Study of ABT-652 in Subjects With Excessive Daytime Sleepiness\tPhase 1\tsleep study\t36\n3671\tSafety Study of ABT-263 in Combination With Gemzar (Gemcitabine) in Subjects With Solid Tumors\tPhase 1\ttumors\t46\n3672\tAn Open-Label Treatment Protocol to Provide Metreleptin for the Treatment of Diabetes Mellitus and/or Hypertriglyceridemia Associated With Lipodystrophy\t\tdiabetes\t41\n3680\tEfficacy and Safety of Single Doses of Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) Compared to Placebo in Patients With Persistent Asthma\tPhase 2 / Phase 3\tasthma\t45\n3683\tStudy to Assess Steady-State Trough Concentrations Safety and Immunogenicity of Abatacept After Subcutaneous (SC) Administration to Subjects With Rheumatoid Arthritis (RA)\tPhase 1 / Phase 2\tarthritis\t87\n3691\tEvaluation of Specific Infection-Fighting Cells For Prediction of Immune Response to Anti-HIV and Immune-Boosting Medication\t\thiv\t0\n3698\tMethod-of-Use Study Assessing the Effect of Naltrexone Sustained Release (SR)/ Bupropion SR on Body Weight and Cardiovascular Risk Factors in Overweight and Obese Subjects\tPhase 3\theart disease\t242\n3717\tDabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery\tPhase 2\tsurgery\t280\n3724\tEvaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy\tPhase 3\theart disease\t4200\n3728\tA Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors\tPhase 4\tdiabetes\t12000\n3730\tThe Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects\tPhase 3\theart disease\t17000\n3731\tEvaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and Exacerbations in Moderate to Very Severe COPD Patients.\tPhase 4\theart disease\t4000\n3738\tFurther Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk\tPhase 3\theart disease\t27564\n3746\tGemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery\tPhase 3\tsurgery\t216\n3754\tIpilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery\tPhase 3\tsurgery\t1500\n3778\tComparison of Self Adjustment Versus Standard of Care Treatment in Subjects With Type 2 Diabetes\tPhase 4\tdiabetes\t5652\n3788\tThe Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects\tPhase 3\theart disease\t10653\n3795\tEfficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes\tPhase 3\tdiabetes\t1049\n3798\tA Study of RO4607381 in Stable Coronary Heart Disease Patients With Recent Acute Coronary Syndrome\tPhase 3\theart disease\t15865\n3799\tA Study to Describe Pediatric Influenza Vaccine Coverage\tPhase 4\tinfluenza\t147494\n3807\tA Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus\tPhase 3\tdiabetes\t19000\n3808\tA Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Events\tPhase 3\tdiabetes\t7637\n3811\tCardiovascular Inflammation Reduction Trial\tPhase 3\theart disease\t7000\n3818\tSafety and Efficacy of Albiglutide in Type 2 Diabetes\tPhase 3\tdiabetes\t310\n3819\tA Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes\tPhase 3\tdiabetes\t685\n3832\tCardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)\tPhase 3\theart disease\t10066\n3833\tPrevention of Cardiovascular Events (eg Death From Heart or Vascular Disease Heart Attack or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin\tPhase 3\theart disease\t21379\n3834\tCardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Comorbidities\tPhase 3\theart disease\t6198\n3848\tCardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)\tPhase 4\tdiabetes\t8300\n3850\tA Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease\tPhase 3\theart disease\t16415\n3851\tStrategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease\tPhase 3\tkidney disease\t756\n3852\tStudy of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease\tPhase 3\tdiabetes\t3207\n3853\tCardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)\tPhase 3\theart disease\t8910\n3854\tSAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma.\tPhase 4\tasthma\t11751\n3857\tEvaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)\tPhase 3\tdiabetes\t6068\n3858\tExenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus\tPhase 3\tdiabetes\t14000\n3866\tSafety and Efficacy Study of Albiglutide in Type 2 Diabetes\tPhase 3\tdiabetes\t309\n3874\tJUPITER - Crestor 20mg Versus Placebo in Prevention of Cardiovascular (CV) Events\tPhase 3\theart disease\t17802\n3879\tNaltrexone/Bupropion Cardiovascular Outcomes Study\tPhase 4\theart disease\t67\n3889\tCAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes\tPhase 3\tdiabetes\t6115\n3892\tCardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome\tPhase 3\tdiabetes\t5380\n3895\tA Study to Determine the Safety and Efficacy of Albiglutide in Patients With Type 2 Diabetes\tPhase 3\tdiabetes\t779\n3896\tSafety and Efficacy Study Comparing ABT-143 to Simvastatin in Subjects With Elevated Levels of Low Density Lipoprotein Cholesterol (&quot;Bad Cholesterol&quot;) and Triglycerides\tPhase 3\theart disease\t474\n3899\tStudy Evaluating 13 Valent Pneumococcal Conjugate Vaccine With Trivalent Inactivated Influenza Vaccine\tPhase 3\tinfluenza\t1116\n3929\tDocetaxel in Treating Patients With Solid Tumors\tPhase 2\ttumors\t109\n3932\tFurther Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk Open-label Extension\tPhase 3\theart disease\t5000\n3933\tNivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery\tPhase 2\tsurgery\t84\n3937\tNivolumab and Ipilimumab With or Without Sargramostim in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery\tPhase 2 / Phase 3\tsurgery\t400\n3940\tSafety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis\tPhase 4\tarthritis\t4000\n3944\tAfatinib After Chemoradiation and Surgery in Treating Patients With Stage III-IV Squamous Cell Carcinoma of the Head and Neck at High-Risk of Recurrence\tPhase 2\tsurgery\t3\n3946\tA Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes\tPhase 3\tdiabetes\t460\n3948\tDual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes\tPhase 3\tdiabetes\t1663\n3956\tA Study Of Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to or Are Unable to Tolerate Biologic and Non-Biologic Disease-modifying Antirheumatic Drugs (DMARDs)\tPhase 3\tarthritis\t886\n3972\tCisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors\tPhase 3\ttumors\t1\n3982\tEfficacy in Controlling Glycaemia With Victoza&#174; (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 Diabetes\tPhase 4\tdiabetes\t1994\n3989\tHigh-Dose Recombinant Interferon Alfa-2B Ipilimumab or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery\tPhase 3\tsurgery\t1378\n3992\tPhase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults\tPhase 3\tinfluenza\t1161\n3994\tIpilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery\tPhase 2\tsurgery\t168\n3998\tMulticenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events\tPhase 3\theart disease\t17276\n4005\tSafety and Efficacy of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients\tPhase 3\tarthritis\t397\n4010\tLiraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results - A Long Term Evaluation\tPhase 3\tdiabetes\t9340\n4015\tSafety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone Alone\tPhase 3\tdiabetes\t141\n4017\tAn Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants\t\trespiratory disease\t3000\n4019\tEfficacy and Long-Term Safety of Vildagliptin as Monotherapy in Patients With Type 2 Diabetes\tPhase 2 / Phase 3\tdiabetes\t338\n4023\tEfficacy of Lapaquistat Acetate Co-Administered With Statins in Subjects With Hypercholesterolemia\tPhase 3\theart disease\t411\n4024\tOut-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Metformin Only\tPhase 2\tdiabetes\t361\n4026\tA Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis\t\tdermatitis\t8037\n4043\tEffect of Albiglutide When Added to Standard Blood Glucose Lowering Therapies on Major Cardiovascular Events in Subjects With Type 2 Diabetes Mellitus\tPhase 4\tdiabetes\t9400\n4048\tNon-inferiority Study to Compare the Efficacy and Safety of Mylan&apos;s Insulin Glargine With Lantus&#174; in Type 2 Diabetes Mellitus Patients (INSTRIDE 2)\tPhase 3\tdiabetes\t600\n4054\tODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab\tPhase 3\theart disease\t18600\n4058\tA Study of Dalcetrapib in Patients With Stable Coronary Heart Disease With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease\tPhase 3\theart disease\t2220\n4061\tA Study of Fluzone&#174; High-Dose Vaccine Compared With Fluzone&#174; Vaccine In Elderly Adults\tPhase 4\telderly\t31989\n4066\tA Study of Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors\tPhase 4\tarthritis\t3080\n4070\tEffect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE&#8482; - Diabetes\tPhase 3\tdiabetes\t846\n4073\tEfficacy and Safety of Linagliptin (BI 1356) in Black/African Americans With Type 2 Diabetes With a MTT Sub-study\tPhase 3\tdiabetes\t234\n4075\tDoes Saxagliptin Reduce the Risk of Cardiovascular Events When Used Alone or Added to Other Diabetes Medications\tPhase 4\tdiabetes\t18206\n4078\tA Study of Tamiflu (Oseltamivir) for Treatment of Influenza With a Focus on (H1N1) 2009 Flu Strain\tPhase 4\tinfluenza\t102\n4082\tMulti-Year Study of Fluzone High-Dose Influenza Vaccine Compared With Fluzone&#174; Vaccine in Adults Aged 65 Years and Older\tPhase 3\tinfluenza\t9172\n4085\tCollecting Tumor Samples From Patients With Gynecological Tumors\t\ttumors\t275\n4096\tA Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis\tPhase 3\tarthritis\t619\n4101\tExubera Large Simple Trial To Evaluate Long-Term Pulmonary And Cardiovascular Safety\tPhase 4\theart disease\t1976\n4106\tA Clinical Trial Comparing Torcetrapib/Atorvastatin to Ezetimibe/Simvastatin In Subjects With A Cholesterol Disorder.\tPhase 3\theart disease\t1784\n4123\tNon-inferiority Study to Compare the Efficacy and Safety of Mylan&apos;s Insulin Glargine With Lantus&#174; in Type 1 Diabetes Mellitus Patients (INSTRIDE 1)\tPhase 3\tdiabetes\t500\n4125\tEvaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects\tPhase 3\theart disease\t1972\n4126\tSafety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD) Not on Dialysis\tPhase 3\tkidney disease\t2600\n4132\tRandomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events\tPhase 3\theart disease\t690\n4133\tEfficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes\tPhase 3\tdiabetes\t736\n4134\tEfficacy and Safety of Insulin Glargine/ Lixisenatide Fixed Ratio Combination Compared to Insulin Glargine Alone and Lixisenatide Alone on Top of Metformin in Patients With T2DM\tPhase 3\tdiabetes\t1170\n4137\tA Study of the Impact of Methotrexate (MTX) Discontinuation on the Efficacy of Subcutaneous Tocilizumab With Methotrexate in Participants With Moderate to Severe Active Rheumatoid Arthritis\tPhase 3\tarthritis\t718\n4139\tStudy of Safety of Foradil in Patients With Persistent Asthma\tPhase 4\tasthma\t827\n4144\tTrial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 Diabetes\tPhase 3\tdiabetes\t3297\n4148\tBevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors\tPhase 2\ttumors\t75\n4150\tEfficacy and Safety of Azilsartan Medoxomil Used in Combination With Metformin in Participants With Hypertension and Diabetes\tPhase 3\tdiabetes\t105\n4156\tLong-Term Safety and Tolerability of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients\tPhase 3\tarthritis\t233\n4168\tA Study to Evaluate the Immunogenicity of Quadrivalent Live Attenuated Influenza Vaccine (LAIV) in Children\tPhase 3\tinfluenza\t2312\n4169\tPROPHESYS 3: Observational Study on Predictors of Response in Patients With Treatment-na&#239;ve Chronic Hepatitis C Initiated on Treatment With Pegasys (Peginterferon Alfa-2a) or Peginterferon-alfa-2b\t\thepatitis\t1656\n4170\tSafety and Efficacy of XOMA 052 in Subjects With Type 2 Diabetes Mellitus on Stable Metformin Monotherapy\tPhase 2\tdiabetes\t421\n4172\tNovel Influenza A (H1N1) Surveillance Registry\t\tinfluenza\t894\n4173\tA Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease\tPhase 3\tdiabetes\t2118\n4184\tBiomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma\t\ttumors\t10000\n4186\tStudy of Kidney Tumors in Younger Patients\t\tkidney disease\t5000\n4196\tTrial to Evaluate the Efficacy of GSK Biologicals&apos; Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older\tPhase 3\tinfluenza\t43695\n4199\tA Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Thiazolidinedione or a Combination of Both.\tPhase 3\tdiabetes\t1189\n4206\tA Long-Term Placebo-Controlled X-Ray Study Investigating the Safety and Efficacy of SD-6010 in Subjects With Osteoarthritis of the Knee\tPhase 2 / Phase 3\tarthritis\t5077\n4216\tA Comparison of SYMBICORT&#174; pMDI With Budesonide HFA pMDI in African American Subjects With Asthma.\tPhase 3\tasthma\t742\n4225\tVincristine Dactinomycin and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I Stage II or Stage III Wilms&apos; Tumor\tPhase 3\ttumors\t808\n4228\tRosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On Insulin\tPhase 4\tdiabetes\t630\n4230\tStudy of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes Mellitus\tPhase 3\tdiabetes\t493\n4256\tDNA Variations in the Gene in Young Patients With Wilms&apos; Tumor\t\ttumors\t471\n4269\tLobradimil and Carboplatin in Treating Children With Brain Tumors\tPhase 2\ttumors\t\n4282\tSurgery in Treating Children With Neuroblastoma\tPhase 3\tsurgery\t968\n4289\tRadiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IV Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery\tPhase 2\tsurgery\t345\n4293\tA Study Comparing ABT-494 to Placebo and to Adalimumab in Subjects With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate\tPhase 3\tarthritis\t1500\n4300\tLong Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee\tPhase 3\tarthritis\t3000\n4304\tChronic Dosing Cross-Over Study to Assess the Efficacy and Safety of Glycopyrronium (PT001) in Adult Subjects With Intermittent Asthma or Mild to Moderate Persistent Asthma\tPhase 2\tasthma\t249\n4305\tA Study of Apixaban in Patients With Atrial Fibrillation Not Caused by a Heart Valve Problem Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event Such as a Heart Attack or a Procedure to Open the Vessels of the Heart\tPhase 4\theart disease\t4600\n4307\tComparison of the Safety and Efficacy of HOE901-U300 With Lantus in Older Patients With Type2 Diabetes Insufficiently Controlled on Their Current Antidiabetic Medications\tPhase 3\tdiabetes\t1014\n4312\t24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension\tPhase 3\tdiabetes\t154\n4314\tA Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma\tPhase 3\tasthma\t1140\n4317\tEfficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-na&#239;ve Subjects With Type 2 Diabetes\tPhase 3\tdiabetes\t1082\n4326\tRandomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events\tPhase 3\theart disease\t2139\n4331\tPazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors\tPhase 2\ttumors\t165\n4337\tComparison Study of the Glycemic Effects Safety and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes Mellitus\tPhase 3\tdiabetes\t365\n4342\tMonthly And Twice Monthly Subcutaneous Dosing Of PF-04950615 (RN316) In Hypercholesterolemic Subjects On A Statin\tPhase 2\theart disease\t356\n4349\tA Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High Risk Patients With Hypertriglyceridemia and on Statin. The Primary Objective is to Evaluate the Effect of 4 g/Day AMR101 for Preventing the Occurrence of a First Major Cardiovascular Event.\tPhase 3\theart disease\t8000\n4350\tEfficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes\tPhase 3\tdiabetes\t2454\n4353\tA 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents\tPhase 3\tasthma\t12463\n4358\tStudy to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and Diabetes\tPhase 4\tdiabetes\t975\n4361\tA Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate (MTX) in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One Tumor Necrosis Factor (TNF)-Inhibitor\tPhase 4\tarthritis\t96\n4373\tA Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment.\tPhase 3\tdiabetes\t507\n4376\tA Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus\tPhase 3\tdiabetes\t7226\n4379\tEfficacy and Safety of BI 10773 in Combination With Insulin in Patients With Type 2 Diabetes\tPhase 2\tdiabetes\t494\n4381\tEfficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus\tPhase 2\tdiabetes\t426\n4383\tA Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine\tPhase 3\tdiabetes\t586\n4384\tSafety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Pioglitazone\tPhase 3\tdiabetes\t252\n4387\tSafety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Glimepiride With or Without Metformin\tPhase 3\tdiabetes\t677\n4393\tCollecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma\t\ttumors\t1000\n4406\tSafety and Efficacy of Ramelteon in Elderly Subjects With Chronic Insomnia\tPhase 3\telderly\t829\n4408\tA Double-blind Parallel Group Placebo-Controlled Outpatient Trial of PD 00200390 in Adults With Nonrestorative Sleep\tPhase 2\tsleep study\t306\n4413\tA Study In Patients With Neuropathic Pain From Post-Herpetic Neuralgia (PHN)\tPhase 2\tneurological\t376\n4414\tEarly Versus Delayed Enteral Feeding and Omega-3 Fatty Acid/Antioxidant Supplementation for Treating People With Acute Lung Injury or Acute Respiratory Distress Syndrome (The EDEN-Omega Study)\tPhase 3\trespiratory disease\t272\n4419\tComparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma\tPhase 3\tneurological\t665\n4426\tEfficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Knee\tPhase 3\tarthritis\t1020\n4436\tA Study of the Safety of Rituxan in Patients With Rheumatoid Arthritis After an Inadequate Response to Previous Anti-TNF Therapy (SUNSTONE)\tPhase 4\tarthritis\t1026\n4437\tAirway Limitation Study: Study In Primary Care Centers Of Chronic Bronchitis In Long-Term Cigarette Smokers Of At Least 40 Years Of Age With Symptoms Of Cough And Shortness Of Breath\t\tsmoker study\t1283\n4439\tLong-Term Effectiveness And Safety Of CP-690550 For The Treatment Of Rheumatoid Arthritis\tPhase 3\tarthritis\t4500\n4440\tEffect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 Diabetes\tPhase 3\tdiabetes\t560\n4452\tEfficacy and Safety Study of Alogliptin and Insulin in the Treatment of Type 2 Diabetes.\tPhase 3\tdiabetes\t390\n4453\tThe DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Patients With Type 2 Diabetes (IOOV)\tPhase 4\tdiabetes\t2091\n4461\tExtension Study of the Safety and Efficacy of Armodafinil in the Treatment of Patients With Excessive Sleepiness\tPhase 3\tsleep study\t743\n4462\tEfficacy and Safety of Adalimumab in Patients With Active Rheumatoid Arthritis Treated Concomitantly With Methotrexate.\tPhase 3\tarthritis\t619\n4467\tA Study of Torcetrapib/Atorvastatin vs Atorvastatin Alone or Placebo in Patients With High Cholesterol\tPhase 3\theart disease\t3800\n4468\tA Coronary IVUS Study to Compare Torcetrapib/Atorvastatin to Atorvastatin Alone in Subjects With Coronary Heart Disease\tPhase 3\theart disease\t1100\n4469\tStudy of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children\tPhase 3\trespiratory disease\t6635\n4470\tTrivalent Live Cold Adapted Influenza Vaccine (CAIV-T) Against Inactivated Influenza Vaccine (TIV) in Children 6&#8211;59 Months of Age\tPhase 3\tinfluenza\t8500\n4474\tA Study of the Safety and Efficacy of Nitric Oxide Reduction in Patients With Cardiogenic Shock After a Heart Attack\tPhase 3\theart disease\t658\n4475\tStudy of Muraglitazar Versus Pioglitazone in Type 2 Diabetes\tPhase 3\tdiabetes\t1440\n4476\tStudy Of Asthma In Patients Of African Descent\tPhase 4\tasthma\t479\n4489\tEffect Of Carvedilol Versus Metoprolol On Glycemic Control In Patients With Type II Diabetes And Hypertension\tPhase 4\tdiabetes\t501\n4494\tAtazanavir for HIV Infected Individuals: An Early Access Program\t\thiv\t\n4495\tEvaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a Sulfonylurea\tPhase 3\tdiabetes\t377\n4496\tEvaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With Metformin\tPhase 3\tdiabetes\t336\n4498\tIsotretinoin With or Without Dinutuximab Aldesleukin and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma\tPhase 3\tneurological\t1449\n4503\tEvaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases\t\tneurological\t59\n4528\tRadiation Therapy With or Without Radiosurgery in Treating Patients With Brain Metastases\tPhase 3\tsurgery\t333\n4540\tA Study to Compare ABT-494 to Placebo in Subjects With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response or Intolerance to Biologic DMARDs\tPhase 3\tarthritis\t450\n4544\tExtension Study to Assess Safety and Efficacy of Mylan&apos;s Insulin Glargine and Lantus&#174; in Type 1 Diabetes Mellitus Patients\tPhase 3\tdiabetes\t138\n4550\tEfficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes\tPhase 3\tdiabetes\t1860\n4554\tA Study Looking at Targeted Therapy According to Tumor Markers for People With Meningiomas\tPhase 2\ttumors\t56\n4557\tA Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis\tPhase 3\tkidney disease\t432\n4562\tEvaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest)\tPhase 3\tasthma\t1858\n4563\t&quot;A Long-Term Safety Study of JZP-110 in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or OSA&quot;\tPhase 3\tsleep study\t600\n4564\t&quot;Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in Narcolepsy&quot;\tPhase 3\tsleep study\t240\n4579\tA Study of Evacetrapib (LY2484595) in Participants With High Cholesterol\tPhase 3\theart disease\t366\n4581\tBGJ398 for Patients With Tumors With FGFR Genetic Alterations\tPhase 2\ttumors\t90\n4586\tConcomitant Administration of 13-valent Pneumococcal Conjugate Vaccine (13vPnC) With Influenza Vaccine in 23-valent Pneumococcal Polysaccharide (23vPS) Pre-vaccinated Adults.\tPhase 4\tinfluenza\t882\n4589\tA Study to Examine Patient Characteristics Health Care Management and Health Outcomes of Hepatitis C Virus (HCV) Patients Treated With Simeprevir\tPhase 4\thepatitis\t315\n4590\tA Study of the Efficacy and Safety of Etrolizumab in Ulcerative Colitis Participants Who Are Refractory to or Intolerant of Tumor Necrosis Factor (TNF) Inhibitors\tPhase 3\ttumors\t800\n4598\tCardiovascular Outcomes Following Ertugliflozin Treatment in Type 2 Diabetes Mellitus Participants With Vascular Disease The VERTIS CV Study (MK-8835-004)\tPhase 3\tdiabetes\t8000\n4600\tUNITY 1: A Study of an Investigational Treatment Regimen of Daclatasvir (DCV) + Asunaprevir (ASV) + BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) for 12 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Genotype 1 Infection in Non-cirrhotic Subjects\tPhase 3\thepatitis\t416\n4604\tA Golimumab Phase 3b Multicenter Assessment of Intravenous Efficacy in Rheumatoid Arthritis Subjects Who Have Diminished Disease Control Despite Treatment With Infliximab (REMICADE&#174;)\tPhase 3\tarthritis\t11\n4607\tStudy of Intra-articular Injections vs Placebo in Patients With Pain From Osteoarthritis of the Knee\tPhase 3\tarthritis\t287\n4610\tTAK-875 (Fasiglifam) in Combination With Sitagliptin in Adults With Type 2 Diabetes\tPhase 3\tdiabetes\t90\n4615\tA Study on The Potential of Aleglitazar to Reduce Cardiovascular Risk in Patients With Stable Cardiovascular Disease and Glucose Abnormalities\tPhase 3\theart disease\t1999\n4617\tA Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Nephropathy\tPhase 2\tdiabetes\t226\n4620\tA Trial of NNC0109-0012 an Anti-IL-20 Biologic in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Anti-TNFa Biologics\tPhase 2\tarthritis\t239\n4623\tSafety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza\tPhase 3\tinfluenza\t1941\n4626\tA Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone\tPhase 3\tdiabetes\t442\n4627\tComparison of Fasiglifam (TAK-875) to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes\tPhase 3\tdiabetes\t916\n4631\tComparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Basal Insulin With Oral Antidiabetic Therapy\tPhase 3\tdiabetes\t811\n4633\tHCV-TARGET- Hepatitis C Therapeutic Registry and Research Network\t\thepatitis\t4500\n4636\tComparison of TAK-875 (Fasiglifam) With Placebo in Participants With Type 2 Diabetes\tPhase 3\tdiabetes\t421\n4658\tEvaluation of Long-term Safety and Effectiveness of Fostamatinib in the Treatment of Rheumatoid Arthritis (RA)\tPhase 3\tarthritis\t1917\n4666\tSafety of Buprenorphine Transdermal Patch (BTDS) in Osteoarthritis Pain: a 52-Week Extension Phase\tPhase 3\tarthritis\t196\n4669\tA Study in Participants With Diabetic Kidney Disease\tPhase 2\tkidney disease\t417\n","comment":"","msgTable":[[{"key":"study","value":"2"},{"key":"study","value":"Study of the Efficacy Safety &amp; Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury"},{"key":"study","value":"Phase 2"},{"key":"study","value":"burns"},{"key":"study","value":"150"}],[{"key":"phase","value":"3"},{"key":"phase","value":"Study of the Efficacy Safety and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis"},{"key":"phase","value":"Phase 2"},{"key":"phase","value":"dermatitis"},{"key":"phase","value":"450"}],[{"key":"category","value":"4"},{"key":"category","value":"DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis"},{"key":"category","value":"Phase 2"},{"key":"category","value":"fasciitis"},{"key":"category","value":"60"}],[{"key":"number_enrolled","value":"10"},{"key":"number_enrolled","value":"A Study Promoting Critical Illness Recovery in the Elderly-- Pilot"},{"key":"number_enrolled","value":""},{"key":"number_enrolled","value":"elderly"},{"key":"number_enrolled","value":"20"}],[{"value":"17"},{"value":"Probiotics in Occupational Shift Workers"},{"value":""},{"value":"probiotics"},{"value":"60"}],[{"value":"18"},{"value":"Protein Supplementation Post Bariatric Surgery"},{"value":""},{"value":"surgery"},{"value":"60"}],[{"value":"23"},{"value":"Optimal Volume Rate and Interval of Bolus Nerve Catheters for Shoulder Surgery"},{"value":"Phase 4"},{"value":"surgery"},{"value":"99"}],[{"value":"25"},{"value":"Magnetic Resonance Imaging of Human Biometrics"},{"value":""},{"value":"biometric"},{"value":"30"}],[{"value":"30"},{"value":"Neuroimaging Reward Behavioral Treatment and Smoking Cessation"},{"value":"Phase 1 / Phase 2"},{"value":"smoker study"},{"value":"100"}],[{"value":"34"},{"value":"Feasibility and Smokers&apos; Reactions to DNA Feedback"},{"value":""},{"value":"smoker study"},{"value":"100"}],[{"value":"37"},{"value":"TMS Modulation of Insula-related Brain Networks.02"},{"value":""},{"value":"neurological"},{"value":"60"}],[{"value":"42"},{"value":"A Pilot Study of Nocturnal Hypoglycemia Prevention in Type 1 Diabetes Using the Vigilant Diabetes Management Companion"},{"value":""},{"value":"diabetes"},{"value":"24"}],[{"value":"43"},{"value":"Combination Nicotine Patch / Lorcaserin for Smoking Cessation"},{"value":"Phase 2"},{"value":"smoker study"},{"value":"300"}],[{"value":"45"},{"value":"An Observational Study of Post-cesarean Delivery Respiratory Patterns Using a Non-invasive Minute Ventilation Monitor (Exspiron &#8482; System)"},{"value":""},{"value":"respiratory disease"},{"value":"100"}],[{"value":"48"},{"value":"Sleep Dysfunction and Neurocognitive Outcomes in Adolescent ADHD"},{"value":""},{"value":"neurological"},{"value":"60"}],[{"value":"53"},{"value":"Effects of Exercise Training Intensity on Fitness and Insulin Sensitivity in African Americans"},{"value":""},{"value":"diabetes"},{"value":"60"}],[{"value":"57"},{"value":"SIMT Stereotactic Radiosurgery Outcomes Study"},{"value":""},{"value":"surgery"},{"value":"40"}],[{"value":"71"},{"value":"COMRADE: Collaborative Care Management for Distress and Depression in Rural Diabetes"},{"value":""},{"value":"diabetes"},{"value":"139"}],[{"value":"83"},{"value":"Effects of E-cigarettes (ECIGs) on Pulmonary Inflammation and Behavior in HIV Infected Smokers"},{"value":""},{"value":"hiv"},{"value":"20"}],[{"value":"86"},{"value":"Study on Smoking Cessation and Cost Outcomes in the Duke Smoking Cessation Program"},{"value":""},{"value":"smoker study"},{"value":"3000"}],[{"value":"93"},{"value":"Mobile Technology and Online Tools to Improve Asthma Control in Adolescents"},{"value":"Phase 2"},{"value":"asthma"},{"value":"70"}],[{"value":"106"},{"value":"Mobile Technology and Online Tools to Improve Asthma Control in Adolescents - Usability"},{"value":"Phase 2"},{"value":"asthma"},{"value":"25"}],[{"value":"109"},{"value":"Intranasal Insulin and Post-stroke Cognition: A Pilot Study"},{"value":""},{"value":"diabetes"},{"value":"40"}],[{"value":"112"},{"value":"Respiratory Muscle Training in LOPD"},{"value":""},{"value":"respiratory disease"},{"value":"28"}],[{"value":"125"},{"value":"Bedside Ultrasound to Measure Optic Nerve Sheath Diameter in Pediatric CSF Shunts"},{"value":""},{"value":"nerve study"},{"value":"87"}],[{"value":"138"},{"value":"Qualitative Qualitative and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors"},{"value":""},{"value":"tumors"},{"value":"50"}],[{"value":"142"},{"value":"Analgesic Benefit of PECS Blocks for Biceps Tenodesis Shoulder Surgery"},{"value":"Phase 4"},{"value":"surgery"},{"value":"40"}],[{"value":"144"},{"value":"The Effect of Reducing Posttraumatic Stress Disorder Symptoms on Cardiovascular Risk"},{"value":""},{"value":"heart disease"},{"value":"120"}],[{"value":"145"},{"value":"Antagonism of Opioid-Induced Respiratory Depression by CX1739 With Preservation of Opioid Analgesia"},{"value":"Phase 2"},{"value":"respiratory disease"},{"value":"18"}],[{"value":"149"},{"value":"Efficacy and Tolerability of New Topical Formulations in Subjects With Atopic Dermatitis"},{"value":"Phase 4"},{"value":"dermatitis"},{"value":"53"}],[{"value":"178"},{"value":"Dietary Acid Load Kidney Function and Disability in Elderly"},{"value":""},{"value":"kidney disease"},{"value":"80"}],[{"value":"182"},{"value":"TMS Modulation of Insula-related Brain Networks"},{"value":""},{"value":"neurological"},{"value":"12"}],[{"value":"184"},{"value":"The Use of Tranexamic Acid to Reduce Blood Loss in Acetabular Surgery"},{"value":"Phase 3"},{"value":"surgery"},{"value":"65"}],[{"value":"186"},{"value":"Contrast-enhanced Ultrasound of the Kidney"},{"value":"Phase 2"},{"value":"kidney disease"},{"value":"75"}],[{"value":"190"},{"value":"Prospective Evaluation of Patient Reported Xerostomia After Whole Brain Radiation"},{"value":""},{"value":"neurological"},{"value":"60"}],[{"value":"193"},{"value":"Safety Study of CN-105 Neuroprotective Peptide for Intracerebral Hemorrhage"},{"value":"Phase 1"},{"value":"neurological"},{"value":"48"}],[{"value":"200"},{"value":"STepped Exercise Program for Knee OsteoArthritis"},{"value":""},{"value":"arthritis"},{"value":"345"}],[{"value":"207"},{"value":"Efficacy of Neuro+ Attention Training"},{"value":""},{"value":"neurological"},{"value":"60"}],[{"value":"210"},{"value":"The Compartmental Biology of HIV in the Male Genital Tract"},{"value":""},{"value":"hiv"},{"value":"24"}],[{"value":"212"},{"value":"Exercise Intolerance in Elderly Patients With HFpEF(Heart Failure With Preserved Ejection Fraction)"},{"value":""},{"value":"elderly"},{"value":"84"}],[{"value":"213"},{"value":"Stage Ib Trial of mSMART for Smoking Cessation Medication Adherence"},{"value":""},{"value":"smoker study"},{"value":"60"}],[{"value":"214"},{"value":"The KNEEhabilitation Study: Improving Disability in Individuals With Knee Osteoarthritis"},{"value":"Phase 1 / Phase 2"},{"value":"arthritis"},{"value":"90"}],[{"value":"230"},{"value":"Angiotensin Receptors and Age Related Mitochondrial Decline in HIV Patients"},{"value":"Phase 2"},{"value":"hiv"},{"value":"40"}],[{"value":"231"},{"value":"Vibratory Stimuli A Novel Rehabilitation Method for Preventing Post - Traumatic Knee Osteoarthritis"},{"value":""},{"value":"arthritis"},{"value":"75"}],[{"value":"244"},{"value":"Muscadine Grape Skin Extract in Treating Patients With Malignancy That Is Metastatic or Cannot Be Removed by Surgery"},{"value":"Phase 1"},{"value":"surgery"},{"value":"30"}],[{"value":"252"},{"value":"Reducing HIV Risk Among Adolescents: Evaluating Project HEART"},{"value":""},{"value":"hiv"},{"value":"222"}],[{"value":"254"},{"value":"Evaluation of Cardiorespiratory Performance After Interval Exercise Training Prior to Hematopoietic Cell Transplantation"},{"value":""},{"value":"respiratory disease"},{"value":"40"}],[{"value":"258"},{"value":"Neuromodulation Enhanced Cognitive Restructuring: A Proof of Concept Study"},{"value":""},{"value":"neurological"},{"value":"65"}],[{"value":"261"},{"value":"Lazanda Fentanyl Nasal Spray Pre Radiofrequency Nerve Ablations(RFA) of Lumbar Facet Joints"},{"value":"Phase 4"},{"value":"nerve study"},{"value":"23"}],[{"value":"265"},{"value":"Platelets as Regulators of Inflammation in Cardiac Surgery"},{"value":""},{"value":"surgery"},{"value":"100"}],[{"value":"270"},{"value":"Pain Coping Skills Training for African Americans With Osteoarthritis"},{"value":""},{"value":"arthritis"},{"value":"248"}],[{"value":"273"},{"value":"Effects of Smoking Environments on Craving and Smoking (CameraCue2.0)"},{"value":""},{"value":"smoker study"},{"value":"120"}],[{"value":"274"},{"value":"Incretin Action in Physiology and Diabetes"},{"value":"Phase 1"},{"value":"diabetes"},{"value":"25"}],[{"value":"279"},{"value":"Strengthening Instrumental Extinction to Prevent Smoking Relapse (VLNCCue)"},{"value":""},{"value":"smoker study"},{"value":"300"}],[{"value":"285"},{"value":"Nivolumab With DC Vaccines for Recurrent Brain Tumors"},{"value":"Phase 1"},{"value":"tumors"},{"value":"66"}],[{"value":"286"},{"value":"High Intensity Interval Training and Rheumatoid Arthritis"},{"value":""},{"value":"arthritis"},{"value":"26"}],[{"value":"295"},{"value":"Mobile Contingency Management for Smoking Cessation in Returning US Veterans"},{"value":""},{"value":"smoker study"},{"value":"260"}],[{"value":"301"},{"value":"Vestibular Function After Cochlear Implantation Using Soft Surgery Techniques"},{"value":""},{"value":"surgery"},{"value":"30"}],[{"value":"305"},{"value":"Telephone-based Smoking Cessation"},{"value":""},{"value":"smoker study"},{"value":"350"}],[{"value":"306"},{"value":"Using Question Prompt Lists During Pediatric Asthma Visits to Increase Adolescent Involvement"},{"value":""},{"value":"asthma"},{"value":"360"}],[{"value":"307"},{"value":"Temporary Autonomic Blockade to Prevent Atrial Fibrillation After Cardiac Surgery"},{"value":"Phase 1 / Phase 2"},{"value":"surgery"},{"value":"130"}],[{"value":"308"},{"value":"The Use of Aging Biomarkers to Predict Adverse Outcomes After Cardiac Surgery"},{"value":""},{"value":"surgery"},{"value":"186"}],[{"value":"310"},{"value":"Electronic Nicotine Delivery Systems as a Smoking Cessation Treatment"},{"value":"Phase 2"},{"value":"smoker study"},{"value":"300"}],[{"value":"311"},{"value":"Rejuvenated Washed Packed Red Blood Cells in Pediatric Cardiac Surgery"},{"value":"Phase 4"},{"value":"surgery"},{"value":"15"}],[{"value":"316"},{"value":"Feasibility of an Interval Exercise and Nutrition Intervention to Reduce Cardiovascular Disease Risk Factors"},{"value":""},{"value":"heart disease"},{"value":"15"}],[{"value":"327"},{"value":"Pathways to Improving Functional Capacity in Older Patients With Chronic Kidney Disease and Cardiovascular Disease"},{"value":""},{"value":"heart disease"},{"value":"0"}],[{"value":"328"},{"value":"Predictors of Opioid-Induced Respiratory Depression (OIRD)"},{"value":"Phase 1"},{"value":"respiratory disease"},{"value":"20"}],[{"value":"331"},{"value":"Personalized Health Planning in Shared Medical Appointments for Individuals With Type II Diabetes Pilot Study"},{"value":""},{"value":"diabetes"},{"value":"20"}],[{"value":"338"},{"value":"Systemic Steroids for Peripheral Nerve Blocks"},{"value":"Phase 4"},{"value":"nerve study"},{"value":"115"}],[{"value":"340"},{"value":"Study of Nasal Insulin to Fight Forgetfulness - Short-Acting Insulin Aspart"},{"value":"Phase 1"},{"value":"diabetes"},{"value":"30"}],[{"value":"341"},{"value":"Perineural Steroids for Peripheral Nerve Blocks"},{"value":"Phase 4"},{"value":"nerve study"},{"value":"115"}],[{"value":"361"},{"value":"VIDA Mobile Health Cardiovascular Prevention Program"},{"value":""},{"value":"heart disease"},{"value":"40"}],[{"value":"363"},{"value":"Acid-Base Compensation in Chronic Kidney Disease"},{"value":"Phase 1"},{"value":"kidney disease"},{"value":"16"}],[{"value":"372"},{"value":"Integrated Population Program for Diabetic Kidney Disease"},{"value":""},{"value":"kidney disease"},{"value":"131"}],[{"value":"373"},{"value":"Effects of Smoking Environment on Craving and Smoking"},{"value":""},{"value":"smoker study"},{"value":"41"}],[{"value":"374"},{"value":"PackHealth: Asthma Engagement Tool"},{"value":""},{"value":"asthma"},{"value":"50"}],[{"value":"375"},{"value":"Clinical Study to Evaluate Patient Outcomes Following Pharmacogenetic Testing of Subjects Exhibiting Neuropsychiatric Disorders"},{"value":""},{"value":"neurological"},{"value":"220"}],[{"value":"379"},{"value":"Determine the Prevalence and Severity of Asthma in HIV (Human Immunodeficiency Virus) Infected Patients"},{"value":""},{"value":"asthma"},{"value":"93"}],[{"value":"386"},{"value":"Obstructive Sleep Apnea in Pregnancy"},{"value":""},{"value":"sleep study"},{"value":"150"}],[{"value":"390"},{"value":"Does Physical Therapy Prevent Total Knee Arthroplasty in Patients With End Stage Osteoarthritis"},{"value":""},{"value":"arthritis"},{"value":"260"}],[{"value":"394"},{"value":"Website Application Based Education and Text Messaging in Improving Skin Wound Care in Patients Undergoing Mohs Surgery"},{"value":""},{"value":"surgery"},{"value":"90"}],[{"value":"397"},{"value":"Transplant Social Worker Support for Live Kidney Donation in African Americans"},{"value":""},{"value":"kidney disease"},{"value":"570"}],[{"value":"398"},{"value":"Nutrition Education for Cardiovascular Disease Prevention in Spinal Cord Injury"},{"value":""},{"value":"heart disease"},{"value":"200"}],[{"value":"406"},{"value":"Perampanel in Seizure Patients With Primary Glial Brain Tumors"},{"value":"Phase 4"},{"value":"tumors"},{"value":"71"}],[{"value":"431"},{"value":"FLT PET/MR for Evaluation of Pseudoprogression in Patients With Brain Lesions"},{"value":""},{"value":"neurological"},{"value":"15"}],[{"value":"433"},{"value":"NHALES (Natural History of Asthma With Longitudinal Environmental Sampling)"},{"value":""},{"value":"asthma"},{"value":"200"}],[{"value":"443"},{"value":"Causes of Comorbid Infertility Among Women With Rheumatoid Arthritis"},{"value":""},{"value":"arthritis"},{"value":"150"}],[{"value":"445"},{"value":"Physical Therapy Versus Internet-Based Exercise Training for Patients With Knee Osteoarthritis"},{"value":""},{"value":"arthritis"},{"value":"350"}],[{"value":"471"},{"value":"Effects of Neuromodulation on Verbal Fluency in Post-stroke Aphasia"},{"value":""},{"value":"neurological"},{"value":"12"}],[{"value":"473"},{"value":"Contingency Management Quitting Smoking and ADHD"},{"value":"Phase 1"},{"value":"smoker study"},{"value":"60"}],[{"value":"477"},{"value":"Relationship of Pulmonary Contusion to Pulmonary Inflammation and Incidence of Acute Respiratory Distress Syndrome"},{"value":""},{"value":"respiratory disease"},{"value":"10"}],[{"value":"478"},{"value":"Novel Biomarkers for Risk Prediction of Contrast-Induced Acute Kidney Injury Post Coronary Angiography"},{"value":""},{"value":"kidney disease"},{"value":"200"}],[{"value":"479"},{"value":"Respiratory Viral Infections in Pediatric Transplantation"},{"value":""},{"value":"respiratory disease"},{"value":"2669"}],[{"value":"487"},{"value":"Oxytocin Treatment of Alcohol Dependence"},{"value":"Phase 2"},{"value":"alcohol"},{"value":"50"}],[{"value":"492"},{"value":"Abstinence Reinforcement Therapy (ART) for Homeless Veteran Smokers"},{"value":""},{"value":"smoker study"},{"value":"165"}],[{"value":"493"},{"value":"Arthritis Pilot for Preserving Muscle While Losing Weight"},{"value":""},{"value":"arthritis"},{"value":"37"}],[{"value":"498"},{"value":"Function and Scoliosis Surgery"},{"value":""},{"value":"surgery"},{"value":"15"}],[{"value":"500"},{"value":"Study of an Emergency Department-based Intervention to Reduce Alcohol Misuse in Older Adults"},{"value":""},{"value":"alcohol"},{"value":"150"}],[{"value":"503"},{"value":"Effects of Chemoradiation and Surgery on Cardiopulmonary Fitness and Tumor Neoplastic Phenotype in Gastrointestinal Malignancies"},{"value":""},{"value":"tumors"},{"value":"25"}],[{"value":"504"},{"value":"Effect of Non-Alcoholic Steatohepatitis (NASH) on the Pharmacokinetics of 99mTechnetium-Mebrofenin"},{"value":"Phase 1"},{"value":"alcohol"},{"value":"20"}],[{"value":"510"},{"value":"Surgery Prevention by Transforaminal Injection of Epidural Steroids for Cervical Radicular Pain"},{"value":"Phase 4"},{"value":"surgery"},{"value":"60"}],[{"value":"513"},{"value":"Fabrication of a Definitive Cad/Cam Titanium Abutment Prior to Guided Surgery: a Pilot Study."},{"value":""},{"value":"surgery"},{"value":"28"}],[{"value":"521"},{"value":"The Effect of Prophylactic Antipyretics on Immune Responses and Fever After 2014-2015 and 2015-2016 Inactivated Influenza Vaccine"},{"value":"Phase 4"},{"value":"influenza"},{"value":"104"}],[{"value":"524"},{"value":"Electronic Medical Record Review in Monitoring the Effects of Adherence on Myelosuppression and Morbidity in Patients With Newly Diagnosed Brain Tumors Receiving Temozolomide and Radiation Therapy"},{"value":""},{"value":"tumors"},{"value":"240"}],[{"value":"525"},{"value":"A Validated Necrosis Assay to Determine the Need for Revision Surgery in Metal-on-metal Total Hip Arthroplasty"},{"value":""},{"value":"surgery"},{"value":"100"}],[{"value":"527"},{"value":"Phase I Study of HIV 1 Antigen Expanded Specific T Cell Therapy"},{"value":"Phase 1"},{"value":"hiv"},{"value":"12"}],[{"value":"530"},{"value":"Hydration Monitor Validation in Elderly"},{"value":""},{"value":"elderly"},{"value":"73"}],[{"value":"536"},{"value":"Multimodal Analgesia vs. Routine Care Pain Management for Lumbar Spine Fusion Surgery: A Prospective Randomized Study"},{"value":"Phase 4"},{"value":"surgery"},{"value":"124"}],[{"value":"543"},{"value":"TEA vs. PVB vs. PCA in Liver Resection Surgery"},{"value":""},{"value":"surgery"},{"value":"10"}],[{"value":"547"},{"value":"Aromatherapy Using a Nasal Clip After Surgery"},{"value":""},{"value":"surgery"},{"value":"300"}],[{"value":"550"},{"value":"Effects of Wood Smoke Particles on Influenza-induced Nasal Inflammation in Normal Volunteers"},{"value":"Phase 0"},{"value":"influenza"},{"value":"39"}],[{"value":"555"},{"value":"Hepatitis C Alcohol Reduction Treatment"},{"value":""},{"value":"alcohol"},{"value":"230"}],[{"value":"576"},{"value":"Pain Expectations in Subjects With Osteoarthritis"},{"value":"Phase 4"},{"value":"arthritis"},{"value":"30"}],[{"value":"577"},{"value":"A Double-Blind Placebo-Controlled Cross-over Study of Armodafinil Treatment of Daytime Sleepiness Associated With Treated Nocturia"},{"value":"Phase 2 / Phase 3"},{"value":"sleep study"},{"value":"27"}],[{"value":"578"},{"value":"Interleukin-2&#8212;Induced Cognitive/Affective/Sleep Symptoms"},{"value":""},{"value":"sleep study"},{"value":"30"}],[{"value":"587"},{"value":"A Pilot Study of a Non-Invasive Neuromodulation Device for Treatment of Parkinson&apos;s Disease"},{"value":""},{"value":"neurological"},{"value":"6"}],[{"value":"589"},{"value":"Determining Relationships Among Maternity Stress &amp; Sleep"},{"value":""},{"value":"sleep study"},{"value":"17"}],[{"value":"596"},{"value":"Examining the Effects of Neuromodulation on Glucose Metabolism in Type 2 Diabetes"},{"value":""},{"value":"diabetes"},{"value":"6"}],[{"value":"598"},{"value":"Multivitamin Adherence Following Bariatric Surgery"},{"value":""},{"value":"surgery"},{"value":"30"}],[{"value":"601"},{"value":"Exercise Heart Failure and Type 2 Diabetes"},{"value":""},{"value":"diabetes"},{"value":"0"}],[{"value":"609"},{"value":"Modulation of Insulin Sensitivity by Betaine Upregulation of FGF21"},{"value":""},{"value":"diabetes"},{"value":"23"}],[{"value":"611"},{"value":"Mobile Sensing of Smoking Behavior"},{"value":""},{"value":"smoker study"},{"value":"2"}],[{"value":"614"},{"value":"A Family-Based Diabetes Intervention for Hispanic Adults in an Emerging Community"},{"value":""},{"value":"diabetes"},{"value":"156"}],[{"value":"624"},{"value":"Anti-thrombin III (ATIII) vs Placebo in Children (&lt;7mo) Undergoing Open Congenital Cardiac Surgery"},{"value":"Phase 2"},{"value":"surgery"},{"value":"40"}],[{"value":"626"},{"value":"Efficacy of Intrathecal Oxytocin in Patients With Neuropathic Pain"},{"value":"Phase 2"},{"value":"neurological"},{"value":"40"}],[{"value":"628"},{"value":"A Safety and Efficacy Study of NNZ-2566 in Patients With Mild Traumatic Brain Injury (mTBI)"},{"value":"Phase 2"},{"value":"neurological"},{"value":"132"}],[{"value":"637"},{"value":"Nonconvulsive Seizure Identification on Quantitative EEG by Neuro ICU Nurses"},{"value":""},{"value":"neurological"},{"value":"30"}],[{"value":"639"},{"value":"Effects of a Cocoa Shot on the Human Brain 2"},{"value":"Phase 1"},{"value":"neurological"},{"value":"24"}],[{"value":"640"},{"value":"Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET)"},{"value":""},{"value":"tumors"},{"value":"85"}],[{"value":"646"},{"value":"Integrated Approaches for Identifying Molecular Targets in Alcoholic Hepatitis"},{"value":""},{"value":"alcohol"},{"value":"700"}],[{"value":"649"},{"value":"Study of Tolerability and Efficacy of BVS857 in Severe Burn Subjects"},{"value":"Phase 2"},{"value":"burns"},{"value":"1"}],[{"value":"652"},{"value":"Testing Methods of Self-persuasion Involving Cigarette Smoking"},{"value":""},{"value":"smoker study"},{"value":"48"}],[{"value":"659"},{"value":"Efficacy and Safety of the DASH Diet in Adults With Moderate Chronic Kidney Disease: Pilot Study"},{"value":""},{"value":"kidney disease"},{"value":"42"}],[{"value":"660"},{"value":"Use of Recombinant Hyaluronidase Human is Effective for the Use of Local Blocks for Eyelid&apos;s Surgery"},{"value":""},{"value":"surgery"},{"value":"0"}],[{"value":"663"},{"value":"Intravenous Exenatide in Patients With Acute Brain Injury"},{"value":"Phase 4"},{"value":"neurological"},{"value":"24"}],[{"value":"669"},{"value":"Improving Diabetes Outcomes for Persons With Severe Mental Illness"},{"value":""},{"value":"diabetes"},{"value":"25"}],[{"value":"678"},{"value":"Airway Inflammatory Response During Illness in Children With Respiratory Failure"},{"value":""},{"value":"respiratory disease"},{"value":"20"}],[{"value":"692"},{"value":"Three Approaches to Glucose Monitoring in Non-insulin Treated Diabetes"},{"value":""},{"value":"diabetes"},{"value":"450"}],[{"value":"701"},{"value":"Isolation of Circulating Tumor Cells Using a Novel EMT-Based Capture Method"},{"value":""},{"value":"tumors"},{"value":"80"}],[{"value":"709"},{"value":"Effects of Tobacco Products on Live Attenuated Influenza Virus (LAIV) Infections in Human Volunteers"},{"value":""},{"value":"influenza"},{"value":"100"}],[{"value":"712"},{"value":"Effects of Shock Absorbing Insoles on Knee Pain and Walking in Persons With Knee Osteoarthritis"},{"value":"Phase 2"},{"value":"arthritis"},{"value":"60"}],[{"value":"728"},{"value":"Echinacea and Acute Respiratory Illness"},{"value":""},{"value":"respiratory disease"},{"value":"40"}],[{"value":"736"},{"value":"Brain Connectivity in Age-Related Macular Degeneration"},{"value":""},{"value":"neurological"},{"value":"300"}],[{"value":"739"},{"value":"BABY STEPS II: SMS Scheduled Gradual Reduction Text Messages to Help Pregnant Smokers Quit"},{"value":""},{"value":"smoker study"},{"value":"522"}],[{"value":"743"},{"value":"Use of Technological Advances to Prevent Smoking Relapse Among Smokers With PTSD"},{"value":""},{"value":"smoker study"},{"value":"15"}],[{"value":"747"},{"value":"Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)"},{"value":"Phase 2"},{"value":"heart disease"},{"value":"250"}],[{"value":"751"},{"value":"Total Ankle Replacement for Ankle Arthritis"},{"value":""},{"value":"arthritis"},{"value":"1000"}],[{"value":"755"},{"value":"Efficacy and Safety of High Dose Baclofen for Alcohol Dependence"},{"value":"Phase 2"},{"value":"alcohol"},{"value":"120"}],[{"value":"757"},{"value":"Jump Starting Shared Medical Appointments for Diabetes With Weight Management"},{"value":""},{"value":"diabetes"},{"value":"308"}],[{"value":"760"},{"value":"Neurocognitive Visual Reaction Training"},{"value":""},{"value":"neurological"},{"value":"21"}],[{"value":"763"},{"value":"Effect of Tourniquet on Sensory Nerve Conduction Threshold (sNCT) and OxyNeuroGram (ONG) Index- A Volunteer Study"},{"value":""},{"value":"neurological"},{"value":"10"}],[{"value":"774"},{"value":"Study of Awareness and Detection of Familial Hypercholesterolemia"},{"value":""},{"value":"heart disease"},{"value":"5000"}],[{"value":"779"},{"value":"Complementary Neurosteroid Intervention in Gulf War Illnesses (GWVI)"},{"value":"Phase 2"},{"value":"neurological"},{"value":"140"}],[{"value":"781"},{"value":"Establishment of a Human Tissue Bank for Studying the Microbial Etiology of Neurodegenerative Diseases"},{"value":""},{"value":"neurological"},{"value":"300"}],[{"value":"787"},{"value":"Establishment of a Tissue Bank (Blood CSF) for the Understanding of the Disease Progression and Early Diagnosis of Motor Neuron Disease (MND)"},{"value":""},{"value":"neurological"},{"value":"1000"}],[{"value":"796"},{"value":"Brain Imaging of Intranasal Oxytocin Treatment in Autism"},{"value":"Phase 1"},{"value":"neurological"},{"value":"28"}],[{"value":"811"},{"value":"Evaluation of Efficacy and Accuracy of Aquamantys Device in General Surgery"},{"value":""},{"value":"surgery"},{"value":"20"}],[{"value":"813"},{"value":"Fluid Intake Application to Reduce Kidney Stone Risks"},{"value":""},{"value":"kidney disease"},{"value":"50"}],[{"value":"816"},{"value":"Effects of a Cocoa Shot on the Human Brain"},{"value":"Phase 0"},{"value":"neurological"},{"value":"6"}],[{"value":"818"},{"value":"The Effect of Anticholinergics on Cognitive Function in the Elderly"},{"value":"Phase 4"},{"value":"elderly"},{"value":"59"}],[{"value":"820"},{"value":"Blood Pressure Heart Rate Variability &amp; Sleep in Veterans With PTSD"},{"value":""},{"value":"sleep study"},{"value":"19"}],[{"value":"832"},{"value":"Auditory Brainstem Implantation in Young Children"},{"value":"Phase 0"},{"value":"neurological"},{"value":"10"}],[{"value":"836"},{"value":"CPT and Smoking Cessation"},{"value":"Phase 2 / Phase 3"},{"value":"smoker study"},{"value":"50"}],[{"value":"838"},{"value":"Virtual Reality for Osteoarthritis Knee Pain Pilot"},{"value":""},{"value":"arthritis"},{"value":"30"}],[{"value":"841"},{"value":"Neurosteroids as Novel Therapeutic Agents for Chronic Pain in OEF/OIF Veterans"},{"value":"Phase 2 / Phase 3"},{"value":"neurological"},{"value":"90"}],[{"value":"846"},{"value":"Observational Assessment of Baseline Asthma Control in African-American Children"},{"value":""},{"value":"asthma"},{"value":"25"}],[{"value":"873"},{"value":"Sleep Apnea and Visual Perceptual Skill Learning"},{"value":""},{"value":"sleep study"},{"value":"14"}],[{"value":"874"},{"value":"An Evaluation of Neurofeedback Efficacy in Adults With ADHD"},{"value":""},{"value":"neurological"},{"value":"30"}],[{"value":"877"},{"value":"Superior Laryngeal Nerve Block For Awake Endotracheal Intubation Study"},{"value":""},{"value":"nerve study"},{"value":"95"}],[{"value":"879"},{"value":"Sulforaphane Supplementation in Atopic Asthmatics"},{"value":"Phase 1"},{"value":"asthma"},{"value":"16"}],[{"value":"886"},{"value":"Environments as Smoking Cues: Imaging Brain Substrates Developing New Treatments (CameraCue)"},{"value":""},{"value":"smoker study"},{"value":"67"}],[{"value":"890"},{"value":"Translational Research Evaluating Neurocognitive Memory Processes"},{"value":""},{"value":"neurological"},{"value":"76"}],[{"value":"893"},{"value":"Latinos Combating Diabetes"},{"value":""},{"value":"diabetes"},{"value":"225"}],[{"value":"899"},{"value":"Simultaneous Risk Factor Control Using Telehealth to slOw Progression of Diabetic Kidney Disease (STOP-DKD)"},{"value":""},{"value":"kidney disease"},{"value":"285"}],[{"value":"900"},{"value":"Milnacipran and Neurocognition Pain and Fatigue in Fibromyalgia : A 13-week Randomized Placebo Controlled Cross Over Trial"},{"value":"Phase 3"},{"value":"neurological"},{"value":"26"}],[{"value":"908"},{"value":"Bone Metabolism After Bariatric Surgery"},{"value":""},{"value":"surgery"},{"value":"40"}],[{"value":"916"},{"value":"Parents and Children Together Preventing Diabetes (PACT PD)"},{"value":""},{"value":"diabetes"},{"value":"72"}],[{"value":"918"},{"value":"Nicotine Non-Smokers With and Without ADHD and Genetics Study"},{"value":"Phase 1"},{"value":"smoker study"},{"value":"150"}],[{"value":"925"},{"value":"Trial of Directed High-dose Nasal Steroids on Residual Smell Loss in Sinus Patients After Sinus Surgery"},{"value":"Phase 2"},{"value":"surgery"},{"value":"0"}],[{"value":"931"},{"value":"Postoperative Subtenons Anesthesia for Postoperative Pain in Pediatric Strabismus Surgery"},{"value":""},{"value":"surgery"},{"value":"57"}],[{"value":"941"},{"value":"Lifestyle Intervention for Treatment of Diabetes"},{"value":""},{"value":"diabetes"},{"value":"260"}],[{"value":"942"},{"value":"Empowering Rural African American Women and Communities to Improve Diabetes Outcomes"},{"value":""},{"value":"diabetes"},{"value":"200"}],[{"value":"945"},{"value":"Mindfulness: a Novel Approach for the Management of Diabetes-related Distress"},{"value":"Phase 2 / Phase 3"},{"value":"diabetes"},{"value":"90"}],[{"value":"951"},{"value":"PET/MRI in CNS and Extra-CNS Tumors of Patients With Neurofibromatosis-1 (NF1)"},{"value":""},{"value":"tumors"},{"value":"15"}],[{"value":"954"},{"value":"A Trial Examining the Efficacy of Escitalopram Oxalate Upon Depressive Symptoms and Fatigue in HIV Seropositive Women"},{"value":"Phase 4"},{"value":"hiv"},{"value":"5"}],[{"value":"959"},{"value":"Post-traumatic Arthritis Associated With Joint Injury"},{"value":""},{"value":"arthritis"},{"value":"30"}],[{"value":"963"},{"value":"Carolina Alcohol and Drug Resources"},{"value":""},{"value":"alcohol"},{"value":"690"}],[{"value":"967"},{"value":"Contingency Management for Smoking Cessation in Homeless Smokers"},{"value":""},{"value":"smoker study"},{"value":"25"}],[{"value":"972"},{"value":"Understanding the Response to Fesoterodine Through Genetic Evaluation in the Elderly (URGE)"},{"value":""},{"value":"elderly"},{"value":"66"}],[{"value":"973"},{"value":"iCare vs Tonopen vs Goldmann Applanation Post-vitrectomy Surgery"},{"value":""},{"value":"surgery"},{"value":"68"}],[{"value":"974"},{"value":"Regulation of Branched-chain Amino Acid Metabolism in Pre-Diabetes"},{"value":""},{"value":"diabetes"},{"value":"132"}],[{"value":"975"},{"value":"Neuromuscular Ultrasound in ALS"},{"value":""},{"value":"neurological"},{"value":"40"}],[{"value":"980"},{"value":"Pilot Testing a Patient and Provider Intervention for Managing Osteoarthritis in Hispanic Adults."},{"value":""},{"value":"arthritis"},{"value":"16"}],[{"value":"985"},{"value":"Advanced Comprehensive Diabetes Care for Veterans With Poorly-Controlled Diabetes"},{"value":"Phase 0"},{"value":"diabetes"},{"value":"50"}],[{"value":"994"},{"value":"Cryosurgery and Radiation Therapy in Treating Patients With Painful Bone Metastases"},{"value":""},{"value":"surgery"},{"value":"1"}],[{"value":"1000"},{"value":"Physiologic Mechanisms in Pediatric Traumatic Brain Injury (TBI)"},{"value":""},{"value":"neurological"},{"value":"60"}],[{"value":"1001"},{"value":"Neurophysiology of Postpartum Depression in an Experimental Model of Pregnancy and Parturition"},{"value":""},{"value":"neurological"},{"value":"30"}],[{"value":"1014"},{"value":"Delayed-Enhancement Cardiovascular Magnetic Resonance in Patients With Sarcoidosis"},{"value":""},{"value":"heart disease"},{"value":"400"}],[{"value":"1029"},{"value":"Study to Evaluate the Impact of FeNO Assessments on Asthma Management Decisions in Subject 7 to 60 Years of Age"},{"value":""},{"value":"asthma"},{"value":"50"}],[{"value":"1038"},{"value":"Abstinence Reinforcement Therapy (ART) for Rural Veteran Smokers"},{"value":""},{"value":"smoker study"},{"value":"300"}],[{"value":"1048"},{"value":"Exploring Massage Benefits for Arthritis of the Knee for VA Healthcare Users"},{"value":""},{"value":"arthritis"},{"value":"25"}],[{"value":"1055"},{"value":"Effect Of Acute Inflammatory Mediators On Functional Limitations In Patients With Acute Respiratory Failure"},{"value":"Phase 1 / Phase 2"},{"value":"respiratory disease"},{"value":"100"}],[{"value":"1058"},{"value":"Almased Multi-Center Diabetes Intervention Trial"},{"value":""},{"value":"diabetes"},{"value":"240"}],[{"value":"1059"},{"value":"Assessing Short and Long Term Compliance With Caloric Intake in HIV Positive Women Taking Complera"},{"value":""},{"value":"hiv"},{"value":"33"}],[{"value":"1060"},{"value":"The Effects of Respiratory Muscle Strength Training (RMST) on Inspiratory and Expiratory Muscle Strength in Adults and Children With Pompe Disease"},{"value":""},{"value":"respiratory disease"},{"value":"11"}],[{"value":"1065"},{"value":"MRI to Assess the Effects of Dysautonomia and Chronic Nausea on Brain Transmitters"},{"value":""},{"value":"neurological"},{"value":"18"}],[{"value":"1067"},{"value":"MiraLAX Versus Placebo to Prevent Constipation Following Urogynecologic Surgery"},{"value":""},{"value":"surgery"},{"value":"131"}],[{"value":"1072"},{"value":"Mild Traumatic Brain Injury Registry"},{"value":""},{"value":"neurological"},{"value":"40"}],[{"value":"1088"},{"value":"Advanced Image Guidance Utilized in Liver Surgery"},{"value":""},{"value":"surgery"},{"value":"13"}],[{"value":"1092"},{"value":"Gene Expression Variation and Implant Wound Healing Among Smokers and Diabetics"},{"value":""},{"value":"smoker study"},{"value":"44"}],[{"value":"1094"},{"value":"Surgical Outcomes Database For Faculty of Hepatopancreatic Biliary Surgery"},{"value":""},{"value":"surgery"},{"value":"300"}],[{"value":"1099"},{"value":"Visceral (Kidney and Abdominal Organ) Function After Fenestrated and Branched Endovascular Aneurysm Repair (FEVAR/BEVAR) of Thoracoabdominal Aortic Aneurysms"},{"value":""},{"value":"kidney disease"},{"value":"160"}],[{"value":"1100"},{"value":"Study of Effectiveness of Liraglutide Added to High Dose Insulin in Type II Diabetics"},{"value":"Phase 4"},{"value":"diabetes"},{"value":"36"}],[{"value":"1109"},{"value":"The Effects of Smoking Withdrawal On Resting State Functional Connectivity"},{"value":""},{"value":"smoker study"},{"value":"0"}],[{"value":"1112"},{"value":"Neurostimulation Device for Treatment of Migraine Headache"},{"value":""},{"value":"neurological"},{"value":"7"}],[{"value":"1116"},{"value":"HIV Prevention Among Latino MSM: Evaluation of a Locally Developed Intervention"},{"value":""},{"value":"hiv"},{"value":"304"}],[{"value":"1119"},{"value":"Effects of Tai Chi Chuan on Psychobiological Indicators of Anxiety and Sleep Quality in Young Adults"},{"value":""},{"value":"sleep study"},{"value":"75"}],[{"value":"1122"},{"value":"Ventilatory Heterogeneity in Participants With Asthma (MK-0476-513)"},{"value":"Phase 1"},{"value":"asthma"},{"value":"34"}],[{"value":"1123"},{"value":"Evaluation of DVD and Internet Decision Aids for Hip and Knee Osteoarthritis: Focus on Health Literacy"},{"value":""},{"value":"arthritis"},{"value":"155"}],[{"value":"1129"},{"value":"Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery"},{"value":"Phase 2"},{"value":"surgery"},{"value":"40"}],[{"value":"1137"},{"value":"Combinatorial Therapy for Peristent Type 2 Diabetes After Gastric Banding"},{"value":"Phase 4"},{"value":"diabetes"},{"value":"9"}],[{"value":"1141"},{"value":"Mindful Movement and Breathing to Improve Outcomes of Gynecologic Surgery"},{"value":"Phase 0"},{"value":"surgery"},{"value":"10"}],[{"value":"1142"},{"value":"Study of Anesthesia Techniques to Reduce Nausea and Vomiting After Jaw Corrective Surgery"},{"value":""},{"value":"surgery"},{"value":"233"}],[{"value":"1154"},{"value":"ENLIGHTEN: Exercise and NutritionaL Interventions for coGnitive and Cardiovascular HealTh ENhancement"},{"value":""},{"value":"heart disease"},{"value":"160"}],[{"value":"1158"},{"value":"To Compare the Safety Tolerability and Pharmacokinetics of QBX258 in Patients With Asthma"},{"value":"Phase 1"},{"value":"asthma"},{"value":"50"}],[{"value":"1170"},{"value":"Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery"},{"value":"Phase 2"},{"value":"surgery"},{"value":"20"}],[{"value":"1173"},{"value":"Cardiovascular Effects of Incremental Diesel Exhaust Inhalation in Middle-Aged Healthy GSTM1 Null Human Volunteers"},{"value":""},{"value":"heart disease"},{"value":"6"}],[{"value":"1182"},{"value":"Mapping Multidimensional Illness Trajectories of Patients With End-stage Kidney Disease"},{"value":""},{"value":"kidney disease"},{"value":"227"}],[{"value":"1186"},{"value":"A Phase I Study To Evaluate The Antitumor Activity And Safety Of AVX901"},{"value":"Phase 1"},{"value":"tumors"},{"value":"22"}],[{"value":"1195"},{"value":"Effect of Blueberries on Cognition and Body Composition in Elderly With Mild Cognitive Decline"},{"value":"Phase 2"},{"value":"elderly"},{"value":"123"}],[{"value":"1197"},{"value":"Eating Disorders in Type 1 Diabetes: Mechanisms of Comorbidity"},{"value":""},{"value":"diabetes"},{"value":"83"}],[{"value":"1200"},{"value":"Study to Evaluate the Effect of RGMA001 on Patients With Non Alcoholic Fatty Liver Disease (NAFLD)"},{"value":""},{"value":"alcohol"},{"value":"40"}],[{"value":"1206"},{"value":"Neurostimulation in Temporomandibular Disorders (TMD) Patients"},{"value":""},{"value":"neurological"},{"value":"5"}],[{"value":"1216"},{"value":"Strength Training for ARthritis Trial"},{"value":"Phase 2"},{"value":"arthritis"},{"value":"375"}],[{"value":"1226"},{"value":"Trivalent Influenza Vaccine in Preventing Flu in Patients With Central Nervous System Tumors"},{"value":"Phase 0"},{"value":"influenza"},{"value":"38"}],[{"value":"1229"},{"value":"Efficacy of Fluocinonide Cream 0.1% (Vanos(R)) in Reducing Itch in Subjects With Atopic Dermatitis"},{"value":""},{"value":"dermatitis"},{"value":"10"}],[{"value":"1233"},{"value":"Vasospasm in Pediatric Traumatic Brain Injury"},{"value":""},{"value":"neurological"},{"value":"6"}],[{"value":"1234"},{"value":"Obesity in HIV After Antiretroviral Therapy"},{"value":""},{"value":"hiv"},{"value":"200"}],[{"value":"1241"},{"value":"Development of a Tumor Molecular Analyses Program and Its Use to Support Treatment Decisions"},{"value":""},{"value":"tumors"},{"value":"5000"}],[{"value":"1242"},{"value":"Study to Assess the Effects of Daily Administration of Pioglitazone on Brain Hemodynamics in Healthy Elderly Participants"},{"value":"Phase 1"},{"value":"elderly"},{"value":"61"}],[{"value":"1255"},{"value":"Patient and Provider Interventions for Managing Osteoarthritis in Primary Care"},{"value":""},{"value":"arthritis"},{"value":"537"}],[{"value":"1261"},{"value":"Mindfulness-based Personalized Health Planning for Reducing Risk of Heart Disease and Diabetes"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"140"}],[{"value":"1268"},{"value":"Neural Markers and Rehabilitation of Executive Functioning in Veterans With Traumatic Brain Injury and Posttraumatic Stress Disorder"},{"value":""},{"value":"neurological"},{"value":"100"}],[{"value":"1270"},{"value":"Early Brain Development in Twins"},{"value":""},{"value":"neurological"},{"value":"600"}],[{"value":"1278"},{"value":"Neuromuscular Ultrasound for Focal Neuropathies"},{"value":""},{"value":"neurological"},{"value":"120"}],[{"value":"1280"},{"value":"Pain and Function After Orthopedic Surgery"},{"value":""},{"value":"surgery"},{"value":"75"}],[{"value":"1282"},{"value":"Pediatric Atopic Dermatitis (AD) Internet Survey"},{"value":""},{"value":"dermatitis"},{"value":"40"}],[{"value":"1284"},{"value":"Strategies for Enhancing Mucosal Immunity to Influenza Vaccine"},{"value":"Phase 0"},{"value":"influenza"},{"value":"60"}],[{"value":"1287"},{"value":"Personalized Diabetic Kidney Disease Risk Info to Initiate and Maintain Health Behavior Changes"},{"value":""},{"value":"kidney disease"},{"value":"19"}],[{"value":"1297"},{"value":"Families and Pediatric Cardiac Surgery Multidisciplinary Teams: How Well Do We Communicate"},{"value":""},{"value":"surgery"},{"value":"23"}],[{"value":"1304"},{"value":"Effect of Growth Hormone on Early Brain Development in Girls With Turner Syndrome"},{"value":""},{"value":"neurological"},{"value":"25"}],[{"value":"1307"},{"value":"Brain Connectivity in Neurodevelopmental Disorders in Response to Treatment"},{"value":""},{"value":"neurological"},{"value":"25"}],[{"value":"1316"},{"value":"Stress Reduction Training to Improve Sleep Quality Stress Physiology &amp; Cardiovascular Disease (CVD) Risk Markers"},{"value":""},{"value":"heart disease"},{"value":"87"}],[{"value":"1318"},{"value":"Neuroactive Steroids and Traumatic Brain Injury (TBI) in OEF/OIF Veterans"},{"value":"Phase 2"},{"value":"neurological"},{"value":"82"}],[{"value":"1324"},{"value":"Early Intervention for Morbidly Obese Patients After Roux-en-Y Gastric Bypass (RYGB) Surgery"},{"value":""},{"value":"surgery"},{"value":"8"}],[{"value":"1328"},{"value":"Patient Positioning in Lumbar Fusion Surgery and Its Impact on Spinal Sagittal Balance and Surgeon Satisfaction"},{"value":""},{"value":"surgery"},{"value":"7"}],[{"value":"1331"},{"value":"Cardiovascular Effects in Psoriasis Patients Treated With Adalimumab."},{"value":""},{"value":"heart disease"},{"value":"17"}],[{"value":"1332"},{"value":"The Effect of Vorinostat on HIV RNA Expression in the Resting CD4+ T Cells of HIV+ Pts on Stable ART"},{"value":"Phase 1 / Phase 2"},{"value":"hiv"},{"value":"37"}],[{"value":"1333"},{"value":"Measurement of Kidney Blood Flow and Oxygen Levels by MRI"},{"value":""},{"value":"kidney disease"},{"value":"10"}],[{"value":"1341"},{"value":"TissueLink Study During Multi-Level Spine Surgery"},{"value":"Phase 4"},{"value":"surgery"},{"value":"60"}],[{"value":"1347"},{"value":"Sweet Preference and Alcohol Craving"},{"value":"Phase 2"},{"value":"alcohol"},{"value":"80"}],[{"value":"1351"},{"value":"Clinical Assessment of Nonin 7600 Near Infrared Spectroscopy (NIRS) Tissue Oximetry During Cardiovascular Surgery"},{"value":""},{"value":"heart disease"},{"value":"50"}],[{"value":"1355"},{"value":"Feasibility of a Minimally Invasive Image-Guided Surgery System for Hepatic Procedures"},{"value":""},{"value":"surgery"},{"value":"30"}],[{"value":"1364"},{"value":"Effects of Sulforaphane (SFN) on Immune Response to Live Attenuated Influenza Virus in Smokers and Nonsmokers"},{"value":""},{"value":"influenza"},{"value":"51"}],[{"value":"1372"},{"value":"Effect of Calcium Polycarbophil on Type II Diabetes Mellitus Control: a Randomized Double-blind Study"},{"value":""},{"value":"diabetes"},{"value":"48"}],[{"value":"1376"},{"value":"A Study of FolateScan in Patients With Knee Osteoarthritis"},{"value":""},{"value":"arthritis"},{"value":"25"}],[{"value":"1377"},{"value":"Benazepril Hydrochloride Lisinopril Ramipril or Losartan Potassium in Treating Hypertension in Patients With Solid Tumors"},{"value":"Phase 2"},{"value":"tumors"},{"value":"6"}],[{"value":"1378"},{"value":"Yoga Therapy in Treating Patients With Malignant Brain Tumors"},{"value":""},{"value":"tumors"},{"value":"9"}],[{"value":"1379"},{"value":"Atypical Antipsychotic Treatment Effect On Brain Function In Schizophrenia Measured By FMRI"},{"value":""},{"value":"neurological"},{"value":"34"}],[{"value":"1380"},{"value":"Efficacy and Tolerability Study of Device RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis in Adults"},{"value":"Phase 2"},{"value":"dermatitis"},{"value":"17"}],[{"value":"1381"},{"value":"We Can Prevent Diabetes: A Behavioral Intervention to Reduce Diabetes Risk in African Americans"},{"value":"Phase 1 / Phase 2"},{"value":"diabetes"},{"value":"74"}],[{"value":"1390"},{"value":"Discharge Planning for Elderly Patients in the Emergency Department: Use of a Brief Phone Call After Discharge to Improve Medication Utilization and Physician Follow-up"},{"value":""},{"value":"elderly"},{"value":"157"}],[{"value":"1396"},{"value":"Ehealth: Second Life Impacts Diabetes Education &amp; Self-Management"},{"value":""},{"value":"diabetes"},{"value":"20"}],[{"value":"1398"},{"value":"Understanding of Genetic Risk Information for Type 2 Diabetes"},{"value":""},{"value":"diabetes"},{"value":"300"}],[{"value":"1400"},{"value":"Statin Therapy To Limit Cognitive Dysfunction After Cardiac Surgery"},{"value":""},{"value":"surgery"},{"value":"0"}],[{"value":"1403"},{"value":"Incidence of Respiratory Depression in Cesarean Section"},{"value":""},{"value":"respiratory disease"},{"value":"100"}],[{"value":"1412"},{"value":"Reusable Versus Disposable Draping System in Breast Reconstruction Surgery"},{"value":""},{"value":"surgery"},{"value":"107"}],[{"value":"1422"},{"value":"Evaluation of Continuous Saphenous Nerve Block to Supplement a Continuous Sciatic Nerve Block After Ankle Surgery"},{"value":""},{"value":"surgery"},{"value":"74"}],[{"value":"1430"},{"value":"Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors"},{"value":"Phase 1"},{"value":"tumors"},{"value":"18"}],[{"value":"1439"},{"value":"Cardiovascular Intervention Improvement Telemedicine Study"},{"value":""},{"value":"heart disease"},{"value":"428"}],[{"value":"1445"},{"value":"Personalized Cardiovascular Risk Information to Initiate and Maintain Health Behavior Changes"},{"value":""},{"value":"heart disease"},{"value":"98"}],[{"value":"1452"},{"value":"Patient and Provider Interventions for Managing Osteoarthritis in Primary Care"},{"value":""},{"value":"arthritis"},{"value":"300"}],[{"value":"1457"},{"value":"Neuroimaging of Smokers With and Without Attention Deficit Hyperactivity Disorder (ADHD)"},{"value":""},{"value":"smoker study"},{"value":"101"}],[{"value":"1462"},{"value":"A Panobinostat Presurgery"},{"value":"Phase 2"},{"value":"surgery"},{"value":"0"}],[{"value":"1463"},{"value":"Evaluating the Effect of Mucinex 1200mg on Mucociliary and Cough Clearance During an Acute Respiratory Infection"},{"value":"Phase 2"},{"value":"respiratory disease"},{"value":"38"}],[{"value":"1468"},{"value":"Fast Spectral Imaging Device for Tumor Margin Mapping"},{"value":""},{"value":"tumors"},{"value":"54"}],[{"value":"1472"},{"value":"A Pilot Trial in a Sleep Laboratory Setting to Observe Night Time Bladder Function of Subjects With Overactive Bladder (OAB)"},{"value":""},{"value":"sleep study"},{"value":"15"}],[{"value":"1494"},{"value":"Genetic Testing for Type 2 Diabetes"},{"value":""},{"value":"diabetes"},{"value":"601"}],[{"value":"1495"},{"value":"Transoral Robotic Surgery (TORS) for Oral and Laryngopharyngeal Lesions Using Da Vinci Robotic Surgical System"},{"value":"Phase 0"},{"value":"surgery"},{"value":"60"}],[{"value":"1496"},{"value":"Group Physical Therapy for Knee Osteoarthritis"},{"value":""},{"value":"arthritis"},{"value":"320"}],[{"value":"1497"},{"value":"Neurobiology of Nicotine and Non-nicotine Components of Tobacco Addiction"},{"value":"Phase 1"},{"value":"neurological"},{"value":"147"}],[{"value":"1498"},{"value":"Supplemental Nicotine Administration for Smoking Cessation in Posttraumatic Stress Disorder (PTSD)"},{"value":""},{"value":"smoker study"},{"value":"69"}],[{"value":"1499"},{"value":"Safety Study of Bevacizumab Everolimus and LBH589 (BEL) for Advanced Solid Tumors"},{"value":"Phase 1"},{"value":"tumors"},{"value":"14"}],[{"value":"1503"},{"value":"Managing Chronic Kidney Disease in Eastern North Carolina"},{"value":""},{"value":"kidney disease"},{"value":"1257"}],[{"value":"1511"},{"value":"A Study Evaluating the Efficacy of Fluocinonide Cream 0.1% (Vanos) in Subjects With Atopic Dermatitis"},{"value":"Phase 4"},{"value":"dermatitis"},{"value":"20"}],[{"value":"1512"},{"value":"Investigating Fitness Interventions in the Elderly (INFINITE)"},{"value":""},{"value":"elderly"},{"value":"180"}],[{"value":"1514"},{"value":"Pilot Study of Lovaza (Omega 3 Fatty Acids) to Improve Cardiac Antioxidant/Anti-inflammatory Profile Before Cardiac Surgery"},{"value":"Phase 4"},{"value":"surgery"},{"value":"24"}],[{"value":"1515"},{"value":"Reducing Donor Specific Antibody (DSA) Strength in Maintenance Kidney Transplant Recipients (DSA Study)"},{"value":"Phase 4"},{"value":"kidney disease"},{"value":"32"}],[{"value":"1518"},{"value":"En Pareja: A Latino Couples Intervention to Help Expectant Fathers Quit Smoking"},{"value":""},{"value":"smoker study"},{"value":"705"}],[{"value":"1521"},{"value":"p16 Methylation for Smoking Cessation"},{"value":""},{"value":"smoker study"},{"value":"35"}],[{"value":"1527"},{"value":"Armodafinil in Treating Fatigue Caused By Radiation Therapy in Patients With Primary Brain Tumors"},{"value":"Phase 2"},{"value":"tumors"},{"value":"54"}],[{"value":"1532"},{"value":"Pilot Trial in Sleep Laboratory Setting to Compare the Physiology of Night Time Bladder Function in Subjects With Overactive Bladder (OAB) Versus Subjects That Have Insomnia and Healthy Normal Subjects"},{"value":"Phase 4"},{"value":"sleep study"},{"value":"26"}],[{"value":"1538"},{"value":"Intensive Computerized Brain Training (ICBT) in Youth With Early Onset Psychosis (EOP)"},{"value":""},{"value":"neurological"},{"value":"35"}],[{"value":"1542"},{"value":"Dietary Patterns and Cardiovascular (CVD) Risk in Spinal Cord Injury (SCI) Factors In Individuals With Chronic Spinal Cord Injury"},{"value":""},{"value":"heart disease"},{"value":"100"}],[{"value":"1544"},{"value":"Safety Metabolism and Antioxidant Activity of Silymarin and Green Tea Extract in Patients With Chronic Hepatitis C"},{"value":"Phase 1 / Phase 2"},{"value":"hepatitis"},{"value":"60"}],[{"value":"1547"},{"value":"Optimal Planning Target Volume With Stereotactic Radiosurgery"},{"value":""},{"value":"surgery"},{"value":"49"}],[{"value":"1549"},{"value":"Radiosurgery and Avastin for Recurrent Malignant Gliomas"},{"value":""},{"value":"surgery"},{"value":"15"}],[{"value":"1550"},{"value":"Dexmedetomidine Sedation With Third Molar Surgery"},{"value":"Phase 4"},{"value":"surgery"},{"value":"18"}],[{"value":"1551"},{"value":"Moderate to Persistent Asthma in the Obese Subject"},{"value":"Phase 4"},{"value":"asthma"},{"value":"38"}],[{"value":"1563"},{"value":"Internet-Based Smoking Cessation for Operations Enduring Freedom and Iraqi Freedom (OEF/OIF) Veterans"},{"value":""},{"value":"smoker study"},{"value":"413"}],[{"value":"1582"},{"value":"The Arthritis Diet and Activity Promotion Trial"},{"value":""},{"value":"arthritis"},{"value":"318"}],[{"value":"1585"},{"value":"Tailored Case Management for Diabetes and Hypertension"},{"value":""},{"value":"diabetes"},{"value":"377"}],[{"value":"1588"},{"value":"Standardized Rehabilitation for Intensive Care Unit (ICU) Patients With Acute Respiratory Failure"},{"value":""},{"value":"respiratory disease"},{"value":"300"}],[{"value":"1589"},{"value":"Lowering Salt Intake in Chronic Kidney Disease: A Pilot Randomized Crossover Trial"},{"value":""},{"value":"kidney disease"},{"value":"35"}],[{"value":"1595"},{"value":"Exercise Dose-Response Effects in Prediabetes"},{"value":""},{"value":"diabetes"},{"value":"288"}],[{"value":"1600"},{"value":"Exercise Intolerance in Elderly Patients With Diastolic Heart Failure"},{"value":""},{"value":"elderly"},{"value":"100"}],[{"value":"1628"},{"value":"Functional Imaging of Tumor and Normal Tissue"},{"value":""},{"value":"tumors"},{"value":"21"}],[{"value":"1638"},{"value":"A Study of Inhalation of 20000 EU CCRE and Mucociliary Clearance (MCC) in Otherwise Healthy Individuals Who Are Current Cigarette Smokers"},{"value":"Phase 1"},{"value":"smoker study"},{"value":"12"}],[{"value":"1641"},{"value":"Safety and Efficacy Study to Compare Continuous Infusion of Interferon With Standard of Care for Chronic Hepatitis C"},{"value":"Phase 2"},{"value":"hepatitis"},{"value":"116"}],[{"value":"1642"},{"value":"Preventing Postpartum Return to Smoking"},{"value":""},{"value":"smoker study"},{"value":"386"}],[{"value":"1651"},{"value":"A Controlled Laboratory Study of the Effects on Cue-Induced Craving in Dependent Smokers"},{"value":"Phase 2"},{"value":"smoker study"},{"value":"21"}],[{"value":"1656"},{"value":"Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors"},{"value":""},{"value":"tumors"},{"value":"2500"}],[{"value":"1662"},{"value":"Prevalence of Sleep Disturbances in Psoriasis"},{"value":""},{"value":"sleep study"},{"value":"80"}],[{"value":"1663"},{"value":"Evaluation of a Tailored Smoking Cessation Treatment Algorithm Based on Initial Treatment Response and Genotype"},{"value":"Phase 3"},{"value":"smoker study"},{"value":"606"}],[{"value":"1664"},{"value":"Vaccine Therapy in Treating Patients Undergoing Surgery for Recurrent Glioblastoma Multiforme"},{"value":"Phase 1"},{"value":"surgery"},{"value":"50"}],[{"value":"1666"},{"value":"Safety/Biomarker Study of CNTO 95 and Avastin in Solid Tumors"},{"value":"Phase 1"},{"value":"tumors"},{"value":"13"}],[{"value":"1667"},{"value":"Treatment Effects of Escitalopram (Lexapro&#174;) on Generalized Anxiety Disorder in Patients With HIV and AIDS"},{"value":"Phase 3"},{"value":"hiv"},{"value":"30"}],[{"value":"1668"},{"value":"Mindfulness Emotional Well-being and Sleep Quality"},{"value":""},{"value":"sleep study"},{"value":"372"}],[{"value":"1674"},{"value":"Sex Differences in Early Brain Development; Brain Development in Turner Syndrome"},{"value":""},{"value":"neurological"},{"value":"295"}],[{"value":"1675"},{"value":"Efficacy and Tolerability of Baclofen for Alcohol Dependence"},{"value":"Phase 2 / Phase 3"},{"value":"alcohol"},{"value":"80"}],[{"value":"1682"},{"value":"Study of Massage Therapy Within a Brain Tumor Setting"},{"value":""},{"value":"tumors"},{"value":"10"}],[{"value":"1683"},{"value":"BTC Neuropsychological Database"},{"value":""},{"value":"neurological"},{"value":"0"}],[{"value":"1699"},{"value":"Validation of Brain Oxygenation Monitor on Pediatric Patients"},{"value":""},{"value":"neurological"},{"value":"72"}],[{"value":"1702"},{"value":"Compatibility of a Mild Moisturizing Hand Cleanser for Patients With Mild to Moderate Hand Dermatitis"},{"value":""},{"value":"dermatitis"},{"value":"46"}],[{"value":"1703"},{"value":"Bronchoscopy Assisted Sampling of Cells and Fluid From the Lower Respiratory Tract of Human Subjects"},{"value":""},{"value":"respiratory disease"},{"value":"30"}],[{"value":"1706"},{"value":"Effect of a 10000 EU Dose of Endotoxin in Allergic and Mildly Asthmatic Adults"},{"value":"Phase 1"},{"value":"asthma"},{"value":"11"}],[{"value":"1707"},{"value":"A Study of Inhalation of 20000 EU CCRE in Normal Volunteers Compared to Allergic Asthmatic Individuals"},{"value":"Phase 1"},{"value":"asthma"},{"value":"32"}],[{"value":"1709"},{"value":"In Vitro Basophil Responsiveness to Allergen Challenge After Gamma-tocopherol Supplementation in Allergic Asthmatics"},{"value":"Phase 1"},{"value":"asthma"},{"value":"25"}],[{"value":"1710"},{"value":"Improving Neurologic Outcomes in People With Diabetes Who Are Undergoing Heart Surgery"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"133"}],[{"value":"1711"},{"value":"Effectiveness of Metformin Compared to Insulin in Pregnant Women With Mild Preexisting or Early Gestational Diabetes"},{"value":"Phase 2"},{"value":"diabetes"},{"value":"31"}],[{"value":"1715"},{"value":"Role of RhuMab-E25 in Reducing Exhaled Nitric Oxide (NO) in Allergic Asthma"},{"value":"Phase 3"},{"value":"asthma"},{"value":"20"}],[{"value":"1718"},{"value":"Rapid Administration of Insulin in Sepsis"},{"value":"Phase 1"},{"value":"diabetes"},{"value":"20"}],[{"value":"1719"},{"value":"Cholesterol Hypertension and Glucose Education Study"},{"value":""},{"value":"heart disease"},{"value":"362"}],[{"value":"1721"},{"value":"Validation of Brain Oxygenation Monitor"},{"value":""},{"value":"neurological"},{"value":"18"}],[{"value":"1725"},{"value":"Stereotactic Radiosurgery After Surgery in Treating Patients With Brain Metastases"},{"value":"Phase 2"},{"value":"surgery"},{"value":"1"}],[{"value":"1726"},{"value":"Stereotactic Radiosurgery in Treating Patients With Brain Metastases"},{"value":"Phase 2"},{"value":"surgery"},{"value":"6"}],[{"value":"1730"},{"value":"Amantadine and Temporal Discrimination in Patients With Traumatic Brain Injury (TBI)"},{"value":""},{"value":"neurological"},{"value":"16"}],[{"value":"1732"},{"value":"Pharmacokinetics of NRL972 in Patients With Nonalcoholic Steatohepatitis (NASH) and Non-Alcoholic Fatty Liver Disease (NAFLD)"},{"value":"Phase 2"},{"value":"alcohol"},{"value":"125"}],[{"value":"1739"},{"value":"Impact of GBS on CVD in Type 2 Diabetes Mellitus"},{"value":""},{"value":"diabetes"},{"value":"84"}],[{"value":"1745"},{"value":"Effectiveness of Bridging Anticoagulation for Surgery (The BRIDGE Study)"},{"value":"Phase 3"},{"value":"surgery"},{"value":"1884"}],[{"value":"1774"},{"value":"Range of Neutrophil Response to 20000 EU of Clinical Center Reference Endotoxin in Otherwise Healthy Smokers"},{"value":"Phase 1"},{"value":"smoker study"},{"value":"2"}],[{"value":"1783"},{"value":"Evaluating the Effects of Hormone Replacement Therapy on Brain Function (The WHIMS-MRI Study)"},{"value":""},{"value":"neurological"},{"value":"1426"}],[{"value":"1788"},{"value":"Metformin for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD)"},{"value":"Phase 4"},{"value":"alcohol"},{"value":"11"}],[{"value":"1789"},{"value":"Attention Deficit Hyperactivity Disorder (ADHD) Smoking Cessation Study"},{"value":""},{"value":"smoker study"},{"value":"32"}],[{"value":"1791"},{"value":"A Study to Determine if Carbon Dioxide Lavage During Total Knee Surgery Reduces Intraoperative Embolic Events"},{"value":"Phase 2"},{"value":"surgery"},{"value":"20"}],[{"value":"1797"},{"value":"An Optical Assay System for Intra Operative Assessment of Tumor Margins in Patients"},{"value":""},{"value":"tumors"},{"value":"530"}],[{"value":"1801"},{"value":"Treating Co-Morbid Sleep Difficulties in Veterans With Posttraumatic Stress Disorder (PTSD): A Pilot Study"},{"value":""},{"value":"sleep study"},{"value":"22"}],[{"value":"1802"},{"value":"Concurrent Nicotine Patch / Denicotinized Cigarette Therapy for Smoking Cessation II"},{"value":"Phase 3"},{"value":"smoker study"},{"value":"479"}],[{"value":"1814"},{"value":"A Multicenter Randomized Placebo-Controlled Phase 2 Study to Evaluate the Clinical Efficacy Safety and Tolerability of ARX-F01 Sublingual Sufentanil in Patients Undergoing Major Abdominal Surgery"},{"value":"Phase 2"},{"value":"surgery"},{"value":"88"}],[{"value":"1818"},{"value":"Loteprednol Etabonate in an Ophthalmic Base vs Vehicle for the Treatment of Inflammation Following Cataract Surgery"},{"value":"Phase 3"},{"value":"surgery"},{"value":"400"}],[{"value":"1819"},{"value":"Effects of Capsaicin on the Structure Distribution and Function of Cutaneous Small Nerve Fibers in Psoriatic Skin"},{"value":"Phase 4"},{"value":"nerve study"},{"value":"12"}],[{"value":"1822"},{"value":"Comprehensive Investigation of Opiates Neuropeptides Barrier Function Scratching and Sleep Physiology"},{"value":""},{"value":"neurological"},{"value":"31"}],[{"value":"1824"},{"value":"Adherence to Topical Hydrocortisone 17-Butyrate 0.1% (Locoid&#174;) Using Different Vehicles in Adults With Atopic Dermatitis"},{"value":"Phase 4"},{"value":"dermatitis"},{"value":"30"}],[{"value":"1830"},{"value":"Neuroimaging Attentional Impairment During Abstinence"},{"value":""},{"value":"neurological"},{"value":"80"}],[{"value":"1833"},{"value":"Comprehensive Investigation of Heart Rate Variability as a Measure of the Autonomic Nervous System in Atopic Dermatitis"},{"value":""},{"value":"dermatitis"},{"value":"45"}],[{"value":"1837"},{"value":"Efficacy of Desonide (Desonatetm) Gel 0.05% in Younger and Older Subjects With Atopic Dermatitis"},{"value":"Phase 4"},{"value":"dermatitis"},{"value":"41"}],[{"value":"1845"},{"value":"Supplemental Choline and Brain Development in Humans"},{"value":""},{"value":"neurological"},{"value":"150"}],[{"value":"1855"},{"value":"Immunotherapy of Melanoma With Tumor Antigen RNA and Small Inhibitory RNA Transfected Autologous Dendritic Cells"},{"value":"Phase 1"},{"value":"tumors"},{"value":"12"}],[{"value":"1857"},{"value":"Neuroimaging Decision Making and Response Inhibition During Smoking Abstinence"},{"value":""},{"value":"smoker study"},{"value":"62"}],[{"value":"1862"},{"value":"Role of TLR4 in Environmental Asthma"},{"value":"Phase 1"},{"value":"asthma"},{"value":"855"}],[{"value":"1864"},{"value":"Nitric Oxide LPS and the Pathogenesis of Asthma Phase 1"},{"value":""},{"value":"asthma"},{"value":"420"}],[{"value":"1869"},{"value":"Efficacy Study of PN400 (VIMOVO) Twice Daily and Celebrex Once Daily in Patients With Osteoarthritis"},{"value":"Phase 3"},{"value":"arthritis"},{"value":"610"}],[{"value":"1873"},{"value":"Efficacy Study of PN400 (VIMOVO) Twice Daily and Celebrex Once Daily in Patients With Osteoarthritis"},{"value":"Phase 3"},{"value":"arthritis"},{"value":"614"}],[{"value":"1875"},{"value":"The Effect of Visual Stimuli on Itch Perception Intensity in Healthy and Atopic Dermatitis Patients"},{"value":""},{"value":"dermatitis"},{"value":"25"}],[{"value":"1876"},{"value":"Phase 2B Dose-Ranging Study of PAC113 Mouthrinse in HIV Seropositive Individuals With Oral Candidiasis"},{"value":"Phase 2"},{"value":"hiv"},{"value":"223"}],[{"value":"1881"},{"value":"Measuring Adherence to Topical Therapy in Children With Atopic Dermatitis and the Impact of a Return Visit"},{"value":"Phase 4"},{"value":"dermatitis"},{"value":"30"}],[{"value":"1886"},{"value":"Genetics of Asthma - Bronchoscopy Studies"},{"value":"Phase 1"},{"value":"asthma"},{"value":"17"}],[{"value":"1890"},{"value":"Nitric Oxide LPS and the Pathogenesis of Asthma Phase II"},{"value":"Phase 1"},{"value":"asthma"},{"value":"70"}],[{"value":"1891"},{"value":"Group Physical Therapy for Knee Osteoarthritis"},{"value":""},{"value":"arthritis"},{"value":"24"}],[{"value":"1895"},{"value":"The Gene Expression Studies of the Role of Tumor Microenvironments in Tumor Progression"},{"value":""},{"value":"tumors"},{"value":"0"}],[{"value":"1899"},{"value":"Insulin Resistance in Nonalcoholic Fatty Liver Disease: A Case Control Study"},{"value":""},{"value":"diabetes"},{"value":"80"}],[{"value":"1911"},{"value":"Healthy Living Partnership to Prevent Diabetes"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"301"}],[{"value":"1915"},{"value":"Safety Study of 20000 EU of Clinical Center Reference Endotoxin in Allergic Adults With and Without Mild Asthma"},{"value":"Phase 1"},{"value":"asthma"},{"value":"4"}],[{"value":"1916"},{"value":"Feasibility Study of Vessel Analysis for Noninvasive Diagnosis of Malignancy in Breast Tumors"},{"value":""},{"value":"tumors"},{"value":"6"}],[{"value":"1918"},{"value":"Innohep for Prophylaxis of Venous Thromboembolism in Brain Tumor Patients"},{"value":""},{"value":"tumors"},{"value":"40"}],[{"value":"1920"},{"value":"Coronary Heart Disease as Measured by Coronary Calcium Score Among Individuals With Chronic Traumatic Spinal Cord Injury"},{"value":""},{"value":"heart disease"},{"value":"45"}],[{"value":"1924"},{"value":"Nicotine Patch Pretreatment for Smoking Cessation in PTSD"},{"value":"Phase 0"},{"value":"smoker study"},{"value":"87"}],[{"value":"1928"},{"value":"Carbamazepine for the Treatment of Chronic Post-Traumatic Brain Injury Irritability and Aggression"},{"value":""},{"value":"neurological"},{"value":"74"}],[{"value":"1939"},{"value":"Effects of Diesel Exhaust Followed by Administration of Nasal Spray Flu Vaccine on Individuals With &amp; Without Allergies"},{"value":""},{"value":"influenza"},{"value":"54"}],[{"value":"1942"},{"value":"Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-003)"},{"value":"Phase 3"},{"value":"surgery"},{"value":"120"}],[{"value":"1947"},{"value":"MK-0518 Intensification And HDAC Inhibition In Depletion Of Resting CD4+ T Cell HIV Infection"},{"value":"Phase 2"},{"value":"hiv"},{"value":"6"}],[{"value":"1963"},{"value":"Everolimus Fluorouracil Leucovorin Panitumumab and Oxaliplatin in Treating Patients With Solid Tumors That Did Not Respond to Treatment"},{"value":"Phase 1"},{"value":"tumors"},{"value":"74"}],[{"value":"1969"},{"value":"GIOP Prevention Among People With Rheumatoid Arthritis"},{"value":""},{"value":"arthritis"},{"value":"273"}],[{"value":"1972"},{"value":"Brain Imaging of Psychotherapy for Depression"},{"value":""},{"value":"neurological"},{"value":"27"}],[{"value":"1976"},{"value":"U-500R Insulin In Type 2 Diabetes With Severe Insulin Resistance Via Omnipod"},{"value":"Phase 4"},{"value":"diabetes"},{"value":"21"}],[{"value":"1990"},{"value":"Chronic Hepatitis Intervention Project for Drug Users"},{"value":"Phase 3"},{"value":"hepatitis"},{"value":"851"}],[{"value":"1993"},{"value":"Alcohol in the Treatment of Obesity"},{"value":""},{"value":"alcohol"},{"value":"18"}],[{"value":"2005"},{"value":"A Phase I Study of ABT-510 in Combination With Bevacizumab in Advanced Solid Tumors"},{"value":"Phase 1"},{"value":"tumors"},{"value":"45"}],[{"value":"2011"},{"value":"Exenatide Pregnancy Registry - Type 2 Diabetes in Pregnancy"},{"value":"Phase 4"},{"value":"diabetes"},{"value":"7"}],[{"value":"2018"},{"value":"Duke Conte Center for the Neuroscience of Depression in Late Life"},{"value":""},{"value":"neurological"},{"value":"795"}],[{"value":"2022"},{"value":"Pathogenesis and Genetics of Environmental Asthma Ozone Study"},{"value":""},{"value":"asthma"},{"value":"170"}],[{"value":"2023"},{"value":"Sorafenib Combined With Cisplatin and Etoposide or Carboplatin and Pemetrexed in Treating Patients With Metastatic Solid Tumors"},{"value":"Phase 1"},{"value":"tumors"},{"value":"31"}],[{"value":"2024"},{"value":"A Randomized Double-Blind Study Testing the Effects of Pregabalin on Diabetic Neuropathy"},{"value":"Phase 4"},{"value":"neurological"},{"value":"40"}],[{"value":"2026"},{"value":"ENCORE: Exercise and Nutritional Interventions for Cardiovascular Health"},{"value":""},{"value":"heart disease"},{"value":"144"}],[{"value":"2028"},{"value":"Isolation and Culture of Circulating Tumor Cells From Peripheral Blood"},{"value":""},{"value":"tumors"},{"value":"500"}],[{"value":"2029"},{"value":"Retisert and Cataract Surgery in Patients With Severe Uveitis"},{"value":""},{"value":"surgery"},{"value":"21"}],[{"value":"2030"},{"value":"Neurocognitive Outcomes of Depression in the Elderly"},{"value":""},{"value":"elderly"},{"value":"795"}],[{"value":"2031"},{"value":"Utility of Exercise-induced N-terminal (NT) Pro-brain Natriuretic Peptide Levels in Predicting Prognosis in Asymptomatic Aortic Stenosis"},{"value":""},{"value":"neurological"},{"value":"110"}],[{"value":"2049"},{"value":"Precedex Versus Propofol-Awakening for Reducing Brain Injury Expansion"},{"value":"Phase 1 / Phase 2"},{"value":"neurological"},{"value":"8"}],[{"value":"2056"},{"value":"Evaluation of Walk With Ease in Arthritis"},{"value":"Phase 3"},{"value":"arthritis"},{"value":"468"}],[{"value":"2065"},{"value":"NICardipine Neuroprotection in AortiC Surgery (NICNACS)"},{"value":"Phase 2"},{"value":"surgery"},{"value":"7"}],[{"value":"2067"},{"value":"Ketamine In Thoracic Surgery (KITS) Trial"},{"value":"Phase 2"},{"value":"surgery"},{"value":"40"}],[{"value":"2071"},{"value":"Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed Progressive or Recurrent Primary Malignant Brain Tumors"},{"value":""},{"value":"tumors"},{"value":"16"}],[{"value":"2079"},{"value":"Effect of Nepafenac on Post-operative Macular Swelling Following Uncomplicated Cataract Surgery"},{"value":"Phase 4"},{"value":"surgery"},{"value":"82"}],[{"value":"2085"},{"value":"Use of Bicarbonate to Reduce the Incidence of Acute Renal Failure After Cardiac Surgery"},{"value":""},{"value":"surgery"},{"value":"123"}],[{"value":"2092"},{"value":"Angiotensin-(1-7) in Treating Patients With Metastatic or Unresectable Solid Tumors"},{"value":"Phase 1"},{"value":"tumors"},{"value":"18"}],[{"value":"2094"},{"value":"Improving Care for Primary Care Patients With Diabetes and Poor Literacy and Numeracy Skills"},{"value":"Phase 4"},{"value":"diabetes"},{"value":"110"}],[{"value":"2095"},{"value":"Safety and Efficacy Study of Re-treatment With Rituximab (MabThera/Rituxan) in Patients With Active Rheumatoid Arthritis Who Respond Poorly to Anti-TNF&#945; Therapies"},{"value":"Phase 3"},{"value":"arthritis"},{"value":"341"}],[{"value":"2097"},{"value":"Effect of Burn Size on Cytomegalovirus Reactivation and Correlates of T Cell Immune Function in Burned Patients"},{"value":""},{"value":"burns"},{"value":"60"}],[{"value":"2101"},{"value":"The Treatment of Insomnia in Patients With HIV Disease"},{"value":"Phase 4"},{"value":"hiv"},{"value":"44"}],[{"value":"2111"},{"value":"Cigarette Smoke and Susceptibility to Influenza Infection"},{"value":""},{"value":"influenza"},{"value":"138"}],[{"value":"2112"},{"value":"Development and Evaluation of A Mailed Arthritis Self-Management Program"},{"value":""},{"value":"arthritis"},{"value":"900"}],[{"value":"2114"},{"value":"Family-supported Smoking Cessation for Chronically Ill Veterans"},{"value":""},{"value":"smoker study"},{"value":"471"}],[{"value":"2129"},{"value":"Lifestyle Modification for Obesity-Related Type 2 Diabetes"},{"value":"Phase 4"},{"value":"diabetes"},{"value":"90"}],[{"value":"2132"},{"value":"Overcoming Psychiatric Barriers to the Treatment of Hepatitis C"},{"value":""},{"value":"hepatitis"},{"value":"101"}],[{"value":"2148"},{"value":"Sleep Specialty Consultation: Improving Management of Sleep Disorders"},{"value":""},{"value":"sleep study"},{"value":"156"}],[{"value":"2150"},{"value":"Improving Drug Use for Elderly Heart Failure Patients"},{"value":""},{"value":"elderly"},{"value":"314"}],[{"value":"2153"},{"value":"Safety Study of a Vitamin E Supplement in Normal Volunteers and Those With Both Allergy and Asthma"},{"value":"Phase 1"},{"value":"asthma"},{"value":"16"}],[{"value":"2157"},{"value":"Intensive Diet and Exercise for Improving Knee Osteoarthritis in Obese and Overweight Older Adults"},{"value":"Phase 2"},{"value":"arthritis"},{"value":"454"}],[{"value":"2161"},{"value":"Zinc Supplements in Lowering Cadmium Levels in Smokers"},{"value":"Phase 2"},{"value":"smoker study"},{"value":"61"}],[{"value":"2163"},{"value":"Effects of an Alternative Treatment for Military Sexual Trauma on PTSD Symptoms Neurosteroids and Brain Function"},{"value":""},{"value":"neurological"},{"value":"34"}],[{"value":"2164"},{"value":"Functional Brain Imaging of Medication Treatment Response in Mild Alzheimer&apos;s Disease Patients"},{"value":"Phase 4"},{"value":"neurological"},{"value":"4"}],[{"value":"2193"},{"value":"Exposure to Neurotoxins as Risk Factors for Amyotrophic Lateral Sclerosis"},{"value":""},{"value":"neurological"},{"value":"0"}],[{"value":"2198"},{"value":"Effect of Dexmedetomidine Upon Sleep Postoperatively"},{"value":"Phase 4"},{"value":"sleep study"},{"value":"0"}],[{"value":"2202"},{"value":"Study of Alemtuzumab Versus Anti-thymocyte Globulin to Help Prevent Rejection in Kidney and Pancreas Transplantation"},{"value":"Phase 4"},{"value":"kidney disease"},{"value":"275"}],[{"value":"2204"},{"value":"Levetiracetam for Cramps Spasticity and Neuroprotection in Motor Neuron Disease"},{"value":"Phase 2"},{"value":"neurological"},{"value":"20"}],[{"value":"2205"},{"value":"Study of an Intervention to Improve Use of Life-saving Medications for Heart Disease"},{"value":""},{"value":"heart disease"},{"value":"143"}],[{"value":"2207"},{"value":"A Patient-Spouse Intervention for Self-Managing High Cholesterol"},{"value":""},{"value":"heart disease"},{"value":"255"}],[{"value":"2209"},{"value":"Vinflunine and Erlotinib or Pemetrexed in Treating Patients With Unresectable or Metastatic Solid Tumors"},{"value":"Phase 1"},{"value":"tumors"},{"value":"41"}],[{"value":"2211"},{"value":"Examining the Link Between Trace Elements and Cardiovascular Disease Risk Factors in Young Adults"},{"value":""},{"value":"heart disease"},{"value":"4362"}],[{"value":"2213"},{"value":"The Impact of Patient Involvement in Decision-Making About Heart Disease Prevention"},{"value":""},{"value":"heart disease"},{"value":"120"}],[{"value":"2220"},{"value":"Study of Valproic Acid to Treat HIV Infected Adults"},{"value":"Phase 1"},{"value":"hiv"},{"value":"14"}],[{"value":"2223"},{"value":"Extracranial Stereotactic Radiosurgery in Treating Patients With Solid Tumors"},{"value":"Phase 1 / Phase 2"},{"value":"tumors"},{"value":"48"}],[{"value":"2224"},{"value":"A Church Based Intervention to Improve Diabetes Care"},{"value":""},{"value":"diabetes"},{"value":"201"}],[{"value":"2229"},{"value":"Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine in Treating Patients With Advanced Metastatic Solid Tumors"},{"value":"Phase 1"},{"value":"tumors"},{"value":"18"}],[{"value":"2233"},{"value":"Weight Management and Coping Skills Training For Patients With Knee Osteoarthritis"},{"value":""},{"value":"arthritis"},{"value":"412"}],[{"value":"2234"},{"value":"Vatalanib and Everolimus in Treating Patients With Advanced Solid Tumors"},{"value":"Phase 1"},{"value":"tumors"},{"value":"37"}],[{"value":"2235"},{"value":"Exercise to Treat Depression in Individuals With Coronary Heart Disease"},{"value":"Phase 3"},{"value":"heart disease"},{"value":"101"}],[{"value":"2244"},{"value":"Self-Management of Osteoarthritis"},{"value":""},{"value":"arthritis"},{"value":"523"}],[{"value":"2247"},{"value":"Measuring Cholesterol in the Fasting and Postmeal State in Patients With Type 2 Diabetes"},{"value":""},{"value":"diabetes"},{"value":"30"}],[{"value":"2248"},{"value":"Sleep Disorders and Gastroesophageal Reflux Disease (GERD)"},{"value":"Phase 4"},{"value":"sleep study"},{"value":"20"}],[{"value":"2249"},{"value":"Effect of Ozone on Airway Inflammation in Allergic Asthmatics Treated With Omalizumab"},{"value":""},{"value":"asthma"},{"value":"1"}],[{"value":"2250"},{"value":"Genetic Susceptibility to Ozone in Mild Asthmatic Volunteers"},{"value":""},{"value":"asthma"},{"value":"52"}],[{"value":"2263"},{"value":"A Phase I Study of STA-5312 in Subjects With Advanced or Metastatic Solid Tumors"},{"value":"Phase 1"},{"value":"tumors"},{"value":"30"}],[{"value":"2264"},{"value":"Bevacizumab Everolimus and Erlotinib in Treating Patients With Advanced Solid Tumors"},{"value":"Phase 1"},{"value":"tumors"},{"value":"65"}],[{"value":"2266"},{"value":"Effects of Resistance and Aerobic Exercise on Cardiovascular Health"},{"value":"Phase 2"},{"value":"heart disease"},{"value":"261"}],[{"value":"2276"},{"value":"Policosanol for the Treatment of Hypercholesterolemia"},{"value":""},{"value":"heart disease"},{"value":"40"}],[{"value":"2277"},{"value":"Imatinib Mesylate and Capecitabine in Treating Patients With Advanced Solid Tumors"},{"value":"Phase 1"},{"value":"tumors"},{"value":"25"}],[{"value":"2278"},{"value":"Improving Sleep and Psychological Functioning in People With Depression and Insomnia"},{"value":"Phase 4"},{"value":"sleep study"},{"value":"96"}],[{"value":"2284"},{"value":"A Trial to Assess the Efficacy and Safety of SPM 927 in Subjects With Painful Distal Diabetic Neuropathy"},{"value":"Phase 2 / Phase 3"},{"value":"neurological"},{"value":"496"}],[{"value":"2299"},{"value":"Comparing ASHC and CDSMP Outcomes In Arthritis"},{"value":""},{"value":"arthritis"},{"value":"416"}],[{"value":"2303"},{"value":"Interventions to Improve Hypertension Control and Reduce Cardiovascular Disease Risk"},{"value":"Phase 2"},{"value":"heart disease"},{"value":"574"}],[{"value":"2310"},{"value":"The Role of Vitamins E and C in Maintaining Lung Health in People With Asthma"},{"value":"Phase 1"},{"value":"asthma"},{"value":"16"}],[{"value":"2314"},{"value":"Comparing Paroxetine and Duloxetine on Cardiovascular Measures"},{"value":"Phase 2 / Phase 3"},{"value":"heart disease"},{"value":"40"}],[{"value":"2317"},{"value":"Trial to Assess the Efficacy and Safety of SPM 927 (200 400 and 600mg/Day) in Subjects With Painful Distal Diabetic Neuropathy"},{"value":"Phase 3"},{"value":"neurological"},{"value":"654"}],[{"value":"2321"},{"value":"PIE II: Pharmacological Intervention in the Elderly II"},{"value":"Phase 3"},{"value":"elderly"},{"value":"80"}],[{"value":"2331"},{"value":"Tumor RNA Transfected Dendritic Cell Vaccines"},{"value":"Phase 1"},{"value":"tumors"},{"value":""}],[{"value":"2344"},{"value":"Safety of KAI-9803 for Injection With Angioplasty Following Heart Attack"},{"value":"Phase 1 / Phase 2"},{"value":"heart disease"},{"value":"154"}],[{"value":"2351"},{"value":"Painful HIV Neuropathy and Alpha-Lipoic Acid"},{"value":"Phase 1 / Phase 2"},{"value":"hiv"},{"value":"60"}],[{"value":"2355"},{"value":"Assessing the Results of Lip Surgery in Patients With Cleft Lip and Palate"},{"value":"Phase 2 / Phase 3"},{"value":"surgery"},{"value":"127"}],[{"value":"2358"},{"value":"HIV Symptom Management Program for African American Mothers"},{"value":"Phase 3"},{"value":"hiv"},{"value":""}],[{"value":"2363"},{"value":"Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma"},{"value":"Phase 1"},{"value":"surgery"},{"value":"18"}],[{"value":"2364"},{"value":"Study of Karenitecin (BNP1350) in Patients With Brain Tumors"},{"value":"Phase 2"},{"value":"tumors"},{"value":"40"}],[{"value":"2366"},{"value":"Reduced Manipulation of the Aorta and Neurobehavioral Outcome Trial"},{"value":"Phase 3"},{"value":"neurological"},{"value":"300"}],[{"value":"2373"},{"value":"Phase 1 Study OF CDC-501 in Patients With Solid Tumors"},{"value":"Phase 1"},{"value":"tumors"},{"value":"24"}],[{"value":"2382"},{"value":"Screening Adolescents for Type 2 Diabetes Mellitus in a Community Clinic"},{"value":""},{"value":"diabetes"},{"value":"400"}],[{"value":"2383"},{"value":"Effects of Magnesium on Individuals Undergoing Coronary Artery Bypass Graft Surgery"},{"value":"Phase 2"},{"value":"surgery"},{"value":"389"}],[{"value":"2384"},{"value":"Imatinib Mesylate in Treating Patients With Primary Gastrointestinal Stromal Tumor That Has Been Completely Removed By Surgery"},{"value":"Phase 3"},{"value":"tumors"},{"value":"732"}],[{"value":"2394"},{"value":"Imatinib Mesylate in Treating Patients With Gastrointestinal Stromal Tumor That Has Been Completely Removed During Surgery"},{"value":"Phase 2"},{"value":"tumors"},{"value":"89"}],[{"value":"2396"},{"value":"Antibiotics to Reduce Chorioamnionitis-Related Perinatal HIV Transmission"},{"value":"Phase 3"},{"value":"hiv"},{"value":"3720"}],[{"value":"2397"},{"value":"Treatment to Quit Smoking"},{"value":"Phase 2"},{"value":"smoker study"},{"value":""}],[{"value":"2398"},{"value":"The Genetics of Environmental Asthma"},{"value":""},{"value":"asthma"},{"value":"176"}],[{"value":"2399"},{"value":"Intensive Pharmacokinetics of the Nelfinavir-Rifabutin Interaction in Patients With HIV-Related Tuberculosis Treated With a Rifabutin-Based Regimen"},{"value":""},{"value":"tuberculosis"},{"value":""}],[{"value":"2407"},{"value":"To Determine the Prevalence of HIV and Other Related Infections Such as Hepatitis C Along With Associated Risk Behaviors in Patients With Severe Mental Illness (SMI)."},{"value":""},{"value":"hepatitis"},{"value":""}],[{"value":"2408"},{"value":"Finding Diabetes Mellitus Among Veterans"},{"value":""},{"value":"diabetes"},{"value":"1276"}],[{"value":"2415"},{"value":"Acute Glycemic Effects of a Very Low Fat Diet in Type 2 Diabetes"},{"value":""},{"value":"diabetes"},{"value":""}],[{"value":"2416"},{"value":"Active Immunotherapy Of Metastatic Renal Cell Carcinoma Using Autologous Dendritic Cells Transfected With Autologous Total Tumor RNA"},{"value":"Phase 1"},{"value":"tumors"},{"value":""}],[{"value":"2417"},{"value":"A Safety and Feasibility Study of Active Immunotherapy in Patients With Metastatic Prostate Carcinoma Using Autologous Dendritic Cells Pulsed With Antigen Encoded in Amplified Autologous Tumor RNA"},{"value":"Phase 1"},{"value":"tumors"},{"value":""}],[{"value":"2418"},{"value":"Effectiveness of AZT and Nevirapine in Preventing HIV Transmission From Ugandan Mothers to Their Newborns"},{"value":"Phase 3"},{"value":"hiv"},{"value":"1500"}],[{"value":"2419"},{"value":"Genetic Study in Patients Receiving Treatment for Hodgkin&apos;s Disease or Childhood Brain Tumor"},{"value":""},{"value":"tumors"},{"value":"19"}],[{"value":"2427"},{"value":"Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors"},{"value":"Phase 2"},{"value":"tumors"},{"value":""}],[{"value":"2428"},{"value":"Temozolomide in Treating Patients With Brain Metastases"},{"value":"Phase 2"},{"value":"neurological"},{"value":""}],[{"value":"2429"},{"value":"Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors"},{"value":"Phase 1 / Phase 2"},{"value":"tumors"},{"value":"30"}],[{"value":"2437"},{"value":"Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received Treatment"},{"value":"Phase 4"},{"value":"hiv"},{"value":"300"}],[{"value":"2442"},{"value":"Phase II Study of Stereotypes and Mental Retardation: Neurobiological Basis"},{"value":"Phase 2"},{"value":"neurological"},{"value":"40"}],[{"value":"2445"},{"value":"Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Locally Advanced Melanoma of the Arm or Leg"},{"value":"Phase 3"},{"value":"tumors"},{"value":"216"}],[{"value":"2446"},{"value":"Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors"},{"value":"Phase 1"},{"value":"tumors"},{"value":"21"}],[{"value":"2447"},{"value":"Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain Tumors"},{"value":"Phase 1 / Phase 2"},{"value":"tumors"},{"value":"10"}],[{"value":"2451"},{"value":"Intrathecal Busulfan in Treating Patients With Recurrent Refractory or Metastatic Leptomeningeal Tumors"},{"value":"Phase 1"},{"value":"tumors"},{"value":"20"}],[{"value":"2452"},{"value":"Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors"},{"value":"Phase 1 / Phase 2"},{"value":"tumors"},{"value":""}],[{"value":"2458"},{"value":"Carmustine Plus O(6)-Benzylguanine in Treating Patients With Recurrent or Progressive Gliomas of the Brain"},{"value":"Phase 1"},{"value":"neurological"},{"value":"56"}],[{"value":"2468"},{"value":"Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain Tumors"},{"value":"Phase 1"},{"value":"tumors"},{"value":"6"}],[{"value":"2471"},{"value":"Monoclonal Antibody Therapy in Treating Patients With Brain Metastases"},{"value":"Phase 1 / Phase 2"},{"value":"neurological"},{"value":"6"}],[{"value":"2476"},{"value":"A Study of Retrovir in the Prevention of HIV Infection in Health Care Workers Accidentally Exposed to the Virus"},{"value":""},{"value":"hiv"},{"value":""}],[{"value":"2478"},{"value":"A Study of Zidovudine and T Lymphocyte Transfer in the Treatment of HIV Type III in Patients With AIDS"},{"value":""},{"value":"hiv"},{"value":""}],[{"value":"2483"},{"value":"A Prospective Double-Blind Study of Retrovir in Early HIV Infection"},{"value":""},{"value":"hiv"},{"value":""}],[{"value":"2484"},{"value":"A Pilot Study To Evaluate the Effect of Retrovir (Zidovudine: AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Associated Dementia and Neuromuscular Diseases"},{"value":""},{"value":"neurological"},{"value":""}],[{"value":"2485"},{"value":"An Oral Dose-Ranging Finding Study in Patients With HIV Disease CDC Classification Groups IIB III and IV-C2"},{"value":""},{"value":"hiv"},{"value":""}],[{"value":"2490"},{"value":"A Study of Zidovudine in the Prevention of HIV Infection in Individuals Exposed to the Virus"},{"value":""},{"value":"hiv"},{"value":""}],[{"value":"2491"},{"value":"A Study of Nonoxynol-9 (N-9) and HIV Infection"},{"value":"Phase 3"},{"value":"hiv"},{"value":"4400"}],[{"value":"2492"},{"value":"A Treatment IND for Retrovir Brand Zidovudine (AZT) Therapy of Pediatric Patients With HIV Disease"},{"value":""},{"value":"hiv"},{"value":""}],[{"value":"2494"},{"value":"iOmit: Reducing Intentional Insulin Misuse in Type 1 Diabetes"},{"value":""},{"value":"diabetes"},{"value":"60"}],[{"value":"2501"},{"value":"To Determine the Measurement Properties of the ACT in an African American Adolescent Population With Persistent Asthma"},{"value":""},{"value":"asthma"},{"value":"80"}],[{"value":"2502"},{"value":"To Determine the Validity of the ACT in an Adolescent Population With Persistent Asthma"},{"value":""},{"value":"asthma"},{"value":"80"}],[{"value":"2506"},{"value":"Safety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV Infection"},{"value":""},{"value":"hiv"},{"value":"40"}],[{"value":"2507"},{"value":"Biomarkers of Aging as Predictors of Kidney Transplant Function"},{"value":""},{"value":"kidney disease"},{"value":"35"}],[{"value":"2515"},{"value":"Respiratory Event-Related Potentials in Patients With Spinal Cord Injury"},{"value":""},{"value":"respiratory disease"},{"value":"40"}],[{"value":"2521"},{"value":"Patient Self-management and Gene Guided Therapy for Chronic Hepatitis C"},{"value":""},{"value":"hepatitis"},{"value":"20"}],[{"value":"2531"},{"value":"Optimizing Outcomes in Women With Gestational Diabetes Mellitus and Their Infants"},{"value":""},{"value":"diabetes"},{"value":"200"}],[{"value":"2535"},{"value":"Cholesterol Medication Packaging Study"},{"value":""},{"value":"heart disease"},{"value":"240"}],[{"value":"2536"},{"value":"Donepezil Compared to Placebo in Patients With Chronic Neuropathic Pain"},{"value":"Phase 4"},{"value":"neurological"},{"value":"33"}],[{"value":"2538"},{"value":"Treatment of Acute HIV Infection With Quad Fixed-dose Combination (FDC) Tablet"},{"value":"Phase 3"},{"value":"hiv"},{"value":"30"}],[{"value":"2539"},{"value":"Internet-Based Osteoarthritis Pain Coping Skills Intervention"},{"value":"Phase 3"},{"value":"arthritis"},{"value":"113"}],[{"value":"2542"},{"value":"Tailored Smoking Cessation Treatment for LIVE FOR LIFE&#174; Participants"},{"value":"Phase 2 / Phase 3"},{"value":"smoker study"},{"value":"19"}],[{"value":"2544"},{"value":"Safety Efficacy and Dosing of Stereotactic Radiosurgery for Hepato-cellular Carc/Colo-rectal Liver Metastases"},{"value":"Phase 1"},{"value":"surgery"},{"value":"30"}],[{"value":"2546"},{"value":"Mechanistic Evaluations of Pre-Cessation Therapies for Smoking Cessation"},{"value":"Phase 3"},{"value":"smoker study"},{"value":"282"}],[{"value":"2553"},{"value":"Title: Comparative Effectiveness of Asthma Interventions Within an AHRQ PBRN"},{"value":""},{"value":"asthma"},{"value":"1040"}],[{"value":"2556"},{"value":"Oxytocin Treatment of Alcohol Withdrawal"},{"value":"Phase 1"},{"value":"alcohol"},{"value":"14"}],[{"value":"2557"},{"value":"Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma Bone Sarcoma or Soft Tissue Sarcoma"},{"value":"Phase 1"},{"value":"neurological"},{"value":"7"}],[{"value":"2560"},{"value":"Pacing Affects Cardiovascular Endpoints in Patients With Right Bundle-Branch Block (The PACE-RBBB Trial)"},{"value":""},{"value":"heart disease"},{"value":"16"}],[{"value":"2561"},{"value":"Collaborative Study Of Neurofeedback Training Of 6-18 Year Olds With Autism"},{"value":"Phase 1"},{"value":"neurological"},{"value":"30"}],[{"value":"2562"},{"value":"Project POWER Adapting Project SAFE: Reducing STD/HIV Risk in Women Prisoners"},{"value":""},{"value":"hiv"},{"value":"598"}],[{"value":"2563"},{"value":"FMRI Brain Activation of Aripiprazole Treatment in Autism Spectrum Disorders"},{"value":"Phase 4"},{"value":"neurological"},{"value":"13"}],[{"value":"2569"},{"value":"Treatment of Acute HIV With Emtricitabine Tenofovir and Efavirenz (CID 0805)"},{"value":"Phase 4"},{"value":"hiv"},{"value":"90"}],[{"value":"2571"},{"value":"The Effects of One-Time Pregnenolone Dehydroepiandrosterone (DHEA) or Placebo Administration On Withdrawal Symptoms Mood Craving And Cigarette Evaluation Ratings In Male Smokers"},{"value":"Phase 2"},{"value":"smoker study"},{"value":"22"}],[{"value":"2572"},{"value":"Study to Evaluate HIV Viremia and Persistence in Acutely HIV-Infected ARV Na&#239;ve Patients Treated With Darunavir/Ritonavir and Etravirine"},{"value":"Phase 4"},{"value":"hiv"},{"value":"15"}],[{"value":"2573"},{"value":"Effect of Type 2 Diabetes Genetic Risk Information on Health Behaviors and Outcomes"},{"value":""},{"value":"diabetes"},{"value":"450"}],[{"value":"2574"},{"value":"Cognitive Effects of Inhalational Versus Intravenous General Anesthesia in the Elderly"},{"value":""},{"value":"elderly"},{"value":"200"}],[{"value":"2577"},{"value":"Raltegravir as Early Therapy in African-Americans Living With HIV Study"},{"value":"Phase 4"},{"value":"hiv"},{"value":"43"}],[{"value":"2580"},{"value":"Feasibility of Cocooning Immunization Strategy With Influenza Vaccine"},{"value":""},{"value":"influenza"},{"value":"544"}],[{"value":"2582"},{"value":"Erythropoietin Resistance in Anemia of Chronic Kidney Disease"},{"value":""},{"value":"kidney disease"},{"value":"32"}],[{"value":"2584"},{"value":"Evaluating a Web-Based Educational Program for Adults at Risk for Coronary Heart Disease (The Heart to Heart Feasibility Study)"},{"value":""},{"value":"heart disease"},{"value":"186"}],[{"value":"2588"},{"value":"Clonidine-induced Spinal Acetylcholine Release: Normal Volunteers vs. Neuropathic Pain"},{"value":"Phase 2"},{"value":"neurological"},{"value":"43"}],[{"value":"2589"},{"value":"Clonidine Versus Adenosine to Treat Neuropathic Pain"},{"value":"Phase 2"},{"value":"neurological"},{"value":"24"}],[{"value":"2594"},{"value":"Functional Brain Imaging and Employment in First-Episode Psychotic Patients Treated With Risperdal"},{"value":"Phase 4"},{"value":"neurological"},{"value":"30"}],[{"value":"2599"},{"value":"Testing Pharmacological Therapies for Pregnant Smokers"},{"value":"Phase 4"},{"value":"smoker study"},{"value":"181"}],[{"value":"2602"},{"value":"Sensory Re-Training Following Facial Surgery for Correction of Facial Skeletal Disharmony"},{"value":"Phase 3"},{"value":"surgery"},{"value":"186"}],[{"value":"2604"},{"value":"Coping Skills Training for Early Rheumatoid Arthritis"},{"value":""},{"value":"arthritis"},{"value":"105"}],[{"value":"2611"},{"value":"Effects of Nicotine Reduction on Smoking Behavior in ADHD Smokers"},{"value":""},{"value":"smoker study"},{"value":"350"}],[{"value":"2623"},{"value":"Double-Blind 2-Site Randomized Clinical Trial of Neurofeedback for ADHD"},{"value":""},{"value":"neurological"},{"value":"140"}],[{"value":"2625"},{"value":"Study To Compare Single Dose Of Three Modified Release Formulations Of PF-04937319 With Immediate Release Material-Sparing-Tablet (IR MST) Formulation Previously Studied In Adults With Type 2 Diabetes Mellitus."},{"value":"Phase 1"},{"value":"diabetes"},{"value":"39"}],[{"value":"2641"},{"value":"Evaluation of Behavioral Intervention for HIV Positive Prisoners in NC and TX"},{"value":""},{"value":"hiv"},{"value":"381"}],[{"value":"2642"},{"value":"Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120)"},{"value":"Phase 2"},{"value":"diabetes"},{"value":"36"}],[{"value":"2643"},{"value":"Intraoperative OCT Guidance of Intraocular Surgery"},{"value":""},{"value":"surgery"},{"value":"802"}],[{"value":"2646"},{"value":"School Support as Structural HIV Prevention for Adolescent Orphans in Kenya"},{"value":"Phase 2"},{"value":"hiv"},{"value":"835"}],[{"value":"2652"},{"value":"A Novel Optical Spectral Imaging System for Imaging Breast Tumor Margins"},{"value":""},{"value":"tumors"},{"value":"210"}],[{"value":"2668"},{"value":"CP-868596 And CP-868596 Plus AG-013736 In Combination With Docetaxel In Advanced Solid Tumors"},{"value":"Phase 1"},{"value":"tumors"},{"value":"50"}],[{"value":"2669"},{"value":"Lidocaine For Neuroprotection During Cardiac Surgery"},{"value":""},{"value":"surgery"},{"value":"476"}],[{"value":"2680"},{"value":"Physical Activity Following Surgery Induced Weight Loss"},{"value":""},{"value":"surgery"},{"value":"128"}],[{"value":"2686"},{"value":"Three Way Interaction Between Gabapentin Duloxetine and Donepezil in Patients With Diabetic Neuropathy"},{"value":""},{"value":"neurological"},{"value":"22"}],[{"value":"2696"},{"value":"Study of Campral (Acamprosate) for Alcohol Dependence in a Family Medicine Clinic"},{"value":"Phase 4"},{"value":"alcohol"},{"value":"100"}],[{"value":"2699"},{"value":"Comparison Of Molecular Targets In Mild To Severe Asthmatics And Healthy Subjects"},{"value":"Phase 1"},{"value":"asthma"},{"value":"58"}],[{"value":"2700"},{"value":"Can Group Visits Improve Outcomes of Veterans With Diabetes"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"239"}],[{"value":"2706"},{"value":"MEND-CABG (MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery)"},{"value":"Phase 2"},{"value":"surgery"},{"value":"900"}],[{"value":"2710"},{"value":"GW786034 in Treating Patients With Advanced Solid Tumors"},{"value":"Phase 1"},{"value":"tumors"},{"value":""}],[{"value":"2715"},{"value":"Vaccine Therapy in Treating Patients With Metastatic Melanoma Who Are Undergoing Surgery for Lymph Node and Tumor Removal"},{"value":"Phase 1 / Phase 2"},{"value":"tumors"},{"value":""}],[{"value":"2719"},{"value":"A Study of Zidovudine in HIV-Infected Patients With Kidney Problems"},{"value":"Phase 1"},{"value":"kidney disease"},{"value":"0"}],[{"value":"2721"},{"value":"Weight Loss and Exercise for Communities With Arthritis in North Carolina"},{"value":"Phase 3"},{"value":"arthritis"},{"value":"820"}],[{"value":"2725"},{"value":"Evaluation of Moclobemide a Reversible MAO-A Inhibitor as an Adjunct to Nicotine Replacement Therapy in Female Smokers"},{"value":"Phase 2"},{"value":"smoker study"},{"value":"76"}],[{"value":"2733"},{"value":"Evaluating Once Daily Etravirine in Treatment-Naive Adults With HIV Infection"},{"value":"Phase 2"},{"value":"hiv"},{"value":"80"}],[{"value":"2739"},{"value":"Effects of Anti-HIV Therapy on Red Blood Cells of HIV-infected Mothers and Their Infants"},{"value":""},{"value":"hiv"},{"value":"0"}],[{"value":"2769"},{"value":"Treatment for Teens With Alcohol Abuse and Depression"},{"value":""},{"value":"alcohol"},{"value":"170"}],[{"value":"2773"},{"value":"Diabetes Self-Management &amp; Support LIVE"},{"value":""},{"value":"diabetes"},{"value":"300"}],[{"value":"2775"},{"value":"Cardioneuroablation for Neurocardiogenic Syncope"},{"value":""},{"value":"neurological"},{"value":"3"}],[{"value":"2778"},{"value":"High-Dose Trivalent Influenza Vaccine in Inducing Immune Response Patients With Central Nervous System Tumors"},{"value":"Phase 1"},{"value":"influenza"},{"value":"60"}],[{"value":"2781"},{"value":"Mechanisms and Functional Outcomes of Exercise Progression Models in the Elderly"},{"value":""},{"value":"elderly"},{"value":"108"}],[{"value":"2785"},{"value":"A Prospective Evaluation of the Effect of Curcumin on Dose Limiting Toxicity and Pharmacokinetics of Irinotecan in Patients With Solid Tumors."},{"value":"Phase 1"},{"value":"tumors"},{"value":"23"}],[{"value":"2786"},{"value":"Deployment Related Mild Traumatic Brain Injury (mTBI)"},{"value":""},{"value":"neurological"},{"value":"1500"}],[{"value":"2791"},{"value":"Severe Asthma Research Program - Wake Forest University"},{"value":""},{"value":"asthma"},{"value":"700"}],[{"value":"2798"},{"value":"Symptomatic Pulmonary Arterial Hypertension After Mitral Valve Surgery"},{"value":""},{"value":"surgery"},{"value":"100"}],[{"value":"2812"},{"value":"Study to Evaluate the Bronchoprotective Effects of a Single Dose of N6022 in Patients With Mild Asthma"},{"value":"Phase 1 / Phase 2"},{"value":"asthma"},{"value":"14"}],[{"value":"2823"},{"value":"Prospective Evaluation of the Incidence of NSF in Patients With Kidney Disease Undergoing MR"},{"value":""},{"value":"kidney disease"},{"value":"2"}],[{"value":"2828"},{"value":"Lymphedema Following Hand/Wrist Surgery in Women Post Axillary Node Dissection"},{"value":"Phase 4"},{"value":"surgery"},{"value":"206"}],[{"value":"2854"},{"value":"Glucose/Insulin Responses:Subjects With Type 2 Diabetes Consuming Diabetes-Specific vs Standard Nutritional Formulas"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"54"}],[{"value":"2855"},{"value":"Induction of Donor Specific Tolerance in Recipients of Living Kidney Allografts by Donor FCRx Infusion"},{"value":"Phase 2"},{"value":"kidney disease"},{"value":"60"}],[{"value":"2858"},{"value":"Arthritis Self-Management Education Program"},{"value":""},{"value":"arthritis"},{"value":"690"}],[{"value":"2860"},{"value":"Donepezil in Treating Young Patients With Primary Brain Tumors Previously Treated With Radiation Therapy to the Brain"},{"value":""},{"value":"tumors"},{"value":"14"}],[{"value":"2868"},{"value":"Effect of Brain Lesion Severity on Treatment Response in Late-Life Depression"},{"value":""},{"value":"neurological"},{"value":"131"}],[{"value":"2886"},{"value":"Pain and Stress Management for People With Rheumatoid Arthritis"},{"value":"Phase 2"},{"value":"arthritis"},{"value":"280"}],[{"value":"2888"},{"value":"Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors"},{"value":"Phase 1"},{"value":"tumors"},{"value":""}],[{"value":"2900"},{"value":"A Study of Foscarnet in the Treatment of HIV Infection in Patients Who Have Taken Zidovudine for a Long Time"},{"value":"Phase 1"},{"value":"hiv"},{"value":"12"}],[{"value":"2915"},{"value":"Early Mobility for the Critically Injured Burn Patient"},{"value":""},{"value":"burns"},{"value":"150"}],[{"value":"2922"},{"value":"Safety and Immune Response of Candidate H1N1 Influenza Vaccine GSK2340274A Following Seasonal Influenza Vaccination in Adults"},{"value":"Phase 1"},{"value":"influenza"},{"value":"133"}],[{"value":"2925"},{"value":"Automated Chest Physiotherapy to Improve Outcomes in Neuro"},{"value":""},{"value":"neurological"},{"value":"40"}],[{"value":"2932"},{"value":"Proof-Of-Concept Investigation With a Neurosteroid Analog (Ganaxolone) as a Smoking Cessation Candidate"},{"value":"Phase 2"},{"value":"smoker study"},{"value":"36"}],[{"value":"2933"},{"value":"Combination Bupropion / Varenicline for Smoking Cessation in Male Smokers"},{"value":"Phase 2"},{"value":"smoker study"},{"value":"376"}],[{"value":"2934"},{"value":"Meclizine as a Potential Smoking Cessation Treatment"},{"value":"Phase 2"},{"value":"smoker study"},{"value":"146"}],[{"value":"2935"},{"value":"Concurrent Bupropion / Varenicline for Smoking Cessation"},{"value":"Phase 3"},{"value":"smoker study"},{"value":"702"}],[{"value":"2943"},{"value":"Trial of Collaborative Depression Care Management for HIV Patients"},{"value":""},{"value":"hiv"},{"value":"304"}],[{"value":"2952"},{"value":"Safety Study of MGD009 in B7-H3-expressing Tumors"},{"value":"Phase 1"},{"value":"tumors"},{"value":"114"}],[{"value":"2956"},{"value":"Study to Determine the Pharmacokinetics and Tolerability of Fluticasone Propionate MDPI and Fluticasone Propionate/Salmeterol MDPI Compared to High Strength FLOVENT&#174; DISKUS&#174; and ADVAIR&#174; DISKUS&#174; in Patients With Persistent Asthma 12 Years of Age and Older"},{"value":"Phase 1"},{"value":"asthma"},{"value":"43"}],[{"value":"2957"},{"value":"Phase 1/2a Dose-Escalation Study of CRLX301 in Patients With Advanced Solid Tumors"},{"value":"Phase 1 / Phase 2"},{"value":"tumors"},{"value":"60"}],[{"value":"2959"},{"value":"First in Human Dose Escalation Study of TEW-7197 in Subjects With Advanced Stage Solid Tumors"},{"value":"Phase 1"},{"value":"tumors"},{"value":"50"}],[{"value":"2962"},{"value":"Clinical Performance Study of the Ultra Influenza A&amp;B Test Using Nasal Swabs for Identifying Subjects Who Are Infected With the Influenza Virus Strain Type A or Type B"},{"value":""},{"value":"influenza"},{"value":"677"}],[{"value":"2965"},{"value":"Surgery and Oxaliplatin or Mitomycin C in Treating Patients With Tumors of the Appendix"},{"value":"Phase 2"},{"value":"tumors"},{"value":"116"}],[{"value":"2970"},{"value":"Safety and Efficacy of LCL161 in Patients With Solid Tumors"},{"value":"Phase 1"},{"value":"tumors"},{"value":"71"}],[{"value":"2981"},{"value":"Efficacy of Seprapack Sinus Dressing Versus No Dressing in the Prevention of Intranasal Adhesions Following Sinus Surgery"},{"value":""},{"value":"surgery"},{"value":""}],[{"value":"2984"},{"value":"Study to Evaluate the Safety and Pharmacokinetics of MEDI9090 in Subjects With Advanced Solid Tumors"},{"value":"Phase 1"},{"value":"tumors"},{"value":"36"}],[{"value":"2990"},{"value":"A Double Blind Open Label Comparator Study to Compare Treatments in 4 to 11 Year Old Patients With Asthma"},{"value":"Phase 1"},{"value":"asthma"},{"value":"20"}],[{"value":"3003"},{"value":"Study of A Cell-Phone System to Improve Health of Youth With Diabetes"},{"value":""},{"value":"diabetes"},{"value":"74"}],[{"value":"3004"},{"value":"Pharmacokinetics and Clinical Response of Tolvaptan in Neurocritical Care Patients"},{"value":""},{"value":"neurological"},{"value":"1"}],[{"value":"3008"},{"value":"The Pathogenesis of Hepatitis C Virus Vertical Transmission"},{"value":""},{"value":"hepatitis"},{"value":"50"}],[{"value":"3009"},{"value":"Efficacy and Safety of Beta-adrenoceptor Inverse Agonist Nadolol in Mild Asthma"},{"value":"Phase 2"},{"value":"asthma"},{"value":"60"}],[{"value":"3014"},{"value":"NAPS-MS: NAtalizumab Effects on Parameters of Sleep in Patients With Multiple Sclerosis Experiencing Fatigue or Sleepiness"},{"value":"Phase 4"},{"value":"sleep study"},{"value":"37"}],[{"value":"3028"},{"value":"A Phase 1 Dose Escalation Study of AMG 780 in Adult Subjects With Advanced Solid Tumors"},{"value":"Phase 1"},{"value":"tumors"},{"value":"44"}],[{"value":"3032"},{"value":"Trial of Tasigna (Nilotinib) 400 mg Twice Daily Alone or With Gleevec (Imatinib Mesylate) 400 mg Daily for Patients With Advanced Gastrointestinal Stromal Tumor (GIST)"},{"value":"Phase 2"},{"value":"tumors"},{"value":"5"}],[{"value":"3034"},{"value":"Collection and Extraction of Respiratory Specimens"},{"value":""},{"value":"respiratory disease"},{"value":"600"}],[{"value":"3037"},{"value":"Sanofi H1N1 Influenza Vaccine Administered at Two Dose Levels in Adult and Elderly Populations"},{"value":"Phase 2"},{"value":"influenza"},{"value":"406"}],[{"value":"3041"},{"value":"Safety and Dosage Study of RAD001 (Everolimus) in Combination With Current Standard of Care to Treat Advanced Solid Tumors."},{"value":"Phase 1"},{"value":"tumors"},{"value":"32"}],[{"value":"3045"},{"value":"Study of IMC-1121B in Patients With Advanced Solid Tumors Not Responding To Standard Therapy"},{"value":"Phase 1"},{"value":"tumors"},{"value":"25"}],[{"value":"3055"},{"value":"Study of Tumor Necrosis Factor Receptor Fusion Protein Etanercept (Enbrel) in Psoriasis of the Hands and/or Feet"},{"value":"Phase 1 / Phase 2"},{"value":"tumors"},{"value":"20"}],[{"value":"3083"},{"value":"Safety of the Candidate Vaccine C4-V3 Alone or With Interleukin-12 (IL-12) in HIV-Infected Patients Receiving Effective Anti-HIV Drug Therapy"},{"value":"Phase 1"},{"value":"hiv"},{"value":"12"}],[{"value":"3089"},{"value":"A Multicenter 2 Part Study to Assess the Efficacy and Safety of H.P. Acthar&#174; Gel in Subjects With Rheumatoid Arthritis"},{"value":"Phase 4"},{"value":"arthritis"},{"value":"232"}],[{"value":"3091"},{"value":"Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder"},{"value":"Phase 2"},{"value":"sleep study"},{"value":"80"}],[{"value":"3113"},{"value":"Exploring Massage Benefits for Arthritis of the Knee"},{"value":"Phase 2"},{"value":"arthritis"},{"value":"222"}],[{"value":"3144"},{"value":"A Phase 1 Double-Blind Randomized Single Dose Escalation Safety Study of Intra-articular OP-1 in Subjects With Osteoarthritis of the Knee"},{"value":"Phase 1"},{"value":"arthritis"},{"value":"33"}],[{"value":"3154"},{"value":"FibroScan in Patients With Hepatitis B and C Presenting for Liver Biopsy"},{"value":"Phase 3"},{"value":"hepatitis"},{"value":"300"}],[{"value":"3157"},{"value":"Safety and Tolerability of Pegylated Interferon (PEG-IFN) Alfa-2a in HIV Infected People"},{"value":"Phase 2"},{"value":"hiv"},{"value":"12"}],[{"value":"3160"},{"value":"A Study of 141W94 in Combination With Other Anti-HIV Drugs"},{"value":"Phase 1"},{"value":"hiv"},{"value":"48"}],[{"value":"3173"},{"value":"Southeastern Diabetes Initiative Clinical Intervention"},{"value":""},{"value":"diabetes"},{"value":"648"}],[{"value":"3181"},{"value":"Risk of Developing Antibodies to Heparin-PF4 After Heart Surgery"},{"value":""},{"value":"surgery"},{"value":"1015"}],[{"value":"3183"},{"value":"A Study of Autologous Neo-Kidney Augment&#8482; (NKA) in Type 2 Diabetics With Chronic Kidney Disease"},{"value":"Phase 2"},{"value":"kidney disease"},{"value":"50"}],[{"value":"3188"},{"value":"Heart to Health: A Combined Lifestyle and Medication Intervention to Reduce Cardiovascular Disease (CVD) Risk"},{"value":""},{"value":"heart disease"},{"value":"489"}],[{"value":"3191"},{"value":"Early Weight Bearing on Supracondylar Distal Femur Fractures in Elderly Patients"},{"value":""},{"value":"elderly"},{"value":"200"}],[{"value":"3204"},{"value":"Study to Investigate the Safety Pharmacokinetics Pharmacodynamics and Clinical Activity of GSK2126458 and GSK1120212 Combination Therapy in Subjects With Advanced Solid Tumors."},{"value":"Phase 1"},{"value":"tumors"},{"value":"69"}],[{"value":"3205"},{"value":"A Study of Influenza Virus Vaccines in Children and Adults"},{"value":"Phase 2"},{"value":"influenza"},{"value":"600"}],[{"value":"3211"},{"value":"Early Life Factors and Respiratory Health in Mexico City Children"},{"value":""},{"value":"respiratory disease"},{"value":"6800"}],[{"value":"3213"},{"value":"Influenza Vaccine Feasibility Study in Children With Persistent Asthma"},{"value":"Phase 4"},{"value":"asthma"},{"value":"50"}],[{"value":"3222"},{"value":"PTC596 in Patients With Advanced Solid Tumors"},{"value":"Phase 1"},{"value":"tumors"},{"value":"60"}],[{"value":"3227"},{"value":"Safety and Efficacy Study of Single Doses of TT-034 in Patients With Chronic Hepatitis C"},{"value":"Phase 1 / Phase 2"},{"value":"hepatitis"},{"value":"9"}],[{"value":"3228"},{"value":"A Study to Evaluate the Safety Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABT-122 in Subjects With Rheumatoid Arthritis"},{"value":"Phase 1"},{"value":"arthritis"},{"value":"19"}],[{"value":"3230"},{"value":"RESULT (REflux Surgery in Lung Transplantation) Preliminary Study Protocol"},{"value":""},{"value":"surgery"},{"value":"647"}],[{"value":"3232"},{"value":"Study of SCY-635 Pegasys and Copegus in Hepatitis C"},{"value":"Phase 2"},{"value":"hepatitis"},{"value":"11"}],[{"value":"3235"},{"value":"Bioavailability and Food Effect Study of TKI258 (CSF Capsule vs. FMI Tablet) in Adult Patients With Advanced Solid Tumors"},{"value":"Phase 1"},{"value":"tumors"},{"value":"63"}],[{"value":"3241"},{"value":"Study of ACE-041 in Patients With Advanced Solid Tumors or Relapsed/Refractory Multiple Myeloma"},{"value":"Phase 1"},{"value":"tumors"},{"value":"37"}],[{"value":"3254"},{"value":"Affect Recognition: Enhancing Performance of Persons With Acquired Brain Injury (ABI)"},{"value":"Phase 2 / Phase 3"},{"value":"neurological"},{"value":"71"}],[{"value":"3261"},{"value":"Effects of Treating Obstructive Sleep Apnea in Epilepsy"},{"value":"Phase 2"},{"value":"epilepsy"},{"value":"68"}],[{"value":"3264"},{"value":"Risk Evaluation and Education for Alzheimer&apos;s Disease - the Study of Communicating Amyloid Neuroimaging (REVEAL-SCAN)"},{"value":""},{"value":"neurological"},{"value":"270"}],[{"value":"3284"},{"value":"Evaluating the Impact of Year Long Augmented Diabetes Self Management Support"},{"value":""},{"value":"diabetes"},{"value":"449"}],[{"value":"3288"},{"value":"The Tobacco Alcohol Prescription Medication and Other Substances Tool"},{"value":""},{"value":"alcohol"},{"value":"2000"}],[{"value":"3317"},{"value":"Bioavailability and Food Effect Study of TKI258 (CSF Capsules vs. FMI Capsules)in Adult Patients With Advanced Solid Tumors"},{"value":"Phase 1"},{"value":"tumors"},{"value":"60"}],[{"value":"3320"},{"value":"Safety Trial of Single Versus Multiple Dose Thymoglobulin Induction in Kidney Transplantation"},{"value":"Phase 2"},{"value":"kidney disease"},{"value":"99"}],[{"value":"3329"},{"value":"Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) Tumors"},{"value":"Phase 2"},{"value":"tumors"},{"value":"26"}],[{"value":"3333"},{"value":"A Study of R547 in Patients With Advanced Solid Tumors."},{"value":"Phase 1"},{"value":"tumors"},{"value":"58"}],[{"value":"3342"},{"value":"Dose-Escalation Study Of SB-485232 Administered As Daily Subcutaneous Injections In Adults With Solid Tumors"},{"value":"Phase 1"},{"value":"tumors"},{"value":"25"}],[{"value":"3344"},{"value":"Donepezil or EGb761 in Improving Neurocognitive Function in Patients Who Have Previously Undergone Radiation Therapy for Primary Brain Tumor or Brain Metastases"},{"value":"Phase 2"},{"value":"tumors"},{"value":""}],[{"value":"3345"},{"value":"Omega-3 Fatty Acids That Affect the Immune System in Kidney Transplant Patients"},{"value":"Phase 0"},{"value":"kidney disease"},{"value":"75"}],[{"value":"3347"},{"value":"Single Dose and 34-Day Tolerance Study of INGAP Peptide in Insulin Deficient Patients"},{"value":"Phase 1 / Phase 2"},{"value":"diabetes"},{"value":"62"}],[{"value":"3349"},{"value":"Improving Diabetes Care Via Telephone Assessment and Patient Education"},{"value":""},{"value":"diabetes"},{"value":"480"}],[{"value":"3352"},{"value":"Trial of Nonpharmacologic Interventions in Elderly (TONE)"},{"value":"Phase 3"},{"value":"elderly"},{"value":""}],[{"value":"3359"},{"value":"Safety Study of Inhaled Carbon Monoxide to Treat Acute Respiratory Distress Syndrome (ARDS)"},{"value":"Phase 1"},{"value":"respiratory disease"},{"value":"48"}],[{"value":"3363"},{"value":"Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors"},{"value":"Phase 2"},{"value":"tumors"},{"value":"0"}],[{"value":"3373"},{"value":"Cardiovascular Effects of Exposure to Ozone"},{"value":""},{"value":"heart disease"},{"value":"90"}],[{"value":"3374"},{"value":"A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors"},{"value":"Phase 1"},{"value":"tumors"},{"value":"30"}],[{"value":"3382"},{"value":"Dosimetry Study of I-131-CLR1404 in Patients With Relapsed or Refractory Advanced Solid Tumors"},{"value":"Phase 1"},{"value":"tumors"},{"value":"9"}],[{"value":"3383"},{"value":"Study to Compare the Safety and Anti-HIV Effect of GSK1265744 Versus Placebo in HIV-1 Infected Adults (ITZ112929)"},{"value":"Phase 2"},{"value":"hiv"},{"value":"9"}],[{"value":"3385"},{"value":"Safety Study of ABT-263 in Combination With Paclitaxel in Subjects With Solid Tumors"},{"value":"Phase 1"},{"value":"tumors"},{"value":"19"}],[{"value":"3396"},{"value":"Safety and Tolerability Study of SNS-314 for Advanced Solid Tumors"},{"value":"Phase 1"},{"value":"tumors"},{"value":"50"}],[{"value":"3407"},{"value":"A Comparison of Two Anti-HIV Drug Regimens for Youth Who Have Failed Prior Therapy"},{"value":"Phase 2"},{"value":"hiv"},{"value":"6"}],[{"value":"3408"},{"value":"Safety Assessment of Weekly Intravenous Infusions of SNS-595 for the Treatment of Solid Tumors"},{"value":"Phase 1"},{"value":"tumors"},{"value":""}],[{"value":"3409"},{"value":"Initial Safety Assessment of SNS-595 for the Treatment of Solid Tumors."},{"value":"Phase 1"},{"value":"tumors"},{"value":""}],[{"value":"3412"},{"value":"NBI-3001 Followed by Surgery in Treating Patients With Recurrent Glioblastoma Multiforme"},{"value":"Phase 2"},{"value":"surgery"},{"value":""}],[{"value":"3422"},{"value":"Radiation Therapy Plus Thalidomide and Temozolomide in Treating Patients With Newly Diagnosed Brain Metastases"},{"value":"Phase 2"},{"value":"neurological"},{"value":""}],[{"value":"3444"},{"value":"A Non-Invasive Neuromodulation Device for Treatment of Migraine Headache"},{"value":""},{"value":"neurological"},{"value":"81"}],[{"value":"3448"},{"value":"A Smoking Cessation Study to Understand the Biological and Functional Changes After One Year of Smoking Cessation"},{"value":""},{"value":"smoker study"},{"value":"1020"}],[{"value":"3455"},{"value":"IL13-PE38QQR Infusion After Tumor Resection Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma"},{"value":"Phase 1"},{"value":"tumors"},{"value":"24"}],[{"value":"3468"},{"value":"2010-2011 Trivalent Influenza Vaccine (TIV) in Pregnant Women"},{"value":"Phase 2"},{"value":"influenza"},{"value":"183"}],[{"value":"3473"},{"value":"Combination Study of BMS-754807 and Erbitux&#174; in Subjects With Advanced or Metastatic Solid Tumors"},{"value":"Phase 1 / Phase 2"},{"value":"tumors"},{"value":"54"}],[{"value":"3478"},{"value":"Phase II Trial of Silymarin for Patients With Chronic Hepatitis C Who Have Failed Conventional Antiviral Treatment"},{"value":"Phase 2"},{"value":"hepatitis"},{"value":"154"}],[{"value":"3480"},{"value":"Efficacy and Safety Study of Caldolor (Intravenous Ibuprofen) in Hospitalized Adult and Pediatric Burn Patients"},{"value":"Phase 3"},{"value":"burns"},{"value":"61"}],[{"value":"3486"},{"value":"Autologous Neo-Kidney Augment (NKA) in Patients With Type 2 Diabetes and Chronic Kidney Disease (CKD)"},{"value":"Phase 2"},{"value":"diabetes"},{"value":"30"}],[{"value":"3490"},{"value":"A Study Evaluating Oxybutynin in Patients With Neurogenic Overactive Bladder Associated With a Neurological Condition"},{"value":"Phase 4"},{"value":"neurological"},{"value":"24"}],[{"value":"3502"},{"value":"A Study of the Safety and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee"},{"value":"Phase 2"},{"value":"arthritis"},{"value":"81"}],[{"value":"3505"},{"value":"Study of Diclofenac Capsules to Treat Pain Following Surgery in Children Ages 6 to &lt;17 Years of Age"},{"value":"Phase 2"},{"value":"surgery"},{"value":"30"}],[{"value":"3507"},{"value":"Safety and PK Study of CC-90003 in Relapsed/Refractory Solid Tumors"},{"value":"Phase 1"},{"value":"tumors"},{"value":"19"}],[{"value":"3517"},{"value":"Genetic Studies of Non-Alcoholic Fatty Liver Disease"},{"value":""},{"value":"alcohol"},{"value":"1000"}],[{"value":"3530"},{"value":"Comparison of the Efficacy and Safety of Two Topical Creams for Pediatric Atopic Dermatitis"},{"value":"Phase 4"},{"value":"dermatitis"},{"value":"100"}],[{"value":"3531"},{"value":"A Clinical Demonstration of EEG Brain-computer Interface for ALS Patients"},{"value":""},{"value":"neurological"},{"value":"27"}],[{"value":"3534"},{"value":"FLU A+B Nasal Swab Clinical Study"},{"value":""},{"value":"influenza"},{"value":"800"}],[{"value":"3543"},{"value":"Study of XTL6865 in Patients With Chronic Hepatitis C Virus Infection"},{"value":"Phase 1"},{"value":"hepatitis"},{"value":"36"}],[{"value":"3544"},{"value":"The Effects of the Magnetic Molecular Energizer (MME) on Diabetic Peripheral Neuropathy"},{"value":"Phase 3"},{"value":"neurological"},{"value":"100"}],[{"value":"3558"},{"value":"Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis"},{"value":"Phase 2"},{"value":"dermatitis"},{"value":"150"}],[{"value":"3563"},{"value":"Safety Tolerability and PK of AN2728 in Adolescents With Atopic Dermatitis"},{"value":"Phase 1 / Phase 2"},{"value":"dermatitis"},{"value":"23"}],[{"value":"3575"},{"value":"Study of Indomethacin Capsules to Treat Pain Following Surgery in Children Ages 6 to &lt;17 Years of Age"},{"value":"Phase 2"},{"value":"surgery"},{"value":"30"}],[{"value":"3576"},{"value":"A Phase 1/2 Study of MEDI4276 in Adults Subjects With Select HER2-expressing Advanced Solid Tumors."},{"value":"Phase 1 / Phase 2"},{"value":"tumors"},{"value":"216"}],[{"value":"3581"},{"value":"Autologous Cell Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery"},{"value":"Phase 1 / Phase 2"},{"value":"surgery"},{"value":"30"}],[{"value":"3589"},{"value":"Tumor Collection From Routine Nephrectomy for Subjects With Advanced Stage RCC"},{"value":""},{"value":"tumors"},{"value":"11"}],[{"value":"3590"},{"value":"A Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated Biomarkers"},{"value":"Phase 2"},{"value":"tumors"},{"value":"18"}],[{"value":"3593"},{"value":"A Study to Evaluate the Effectiveness and Safety of RXI 109 on the Outcome of Scar Revision Surgery in Healthy Adults"},{"value":"Phase 2"},{"value":"surgery"},{"value":"25"}],[{"value":"3594"},{"value":"A Phase 1 Open-label Safety Study of NKA in Patients With Type 2 Diabetes"},{"value":"Phase 1"},{"value":"diabetes"},{"value":"1"}],[{"value":"3597"},{"value":"A First-in-Human Double Blind Single Dose Study in Healthy Subjects and Subjects With Mild Atopic Asthma."},{"value":"Phase 1"},{"value":"asthma"},{"value":"70"}],[{"value":"3612"},{"value":"Hyperbaric Oxygen Therapy (HBO2) for Persistent Post-concussive Symptoms After Mild Traumatic Brain Injury (mTBI)"},{"value":"Phase 2"},{"value":"neurological"},{"value":"79"}],[{"value":"3613"},{"value":"Collection and Testing of Respiratory Samples"},{"value":""},{"value":"respiratory disease"},{"value":"272"}],[{"value":"3614"},{"value":"1-Methyl-D-Tryptophan and Docetaxel in Treating Patients With Metastatic Solid Tumors"},{"value":"Phase 1"},{"value":"tumors"},{"value":"27"}],[{"value":"3619"},{"value":"A Phase 2a Study to Evaluate the Safety and Efficacy of AZX100 in Trocar Sites of Arthroscopic Shoulder Surgery Patients"},{"value":"Phase 2"},{"value":"surgery"},{"value":"150"}],[{"value":"3626"},{"value":"Phase 2 Study of the Safety of Diannexin in Kidney Transplant Recipients"},{"value":"Phase 2"},{"value":"kidney disease"},{"value":"58"}],[{"value":"3631"},{"value":"Influenza Vaccine in Premature Infants"},{"value":"Phase 4"},{"value":"influenza"},{"value":"66"}],[{"value":"3640"},{"value":"Registry for African Americans With Early Rheumatoid Arthritis"},{"value":""},{"value":"arthritis"},{"value":"357"}],[{"value":"3643"},{"value":"Study of Adding Entecavir to Current Lamivudine Therapy in HIV and HBV Co-Infected Patients"},{"value":"Phase 2 / Phase 3"},{"value":"hiv"},{"value":""}],[{"value":"3648"},{"value":"Open Label Drug-Drug Interaction (DDI) Study of Dupilumab (REGN668/SAR231893) in Patients With Moderate to Severe Atopic Dermatitis (AD)"},{"value":"Phase 1"},{"value":"dermatitis"},{"value":"14"}],[{"value":"3666"},{"value":"Vaccine Immunotherapy for Recurrent Medulloblastoma and Primitive Neuroectodermal Tumor"},{"value":"Phase 1 / Phase 2"},{"value":"tumors"},{"value":"50"}],[{"value":"3669"},{"value":"Safety Tolerability Pharmacokinetic and Pharmacodynamic Study of ABT-652 in Subjects With Excessive Daytime Sleepiness"},{"value":"Phase 1"},{"value":"sleep study"},{"value":"36"}],[{"value":"3671"},{"value":"Safety Study of ABT-263 in Combination With Gemzar (Gemcitabine) in Subjects With Solid Tumors"},{"value":"Phase 1"},{"value":"tumors"},{"value":"46"}],[{"value":"3672"},{"value":"An Open-Label Treatment Protocol to Provide Metreleptin for the Treatment of Diabetes Mellitus and/or Hypertriglyceridemia Associated With Lipodystrophy"},{"value":""},{"value":"diabetes"},{"value":"41"}],[{"value":"3680"},{"value":"Efficacy and Safety of Single Doses of Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) Compared to Placebo in Patients With Persistent Asthma"},{"value":"Phase 2 / Phase 3"},{"value":"asthma"},{"value":"45"}],[{"value":"3683"},{"value":"Study to Assess Steady-State Trough Concentrations Safety and Immunogenicity of Abatacept After Subcutaneous (SC) Administration to Subjects With Rheumatoid Arthritis (RA)"},{"value":"Phase 1 / Phase 2"},{"value":"arthritis"},{"value":"87"}],[{"value":"3691"},{"value":"Evaluation of Specific Infection-Fighting Cells For Prediction of Immune Response to Anti-HIV and Immune-Boosting Medication"},{"value":""},{"value":"hiv"},{"value":"0"}],[{"value":"3698"},{"value":"Method-of-Use Study Assessing the Effect of Naltrexone Sustained Release (SR)/ Bupropion SR on Body Weight and Cardiovascular Risk Factors in Overweight and Obese Subjects"},{"value":"Phase 3"},{"value":"heart disease"},{"value":"242"}],[{"value":"3717"},{"value":"Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery"},{"value":"Phase 2"},{"value":"surgery"},{"value":"280"}],[{"value":"3724"},{"value":"Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy"},{"value":"Phase 3"},{"value":"heart disease"},{"value":"4200"}],[{"value":"3728"},{"value":"A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors"},{"value":"Phase 4"},{"value":"diabetes"},{"value":"12000"}],[{"value":"3730"},{"value":"The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects"},{"value":"Phase 3"},{"value":"heart disease"},{"value":"17000"}],[{"value":"3731"},{"value":"Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and Exacerbations in Moderate to Very Severe COPD Patients."},{"value":"Phase 4"},{"value":"heart disease"},{"value":"4000"}],[{"value":"3738"},{"value":"Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk"},{"value":"Phase 3"},{"value":"heart disease"},{"value":"27564"}],[{"value":"3746"},{"value":"Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery"},{"value":"Phase 3"},{"value":"surgery"},{"value":"216"}],[{"value":"3754"},{"value":"Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery"},{"value":"Phase 3"},{"value":"surgery"},{"value":"1500"}],[{"value":"3778"},{"value":"Comparison of Self Adjustment Versus Standard of Care Treatment in Subjects With Type 2 Diabetes"},{"value":"Phase 4"},{"value":"diabetes"},{"value":"5652"}],[{"value":"3788"},{"value":"The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects"},{"value":"Phase 3"},{"value":"heart disease"},{"value":"10653"}],[{"value":"3795"},{"value":"Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"1049"}],[{"value":"3798"},{"value":"A Study of RO4607381 in Stable Coronary Heart Disease Patients With Recent Acute Coronary Syndrome"},{"value":"Phase 3"},{"value":"heart disease"},{"value":"15865"}],[{"value":"3799"},{"value":"A Study to Describe Pediatric Influenza Vaccine Coverage"},{"value":"Phase 4"},{"value":"influenza"},{"value":"147494"}],[{"value":"3807"},{"value":"A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"19000"}],[{"value":"3808"},{"value":"A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Events"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"7637"}],[{"value":"3811"},{"value":"Cardiovascular Inflammation Reduction Trial"},{"value":"Phase 3"},{"value":"heart disease"},{"value":"7000"}],[{"value":"3818"},{"value":"Safety and Efficacy of Albiglutide in Type 2 Diabetes"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"310"}],[{"value":"3819"},{"value":"A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"685"}],[{"value":"3832"},{"value":"Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)"},{"value":"Phase 3"},{"value":"heart disease"},{"value":"10066"}],[{"value":"3833"},{"value":"Prevention of Cardiovascular Events (eg Death From Heart or Vascular Disease Heart Attack or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin"},{"value":"Phase 3"},{"value":"heart disease"},{"value":"21379"}],[{"value":"3834"},{"value":"Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Comorbidities"},{"value":"Phase 3"},{"value":"heart disease"},{"value":"6198"}],[{"value":"3848"},{"value":"Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)"},{"value":"Phase 4"},{"value":"diabetes"},{"value":"8300"}],[{"value":"3850"},{"value":"A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease"},{"value":"Phase 3"},{"value":"heart disease"},{"value":"16415"}],[{"value":"3851"},{"value":"Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease"},{"value":"Phase 3"},{"value":"kidney disease"},{"value":"756"}],[{"value":"3852"},{"value":"Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"3207"}],[{"value":"3853"},{"value":"Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)"},{"value":"Phase 3"},{"value":"heart disease"},{"value":"8910"}],[{"value":"3854"},{"value":"SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma."},{"value":"Phase 4"},{"value":"asthma"},{"value":"11751"}],[{"value":"3857"},{"value":"Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"6068"}],[{"value":"3858"},{"value":"Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"14000"}],[{"value":"3866"},{"value":"Safety and Efficacy Study of Albiglutide in Type 2 Diabetes"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"309"}],[{"value":"3874"},{"value":"JUPITER - Crestor 20mg Versus Placebo in Prevention of Cardiovascular (CV) Events"},{"value":"Phase 3"},{"value":"heart disease"},{"value":"17802"}],[{"value":"3879"},{"value":"Naltrexone/Bupropion Cardiovascular Outcomes Study"},{"value":"Phase 4"},{"value":"heart disease"},{"value":"67"}],[{"value":"3889"},{"value":"CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"6115"}],[{"value":"3892"},{"value":"Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"5380"}],[{"value":"3895"},{"value":"A Study to Determine the Safety and Efficacy of Albiglutide in Patients With Type 2 Diabetes"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"779"}],[{"value":"3896"},{"value":"Safety and Efficacy Study Comparing ABT-143 to Simvastatin in Subjects With Elevated Levels of Low Density Lipoprotein Cholesterol (&quot;Bad Cholesterol&quot;) and Triglycerides"},{"value":"Phase 3"},{"value":"heart disease"},{"value":"474"}],[{"value":"3899"},{"value":"Study Evaluating 13 Valent Pneumococcal Conjugate Vaccine With Trivalent Inactivated Influenza Vaccine"},{"value":"Phase 3"},{"value":"influenza"},{"value":"1116"}],[{"value":"3929"},{"value":"Docetaxel in Treating Patients With Solid Tumors"},{"value":"Phase 2"},{"value":"tumors"},{"value":"109"}],[{"value":"3932"},{"value":"Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk Open-label Extension"},{"value":"Phase 3"},{"value":"heart disease"},{"value":"5000"}],[{"value":"3933"},{"value":"Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery"},{"value":"Phase 2"},{"value":"surgery"},{"value":"84"}],[{"value":"3937"},{"value":"Nivolumab and Ipilimumab With or Without Sargramostim in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery"},{"value":"Phase 2 / Phase 3"},{"value":"surgery"},{"value":"400"}],[{"value":"3940"},{"value":"Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis"},{"value":"Phase 4"},{"value":"arthritis"},{"value":"4000"}],[{"value":"3944"},{"value":"Afatinib After Chemoradiation and Surgery in Treating Patients With Stage III-IV Squamous Cell Carcinoma of the Head and Neck at High-Risk of Recurrence"},{"value":"Phase 2"},{"value":"surgery"},{"value":"3"}],[{"value":"3946"},{"value":"A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"460"}],[{"value":"3948"},{"value":"Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"1663"}],[{"value":"3956"},{"value":"A Study Of Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to or Are Unable to Tolerate Biologic and Non-Biologic Disease-modifying Antirheumatic Drugs (DMARDs)"},{"value":"Phase 3"},{"value":"arthritis"},{"value":"886"}],[{"value":"3972"},{"value":"Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors"},{"value":"Phase 3"},{"value":"tumors"},{"value":"1"}],[{"value":"3982"},{"value":"Efficacy in Controlling Glycaemia With Victoza&#174; (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 Diabetes"},{"value":"Phase 4"},{"value":"diabetes"},{"value":"1994"}],[{"value":"3989"},{"value":"High-Dose Recombinant Interferon Alfa-2B Ipilimumab or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery"},{"value":"Phase 3"},{"value":"surgery"},{"value":"1378"}],[{"value":"3992"},{"value":"Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults"},{"value":"Phase 3"},{"value":"influenza"},{"value":"1161"}],[{"value":"3994"},{"value":"Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery"},{"value":"Phase 2"},{"value":"surgery"},{"value":"168"}],[{"value":"3998"},{"value":"Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events"},{"value":"Phase 3"},{"value":"heart disease"},{"value":"17276"}],[{"value":"4005"},{"value":"Safety and Efficacy of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients"},{"value":"Phase 3"},{"value":"arthritis"},{"value":"397"}],[{"value":"4010"},{"value":"Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results - A Long Term Evaluation"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"9340"}],[{"value":"4015"},{"value":"Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone Alone"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"141"}],[{"value":"4017"},{"value":"An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants"},{"value":""},{"value":"respiratory disease"},{"value":"3000"}],[{"value":"4019"},{"value":"Efficacy and Long-Term Safety of Vildagliptin as Monotherapy in Patients With Type 2 Diabetes"},{"value":"Phase 2 / Phase 3"},{"value":"diabetes"},{"value":"338"}],[{"value":"4023"},{"value":"Efficacy of Lapaquistat Acetate Co-Administered With Statins in Subjects With Hypercholesterolemia"},{"value":"Phase 3"},{"value":"heart disease"},{"value":"411"}],[{"value":"4024"},{"value":"Out-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Metformin Only"},{"value":"Phase 2"},{"value":"diabetes"},{"value":"361"}],[{"value":"4026"},{"value":"A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis"},{"value":""},{"value":"dermatitis"},{"value":"8037"}],[{"value":"4043"},{"value":"Effect of Albiglutide When Added to Standard Blood Glucose Lowering Therapies on Major Cardiovascular Events in Subjects With Type 2 Diabetes Mellitus"},{"value":"Phase 4"},{"value":"diabetes"},{"value":"9400"}],[{"value":"4048"},{"value":"Non-inferiority Study to Compare the Efficacy and Safety of Mylan&apos;s Insulin Glargine With Lantus&#174; in Type 2 Diabetes Mellitus Patients (INSTRIDE 2)"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"600"}],[{"value":"4054"},{"value":"ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab"},{"value":"Phase 3"},{"value":"heart disease"},{"value":"18600"}],[{"value":"4058"},{"value":"A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease"},{"value":"Phase 3"},{"value":"heart disease"},{"value":"2220"}],[{"value":"4061"},{"value":"A Study of Fluzone&#174; High-Dose Vaccine Compared With Fluzone&#174; Vaccine In Elderly Adults"},{"value":"Phase 4"},{"value":"elderly"},{"value":"31989"}],[{"value":"4066"},{"value":"A Study of Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors"},{"value":"Phase 4"},{"value":"arthritis"},{"value":"3080"}],[{"value":"4070"},{"value":"Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE&#8482; - Diabetes"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"846"}],[{"value":"4073"},{"value":"Efficacy and Safety of Linagliptin (BI 1356) in Black/African Americans With Type 2 Diabetes With a MTT Sub-study"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"234"}],[{"value":"4075"},{"value":"Does Saxagliptin Reduce the Risk of Cardiovascular Events When Used Alone or Added to Other Diabetes Medications"},{"value":"Phase 4"},{"value":"diabetes"},{"value":"18206"}],[{"value":"4078"},{"value":"A Study of Tamiflu (Oseltamivir) for Treatment of Influenza With a Focus on (H1N1) 2009 Flu Strain"},{"value":"Phase 4"},{"value":"influenza"},{"value":"102"}],[{"value":"4082"},{"value":"Multi-Year Study of Fluzone High-Dose Influenza Vaccine Compared With Fluzone&#174; Vaccine in Adults Aged 65 Years and Older"},{"value":"Phase 3"},{"value":"influenza"},{"value":"9172"}],[{"value":"4085"},{"value":"Collecting Tumor Samples From Patients With Gynecological Tumors"},{"value":""},{"value":"tumors"},{"value":"275"}],[{"value":"4096"},{"value":"A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis"},{"value":"Phase 3"},{"value":"arthritis"},{"value":"619"}],[{"value":"4101"},{"value":"Exubera Large Simple Trial To Evaluate Long-Term Pulmonary And Cardiovascular Safety"},{"value":"Phase 4"},{"value":"heart disease"},{"value":"1976"}],[{"value":"4106"},{"value":"A Clinical Trial Comparing Torcetrapib/Atorvastatin to Ezetimibe/Simvastatin In Subjects With A Cholesterol Disorder."},{"value":"Phase 3"},{"value":"heart disease"},{"value":"1784"}],[{"value":"4123"},{"value":"Non-inferiority Study to Compare the Efficacy and Safety of Mylan&apos;s Insulin Glargine With Lantus&#174; in Type 1 Diabetes Mellitus Patients (INSTRIDE 1)"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"500"}],[{"value":"4125"},{"value":"Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects"},{"value":"Phase 3"},{"value":"heart disease"},{"value":"1972"}],[{"value":"4126"},{"value":"Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD) Not on Dialysis"},{"value":"Phase 3"},{"value":"kidney disease"},{"value":"2600"}],[{"value":"4132"},{"value":"Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events"},{"value":"Phase 3"},{"value":"heart disease"},{"value":"690"}],[{"value":"4133"},{"value":"Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"736"}],[{"value":"4134"},{"value":"Efficacy and Safety of Insulin Glargine/ Lixisenatide Fixed Ratio Combination Compared to Insulin Glargine Alone and Lixisenatide Alone on Top of Metformin in Patients With T2DM"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"1170"}],[{"value":"4137"},{"value":"A Study of the Impact of Methotrexate (MTX) Discontinuation on the Efficacy of Subcutaneous Tocilizumab With Methotrexate in Participants With Moderate to Severe Active Rheumatoid Arthritis"},{"value":"Phase 3"},{"value":"arthritis"},{"value":"718"}],[{"value":"4139"},{"value":"Study of Safety of Foradil in Patients With Persistent Asthma"},{"value":"Phase 4"},{"value":"asthma"},{"value":"827"}],[{"value":"4144"},{"value":"Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 Diabetes"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"3297"}],[{"value":"4148"},{"value":"Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors"},{"value":"Phase 2"},{"value":"tumors"},{"value":"75"}],[{"value":"4150"},{"value":"Efficacy and Safety of Azilsartan Medoxomil Used in Combination With Metformin in Participants With Hypertension and Diabetes"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"105"}],[{"value":"4156"},{"value":"Long-Term Safety and Tolerability of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients"},{"value":"Phase 3"},{"value":"arthritis"},{"value":"233"}],[{"value":"4168"},{"value":"A Study to Evaluate the Immunogenicity of Quadrivalent Live Attenuated Influenza Vaccine (LAIV) in Children"},{"value":"Phase 3"},{"value":"influenza"},{"value":"2312"}],[{"value":"4169"},{"value":"PROPHESYS 3: Observational Study on Predictors of Response in Patients With Treatment-na&#239;ve Chronic Hepatitis C Initiated on Treatment With Pegasys (Peginterferon Alfa-2a) or Peginterferon-alfa-2b"},{"value":""},{"value":"hepatitis"},{"value":"1656"}],[{"value":"4170"},{"value":"Safety and Efficacy of XOMA 052 in Subjects With Type 2 Diabetes Mellitus on Stable Metformin Monotherapy"},{"value":"Phase 2"},{"value":"diabetes"},{"value":"421"}],[{"value":"4172"},{"value":"Novel Influenza A (H1N1) Surveillance Registry"},{"value":""},{"value":"influenza"},{"value":"894"}],[{"value":"4173"},{"value":"A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"2118"}],[{"value":"4184"},{"value":"Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma"},{"value":""},{"value":"tumors"},{"value":"10000"}],[{"value":"4186"},{"value":"Study of Kidney Tumors in Younger Patients"},{"value":""},{"value":"kidney disease"},{"value":"5000"}],[{"value":"4196"},{"value":"Trial to Evaluate the Efficacy of GSK Biologicals&apos; Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older"},{"value":"Phase 3"},{"value":"influenza"},{"value":"43695"}],[{"value":"4199"},{"value":"A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Thiazolidinedione or a Combination of Both."},{"value":"Phase 3"},{"value":"diabetes"},{"value":"1189"}],[{"value":"4206"},{"value":"A Long-Term Placebo-Controlled X-Ray Study Investigating the Safety and Efficacy of SD-6010 in Subjects With Osteoarthritis of the Knee"},{"value":"Phase 2 / Phase 3"},{"value":"arthritis"},{"value":"5077"}],[{"value":"4216"},{"value":"A Comparison of SYMBICORT&#174; pMDI With Budesonide HFA pMDI in African American Subjects With Asthma."},{"value":"Phase 3"},{"value":"asthma"},{"value":"742"}],[{"value":"4225"},{"value":"Vincristine Dactinomycin and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I Stage II or Stage III Wilms&apos; Tumor"},{"value":"Phase 3"},{"value":"tumors"},{"value":"808"}],[{"value":"4228"},{"value":"Rosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On Insulin"},{"value":"Phase 4"},{"value":"diabetes"},{"value":"630"}],[{"value":"4230"},{"value":"Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes Mellitus"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"493"}],[{"value":"4256"},{"value":"DNA Variations in the Gene in Young Patients With Wilms&apos; Tumor"},{"value":""},{"value":"tumors"},{"value":"471"}],[{"value":"4269"},{"value":"Lobradimil and Carboplatin in Treating Children With Brain Tumors"},{"value":"Phase 2"},{"value":"tumors"},{"value":""}],[{"value":"4282"},{"value":"Surgery in Treating Children With Neuroblastoma"},{"value":"Phase 3"},{"value":"surgery"},{"value":"968"}],[{"value":"4289"},{"value":"Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IV Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery"},{"value":"Phase 2"},{"value":"surgery"},{"value":"345"}],[{"value":"4293"},{"value":"A Study Comparing ABT-494 to Placebo and to Adalimumab in Subjects With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate"},{"value":"Phase 3"},{"value":"arthritis"},{"value":"1500"}],[{"value":"4300"},{"value":"Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee"},{"value":"Phase 3"},{"value":"arthritis"},{"value":"3000"}],[{"value":"4304"},{"value":"Chronic Dosing Cross-Over Study to Assess the Efficacy and Safety of Glycopyrronium (PT001) in Adult Subjects With Intermittent Asthma or Mild to Moderate Persistent Asthma"},{"value":"Phase 2"},{"value":"asthma"},{"value":"249"}],[{"value":"4305"},{"value":"A Study of Apixaban in Patients With Atrial Fibrillation Not Caused by a Heart Valve Problem Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event Such as a Heart Attack or a Procedure to Open the Vessels of the Heart"},{"value":"Phase 4"},{"value":"heart disease"},{"value":"4600"}],[{"value":"4307"},{"value":"Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Older Patients With Type2 Diabetes Insufficiently Controlled on Their Current Antidiabetic Medications"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"1014"}],[{"value":"4312"},{"value":"24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"154"}],[{"value":"4314"},{"value":"A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma"},{"value":"Phase 3"},{"value":"asthma"},{"value":"1140"}],[{"value":"4317"},{"value":"Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-na&#239;ve Subjects With Type 2 Diabetes"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"1082"}],[{"value":"4326"},{"value":"Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events"},{"value":"Phase 3"},{"value":"heart disease"},{"value":"2139"}],[{"value":"4331"},{"value":"Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors"},{"value":"Phase 2"},{"value":"tumors"},{"value":"165"}],[{"value":"4337"},{"value":"Comparison Study of the Glycemic Effects Safety and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes Mellitus"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"365"}],[{"value":"4342"},{"value":"Monthly And Twice Monthly Subcutaneous Dosing Of PF-04950615 (RN316) In Hypercholesterolemic Subjects On A Statin"},{"value":"Phase 2"},{"value":"heart disease"},{"value":"356"}],[{"value":"4349"},{"value":"A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High Risk Patients With Hypertriglyceridemia and on Statin. The Primary Objective is to Evaluate the Effect of 4 g/Day AMR101 for Preventing the Occurrence of a First Major Cardiovascular Event."},{"value":"Phase 3"},{"value":"heart disease"},{"value":"8000"}],[{"value":"4350"},{"value":"Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"2454"}],[{"value":"4353"},{"value":"A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents"},{"value":"Phase 3"},{"value":"asthma"},{"value":"12463"}],[{"value":"4358"},{"value":"Study to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and Diabetes"},{"value":"Phase 4"},{"value":"diabetes"},{"value":"975"}],[{"value":"4361"},{"value":"A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate (MTX) in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One Tumor Necrosis Factor (TNF)-Inhibitor"},{"value":"Phase 4"},{"value":"arthritis"},{"value":"96"}],[{"value":"4373"},{"value":"A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment."},{"value":"Phase 3"},{"value":"diabetes"},{"value":"507"}],[{"value":"4376"},{"value":"A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"7226"}],[{"value":"4379"},{"value":"Efficacy and Safety of BI 10773 in Combination With Insulin in Patients With Type 2 Diabetes"},{"value":"Phase 2"},{"value":"diabetes"},{"value":"494"}],[{"value":"4381"},{"value":"Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus"},{"value":"Phase 2"},{"value":"diabetes"},{"value":"426"}],[{"value":"4383"},{"value":"A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"586"}],[{"value":"4384"},{"value":"Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Pioglitazone"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"252"}],[{"value":"4387"},{"value":"Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Glimepiride With or Without Metformin"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"677"}],[{"value":"4393"},{"value":"Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma"},{"value":""},{"value":"tumors"},{"value":"1000"}],[{"value":"4406"},{"value":"Safety and Efficacy of Ramelteon in Elderly Subjects With Chronic Insomnia"},{"value":"Phase 3"},{"value":"elderly"},{"value":"829"}],[{"value":"4408"},{"value":"A Double-blind Parallel Group Placebo-Controlled Outpatient Trial of PD 00200390 in Adults With Nonrestorative Sleep"},{"value":"Phase 2"},{"value":"sleep study"},{"value":"306"}],[{"value":"4413"},{"value":"A Study In Patients With Neuropathic Pain From Post-Herpetic Neuralgia (PHN)"},{"value":"Phase 2"},{"value":"neurological"},{"value":"376"}],[{"value":"4414"},{"value":"Early Versus Delayed Enteral Feeding and Omega-3 Fatty Acid/Antioxidant Supplementation for Treating People With Acute Lung Injury or Acute Respiratory Distress Syndrome (The EDEN-Omega Study)"},{"value":"Phase 3"},{"value":"respiratory disease"},{"value":"272"}],[{"value":"4419"},{"value":"Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma"},{"value":"Phase 3"},{"value":"neurological"},{"value":"665"}],[{"value":"4426"},{"value":"Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Knee"},{"value":"Phase 3"},{"value":"arthritis"},{"value":"1020"}],[{"value":"4436"},{"value":"A Study of the Safety of Rituxan in Patients With Rheumatoid Arthritis After an Inadequate Response to Previous Anti-TNF Therapy (SUNSTONE)"},{"value":"Phase 4"},{"value":"arthritis"},{"value":"1026"}],[{"value":"4437"},{"value":"Airway Limitation Study: Study In Primary Care Centers Of Chronic Bronchitis In Long-Term Cigarette Smokers Of At Least 40 Years Of Age With Symptoms Of Cough And Shortness Of Breath"},{"value":""},{"value":"smoker study"},{"value":"1283"}],[{"value":"4439"},{"value":"Long-Term Effectiveness And Safety Of CP-690550 For The Treatment Of Rheumatoid Arthritis"},{"value":"Phase 3"},{"value":"arthritis"},{"value":"4500"}],[{"value":"4440"},{"value":"Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 Diabetes"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"560"}],[{"value":"4452"},{"value":"Efficacy and Safety Study of Alogliptin and Insulin in the Treatment of Type 2 Diabetes."},{"value":"Phase 3"},{"value":"diabetes"},{"value":"390"}],[{"value":"4453"},{"value":"The DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Patients With Type 2 Diabetes (IOOV)"},{"value":"Phase 4"},{"value":"diabetes"},{"value":"2091"}],[{"value":"4461"},{"value":"Extension Study of the Safety and Efficacy of Armodafinil in the Treatment of Patients With Excessive Sleepiness"},{"value":"Phase 3"},{"value":"sleep study"},{"value":"743"}],[{"value":"4462"},{"value":"Efficacy and Safety of Adalimumab in Patients With Active Rheumatoid Arthritis Treated Concomitantly With Methotrexate."},{"value":"Phase 3"},{"value":"arthritis"},{"value":"619"}],[{"value":"4467"},{"value":"A Study of Torcetrapib/Atorvastatin vs Atorvastatin Alone or Placebo in Patients With High Cholesterol"},{"value":"Phase 3"},{"value":"heart disease"},{"value":"3800"}],[{"value":"4468"},{"value":"A Coronary IVUS Study to Compare Torcetrapib/Atorvastatin to Atorvastatin Alone in Subjects With Coronary Heart Disease"},{"value":"Phase 3"},{"value":"heart disease"},{"value":"1100"}],[{"value":"4469"},{"value":"Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children"},{"value":"Phase 3"},{"value":"respiratory disease"},{"value":"6635"}],[{"value":"4470"},{"value":"Trivalent Live Cold Adapted Influenza Vaccine (CAIV-T) Against Inactivated Influenza Vaccine (TIV) in Children 6&#8211;59 Months of Age"},{"value":"Phase 3"},{"value":"influenza"},{"value":"8500"}],[{"value":"4474"},{"value":"A Study of the Safety and Efficacy of Nitric Oxide Reduction in Patients With Cardiogenic Shock After a Heart Attack"},{"value":"Phase 3"},{"value":"heart disease"},{"value":"658"}],[{"value":"4475"},{"value":"Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"1440"}],[{"value":"4476"},{"value":"Study Of Asthma In Patients Of African Descent"},{"value":"Phase 4"},{"value":"asthma"},{"value":"479"}],[{"value":"4489"},{"value":"Effect Of Carvedilol Versus Metoprolol On Glycemic Control In Patients With Type II Diabetes And Hypertension"},{"value":"Phase 4"},{"value":"diabetes"},{"value":"501"}],[{"value":"4494"},{"value":"Atazanavir for HIV Infected Individuals: An Early Access Program"},{"value":""},{"value":"hiv"},{"value":""}],[{"value":"4495"},{"value":"Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a Sulfonylurea"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"377"}],[{"value":"4496"},{"value":"Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With Metformin"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"336"}],[{"value":"4498"},{"value":"Isotretinoin With or Without Dinutuximab Aldesleukin and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma"},{"value":"Phase 3"},{"value":"neurological"},{"value":"1449"}],[{"value":"4503"},{"value":"Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases"},{"value":""},{"value":"neurological"},{"value":"59"}],[{"value":"4528"},{"value":"Radiation Therapy With or Without Radiosurgery in Treating Patients With Brain Metastases"},{"value":"Phase 3"},{"value":"surgery"},{"value":"333"}],[{"value":"4540"},{"value":"A Study to Compare ABT-494 to Placebo in Subjects With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response or Intolerance to Biologic DMARDs"},{"value":"Phase 3"},{"value":"arthritis"},{"value":"450"}],[{"value":"4544"},{"value":"Extension Study to Assess Safety and Efficacy of Mylan&apos;s Insulin Glargine and Lantus&#174; in Type 1 Diabetes Mellitus Patients"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"138"}],[{"value":"4550"},{"value":"Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"1860"}],[{"value":"4554"},{"value":"A Study Looking at Targeted Therapy According to Tumor Markers for People With Meningiomas"},{"value":"Phase 2"},{"value":"tumors"},{"value":"56"}],[{"value":"4557"},{"value":"A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis"},{"value":"Phase 3"},{"value":"kidney disease"},{"value":"432"}],[{"value":"4562"},{"value":"Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest)"},{"value":"Phase 3"},{"value":"asthma"},{"value":"1858"}],[{"value":"4563"},{"value":"&quot;A Long-Term Safety Study of JZP-110 in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or OSA&quot;"},{"value":"Phase 3"},{"value":"sleep study"},{"value":"600"}],[{"value":"4564"},{"value":"&quot;Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in Narcolepsy&quot;"},{"value":"Phase 3"},{"value":"sleep study"},{"value":"240"}],[{"value":"4579"},{"value":"A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol"},{"value":"Phase 3"},{"value":"heart disease"},{"value":"366"}],[{"value":"4581"},{"value":"BGJ398 for Patients With Tumors With FGFR Genetic Alterations"},{"value":"Phase 2"},{"value":"tumors"},{"value":"90"}],[{"value":"4586"},{"value":"Concomitant Administration of 13-valent Pneumococcal Conjugate Vaccine (13vPnC) With Influenza Vaccine in 23-valent Pneumococcal Polysaccharide (23vPS) Pre-vaccinated Adults."},{"value":"Phase 4"},{"value":"influenza"},{"value":"882"}],[{"value":"4589"},{"value":"A Study to Examine Patient Characteristics Health Care Management and Health Outcomes of Hepatitis C Virus (HCV) Patients Treated With Simeprevir"},{"value":"Phase 4"},{"value":"hepatitis"},{"value":"315"}],[{"value":"4590"},{"value":"A Study of the Efficacy and Safety of Etrolizumab in Ulcerative Colitis Participants Who Are Refractory to or Intolerant of Tumor Necrosis Factor (TNF) Inhibitors"},{"value":"Phase 3"},{"value":"tumors"},{"value":"800"}],[{"value":"4598"},{"value":"Cardiovascular Outcomes Following Ertugliflozin Treatment in Type 2 Diabetes Mellitus Participants With Vascular Disease The VERTIS CV Study (MK-8835-004)"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"8000"}],[{"value":"4600"},{"value":"UNITY 1: A Study of an Investigational Treatment Regimen of Daclatasvir (DCV) + Asunaprevir (ASV) + BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) for 12 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Genotype 1 Infection in Non-cirrhotic Subjects"},{"value":"Phase 3"},{"value":"hepatitis"},{"value":"416"}],[{"value":"4604"},{"value":"A Golimumab Phase 3b Multicenter Assessment of Intravenous Efficacy in Rheumatoid Arthritis Subjects Who Have Diminished Disease Control Despite Treatment With Infliximab (REMICADE&#174;)"},{"value":"Phase 3"},{"value":"arthritis"},{"value":"11"}],[{"value":"4607"},{"value":"Study of Intra-articular Injections vs Placebo in Patients With Pain From Osteoarthritis of the Knee"},{"value":"Phase 3"},{"value":"arthritis"},{"value":"287"}],[{"value":"4610"},{"value":"TAK-875 (Fasiglifam) in Combination With Sitagliptin in Adults With Type 2 Diabetes"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"90"}],[{"value":"4615"},{"value":"A Study on The Potential of Aleglitazar to Reduce Cardiovascular Risk in Patients With Stable Cardiovascular Disease and Glucose Abnormalities"},{"value":"Phase 3"},{"value":"heart disease"},{"value":"1999"}],[{"value":"4617"},{"value":"A Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Nephropathy"},{"value":"Phase 2"},{"value":"diabetes"},{"value":"226"}],[{"value":"4620"},{"value":"A Trial of NNC0109-0012 an Anti-IL-20 Biologic in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Anti-TNFa Biologics"},{"value":"Phase 2"},{"value":"arthritis"},{"value":"239"}],[{"value":"4623"},{"value":"Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza"},{"value":"Phase 3"},{"value":"influenza"},{"value":"1941"}],[{"value":"4626"},{"value":"A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"442"}],[{"value":"4627"},{"value":"Comparison of Fasiglifam (TAK-875) to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"916"}],[{"value":"4631"},{"value":"Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Basal Insulin With Oral Antidiabetic Therapy"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"811"}],[{"value":"4633"},{"value":"HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network"},{"value":""},{"value":"hepatitis"},{"value":"4500"}],[{"value":"4636"},{"value":"Comparison of TAK-875 (Fasiglifam) With Placebo in Participants With Type 2 Diabetes"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"421"}],[{"value":"4658"},{"value":"Evaluation of Long-term Safety and Effectiveness of Fostamatinib in the Treatment of Rheumatoid Arthritis (RA)"},{"value":"Phase 3"},{"value":"arthritis"},{"value":"1917"}],[{"value":"4666"},{"value":"Safety of Buprenorphine Transdermal Patch (BTDS) in Osteoarthritis Pain: a 52-Week Extension Phase"},{"value":"Phase 3"},{"value":"arthritis"},{"value":"196"}],[{"value":"4669"},{"value":"A Study in Participants With Diabetic Kidney Disease"},{"value":"Phase 2"},{"value":"kidney disease"},{"value":"417"}]],"columnNames":[{"name":"rank","index":0,"aggr":"sum"},{"name":"study","index":1,"aggr":"sum"},{"name":"phase","index":2,"aggr":"sum"},{"name":"category","index":3,"aggr":"sum"},{"name":"number_enrolled","index":4,"aggr":"sum"}],"rows":[["2","Study of the Efficacy Safety &amp; Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury","Phase 2","burns","150"],["3","Study of the Efficacy Safety and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis","Phase 2","dermatitis","450"],["4","DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis","Phase 2","fasciitis","60"],["10","A Study Promoting Critical Illness Recovery in the Elderly-- Pilot","","elderly","20"],["17","Probiotics in Occupational Shift Workers","","probiotics","60"],["18","Protein Supplementation Post Bariatric Surgery","","surgery","60"],["23","Optimal Volume Rate and Interval of Bolus Nerve Catheters for Shoulder Surgery","Phase 4","surgery","99"],["25","Magnetic Resonance Imaging of Human Biometrics","","biometric","30"],["30","Neuroimaging Reward Behavioral Treatment and Smoking Cessation","Phase 1 / Phase 2","smoker study","100"],["34","Feasibility and Smokers&apos; Reactions to DNA Feedback","","smoker study","100"],["37","TMS Modulation of Insula-related Brain Networks.02","","neurological","60"],["42","A Pilot Study of Nocturnal Hypoglycemia Prevention in Type 1 Diabetes Using the Vigilant Diabetes Management Companion","","diabetes","24"],["43","Combination Nicotine Patch / Lorcaserin for Smoking Cessation","Phase 2","smoker study","300"],["45","An Observational Study of Post-cesarean Delivery Respiratory Patterns Using a Non-invasive Minute Ventilation Monitor (Exspiron &#8482; System)","","respiratory disease","100"],["48","Sleep Dysfunction and Neurocognitive Outcomes in Adolescent ADHD","","neurological","60"],["53","Effects of Exercise Training Intensity on Fitness and Insulin Sensitivity in African Americans","","diabetes","60"],["57","SIMT Stereotactic Radiosurgery Outcomes Study","","surgery","40"],["71","COMRADE: Collaborative Care Management for Distress and Depression in Rural Diabetes","","diabetes","139"],["83","Effects of E-cigarettes (ECIGs) on Pulmonary Inflammation and Behavior in HIV Infected Smokers","","hiv","20"],["86","Study on Smoking Cessation and Cost Outcomes in the Duke Smoking Cessation Program","","smoker study","3000"],["93","Mobile Technology and Online Tools to Improve Asthma Control in Adolescents","Phase 2","asthma","70"],["106","Mobile Technology and Online Tools to Improve Asthma Control in Adolescents - Usability","Phase 2","asthma","25"],["109","Intranasal Insulin and Post-stroke Cognition: A Pilot Study","","diabetes","40"],["112","Respiratory Muscle Training in LOPD","","respiratory disease","28"],["125","Bedside Ultrasound to Measure Optic Nerve Sheath Diameter in Pediatric CSF Shunts","","nerve study","87"],["138","Qualitative Qualitative and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors","","tumors","50"],["142","Analgesic Benefit of PECS Blocks for Biceps Tenodesis Shoulder Surgery","Phase 4","surgery","40"],["144","The Effect of Reducing Posttraumatic Stress Disorder Symptoms on Cardiovascular Risk","","heart disease","120"],["145","Antagonism of Opioid-Induced Respiratory Depression by CX1739 With Preservation of Opioid Analgesia","Phase 2","respiratory disease","18"],["149","Efficacy and Tolerability of New Topical Formulations in Subjects With Atopic Dermatitis","Phase 4","dermatitis","53"],["178","Dietary Acid Load Kidney Function and Disability in Elderly","","kidney disease","80"],["182","TMS Modulation of Insula-related Brain Networks","","neurological","12"],["184","The Use of Tranexamic Acid to Reduce Blood Loss in Acetabular Surgery","Phase 3","surgery","65"],["186","Contrast-enhanced Ultrasound of the Kidney","Phase 2","kidney disease","75"],["190","Prospective Evaluation of Patient Reported Xerostomia After Whole Brain Radiation","","neurological","60"],["193","Safety Study of CN-105 Neuroprotective Peptide for Intracerebral Hemorrhage","Phase 1","neurological","48"],["200","STepped Exercise Program for Knee OsteoArthritis","","arthritis","345"],["207","Efficacy of Neuro+ Attention Training","","neurological","60"],["210","The Compartmental Biology of HIV in the Male Genital Tract","","hiv","24"],["212","Exercise Intolerance in Elderly Patients With HFpEF(Heart Failure With Preserved Ejection Fraction)","","elderly","84"],["213","Stage Ib Trial of mSMART for Smoking Cessation Medication Adherence","","smoker study","60"],["214","The KNEEhabilitation Study: Improving Disability in Individuals With Knee Osteoarthritis","Phase 1 / Phase 2","arthritis","90"],["230","Angiotensin Receptors and Age Related Mitochondrial Decline in HIV Patients","Phase 2","hiv","40"],["231","Vibratory Stimuli A Novel Rehabilitation Method for Preventing Post - Traumatic Knee Osteoarthritis","","arthritis","75"],["244","Muscadine Grape Skin Extract in Treating Patients With Malignancy That Is Metastatic or Cannot Be Removed by Surgery","Phase 1","surgery","30"],["252","Reducing HIV Risk Among Adolescents: Evaluating Project HEART","","hiv","222"],["254","Evaluation of Cardiorespiratory Performance After Interval Exercise Training Prior to Hematopoietic Cell Transplantation","","respiratory disease","40"],["258","Neuromodulation Enhanced Cognitive Restructuring: A Proof of Concept Study","","neurological","65"],["261","Lazanda Fentanyl Nasal Spray Pre Radiofrequency Nerve Ablations(RFA) of Lumbar Facet Joints","Phase 4","nerve study","23"],["265","Platelets as Regulators of Inflammation in Cardiac Surgery","","surgery","100"],["270","Pain Coping Skills Training for African Americans With Osteoarthritis","","arthritis","248"],["273","Effects of Smoking Environments on Craving and Smoking (CameraCue2.0)","","smoker study","120"],["274","Incretin Action in Physiology and Diabetes","Phase 1","diabetes","25"],["279","Strengthening Instrumental Extinction to Prevent Smoking Relapse (VLNCCue)","","smoker study","300"],["285","Nivolumab With DC Vaccines for Recurrent Brain Tumors","Phase 1","tumors","66"],["286","High Intensity Interval Training and Rheumatoid Arthritis","","arthritis","26"],["295","Mobile Contingency Management for Smoking Cessation in Returning US Veterans","","smoker study","260"],["301","Vestibular Function After Cochlear Implantation Using Soft Surgery Techniques","","surgery","30"],["305","Telephone-based Smoking Cessation","","smoker study","350"],["306","Using Question Prompt Lists During Pediatric Asthma Visits to Increase Adolescent Involvement","","asthma","360"],["307","Temporary Autonomic Blockade to Prevent Atrial Fibrillation After Cardiac Surgery","Phase 1 / Phase 2","surgery","130"],["308","The Use of Aging Biomarkers to Predict Adverse Outcomes After Cardiac Surgery","","surgery","186"],["310","Electronic Nicotine Delivery Systems as a Smoking Cessation Treatment","Phase 2","smoker study","300"],["311","Rejuvenated Washed Packed Red Blood Cells in Pediatric Cardiac Surgery","Phase 4","surgery","15"],["316","Feasibility of an Interval Exercise and Nutrition Intervention to Reduce Cardiovascular Disease Risk Factors","","heart disease","15"],["327","Pathways to Improving Functional Capacity in Older Patients With Chronic Kidney Disease and Cardiovascular Disease","","heart disease","0"],["328","Predictors of Opioid-Induced Respiratory Depression (OIRD)","Phase 1","respiratory disease","20"],["331","Personalized Health Planning in Shared Medical Appointments for Individuals With Type II Diabetes Pilot Study","","diabetes","20"],["338","Systemic Steroids for Peripheral Nerve Blocks","Phase 4","nerve study","115"],["340","Study of Nasal Insulin to Fight Forgetfulness - Short-Acting Insulin Aspart","Phase 1","diabetes","30"],["341","Perineural Steroids for Peripheral Nerve Blocks","Phase 4","nerve study","115"],["361","VIDA Mobile Health Cardiovascular Prevention Program","","heart disease","40"],["363","Acid-Base Compensation in Chronic Kidney Disease","Phase 1","kidney disease","16"],["372","Integrated Population Program for Diabetic Kidney Disease","","kidney disease","131"],["373","Effects of Smoking Environment on Craving and Smoking","","smoker study","41"],["374","PackHealth: Asthma Engagement Tool","","asthma","50"],["375","Clinical Study to Evaluate Patient Outcomes Following Pharmacogenetic Testing of Subjects Exhibiting Neuropsychiatric Disorders","","neurological","220"],["379","Determine the Prevalence and Severity of Asthma in HIV (Human Immunodeficiency Virus) Infected Patients","","asthma","93"],["386","Obstructive Sleep Apnea in Pregnancy","","sleep study","150"],["390","Does Physical Therapy Prevent Total Knee Arthroplasty in Patients With End Stage Osteoarthritis","","arthritis","260"],["394","Website Application Based Education and Text Messaging in Improving Skin Wound Care in Patients Undergoing Mohs Surgery","","surgery","90"],["397","Transplant Social Worker Support for Live Kidney Donation in African Americans","","kidney disease","570"],["398","Nutrition Education for Cardiovascular Disease Prevention in Spinal Cord Injury","","heart disease","200"],["406","Perampanel in Seizure Patients With Primary Glial Brain Tumors","Phase 4","tumors","71"],["431","FLT PET/MR for Evaluation of Pseudoprogression in Patients With Brain Lesions","","neurological","15"],["433","NHALES (Natural History of Asthma With Longitudinal Environmental Sampling)","","asthma","200"],["443","Causes of Comorbid Infertility Among Women With Rheumatoid Arthritis","","arthritis","150"],["445","Physical Therapy Versus Internet-Based Exercise Training for Patients With Knee Osteoarthritis","","arthritis","350"],["471","Effects of Neuromodulation on Verbal Fluency in Post-stroke Aphasia","","neurological","12"],["473","Contingency Management Quitting Smoking and ADHD","Phase 1","smoker study","60"],["477","Relationship of Pulmonary Contusion to Pulmonary Inflammation and Incidence of Acute Respiratory Distress Syndrome","","respiratory disease","10"],["478","Novel Biomarkers for Risk Prediction of Contrast-Induced Acute Kidney Injury Post Coronary Angiography","","kidney disease","200"],["479","Respiratory Viral Infections in Pediatric Transplantation","","respiratory disease","2669"],["487","Oxytocin Treatment of Alcohol Dependence","Phase 2","alcohol","50"],["492","Abstinence Reinforcement Therapy (ART) for Homeless Veteran Smokers","","smoker study","165"],["493","Arthritis Pilot for Preserving Muscle While Losing Weight","","arthritis","37"],["498","Function and Scoliosis Surgery","","surgery","15"],["500","Study of an Emergency Department-based Intervention to Reduce Alcohol Misuse in Older Adults","","alcohol","150"],["503","Effects of Chemoradiation and Surgery on Cardiopulmonary Fitness and Tumor Neoplastic Phenotype in Gastrointestinal Malignancies","","tumors","25"],["504","Effect of Non-Alcoholic Steatohepatitis (NASH) on the Pharmacokinetics of 99mTechnetium-Mebrofenin","Phase 1","alcohol","20"],["510","Surgery Prevention by Transforaminal Injection of Epidural Steroids for Cervical Radicular Pain","Phase 4","surgery","60"],["513","Fabrication of a Definitive Cad/Cam Titanium Abutment Prior to Guided Surgery: a Pilot Study.","","surgery","28"],["521","The Effect of Prophylactic Antipyretics on Immune Responses and Fever After 2014-2015 and 2015-2016 Inactivated Influenza Vaccine","Phase 4","influenza","104"],["524","Electronic Medical Record Review in Monitoring the Effects of Adherence on Myelosuppression and Morbidity in Patients With Newly Diagnosed Brain Tumors Receiving Temozolomide and Radiation Therapy","","tumors","240"],["525","A Validated Necrosis Assay to Determine the Need for Revision Surgery in Metal-on-metal Total Hip Arthroplasty","","surgery","100"],["527","Phase I Study of HIV 1 Antigen Expanded Specific T Cell Therapy","Phase 1","hiv","12"],["530","Hydration Monitor Validation in Elderly","","elderly","73"],["536","Multimodal Analgesia vs. Routine Care Pain Management for Lumbar Spine Fusion Surgery: A Prospective Randomized Study","Phase 4","surgery","124"],["543","TEA vs. PVB vs. PCA in Liver Resection Surgery","","surgery","10"],["547","Aromatherapy Using a Nasal Clip After Surgery","","surgery","300"],["550","Effects of Wood Smoke Particles on Influenza-induced Nasal Inflammation in Normal Volunteers","Phase 0","influenza","39"],["555","Hepatitis C Alcohol Reduction Treatment","","alcohol","230"],["576","Pain Expectations in Subjects With Osteoarthritis","Phase 4","arthritis","30"],["577","A Double-Blind Placebo-Controlled Cross-over Study of Armodafinil Treatment of Daytime Sleepiness Associated With Treated Nocturia","Phase 2 / Phase 3","sleep study","27"],["578","Interleukin-2&#8212;Induced Cognitive/Affective/Sleep Symptoms","","sleep study","30"],["587","A Pilot Study of a Non-Invasive Neuromodulation Device for Treatment of Parkinson&apos;s Disease","","neurological","6"],["589","Determining Relationships Among Maternity Stress &amp; Sleep","","sleep study","17"],["596","Examining the Effects of Neuromodulation on Glucose Metabolism in Type 2 Diabetes","","diabetes","6"],["598","Multivitamin Adherence Following Bariatric Surgery","","surgery","30"],["601","Exercise Heart Failure and Type 2 Diabetes","","diabetes","0"],["609","Modulation of Insulin Sensitivity by Betaine Upregulation of FGF21","","diabetes","23"],["611","Mobile Sensing of Smoking Behavior","","smoker study","2"],["614","A Family-Based Diabetes Intervention for Hispanic Adults in an Emerging Community","","diabetes","156"],["624","Anti-thrombin III (ATIII) vs Placebo in Children (&lt;7mo) Undergoing Open Congenital Cardiac Surgery","Phase 2","surgery","40"],["626","Efficacy of Intrathecal Oxytocin in Patients With Neuropathic Pain","Phase 2","neurological","40"],["628","A Safety and Efficacy Study of NNZ-2566 in Patients With Mild Traumatic Brain Injury (mTBI)","Phase 2","neurological","132"],["637","Nonconvulsive Seizure Identification on Quantitative EEG by Neuro ICU Nurses","","neurological","30"],["639","Effects of a Cocoa Shot on the Human Brain 2","Phase 1","neurological","24"],["640","Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET)","","tumors","85"],["646","Integrated Approaches for Identifying Molecular Targets in Alcoholic Hepatitis","","alcohol","700"],["649","Study of Tolerability and Efficacy of BVS857 in Severe Burn Subjects","Phase 2","burns","1"],["652","Testing Methods of Self-persuasion Involving Cigarette Smoking","","smoker study","48"],["659","Efficacy and Safety of the DASH Diet in Adults With Moderate Chronic Kidney Disease: Pilot Study","","kidney disease","42"],["660","Use of Recombinant Hyaluronidase Human is Effective for the Use of Local Blocks for Eyelid&apos;s Surgery","","surgery","0"],["663","Intravenous Exenatide in Patients With Acute Brain Injury","Phase 4","neurological","24"],["669","Improving Diabetes Outcomes for Persons With Severe Mental Illness","","diabetes","25"],["678","Airway Inflammatory Response During Illness in Children With Respiratory Failure","","respiratory disease","20"],["692","Three Approaches to Glucose Monitoring in Non-insulin Treated Diabetes","","diabetes","450"],["701","Isolation of Circulating Tumor Cells Using a Novel EMT-Based Capture Method","","tumors","80"],["709","Effects of Tobacco Products on Live Attenuated Influenza Virus (LAIV) Infections in Human Volunteers","","influenza","100"],["712","Effects of Shock Absorbing Insoles on Knee Pain and Walking in Persons With Knee Osteoarthritis","Phase 2","arthritis","60"],["728","Echinacea and Acute Respiratory Illness","","respiratory disease","40"],["736","Brain Connectivity in Age-Related Macular Degeneration","","neurological","300"],["739","BABY STEPS II: SMS Scheduled Gradual Reduction Text Messages to Help Pregnant Smokers Quit","","smoker study","522"],["743","Use of Technological Advances to Prevent Smoking Relapse Among Smokers With PTSD","","smoker study","15"],["747","Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)","Phase 2","heart disease","250"],["751","Total Ankle Replacement for Ankle Arthritis","","arthritis","1000"],["755","Efficacy and Safety of High Dose Baclofen for Alcohol Dependence","Phase 2","alcohol","120"],["757","Jump Starting Shared Medical Appointments for Diabetes With Weight Management","","diabetes","308"],["760","Neurocognitive Visual Reaction Training","","neurological","21"],["763","Effect of Tourniquet on Sensory Nerve Conduction Threshold (sNCT) and OxyNeuroGram (ONG) Index- A Volunteer Study","","neurological","10"],["774","Study of Awareness and Detection of Familial Hypercholesterolemia","","heart disease","5000"],["779","Complementary Neurosteroid Intervention in Gulf War Illnesses (GWVI)","Phase 2","neurological","140"],["781","Establishment of a Human Tissue Bank for Studying the Microbial Etiology of Neurodegenerative Diseases","","neurological","300"],["787","Establishment of a Tissue Bank (Blood CSF) for the Understanding of the Disease Progression and Early Diagnosis of Motor Neuron Disease (MND)","","neurological","1000"],["796","Brain Imaging of Intranasal Oxytocin Treatment in Autism","Phase 1","neurological","28"],["811","Evaluation of Efficacy and Accuracy of Aquamantys Device in General Surgery","","surgery","20"],["813","Fluid Intake Application to Reduce Kidney Stone Risks","","kidney disease","50"],["816","Effects of a Cocoa Shot on the Human Brain","Phase 0","neurological","6"],["818","The Effect of Anticholinergics on Cognitive Function in the Elderly","Phase 4","elderly","59"],["820","Blood Pressure Heart Rate Variability &amp; Sleep in Veterans With PTSD","","sleep study","19"],["832","Auditory Brainstem Implantation in Young Children","Phase 0","neurological","10"],["836","CPT and Smoking Cessation","Phase 2 / Phase 3","smoker study","50"],["838","Virtual Reality for Osteoarthritis Knee Pain Pilot","","arthritis","30"],["841","Neurosteroids as Novel Therapeutic Agents for Chronic Pain in OEF/OIF Veterans","Phase 2 / Phase 3","neurological","90"],["846","Observational Assessment of Baseline Asthma Control in African-American Children","","asthma","25"],["873","Sleep Apnea and Visual Perceptual Skill Learning","","sleep study","14"],["874","An Evaluation of Neurofeedback Efficacy in Adults With ADHD","","neurological","30"],["877","Superior Laryngeal Nerve Block For Awake Endotracheal Intubation Study","","nerve study","95"],["879","Sulforaphane Supplementation in Atopic Asthmatics","Phase 1","asthma","16"],["886","Environments as Smoking Cues: Imaging Brain Substrates Developing New Treatments (CameraCue)","","smoker study","67"],["890","Translational Research Evaluating Neurocognitive Memory Processes","","neurological","76"],["893","Latinos Combating Diabetes","","diabetes","225"],["899","Simultaneous Risk Factor Control Using Telehealth to slOw Progression of Diabetic Kidney Disease (STOP-DKD)","","kidney disease","285"],["900","Milnacipran and Neurocognition Pain and Fatigue in Fibromyalgia : A 13-week Randomized Placebo Controlled Cross Over Trial","Phase 3","neurological","26"],["908","Bone Metabolism After Bariatric Surgery","","surgery","40"],["916","Parents and Children Together Preventing Diabetes (PACT PD)","","diabetes","72"],["918","Nicotine Non-Smokers With and Without ADHD and Genetics Study","Phase 1","smoker study","150"],["925","Trial of Directed High-dose Nasal Steroids on Residual Smell Loss in Sinus Patients After Sinus Surgery","Phase 2","surgery","0"],["931","Postoperative Subtenons Anesthesia for Postoperative Pain in Pediatric Strabismus Surgery","","surgery","57"],["941","Lifestyle Intervention for Treatment of Diabetes","","diabetes","260"],["942","Empowering Rural African American Women and Communities to Improve Diabetes Outcomes","","diabetes","200"],["945","Mindfulness: a Novel Approach for the Management of Diabetes-related Distress","Phase 2 / Phase 3","diabetes","90"],["951","PET/MRI in CNS and Extra-CNS Tumors of Patients With Neurofibromatosis-1 (NF1)","","tumors","15"],["954","A Trial Examining the Efficacy of Escitalopram Oxalate Upon Depressive Symptoms and Fatigue in HIV Seropositive Women","Phase 4","hiv","5"],["959","Post-traumatic Arthritis Associated With Joint Injury","","arthritis","30"],["963","Carolina Alcohol and Drug Resources","","alcohol","690"],["967","Contingency Management for Smoking Cessation in Homeless Smokers","","smoker study","25"],["972","Understanding the Response to Fesoterodine Through Genetic Evaluation in the Elderly (URGE)","","elderly","66"],["973","iCare vs Tonopen vs Goldmann Applanation Post-vitrectomy Surgery","","surgery","68"],["974","Regulation of Branched-chain Amino Acid Metabolism in Pre-Diabetes","","diabetes","132"],["975","Neuromuscular Ultrasound in ALS","","neurological","40"],["980","Pilot Testing a Patient and Provider Intervention for Managing Osteoarthritis in Hispanic Adults.","","arthritis","16"],["985","Advanced Comprehensive Diabetes Care for Veterans With Poorly-Controlled Diabetes","Phase 0","diabetes","50"],["994","Cryosurgery and Radiation Therapy in Treating Patients With Painful Bone Metastases","","surgery","1"],["1000","Physiologic Mechanisms in Pediatric Traumatic Brain Injury (TBI)","","neurological","60"],["1001","Neurophysiology of Postpartum Depression in an Experimental Model of Pregnancy and Parturition","","neurological","30"],["1014","Delayed-Enhancement Cardiovascular Magnetic Resonance in Patients With Sarcoidosis","","heart disease","400"],["1029","Study to Evaluate the Impact of FeNO Assessments on Asthma Management Decisions in Subject 7 to 60 Years of Age","","asthma","50"],["1038","Abstinence Reinforcement Therapy (ART) for Rural Veteran Smokers","","smoker study","300"],["1048","Exploring Massage Benefits for Arthritis of the Knee for VA Healthcare Users","","arthritis","25"],["1055","Effect Of Acute Inflammatory Mediators On Functional Limitations In Patients With Acute Respiratory Failure","Phase 1 / Phase 2","respiratory disease","100"],["1058","Almased Multi-Center Diabetes Intervention Trial","","diabetes","240"],["1059","Assessing Short and Long Term Compliance With Caloric Intake in HIV Positive Women Taking Complera","","hiv","33"],["1060","The Effects of Respiratory Muscle Strength Training (RMST) on Inspiratory and Expiratory Muscle Strength in Adults and Children With Pompe Disease","","respiratory disease","11"],["1065","MRI to Assess the Effects of Dysautonomia and Chronic Nausea on Brain Transmitters","","neurological","18"],["1067","MiraLAX Versus Placebo to Prevent Constipation Following Urogynecologic Surgery","","surgery","131"],["1072","Mild Traumatic Brain Injury Registry","","neurological","40"],["1088","Advanced Image Guidance Utilized in Liver Surgery","","surgery","13"],["1092","Gene Expression Variation and Implant Wound Healing Among Smokers and Diabetics","","smoker study","44"],["1094","Surgical Outcomes Database For Faculty of Hepatopancreatic Biliary Surgery","","surgery","300"],["1099","Visceral (Kidney and Abdominal Organ) Function After Fenestrated and Branched Endovascular Aneurysm Repair (FEVAR/BEVAR) of Thoracoabdominal Aortic Aneurysms","","kidney disease","160"],["1100","Study of Effectiveness of Liraglutide Added to High Dose Insulin in Type II Diabetics","Phase 4","diabetes","36"],["1109","The Effects of Smoking Withdrawal On Resting State Functional Connectivity","","smoker study","0"],["1112","Neurostimulation Device for Treatment of Migraine Headache","","neurological","7"],["1116","HIV Prevention Among Latino MSM: Evaluation of a Locally Developed Intervention","","hiv","304"],["1119","Effects of Tai Chi Chuan on Psychobiological Indicators of Anxiety and Sleep Quality in Young Adults","","sleep study","75"],["1122","Ventilatory Heterogeneity in Participants With Asthma (MK-0476-513)","Phase 1","asthma","34"],["1123","Evaluation of DVD and Internet Decision Aids for Hip and Knee Osteoarthritis: Focus on Health Literacy","","arthritis","155"],["1129","Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery","Phase 2","surgery","40"],["1137","Combinatorial Therapy for Peristent Type 2 Diabetes After Gastric Banding","Phase 4","diabetes","9"],["1141","Mindful Movement and Breathing to Improve Outcomes of Gynecologic Surgery","Phase 0","surgery","10"],["1142","Study of Anesthesia Techniques to Reduce Nausea and Vomiting After Jaw Corrective Surgery","","surgery","233"],["1154","ENLIGHTEN: Exercise and NutritionaL Interventions for coGnitive and Cardiovascular HealTh ENhancement","","heart disease","160"],["1158","To Compare the Safety Tolerability and Pharmacokinetics of QBX258 in Patients With Asthma","Phase 1","asthma","50"],["1170","Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery","Phase 2","surgery","20"],["1173","Cardiovascular Effects of Incremental Diesel Exhaust Inhalation in Middle-Aged Healthy GSTM1 Null Human Volunteers","","heart disease","6"],["1182","Mapping Multidimensional Illness Trajectories of Patients With End-stage Kidney Disease","","kidney disease","227"],["1186","A Phase I Study To Evaluate The Antitumor Activity And Safety Of AVX901","Phase 1","tumors","22"],["1195","Effect of Blueberries on Cognition and Body Composition in Elderly With Mild Cognitive Decline","Phase 2","elderly","123"],["1197","Eating Disorders in Type 1 Diabetes: Mechanisms of Comorbidity","","diabetes","83"],["1200","Study to Evaluate the Effect of RGMA001 on Patients With Non Alcoholic Fatty Liver Disease (NAFLD)","","alcohol","40"],["1206","Neurostimulation in Temporomandibular Disorders (TMD) Patients","","neurological","5"],["1216","Strength Training for ARthritis Trial","Phase 2","arthritis","375"],["1226","Trivalent Influenza Vaccine in Preventing Flu in Patients With Central Nervous System Tumors","Phase 0","influenza","38"],["1229","Efficacy of Fluocinonide Cream 0.1% (Vanos(R)) in Reducing Itch in Subjects With Atopic Dermatitis","","dermatitis","10"],["1233","Vasospasm in Pediatric Traumatic Brain Injury","","neurological","6"],["1234","Obesity in HIV After Antiretroviral Therapy","","hiv","200"],["1241","Development of a Tumor Molecular Analyses Program and Its Use to Support Treatment Decisions","","tumors","5000"],["1242","Study to Assess the Effects of Daily Administration of Pioglitazone on Brain Hemodynamics in Healthy Elderly Participants","Phase 1","elderly","61"],["1255","Patient and Provider Interventions for Managing Osteoarthritis in Primary Care","","arthritis","537"],["1261","Mindfulness-based Personalized Health Planning for Reducing Risk of Heart Disease and Diabetes","Phase 3","diabetes","140"],["1268","Neural Markers and Rehabilitation of Executive Functioning in Veterans With Traumatic Brain Injury and Posttraumatic Stress Disorder","","neurological","100"],["1270","Early Brain Development in Twins","","neurological","600"],["1278","Neuromuscular Ultrasound for Focal Neuropathies","","neurological","120"],["1280","Pain and Function After Orthopedic Surgery","","surgery","75"],["1282","Pediatric Atopic Dermatitis (AD) Internet Survey","","dermatitis","40"],["1284","Strategies for Enhancing Mucosal Immunity to Influenza Vaccine","Phase 0","influenza","60"],["1287","Personalized Diabetic Kidney Disease Risk Info to Initiate and Maintain Health Behavior Changes","","kidney disease","19"],["1297","Families and Pediatric Cardiac Surgery Multidisciplinary Teams: How Well Do We Communicate","","surgery","23"],["1304","Effect of Growth Hormone on Early Brain Development in Girls With Turner Syndrome","","neurological","25"],["1307","Brain Connectivity in Neurodevelopmental Disorders in Response to Treatment","","neurological","25"],["1316","Stress Reduction Training to Improve Sleep Quality Stress Physiology &amp; Cardiovascular Disease (CVD) Risk Markers","","heart disease","87"],["1318","Neuroactive Steroids and Traumatic Brain Injury (TBI) in OEF/OIF Veterans","Phase 2","neurological","82"],["1324","Early Intervention for Morbidly Obese Patients After Roux-en-Y Gastric Bypass (RYGB) Surgery","","surgery","8"],["1328","Patient Positioning in Lumbar Fusion Surgery and Its Impact on Spinal Sagittal Balance and Surgeon Satisfaction","","surgery","7"],["1331","Cardiovascular Effects in Psoriasis Patients Treated With Adalimumab.","","heart disease","17"],["1332","The Effect of Vorinostat on HIV RNA Expression in the Resting CD4+ T Cells of HIV+ Pts on Stable ART","Phase 1 / Phase 2","hiv","37"],["1333","Measurement of Kidney Blood Flow and Oxygen Levels by MRI","","kidney disease","10"],["1341","TissueLink Study During Multi-Level Spine Surgery","Phase 4","surgery","60"],["1347","Sweet Preference and Alcohol Craving","Phase 2","alcohol","80"],["1351","Clinical Assessment of Nonin 7600 Near Infrared Spectroscopy (NIRS) Tissue Oximetry During Cardiovascular Surgery","","heart disease","50"],["1355","Feasibility of a Minimally Invasive Image-Guided Surgery System for Hepatic Procedures","","surgery","30"],["1364","Effects of Sulforaphane (SFN) on Immune Response to Live Attenuated Influenza Virus in Smokers and Nonsmokers","","influenza","51"],["1372","Effect of Calcium Polycarbophil on Type II Diabetes Mellitus Control: a Randomized Double-blind Study","","diabetes","48"],["1376","A Study of FolateScan in Patients With Knee Osteoarthritis","","arthritis","25"],["1377","Benazepril Hydrochloride Lisinopril Ramipril or Losartan Potassium in Treating Hypertension in Patients With Solid Tumors","Phase 2","tumors","6"],["1378","Yoga Therapy in Treating Patients With Malignant Brain Tumors","","tumors","9"],["1379","Atypical Antipsychotic Treatment Effect On Brain Function In Schizophrenia Measured By FMRI","","neurological","34"],["1380","Efficacy and Tolerability Study of Device RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis in Adults","Phase 2","dermatitis","17"],["1381","We Can Prevent Diabetes: A Behavioral Intervention to Reduce Diabetes Risk in African Americans","Phase 1 / Phase 2","diabetes","74"],["1390","Discharge Planning for Elderly Patients in the Emergency Department: Use of a Brief Phone Call After Discharge to Improve Medication Utilization and Physician Follow-up","","elderly","157"],["1396","Ehealth: Second Life Impacts Diabetes Education &amp; Self-Management","","diabetes","20"],["1398","Understanding of Genetic Risk Information for Type 2 Diabetes","","diabetes","300"],["1400","Statin Therapy To Limit Cognitive Dysfunction After Cardiac Surgery","","surgery","0"],["1403","Incidence of Respiratory Depression in Cesarean Section","","respiratory disease","100"],["1412","Reusable Versus Disposable Draping System in Breast Reconstruction Surgery","","surgery","107"],["1422","Evaluation of Continuous Saphenous Nerve Block to Supplement a Continuous Sciatic Nerve Block After Ankle Surgery","","surgery","74"],["1430","Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors","Phase 1","tumors","18"],["1439","Cardiovascular Intervention Improvement Telemedicine Study","","heart disease","428"],["1445","Personalized Cardiovascular Risk Information to Initiate and Maintain Health Behavior Changes","","heart disease","98"],["1452","Patient and Provider Interventions for Managing Osteoarthritis in Primary Care","","arthritis","300"],["1457","Neuroimaging of Smokers With and Without Attention Deficit Hyperactivity Disorder (ADHD)","","smoker study","101"],["1462","A Panobinostat Presurgery","Phase 2","surgery","0"],["1463","Evaluating the Effect of Mucinex 1200mg on Mucociliary and Cough Clearance During an Acute Respiratory Infection","Phase 2","respiratory disease","38"],["1468","Fast Spectral Imaging Device for Tumor Margin Mapping","","tumors","54"],["1472","A Pilot Trial in a Sleep Laboratory Setting to Observe Night Time Bladder Function of Subjects With Overactive Bladder (OAB)","","sleep study","15"],["1494","Genetic Testing for Type 2 Diabetes","","diabetes","601"],["1495","Transoral Robotic Surgery (TORS) for Oral and Laryngopharyngeal Lesions Using Da Vinci Robotic Surgical System","Phase 0","surgery","60"],["1496","Group Physical Therapy for Knee Osteoarthritis","","arthritis","320"],["1497","Neurobiology of Nicotine and Non-nicotine Components of Tobacco Addiction","Phase 1","neurological","147"],["1498","Supplemental Nicotine Administration for Smoking Cessation in Posttraumatic Stress Disorder (PTSD)","","smoker study","69"],["1499","Safety Study of Bevacizumab Everolimus and LBH589 (BEL) for Advanced Solid Tumors","Phase 1","tumors","14"],["1503","Managing Chronic Kidney Disease in Eastern North Carolina","","kidney disease","1257"],["1511","A Study Evaluating the Efficacy of Fluocinonide Cream 0.1% (Vanos) in Subjects With Atopic Dermatitis","Phase 4","dermatitis","20"],["1512","Investigating Fitness Interventions in the Elderly (INFINITE)","","elderly","180"],["1514","Pilot Study of Lovaza (Omega 3 Fatty Acids) to Improve Cardiac Antioxidant/Anti-inflammatory Profile Before Cardiac Surgery","Phase 4","surgery","24"],["1515","Reducing Donor Specific Antibody (DSA) Strength in Maintenance Kidney Transplant Recipients (DSA Study)","Phase 4","kidney disease","32"],["1518","En Pareja: A Latino Couples Intervention to Help Expectant Fathers Quit Smoking","","smoker study","705"],["1521","p16 Methylation for Smoking Cessation","","smoker study","35"],["1527","Armodafinil in Treating Fatigue Caused By Radiation Therapy in Patients With Primary Brain Tumors","Phase 2","tumors","54"],["1532","Pilot Trial in Sleep Laboratory Setting to Compare the Physiology of Night Time Bladder Function in Subjects With Overactive Bladder (OAB) Versus Subjects That Have Insomnia and Healthy Normal Subjects","Phase 4","sleep study","26"],["1538","Intensive Computerized Brain Training (ICBT) in Youth With Early Onset Psychosis (EOP)","","neurological","35"],["1542","Dietary Patterns and Cardiovascular (CVD) Risk in Spinal Cord Injury (SCI) Factors In Individuals With Chronic Spinal Cord Injury","","heart disease","100"],["1544","Safety Metabolism and Antioxidant Activity of Silymarin and Green Tea Extract in Patients With Chronic Hepatitis C","Phase 1 / Phase 2","hepatitis","60"],["1547","Optimal Planning Target Volume With Stereotactic Radiosurgery","","surgery","49"],["1549","Radiosurgery and Avastin for Recurrent Malignant Gliomas","","surgery","15"],["1550","Dexmedetomidine Sedation With Third Molar Surgery","Phase 4","surgery","18"],["1551","Moderate to Persistent Asthma in the Obese Subject","Phase 4","asthma","38"],["1563","Internet-Based Smoking Cessation for Operations Enduring Freedom and Iraqi Freedom (OEF/OIF) Veterans","","smoker study","413"],["1582","The Arthritis Diet and Activity Promotion Trial","","arthritis","318"],["1585","Tailored Case Management for Diabetes and Hypertension","","diabetes","377"],["1588","Standardized Rehabilitation for Intensive Care Unit (ICU) Patients With Acute Respiratory Failure","","respiratory disease","300"],["1589","Lowering Salt Intake in Chronic Kidney Disease: A Pilot Randomized Crossover Trial","","kidney disease","35"],["1595","Exercise Dose-Response Effects in Prediabetes","","diabetes","288"],["1600","Exercise Intolerance in Elderly Patients With Diastolic Heart Failure","","elderly","100"],["1628","Functional Imaging of Tumor and Normal Tissue","","tumors","21"],["1638","A Study of Inhalation of 20000 EU CCRE and Mucociliary Clearance (MCC) in Otherwise Healthy Individuals Who Are Current Cigarette Smokers","Phase 1","smoker study","12"],["1641","Safety and Efficacy Study to Compare Continuous Infusion of Interferon With Standard of Care for Chronic Hepatitis C","Phase 2","hepatitis","116"],["1642","Preventing Postpartum Return to Smoking","","smoker study","386"],["1651","A Controlled Laboratory Study of the Effects on Cue-Induced Craving in Dependent Smokers","Phase 2","smoker study","21"],["1656","Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors","","tumors","2500"],["1662","Prevalence of Sleep Disturbances in Psoriasis","","sleep study","80"],["1663","Evaluation of a Tailored Smoking Cessation Treatment Algorithm Based on Initial Treatment Response and Genotype","Phase 3","smoker study","606"],["1664","Vaccine Therapy in Treating Patients Undergoing Surgery for Recurrent Glioblastoma Multiforme","Phase 1","surgery","50"],["1666","Safety/Biomarker Study of CNTO 95 and Avastin in Solid Tumors","Phase 1","tumors","13"],["1667","Treatment Effects of Escitalopram (Lexapro&#174;) on Generalized Anxiety Disorder in Patients With HIV and AIDS","Phase 3","hiv","30"],["1668","Mindfulness Emotional Well-being and Sleep Quality","","sleep study","372"],["1674","Sex Differences in Early Brain Development; Brain Development in Turner Syndrome","","neurological","295"],["1675","Efficacy and Tolerability of Baclofen for Alcohol Dependence","Phase 2 / Phase 3","alcohol","80"],["1682","Study of Massage Therapy Within a Brain Tumor Setting","","tumors","10"],["1683","BTC Neuropsychological Database","","neurological","0"],["1699","Validation of Brain Oxygenation Monitor on Pediatric Patients","","neurological","72"],["1702","Compatibility of a Mild Moisturizing Hand Cleanser for Patients With Mild to Moderate Hand Dermatitis","","dermatitis","46"],["1703","Bronchoscopy Assisted Sampling of Cells and Fluid From the Lower Respiratory Tract of Human Subjects","","respiratory disease","30"],["1706","Effect of a 10000 EU Dose of Endotoxin in Allergic and Mildly Asthmatic Adults","Phase 1","asthma","11"],["1707","A Study of Inhalation of 20000 EU CCRE in Normal Volunteers Compared to Allergic Asthmatic Individuals","Phase 1","asthma","32"],["1709","In Vitro Basophil Responsiveness to Allergen Challenge After Gamma-tocopherol Supplementation in Allergic Asthmatics","Phase 1","asthma","25"],["1710","Improving Neurologic Outcomes in People With Diabetes Who Are Undergoing Heart Surgery","Phase 3","diabetes","133"],["1711","Effectiveness of Metformin Compared to Insulin in Pregnant Women With Mild Preexisting or Early Gestational Diabetes","Phase 2","diabetes","31"],["1715","Role of RhuMab-E25 in Reducing Exhaled Nitric Oxide (NO) in Allergic Asthma","Phase 3","asthma","20"],["1718","Rapid Administration of Insulin in Sepsis","Phase 1","diabetes","20"],["1719","Cholesterol Hypertension and Glucose Education Study","","heart disease","362"],["1721","Validation of Brain Oxygenation Monitor","","neurological","18"],["1725","Stereotactic Radiosurgery After Surgery in Treating Patients With Brain Metastases","Phase 2","surgery","1"],["1726","Stereotactic Radiosurgery in Treating Patients With Brain Metastases","Phase 2","surgery","6"],["1730","Amantadine and Temporal Discrimination in Patients With Traumatic Brain Injury (TBI)","","neurological","16"],["1732","Pharmacokinetics of NRL972 in Patients With Nonalcoholic Steatohepatitis (NASH) and Non-Alcoholic Fatty Liver Disease (NAFLD)","Phase 2","alcohol","125"],["1739","Impact of GBS on CVD in Type 2 Diabetes Mellitus","","diabetes","84"],["1745","Effectiveness of Bridging Anticoagulation for Surgery (The BRIDGE Study)","Phase 3","surgery","1884"],["1774","Range of Neutrophil Response to 20000 EU of Clinical Center Reference Endotoxin in Otherwise Healthy Smokers","Phase 1","smoker study","2"],["1783","Evaluating the Effects of Hormone Replacement Therapy on Brain Function (The WHIMS-MRI Study)","","neurological","1426"],["1788","Metformin for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD)","Phase 4","alcohol","11"],["1789","Attention Deficit Hyperactivity Disorder (ADHD) Smoking Cessation Study","","smoker study","32"],["1791","A Study to Determine if Carbon Dioxide Lavage During Total Knee Surgery Reduces Intraoperative Embolic Events","Phase 2","surgery","20"],["1797","An Optical Assay System for Intra Operative Assessment of Tumor Margins in Patients","","tumors","530"],["1801","Treating Co-Morbid Sleep Difficulties in Veterans With Posttraumatic Stress Disorder (PTSD): A Pilot Study","","sleep study","22"],["1802","Concurrent Nicotine Patch / Denicotinized Cigarette Therapy for Smoking Cessation II","Phase 3","smoker study","479"],["1814","A Multicenter Randomized Placebo-Controlled Phase 2 Study to Evaluate the Clinical Efficacy Safety and Tolerability of ARX-F01 Sublingual Sufentanil in Patients Undergoing Major Abdominal Surgery","Phase 2","surgery","88"],["1818","Loteprednol Etabonate in an Ophthalmic Base vs Vehicle for the Treatment of Inflammation Following Cataract Surgery","Phase 3","surgery","400"],["1819","Effects of Capsaicin on the Structure Distribution and Function of Cutaneous Small Nerve Fibers in Psoriatic Skin","Phase 4","nerve study","12"],["1822","Comprehensive Investigation of Opiates Neuropeptides Barrier Function Scratching and Sleep Physiology","","neurological","31"],["1824","Adherence to Topical Hydrocortisone 17-Butyrate 0.1% (Locoid&#174;) Using Different Vehicles in Adults With Atopic Dermatitis","Phase 4","dermatitis","30"],["1830","Neuroimaging Attentional Impairment During Abstinence","","neurological","80"],["1833","Comprehensive Investigation of Heart Rate Variability as a Measure of the Autonomic Nervous System in Atopic Dermatitis","","dermatitis","45"],["1837","Efficacy of Desonide (Desonatetm) Gel 0.05% in Younger and Older Subjects With Atopic Dermatitis","Phase 4","dermatitis","41"],["1845","Supplemental Choline and Brain Development in Humans","","neurological","150"],["1855","Immunotherapy of Melanoma With Tumor Antigen RNA and Small Inhibitory RNA Transfected Autologous Dendritic Cells","Phase 1","tumors","12"],["1857","Neuroimaging Decision Making and Response Inhibition During Smoking Abstinence","","smoker study","62"],["1862","Role of TLR4 in Environmental Asthma","Phase 1","asthma","855"],["1864","Nitric Oxide LPS and the Pathogenesis of Asthma Phase 1","","asthma","420"],["1869","Efficacy Study of PN400 (VIMOVO) Twice Daily and Celebrex Once Daily in Patients With Osteoarthritis","Phase 3","arthritis","610"],["1873","Efficacy Study of PN400 (VIMOVO) Twice Daily and Celebrex Once Daily in Patients With Osteoarthritis","Phase 3","arthritis","614"],["1875","The Effect of Visual Stimuli on Itch Perception Intensity in Healthy and Atopic Dermatitis Patients","","dermatitis","25"],["1876","Phase 2B Dose-Ranging Study of PAC113 Mouthrinse in HIV Seropositive Individuals With Oral Candidiasis","Phase 2","hiv","223"],["1881","Measuring Adherence to Topical Therapy in Children With Atopic Dermatitis and the Impact of a Return Visit","Phase 4","dermatitis","30"],["1886","Genetics of Asthma - Bronchoscopy Studies","Phase 1","asthma","17"],["1890","Nitric Oxide LPS and the Pathogenesis of Asthma Phase II","Phase 1","asthma","70"],["1891","Group Physical Therapy for Knee Osteoarthritis","","arthritis","24"],["1895","The Gene Expression Studies of the Role of Tumor Microenvironments in Tumor Progression","","tumors","0"],["1899","Insulin Resistance in Nonalcoholic Fatty Liver Disease: A Case Control Study","","diabetes","80"],["1911","Healthy Living Partnership to Prevent Diabetes","Phase 3","diabetes","301"],["1915","Safety Study of 20000 EU of Clinical Center Reference Endotoxin in Allergic Adults With and Without Mild Asthma","Phase 1","asthma","4"],["1916","Feasibility Study of Vessel Analysis for Noninvasive Diagnosis of Malignancy in Breast Tumors","","tumors","6"],["1918","Innohep for Prophylaxis of Venous Thromboembolism in Brain Tumor Patients","","tumors","40"],["1920","Coronary Heart Disease as Measured by Coronary Calcium Score Among Individuals With Chronic Traumatic Spinal Cord Injury","","heart disease","45"],["1924","Nicotine Patch Pretreatment for Smoking Cessation in PTSD","Phase 0","smoker study","87"],["1928","Carbamazepine for the Treatment of Chronic Post-Traumatic Brain Injury Irritability and Aggression","","neurological","74"],["1939","Effects of Diesel Exhaust Followed by Administration of Nasal Spray Flu Vaccine on Individuals With &amp; Without Allergies","","influenza","54"],["1942","Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-003)","Phase 3","surgery","120"],["1947","MK-0518 Intensification And HDAC Inhibition In Depletion Of Resting CD4+ T Cell HIV Infection","Phase 2","hiv","6"],["1963","Everolimus Fluorouracil Leucovorin Panitumumab and Oxaliplatin in Treating Patients With Solid Tumors That Did Not Respond to Treatment","Phase 1","tumors","74"],["1969","GIOP Prevention Among People With Rheumatoid Arthritis","","arthritis","273"],["1972","Brain Imaging of Psychotherapy for Depression","","neurological","27"],["1976","U-500R Insulin In Type 2 Diabetes With Severe Insulin Resistance Via Omnipod","Phase 4","diabetes","21"],["1990","Chronic Hepatitis Intervention Project for Drug Users","Phase 3","hepatitis","851"],["1993","Alcohol in the Treatment of Obesity","","alcohol","18"],["2005","A Phase I Study of ABT-510 in Combination With Bevacizumab in Advanced Solid Tumors","Phase 1","tumors","45"],["2011","Exenatide Pregnancy Registry - Type 2 Diabetes in Pregnancy","Phase 4","diabetes","7"],["2018","Duke Conte Center for the Neuroscience of Depression in Late Life","","neurological","795"],["2022","Pathogenesis and Genetics of Environmental Asthma Ozone Study","","asthma","170"],["2023","Sorafenib Combined With Cisplatin and Etoposide or Carboplatin and Pemetrexed in Treating Patients With Metastatic Solid Tumors","Phase 1","tumors","31"],["2024","A Randomized Double-Blind Study Testing the Effects of Pregabalin on Diabetic Neuropathy","Phase 4","neurological","40"],["2026","ENCORE: Exercise and Nutritional Interventions for Cardiovascular Health","","heart disease","144"],["2028","Isolation and Culture of Circulating Tumor Cells From Peripheral Blood","","tumors","500"],["2029","Retisert and Cataract Surgery in Patients With Severe Uveitis","","surgery","21"],["2030","Neurocognitive Outcomes of Depression in the Elderly","","elderly","795"],["2031","Utility of Exercise-induced N-terminal (NT) Pro-brain Natriuretic Peptide Levels in Predicting Prognosis in Asymptomatic Aortic Stenosis","","neurological","110"],["2049","Precedex Versus Propofol-Awakening for Reducing Brain Injury Expansion","Phase 1 / Phase 2","neurological","8"],["2056","Evaluation of Walk With Ease in Arthritis","Phase 3","arthritis","468"],["2065","NICardipine Neuroprotection in AortiC Surgery (NICNACS)","Phase 2","surgery","7"],["2067","Ketamine In Thoracic Surgery (KITS) Trial","Phase 2","surgery","40"],["2071","Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed Progressive or Recurrent Primary Malignant Brain Tumors","","tumors","16"],["2079","Effect of Nepafenac on Post-operative Macular Swelling Following Uncomplicated Cataract Surgery","Phase 4","surgery","82"],["2085","Use of Bicarbonate to Reduce the Incidence of Acute Renal Failure After Cardiac Surgery","","surgery","123"],["2092","Angiotensin-(1-7) in Treating Patients With Metastatic or Unresectable Solid Tumors","Phase 1","tumors","18"],["2094","Improving Care for Primary Care Patients With Diabetes and Poor Literacy and Numeracy Skills","Phase 4","diabetes","110"],["2095","Safety and Efficacy Study of Re-treatment With Rituximab (MabThera/Rituxan) in Patients With Active Rheumatoid Arthritis Who Respond Poorly to Anti-TNF&#945; Therapies","Phase 3","arthritis","341"],["2097","Effect of Burn Size on Cytomegalovirus Reactivation and Correlates of T Cell Immune Function in Burned Patients","","burns","60"],["2101","The Treatment of Insomnia in Patients With HIV Disease","Phase 4","hiv","44"],["2111","Cigarette Smoke and Susceptibility to Influenza Infection","","influenza","138"],["2112","Development and Evaluation of A Mailed Arthritis Self-Management Program","","arthritis","900"],["2114","Family-supported Smoking Cessation for Chronically Ill Veterans","","smoker study","471"],["2129","Lifestyle Modification for Obesity-Related Type 2 Diabetes","Phase 4","diabetes","90"],["2132","Overcoming Psychiatric Barriers to the Treatment of Hepatitis C","","hepatitis","101"],["2148","Sleep Specialty Consultation: Improving Management of Sleep Disorders","","sleep study","156"],["2150","Improving Drug Use for Elderly Heart Failure Patients","","elderly","314"],["2153","Safety Study of a Vitamin E Supplement in Normal Volunteers and Those With Both Allergy and Asthma","Phase 1","asthma","16"],["2157","Intensive Diet and Exercise for Improving Knee Osteoarthritis in Obese and Overweight Older Adults","Phase 2","arthritis","454"],["2161","Zinc Supplements in Lowering Cadmium Levels in Smokers","Phase 2","smoker study","61"],["2163","Effects of an Alternative Treatment for Military Sexual Trauma on PTSD Symptoms Neurosteroids and Brain Function","","neurological","34"],["2164","Functional Brain Imaging of Medication Treatment Response in Mild Alzheimer&apos;s Disease Patients","Phase 4","neurological","4"],["2193","Exposure to Neurotoxins as Risk Factors for Amyotrophic Lateral Sclerosis","","neurological","0"],["2198","Effect of Dexmedetomidine Upon Sleep Postoperatively","Phase 4","sleep study","0"],["2202","Study of Alemtuzumab Versus Anti-thymocyte Globulin to Help Prevent Rejection in Kidney and Pancreas Transplantation","Phase 4","kidney disease","275"],["2204","Levetiracetam for Cramps Spasticity and Neuroprotection in Motor Neuron Disease","Phase 2","neurological","20"],["2205","Study of an Intervention to Improve Use of Life-saving Medications for Heart Disease","","heart disease","143"],["2207","A Patient-Spouse Intervention for Self-Managing High Cholesterol","","heart disease","255"],["2209","Vinflunine and Erlotinib or Pemetrexed in Treating Patients With Unresectable or Metastatic Solid Tumors","Phase 1","tumors","41"],["2211","Examining the Link Between Trace Elements and Cardiovascular Disease Risk Factors in Young Adults","","heart disease","4362"],["2213","The Impact of Patient Involvement in Decision-Making About Heart Disease Prevention","","heart disease","120"],["2220","Study of Valproic Acid to Treat HIV Infected Adults","Phase 1","hiv","14"],["2223","Extracranial Stereotactic Radiosurgery in Treating Patients With Solid Tumors","Phase 1 / Phase 2","tumors","48"],["2224","A Church Based Intervention to Improve Diabetes Care","","diabetes","201"],["2229","Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine in Treating Patients With Advanced Metastatic Solid Tumors","Phase 1","tumors","18"],["2233","Weight Management and Coping Skills Training For Patients With Knee Osteoarthritis","","arthritis","412"],["2234","Vatalanib and Everolimus in Treating Patients With Advanced Solid Tumors","Phase 1","tumors","37"],["2235","Exercise to Treat Depression in Individuals With Coronary Heart Disease","Phase 3","heart disease","101"],["2244","Self-Management of Osteoarthritis","","arthritis","523"],["2247","Measuring Cholesterol in the Fasting and Postmeal State in Patients With Type 2 Diabetes","","diabetes","30"],["2248","Sleep Disorders and Gastroesophageal Reflux Disease (GERD)","Phase 4","sleep study","20"],["2249","Effect of Ozone on Airway Inflammation in Allergic Asthmatics Treated With Omalizumab","","asthma","1"],["2250","Genetic Susceptibility to Ozone in Mild Asthmatic Volunteers","","asthma","52"],["2263","A Phase I Study of STA-5312 in Subjects With Advanced or Metastatic Solid Tumors","Phase 1","tumors","30"],["2264","Bevacizumab Everolimus and Erlotinib in Treating Patients With Advanced Solid Tumors","Phase 1","tumors","65"],["2266","Effects of Resistance and Aerobic Exercise on Cardiovascular Health","Phase 2","heart disease","261"],["2276","Policosanol for the Treatment of Hypercholesterolemia","","heart disease","40"],["2277","Imatinib Mesylate and Capecitabine in Treating Patients With Advanced Solid Tumors","Phase 1","tumors","25"],["2278","Improving Sleep and Psychological Functioning in People With Depression and Insomnia","Phase 4","sleep study","96"],["2284","A Trial to Assess the Efficacy and Safety of SPM 927 in Subjects With Painful Distal Diabetic Neuropathy","Phase 2 / Phase 3","neurological","496"],["2299","Comparing ASHC and CDSMP Outcomes In Arthritis","","arthritis","416"],["2303","Interventions to Improve Hypertension Control and Reduce Cardiovascular Disease Risk","Phase 2","heart disease","574"],["2310","The Role of Vitamins E and C in Maintaining Lung Health in People With Asthma","Phase 1","asthma","16"],["2314","Comparing Paroxetine and Duloxetine on Cardiovascular Measures","Phase 2 / Phase 3","heart disease","40"],["2317","Trial to Assess the Efficacy and Safety of SPM 927 (200 400 and 600mg/Day) in Subjects With Painful Distal Diabetic Neuropathy","Phase 3","neurological","654"],["2321","PIE II: Pharmacological Intervention in the Elderly II","Phase 3","elderly","80"],["2331","Tumor RNA Transfected Dendritic Cell Vaccines","Phase 1","tumors",""],["2344","Safety of KAI-9803 for Injection With Angioplasty Following Heart Attack","Phase 1 / Phase 2","heart disease","154"],["2351","Painful HIV Neuropathy and Alpha-Lipoic Acid","Phase 1 / Phase 2","hiv","60"],["2355","Assessing the Results of Lip Surgery in Patients With Cleft Lip and Palate","Phase 2 / Phase 3","surgery","127"],["2358","HIV Symptom Management Program for African American Mothers","Phase 3","hiv",""],["2363","Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma","Phase 1","surgery","18"],["2364","Study of Karenitecin (BNP1350) in Patients With Brain Tumors","Phase 2","tumors","40"],["2366","Reduced Manipulation of the Aorta and Neurobehavioral Outcome Trial","Phase 3","neurological","300"],["2373","Phase 1 Study OF CDC-501 in Patients With Solid Tumors","Phase 1","tumors","24"],["2382","Screening Adolescents for Type 2 Diabetes Mellitus in a Community Clinic","","diabetes","400"],["2383","Effects of Magnesium on Individuals Undergoing Coronary Artery Bypass Graft Surgery","Phase 2","surgery","389"],["2384","Imatinib Mesylate in Treating Patients With Primary Gastrointestinal Stromal Tumor That Has Been Completely Removed By Surgery","Phase 3","tumors","732"],["2394","Imatinib Mesylate in Treating Patients With Gastrointestinal Stromal Tumor That Has Been Completely Removed During Surgery","Phase 2","tumors","89"],["2396","Antibiotics to Reduce Chorioamnionitis-Related Perinatal HIV Transmission","Phase 3","hiv","3720"],["2397","Treatment to Quit Smoking","Phase 2","smoker study",""],["2398","The Genetics of Environmental Asthma","","asthma","176"],["2399","Intensive Pharmacokinetics of the Nelfinavir-Rifabutin Interaction in Patients With HIV-Related Tuberculosis Treated With a Rifabutin-Based Regimen","","tuberculosis",""],["2407","To Determine the Prevalence of HIV and Other Related Infections Such as Hepatitis C Along With Associated Risk Behaviors in Patients With Severe Mental Illness (SMI).","","hepatitis",""],["2408","Finding Diabetes Mellitus Among Veterans","","diabetes","1276"],["2415","Acute Glycemic Effects of a Very Low Fat Diet in Type 2 Diabetes","","diabetes",""],["2416","Active Immunotherapy Of Metastatic Renal Cell Carcinoma Using Autologous Dendritic Cells Transfected With Autologous Total Tumor RNA","Phase 1","tumors",""],["2417","A Safety and Feasibility Study of Active Immunotherapy in Patients With Metastatic Prostate Carcinoma Using Autologous Dendritic Cells Pulsed With Antigen Encoded in Amplified Autologous Tumor RNA","Phase 1","tumors",""],["2418","Effectiveness of AZT and Nevirapine in Preventing HIV Transmission From Ugandan Mothers to Their Newborns","Phase 3","hiv","1500"],["2419","Genetic Study in Patients Receiving Treatment for Hodgkin&apos;s Disease or Childhood Brain Tumor","","tumors","19"],["2427","Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors","Phase 2","tumors",""],["2428","Temozolomide in Treating Patients With Brain Metastases","Phase 2","neurological",""],["2429","Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors","Phase 1 / Phase 2","tumors","30"],["2437","Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received Treatment","Phase 4","hiv","300"],["2442","Phase II Study of Stereotypes and Mental Retardation: Neurobiological Basis","Phase 2","neurological","40"],["2445","Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Locally Advanced Melanoma of the Arm or Leg","Phase 3","tumors","216"],["2446","Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors","Phase 1","tumors","21"],["2447","Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain Tumors","Phase 1 / Phase 2","tumors","10"],["2451","Intrathecal Busulfan in Treating Patients With Recurrent Refractory or Metastatic Leptomeningeal Tumors","Phase 1","tumors","20"],["2452","Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors","Phase 1 / Phase 2","tumors",""],["2458","Carmustine Plus O(6)-Benzylguanine in Treating Patients With Recurrent or Progressive Gliomas of the Brain","Phase 1","neurological","56"],["2468","Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain Tumors","Phase 1","tumors","6"],["2471","Monoclonal Antibody Therapy in Treating Patients With Brain Metastases","Phase 1 / Phase 2","neurological","6"],["2476","A Study of Retrovir in the Prevention of HIV Infection in Health Care Workers Accidentally Exposed to the Virus","","hiv",""],["2478","A Study of Zidovudine and T Lymphocyte Transfer in the Treatment of HIV Type III in Patients With AIDS","","hiv",""],["2483","A Prospective Double-Blind Study of Retrovir in Early HIV Infection","","hiv",""],["2484","A Pilot Study To Evaluate the Effect of Retrovir (Zidovudine: AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Associated Dementia and Neuromuscular Diseases","","neurological",""],["2485","An Oral Dose-Ranging Finding Study in Patients With HIV Disease CDC Classification Groups IIB III and IV-C2","","hiv",""],["2490","A Study of Zidovudine in the Prevention of HIV Infection in Individuals Exposed to the Virus","","hiv",""],["2491","A Study of Nonoxynol-9 (N-9) and HIV Infection","Phase 3","hiv","4400"],["2492","A Treatment IND for Retrovir Brand Zidovudine (AZT) Therapy of Pediatric Patients With HIV Disease","","hiv",""],["2494","iOmit: Reducing Intentional Insulin Misuse in Type 1 Diabetes","","diabetes","60"],["2501","To Determine the Measurement Properties of the ACT in an African American Adolescent Population With Persistent Asthma","","asthma","80"],["2502","To Determine the Validity of the ACT in an Adolescent Population With Persistent Asthma","","asthma","80"],["2506","Safety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV Infection","","hiv","40"],["2507","Biomarkers of Aging as Predictors of Kidney Transplant Function","","kidney disease","35"],["2515","Respiratory Event-Related Potentials in Patients With Spinal Cord Injury","","respiratory disease","40"],["2521","Patient Self-management and Gene Guided Therapy for Chronic Hepatitis C","","hepatitis","20"],["2531","Optimizing Outcomes in Women With Gestational Diabetes Mellitus and Their Infants","","diabetes","200"],["2535","Cholesterol Medication Packaging Study","","heart disease","240"],["2536","Donepezil Compared to Placebo in Patients With Chronic Neuropathic Pain","Phase 4","neurological","33"],["2538","Treatment of Acute HIV Infection With Quad Fixed-dose Combination (FDC) Tablet","Phase 3","hiv","30"],["2539","Internet-Based Osteoarthritis Pain Coping Skills Intervention","Phase 3","arthritis","113"],["2542","Tailored Smoking Cessation Treatment for LIVE FOR LIFE&#174; Participants","Phase 2 / Phase 3","smoker study","19"],["2544","Safety Efficacy and Dosing of Stereotactic Radiosurgery for Hepato-cellular Carc/Colo-rectal Liver Metastases","Phase 1","surgery","30"],["2546","Mechanistic Evaluations of Pre-Cessation Therapies for Smoking Cessation","Phase 3","smoker study","282"],["2553","Title: Comparative Effectiveness of Asthma Interventions Within an AHRQ PBRN","","asthma","1040"],["2556","Oxytocin Treatment of Alcohol Withdrawal","Phase 1","alcohol","14"],["2557","Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma Bone Sarcoma or Soft Tissue Sarcoma","Phase 1","neurological","7"],["2560","Pacing Affects Cardiovascular Endpoints in Patients With Right Bundle-Branch Block (The PACE-RBBB Trial)","","heart disease","16"],["2561","Collaborative Study Of Neurofeedback Training Of 6-18 Year Olds With Autism","Phase 1","neurological","30"],["2562","Project POWER Adapting Project SAFE: Reducing STD/HIV Risk in Women Prisoners","","hiv","598"],["2563","FMRI Brain Activation of Aripiprazole Treatment in Autism Spectrum Disorders","Phase 4","neurological","13"],["2569","Treatment of Acute HIV With Emtricitabine Tenofovir and Efavirenz (CID 0805)","Phase 4","hiv","90"],["2571","The Effects of One-Time Pregnenolone Dehydroepiandrosterone (DHEA) or Placebo Administration On Withdrawal Symptoms Mood Craving And Cigarette Evaluation Ratings In Male Smokers","Phase 2","smoker study","22"],["2572","Study to Evaluate HIV Viremia and Persistence in Acutely HIV-Infected ARV Na&#239;ve Patients Treated With Darunavir/Ritonavir and Etravirine","Phase 4","hiv","15"],["2573","Effect of Type 2 Diabetes Genetic Risk Information on Health Behaviors and Outcomes","","diabetes","450"],["2574","Cognitive Effects of Inhalational Versus Intravenous General Anesthesia in the Elderly","","elderly","200"],["2577","Raltegravir as Early Therapy in African-Americans Living With HIV Study","Phase 4","hiv","43"],["2580","Feasibility of Cocooning Immunization Strategy With Influenza Vaccine","","influenza","544"],["2582","Erythropoietin Resistance in Anemia of Chronic Kidney Disease","","kidney disease","32"],["2584","Evaluating a Web-Based Educational Program for Adults at Risk for Coronary Heart Disease (The Heart to Heart Feasibility Study)","","heart disease","186"],["2588","Clonidine-induced Spinal Acetylcholine Release: Normal Volunteers vs. Neuropathic Pain","Phase 2","neurological","43"],["2589","Clonidine Versus Adenosine to Treat Neuropathic Pain","Phase 2","neurological","24"],["2594","Functional Brain Imaging and Employment in First-Episode Psychotic Patients Treated With Risperdal","Phase 4","neurological","30"],["2599","Testing Pharmacological Therapies for Pregnant Smokers","Phase 4","smoker study","181"],["2602","Sensory Re-Training Following Facial Surgery for Correction of Facial Skeletal Disharmony","Phase 3","surgery","186"],["2604","Coping Skills Training for Early Rheumatoid Arthritis","","arthritis","105"],["2611","Effects of Nicotine Reduction on Smoking Behavior in ADHD Smokers","","smoker study","350"],["2623","Double-Blind 2-Site Randomized Clinical Trial of Neurofeedback for ADHD","","neurological","140"],["2625","Study To Compare Single Dose Of Three Modified Release Formulations Of PF-04937319 With Immediate Release Material-Sparing-Tablet (IR MST) Formulation Previously Studied In Adults With Type 2 Diabetes Mellitus.","Phase 1","diabetes","39"],["2641","Evaluation of Behavioral Intervention for HIV Positive Prisoners in NC and TX","","hiv","381"],["2642","Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120)","Phase 2","diabetes","36"],["2643","Intraoperative OCT Guidance of Intraocular Surgery","","surgery","802"],["2646","School Support as Structural HIV Prevention for Adolescent Orphans in Kenya","Phase 2","hiv","835"],["2652","A Novel Optical Spectral Imaging System for Imaging Breast Tumor Margins","","tumors","210"],["2668","CP-868596 And CP-868596 Plus AG-013736 In Combination With Docetaxel In Advanced Solid Tumors","Phase 1","tumors","50"],["2669","Lidocaine For Neuroprotection During Cardiac Surgery","","surgery","476"],["2680","Physical Activity Following Surgery Induced Weight Loss","","surgery","128"],["2686","Three Way Interaction Between Gabapentin Duloxetine and Donepezil in Patients With Diabetic Neuropathy","","neurological","22"],["2696","Study of Campral (Acamprosate) for Alcohol Dependence in a Family Medicine Clinic","Phase 4","alcohol","100"],["2699","Comparison Of Molecular Targets In Mild To Severe Asthmatics And Healthy Subjects","Phase 1","asthma","58"],["2700","Can Group Visits Improve Outcomes of Veterans With Diabetes","Phase 3","diabetes","239"],["2706","MEND-CABG (MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery)","Phase 2","surgery","900"],["2710","GW786034 in Treating Patients With Advanced Solid Tumors","Phase 1","tumors",""],["2715","Vaccine Therapy in Treating Patients With Metastatic Melanoma Who Are Undergoing Surgery for Lymph Node and Tumor Removal","Phase 1 / Phase 2","tumors",""],["2719","A Study of Zidovudine in HIV-Infected Patients With Kidney Problems","Phase 1","kidney disease","0"],["2721","Weight Loss and Exercise for Communities With Arthritis in North Carolina","Phase 3","arthritis","820"],["2725","Evaluation of Moclobemide a Reversible MAO-A Inhibitor as an Adjunct to Nicotine Replacement Therapy in Female Smokers","Phase 2","smoker study","76"],["2733","Evaluating Once Daily Etravirine in Treatment-Naive Adults With HIV Infection","Phase 2","hiv","80"],["2739","Effects of Anti-HIV Therapy on Red Blood Cells of HIV-infected Mothers and Their Infants","","hiv","0"],["2769","Treatment for Teens With Alcohol Abuse and Depression","","alcohol","170"],["2773","Diabetes Self-Management &amp; Support LIVE","","diabetes","300"],["2775","Cardioneuroablation for Neurocardiogenic Syncope","","neurological","3"],["2778","High-Dose Trivalent Influenza Vaccine in Inducing Immune Response Patients With Central Nervous System Tumors","Phase 1","influenza","60"],["2781","Mechanisms and Functional Outcomes of Exercise Progression Models in the Elderly","","elderly","108"],["2785","A Prospective Evaluation of the Effect of Curcumin on Dose Limiting Toxicity and Pharmacokinetics of Irinotecan in Patients With Solid Tumors.","Phase 1","tumors","23"],["2786","Deployment Related Mild Traumatic Brain Injury (mTBI)","","neurological","1500"],["2791","Severe Asthma Research Program - Wake Forest University","","asthma","700"],["2798","Symptomatic Pulmonary Arterial Hypertension After Mitral Valve Surgery","","surgery","100"],["2812","Study to Evaluate the Bronchoprotective Effects of a Single Dose of N6022 in Patients With Mild Asthma","Phase 1 / Phase 2","asthma","14"],["2823","Prospective Evaluation of the Incidence of NSF in Patients With Kidney Disease Undergoing MR","","kidney disease","2"],["2828","Lymphedema Following Hand/Wrist Surgery in Women Post Axillary Node Dissection","Phase 4","surgery","206"],["2854","Glucose/Insulin Responses:Subjects With Type 2 Diabetes Consuming Diabetes-Specific vs Standard Nutritional Formulas","Phase 3","diabetes","54"],["2855","Induction of Donor Specific Tolerance in Recipients of Living Kidney Allografts by Donor FCRx Infusion","Phase 2","kidney disease","60"],["2858","Arthritis Self-Management Education Program","","arthritis","690"],["2860","Donepezil in Treating Young Patients With Primary Brain Tumors Previously Treated With Radiation Therapy to the Brain","","tumors","14"],["2868","Effect of Brain Lesion Severity on Treatment Response in Late-Life Depression","","neurological","131"],["2886","Pain and Stress Management for People With Rheumatoid Arthritis","Phase 2","arthritis","280"],["2888","Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors","Phase 1","tumors",""],["2900","A Study of Foscarnet in the Treatment of HIV Infection in Patients Who Have Taken Zidovudine for a Long Time","Phase 1","hiv","12"],["2915","Early Mobility for the Critically Injured Burn Patient","","burns","150"],["2922","Safety and Immune Response of Candidate H1N1 Influenza Vaccine GSK2340274A Following Seasonal Influenza Vaccination in Adults","Phase 1","influenza","133"],["2925","Automated Chest Physiotherapy to Improve Outcomes in Neuro","","neurological","40"],["2932","Proof-Of-Concept Investigation With a Neurosteroid Analog (Ganaxolone) as a Smoking Cessation Candidate","Phase 2","smoker study","36"],["2933","Combination Bupropion / Varenicline for Smoking Cessation in Male Smokers","Phase 2","smoker study","376"],["2934","Meclizine as a Potential Smoking Cessation Treatment","Phase 2","smoker study","146"],["2935","Concurrent Bupropion / Varenicline for Smoking Cessation","Phase 3","smoker study","702"],["2943","Trial of Collaborative Depression Care Management for HIV Patients","","hiv","304"],["2952","Safety Study of MGD009 in B7-H3-expressing Tumors","Phase 1","tumors","114"],["2956","Study to Determine the Pharmacokinetics and Tolerability of Fluticasone Propionate MDPI and Fluticasone Propionate/Salmeterol MDPI Compared to High Strength FLOVENT&#174; DISKUS&#174; and ADVAIR&#174; DISKUS&#174; in Patients With Persistent Asthma 12 Years of Age and Older","Phase 1","asthma","43"],["2957","Phase 1/2a Dose-Escalation Study of CRLX301 in Patients With Advanced Solid Tumors","Phase 1 / Phase 2","tumors","60"],["2959","First in Human Dose Escalation Study of TEW-7197 in Subjects With Advanced Stage Solid Tumors","Phase 1","tumors","50"],["2962","Clinical Performance Study of the Ultra Influenza A&amp;B Test Using Nasal Swabs for Identifying Subjects Who Are Infected With the Influenza Virus Strain Type A or Type B","","influenza","677"],["2965","Surgery and Oxaliplatin or Mitomycin C in Treating Patients With Tumors of the Appendix","Phase 2","tumors","116"],["2970","Safety and Efficacy of LCL161 in Patients With Solid Tumors","Phase 1","tumors","71"],["2981","Efficacy of Seprapack Sinus Dressing Versus No Dressing in the Prevention of Intranasal Adhesions Following Sinus Surgery","","surgery",""],["2984","Study to Evaluate the Safety and Pharmacokinetics of MEDI9090 in Subjects With Advanced Solid Tumors","Phase 1","tumors","36"],["2990","A Double Blind Open Label Comparator Study to Compare Treatments in 4 to 11 Year Old Patients With Asthma","Phase 1","asthma","20"],["3003","Study of A Cell-Phone System to Improve Health of Youth With Diabetes","","diabetes","74"],["3004","Pharmacokinetics and Clinical Response of Tolvaptan in Neurocritical Care Patients","","neurological","1"],["3008","The Pathogenesis of Hepatitis C Virus Vertical Transmission","","hepatitis","50"],["3009","Efficacy and Safety of Beta-adrenoceptor Inverse Agonist Nadolol in Mild Asthma","Phase 2","asthma","60"],["3014","NAPS-MS: NAtalizumab Effects on Parameters of Sleep in Patients With Multiple Sclerosis Experiencing Fatigue or Sleepiness","Phase 4","sleep study","37"],["3028","A Phase 1 Dose Escalation Study of AMG 780 in Adult Subjects With Advanced Solid Tumors","Phase 1","tumors","44"],["3032","Trial of Tasigna (Nilotinib) 400 mg Twice Daily Alone or With Gleevec (Imatinib Mesylate) 400 mg Daily for Patients With Advanced Gastrointestinal Stromal Tumor (GIST)","Phase 2","tumors","5"],["3034","Collection and Extraction of Respiratory Specimens","","respiratory disease","600"],["3037","Sanofi H1N1 Influenza Vaccine Administered at Two Dose Levels in Adult and Elderly Populations","Phase 2","influenza","406"],["3041","Safety and Dosage Study of RAD001 (Everolimus) in Combination With Current Standard of Care to Treat Advanced Solid Tumors.","Phase 1","tumors","32"],["3045","Study of IMC-1121B in Patients With Advanced Solid Tumors Not Responding To Standard Therapy","Phase 1","tumors","25"],["3055","Study of Tumor Necrosis Factor Receptor Fusion Protein Etanercept (Enbrel) in Psoriasis of the Hands and/or Feet","Phase 1 / Phase 2","tumors","20"],["3083","Safety of the Candidate Vaccine C4-V3 Alone or With Interleukin-12 (IL-12) in HIV-Infected Patients Receiving Effective Anti-HIV Drug Therapy","Phase 1","hiv","12"],["3089","A Multicenter 2 Part Study to Assess the Efficacy and Safety of H.P. Acthar&#174; Gel in Subjects With Rheumatoid Arthritis","Phase 4","arthritis","232"],["3091","Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder","Phase 2","sleep study","80"],["3113","Exploring Massage Benefits for Arthritis of the Knee","Phase 2","arthritis","222"],["3144","A Phase 1 Double-Blind Randomized Single Dose Escalation Safety Study of Intra-articular OP-1 in Subjects With Osteoarthritis of the Knee","Phase 1","arthritis","33"],["3154","FibroScan in Patients With Hepatitis B and C Presenting for Liver Biopsy","Phase 3","hepatitis","300"],["3157","Safety and Tolerability of Pegylated Interferon (PEG-IFN) Alfa-2a in HIV Infected People","Phase 2","hiv","12"],["3160","A Study of 141W94 in Combination With Other Anti-HIV Drugs","Phase 1","hiv","48"],["3173","Southeastern Diabetes Initiative Clinical Intervention","","diabetes","648"],["3181","Risk of Developing Antibodies to Heparin-PF4 After Heart Surgery","","surgery","1015"],["3183","A Study of Autologous Neo-Kidney Augment&#8482; (NKA) in Type 2 Diabetics With Chronic Kidney Disease","Phase 2","kidney disease","50"],["3188","Heart to Health: A Combined Lifestyle and Medication Intervention to Reduce Cardiovascular Disease (CVD) Risk","","heart disease","489"],["3191","Early Weight Bearing on Supracondylar Distal Femur Fractures in Elderly Patients","","elderly","200"],["3204","Study to Investigate the Safety Pharmacokinetics Pharmacodynamics and Clinical Activity of GSK2126458 and GSK1120212 Combination Therapy in Subjects With Advanced Solid Tumors.","Phase 1","tumors","69"],["3205","A Study of Influenza Virus Vaccines in Children and Adults","Phase 2","influenza","600"],["3211","Early Life Factors and Respiratory Health in Mexico City Children","","respiratory disease","6800"],["3213","Influenza Vaccine Feasibility Study in Children With Persistent Asthma","Phase 4","asthma","50"],["3222","PTC596 in Patients With Advanced Solid Tumors","Phase 1","tumors","60"],["3227","Safety and Efficacy Study of Single Doses of TT-034 in Patients With Chronic Hepatitis C","Phase 1 / Phase 2","hepatitis","9"],["3228","A Study to Evaluate the Safety Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABT-122 in Subjects With Rheumatoid Arthritis","Phase 1","arthritis","19"],["3230","RESULT (REflux Surgery in Lung Transplantation) Preliminary Study Protocol","","surgery","647"],["3232","Study of SCY-635 Pegasys and Copegus in Hepatitis C","Phase 2","hepatitis","11"],["3235","Bioavailability and Food Effect Study of TKI258 (CSF Capsule vs. FMI Tablet) in Adult Patients With Advanced Solid Tumors","Phase 1","tumors","63"],["3241","Study of ACE-041 in Patients With Advanced Solid Tumors or Relapsed/Refractory Multiple Myeloma","Phase 1","tumors","37"],["3254","Affect Recognition: Enhancing Performance of Persons With Acquired Brain Injury (ABI)","Phase 2 / Phase 3","neurological","71"],["3261","Effects of Treating Obstructive Sleep Apnea in Epilepsy","Phase 2","epilepsy","68"],["3264","Risk Evaluation and Education for Alzheimer&apos;s Disease - the Study of Communicating Amyloid Neuroimaging (REVEAL-SCAN)","","neurological","270"],["3284","Evaluating the Impact of Year Long Augmented Diabetes Self Management Support","","diabetes","449"],["3288","The Tobacco Alcohol Prescription Medication and Other Substances Tool","","alcohol","2000"],["3317","Bioavailability and Food Effect Study of TKI258 (CSF Capsules vs. FMI Capsules)in Adult Patients With Advanced Solid Tumors","Phase 1","tumors","60"],["3320","Safety Trial of Single Versus Multiple Dose Thymoglobulin Induction in Kidney Transplantation","Phase 2","kidney disease","99"],["3329","Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) Tumors","Phase 2","tumors","26"],["3333","A Study of R547 in Patients With Advanced Solid Tumors.","Phase 1","tumors","58"],["3342","Dose-Escalation Study Of SB-485232 Administered As Daily Subcutaneous Injections In Adults With Solid Tumors","Phase 1","tumors","25"],["3344","Donepezil or EGb761 in Improving Neurocognitive Function in Patients Who Have Previously Undergone Radiation Therapy for Primary Brain Tumor or Brain Metastases","Phase 2","tumors",""],["3345","Omega-3 Fatty Acids That Affect the Immune System in Kidney Transplant Patients","Phase 0","kidney disease","75"],["3347","Single Dose and 34-Day Tolerance Study of INGAP Peptide in Insulin Deficient Patients","Phase 1 / Phase 2","diabetes","62"],["3349","Improving Diabetes Care Via Telephone Assessment and Patient Education","","diabetes","480"],["3352","Trial of Nonpharmacologic Interventions in Elderly (TONE)","Phase 3","elderly",""],["3359","Safety Study of Inhaled Carbon Monoxide to Treat Acute Respiratory Distress Syndrome (ARDS)","Phase 1","respiratory disease","48"],["3363","Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors","Phase 2","tumors","0"],["3373","Cardiovascular Effects of Exposure to Ozone","","heart disease","90"],["3374","A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors","Phase 1","tumors","30"],["3382","Dosimetry Study of I-131-CLR1404 in Patients With Relapsed or Refractory Advanced Solid Tumors","Phase 1","tumors","9"],["3383","Study to Compare the Safety and Anti-HIV Effect of GSK1265744 Versus Placebo in HIV-1 Infected Adults (ITZ112929)","Phase 2","hiv","9"],["3385","Safety Study of ABT-263 in Combination With Paclitaxel in Subjects With Solid Tumors","Phase 1","tumors","19"],["3396","Safety and Tolerability Study of SNS-314 for Advanced Solid Tumors","Phase 1","tumors","50"],["3407","A Comparison of Two Anti-HIV Drug Regimens for Youth Who Have Failed Prior Therapy","Phase 2","hiv","6"],["3408","Safety Assessment of Weekly Intravenous Infusions of SNS-595 for the Treatment of Solid Tumors","Phase 1","tumors",""],["3409","Initial Safety Assessment of SNS-595 for the Treatment of Solid Tumors.","Phase 1","tumors",""],["3412","NBI-3001 Followed by Surgery in Treating Patients With Recurrent Glioblastoma Multiforme","Phase 2","surgery",""],["3422","Radiation Therapy Plus Thalidomide and Temozolomide in Treating Patients With Newly Diagnosed Brain Metastases","Phase 2","neurological",""],["3444","A Non-Invasive Neuromodulation Device for Treatment of Migraine Headache","","neurological","81"],["3448","A Smoking Cessation Study to Understand the Biological and Functional Changes After One Year of Smoking Cessation","","smoker study","1020"],["3455","IL13-PE38QQR Infusion After Tumor Resection Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma","Phase 1","tumors","24"],["3468","2010-2011 Trivalent Influenza Vaccine (TIV) in Pregnant Women","Phase 2","influenza","183"],["3473","Combination Study of BMS-754807 and Erbitux&#174; in Subjects With Advanced or Metastatic Solid Tumors","Phase 1 / Phase 2","tumors","54"],["3478","Phase II Trial of Silymarin for Patients With Chronic Hepatitis C Who Have Failed Conventional Antiviral Treatment","Phase 2","hepatitis","154"],["3480","Efficacy and Safety Study of Caldolor (Intravenous Ibuprofen) in Hospitalized Adult and Pediatric Burn Patients","Phase 3","burns","61"],["3486","Autologous Neo-Kidney Augment (NKA) in Patients With Type 2 Diabetes and Chronic Kidney Disease (CKD)","Phase 2","diabetes","30"],["3490","A Study Evaluating Oxybutynin in Patients With Neurogenic Overactive Bladder Associated With a Neurological Condition","Phase 4","neurological","24"],["3502","A Study of the Safety and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee","Phase 2","arthritis","81"],["3505","Study of Diclofenac Capsules to Treat Pain Following Surgery in Children Ages 6 to &lt;17 Years of Age","Phase 2","surgery","30"],["3507","Safety and PK Study of CC-90003 in Relapsed/Refractory Solid Tumors","Phase 1","tumors","19"],["3517","Genetic Studies of Non-Alcoholic Fatty Liver Disease","","alcohol","1000"],["3530","Comparison of the Efficacy and Safety of Two Topical Creams for Pediatric Atopic Dermatitis","Phase 4","dermatitis","100"],["3531","A Clinical Demonstration of EEG Brain-computer Interface for ALS Patients","","neurological","27"],["3534","FLU A+B Nasal Swab Clinical Study","","influenza","800"],["3543","Study of XTL6865 in Patients With Chronic Hepatitis C Virus Infection","Phase 1","hepatitis","36"],["3544","The Effects of the Magnetic Molecular Energizer (MME) on Diabetic Peripheral Neuropathy","Phase 3","neurological","100"],["3558","Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis","Phase 2","dermatitis","150"],["3563","Safety Tolerability and PK of AN2728 in Adolescents With Atopic Dermatitis","Phase 1 / Phase 2","dermatitis","23"],["3575","Study of Indomethacin Capsules to Treat Pain Following Surgery in Children Ages 6 to &lt;17 Years of Age","Phase 2","surgery","30"],["3576","A Phase 1/2 Study of MEDI4276 in Adults Subjects With Select HER2-expressing Advanced Solid Tumors.","Phase 1 / Phase 2","tumors","216"],["3581","Autologous Cell Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery","Phase 1 / Phase 2","surgery","30"],["3589","Tumor Collection From Routine Nephrectomy for Subjects With Advanced Stage RCC","","tumors","11"],["3590","A Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated Biomarkers","Phase 2","tumors","18"],["3593","A Study to Evaluate the Effectiveness and Safety of RXI 109 on the Outcome of Scar Revision Surgery in Healthy Adults","Phase 2","surgery","25"],["3594","A Phase 1 Open-label Safety Study of NKA in Patients With Type 2 Diabetes","Phase 1","diabetes","1"],["3597","A First-in-Human Double Blind Single Dose Study in Healthy Subjects and Subjects With Mild Atopic Asthma.","Phase 1","asthma","70"],["3612","Hyperbaric Oxygen Therapy (HBO2) for Persistent Post-concussive Symptoms After Mild Traumatic Brain Injury (mTBI)","Phase 2","neurological","79"],["3613","Collection and Testing of Respiratory Samples","","respiratory disease","272"],["3614","1-Methyl-D-Tryptophan and Docetaxel in Treating Patients With Metastatic Solid Tumors","Phase 1","tumors","27"],["3619","A Phase 2a Study to Evaluate the Safety and Efficacy of AZX100 in Trocar Sites of Arthroscopic Shoulder Surgery Patients","Phase 2","surgery","150"],["3626","Phase 2 Study of the Safety of Diannexin in Kidney Transplant Recipients","Phase 2","kidney disease","58"],["3631","Influenza Vaccine in Premature Infants","Phase 4","influenza","66"],["3640","Registry for African Americans With Early Rheumatoid Arthritis","","arthritis","357"],["3643","Study of Adding Entecavir to Current Lamivudine Therapy in HIV and HBV Co-Infected Patients","Phase 2 / Phase 3","hiv",""],["3648","Open Label Drug-Drug Interaction (DDI) Study of Dupilumab (REGN668/SAR231893) in Patients With Moderate to Severe Atopic Dermatitis (AD)","Phase 1","dermatitis","14"],["3666","Vaccine Immunotherapy for Recurrent Medulloblastoma and Primitive Neuroectodermal Tumor","Phase 1 / Phase 2","tumors","50"],["3669","Safety Tolerability Pharmacokinetic and Pharmacodynamic Study of ABT-652 in Subjects With Excessive Daytime Sleepiness","Phase 1","sleep study","36"],["3671","Safety Study of ABT-263 in Combination With Gemzar (Gemcitabine) in Subjects With Solid Tumors","Phase 1","tumors","46"],["3672","An Open-Label Treatment Protocol to Provide Metreleptin for the Treatment of Diabetes Mellitus and/or Hypertriglyceridemia Associated With Lipodystrophy","","diabetes","41"],["3680","Efficacy and Safety of Single Doses of Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) Compared to Placebo in Patients With Persistent Asthma","Phase 2 / Phase 3","asthma","45"],["3683","Study to Assess Steady-State Trough Concentrations Safety and Immunogenicity of Abatacept After Subcutaneous (SC) Administration to Subjects With Rheumatoid Arthritis (RA)","Phase 1 / Phase 2","arthritis","87"],["3691","Evaluation of Specific Infection-Fighting Cells For Prediction of Immune Response to Anti-HIV and Immune-Boosting Medication","","hiv","0"],["3698","Method-of-Use Study Assessing the Effect of Naltrexone Sustained Release (SR)/ Bupropion SR on Body Weight and Cardiovascular Risk Factors in Overweight and Obese Subjects","Phase 3","heart disease","242"],["3717","Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery","Phase 2","surgery","280"],["3724","Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy","Phase 3","heart disease","4200"],["3728","A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors","Phase 4","diabetes","12000"],["3730","The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects","Phase 3","heart disease","17000"],["3731","Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and Exacerbations in Moderate to Very Severe COPD Patients.","Phase 4","heart disease","4000"],["3738","Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk","Phase 3","heart disease","27564"],["3746","Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery","Phase 3","surgery","216"],["3754","Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery","Phase 3","surgery","1500"],["3778","Comparison of Self Adjustment Versus Standard of Care Treatment in Subjects With Type 2 Diabetes","Phase 4","diabetes","5652"],["3788","The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects","Phase 3","heart disease","10653"],["3795","Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes","Phase 3","diabetes","1049"],["3798","A Study of RO4607381 in Stable Coronary Heart Disease Patients With Recent Acute Coronary Syndrome","Phase 3","heart disease","15865"],["3799","A Study to Describe Pediatric Influenza Vaccine Coverage","Phase 4","influenza","147494"],["3807","A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus","Phase 3","diabetes","19000"],["3808","A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Events","Phase 3","diabetes","7637"],["3811","Cardiovascular Inflammation Reduction Trial","Phase 3","heart disease","7000"],["3818","Safety and Efficacy of Albiglutide in Type 2 Diabetes","Phase 3","diabetes","310"],["3819","A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes","Phase 3","diabetes","685"],["3832","Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)","Phase 3","heart disease","10066"],["3833","Prevention of Cardiovascular Events (eg Death From Heart or Vascular Disease Heart Attack or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin","Phase 3","heart disease","21379"],["3834","Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Comorbidities","Phase 3","heart disease","6198"],["3848","Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)","Phase 4","diabetes","8300"],["3850","A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease","Phase 3","heart disease","16415"],["3851","Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease","Phase 3","kidney disease","756"],["3852","Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease","Phase 3","diabetes","3207"],["3853","Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)","Phase 3","heart disease","8910"],["3854","SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma.","Phase 4","asthma","11751"],["3857","Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)","Phase 3","diabetes","6068"],["3858","Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus","Phase 3","diabetes","14000"],["3866","Safety and Efficacy Study of Albiglutide in Type 2 Diabetes","Phase 3","diabetes","309"],["3874","JUPITER - Crestor 20mg Versus Placebo in Prevention of Cardiovascular (CV) Events","Phase 3","heart disease","17802"],["3879","Naltrexone/Bupropion Cardiovascular Outcomes Study","Phase 4","heart disease","67"],["3889","CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes","Phase 3","diabetes","6115"],["3892","Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome","Phase 3","diabetes","5380"],["3895","A Study to Determine the Safety and Efficacy of Albiglutide in Patients With Type 2 Diabetes","Phase 3","diabetes","779"],["3896","Safety and Efficacy Study Comparing ABT-143 to Simvastatin in Subjects With Elevated Levels of Low Density Lipoprotein Cholesterol (&quot;Bad Cholesterol&quot;) and Triglycerides","Phase 3","heart disease","474"],["3899","Study Evaluating 13 Valent Pneumococcal Conjugate Vaccine With Trivalent Inactivated Influenza Vaccine","Phase 3","influenza","1116"],["3929","Docetaxel in Treating Patients With Solid Tumors","Phase 2","tumors","109"],["3932","Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk Open-label Extension","Phase 3","heart disease","5000"],["3933","Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery","Phase 2","surgery","84"],["3937","Nivolumab and Ipilimumab With or Without Sargramostim in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery","Phase 2 / Phase 3","surgery","400"],["3940","Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis","Phase 4","arthritis","4000"],["3944","Afatinib After Chemoradiation and Surgery in Treating Patients With Stage III-IV Squamous Cell Carcinoma of the Head and Neck at High-Risk of Recurrence","Phase 2","surgery","3"],["3946","A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes","Phase 3","diabetes","460"],["3948","Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes","Phase 3","diabetes","1663"],["3956","A Study Of Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to or Are Unable to Tolerate Biologic and Non-Biologic Disease-modifying Antirheumatic Drugs (DMARDs)","Phase 3","arthritis","886"],["3972","Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors","Phase 3","tumors","1"],["3982","Efficacy in Controlling Glycaemia With Victoza&#174; (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 Diabetes","Phase 4","diabetes","1994"],["3989","High-Dose Recombinant Interferon Alfa-2B Ipilimumab or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery","Phase 3","surgery","1378"],["3992","Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults","Phase 3","influenza","1161"],["3994","Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery","Phase 2","surgery","168"],["3998","Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events","Phase 3","heart disease","17276"],["4005","Safety and Efficacy of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients","Phase 3","arthritis","397"],["4010","Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results - A Long Term Evaluation","Phase 3","diabetes","9340"],["4015","Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone Alone","Phase 3","diabetes","141"],["4017","An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants","","respiratory disease","3000"],["4019","Efficacy and Long-Term Safety of Vildagliptin as Monotherapy in Patients With Type 2 Diabetes","Phase 2 / Phase 3","diabetes","338"],["4023","Efficacy of Lapaquistat Acetate Co-Administered With Statins in Subjects With Hypercholesterolemia","Phase 3","heart disease","411"],["4024","Out-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Metformin Only","Phase 2","diabetes","361"],["4026","A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis","","dermatitis","8037"],["4043","Effect of Albiglutide When Added to Standard Blood Glucose Lowering Therapies on Major Cardiovascular Events in Subjects With Type 2 Diabetes Mellitus","Phase 4","diabetes","9400"],["4048","Non-inferiority Study to Compare the Efficacy and Safety of Mylan&apos;s Insulin Glargine With Lantus&#174; in Type 2 Diabetes Mellitus Patients (INSTRIDE 2)","Phase 3","diabetes","600"],["4054","ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab","Phase 3","heart disease","18600"],["4058","A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease","Phase 3","heart disease","2220"],["4061","A Study of Fluzone&#174; High-Dose Vaccine Compared With Fluzone&#174; Vaccine In Elderly Adults","Phase 4","elderly","31989"],["4066","A Study of Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors","Phase 4","arthritis","3080"],["4070","Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE&#8482; - Diabetes","Phase 3","diabetes","846"],["4073","Efficacy and Safety of Linagliptin (BI 1356) in Black/African Americans With Type 2 Diabetes With a MTT Sub-study","Phase 3","diabetes","234"],["4075","Does Saxagliptin Reduce the Risk of Cardiovascular Events When Used Alone or Added to Other Diabetes Medications","Phase 4","diabetes","18206"],["4078","A Study of Tamiflu (Oseltamivir) for Treatment of Influenza With a Focus on (H1N1) 2009 Flu Strain","Phase 4","influenza","102"],["4082","Multi-Year Study of Fluzone High-Dose Influenza Vaccine Compared With Fluzone&#174; Vaccine in Adults Aged 65 Years and Older","Phase 3","influenza","9172"],["4085","Collecting Tumor Samples From Patients With Gynecological Tumors","","tumors","275"],["4096","A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis","Phase 3","arthritis","619"],["4101","Exubera Large Simple Trial To Evaluate Long-Term Pulmonary And Cardiovascular Safety","Phase 4","heart disease","1976"],["4106","A Clinical Trial Comparing Torcetrapib/Atorvastatin to Ezetimibe/Simvastatin In Subjects With A Cholesterol Disorder.","Phase 3","heart disease","1784"],["4123","Non-inferiority Study to Compare the Efficacy and Safety of Mylan&apos;s Insulin Glargine With Lantus&#174; in Type 1 Diabetes Mellitus Patients (INSTRIDE 1)","Phase 3","diabetes","500"],["4125","Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects","Phase 3","heart disease","1972"],["4126","Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD) Not on Dialysis","Phase 3","kidney disease","2600"],["4132","Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events","Phase 3","heart disease","690"],["4133","Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes","Phase 3","diabetes","736"],["4134","Efficacy and Safety of Insulin Glargine/ Lixisenatide Fixed Ratio Combination Compared to Insulin Glargine Alone and Lixisenatide Alone on Top of Metformin in Patients With T2DM","Phase 3","diabetes","1170"],["4137","A Study of the Impact of Methotrexate (MTX) Discontinuation on the Efficacy of Subcutaneous Tocilizumab With Methotrexate in Participants With Moderate to Severe Active Rheumatoid Arthritis","Phase 3","arthritis","718"],["4139","Study of Safety of Foradil in Patients With Persistent Asthma","Phase 4","asthma","827"],["4144","Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 Diabetes","Phase 3","diabetes","3297"],["4148","Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors","Phase 2","tumors","75"],["4150","Efficacy and Safety of Azilsartan Medoxomil Used in Combination With Metformin in Participants With Hypertension and Diabetes","Phase 3","diabetes","105"],["4156","Long-Term Safety and Tolerability of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients","Phase 3","arthritis","233"],["4168","A Study to Evaluate the Immunogenicity of Quadrivalent Live Attenuated Influenza Vaccine (LAIV) in Children","Phase 3","influenza","2312"],["4169","PROPHESYS 3: Observational Study on Predictors of Response in Patients With Treatment-na&#239;ve Chronic Hepatitis C Initiated on Treatment With Pegasys (Peginterferon Alfa-2a) or Peginterferon-alfa-2b","","hepatitis","1656"],["4170","Safety and Efficacy of XOMA 052 in Subjects With Type 2 Diabetes Mellitus on Stable Metformin Monotherapy","Phase 2","diabetes","421"],["4172","Novel Influenza A (H1N1) Surveillance Registry","","influenza","894"],["4173","A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease","Phase 3","diabetes","2118"],["4184","Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma","","tumors","10000"],["4186","Study of Kidney Tumors in Younger Patients","","kidney disease","5000"],["4196","Trial to Evaluate the Efficacy of GSK Biologicals&apos; Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older","Phase 3","influenza","43695"],["4199","A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Thiazolidinedione or a Combination of Both.","Phase 3","diabetes","1189"],["4206","A Long-Term Placebo-Controlled X-Ray Study Investigating the Safety and Efficacy of SD-6010 in Subjects With Osteoarthritis of the Knee","Phase 2 / Phase 3","arthritis","5077"],["4216","A Comparison of SYMBICORT&#174; pMDI With Budesonide HFA pMDI in African American Subjects With Asthma.","Phase 3","asthma","742"],["4225","Vincristine Dactinomycin and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I Stage II or Stage III Wilms&apos; Tumor","Phase 3","tumors","808"],["4228","Rosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On Insulin","Phase 4","diabetes","630"],["4230","Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes Mellitus","Phase 3","diabetes","493"],["4256","DNA Variations in the Gene in Young Patients With Wilms&apos; Tumor","","tumors","471"],["4269","Lobradimil and Carboplatin in Treating Children With Brain Tumors","Phase 2","tumors",""],["4282","Surgery in Treating Children With Neuroblastoma","Phase 3","surgery","968"],["4289","Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IV Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery","Phase 2","surgery","345"],["4293","A Study Comparing ABT-494 to Placebo and to Adalimumab in Subjects With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate","Phase 3","arthritis","1500"],["4300","Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee","Phase 3","arthritis","3000"],["4304","Chronic Dosing Cross-Over Study to Assess the Efficacy and Safety of Glycopyrronium (PT001) in Adult Subjects With Intermittent Asthma or Mild to Moderate Persistent Asthma","Phase 2","asthma","249"],["4305","A Study of Apixaban in Patients With Atrial Fibrillation Not Caused by a Heart Valve Problem Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event Such as a Heart Attack or a Procedure to Open the Vessels of the Heart","Phase 4","heart disease","4600"],["4307","Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Older Patients With Type2 Diabetes Insufficiently Controlled on Their Current Antidiabetic Medications","Phase 3","diabetes","1014"],["4312","24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension","Phase 3","diabetes","154"],["4314","A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma","Phase 3","asthma","1140"],["4317","Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-na&#239;ve Subjects With Type 2 Diabetes","Phase 3","diabetes","1082"],["4326","Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events","Phase 3","heart disease","2139"],["4331","Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors","Phase 2","tumors","165"],["4337","Comparison Study of the Glycemic Effects Safety and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes Mellitus","Phase 3","diabetes","365"],["4342","Monthly And Twice Monthly Subcutaneous Dosing Of PF-04950615 (RN316) In Hypercholesterolemic Subjects On A Statin","Phase 2","heart disease","356"],["4349","A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High Risk Patients With Hypertriglyceridemia and on Statin. The Primary Objective is to Evaluate the Effect of 4 g/Day AMR101 for Preventing the Occurrence of a First Major Cardiovascular Event.","Phase 3","heart disease","8000"],["4350","Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes","Phase 3","diabetes","2454"],["4353","A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents","Phase 3","asthma","12463"],["4358","Study to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and Diabetes","Phase 4","diabetes","975"],["4361","A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate (MTX) in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One Tumor Necrosis Factor (TNF)-Inhibitor","Phase 4","arthritis","96"],["4373","A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment.","Phase 3","diabetes","507"],["4376","A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus","Phase 3","diabetes","7226"],["4379","Efficacy and Safety of BI 10773 in Combination With Insulin in Patients With Type 2 Diabetes","Phase 2","diabetes","494"],["4381","Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus","Phase 2","diabetes","426"],["4383","A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine","Phase 3","diabetes","586"],["4384","Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Pioglitazone","Phase 3","diabetes","252"],["4387","Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Glimepiride With or Without Metformin","Phase 3","diabetes","677"],["4393","Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma","","tumors","1000"],["4406","Safety and Efficacy of Ramelteon in Elderly Subjects With Chronic Insomnia","Phase 3","elderly","829"],["4408","A Double-blind Parallel Group Placebo-Controlled Outpatient Trial of PD 00200390 in Adults With Nonrestorative Sleep","Phase 2","sleep study","306"],["4413","A Study In Patients With Neuropathic Pain From Post-Herpetic Neuralgia (PHN)","Phase 2","neurological","376"],["4414","Early Versus Delayed Enteral Feeding and Omega-3 Fatty Acid/Antioxidant Supplementation for Treating People With Acute Lung Injury or Acute Respiratory Distress Syndrome (The EDEN-Omega Study)","Phase 3","respiratory disease","272"],["4419","Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma","Phase 3","neurological","665"],["4426","Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Knee","Phase 3","arthritis","1020"],["4436","A Study of the Safety of Rituxan in Patients With Rheumatoid Arthritis After an Inadequate Response to Previous Anti-TNF Therapy (SUNSTONE)","Phase 4","arthritis","1026"],["4437","Airway Limitation Study: Study In Primary Care Centers Of Chronic Bronchitis In Long-Term Cigarette Smokers Of At Least 40 Years Of Age With Symptoms Of Cough And Shortness Of Breath","","smoker study","1283"],["4439","Long-Term Effectiveness And Safety Of CP-690550 For The Treatment Of Rheumatoid Arthritis","Phase 3","arthritis","4500"],["4440","Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 Diabetes","Phase 3","diabetes","560"],["4452","Efficacy and Safety Study of Alogliptin and Insulin in the Treatment of Type 2 Diabetes.","Phase 3","diabetes","390"],["4453","The DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Patients With Type 2 Diabetes (IOOV)","Phase 4","diabetes","2091"],["4461","Extension Study of the Safety and Efficacy of Armodafinil in the Treatment of Patients With Excessive Sleepiness","Phase 3","sleep study","743"],["4462","Efficacy and Safety of Adalimumab in Patients With Active Rheumatoid Arthritis Treated Concomitantly With Methotrexate.","Phase 3","arthritis","619"],["4467","A Study of Torcetrapib/Atorvastatin vs Atorvastatin Alone or Placebo in Patients With High Cholesterol","Phase 3","heart disease","3800"],["4468","A Coronary IVUS Study to Compare Torcetrapib/Atorvastatin to Atorvastatin Alone in Subjects With Coronary Heart Disease","Phase 3","heart disease","1100"],["4469","Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children","Phase 3","respiratory disease","6635"],["4470","Trivalent Live Cold Adapted Influenza Vaccine (CAIV-T) Against Inactivated Influenza Vaccine (TIV) in Children 6&#8211;59 Months of Age","Phase 3","influenza","8500"],["4474","A Study of the Safety and Efficacy of Nitric Oxide Reduction in Patients With Cardiogenic Shock After a Heart Attack","Phase 3","heart disease","658"],["4475","Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes","Phase 3","diabetes","1440"],["4476","Study Of Asthma In Patients Of African Descent","Phase 4","asthma","479"],["4489","Effect Of Carvedilol Versus Metoprolol On Glycemic Control In Patients With Type II Diabetes And Hypertension","Phase 4","diabetes","501"],["4494","Atazanavir for HIV Infected Individuals: An Early Access Program","","hiv",""],["4495","Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a Sulfonylurea","Phase 3","diabetes","377"],["4496","Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With Metformin","Phase 3","diabetes","336"],["4498","Isotretinoin With or Without Dinutuximab Aldesleukin and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma","Phase 3","neurological","1449"],["4503","Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases","","neurological","59"],["4528","Radiation Therapy With or Without Radiosurgery in Treating Patients With Brain Metastases","Phase 3","surgery","333"],["4540","A Study to Compare ABT-494 to Placebo in Subjects With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response or Intolerance to Biologic DMARDs","Phase 3","arthritis","450"],["4544","Extension Study to Assess Safety and Efficacy of Mylan&apos;s Insulin Glargine and Lantus&#174; in Type 1 Diabetes Mellitus Patients","Phase 3","diabetes","138"],["4550","Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes","Phase 3","diabetes","1860"],["4554","A Study Looking at Targeted Therapy According to Tumor Markers for People With Meningiomas","Phase 2","tumors","56"],["4557","A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis","Phase 3","kidney disease","432"],["4562","Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest)","Phase 3","asthma","1858"],["4563","&quot;A Long-Term Safety Study of JZP-110 in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or OSA&quot;","Phase 3","sleep study","600"],["4564","&quot;Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in Narcolepsy&quot;","Phase 3","sleep study","240"],["4579","A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol","Phase 3","heart disease","366"],["4581","BGJ398 for Patients With Tumors With FGFR Genetic Alterations","Phase 2","tumors","90"],["4586","Concomitant Administration of 13-valent Pneumococcal Conjugate Vaccine (13vPnC) With Influenza Vaccine in 23-valent Pneumococcal Polysaccharide (23vPS) Pre-vaccinated Adults.","Phase 4","influenza","882"],["4589","A Study to Examine Patient Characteristics Health Care Management and Health Outcomes of Hepatitis C Virus (HCV) Patients Treated With Simeprevir","Phase 4","hepatitis","315"],["4590","A Study of the Efficacy and Safety of Etrolizumab in Ulcerative Colitis Participants Who Are Refractory to or Intolerant of Tumor Necrosis Factor (TNF) Inhibitors","Phase 3","tumors","800"],["4598","Cardiovascular Outcomes Following Ertugliflozin Treatment in Type 2 Diabetes Mellitus Participants With Vascular Disease The VERTIS CV Study (MK-8835-004)","Phase 3","diabetes","8000"],["4600","UNITY 1: A Study of an Investigational Treatment Regimen of Daclatasvir (DCV) + Asunaprevir (ASV) + BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) for 12 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Genotype 1 Infection in Non-cirrhotic Subjects","Phase 3","hepatitis","416"],["4604","A Golimumab Phase 3b Multicenter Assessment of Intravenous Efficacy in Rheumatoid Arthritis Subjects Who Have Diminished Disease Control Despite Treatment With Infliximab (REMICADE&#174;)","Phase 3","arthritis","11"],["4607","Study of Intra-articular Injections vs Placebo in Patients With Pain From Osteoarthritis of the Knee","Phase 3","arthritis","287"],["4610","TAK-875 (Fasiglifam) in Combination With Sitagliptin in Adults With Type 2 Diabetes","Phase 3","diabetes","90"],["4615","A Study on The Potential of Aleglitazar to Reduce Cardiovascular Risk in Patients With Stable Cardiovascular Disease and Glucose Abnormalities","Phase 3","heart disease","1999"],["4617","A Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Nephropathy","Phase 2","diabetes","226"],["4620","A Trial of NNC0109-0012 an Anti-IL-20 Biologic in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Anti-TNFa Biologics","Phase 2","arthritis","239"],["4623","Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza","Phase 3","influenza","1941"],["4626","A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone","Phase 3","diabetes","442"],["4627","Comparison of Fasiglifam (TAK-875) to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes","Phase 3","diabetes","916"],["4631","Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Basal Insulin With Oral Antidiabetic Therapy","Phase 3","diabetes","811"],["4633","HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network","","hepatitis","4500"],["4636","Comparison of TAK-875 (Fasiglifam) With Placebo in Participants With Type 2 Diabetes","Phase 3","diabetes","421"],["4658","Evaluation of Long-term Safety and Effectiveness of Fostamatinib in the Treatment of Rheumatoid Arthritis (RA)","Phase 3","arthritis","1917"],["4666","Safety of Buprenorphine Transdermal Patch (BTDS) in Osteoarthritis Pain: a 52-Week Extension Phase","Phase 3","arthritis","196"],["4669","A Study in Participants With Diabetic Kidney Disease","Phase 2","kidney disease","417"]]},"dateCreated":"2016-12-06T17:31:08+0000","status":"READY","errorMessage":"","progressUpdateIntervalMs":500,"$$hashKey":"object:2231"},{"title":"Category Trends over Time","text":"%sql\n\nselect rank,study,phase,category,number_enrolled,start_date from table_df_tokens where category = \"${category=diabetes,diabetes|cancer|heart disease|arthritis|tumors|influenza|sleep study}\" and length(start_date) > 4","dateUpdated":"2016-12-06T17:31:08+0000","config":{"colWidth":12,"editorMode":"ace/mode/sql","editorHide":true,"title":true,"graph":{"mode":"multiBarChart","height":300,"optionOpen":false,"keys":[{"name":"start_date","index":5,"aggr":"sum"}],"values":[{"name":"rank","index":0,"aggr":"count"}],"groups":[],"scatter":{"xAxis":{"name":"rank","index":0,"aggr":"sum"},"yAxis":{"name":"study","index":1,"aggr":"sum"}}},"enabled":true},"settings":{"params":{"category":"diabetes"},"forms":{"category":{"name":"category","defaultValue":"diabetes","options":[{"value":"diabetes","$$hashKey":"object:3092"},{"value":"cancer","$$hashKey":"object:3093"},{"value":"heart disease","$$hashKey":"object:3094"},{"value":"arthritis","$$hashKey":"object:3095"},{"value":"tumors","$$hashKey":"object:3096"},{"value":"influenza","$$hashKey":"object:3097"},{"value":"sleep study","$$hashKey":"object:3098"}],"hidden":false}}},"jobName":"paragraph_1481045468685_-708853576","id":"20161206-035146_74120100","result":{"code":"SUCCESS","type":"TABLE","msg":"rank\tstudy\tphase\tcategory\tnumber_enrolled\tstart_date\n42\tA Pilot Study of Nocturnal Hypoglycemia Prevention in Type 1 Diabetes Using the Vigilant Diabetes Management Companion\t\tdiabetes\t24\tMay 2016\n53\tEffects of Exercise Training Intensity on Fitness and Insulin Sensitivity in African Americans\t\tdiabetes\t60\tOctober 2016\n71\tCOMRADE: Collaborative Care Management for Distress and Depression in Rural Diabetes\t\tdiabetes\t139\tSeptember 2014\n109\tIntranasal Insulin and Post-stroke Cognition: A Pilot Study\t\tdiabetes\t40\tApril 2016\n274\tIncretin Action in Physiology and Diabetes\tPhase 1\tdiabetes\t25\tApril 2016\n331\tPersonalized Health Planning in Shared Medical Appointments for Individuals With Type II Diabetes Pilot Study\t\tdiabetes\t20\tDecember 2015\n340\tStudy of Nasal Insulin to Fight Forgetfulness - Short-Acting Insulin Aspart\tPhase 1\tdiabetes\t30\tMay 2015\n596\tExamining the Effects of Neuromodulation on Glucose Metabolism in Type 2 Diabetes\t\tdiabetes\t6\tJune 2014\n601\tExercise Heart Failure and Type 2 Diabetes\t\tdiabetes\t0\tFebruary 2012\n609\tModulation of Insulin Sensitivity by Betaine Upregulation of FGF21\t\tdiabetes\t23\tMarch 2014\n614\tA Family-Based Diabetes Intervention for Hispanic Adults in an Emerging Community\t\tdiabetes\t156\tNovember 2011\n669\tImproving Diabetes Outcomes for Persons With Severe Mental Illness\t\tdiabetes\t25\tDecember 2013\n692\tThree Approaches to Glucose Monitoring in Non-insulin Treated Diabetes\t\tdiabetes\t450\tJanuary 2014\n757\tJump Starting Shared Medical Appointments for Diabetes With Weight Management\t\tdiabetes\t308\tDecember 2014\n893\tLatinos Combating Diabetes\t\tdiabetes\t225\tApril 2013\n916\tParents and Children Together Preventing Diabetes (PACT PD)\t\tdiabetes\t72\tMarch 2013\n941\tLifestyle Intervention for Treatment of Diabetes\t\tdiabetes\t260\tApril 2013\n942\tEmpowering Rural African American Women and Communities to Improve Diabetes Outcomes\t\tdiabetes\t200\tJanuary 2012\n945\tMindfulness: a Novel Approach for the Management of Diabetes-related Distress\tPhase 2 / Phase 3\tdiabetes\t90\tJanuary 2012\n974\tRegulation of Branched-chain Amino Acid Metabolism in Pre-Diabetes\t\tdiabetes\t132\tJune 2012\n985\tAdvanced Comprehensive Diabetes Care for Veterans With Poorly-Controlled Diabetes\tPhase 0\tdiabetes\t50\tDecember 2013\n1058\tAlmased Multi-Center Diabetes Intervention Trial\t\tdiabetes\t240\tJanuary 2013\n1100\tStudy of Effectiveness of Liraglutide Added to High Dose Insulin in Type II Diabetics\tPhase 4\tdiabetes\t36\tDecember 2011\n1137\tCombinatorial Therapy for Peristent Type 2 Diabetes After Gastric Banding\tPhase 4\tdiabetes\t9\tJune 2012\n1197\tEating Disorders in Type 1 Diabetes: Mechanisms of Comorbidity\t\tdiabetes\t83\tDecember 2011\n1261\tMindfulness-based Personalized Health Planning for Reducing Risk of Heart Disease and Diabetes\tPhase 3\tdiabetes\t140\tMay 2011\n1372\tEffect of Calcium Polycarbophil on Type II Diabetes Mellitus Control: a Randomized Double-blind Study\t\tdiabetes\t48\tOctober 2010\n1381\tWe Can Prevent Diabetes: A Behavioral Intervention to Reduce Diabetes Risk in African Americans\tPhase 1 / Phase 2\tdiabetes\t74\tFebruary 2010\n1396\tEhealth: Second Life Impacts Diabetes Education &amp; Self-Management\t\tdiabetes\t20\tJanuary 2011\n1398\tUnderstanding of Genetic Risk Information for Type 2 Diabetes\t\tdiabetes\t300\tJuly 2010\n1494\tGenetic Testing for Type 2 Diabetes\t\tdiabetes\t601\tAugust 2010\n1585\tTailored Case Management for Diabetes and Hypertension\t\tdiabetes\t377\tMay 2008\n1595\tExercise Dose-Response Effects in Prediabetes\t\tdiabetes\t288\tJuly 2009\n1710\tImproving Neurologic Outcomes in People With Diabetes Who Are Undergoing Heart Surgery\tPhase 3\tdiabetes\t133\tDecember 2008\n1711\tEffectiveness of Metformin Compared to Insulin in Pregnant Women With Mild Preexisting or Early Gestational Diabetes\tPhase 2\tdiabetes\t31\tAugust 2008\n1718\tRapid Administration of Insulin in Sepsis\tPhase 1\tdiabetes\t20\tMarch 2009\n1739\tImpact of GBS on CVD in Type 2 Diabetes Mellitus\t\tdiabetes\t84\tNovember 2008\n1899\tInsulin Resistance in Nonalcoholic Fatty Liver Disease: A Case Control Study\t\tdiabetes\t80\tJuly 2007\n1911\tHealthy Living Partnership to Prevent Diabetes\tPhase 3\tdiabetes\t301\tAugust 2007\n1976\tU-500R Insulin In Type 2 Diabetes With Severe Insulin Resistance Via Omnipod\tPhase 4\tdiabetes\t21\tDecember 2007\n2011\tExenatide Pregnancy Registry - Type 2 Diabetes in Pregnancy\tPhase 4\tdiabetes\t7\tJanuary 2009\n2094\tImproving Care for Primary Care Patients With Diabetes and Poor Literacy and Numeracy Skills\tPhase 4\tdiabetes\t110\tDecember 2006\n2129\tLifestyle Modification for Obesity-Related Type 2 Diabetes\tPhase 4\tdiabetes\t90\tJuly 2004\n2224\tA Church Based Intervention to Improve Diabetes Care\t\tdiabetes\t201\tFebruary 2001\n2247\tMeasuring Cholesterol in the Fasting and Postmeal State in Patients With Type 2 Diabetes\t\tdiabetes\t30\tOctober 2005\n2408\tFinding Diabetes Mellitus Among Veterans\t\tdiabetes\t1276\tApril 1998\n2415\tAcute Glycemic Effects of a Very Low Fat Diet in Type 2 Diabetes\t\tdiabetes\t\tJanuary 2000\n2494\tiOmit: Reducing Intentional Insulin Misuse in Type 1 Diabetes\t\tdiabetes\t60\tMarch 2016\n2531\tOptimizing Outcomes in Women With Gestational Diabetes Mellitus and Their Infants\t\tdiabetes\t200\tMay 2012\n2573\tEffect of Type 2 Diabetes Genetic Risk Information on Health Behaviors and Outcomes\t\tdiabetes\t450\tApril 2009\n2625\tStudy To Compare Single Dose Of Three Modified Release Formulations Of PF-04937319 With Immediate Release Material-Sparing-Tablet (IR MST) Formulation Previously Studied In Adults With Type 2 Diabetes Mellitus.\tPhase 1\tdiabetes\t39\tSeptember 2014\n2642\tStudy of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120)\tPhase 2\tdiabetes\t36\tNovember 2011\n2700\tCan Group Visits Improve Outcomes of Veterans With Diabetes\tPhase 3\tdiabetes\t239\tJune 2006\n2773\tDiabetes Self-Management &amp; Support LIVE\t\tdiabetes\t300\tJuly 2014\n2854\tGlucose/Insulin Responses:Subjects With Type 2 Diabetes Consuming Diabetes-Specific vs Standard Nutritional Formulas\tPhase 3\tdiabetes\t54\tAugust 2002\n3003\tStudy of A Cell-Phone System to Improve Health of Youth With Diabetes\t\tdiabetes\t74\tMarch 2011\n3173\tSoutheastern Diabetes Initiative Clinical Intervention\t\tdiabetes\t648\tApril 2013\n3284\tEvaluating the Impact of Year Long Augmented Diabetes Self Management Support\t\tdiabetes\t449\tJanuary 2015\n3347\tSingle Dose and 34-Day Tolerance Study of INGAP Peptide in Insulin Deficient Patients\tPhase 1 / Phase 2\tdiabetes\t62\tDecember 2001\n3486\tAutologous Neo-Kidney Augment (NKA) in Patients With Type 2 Diabetes and Chronic Kidney Disease (CKD)\tPhase 2\tdiabetes\t30\tJuly 2016\n3594\tA Phase 1 Open-label Safety Study of NKA in Patients With Type 2 Diabetes\tPhase 1\tdiabetes\t1\tDecember 2013\n3672\tAn Open-Label Treatment Protocol to Provide Metreleptin for the Treatment of Diabetes Mellitus and/or Hypertriglyceridemia Associated With Lipodystrophy\t\tdiabetes\t41\tMarch 2009\n3728\tA Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors\tPhase 4\tdiabetes\t12000\tJanuary 2014\n3778\tComparison of Self Adjustment Versus Standard of Care Treatment in Subjects With Type 2 Diabetes\tPhase 4\tdiabetes\t5652\tOctober 2005\n3795\tEfficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes\tPhase 3\tdiabetes\t1049\tFebruary 2009\n3807\tA Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus\tPhase 3\tdiabetes\t19000\tFebruary 2014\n3808\tA Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Events\tPhase 3\tdiabetes\t7637\tOctober 2013\n3818\tSafety and Efficacy of Albiglutide in Type 2 Diabetes\tPhase 3\tdiabetes\t310\tJanuary 2009\n3819\tA Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes\tPhase 3\tdiabetes\t685\tFebruary 2009\n3848\tCardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)\tPhase 4\tdiabetes\t8300\tJuly 2013\n3852\tStudy of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease\tPhase 3\tdiabetes\t3207\tJune 2012\n3857\tEvaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)\tPhase 3\tdiabetes\t6068\tJune 2010\n3858\tExenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus\tPhase 3\tdiabetes\t14000\tJune 2010\n3866\tSafety and Efficacy Study of Albiglutide in Type 2 Diabetes\tPhase 3\tdiabetes\t309\tJanuary 2009\n3889\tCAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes\tPhase 3\tdiabetes\t6115\tOctober 2010\n3892\tCardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome\tPhase 3\tdiabetes\t5380\tSeptember 2009\n3895\tA Study to Determine the Safety and Efficacy of Albiglutide in Patients With Type 2 Diabetes\tPhase 3\tdiabetes\t779\tFebruary 2009\n3946\tA Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes\tPhase 3\tdiabetes\t460\tMarch 2013\n3948\tDual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes\tPhase 3\tdiabetes\t1663\tMay 2011\n3982\tEfficacy in Controlling Glycaemia With Victoza&#174; (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 Diabetes\tPhase 4\tdiabetes\t1994\tMarch 2016\n4010\tLiraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results - A Long Term Evaluation\tPhase 3\tdiabetes\t9340\tAugust 2010\n4015\tSafety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone Alone\tPhase 3\tdiabetes\t141\tMarch 2010\n4019\tEfficacy and Long-Term Safety of Vildagliptin as Monotherapy in Patients With Type 2 Diabetes\tPhase 2 / Phase 3\tdiabetes\t338\tNovember 2008\n4024\tOut-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Metformin Only\tPhase 2\tdiabetes\t361\tApril 2007\n4043\tEffect of Albiglutide When Added to Standard Blood Glucose Lowering Therapies on Major Cardiovascular Events in Subjects With Type 2 Diabetes Mellitus\tPhase 4\tdiabetes\t9400\tJuly 2015\n4048\tNon-inferiority Study to Compare the Efficacy and Safety of Mylan&apos;s Insulin Glargine With Lantus&#174; in Type 2 Diabetes Mellitus Patients (INSTRIDE 2)\tPhase 3\tdiabetes\t600\tAugust 2014\n4070\tEffect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE&#8482; - Diabetes\tPhase 3\tdiabetes\t846\tJune 2011\n4073\tEfficacy and Safety of Linagliptin (BI 1356) in Black/African Americans With Type 2 Diabetes With a MTT Sub-study\tPhase 3\tdiabetes\t234\tSeptember 2010\n4075\tDoes Saxagliptin Reduce the Risk of Cardiovascular Events When Used Alone or Added to Other Diabetes Medications\tPhase 4\tdiabetes\t18206\tMay 2010\n4123\tNon-inferiority Study to Compare the Efficacy and Safety of Mylan&apos;s Insulin Glargine With Lantus&#174; in Type 1 Diabetes Mellitus Patients (INSTRIDE 1)\tPhase 3\tdiabetes\t500\tAugust 2014\n4133\tEfficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes\tPhase 3\tdiabetes\t736\tJanuary 2014\n4134\tEfficacy and Safety of Insulin Glargine/ Lixisenatide Fixed Ratio Combination Compared to Insulin Glargine Alone and Lixisenatide Alone on Top of Metformin in Patients With T2DM\tPhase 3\tdiabetes\t1170\tFebruary 2014\n4144\tTrial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 Diabetes\tPhase 3\tdiabetes\t3297\tFebruary 2013\n4150\tEfficacy and Safety of Azilsartan Medoxomil Used in Combination With Metformin in Participants With Hypertension and Diabetes\tPhase 3\tdiabetes\t105\tJanuary 2012\n4170\tSafety and Efficacy of XOMA 052 in Subjects With Type 2 Diabetes Mellitus on Stable Metformin Monotherapy\tPhase 2\tdiabetes\t421\tJanuary 2010\n4173\tA Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease\tPhase 3\tdiabetes\t2118\tJanuary 2010\n4199\tA Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Thiazolidinedione or a Combination of Both.\tPhase 3\tdiabetes\t1189\tJuly 2008\n4228\tRosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On Insulin\tPhase 4\tdiabetes\t630\tSeptember 2002\n4230\tStudy of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes Mellitus\tPhase 3\tdiabetes\t493\tFebruary 2006\n4307\tComparison of the Safety and Efficacy of HOE901-U300 With Lantus in Older Patients With Type2 Diabetes Insufficiently Controlled on Their Current Antidiabetic Medications\tPhase 3\tdiabetes\t1014\tJanuary 2015\n4312\t24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension\tPhase 3\tdiabetes\t154\tJuly 2014\n4317\tEfficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-na&#239;ve Subjects With Type 2 Diabetes\tPhase 3\tdiabetes\t1082\tAugust 2014\n4337\tComparison Study of the Glycemic Effects Safety and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes Mellitus\tPhase 3\tdiabetes\t365\tFebruary 2013\n4350\tEfficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes\tPhase 3\tdiabetes\t2454\tJanuary 2012\n4358\tStudy to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and Diabetes\tPhase 4\tdiabetes\t975\tMay 2011\n4373\tA Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment.\tPhase 3\tdiabetes\t507\tMay 2010\n4376\tA Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus\tPhase 3\tdiabetes\t7226\tFebruary 2010\n4379\tEfficacy and Safety of BI 10773 in Combination With Insulin in Patients With Type 2 Diabetes\tPhase 2\tdiabetes\t494\tNovember 2009\n4381\tEfficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus\tPhase 2\tdiabetes\t426\tDecember 2009\n4383\tA Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine\tPhase 3\tdiabetes\t586\tSeptember 2009\n4384\tSafety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Pioglitazone\tPhase 3\tdiabetes\t252\tAugust 2009\n4387\tSafety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Glimepiride With or Without Metformin\tPhase 3\tdiabetes\t677\tJuly 2009\n4440\tEffect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 Diabetes\tPhase 3\tdiabetes\t560\tNovember 2006\n4452\tEfficacy and Safety Study of Alogliptin and Insulin in the Treatment of Type 2 Diabetes.\tPhase 3\tdiabetes\t390\tFebruary 2006\n4453\tThe DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Patients With Type 2 Diabetes (IOOV)\tPhase 4\tdiabetes\t2091\tDecember 2005\n4475\tStudy of Muraglitazar Versus Pioglitazone in Type 2 Diabetes\tPhase 3\tdiabetes\t1440\tAugust 2005\n4489\tEffect Of Carvedilol Versus Metoprolol On Glycemic Control In Patients With Type II Diabetes And Hypertension\tPhase 4\tdiabetes\t501\tJune 2001\n4495\tEvaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a Sulfonylurea\tPhase 3\tdiabetes\t377\tFebruary 2002\n4496\tEvaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With Metformin\tPhase 3\tdiabetes\t336\tMarch 2002\n4544\tExtension Study to Assess Safety and Efficacy of Mylan&apos;s Insulin Glargine and Lantus&#174; in Type 1 Diabetes Mellitus Patients\tPhase 3\tdiabetes\t138\tDecember 2015\n4550\tEfficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes\tPhase 3\tdiabetes\t1860\tFebruary 2016\n4598\tCardiovascular Outcomes Following Ertugliflozin Treatment in Type 2 Diabetes Mellitus Participants With Vascular Disease The VERTIS CV Study (MK-8835-004)\tPhase 3\tdiabetes\t8000\tNovember 2013\n4610\tTAK-875 (Fasiglifam) in Combination With Sitagliptin in Adults With Type 2 Diabetes\tPhase 3\tdiabetes\t90\tMay 2013\n4617\tA Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Nephropathy\tPhase 2\tdiabetes\t226\tDecember 2012\n4626\tA Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone\tPhase 3\tdiabetes\t442\tJune 2012\n4627\tComparison of Fasiglifam (TAK-875) to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes\tPhase 3\tdiabetes\t916\tApril 2012\n4631\tComparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Basal Insulin With Oral Antidiabetic Therapy\tPhase 3\tdiabetes\t811\tDecember 2011\n4636\tComparison of TAK-875 (Fasiglifam) With Placebo in Participants With Type 2 Diabetes\tPhase 3\tdiabetes\t421\tNovember 2011\n","comment":"","msgTable":[[{"key":"study","value":"42"},{"key":"study","value":"A Pilot Study of Nocturnal Hypoglycemia Prevention in Type 1 Diabetes Using the Vigilant Diabetes Management Companion"},{"key":"study","value":""},{"key":"study","value":"diabetes"},{"key":"study","value":"24"},{"key":"study","value":"May 2016"}],[{"key":"phase","value":"53"},{"key":"phase","value":"Effects of Exercise Training Intensity on Fitness and Insulin Sensitivity in African Americans"},{"key":"phase","value":""},{"key":"phase","value":"diabetes"},{"key":"phase","value":"60"},{"key":"phase","value":"October 2016"}],[{"key":"category","value":"71"},{"key":"category","value":"COMRADE: Collaborative Care Management for Distress and Depression in Rural Diabetes"},{"key":"category","value":""},{"key":"category","value":"diabetes"},{"key":"category","value":"139"},{"key":"category","value":"September 2014"}],[{"key":"number_enrolled","value":"109"},{"key":"number_enrolled","value":"Intranasal Insulin and Post-stroke Cognition: A Pilot Study"},{"key":"number_enrolled","value":""},{"key":"number_enrolled","value":"diabetes"},{"key":"number_enrolled","value":"40"},{"key":"number_enrolled","value":"April 2016"}],[{"key":"start_date","value":"274"},{"key":"start_date","value":"Incretin Action in Physiology and Diabetes"},{"key":"start_date","value":"Phase 1"},{"key":"start_date","value":"diabetes"},{"key":"start_date","value":"25"},{"key":"start_date","value":"April 2016"}],[{"value":"331"},{"value":"Personalized Health Planning in Shared Medical Appointments for Individuals With Type II Diabetes Pilot Study"},{"value":""},{"value":"diabetes"},{"value":"20"},{"value":"December 2015"}],[{"value":"340"},{"value":"Study of Nasal Insulin to Fight Forgetfulness - Short-Acting Insulin Aspart"},{"value":"Phase 1"},{"value":"diabetes"},{"value":"30"},{"value":"May 2015"}],[{"value":"596"},{"value":"Examining the Effects of Neuromodulation on Glucose Metabolism in Type 2 Diabetes"},{"value":""},{"value":"diabetes"},{"value":"6"},{"value":"June 2014"}],[{"value":"601"},{"value":"Exercise Heart Failure and Type 2 Diabetes"},{"value":""},{"value":"diabetes"},{"value":"0"},{"value":"February 2012"}],[{"value":"609"},{"value":"Modulation of Insulin Sensitivity by Betaine Upregulation of FGF21"},{"value":""},{"value":"diabetes"},{"value":"23"},{"value":"March 2014"}],[{"value":"614"},{"value":"A Family-Based Diabetes Intervention for Hispanic Adults in an Emerging Community"},{"value":""},{"value":"diabetes"},{"value":"156"},{"value":"November 2011"}],[{"value":"669"},{"value":"Improving Diabetes Outcomes for Persons With Severe Mental Illness"},{"value":""},{"value":"diabetes"},{"value":"25"},{"value":"December 2013"}],[{"value":"692"},{"value":"Three Approaches to Glucose Monitoring in Non-insulin Treated Diabetes"},{"value":""},{"value":"diabetes"},{"value":"450"},{"value":"January 2014"}],[{"value":"757"},{"value":"Jump Starting Shared Medical Appointments for Diabetes With Weight Management"},{"value":""},{"value":"diabetes"},{"value":"308"},{"value":"December 2014"}],[{"value":"893"},{"value":"Latinos Combating Diabetes"},{"value":""},{"value":"diabetes"},{"value":"225"},{"value":"April 2013"}],[{"value":"916"},{"value":"Parents and Children Together Preventing Diabetes (PACT PD)"},{"value":""},{"value":"diabetes"},{"value":"72"},{"value":"March 2013"}],[{"value":"941"},{"value":"Lifestyle Intervention for Treatment of Diabetes"},{"value":""},{"value":"diabetes"},{"value":"260"},{"value":"April 2013"}],[{"value":"942"},{"value":"Empowering Rural African American Women and Communities to Improve Diabetes Outcomes"},{"value":""},{"value":"diabetes"},{"value":"200"},{"value":"January 2012"}],[{"value":"945"},{"value":"Mindfulness: a Novel Approach for the Management of Diabetes-related Distress"},{"value":"Phase 2 / Phase 3"},{"value":"diabetes"},{"value":"90"},{"value":"January 2012"}],[{"value":"974"},{"value":"Regulation of Branched-chain Amino Acid Metabolism in Pre-Diabetes"},{"value":""},{"value":"diabetes"},{"value":"132"},{"value":"June 2012"}],[{"value":"985"},{"value":"Advanced Comprehensive Diabetes Care for Veterans With Poorly-Controlled Diabetes"},{"value":"Phase 0"},{"value":"diabetes"},{"value":"50"},{"value":"December 2013"}],[{"value":"1058"},{"value":"Almased Multi-Center Diabetes Intervention Trial"},{"value":""},{"value":"diabetes"},{"value":"240"},{"value":"January 2013"}],[{"value":"1100"},{"value":"Study of Effectiveness of Liraglutide Added to High Dose Insulin in Type II Diabetics"},{"value":"Phase 4"},{"value":"diabetes"},{"value":"36"},{"value":"December 2011"}],[{"value":"1137"},{"value":"Combinatorial Therapy for Peristent Type 2 Diabetes After Gastric Banding"},{"value":"Phase 4"},{"value":"diabetes"},{"value":"9"},{"value":"June 2012"}],[{"value":"1197"},{"value":"Eating Disorders in Type 1 Diabetes: Mechanisms of Comorbidity"},{"value":""},{"value":"diabetes"},{"value":"83"},{"value":"December 2011"}],[{"value":"1261"},{"value":"Mindfulness-based Personalized Health Planning for Reducing Risk of Heart Disease and Diabetes"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"140"},{"value":"May 2011"}],[{"value":"1372"},{"value":"Effect of Calcium Polycarbophil on Type II Diabetes Mellitus Control: a Randomized Double-blind Study"},{"value":""},{"value":"diabetes"},{"value":"48"},{"value":"October 2010"}],[{"value":"1381"},{"value":"We Can Prevent Diabetes: A Behavioral Intervention to Reduce Diabetes Risk in African Americans"},{"value":"Phase 1 / Phase 2"},{"value":"diabetes"},{"value":"74"},{"value":"February 2010"}],[{"value":"1396"},{"value":"Ehealth: Second Life Impacts Diabetes Education &amp; Self-Management"},{"value":""},{"value":"diabetes"},{"value":"20"},{"value":"January 2011"}],[{"value":"1398"},{"value":"Understanding of Genetic Risk Information for Type 2 Diabetes"},{"value":""},{"value":"diabetes"},{"value":"300"},{"value":"July 2010"}],[{"value":"1494"},{"value":"Genetic Testing for Type 2 Diabetes"},{"value":""},{"value":"diabetes"},{"value":"601"},{"value":"August 2010"}],[{"value":"1585"},{"value":"Tailored Case Management for Diabetes and Hypertension"},{"value":""},{"value":"diabetes"},{"value":"377"},{"value":"May 2008"}],[{"value":"1595"},{"value":"Exercise Dose-Response Effects in Prediabetes"},{"value":""},{"value":"diabetes"},{"value":"288"},{"value":"July 2009"}],[{"value":"1710"},{"value":"Improving Neurologic Outcomes in People With Diabetes Who Are Undergoing Heart Surgery"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"133"},{"value":"December 2008"}],[{"value":"1711"},{"value":"Effectiveness of Metformin Compared to Insulin in Pregnant Women With Mild Preexisting or Early Gestational Diabetes"},{"value":"Phase 2"},{"value":"diabetes"},{"value":"31"},{"value":"August 2008"}],[{"value":"1718"},{"value":"Rapid Administration of Insulin in Sepsis"},{"value":"Phase 1"},{"value":"diabetes"},{"value":"20"},{"value":"March 2009"}],[{"value":"1739"},{"value":"Impact of GBS on CVD in Type 2 Diabetes Mellitus"},{"value":""},{"value":"diabetes"},{"value":"84"},{"value":"November 2008"}],[{"value":"1899"},{"value":"Insulin Resistance in Nonalcoholic Fatty Liver Disease: A Case Control Study"},{"value":""},{"value":"diabetes"},{"value":"80"},{"value":"July 2007"}],[{"value":"1911"},{"value":"Healthy Living Partnership to Prevent Diabetes"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"301"},{"value":"August 2007"}],[{"value":"1976"},{"value":"U-500R Insulin In Type 2 Diabetes With Severe Insulin Resistance Via Omnipod"},{"value":"Phase 4"},{"value":"diabetes"},{"value":"21"},{"value":"December 2007"}],[{"value":"2011"},{"value":"Exenatide Pregnancy Registry - Type 2 Diabetes in Pregnancy"},{"value":"Phase 4"},{"value":"diabetes"},{"value":"7"},{"value":"January 2009"}],[{"value":"2094"},{"value":"Improving Care for Primary Care Patients With Diabetes and Poor Literacy and Numeracy Skills"},{"value":"Phase 4"},{"value":"diabetes"},{"value":"110"},{"value":"December 2006"}],[{"value":"2129"},{"value":"Lifestyle Modification for Obesity-Related Type 2 Diabetes"},{"value":"Phase 4"},{"value":"diabetes"},{"value":"90"},{"value":"July 2004"}],[{"value":"2224"},{"value":"A Church Based Intervention to Improve Diabetes Care"},{"value":""},{"value":"diabetes"},{"value":"201"},{"value":"February 2001"}],[{"value":"2247"},{"value":"Measuring Cholesterol in the Fasting and Postmeal State in Patients With Type 2 Diabetes"},{"value":""},{"value":"diabetes"},{"value":"30"},{"value":"October 2005"}],[{"value":"2408"},{"value":"Finding Diabetes Mellitus Among Veterans"},{"value":""},{"value":"diabetes"},{"value":"1276"},{"value":"April 1998"}],[{"value":"2415"},{"value":"Acute Glycemic Effects of a Very Low Fat Diet in Type 2 Diabetes"},{"value":""},{"value":"diabetes"},{"value":""},{"value":"January 2000"}],[{"value":"2494"},{"value":"iOmit: Reducing Intentional Insulin Misuse in Type 1 Diabetes"},{"value":""},{"value":"diabetes"},{"value":"60"},{"value":"March 2016"}],[{"value":"2531"},{"value":"Optimizing Outcomes in Women With Gestational Diabetes Mellitus and Their Infants"},{"value":""},{"value":"diabetes"},{"value":"200"},{"value":"May 2012"}],[{"value":"2573"},{"value":"Effect of Type 2 Diabetes Genetic Risk Information on Health Behaviors and Outcomes"},{"value":""},{"value":"diabetes"},{"value":"450"},{"value":"April 2009"}],[{"value":"2625"},{"value":"Study To Compare Single Dose Of Three Modified Release Formulations Of PF-04937319 With Immediate Release Material-Sparing-Tablet (IR MST) Formulation Previously Studied In Adults With Type 2 Diabetes Mellitus."},{"value":"Phase 1"},{"value":"diabetes"},{"value":"39"},{"value":"September 2014"}],[{"value":"2642"},{"value":"Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120)"},{"value":"Phase 2"},{"value":"diabetes"},{"value":"36"},{"value":"November 2011"}],[{"value":"2700"},{"value":"Can Group Visits Improve Outcomes of Veterans With Diabetes"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"239"},{"value":"June 2006"}],[{"value":"2773"},{"value":"Diabetes Self-Management &amp; Support LIVE"},{"value":""},{"value":"diabetes"},{"value":"300"},{"value":"July 2014"}],[{"value":"2854"},{"value":"Glucose/Insulin Responses:Subjects With Type 2 Diabetes Consuming Diabetes-Specific vs Standard Nutritional Formulas"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"54"},{"value":"August 2002"}],[{"value":"3003"},{"value":"Study of A Cell-Phone System to Improve Health of Youth With Diabetes"},{"value":""},{"value":"diabetes"},{"value":"74"},{"value":"March 2011"}],[{"value":"3173"},{"value":"Southeastern Diabetes Initiative Clinical Intervention"},{"value":""},{"value":"diabetes"},{"value":"648"},{"value":"April 2013"}],[{"value":"3284"},{"value":"Evaluating the Impact of Year Long Augmented Diabetes Self Management Support"},{"value":""},{"value":"diabetes"},{"value":"449"},{"value":"January 2015"}],[{"value":"3347"},{"value":"Single Dose and 34-Day Tolerance Study of INGAP Peptide in Insulin Deficient Patients"},{"value":"Phase 1 / Phase 2"},{"value":"diabetes"},{"value":"62"},{"value":"December 2001"}],[{"value":"3486"},{"value":"Autologous Neo-Kidney Augment (NKA) in Patients With Type 2 Diabetes and Chronic Kidney Disease (CKD)"},{"value":"Phase 2"},{"value":"diabetes"},{"value":"30"},{"value":"July 2016"}],[{"value":"3594"},{"value":"A Phase 1 Open-label Safety Study of NKA in Patients With Type 2 Diabetes"},{"value":"Phase 1"},{"value":"diabetes"},{"value":"1"},{"value":"December 2013"}],[{"value":"3672"},{"value":"An Open-Label Treatment Protocol to Provide Metreleptin for the Treatment of Diabetes Mellitus and/or Hypertriglyceridemia Associated With Lipodystrophy"},{"value":""},{"value":"diabetes"},{"value":"41"},{"value":"March 2009"}],[{"value":"3728"},{"value":"A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors"},{"value":"Phase 4"},{"value":"diabetes"},{"value":"12000"},{"value":"January 2014"}],[{"value":"3778"},{"value":"Comparison of Self Adjustment Versus Standard of Care Treatment in Subjects With Type 2 Diabetes"},{"value":"Phase 4"},{"value":"diabetes"},{"value":"5652"},{"value":"October 2005"}],[{"value":"3795"},{"value":"Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"1049"},{"value":"February 2009"}],[{"value":"3807"},{"value":"A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"19000"},{"value":"February 2014"}],[{"value":"3808"},{"value":"A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Events"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"7637"},{"value":"October 2013"}],[{"value":"3818"},{"value":"Safety and Efficacy of Albiglutide in Type 2 Diabetes"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"310"},{"value":"January 2009"}],[{"value":"3819"},{"value":"A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"685"},{"value":"February 2009"}],[{"value":"3848"},{"value":"Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)"},{"value":"Phase 4"},{"value":"diabetes"},{"value":"8300"},{"value":"July 2013"}],[{"value":"3852"},{"value":"Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"3207"},{"value":"June 2012"}],[{"value":"3857"},{"value":"Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"6068"},{"value":"June 2010"}],[{"value":"3858"},{"value":"Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"14000"},{"value":"June 2010"}],[{"value":"3866"},{"value":"Safety and Efficacy Study of Albiglutide in Type 2 Diabetes"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"309"},{"value":"January 2009"}],[{"value":"3889"},{"value":"CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"6115"},{"value":"October 2010"}],[{"value":"3892"},{"value":"Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"5380"},{"value":"September 2009"}],[{"value":"3895"},{"value":"A Study to Determine the Safety and Efficacy of Albiglutide in Patients With Type 2 Diabetes"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"779"},{"value":"February 2009"}],[{"value":"3946"},{"value":"A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"460"},{"value":"March 2013"}],[{"value":"3948"},{"value":"Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"1663"},{"value":"May 2011"}],[{"value":"3982"},{"value":"Efficacy in Controlling Glycaemia With Victoza&#174; (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 Diabetes"},{"value":"Phase 4"},{"value":"diabetes"},{"value":"1994"},{"value":"March 2016"}],[{"value":"4010"},{"value":"Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results - A Long Term Evaluation"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"9340"},{"value":"August 2010"}],[{"value":"4015"},{"value":"Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone Alone"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"141"},{"value":"March 2010"}],[{"value":"4019"},{"value":"Efficacy and Long-Term Safety of Vildagliptin as Monotherapy in Patients With Type 2 Diabetes"},{"value":"Phase 2 / Phase 3"},{"value":"diabetes"},{"value":"338"},{"value":"November 2008"}],[{"value":"4024"},{"value":"Out-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Metformin Only"},{"value":"Phase 2"},{"value":"diabetes"},{"value":"361"},{"value":"April 2007"}],[{"value":"4043"},{"value":"Effect of Albiglutide When Added to Standard Blood Glucose Lowering Therapies on Major Cardiovascular Events in Subjects With Type 2 Diabetes Mellitus"},{"value":"Phase 4"},{"value":"diabetes"},{"value":"9400"},{"value":"July 2015"}],[{"value":"4048"},{"value":"Non-inferiority Study to Compare the Efficacy and Safety of Mylan&apos;s Insulin Glargine With Lantus&#174; in Type 2 Diabetes Mellitus Patients (INSTRIDE 2)"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"600"},{"value":"August 2014"}],[{"value":"4070"},{"value":"Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE&#8482; - Diabetes"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"846"},{"value":"June 2011"}],[{"value":"4073"},{"value":"Efficacy and Safety of Linagliptin (BI 1356) in Black/African Americans With Type 2 Diabetes With a MTT Sub-study"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"234"},{"value":"September 2010"}],[{"value":"4075"},{"value":"Does Saxagliptin Reduce the Risk of Cardiovascular Events When Used Alone or Added to Other Diabetes Medications"},{"value":"Phase 4"},{"value":"diabetes"},{"value":"18206"},{"value":"May 2010"}],[{"value":"4123"},{"value":"Non-inferiority Study to Compare the Efficacy and Safety of Mylan&apos;s Insulin Glargine With Lantus&#174; in Type 1 Diabetes Mellitus Patients (INSTRIDE 1)"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"500"},{"value":"August 2014"}],[{"value":"4133"},{"value":"Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"736"},{"value":"January 2014"}],[{"value":"4134"},{"value":"Efficacy and Safety of Insulin Glargine/ Lixisenatide Fixed Ratio Combination Compared to Insulin Glargine Alone and Lixisenatide Alone on Top of Metformin in Patients With T2DM"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"1170"},{"value":"February 2014"}],[{"value":"4144"},{"value":"Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 Diabetes"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"3297"},{"value":"February 2013"}],[{"value":"4150"},{"value":"Efficacy and Safety of Azilsartan Medoxomil Used in Combination With Metformin in Participants With Hypertension and Diabetes"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"105"},{"value":"January 2012"}],[{"value":"4170"},{"value":"Safety and Efficacy of XOMA 052 in Subjects With Type 2 Diabetes Mellitus on Stable Metformin Monotherapy"},{"value":"Phase 2"},{"value":"diabetes"},{"value":"421"},{"value":"January 2010"}],[{"value":"4173"},{"value":"A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"2118"},{"value":"January 2010"}],[{"value":"4199"},{"value":"A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Thiazolidinedione or a Combination of Both."},{"value":"Phase 3"},{"value":"diabetes"},{"value":"1189"},{"value":"July 2008"}],[{"value":"4228"},{"value":"Rosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On Insulin"},{"value":"Phase 4"},{"value":"diabetes"},{"value":"630"},{"value":"September 2002"}],[{"value":"4230"},{"value":"Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes Mellitus"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"493"},{"value":"February 2006"}],[{"value":"4307"},{"value":"Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Older Patients With Type2 Diabetes Insufficiently Controlled on Their Current Antidiabetic Medications"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"1014"},{"value":"January 2015"}],[{"value":"4312"},{"value":"24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"154"},{"value":"July 2014"}],[{"value":"4317"},{"value":"Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-na&#239;ve Subjects With Type 2 Diabetes"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"1082"},{"value":"August 2014"}],[{"value":"4337"},{"value":"Comparison Study of the Glycemic Effects Safety and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes Mellitus"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"365"},{"value":"February 2013"}],[{"value":"4350"},{"value":"Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"2454"},{"value":"January 2012"}],[{"value":"4358"},{"value":"Study to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and Diabetes"},{"value":"Phase 4"},{"value":"diabetes"},{"value":"975"},{"value":"May 2011"}],[{"value":"4373"},{"value":"A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment."},{"value":"Phase 3"},{"value":"diabetes"},{"value":"507"},{"value":"May 2010"}],[{"value":"4376"},{"value":"A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"7226"},{"value":"February 2010"}],[{"value":"4379"},{"value":"Efficacy and Safety of BI 10773 in Combination With Insulin in Patients With Type 2 Diabetes"},{"value":"Phase 2"},{"value":"diabetes"},{"value":"494"},{"value":"November 2009"}],[{"value":"4381"},{"value":"Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus"},{"value":"Phase 2"},{"value":"diabetes"},{"value":"426"},{"value":"December 2009"}],[{"value":"4383"},{"value":"A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"586"},{"value":"September 2009"}],[{"value":"4384"},{"value":"Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Pioglitazone"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"252"},{"value":"August 2009"}],[{"value":"4387"},{"value":"Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Glimepiride With or Without Metformin"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"677"},{"value":"July 2009"}],[{"value":"4440"},{"value":"Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 Diabetes"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"560"},{"value":"November 2006"}],[{"value":"4452"},{"value":"Efficacy and Safety Study of Alogliptin and Insulin in the Treatment of Type 2 Diabetes."},{"value":"Phase 3"},{"value":"diabetes"},{"value":"390"},{"value":"February 2006"}],[{"value":"4453"},{"value":"The DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Patients With Type 2 Diabetes (IOOV)"},{"value":"Phase 4"},{"value":"diabetes"},{"value":"2091"},{"value":"December 2005"}],[{"value":"4475"},{"value":"Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"1440"},{"value":"August 2005"}],[{"value":"4489"},{"value":"Effect Of Carvedilol Versus Metoprolol On Glycemic Control In Patients With Type II Diabetes And Hypertension"},{"value":"Phase 4"},{"value":"diabetes"},{"value":"501"},{"value":"June 2001"}],[{"value":"4495"},{"value":"Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a Sulfonylurea"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"377"},{"value":"February 2002"}],[{"value":"4496"},{"value":"Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With Metformin"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"336"},{"value":"March 2002"}],[{"value":"4544"},{"value":"Extension Study to Assess Safety and Efficacy of Mylan&apos;s Insulin Glargine and Lantus&#174; in Type 1 Diabetes Mellitus Patients"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"138"},{"value":"December 2015"}],[{"value":"4550"},{"value":"Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"1860"},{"value":"February 2016"}],[{"value":"4598"},{"value":"Cardiovascular Outcomes Following Ertugliflozin Treatment in Type 2 Diabetes Mellitus Participants With Vascular Disease The VERTIS CV Study (MK-8835-004)"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"8000"},{"value":"November 2013"}],[{"value":"4610"},{"value":"TAK-875 (Fasiglifam) in Combination With Sitagliptin in Adults With Type 2 Diabetes"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"90"},{"value":"May 2013"}],[{"value":"4617"},{"value":"A Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Nephropathy"},{"value":"Phase 2"},{"value":"diabetes"},{"value":"226"},{"value":"December 2012"}],[{"value":"4626"},{"value":"A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"442"},{"value":"June 2012"}],[{"value":"4627"},{"value":"Comparison of Fasiglifam (TAK-875) to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"916"},{"value":"April 2012"}],[{"value":"4631"},{"value":"Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Basal Insulin With Oral Antidiabetic Therapy"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"811"},{"value":"December 2011"}],[{"value":"4636"},{"value":"Comparison of TAK-875 (Fasiglifam) With Placebo in Participants With Type 2 Diabetes"},{"value":"Phase 3"},{"value":"diabetes"},{"value":"421"},{"value":"November 2011"}]],"columnNames":[{"name":"rank","index":0,"aggr":"sum"},{"name":"study","index":1,"aggr":"sum"},{"name":"phase","index":2,"aggr":"sum"},{"name":"category","index":3,"aggr":"sum"},{"name":"number_enrolled","index":4,"aggr":"sum"},{"name":"start_date","index":5,"aggr":"sum"}],"rows":[["42","A Pilot Study of Nocturnal Hypoglycemia Prevention in Type 1 Diabetes Using the Vigilant Diabetes Management Companion","","diabetes","24","May 2016"],["53","Effects of Exercise Training Intensity on Fitness and Insulin Sensitivity in African Americans","","diabetes","60","October 2016"],["71","COMRADE: Collaborative Care Management for Distress and Depression in Rural Diabetes","","diabetes","139","September 2014"],["109","Intranasal Insulin and Post-stroke Cognition: A Pilot Study","","diabetes","40","April 2016"],["274","Incretin Action in Physiology and Diabetes","Phase 1","diabetes","25","April 2016"],["331","Personalized Health Planning in Shared Medical Appointments for Individuals With Type II Diabetes Pilot Study","","diabetes","20","December 2015"],["340","Study of Nasal Insulin to Fight Forgetfulness - Short-Acting Insulin Aspart","Phase 1","diabetes","30","May 2015"],["596","Examining the Effects of Neuromodulation on Glucose Metabolism in Type 2 Diabetes","","diabetes","6","June 2014"],["601","Exercise Heart Failure and Type 2 Diabetes","","diabetes","0","February 2012"],["609","Modulation of Insulin Sensitivity by Betaine Upregulation of FGF21","","diabetes","23","March 2014"],["614","A Family-Based Diabetes Intervention for Hispanic Adults in an Emerging Community","","diabetes","156","November 2011"],["669","Improving Diabetes Outcomes for Persons With Severe Mental Illness","","diabetes","25","December 2013"],["692","Three Approaches to Glucose Monitoring in Non-insulin Treated Diabetes","","diabetes","450","January 2014"],["757","Jump Starting Shared Medical Appointments for Diabetes With Weight Management","","diabetes","308","December 2014"],["893","Latinos Combating Diabetes","","diabetes","225","April 2013"],["916","Parents and Children Together Preventing Diabetes (PACT PD)","","diabetes","72","March 2013"],["941","Lifestyle Intervention for Treatment of Diabetes","","diabetes","260","April 2013"],["942","Empowering Rural African American Women and Communities to Improve Diabetes Outcomes","","diabetes","200","January 2012"],["945","Mindfulness: a Novel Approach for the Management of Diabetes-related Distress","Phase 2 / Phase 3","diabetes","90","January 2012"],["974","Regulation of Branched-chain Amino Acid Metabolism in Pre-Diabetes","","diabetes","132","June 2012"],["985","Advanced Comprehensive Diabetes Care for Veterans With Poorly-Controlled Diabetes","Phase 0","diabetes","50","December 2013"],["1058","Almased Multi-Center Diabetes Intervention Trial","","diabetes","240","January 2013"],["1100","Study of Effectiveness of Liraglutide Added to High Dose Insulin in Type II Diabetics","Phase 4","diabetes","36","December 2011"],["1137","Combinatorial Therapy for Peristent Type 2 Diabetes After Gastric Banding","Phase 4","diabetes","9","June 2012"],["1197","Eating Disorders in Type 1 Diabetes: Mechanisms of Comorbidity","","diabetes","83","December 2011"],["1261","Mindfulness-based Personalized Health Planning for Reducing Risk of Heart Disease and Diabetes","Phase 3","diabetes","140","May 2011"],["1372","Effect of Calcium Polycarbophil on Type II Diabetes Mellitus Control: a Randomized Double-blind Study","","diabetes","48","October 2010"],["1381","We Can Prevent Diabetes: A Behavioral Intervention to Reduce Diabetes Risk in African Americans","Phase 1 / Phase 2","diabetes","74","February 2010"],["1396","Ehealth: Second Life Impacts Diabetes Education &amp; Self-Management","","diabetes","20","January 2011"],["1398","Understanding of Genetic Risk Information for Type 2 Diabetes","","diabetes","300","July 2010"],["1494","Genetic Testing for Type 2 Diabetes","","diabetes","601","August 2010"],["1585","Tailored Case Management for Diabetes and Hypertension","","diabetes","377","May 2008"],["1595","Exercise Dose-Response Effects in Prediabetes","","diabetes","288","July 2009"],["1710","Improving Neurologic Outcomes in People With Diabetes Who Are Undergoing Heart Surgery","Phase 3","diabetes","133","December 2008"],["1711","Effectiveness of Metformin Compared to Insulin in Pregnant Women With Mild Preexisting or Early Gestational Diabetes","Phase 2","diabetes","31","August 2008"],["1718","Rapid Administration of Insulin in Sepsis","Phase 1","diabetes","20","March 2009"],["1739","Impact of GBS on CVD in Type 2 Diabetes Mellitus","","diabetes","84","November 2008"],["1899","Insulin Resistance in Nonalcoholic Fatty Liver Disease: A Case Control Study","","diabetes","80","July 2007"],["1911","Healthy Living Partnership to Prevent Diabetes","Phase 3","diabetes","301","August 2007"],["1976","U-500R Insulin In Type 2 Diabetes With Severe Insulin Resistance Via Omnipod","Phase 4","diabetes","21","December 2007"],["2011","Exenatide Pregnancy Registry - Type 2 Diabetes in Pregnancy","Phase 4","diabetes","7","January 2009"],["2094","Improving Care for Primary Care Patients With Diabetes and Poor Literacy and Numeracy Skills","Phase 4","diabetes","110","December 2006"],["2129","Lifestyle Modification for Obesity-Related Type 2 Diabetes","Phase 4","diabetes","90","July 2004"],["2224","A Church Based Intervention to Improve Diabetes Care","","diabetes","201","February 2001"],["2247","Measuring Cholesterol in the Fasting and Postmeal State in Patients With Type 2 Diabetes","","diabetes","30","October 2005"],["2408","Finding Diabetes Mellitus Among Veterans","","diabetes","1276","April 1998"],["2415","Acute Glycemic Effects of a Very Low Fat Diet in Type 2 Diabetes","","diabetes","","January 2000"],["2494","iOmit: Reducing Intentional Insulin Misuse in Type 1 Diabetes","","diabetes","60","March 2016"],["2531","Optimizing Outcomes in Women With Gestational Diabetes Mellitus and Their Infants","","diabetes","200","May 2012"],["2573","Effect of Type 2 Diabetes Genetic Risk Information on Health Behaviors and Outcomes","","diabetes","450","April 2009"],["2625","Study To Compare Single Dose Of Three Modified Release Formulations Of PF-04937319 With Immediate Release Material-Sparing-Tablet (IR MST) Formulation Previously Studied In Adults With Type 2 Diabetes Mellitus.","Phase 1","diabetes","39","September 2014"],["2642","Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120)","Phase 2","diabetes","36","November 2011"],["2700","Can Group Visits Improve Outcomes of Veterans With Diabetes","Phase 3","diabetes","239","June 2006"],["2773","Diabetes Self-Management &amp; Support LIVE","","diabetes","300","July 2014"],["2854","Glucose/Insulin Responses:Subjects With Type 2 Diabetes Consuming Diabetes-Specific vs Standard Nutritional Formulas","Phase 3","diabetes","54","August 2002"],["3003","Study of A Cell-Phone System to Improve Health of Youth With Diabetes","","diabetes","74","March 2011"],["3173","Southeastern Diabetes Initiative Clinical Intervention","","diabetes","648","April 2013"],["3284","Evaluating the Impact of Year Long Augmented Diabetes Self Management Support","","diabetes","449","January 2015"],["3347","Single Dose and 34-Day Tolerance Study of INGAP Peptide in Insulin Deficient Patients","Phase 1 / Phase 2","diabetes","62","December 2001"],["3486","Autologous Neo-Kidney Augment (NKA) in Patients With Type 2 Diabetes and Chronic Kidney Disease (CKD)","Phase 2","diabetes","30","July 2016"],["3594","A Phase 1 Open-label Safety Study of NKA in Patients With Type 2 Diabetes","Phase 1","diabetes","1","December 2013"],["3672","An Open-Label Treatment Protocol to Provide Metreleptin for the Treatment of Diabetes Mellitus and/or Hypertriglyceridemia Associated With Lipodystrophy","","diabetes","41","March 2009"],["3728","A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors","Phase 4","diabetes","12000","January 2014"],["3778","Comparison of Self Adjustment Versus Standard of Care Treatment in Subjects With Type 2 Diabetes","Phase 4","diabetes","5652","October 2005"],["3795","Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes","Phase 3","diabetes","1049","February 2009"],["3807","A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus","Phase 3","diabetes","19000","February 2014"],["3808","A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Events","Phase 3","diabetes","7637","October 2013"],["3818","Safety and Efficacy of Albiglutide in Type 2 Diabetes","Phase 3","diabetes","310","January 2009"],["3819","A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes","Phase 3","diabetes","685","February 2009"],["3848","Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)","Phase 4","diabetes","8300","July 2013"],["3852","Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease","Phase 3","diabetes","3207","June 2012"],["3857","Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)","Phase 3","diabetes","6068","June 2010"],["3858","Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus","Phase 3","diabetes","14000","June 2010"],["3866","Safety and Efficacy Study of Albiglutide in Type 2 Diabetes","Phase 3","diabetes","309","January 2009"],["3889","CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes","Phase 3","diabetes","6115","October 2010"],["3892","Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome","Phase 3","diabetes","5380","September 2009"],["3895","A Study to Determine the Safety and Efficacy of Albiglutide in Patients With Type 2 Diabetes","Phase 3","diabetes","779","February 2009"],["3946","A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes","Phase 3","diabetes","460","March 2013"],["3948","Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes","Phase 3","diabetes","1663","May 2011"],["3982","Efficacy in Controlling Glycaemia With Victoza&#174; (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 Diabetes","Phase 4","diabetes","1994","March 2016"],["4010","Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results - A Long Term Evaluation","Phase 3","diabetes","9340","August 2010"],["4015","Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone Alone","Phase 3","diabetes","141","March 2010"],["4019","Efficacy and Long-Term Safety of Vildagliptin as Monotherapy in Patients With Type 2 Diabetes","Phase 2 / Phase 3","diabetes","338","November 2008"],["4024","Out-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Metformin Only","Phase 2","diabetes","361","April 2007"],["4043","Effect of Albiglutide When Added to Standard Blood Glucose Lowering Therapies on Major Cardiovascular Events in Subjects With Type 2 Diabetes Mellitus","Phase 4","diabetes","9400","July 2015"],["4048","Non-inferiority Study to Compare the Efficacy and Safety of Mylan&apos;s Insulin Glargine With Lantus&#174; in Type 2 Diabetes Mellitus Patients (INSTRIDE 2)","Phase 3","diabetes","600","August 2014"],["4070","Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE&#8482; - Diabetes","Phase 3","diabetes","846","June 2011"],["4073","Efficacy and Safety of Linagliptin (BI 1356) in Black/African Americans With Type 2 Diabetes With a MTT Sub-study","Phase 3","diabetes","234","September 2010"],["4075","Does Saxagliptin Reduce the Risk of Cardiovascular Events When Used Alone or Added to Other Diabetes Medications","Phase 4","diabetes","18206","May 2010"],["4123","Non-inferiority Study to Compare the Efficacy and Safety of Mylan&apos;s Insulin Glargine With Lantus&#174; in Type 1 Diabetes Mellitus Patients (INSTRIDE 1)","Phase 3","diabetes","500","August 2014"],["4133","Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes","Phase 3","diabetes","736","January 2014"],["4134","Efficacy and Safety of Insulin Glargine/ Lixisenatide Fixed Ratio Combination Compared to Insulin Glargine Alone and Lixisenatide Alone on Top of Metformin in Patients With T2DM","Phase 3","diabetes","1170","February 2014"],["4144","Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 Diabetes","Phase 3","diabetes","3297","February 2013"],["4150","Efficacy and Safety of Azilsartan Medoxomil Used in Combination With Metformin in Participants With Hypertension and Diabetes","Phase 3","diabetes","105","January 2012"],["4170","Safety and Efficacy of XOMA 052 in Subjects With Type 2 Diabetes Mellitus on Stable Metformin Monotherapy","Phase 2","diabetes","421","January 2010"],["4173","A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease","Phase 3","diabetes","2118","January 2010"],["4199","A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Thiazolidinedione or a Combination of Both.","Phase 3","diabetes","1189","July 2008"],["4228","Rosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On Insulin","Phase 4","diabetes","630","September 2002"],["4230","Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes Mellitus","Phase 3","diabetes","493","February 2006"],["4307","Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Older Patients With Type2 Diabetes Insufficiently Controlled on Their Current Antidiabetic Medications","Phase 3","diabetes","1014","January 2015"],["4312","24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension","Phase 3","diabetes","154","July 2014"],["4317","Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-na&#239;ve Subjects With Type 2 Diabetes","Phase 3","diabetes","1082","August 2014"],["4337","Comparison Study of the Glycemic Effects Safety and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes Mellitus","Phase 3","diabetes","365","February 2013"],["4350","Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes","Phase 3","diabetes","2454","January 2012"],["4358","Study to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and Diabetes","Phase 4","diabetes","975","May 2011"],["4373","A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment.","Phase 3","diabetes","507","May 2010"],["4376","A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus","Phase 3","diabetes","7226","February 2010"],["4379","Efficacy and Safety of BI 10773 in Combination With Insulin in Patients With Type 2 Diabetes","Phase 2","diabetes","494","November 2009"],["4381","Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus","Phase 2","diabetes","426","December 2009"],["4383","A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine","Phase 3","diabetes","586","September 2009"],["4384","Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Pioglitazone","Phase 3","diabetes","252","August 2009"],["4387","Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Glimepiride With or Without Metformin","Phase 3","diabetes","677","July 2009"],["4440","Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 Diabetes","Phase 3","diabetes","560","November 2006"],["4452","Efficacy and Safety Study of Alogliptin and Insulin in the Treatment of Type 2 Diabetes.","Phase 3","diabetes","390","February 2006"],["4453","The DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Patients With Type 2 Diabetes (IOOV)","Phase 4","diabetes","2091","December 2005"],["4475","Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes","Phase 3","diabetes","1440","August 2005"],["4489","Effect Of Carvedilol Versus Metoprolol On Glycemic Control In Patients With Type II Diabetes And Hypertension","Phase 4","diabetes","501","June 2001"],["4495","Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a Sulfonylurea","Phase 3","diabetes","377","February 2002"],["4496","Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With Metformin","Phase 3","diabetes","336","March 2002"],["4544","Extension Study to Assess Safety and Efficacy of Mylan&apos;s Insulin Glargine and Lantus&#174; in Type 1 Diabetes Mellitus Patients","Phase 3","diabetes","138","December 2015"],["4550","Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes","Phase 3","diabetes","1860","February 2016"],["4598","Cardiovascular Outcomes Following Ertugliflozin Treatment in Type 2 Diabetes Mellitus Participants With Vascular Disease The VERTIS CV Study (MK-8835-004)","Phase 3","diabetes","8000","November 2013"],["4610","TAK-875 (Fasiglifam) in Combination With Sitagliptin in Adults With Type 2 Diabetes","Phase 3","diabetes","90","May 2013"],["4617","A Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Nephropathy","Phase 2","diabetes","226","December 2012"],["4626","A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone","Phase 3","diabetes","442","June 2012"],["4627","Comparison of Fasiglifam (TAK-875) to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes","Phase 3","diabetes","916","April 2012"],["4631","Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Basal Insulin With Oral Antidiabetic Therapy","Phase 3","diabetes","811","December 2011"],["4636","Comparison of TAK-875 (Fasiglifam) With Placebo in Participants With Type 2 Diabetes","Phase 3","diabetes","421","November 2011"]]},"dateCreated":"2016-12-06T17:31:08+0000","status":"READY","errorMessage":"","progressUpdateIntervalMs":500,"$$hashKey":"object:2232"},{"title":"Generate Data-Driven Topics","text":"%pyspark\n\nimport re\nfrom pyspark.mllib.linalg import SparseVector\nfrom collections import Counter\nfrom pyspark.mllib.clustering import LDA, LDAModel\nfrom pyspark.mllib.linalg import Vectors\n\n\nnumber_clusters = 10\n\n\nrawdata = sc.textFile(\"/clinicaltrials.txt\")\nheader  = rawdata.take(1)\ncorpus  = rawdata.filter(lambda x: x not in header)      \\\n        .map(lambda x: x.split('|')[2])\n\ndef cleanup_text(text):\n    words = text.split(' ')\n    \n    stopwords_core = ['a', u'about', u'above', u'after', u'again', u'against', u'ain', u'all', u'am', u'an', u'and', u'any', u'are', u'aren', u'as', u'at', u'be', u'because', u'been', u'before', u'being', u'below', u'between', u'both', u'but', u'by', u'can', 'come', u'could', u'd', u'did', u'didn', u'do', u'does', u'doesn', u'doing', u'don', u'down', u'during', u'each', u'few', u'for', u'from', u'further', u'had', u'hadn', u'has', u'hasn', u'have', u'haven', u'having', u'he', u'her', u'here', u'hers', u'herself', u'him', u'himself', u'his', u'how', u'i', u'if', u'in', u'into', u'is', u'isn', u'it', u'its', u'itself', u'just', u'll', u'm', u'ma', u'me', u'mightn', u'more', u'most', u'mustn', u'my', u'myself', u'needn', u'no', u'nor', u'not', u'now', u'o', u'of', u'off', u'on', u'once', u'only', u'or', u'other', u'our', u'ours', u'ourselves', u'out', u'over', u'own', u're', u's', 'said', u'same', u'shan', u'she', u'should', u'shouldn', u'so', u'some', u'such', u't', u'than', u'that', u'the', u'their', u'theirs', u'them', u'themselves', u'then', u'there', u'these', u'they', u'this', u'those', u'through', u'to', u'too', u'under', u'until', u'up', u've', u'very', u'was', u'wasn', u'we', u'were', u'weren', u'what', u'when', u'where', u'which', u'while', u'who', u'whom', u'why', u'will', u'with', u'won', u'would', u'y', u'you', u'your', u'yours', u'yourself', u'yourselves']\n    \n    stopwords_custom = ['study','subjects','patients','patient','treating','phase']\n    stopwords = stopwords_core + stopwords_custom\n    stopwords = [word.lower() for word in stopwords]    \n    \n    text_out = [word.lower() for word in words if len(word)>2 and word.lower() not in stopwords]\n    text_out = [re.sub('[^a-zA-Z0-9]','',word) for word in text_out]\n    \n    return text_out\n\ntokenized_corpus = corpus.map(cleanup_text).cache()\n\n'''\ntokenized_corpus = corpus                   \\\n    .map(lambda raw_text: raw_text.split()) \\\n    .cache()\n'''\n\nlocal_vocab_map = tokenized_corpus  \\\n    .flatMap(lambda token: token)   \\\n    .distinct()                     \\\n    .zipWithIndex()\n\nlocal_vocab_map1 = local_vocab_map.collectAsMap()\nvocab_map_vk = sc.broadcast(local_vocab_map1)\nvocab_size = sc.broadcast(len(local_vocab_map1))\n\nlocal_vocab_map2 = local_vocab_map.map(lambda x: (x[1],x[0])).collectAsMap()\nvocab_map_kv = sc.broadcast(local_vocab_map2)\n\nterm_document_matix = tokenized_corpus  \\\n    .map(Counter)                       \\\n    .map(lambda counts: {vocab_map_vk.value[token]: float(counts[token]) for token in counts}) \\\n    .map(lambda index_counts: SparseVector(vocab_size.value, index_counts))                 \\\n    .zipWithIndex().map(lambda x: [x[1], x[0]]).cache()\n\n# Cluster the documents into three topics using LDA\nldaModel = LDA.train(term_document_matix, k=number_clusters)\n\n#ZEND\n","dateUpdated":"2016-12-06T17:59:24+0000","config":{"colWidth":12,"editorMode":"ace/mode/scala","graph":{"mode":"table","height":300,"optionOpen":false,"keys":[],"values":[],"groups":[],"scatter":{}},"enabled":true,"title":true,"editorHide":true},"settings":{"params":{},"forms":{}},"jobName":"paragraph_1481045468687_-708084078","id":"20161206-041957_297102799","result":{"code":"SUCCESS","type":"TEXT","msg":""},"dateCreated":"2016-12-06T17:31:08+0000","dateStarted":"2016-12-06T17:58:51+0000","dateFinished":"2016-12-06T17:58:56+0000","status":"FINISHED","progressUpdateIntervalMs":500,"$$hashKey":"object:3496"},{"title":"View Data-Driven Topics","text":"%pyspark\n\n# Output topics. Each is a distribution over words (matching word count vectors)\nprint(\"Learned topics (as distributions over vocab of \" + str(ldaModel.vocabSize())\n      + \" words):\")\n\ntopics = ldaModel.topicsMatrix()\nfor topic in range(number_clusters):\n    print(\"Topic \" + str(topic) + \":\")\n    words = []\n    for word in range(0, ldaModel.vocabSize()):\n        #print(\" \" + str(topics[word][topic])) + \"\\t\" + str(vocab_map_kv.value[word])\n        words.append([topics[word][topic], vocab_map_kv.value[word]])\n    \n    words_sorted = sorted(words, key=lambda t: (-t[0]))\n    #print words_sorted\n    \n    for i,topic_term in enumerate(words_sorted):\n        if i >= 75 and i < 85:\n            print \"  \" + str(\"%.6f\" % topic_term[0]) + \"\\t\" + str(topic_term[1])","dateUpdated":"2016-12-06T18:03:24+0000","config":{"colWidth":12,"graph":{"mode":"table","height":300,"optionOpen":false,"keys":[],"values":[],"groups":[],"scatter":{}},"enabled":true,"editorMode":"ace/mode/scala","title":true,"editorHide":true},"settings":{"params":{},"forms":{}},"jobName":"paragraph_1481045841809_-1293918735","id":"20161206-173721_1351309027","result":{"code":"SUCCESS","type":"TEXT","msg":"Learned topics (as distributions over vocab of 7870 words):\nTopic 0:\n  6.304594\theart\n  6.226185\thydrochloride\n  6.163358\tprogram\n  6.078709\tknee\n  5.984660\tkidney\n  5.894076\tmanagement\n  5.826010\ttumor\n  5.816441\thigh\n  5.808425\tmoderate\n  5.707562\tpaclitaxel\nTopic 1:\n  6.373363\tpharmacokinetics\n  6.358827\tmanagement\n  6.298370\tkidney\n  6.285788\tsolid\n  6.245693\tplus\n  6.149076\thealth\n  5.935797\tpulmonary\n  5.932550\tmultiple\n  5.887823\tcomparing\n  5.887771\teffectiveness\nTopic 2:\n  6.251285\tuse\n  6.248034\tplacebo\n  6.201799\tdisorder\n  6.074553\tsolid\n  6.016809\tearly\n  5.975371\tmanagement\n  5.951690\tmultiple\n  5.900425\tevaluating\n  5.890669\tcompared\n  5.847030\tassess\nTopic 3:\n  6.262669\thydrochloride\n  6.249228\tsystem\n  6.162220\tresponse\n  6.104536\tolder\n  6.064227\tmultiple\n  6.050795\tearly\n  6.027625\tmalignant\n  5.994554\tprogram\n  5.911816\tuse\n  5.848738\ttraining\nTopic 4:\n  6.320228\tolder\n  6.211035\tearly\n  6.079547\tregistry\n  6.030681\tsolid\n  5.955124\tpulmonary\n  5.946704\teffectiveness\n  5.800107\trelapsed\n  5.748835\thydrochloride\n  5.655096\thigh\n  5.618511\tmoderate\nTopic 5:\n  6.267103\tmanagement\n  6.254530\tundergoing\n  6.137191\tprimary\n  6.120598\tweight\n  6.039521\tfunction\n  6.012514\ttumor\n  6.010863\tmoderate\n  5.990121\tfollowing\n  5.937172\tearly\n  5.918804\tkidney\nTopic 6:\n  6.519039\tcomparison\n  6.385719\tmoderate\n  6.261899\tpulmonary\n  6.242614\trelapsed\n  6.155664\tcarboplatin\n  6.128112\tpharmacokinetics\n  6.061289\tdisorder\n  6.022689\toral\n  5.998338\tearly\n  5.972468\thydrochloride\nTopic 7:\n  6.113144\tsolid\n  6.029350\tprogram\n  6.010558\tcomparison\n  5.995163\tmalignant\n  5.974876\tmoderate\n  5.913920\tmanagement\n  5.894366\ttreat\n  5.881820\tknee\n  5.865378\thydrochloride\n  5.850293\ttransplant\nTopic 8:\n  6.302778\texercise\n  6.274069\tsevere\n  6.260156\ttumor\n  6.247350\tpulmonary\n  6.236429\tearly\n  6.186834\tmalignant\n  6.182212\tmoderate\n  6.135308\tkidney\n  6.022613\tlocally\n  5.992452\tfunction\nTopic 9:\n  6.158872\tkidney\n  6.147600\tcomparison\n  6.108191\tregistry\n  6.004990\tprogram\n  5.974296\tearly\n  5.786063\tassess\n  5.729231\ttreat\n  5.664833\tuse\n  5.645352\tglioma\n  5.532199\tsolid\n"},"dateCreated":"2016-12-06T17:37:21+0000","dateStarted":"2016-12-06T18:02:10+0000","dateFinished":"2016-12-06T18:02:11+0000","status":"FINISHED","progressUpdateIntervalMs":500,"$$hashKey":"object:3566"},{"text":"%md\n\n<h3>What can we do with these results?</h3>\n<b>Enhance Search:  </b>Categories (and enriched variables) can be fed into SOLR to enhance search\n<b>Predictive Modeling:  </b>Categories, flags, and variables can be fed in to a predictive model (ie. What factors/variables influence what studies make it to Phase 4)\n<b>Unsupervised Learning:  </b>Extract data-driven topics (text mining), used to uncover unknown patterns in textual data (can also be applied to structred data as clustering)\n<b>Send to Hive:  </b>Write to Hive as an enriched table and for use with other operational systems.","dateUpdated":"2016-12-06T17:31:08+0000","config":{"colWidth":12,"editorMode":"ace/mode/markdown","editorHide":true,"graph":{"mode":"table","height":300,"optionOpen":false,"keys":[],"values":[],"groups":[],"scatter":{}},"enabled":true},"settings":{"params":{},"forms":{}},"jobName":"paragraph_1481045468687_-708084078","id":"20161204-203055_2038648891","result":{"code":"SUCCESS","type":"HTML","msg":"<h3>What can we do with these results?</h3>\n<p><b>Enhance Search:  </b>Categories (and enriched variables) can be fed into SOLR to enhance search\n<br  /><b>Predictive Modeling:  </b>Categories, flags, and variables can be fed in to a predictive model (ie. What factors/variables influence what studies make it to Phase 4)\n<br  /><b>Unsupervised Learning:  </b>Extract data-driven topics (text mining), used to uncover unknown patterns in textual data (can also be applied to structred data as clustering)\n<br  /><b>Send to Hive:  </b>Write to Hive as an enriched table and for use with other operational systems.</p>\n"},"dateCreated":"2016-12-06T17:31:08+0000","status":"READY","errorMessage":"","progressUpdateIntervalMs":500,"$$hashKey":"object:2233","focus":true},{"config":{"colWidth":6,"graph":{"mode":"table","height":300,"optionOpen":false,"keys":[],"values":[],"groups":[],"scatter":{}},"enabled":true,"editorMode":"ace/mode/scala","title":true},"settings":{"params":{},"forms":{}},"jobName":"paragraph_1481047171427_-151111642","id":"20161206-175931_610818410","dateCreated":"2016-12-06T17:59:31+0000","status":"READY","progressUpdateIntervalMs":500,"focus":true,"$$hashKey":"object:3338","dateUpdated":"2016-12-06T18:05:59+0000","title":"PySpark (Read from Hive)","text":"%pyspark\n\nfrom pyspark.sql import HiveContext\nhive_context = HiveContext(sc)\n\nmyTableTable = hive_context.table(\"default.sample_07\")\nmyTableTable.show(10)\n\n'''\n+-------+--------------------+---------+------+\n|   code|         description|total_emp|salary|\n+-------+--------------------+---------+------+\n|00-0000|     All Occupations|134354250| 40690|\n|11-0000|Management occupa...|  6003930| 96150|\n|11-1011|    Chief executives|   299160|151370|\n|11-1021|General and opera...|  1655410|103780|\n|11-1031|         Legislators|    61110| 33880|\n|11-2011|Advertising and p...|    36300| 91100|\n|11-2021|  Marketing managers|   165240|113400|\n|11-2022|      Sales managers|   322170|106790|\n|11-2031|Public relations ...|    47210| 97170|\n|11-3011|Administrative se...|   239360| 76370|\n+-------+--------------------+---------+------+\n'''"},{"config":{"colWidth":6,"graph":{"mode":"table","height":86,"optionOpen":false,"keys":[],"values":[],"groups":[],"scatter":{}},"enabled":true,"editorMode":"ace/mode/scala","title":true},"settings":{"params":{},"forms":{}},"jobName":"paragraph_1481047549725_1981483112","id":"20161206-180549_1496866754","dateCreated":"2016-12-06T18:05:49+0000","status":"READY","progressUpdateIntervalMs":500,"focus":true,"$$hashKey":"object:3688","dateUpdated":"2016-12-06T18:07:41+0000","title":"PySpark (Write to Hive)","text":"%pyspark\n\n# To save as Hive ORC\ndf.write.saveAsTable(\"table_from_spark_orc\", format=\"orc\", mode=\"overwrite\")\n"},{"config":{"colWidth":6,"graph":{"mode":"table","height":300,"optionOpen":false,"keys":[],"values":[],"groups":[],"scatter":{}},"enabled":true,"editorMode":"ace/mode/scala","title":true},"settings":{"params":{},"forms":{}},"jobName":"paragraph_1481047581213_-1740547099","id":"20161206-180621_288913676","dateCreated":"2016-12-06T18:06:21+0000","status":"READY","progressUpdateIntervalMs":500,"focus":true,"$$hashKey":"object:3764","dateUpdated":"2016-12-06T18:07:28+0000","title":"Execute Hive Commands - List Hive Tables","text":"%hive\n\nshow tables\n\nselect * from default.sample_07 limit 10"}],"name":"ClinicalAnalysis","id":"2C5BBGXKF","angularObjects":{"2C35SAQUV:shared_process":[],"2C1SVJQKC:shared_process":[],"2BZCYSBP1:shared_process":[],"2C3QWZMH9:shared_process":[],"2C2VCMDMA:shared_process":[],"2C2DNH7EH:shared_process":[],"2C2J776HS:shared_process":[],"2C24HD65R:shared_process":[],"2C33UV8C1:shared_process":[]},"config":{"looknfeel":"default"},"info":{}}